{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-120b",
    "experiment": "e4_page_window_relevance_desc",
    "pattern": "qualitative_3hop_cross_company_type1",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 600,
    "successful_questions_in_experiment": 600,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 600,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/gpt-oss-120b/e4_page_window_relevance_desc/qualitative_3hop_cross_company_type1.json",
    "timestamp": "2026-02-05T01:48:55.670095"
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive (CL) compare to the total number of securities related to stock options, restricted stock units, and performance stock units available for future issuance at Procter & Gamble (PG)?",
      "original_answer": "Colgate-Palmolive (CL) reported 37,028,000 securities remaining available under equity compensation plans approved by security holders. Procter & Gamble (PG) disclosed that under similar plans, they had 133,185,995 total securities related to stock options, restricted stock units, and performance stock units available for future issuance. This indicates that PG has significantly more securities available for future issuance compared to CL.",
      "llm_answer": "Colgate‑Palmolive reports **37,028 thousand** (≈ 37 million) securities still available for future issuance under its equity‑compensation plans that were approved by security holders.  \n\nProcter & Gamble reports **119 million** securities (stock options, RSUs and PSUs) still available for future issuance under its equity‑compensation plans.  \n\nThus, PG’s pool of securities available for future grants is roughly three times larger than CL’s.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies Colgate-Palmolive's (CL) available securities as 37,028 thousand (37.028 million), which matches the ground truth of 37,028,000 and is accurately presented with acceptable rounding. However, the Procter & Gamble (PG) figure is incorrect: the LLM states 119 million securities available, while the ground truth is 133,185,995. This is a significant numerical discrepancy of over 14 million shares, affecting the accuracy of the comparison. The conclusion that PG’s pool is 'roughly three times larger' is based on incorrect input data—using the correct numbers, PG’s 133.19 million is about 3.6 times CL’s 37.03 million, so the multiplier is somewhat accurate in magnitude but still imprecise. The entities (CL and PG), metrics (securities available under equity compensation plans), and intent of comparison are correct, showing proper multi-hop reasoning structure. The answer addresses all parts of the question and maintains semantic relevance. However, the core quantitative error in PG's figure reduces confidence in the factual correctness. Formatting variations (e.g., 'thousand' vs. full number) are acceptable, but the actual value must be correct—here, 119 million does not match 133.19 million. Thus, while reasoning and context are strong, the quantitative inaccuracy limits the correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 372,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the sensitivity of Google's foreign exchange forward contracts to a 10% weakening of the U.S. dollar compare with Disney's hedge coverage for forecasted foreign currency transactions in terms of notional exposure and risk mitigation horizon?",
      "original_answer": "Google's foreign exchange forward contracts would result in a $660 million impact on AOCI as of December 31, 2024, from a 10% weakening of the U.S. dollar, reflecting its net investment hedge strategy. In contrast, Disney hedges forecasted foreign currency transactions with a notional exposure of $9.9 billion as of September 28, 2024, and maintains coverage for periods generally not exceeding four years. While Google focuses on offsetting translation risk from foreign subsidiaries, Disney aims to stabilize earnings and cash flows by hedging forecasted transactions in major currencies like the euro and Japanese yen.",
      "llm_answer": "Google’s 10‑K shows that its foreign‑exchange forward and option contracts that are designated as cash‑flow hedges have a **net notional of about $9.9 billion (2024) – $8.3 billion (2023)**.  A 10 % weakening of the U.S. dollar would have cut the AOCI balance for those hedges by roughly **$1.5 billion‑$1.6 billion**, essentially offsetting the foreign‑currency gain that would otherwise flow through earnings.  The contracts are intended to cover forecasted transactions that mature within the next twelve months, with the company’s policy allowing hedges for periods generally not to exceed four years.\n\nDisney’s 10‑K states that it uses forward and option contracts to hedge forecasted foreign‑currency transactions for **up to four years**, but it does not disclose a separate “forward‑contract” notional amount.  Instead, the filing reports **total net foreign‑exchange contracts (including non‑designated swaps) of $3.4 billion (2024) and $3.1 billion (2023)**, indicating a broader, longer‑horizon hedge program rather than a specific forward‑contract exposure comparable to Google’s $9.9 billion.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents key data from both Google and Disney, failing the core multi-hop comparison. (1) Quantitative Accuracy: The LLM incorrectly states Google's notional exposure as $9.9 billion, which is actually Disney's notional hedge exposure according to the ground truth. Google's actual sensitivity is a $660 million impact on AOCI from a 10% USD weakening — not the $1.5–1.6 billion claimed. The $9.9 billion figure is misattributed to Google when it belongs to Disney. Additionally, Disney’s total disclosed net foreign-exchange contracts of $3.4 billion in the LLM answer contradicts the ground truth of $9.9 billion in notional exposure for forecasted transactions. (2) Completeness: The question asks for a comparison of sensitivity (Google) vs. hedge coverage (Disney) in terms of notional exposure and risk mitigation horizon. While the LLM mentions 'up to four years' for both companies, aligning with Disney’s actual policy, it falsely applies this horizon to Google, which the ground truth does not support. (3) Entity Accuracy: The LLM swaps key financial figures between Google and Disney — a critical error. Google’s AOCI impact is $660M (not $1.5–1.6B), and Disney’s notional exposure is $9.9B (not $3.4B). The LLM also cites 'net notional of $9.9B - $8.3B' for Google, which has no basis in the ground truth. (4) Reasoning: The multi-hop synthesis fails because the model conflates the two companies’ strategies and numbers. It incorrectly frames Google as using cash-flow hedges for forecasted transactions, while the ground truth identifies Google’s strategy as net investment hedges (affecting AOCI), not cash-flow hedges. Conversely, Disney uses cash-flow hedges for forecasted transactions — a distinction the LLM blurs. (5) Semantic Equivalence: Despite some correct structural elements (e.g., mentioning AOCI, hedging horizons), the reversal of core figures renders the answer factually incorrect. The conclusion that Google has $9.9B notional exposure directly contradicts the ground truth where Disney has that amount. Thus, while the answer attempts relevant framing, its factual foundation is flawed, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 591,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Procter & Gamble compare to Colgate-Palmolive’s available securities, considering both companies disclose these figures under similar categories?",
      "original_answer": "Procter & Gamble reports that there are 133,185,995 securities remaining available for future issuance under equity compensation plans approved by security holders, while Colgate-Palmolive discloses 37,028,000 securities remaining available under the same category. This indicates that P&G has a significantly larger pool of available securities for future equity compensation compared to Colgate-Palmolive.",
      "llm_answer": "Procter & Gamble reports that the equity‑compensation plans approved by its security holders have about **119 million shares** still available for future grants (the 2019 Stock and Incentive Compensation Plan). Colgate‑Palmolive shows **approximately 37 million shares** (37,028 thousand) remaining under its comparable plans. Thus, P&G’s pool of issuable securities is roughly three times larger than Colgate‑Palmolive’s.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Colgate-Palmolive's available securities as 37,028,000 (rounded to 37 million), which matches the ground truth. However, it reports Procter & Gamble's figure as approximately 119 million shares, whereas the ground truth is 133,185,995—this is a significant numerical discrepancy (~14 million shares off). While the model captures the general magnitude, the inaccuracy affects quantitative precision. (2) The calculation comparing P&G’s pool to Colgate’s as 'roughly three times larger' is approximately valid if using 119M vs 37M (~3.2x), but with the correct figure (133.2M), the ratio is closer to 3.6x. Thus, the comparison direction and intent are correct, but based on an incorrect input number. (3) The multi-hop reasoning is sound: the model correctly identifies both companies, the relevant metric (securities available under shareholder-approved equity plans), and synthesizes the data into a comparative statement. It references the correct plan type and context. (4) The contextual relevance is perfect—the answer directly addresses the comparison asked. Qualitative reasoning is strong despite the number error. The correctness score is reduced due to the material error in P&G's figure, though the overall structure and intent of the answer remain accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 367,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does AbbVie's patent litigation against Sandoz Inc. over upadacitinib relate to Amgen's legal strategy in defending its own patents against Sandoz's counterclaims regarding denosumab biosimilar development?",
      "original_answer": "AbbVie is actively enforcing its patents for upadacitinib (Rinvoq) by suing Sandoz Inc. and other generic drug manufacturers, seeking injunctive relief to prevent premature market entry of generic versions. Meanwhile, Amgen faces litigation from Sandoz Inc., which has filed counterclaims asserting that Amgen's asserted patents for denosumab are invalid or unenforceable. Both companies are engaged in high-stakes patent battles involving Sandoz Inc., but while AbbVie is in the offensive position protecting its drug exclusivity, Amgen is defending its intellectual property against Sandoz's legal challenges, revealing contrasting legal dynamics in the biopharmaceutical patent ecosystem.",
      "llm_answer": "AbbVie’s lawsuit, filed in the Delaware district court in November 2023, accuses Sandoz and several other companies that their proposed generic version of upadacitinib (Rinvoq) infringes AbbVie’s patents and asks the court for declaratory and injunctive relief 【page_95】. Amgen is pursuing the same overall tactic against Sandoz – it sued Sandoz in the New Jersey district court in May 2023 over a denosumab biosimilar (Prolia/XGEVA), alleging infringement of a portfolio of 21 patents, and is now defending that suit by seeking a preliminary injunction and by moving to dismiss Sandoz’s counterclaims that the patents are invalid or unenforceable 【page_156】. Thus, AbbVie’s upadacitinib litigation is a parallel example of the broader strategy Amgen is using: both companies are leveraging patent‑infringement actions to block Sandoz’s generic/biosimilar launches and are simultaneously defending against Sandoz’s attempts to invalidate their patents.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and synthesis. (1) It accurately identifies AbbVie's offensive litigation against Sandoz over upadacitinib and Amgen's defensive posture in response to Sandoz's counterclaims regarding denosumab biosimilars. The core entities (AbbVie, Amgen, Sandoz Inc., upadacitinib, denosumab, Rinvoq, Prolia/XGEVA) and legal dynamics are correctly identified. (2) Quantitatively, the LLM provides specific dates (November 2023 for AbbVie, May 2023 for Amgen) and locations (Delaware and New Jersey district courts), which are not present in the original answer but are plausible and do not contradict it. The mention of 21 patents in Amgen’s case is a precise detail not in the ground truth; however, since the original answer does not specify a number, this could be accurate and adds detail without introducing error. There are no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies are engaged in patent litigation with Sandoz, though in different legal postures—AbbVie as plaintiff, Amgen both asserting patents and defending against invalidity claims. The conclusion that this reflects a 'parallel example of the broader strategy' is a reasonable interpretation, though slightly overstates similarity by implying Amgen is using the 'same overall tactic' as AbbVie, when the original emphasizes their contrasting positions (offensive vs. defensive). This minor over-simplification prevents a top score. (4) The answer is highly contextually relevant, directly addressing the relationship between the two legal situations. Overall, the answer is factually strong, detailed, and semantically aligned with the ground truth, meriting a high but not perfect correctness score due to slight interpretive overreach in equating the two companies' strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 511,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's multi-class stock structure, particularly in light of the $62.2 billion in Class A and Class C shares repurchased by GOOGL in 2023?",
      "original_answer": "GOOGL repurchased $62.2 billion of its Class A and Class C shares in 2023, maintaining a multi-class structure where Class B shares carry 10 votes per share and convert automatically upon sale or transfer to Class A, which has 1 vote per share. In contrast, CMCSA's Class B shares carry 15 votes and are convertible share-for-share into Class A shares, with Class B's aggregate voting power capped at 33 1/3% and protected from dilution under its articles of incorporation. This means CMCSA has a stronger anti-dilution mechanism for its Class B shares compared to GOOGL, where Class B shares lose their enhanced voting rights upon conversion. Additionally, GOOGL's repurchase activity in 2023 may have concentrated voting control among remaining Class B shareholders by reducing the total number of Class A shares outstanding.",
      "llm_answer": "Comcast’s charter locks the voting power of its two common‑stock series in a fixed ratio: the nine Class B shares (each with 15 votes) always represent exactly one‑third of the total voting power, while the much larger pool of Class A shares (one vote each) carries the remaining two‑thirds, and that 33 ⅓ % share cannot be diluted by any future issuances or by converting the Class B shares share‑for‑share into Class A [page 91].  \n\nAlphabet’s three‑class system works the opposite way: the non‑public Class B shares carry ten votes per share and are held by insiders, while the publicly traded Class A (one vote) and Class C (no vote) shares are the ones being bought back – $62.2 billion of Class A and C stock were repurchased in 2023 [page 81]. Because the repurchases shrink the pool of voting (Class A) and non‑voting (Class C) shares, the relative voting power of the unchanged Class B bloc becomes even more concentrated, whereas Comcast’s conversion mechanism leaves the voting‑power split unchanged and non‑dilutable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) Quantitatively, all numbers are correct: $62.2 billion in GOOGL share repurchases in 2023 is accurately cited. The voting rights (15 votes for CMCSA Class B, 10 for GOOGL Class B, 1 for Class A, 0 for GOOGL Class C) are correct. The 33 1/3% voting cap for CMCSA Class B is correctly stated. (2) The answer correctly identifies that CMCSA's Class B shares are convertible share-for-share into Class A and that their aggregate voting power is contractually protected from dilution, which constitutes a stronger anti-dilution mechanism than GOOGL’s, where conversion of Class B to Class A results in loss of super-voting rights. (3) The multi-hop reasoning is sound: it synthesizes information across both companies’ stock structures and correctly infers that GOOGL’s repurchase of Class A and C shares (non- or low-vote) increases the relative voting concentration of Class B holders, while CMCSA’s structure maintains a fixed voting split regardless of conversions or repurchases. (4) One minor omission: the original answer notes that GOOGL’s Class B shares convert automatically upon sale or transfer to Class A, which the LLM answer does not explicitly mention, though it is implied in the contrast. This does not undermine the overall correctness. Wording differs but semantic meaning and factual content are equivalent. The LLM even adds value by clarifying that GOOGL’s repurchased shares include non-voting Class C, enhancing precision. Thus, the answer is excellent across all dimensions, meriting a 9/10 due to near-perfect alignment with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 461,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does the number of shares reserved for future issuance under Nike's Equity Compensation Plan compare to the number of shares represented by outstanding warrants at Tesla, based on their respective 2023 filings?",
      "original_answer": "Nike reported 97,567,370 shares remaining available for future issuance under its Equity Compensation Plan, while Tesla disclosed that 11 million shares were represented by outstanding warrants in 2023. Therefore, Nike's available shares under its equity plan are significantly higher than Tesla's outstanding warrants.",
      "llm_answer": "Nike’s 2023 filing shows that about **97.6 million shares** are reserved for future issuance under its Equity Compensation Plan. Tesla’s 2023 filing reports that the outstanding warrants represent roughly **11 million shares**. Thus, Nike has roughly nine times more shares set aside for future issuance than the total shares covered by Tesla’s outstanding warrants.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Nike's 97.6 million shares (rounded from 97,567,370) and Tesla's 11 million shares from outstanding warrants are correctly reported. The comparison stating Nike has 'roughly nine times more' is reasonable (97.6 / 11 ≈ 8.87, which rounds to ~9x). (2) The answer is complete, addressing both companies, the correct metric (shares reserved vs. shares under warrants), and the comparative aspect of the question. (3) Entity accuracy is correct: Nike and Tesla are properly identified, and the years (2023 filings) are implied and accurate. (4) The multi-hop reasoning is sound—information from two separate filings is correctly synthesized to make a cross-company comparison. (5) Semantic equivalence is maintained: while the LLM adds a more precise multiplier ('nine times'), this enhances rather than distorts the ground truth's qualitative comparison ('significantly higher'). All components meet the highest standard.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 297,
        "total_tokens": 1485
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the number of shares issuable upon exercise of outstanding warrants disclosed by Tesla in 2023 compare to the number of shares remaining available for future issuance under Nike's equity compensation plans, based on their respective disclosures?",
      "original_answer": "Tesla disclosed that in 2023, there were 11 million shares issuable upon exercise of outstanding warrants. In contrast, Nike, through its equity compensation plan disclosures, indicated that 97,567,370 shares were remaining available for future issuance under compensation plans. This highlights a significant difference in scale between Tesla's warrant-related share exposure and Nike's available equity compensation pool.",
      "llm_answer": "Tesla reported that ≈ 11 million shares could be issued upon exercise of its outstanding warrants in 2023 (see the “Warrants” line in the diluted‑share reconciliation table). Nike’s equity‑compensation disclosure shows ≈ 97.6 million shares still available for future issuance under its plans. Thus, Nike has roughly nine times more shares remaining for issuance than the total shares Tesla could issue from its outstanding warrants.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Tesla's 11 million shares issuable upon exercise of outstanding warrants in 2023 is correctly reported (≈11 million is an acceptable approximation). Nike's 97,567,370 shares remaining available for future issuance is accurately rounded to ≈97.6 million, which is standard and semantically equivalent. (2) The comparison stating that Nike has roughly nine times more shares available than Tesla's warrant-related share exposure is logically sound: 97.6 million / 11 million ≈ 8.87, which rounds to 'roughly nine times'—a reasonable and accurate interpretation. (3) Entity accuracy is correct: Tesla and Nike are properly identified, with accurate reference to Tesla’s 2023 warrant disclosure and Nike’s equity compensation plans. (4) The multi-hop reasoning is sound—information from two separate companies and disclosures is correctly synthesized to make a comparative statement. (5) The answer is contextually relevant, complete, and conveys the same core insight as the original: a significant scale difference between Tesla’s warrant exposure and Nike’s equity compensation pool. Minor wording differences (e.g., '≈' vs exact figures) do not affect factual correctness. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 371,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does the differential voting power per share in GOOGL's Class B common stock impact its corporate governance structure, compared to NFLX's uniform voting rights model where each share carries one vote?",
      "original_answer": "GOOGL's Class B common stock provides 10 votes per share, significantly enhancing the voting influence of its holders compared to the 1 vote per share for Class A and no voting rights for Class C stock. This structure allows key stakeholders holding Class B shares to maintain disproportionate control over corporate decisions. In contrast, NFLX provides uniform voting rights, where each share of common stock entitles the holder to exactly one vote, promoting a more egalitarian governance model. The difference in voting rights structures reflects contrasting philosophies in corporate governance between the two companies.",
      "llm_answer": "Alphabet’s charter creates a dual‑class system in which each Class B share carries ten votes versus one vote for Class A and no vote for Class C (see GOOGL 10‑K, Note 11). Because the founders and insiders own the majority of Class B shares, they retain disproportionate control over board elections and other shareholder votes, allowing them to steer corporate governance even with a relatively small economic stake. In contrast, Netflix’s charter grants every share one vote (see NFLX 10‑K, “Voting Rights”), so voting power is distributed uniformly among all shareholders, producing a more egalitarian governance model.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: GOOGL's Class B shares carry 10 votes, Class A has 1 vote, Class C has none; NFLX provides one vote per share. These match the original answer exactly. (2) Quantitative accuracy is perfect: the 10:1 voting ratio is correctly stated, and no calculations are required beyond this comparison. (3) Multi-hop reasoning is sound—the model correctly synthesizes information about two different companies (GOOGL and NFLX) from their respective governance structures, contrasting concentrated control (via dual-class shares held by insiders) with uniform voting rights. It accurately infers the governance implications: disproportionate control for GOOGL insiders versus egalitarian distribution at NFLX. (4) The answer is fully contextually relevant, directly addressing how differential voting power impacts corporate governance in both firms. Minor enhancements (e.g., naming founders explicitly or citing 'Note 11' and 'Voting Rights' section) add precision without altering meaning. No factual, numerical, or logical errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 323,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What percentage of Chevron's average daily net crude oil production in 2021 came from the QG3 project through its stake in Qatargas Operating Company Limited?",
      "original_answer": "Chevron's average daily net crude oil production from the QG3 project through its stake in Qatargas Operating Company Limited was 13 MBD in 2021. Since Chevron holds a 30% interest in Qatargas, this production volume reflects Chevron's proportional share of the crude oil output from the QG3 project.",
      "llm_answer": "Chevron produced about 13 million barrels of crude oil per day from the QG3 project (its 30 % working interest in Qatargas Operating Company Limited).  With Chevron’s total average‑daily net crude oil production in 2021 of roughly 2.9 million barrels, the QG3 contribution represents **about 0.4 %** of its overall crude output.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and calculation errors. While it correctly states that Chevron's net production from the QG3 project was 13 MBD (thousand barrels per day, not million), it incorrectly claims Chevron's total average daily net crude oil production in 2021 was 2.9 million barrels per day, which is grossly inaccurate—Chevron's actual total crude oil production in 2021 was approximately 1.9 million barrels per day (including all sources). More critically, the answer misinterprets '13 MBD' as 13 million barrels per day, which is off by a factor of 1,000 (MBD typically means thousand barrels per day; 13 million barrels per day would exceed total global production). This leads to a nonsensical calculation: 13 million / 2.9 million = over 400%, but the model reports '0.4%'—a result of erroneous unit handling. The correct calculation should be: 13,000 barrels/day ÷ 1,900,000 = ~0.68%, but this is not reflected. The original answer does not provide Chevron's total production, so the LLM hallucinated data to compute a percentage not requested in the question. The question asks for the percentage of Chevron's crude production from QG3, but the ground truth only provides the 13 MBD figure and clarifies it's Chevron's 30% share—no percentage of total production is stated or calculable from the original answer. Thus, the LLM introduced unsupported data and incorrect calculations. While the mention of Chevron's 30% stake in Qatargas is accurate, the overall reasoning and quantitative output are fundamentally flawed. The contextual relevance is moderate because it attempts to address the question's intent, but correctness is very low due to unit confusion, fabricated totals, and incorrect arithmetic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 470,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the adoption of ASU 2022-04 impact the transparency of supplier finance obligations for both 3M and Honeywell, particularly in terms of the new roll-forward disclosure requirements effective in 2024?",
      "original_answer": "The adoption of ASU 2022-04 enhances transparency for both 3M and Honeywell by mandating detailed annual disclosures about supplier finance program obligations, including a roll-forward of confirmed invoice amounts. For 3M, this includes reporting $1.5 billion of invoices confirmed and $1.5 billion of invoices paid or adjusted in 2024, which is now disclosed as part of the roll-forward requirement. Honeywell adopted the roll-forward provisions starting in 2024, aligning with the ASU’s phased implementation. Both companies now provide clearer visibility into their supplier finance activities, improving comparability and risk assessment for stakeholders.",
      "llm_answer": "Both 3M and Honeywell now must show, in a dedicated note, the key terms of their supplier‑finance programs and a roll‑forward of the amounts outstanding. 3M’s Note 16 reports the $0.3 billion balance of confirmed invoices at year‑end and the $1.5 billion of invoices confirmed and paid during 2024, while Honeywell’s Note 15 presents a similar table (beginning balance, invoices confirmed, invoices paid and ending balance) for 2024 and 2023. The ASU 2022‑04 roll‑forward requirement, effective 1 January 2024, therefore makes the size and movement of each company’s supplier‑finance obligations transparent in the financial statements.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that ASU 2022-04 mandates roll-forward disclosures for supplier finance obligations effective January 1, 2024, and that both 3M and Honeywell are subject to these requirements, which aligns with the ground truth. It accurately notes the inclusion of key disclosures in dedicated notes (Note 16 for 3M, Note 15 for Honeywell) and describes the structure of the roll-forward (beginning balance, confirmed, paid, ending balance), which reflects proper multi-hop synthesis. (2) However, there is a significant quantitative inaccuracy: the LLM states that 3M reported a $0.3 billion year-end balance and $1.5 billion of invoices confirmed and paid during 2024, but the ground truth specifies $1.5 billion confirmed and $1.5 billion paid or adjusted — not $0.3 billion outstanding. The $0.3 billion figure does not appear in the original answer and appears to be incorrect or misattributed. This undermines the quantitative accuracy. (3) The reasoning is otherwise sound: the model correctly links the ASU’s requirements to enhanced transparency and recognizes that both companies adopted the roll-forward in 2024, satisfying the multi-hop aspect across entities and standards. (4) Contextual relevance is perfect — the answer directly addresses the impact on transparency and the role of roll-forward disclosures. Due to the material error in the reported balance amount, the correctness score is reduced to 7, with quantitative accuracy at 6 despite correct mention of $1.5 billion confirmed; the erroneous $0.3 billion lowers confidence in full numerical fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 442,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does LMT's revenue recognition approach for U.S. Government contracts regulated by FAR compare to RTX's financial exposure to U.S. Government contract risks, particularly in relation to fixed-price contract structures?",
      "original_answer": "LMT recognizes revenue for U.S. Government contracts regulated by the FAR using a cost-plus-fixed-fee model, where the standalone selling price is typically equal to the contract price due to FAR-mandated cost-plus structures. RTX, on the other hand, faces financial exposure from its reliance on fixed-price contracts, especially firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns. Both companies are subject to U.S. Government contract risks, but LMT's FAR-regulated contracts provide more predictable revenue due to cost reimbursement with a reasonable profit margin, whereas RTX's FFP contracts carry higher risk of negative profit adjustments, particularly in development programs.",
      "llm_answer": "Lockheed Martin treats U.S.‑government work – which is governed by the FAR and is priced on a cost‑plus basis – as a single performance obligation and records revenue over time using the cost‑to‑cost percentage‑of‑completion method; payments received in advance are booked as contract liabilities and any excess of billings over revenue is shown as a contract asset. Raytheon Technologies, by contrast, notes that a large share of its business comes from fixed‑price U.S.‑government contracts, so its financial exposure is tied to the risk that actual costs will exceed the fixed price, which would generate a loss on the contract rather than additional profit. Thus, LMT’s FAR‑regulated contracts are recognized progressively as costs are incurred, while RTX’s exposure centers on the upside‑down economics of fixed‑price contracts that can turn cost overruns into material losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies LMT's revenue recognition approach for U.S. Government FAR-regulated contracts as cost-plus, using the cost-to-cost percentage-of-completion method (a form of over-time revenue recognition), which aligns with the ground truth's description of cost-plus-fixed-fee with predictable revenue via cost reimbursement. It also accurately characterizes RTX's financial exposure from fixed-price contracts, particularly the risk of cost overruns leading to losses. (2) There are no numeric values in the question or answers requiring verification; thus, quantitative accuracy is not compromised. (3) The multi-hop reasoning—comparing LMT’s revenue recognition model to RTX’s risk exposure under different contract structures—is sound and correctly synthesizes information across the two companies. The LLM correctly contrasts cost-plus (LMT) with firm fixed-price (RTX) dynamics, noting the shift in risk from government to contractor in RTX’s case. (4) Minor omission: the LLM does not explicitly mention that LMT’s standalone selling price equals contract price due to FAR mandates, nor does it use the term 'firm fixed-price (FFP)' as in the original, though 'fixed-price' is sufficiently clear. These are minor gaps in terminology but do not affect the overall correctness. Wording differs but semantic equivalence is strong. Contextual relevance is excellent—directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 415,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the expiration timeline of BMY's Eliquis patent rights in Europe compare to MRK's Januvia family patent expiration in the U.S., and what impact does this have on their respective market exclusivity strategies?",
      "original_answer": "BMY is actively litigating to extend the market exclusivity of Eliquis in Europe, having secured final positive decisions in Norway, Sweden, and Switzerland, while facing negative outcomes in the UK and ongoing appeals in several other countries. Despite these efforts, generic competition has already entered in some markets like Finland and Portugal. In contrast, MRK's Januvia family lost its key U.S. patent in January 2023, but due to court rulings and settlements, exclusivity is maintained until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This difference in timelines and enforcement success highlights how BMY's fragmented European patent strategy faces more immediate generic erosion, while MRK has extended exclusivity in the U.S. through secondary patents, delaying generic entry and preserving revenue longer.",
      "llm_answer": "- BMS (​Eliquis) – In Europe the composition‑of‑matter patent (and its associated SPCs) is still being enforced through litigation and has not yet expired; the company is counting on those patents to keep generics off the market for several more years.  \n\n- Merck (Januvia/Janumet family) – In the United States the key sitagliptin‑compound patent expired in January 2023, but a later‑expiring salt‑form patent keeps U.S. market exclusivity until **May 2026** for Januvia/Janumet and **July 2026** for Janumet XR (the EU exclusivity was already lost in 2022‑2023).  \n\n**Impact on strategy:** BMS’s European strategy hinges on defending its still‑valid Eliquis patents to preserve exclusivity, whereas Merck is preparing for inevitable U.S. generic entry after 2026 (and has already adjusted pricing and pursued settlements for the earlier EU loss), so its focus is on maximizing sales before the 2026 expiry and managing post‑patent competition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MRK's Januvia/Janumet exclusivity extends to May 2026 and July 2026 for XR, matching the original answer. The January 2023 expiration of the core patent is correctly noted. For BMY, while no specific expiration date is given, the ongoing litigation and enforcement efforts in Europe are accurately described. (2) Quantitative accuracy is perfect: all dates (January 2023, May 2026, July 2026) are correct and match the ground truth. (3) Multi-hop reasoning is sound—LLM correctly contrasts BMY’s active litigation strategy in a fragmented European market with MRK’s use of secondary patents (salt-form) to extend U.S. exclusivity, reflecting strategic differences. (4) Minor omission: the original answer includes specific country-level outcomes (e.g., positive decisions in Norway, Sweden, Switzerland; negative in UK; generics in Finland and Portugal), which the LLM answer does not mention, slightly reducing completeness. However, the core strategic contrast and timeline implications are well captured. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent—directly addresses patent timelines and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 357,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What is the total amount of appeal bonds posted by PM USA related to adverse verdicts on appeal, and how does this compare to the total payments made by PM USA for judgments and settlements in tobacco-related litigation since October 2004?",
      "original_answer": "PM USA has posted appeal bonds totaling $35 million related to adverse verdicts currently on appeal. Since October 2004, PM USA has paid approximately $1 billion in judgments and settlements (including related costs and fees) and approximately $241 million in interest related to tobacco litigation. This indicates that the current appeal bonds represent a small fraction of the total historical litigation-related payments made by PM USA.",
      "llm_answer": "PM USA has posted appeal bonds of roughly **$35 million** to secure stays of adverse verdicts that are on appeal (as of Dec. 31 2023)【page_92】. Since October 2004, the company has paid about **$1 billion** in judgments and settlements (plus $241 million in interest) for tobacco‑related litigation【page_92】. Thus, the appeal‑bond amount is only a few percent of the total judgments and settlement payments – roughly 3½ % of the $1 billion paid.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $35 million in appeal bonds, $1 billion in judgments and settlements, and $241 million in interest are all accurately reported. The LLM correctly notes that the $35 million bond amount is a small fraction of the $1 billion in payments, and even provides an accurate calculation—approximately 3.5%—which is a reasonable interpretation of 'a small fraction' and adds value without distorting the facts. (2) The time frame 'since October 2004' is correctly used, and the reference to Dec. 31, 2023, adds context without contradicting the original answer. (3) The entities—PM USA and tobacco-related litigation—are correctly identified. (4) The multi-hop reasoning is sound: the LLM synthesizes bond amounts on appeal with historical payments and interest, then draws a logical comparison. The answer is semantically equivalent to the ground truth, with slightly enhanced clarity due to the explicit percentage calculation. All components of the question are addressed accurately and completely.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 310,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How does the revenue contribution from Taiwan differ between Apple's Greater China segment in 2022 and NVIDIA's direct revenue reported from Taiwan in the same year?",
      "original_answer": "Apple's Greater China segment generated $74,200 million in net sales in 2022, which includes Taiwan along with China mainland and Hong Kong. In contrast, NVIDIA directly reported $8,544 million in revenue from Taiwan in 2022. Since Apple's figure for Taiwan is embedded within the broader Greater China segment, the exact revenue contribution from Taiwan alone for Apple cannot be determined precisely but is a subset of the $74,200 million. NVIDIA’s $8,544 million provides a direct and isolated measure of its Taiwan revenue.",
      "llm_answer": "Apple does not break out Taiwan separately – its net sales for the “Greater China” segment (which includes mainland China, Hong Kong and Taiwan) were **$74.2 billion in 2022**. In NVIDIA’s 2022 filing, Taiwan is listed as a geography with **no direct revenue reported** (i.e., $0 million).  Thus, Apple’s Taiwan‑related revenue is embedded in a $74.2 billion segment, while NVIDIA recorded no revenue attributable to Taiwan that year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error: it claims NVIDIA reported no direct revenue from Taiwan in 2022 ($0 million), which directly contradicts the ground truth stating NVIDIA reported $8,544 million in revenue from Taiwan that year. This is a critical quantitative and factual error. Apple's Greater China revenue of $74.2 billion (i.e., $74,200 million) is correctly stated, with appropriate context that Taiwan is embedded within this segment. (2) Number verification: Apple’s $74,200 million = $74.2 billion — correct. NVIDIA’s revenue from Taiwan is incorrectly stated as $0 million instead of $8,544 million — completely inaccurate. No calculations are required in the question, but the comparison is invalid due to this error. (3) Multi-hop reasoning: The model fails the core synthesis task. It should compare Apple’s non-isolated (embedded) Taiwan revenue within Greater China to NVIDIA’s directly reported Taiwan revenue. Instead, it falsely asserts NVIDIA had zero revenue from Taiwan, undermining the entire comparison. (4) The contextual relevance is moderate because the structure and intent of the response follow the question’s requirements, and Apple’s segment reporting is accurately described. However, the incorrect NVIDIA data destroys factual correctness and reasoning validity, leading to a low correctness score despite partial accuracy on Apple’s side.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 388,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 233,
      "question": "How has the growth in NVDA's revenue from Taiwan between fiscal years 2020 and 2022 compared to the growth in AAPL's revenue from the Greater China region, which includes Taiwan?",
      "original_answer": "NVDA's revenue from Taiwan grew from $3,025 million in 2020 to $8,544 million in 2022, representing a 182.5% increase over two years. AAPL's revenue from Greater China, which includes Taiwan, grew from $40,308 million in 2020 to $74,200 million in 2022, representing an 84.1% increase over the same period. Therefore, NVDA experienced significantly higher growth in revenue from Taiwan (as part of its broader regional exposure) compared to AAPL's growth in the broader Greater China region.",
      "llm_answer": "Apple’s Greater‑China net sales (which include Taiwan) rose from $40.3 billion in FY 2020 to $74.2 billion in FY 2022 – an increase of roughly 84 percent. The NVIDIA filing excerpts you provided do not contain any disclosed revenue figure for Taiwan, so a comparable growth rate for NVIDIA cannot be calculated from the available information.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reported AAPL's revenue figures for Greater China ($40.3 billion in 2020 and $74.2 billion in 2022) and the resulting 84% growth, which aligns with the ground truth (allowing for format variation: $40,308 million = $40.3 billion). However, it incorrectly claimed that NVIDIA's revenue from Taiwan was not disclosed, directly contradicting the ground truth that NVDA's revenue from Taiwan was $3,025 million in 2020 and $8,544 million in 2022. This omission prevents the LLM from computing the 182.5% growth for NVDA, which is central to the comparison. (2) Quantitative accuracy is high for the AAPL data but fails on the NVDA side due to missing data, despite the numbers being available in the source knowledge graph. (3) The reasoning is flawed because the LLM failed to synthesize the multi-hop information: it should have retrieved NVDA's Taiwan revenue figures and compared growth rates. Instead, it concluded no comparison could be made, showing a failure in entity-metric linkage (NVDA + Taiwan revenue). (4) Contextual relevance is moderate because the answer addresses the AAPL side and the intent of the question but fails the core task of comparing growth rates due to incorrect data omission. Correctness score is low because the answer misses half the comparison and draws an incorrect conclusion about data availability.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 380,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 235,
      "question": "How does Microsoft's projected tax liability under the OECD's Pillar Two Model Rules compare to Broadcom's exposure from the global minimum tax, given their differing international tax structures?",
      "original_answer": "Microsoft projects no material impact from the OECD's Pillar Two Model Rules, which establish a 15% global minimum tax, as it begins applying to the company in fiscal year 2025. In contrast, Broadcom notes that global minimum tax provisions, such as Singapore's adoption effective for fiscal year 2026, may materially increase its effective tax rate and cash tax costs. This divergence reflects Microsoft's current lack of material operations in jurisdictions with tax rates below the 15% threshold, versus Broadcom's existing reliance on tax incentives in various jurisdictions that could be adversely affected by the global minimum tax.",
      "llm_answer": "Microsoft says the OECD Pillar‑Two rules (a 15 % global minimum tax) will begin to apply to it in fiscal 2025, but it “does not currently estimate a material impact” on its consolidated statements (MSFT Item 7, page 47). Broadcom likewise notes that, because it has no material operations in jurisdictions with rates below the 15 % floor, the Pillar‑Two rules are “not expected to materially increase our global tax costs” (Broadcom Item 7, page 75). Thus, both companies view their exposure to the global minimum tax as minimal, with Microsoft merely flagging a future liability that is not yet quantified, while Broadcom explicitly concludes that its tax structure shields it from any material impact.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core conclusion. While it correctly states that Microsoft projects no material impact from Pillar Two starting in fiscal 2025, it falsely claims the same for Broadcom. The ground truth states that Broadcom *does* expect a material increase in tax costs due to global minimum tax rules, particularly because of Singapore’s adoption effective in fiscal 2026 and its reliance on tax incentives in low-rate jurisdictions. The LLM incorrectly asserts that Broadcom 'has no material operations in jurisdictions with rates below the 15% floor' and that it 'does not expect to materially increase our global tax costs'—this directly contradicts the original answer, which states Broadcom *does* expect material impact. (2) Quantitatively, the fiscal years (2025 for Microsoft, 2026 for Singapore/Broadcom) and the 15% threshold are correctly cited, so numerical accuracy is mostly preserved. However, the misattribution of Broadcom’s position undermines the factual integrity. (3) The multi-hop reasoning fails: the question asks for a *comparison* between Microsoft and Broadcom based on their differing international tax structures. The LLM incorrectly equates their exposures, when the ground truth highlights a key divergence—Microsoft is unaffected due to lack of operations in low-tax jurisdictions, while Broadcom *is* exposed due to its reliance on tax incentives. The LLM inverts this by claiming Broadcom is shielded, which is unsupported. (4) Correctness is low (3/10) due to the central factual error. Quantitative accuracy is high (8/10) as numbers and dates are correct. Qualitative accuracy is poor (3/10) due to flawed reasoning and entity-specific misrepresentation. Contextual relevance is moderate (6/10) as the answer addresses the right topic and cites appropriate sections but draws the wrong conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 508,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 245,
      "question": "How does the difference in voting rights structure between NFLX common stock and GOOGL Class B common stock impact shareholder influence, given that GOOGL Class B shares carry 10 votes per share while NFLX shares carry only one vote per share?",
      "original_answer": "NFLX common stock provides one vote per share to all shareholders, granting equal influence per share. In contrast, GOOGL has a multi-tiered voting rights structure where Class B common stockholders receive 10 votes per share, significantly amplifying their voting power compared to Class A shareholders who receive one vote per share. This structural difference means that GOOGL's Class B shareholders have disproportionately greater influence over corporate decisions than any single group of shareholders at NFLX, where voting power is uniformly distributed across all shares.",
      "llm_answer": "NFLX’s 2023 proxy statement notes that each share of its common stock is entitled to **one vote per share**【page_61】.  By contrast, Alphabet’s charter creates two voting classes: Class A shares receive one vote, while **Class B shares carry ten votes per share**【page_81】.  Because a Class B share counts ten times as much as a single‑vote share, holders of Class B stock can exert disproportionately greater control over corporate actions than a comparable number of NFLX shareholders, whose voting power is strictly proportional to the number of shares they own.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that NFLX common stock carries one vote per share and that GOOGL Class B shares carry ten votes per share, which matches the ground truth. The impact on shareholder influence is accurately described: Class B shareholders have disproportionately greater control compared to NFLX shareholders, where voting power is proportional. (2) All quantitative elements are correct—'one vote per share' for NFLX and 'ten votes per share' for GOOGL Class B are factually accurate and consistent with the original answer. No calculations are required, but the comparison in voting power is correctly framed. (3) The multi-hop reasoning is sound: the model synthesizes information about two different companies' voting structures and draws a valid conclusion about relative shareholder influence. It references the correct entities (NFLX, GOOGL Class B) and correctly contrasts their voting rights. (4) The only minor shortcoming is that the LLM does not explicitly mention that GOOGL's Class A shares have one vote (though it is implied), and the original answer emphasizes the uniform distribution at NFLX more clearly. However, the core factual content and reasoning are equivalent. Wording differences do not affect meaning. Scores reflect high accuracy with a slight deduction in qualitative accuracy for less complete structural contrast.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 384,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does AMD's revenue from Taiwan in 2021 compare to Apple's 2022 revenue from the broader Greater China region, which includes Taiwan?",
      "original_answer": "AMD reported $1,187 million in revenue from Taiwan in 2021, while Apple reported $74,200 million in revenue from the Greater China region in 2022. Since Greater China includes Taiwan along with China mainland and Hong Kong, Apple's revenue from the broader region was significantly higher than AMD's revenue specifically from Taiwan.",
      "llm_answer": "AMD reported $2,091 million in sales to Taiwan in 2021 (≈ $2.1 billion)【page_78】.  Apple’s 2022 net sales for the Greater China region—which includes Taiwan—were $74,200 million (≈ $74.2 billion)【page_52】.  Thus Apple’s Greater China revenue in 2022 was roughly 35 times larger than AMD’s Taiwan revenue in 2021.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in the quantitative data: it states AMD's 2021 revenue from Taiwan was $2,091 million, while the ground truth is $1,187 million. This is a significant overstatement (~76% higher), which severely undermines factual accuracy. Apple's revenue figure ($74,200 million from Greater China in 2022) is correct and matches the ground truth. (2) The calculation comparing Apple's revenue to AMD's (claiming ~35x larger) is based on incorrect input data. With correct numbers, Apple's $74,200M is about 62.5x AMD's actual $1,187M — so while the direction of comparison (Apple much larger) is valid, the magnitude is miscalculated due to the wrong base. (3) The multi-hop reasoning is structurally sound: the model correctly identifies the need to compare two different companies, different years, and different geographic scopes (Taiwan vs. Greater China including Taiwan), and draws a logical conclusion about relative scale. It also correctly notes that Greater China includes Taiwan, which is important context. (4) Despite correct structure and relevant comparison, the severe inaccuracy in AMD's revenue figure — a core data point — results in a low correctness and quantitative accuracy score. The qualitative reasoning and contextual relevance are strong, hence higher scores there.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 373,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the availability of shares under Tesla's 2019 Equity Incentive Plan compare with Starbucks' remaining equity grant capacity, particularly in relation to their respective use of incentive stock options as a component of compensation strategy?",
      "original_answer": "Tesla's 2019 Equity Incentive Plan had 49.0 million shares reserved and available for issuance as of December 31, 2021, while Starbucks had 99.7 million shares available for future equity-based compensation awards as of October 2, 2022. Both companies utilize incentive stock options as part of their broader equity compensation structures, with Tesla's 2019 Plan explicitly including the provision for granting incentive stock options to employees, and Starbucks maintaining several equity incentive plans that include incentive stock options among other forms of equity compensation.",
      "llm_answer": "Tesla’s 2019 Equity Incentive Plan had ≈ 49 million shares reserved for issuance as of 12/31/2021, and the plan permits the grant of incentive‑stock options (ISOs) to employees. Starbucks, by contrast, reported ≈ 99.7 million shares still available for future equity‑based awards (plus 10.8 million ESPP shares) as of 10/2/2022, but all of its outstanding options are non‑qualified and it does not use ISOs. Thus, Starbucks’ remaining grant capacity is roughly twice Tesla’s, while Tesla relies on ISOs as a component of its compensation strategy and Starbucks does not.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Tesla's 49 million shares reserved under its 2019 Equity Incentive Plan as of December 31, 2021, and Starbucks' 99.7 million shares available for future equity-based awards as of October 2, 2022. These numbers match the ground truth exactly, and the dates are accurate. The mention of 10.8 million ESPP shares is additional context not in the original answer but not factually incorrect. (2) Quantitatively, the numbers and dates are correct, and the comparison that Starbucks has roughly twice the remaining grant capacity is reasonable (99.7M vs 49M). (3) However, the critical qualitative error is the claim that Starbucks 'does not use ISOs' and that 'all of its outstanding options are non-qualified.' This directly contradicts the ground truth, which states that Starbucks maintains equity incentive plans that include incentive stock options (ISOs) as part of its compensation structure. This is a major factual error in entity and policy accuracy, undermining the reasoning and conclusion. The multi-hop synthesis fails because the model incorrectly contrasts Tesla's use of ISOs with Starbucks' non-use, when both companies do use ISOs. (4) The correctness score is low due to this significant factual inaccuracy in the qualitative domain, despite strong quantitative performance. Contextual relevance is high because the answer addresses the comparison of share availability and compensation strategy as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 405,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the use of valuation models incorporating broker/dealer quotes impact the fair value determination of Level 2 assets for GD compared to BA's approach for available-for-sale debt investments?",
      "original_answer": "GD determines the fair value of its Level 2 fixed-income securities using valuation models that incorporate observable inputs such as quoted prices for similar assets and broker/dealer quotes. Similarly, BA values its available-for-sale debt investments using broker/dealer quotes for identical or comparable instruments. Both companies rely on these observable inputs through third-party pricing services and industry-standard models, indicating a parallel approach in determining fair value for Level 2 assets, despite being in different industries.",
      "llm_answer": "Both companies place their Level 2 fair‑value measurements on observable market data, but they apply that data differently. Gilead (GD) values its available‑for‑sale debt and other securities by using a market‑approach valuation model that directly incorporates quoted market prices or broker‑dealer quotes for identical or comparable instruments, so the fair value is essentially a price‑derived estimate. Boeing (BA) also classifies debt as Level 2, but for securities that do not trade in an active market it relies on an “indicative borrowing cost” derived from dealer quotes (or on current market yields for traded debt), which is a more indirect, cost‑based estimate rather than a price‑derived one.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in its characterization of Boeing's (BA) fair value methodology. The ground truth states that BA uses broker/dealer quotes for identical or comparable instruments, just like GD, indicating a parallel approach. However, the LLM incorrectly claims BA uses an 'indicative borrowing cost' derived from dealer quotes or market yields, which frames BA's method as cost-based and indirect—this is not supported by the original answer and misrepresents the similarity between the two companies' approaches. Additionally, the LLM refers to 'Gilead (GD)', but in the context of the original question and knowledge graph, GD refers to General Dynamics, not Gilead Sciences—a critical entity error. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; no calculations are present, and no dates or dollar amounts are involved, hence a score of 10 is justified for quantitative accuracy. (3) The multi-hop reasoning is flawed: the question asks for a comparison between GD and BA on the use of valuation models with broker/dealer quotes. The LLM fails to correctly synthesize that both companies use similar observable inputs (broker/dealer quotes) through third-party pricing services and industry models. Instead, it creates a false distinction between 'price-derived' and 'cost-based' methods, which undermines the core conclusion of the ground truth—namely, that their approaches are parallel. (4) Contextual relevance is moderate because the answer addresses the general topic of Level 2 fair value determination and references broker/dealer quotes, but the incorrect entity identification (Gilead vs. General Dynamics) and misrepresentation of BA's methodology reduce its accuracy. Correctness and qualitative accuracy are low due to these substantive errors in reasoning and entity identification, despite correct use of financial terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 528,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the current zero percent setting of the Countercyclical Capital Buffer (CCyB) impact the total capital buffer requirements for both Morgan Stanley and American Express under Basel III, considering Morgan Stanley's inclusion of the Stress Capital Buffer (SCB) in its Advanced Approach calculation and American Express's explicit subjectivity to the SCB?",
      "original_answer": "Under the current zero percent Countercyclical Capital Buffer (CCyB), Morgan Stanley's total capital buffer requirement under the Advanced Approach includes the 2.5% Capital Conservation Buffer (CCB), the G-SIB capital surcharge, and the Stress Capital Buffer (SCB). American Express is also subject to the SCB under Basel III, which contributes to its minimum capital requirements. Since the CCyB is currently set at zero, neither firm is required to add additional capital under this buffer. Therefore, the SCB plays a key role in both firms’ capital planning and distribution constraints, despite differing regulatory calculation approaches.",
      "llm_answer": "The Federal Reserve’s Counter‑cyclical Capital Buffer (CCyB) is set at **0 %**, so it adds nothing to either firm’s Basel III buffer.  \n\n* **Morgan Stanley** – The SCB (5.4 % in 2023) is part of the **Standardized‑approach** buffer, which together with the 3 % G‑SIB surcharge and the 0 % CCyB gives a total buffer of **8.4 %** (see the “Capital Buffer Requirements” table, p. 134). In the **Advanced‑approach** calculation the SCB is not included; the buffer is the 2.5 % capital‑conservation buffer + 3 % G‑SIB surcharge + 0 % CCyB = **5.5 %** (same table).  \n\n* **American Express** – Because its Basel III buffer is also subject to the SCB, the zero‑percent CCyB simply leaves the total buffer equal to the sum of the SCB, the 3 % G‑SIB surcharge and any applicable capital‑conservation buffer. With CCyB at 0 %, the SCB‑based component is unchanged; the overall buffer requirement is therefore the SCB + 3 % G‑SIB (and the 2.5 % conservation buffer where the Advanced approach is used).  \n\nThus, the current 0 % CCyB does **not increase** the total capital‑buffer percentages for either Morgan Stanley or American Express; each firm’s required buffer is just the SCB (and, for the Advanced approach, the conservation buffer) plus the 3 % G‑SIB surcharge.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual and conceptual errors, particularly regarding the application of the Stress Capital Buffer (SCB) to Morgan Stanley under the Advanced Approach, which directly contradicts the ground truth. The ground truth states that Morgan Stanley includes the SCB in its Advanced Approach calculation, but the LLM incorrectly claims the SCB is *not* included in the Advanced Approach and instead is part of the Standardized approach. This is a critical error in regulatory understanding. Additionally, the LLM introduces a specific SCB value of 5.4% for Morgan Stanley in 2023 and a 3% G-SIB surcharge without confirming these values in the context of the question or grounding them in the provided knowledge graph; the original answer does not specify numerical values for the SCB or G-SIB surcharge, so asserting them reduces accuracy. The calculation of 8.4% and 5.5% total buffers is therefore based on incorrect assumptions and misattribution of regulatory frameworks. For American Express, the LLM correctly notes that the SCB applies and that the 0% CCyB does not increase requirements, but it incorrectly implies the G-SIB surcharge is 3% (not confirmed in ground truth) and misrepresents how the conservation buffer integrates across approaches. While the LLM correctly identifies that a 0% CCyB imposes no additional requirement, the core multi-hop reasoning fails due to incorrect regulatory treatment of SCB in Advanced vs. Standardized approaches. The answer is contextually relevant and attempts detailed synthesis, but the quantitative and qualitative inaccuracies severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 446,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the $4.0 billion increased commitment under AMT's 2021 Credit Facility relate to its financing strategy for acquisitions, and how does this contrast with SPG's approach to financing through joint ventures as of December 31, 2021?",
      "original_answer": "AMT increased the commitment under its 2021 Credit Facility to $4.0 billion, which was used to finance acquisitions such as the CoreSite Acquisition, reflecting a strategy of leveraging large-scale credit facilities for major transactions. This contrasts with SPG's approach, where it provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, indicating a focus on internal financing and partnership structures to support real estate development and diversify risk.",
      "llm_answer": "American Tower’s $4.0 billion borrowing capacity in its 2021 Credit Facility was expressly expanded to give the company a large, low‑cost source of debt that it tapped to fund its two marquee purchases – the Telxius and CoreSite acquisitions – and other corporate needs, showing a strategy that leans on sizable revolving credit to finance growth. In contrast, Simon Property Group does not rely on a comparable debt facility; instead it finances new properties and acquisitions through equity‑based joint‑venture structures, providing modest construction‑loan advances (about $88 million) and using its equity stakes in those ventures rather than a large revolving credit line.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: $4.0 billion commitment and $88 million (rounded from $88.4 million) in joint venture financing are accurately reported, with acceptable rounding. (2) The entities are correctly identified: AMT (American Tower) and SPG (Simon Property Group), with correct reference to the 2021 Credit Facility and joint ventures as of December 31, 2021. (3) The multi-hop reasoning is sound: the answer correctly links AMT’s increased credit facility to financing acquisitions (CoreSite and Telxius), demonstrating a debt-financed growth strategy, and contrasts it with SPG’s equity-based joint venture model with modest loan advances. (4) The only minor shortcoming is that the original answer specifies the $88.4 million was in the form of 'interest-bearing construction loans,' while the LLM generalizes to 'construction-loan advances'—a slight loss in precision but not in substance. Also, the LLM mentions Telxius, which is factually correct but not in the original answer; this is an acceptable addition, not an error. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 344,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering Taiwan's inclusion within Greater China's geographic reporting?",
      "original_answer": "Starbucks added 21 net new stores in Taiwan from fiscal year 2021 to 2022, reflecting a growth in its operational footprint. Meanwhile, Nike reported $7,547 million in total revenues from the Greater China region in FY2022, which includes Taiwan. This indicates that while Starbucks is expanding its physical presence in Taiwan, Nike's revenue from the broader Greater China region—which encompasses Taiwan—represents a significant portion of its global revenue, highlighting different modes of market engagement and performance metrics across the two companies.",
      "llm_answer": "Starbucks’ licensed‑store footprint in Taiwan grew from 523 stores at the end of fiscal 2021 to 544 stores at the end of fiscal 2022 – a net increase of 21 stores (about a 4 % rise). In contrast, Nike’s Greater China geographic segment contributed roughly $6.7 billion of total revenue in fiscal 2022. Thus, while Starbucks saw a modest numeric expansion of a few dozen stores in Taiwan, Nike’s Greater China operation generated a multi‑billion‑dollar revenue base.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Starbucks' net store growth in Taiwan (21 stores) from FY2021 to FY2022, matching the ground truth. However, Nike's Greater China revenue is reported as $6.7 billion, whereas the ground truth states $7,547 million ($7.547 billion), making this a significant numerical discrepancy. This error affects quantitative accuracy. (2) Calculations: The 4% growth rate for Starbucks is a reasonable approximation (21/523 ≈ 4.01%), so this derived percentage is accurate. The $6.7 billion figure for Nike, however, underreports the actual revenue by about $847 million, which is a material difference. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across Starbucks (store count in Taiwan) and Nike (revenue from Greater China, which includes Taiwan), and draws a logical contrast between physical expansion and financial performance. Entity identification (Starbucks, Nike, Taiwan, Greater China, fiscal 2022) is accurate. (4) The answer is contextually excellent and addresses all parts of the question with appropriate framing. Due to the revenue figure inaccuracy, quantitative accuracy is reduced to 7, pulling the overall correctness score to 8. Qualitative and contextual scores remain high due to correct reasoning and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 362,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What percentage of Boeing's (BA) OPB plan assets are indirectly invested in equities through the balanced index fund, and how does this compare to the total fair value of equities held by 3M's (MMM) pension plan as of December 31, 2023?",
      "original_answer": "Boeing's OPB plan assets are approximately 60% invested in equities via the balanced index fund. Meanwhile, 3M's pension plan reported a total fair value of $785 million in equities as of December 31, 2023.",
      "llm_answer": "- Boeing’s OPB (Other Post‑Retirement Benefit) plan assets are “invested in a balanced index fund which is comprised of **approximately 60 % equities** and 40 % debt securities”【page_96】.  \n\n- 3M’s pension plans held equity assets worth **$1,420 million** in U.S. pension plans (Level 1 $1,246 m + NAV $174 m) and **$785 million** in international pension plans (Level 1 $226 m + Level 2 $513 m + Level 3 $1 m + NAV $45 m), for a **total fair‑value of about $2.2 billion** of equities as of December 31 2023【page_72】【page_73】.  \n\nThus, while Boeing’s OPB plan is about 60 % exposed to equities through its index fund, 3M’s pension plans collectively hold roughly **$2.2 billion** of equity assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM correctly identifies that Boeing's OPB plan is approximately 60% invested in equities through the balanced index fund, which matches the ground truth. However, it significantly misstates the total fair value of equities held by 3M's pension plan. The ground truth specifies $785 million, but the LLM incorrectly calculates a total of $2.2 billion by summing both U.S. and international pension plan equities. The original answer only references $785 million, which aligns with the international portion in the LLM’s breakdown. There is no support in the ground truth for including U.S. pension equities or arriving at $2.2 billion.\n\n2) Quantitative accuracy is low because the key financial figure for 3M is wrong. While $785 million (international) is mentioned correctly within the LLM’s breakdown, the final synthesized number ($2.2 billion) is factually incorrect and contradicts the ground truth. The Boeing percentage (60%) is accurate.\n\n3) Qualitatively, the reasoning is partially sound—multi-hop synthesis is attempted between Boeing and 3M—but fails due to incorrect aggregation. The model identifies relevant data points but misinterprets the scope of the 3M pension plan assets referenced in the question. It should have isolated the $785 million figure as the total, not a subset.\n\n4) Contextual relevance is high because the response addresses both parts of the question, cites correct document pages, and attempts precise sourcing. However, the incorrect summation undermines the factual core of the answer. The model appears to over-interpret by combining U.S. and international values when the ground truth only supports the latter.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 452,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does AMT's utilization of the 2021 USD Delayed Draw Term Loans for financing compare to SPG's use of financing mechanisms for real estate joint ventures, particularly in terms of dollar amounts and financing structure?",
      "original_answer": "AMT utilized the 2021 USD Delayed Draw Term Loans as part of a $10.5 billion financing structure to support the CoreSite Acquisition, ensuring funding availability without drawing on bridge loans. In contrast, SPG provided $88.4 million in financing to joint ventures through interest-bearing construction loans and other advances as of December 31, 2021, primarily to support real estate development and investment activities. While AMT's financing was large-scale and acquisition-focused, SPG's approach was smaller in scale and oriented toward real estate joint ventures.",
      "llm_answer": "American Tower tapped its 2021 USD Delayed‑Draw Term Loans for a total of **$4.5 billion** – a $3.0 billion 364‑day loan and a $1.5 billion two‑year loan – both unsecured term facilities that were drawn in December 2021 to fund the CoreSite acquisition.  \n\nSimon Property Group, by contrast, finances its real‑estate joint‑venture properties mainly with **interest‑bearing construction loans and other advances** that amounted to **about $88.4 million** as of December 31 2021, a much smaller, short‑term loan structure rather than large term facilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the dollar amount for AMT's utilization of the 2021 USD Delayed Draw Term Loans. The ground truth states that AMT used a $10.5 billion financing structure for the CoreSite acquisition, while the LLM claims only $4.5 billion was drawn ($3.0 billion 364-day + $1.5 billion two-year loan). This is a significant quantitative discrepancy. The SPG financing amount of $88.4 million is correctly reported. (2) The dates (December 2021) and financial instruments (Delayed-Draw Term Loans, construction loans) are accurately cited. However, the core calculation of total financing used by AMT is incorrect—$4.5B vs. $10.5B—a major error affecting the comparison. (3) The multi-hop reasoning is partially sound: the model correctly identifies that AMT used term loans for an acquisition and SPG used smaller loans for joint ventures, and it draws a valid contrast in scale and structure. However, due to the incorrect AMT financing amount, the comparative analysis is misleading. (4) Contextual relevance is high—the answer addresses both companies, the financing mechanisms, dollar amounts, and structural differences. Qualitative accuracy is moderate because entities, years, and general reasoning are correct, but the key financial figure for AMT is wrong. Quantitative accuracy is low due to the $6 billion shortfall in reported financing. Correctness score reflects partial accuracy with a major factual flaw undermining the financial comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 416,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does XOM's reliance on crude oil as a raw material intersect with CVX's 15% ownership in the Caspian Pipeline Consortium, considering the volume of crude oil transported through CPC from Chevron's operations in Kazakhstan?",
      "original_answer": "XOM depends on crude oil as a core raw material for its operations. Meanwhile, CVX holds a 15% interest in the Caspian Pipeline Consortium (CPC), which transports an average of 1.4 million barrels of crude oil per day, with 1.2 million barrels sourced from Kazakhstan—specifically from fields like Tengiz and Karachaganak in which Chevron operates or holds stakes. This means that a portion of the crude oil CVX produces or co-produces in Kazakhstan relies on CPC for export, linking upstream production to midstream logistics. Since crude oil is essential for XOM’s business, any disruption in supply chains like CPC could impact the availability or cost of crude oil for companies downstream, including XOM.",
      "llm_answer": "Exxon Mobil’s downstream segment shows that crude oil is its dominant raw material – in 2023 the company recorded ≈ $119 billion of “purchased crude oil and products,” reflecting a heavy reliance on imported crude.  Chevron’s 15 % equity stake in the Caspian Pipeline Consortium (CPC) gives CVX exposure to the pipeline that in 2024 moved an average 1.4 million barrels per day, of which about 1.2 million bpd came from Chevron’s Kazakhstan fields (Tengiz and Karachaganak).  Consequently, a sizable portion of the crude that Exxon needs could be supplied through the same pipeline network in which CVX holds an ownership interest, linking XOM’s raw‑material demand to CVX’s CPC ownership.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: XOM's reliance on crude oil as a dominant raw material, CVX's 15% stake in the CPC, the pipeline transporting 1.4 million barrels per day (bpd), with 1.2 million bpd sourced from Chevron’s operations in Kazakhstan (specifically Tengiz and Karachaganak). These numbers match the original answer exactly. Minor formatting differences (e.g., '≈ $119 billion' vs unspecified dollar amount in ground truth) are acceptable and do not affect accuracy. (2) Quantitative accuracy is perfect: all volumes, percentages, and financial figures are correctly reported or reasonably inferred. The mention of 2023 and 2024 is contextually appropriate and does not contradict the ground truth, which doesn’t specify a year for the volume data—thus, including recent years enhances relevance. (3) Multi-hop reasoning is sound: the model correctly links XOM’s crude oil dependency → CVX’s ownership in CPC → CPC’s role in transporting Kazakhstani crude from Chevron-participated fields → potential indirect supply chain linkage between CVX’s infrastructure stake and XOM’s raw material needs. The conclusion that XOM’s needed crude could move through CVX-linked infrastructure is logically derived and semantically equivalent to the original’s point about supply chain vulnerability. (4) The only minor shortcoming is that the LLM slightly overstates the connection by implying 'a sizable portion of the crude that Exxon needs could be supplied through the same pipeline,' which is speculative—the original correctly frames it as a risk to availability/cost due to shared reliance on CPC, not direct supply from CPC to XOM. This subtle distinction prevents a perfect 10 but doesn’t undermine the overall correctness. All entities (XOM, CVX, CPC, Tengiz, Karachaganak) are accurately identified. The answer is fully relevant and synthesizes across companies and operations appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 530,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the decommissioning funding shortfall risk at NEE's nuclear facilities compare to Duke Energy's exposure to nuclear decommissioning trust fund volatility, given the shared environmental and financial risks associated with nuclear power plant operations?",
      "original_answer": "NEE faces potential decommissioning funding shortfalls due to the risk that decommissioning costs could exceed the amount available in its decommissioning funds, which are subject to market and operational uncertainties. Similarly, Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida maintain Nuclear Decommissioning Trust Funds (NDTFs) whose values are subject to market fluctuations. A decline in the market value of these NDTF assets could significantly increase Duke Energy's funding requirements for decommissioning. Both companies are exposed to the financial risks of nuclear power plant decommissioning, with NEE highlighting potential shortfalls and Duke Energy emphasizing the impact of capital market performance on its NDTF investments.",
      "llm_answer": "Both NextEra Energy (NEE) and Duke Energy warn that the money set aside for nuclear‑plant de‑commissioning may prove insufficient. NEE states that a decline in the market value of its nuclear‑decommissioning funds – or poor investment performance – could create a shortfall that would force the company to increase depreciation, incur impairments or raise additional cash, materially hurting its liquidity and results of operations. Duke Energy describes a similar exposure, noting that the value of its Nuclear Decommissioning Trust Fund (NDTF) can fluctuate with capital‑market conditions, and a fall in those assets could require “significant additional funding” and negatively affect its financial position.  In short, NEE focuses on the risk of a funding shortfall, while Duke emphasizes the volatility of its de‑commissioning trust‑fund assets, but both face comparable financial‑and‑environmental risks tied to nuclear plant de‑commissioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: both NEE and Duke Energy face risks related to nuclear decommissioning funding, with NEE emphasizing potential shortfalls due to market and investment performance, and Duke Energy highlighting the volatility of its Nuclear Decommissioning Trust Fund (NDTF) values due to capital market fluctuations. The LLM correctly identifies that both companies are exposed to financial risks from decommissioning, with slightly different emphases—shortfall risk for NEE and asset volatility for Duke. (2) There are no numeric values, dates, or calculations in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense, but the LLM does not introduce any incorrect figures and accurately reflects qualitative financial impacts (e.g., 'significant additional funding', 'materially hurting liquidity'), which are consistent with the original. (3) Multi-hop reasoning is sound: the model synthesizes risk disclosures from two different companies, correctly comparing their exposures without conflating them, and draws a valid conclusion about comparable environmental and financial risks. (4) Semantic equivalence is strong—wording differs but meaning matches the original answer precisely. The only minor limitation is that the LLM does not explicitly name Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida as the subsidiaries maintaining NDTFs, though referring to 'Duke Energy' collectively is acceptable in context. No factual errors, excellent contextual relevance, and robust qualitative reasoning justify a 9/10 correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 459,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does LOW's use of pricing models for Level 3 fair value measurements compare to GM's application of unobservable inputs in Level 3 valuations, particularly in light of the stated accounting policy that classifies valuations based on the observability of inputs?",
      "original_answer": "LOW applies pricing models to determine fair value for Level 2 assets and uses an income approach with significant unobservable inputs like volatility and expected term for its Level 3 contingent consideration related to the Canadian retail business sale. This aligns with the accounting policy that defines Level 3 valuations as those using significant unobservable inputs, often involving pricing models or discounted cash flow methodologies. GM similarly relies on unobservable inputs for Level 3 valuations, particularly in its GM Financial receivables, where static pool modeling and economic forecasts such as unemployment rates and GDP growth are used to estimate expected credit losses. Both companies follow the same accounting hierarchy but apply it differently depending on the nature of their assets and business operations.",
      "llm_answer": "Lowe’s Level 3 fair‑value amounts are measured with a pricing‑model approach – the company values its contingent‑consideration liability using an option‑pricing model that relies on unobservable inputs such as total equity value, volatility and expected term (the only Level 3 item disclosed). General Motors, by contrast, classifies any instrument whose significant inputs are not observable as Level 3 and measures those items (e.g., retained interests in securitizations) with discounted‑cash‑flow or other valuation techniques that require management‑judged, unobservable assumptions. Both firms apply the hierarchy rule that Level 3 measurements are driven by unobservable inputs, but Lowe’s disclosure highlights a specific model‑based valuation, whereas GM’s Level 3 valuations are broader and stem from judgment‑heavy cash‑flow models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: LOW uses an option-pricing model with unobservable inputs (volatility, expected term, total equity value) for its Level 3 contingent consideration, which is its only disclosed Level 3 item—this matches the original answer’s reference to the Canadian retail business sale. GM applies unobservable inputs in Level 3 valuations, particularly for GM Financial receivables using discounted cash flows and economic forecasts like unemployment and GDP growth; the LLM correctly identifies GM’s use of judgment-heavy models for retained interests in securitizations and similar instruments. (2) There are no numeric values to verify, so quantitative accuracy is unaffected and scores a 10. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that both companies follow the same accounting hierarchy (Level 3 = significant unobservable inputs) but apply different methodologies based on asset types—LOW with a specific pricing model, GM with broader cash-flow models. The only minor gap is that the LLM does not explicitly mention 'static pool modeling' or 'expected credit losses' for GM, which are specific details in the ground truth, slightly reducing qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the comparison of pricing models and unobservable inputs under the fair value hierarchy. Wording differs but semantic meaning is equivalent. No factual errors—only slight omission of GM’s specific modeling technique.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 432,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the $10.5 billion in committed financing under AMT's 2021 Multicurrency Credit Facility compare with SPG's financing activities in joint ventures, particularly in terms of capital deployment strategy and risk diversification?",
      "original_answer": "AMT secured $10.5 billion in committed financing through its 2021 Multicurrency Credit Facility and related facilities, which were used to fund acquisitions like CoreSite and Telxius, while SPG provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, aligning with its strategy to diversify risk and finance property development. This shows that AMT leveraged large-scale credit facilities for major acquisitions, whereas SPG used smaller, targeted financings to support joint venture operations and risk-sharing.",
      "llm_answer": "American Tower’s $10.5 billion of committed capacity under its 2021 Multicurrency Credit Facility is a single, large‑scale revolving source of liquidity that the company taps to fund multi‑billion‑dollar acquisitions (Telxius, CoreSite), refinance existing debt and support general corporate needs, concentrating most of its financing risk in one facility but giving it ample flexibility and borrowing power. In contrast, Simon Property Group’s joint‑venture financing is modest—primarily equity contributions and construction‑loan advances of roughly $80‑$90 million across dozens of JV properties—so capital is deployed incrementally into many separate partnerships, which spreads risk among partners and limits exposure to any single investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: $10.5 billion for AMT’s credit facility is accurately reported; SPG’s joint venture financing is correctly characterized as approximately $80–$90 million, which matches the ground truth figure of $88.4 million (minor rounding in presentation is acceptable). No calculations were required, but the comparison of scale is appropriately conveyed. (2) Entity accuracy is strong: American Tower (AMT) and Simon Property Group (SPG) are correctly identified, along with relevant transactions (CoreSite, Telxius acquisitions) and the nature of SPG’s joint venture activities. The 2021 Multicurrency Credit Facility is correctly attributed to AMT. (3) Reasoning and multi-hop synthesis are sound: the model correctly contrasts AMT’s centralized, large-scale financing strategy for major acquisitions with SPG’s decentralized, incremental capital deployment across joint ventures to diversify risk. It captures the strategic implications—flexibility vs. risk-sharing—accurately. (4) The answer is semantically equivalent to the original, though phrased more elaborately. One minor point preventing a perfect 10 is that the LLM does not explicitly state that SPG’s financing takes the form of 'interest-bearing construction loans' as specified in the ground truth, instead generalizing to 'construction-loan advances' and 'equity contributions.' While this is close and contextually reasonable, it slightly omits a specific detail about the financial instrument type. Otherwise, the answer fully addresses capital deployment strategy and risk diversification as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 456,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does AMD's revenue exposure to Taiwan in 2023 compare to QCOM's operational dependency on foundry partners in Taiwan, given the geopolitical risks associated with the region?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, indicating a notable but declining revenue exposure compared to previous years. Meanwhile, QCOM explicitly states that its business depends on consistent and reliable chipset supply from foundry partners, particularly in Taiwan. A significant or prolonged military or geopolitical conflict involving China and Taiwan could severely limit or prevent QCOM from receiving chipset supply, which would have a material adverse impact on its business. Given that both companies are exposed to Taiwan—AMD through revenue and QCOM through critical supply chain dependencies—geopolitical instability in the region poses a dual risk, impacting both revenue streams and manufacturing continuity.",
      "llm_answer": "AMD earned $1.84 billion of its $22.68 billion 2023 net revenue from customers in Taiwan – roughly 8 percent of total sales. Qualcomm, by contrast, says its ability to obtain “consistent and reliable chipset supply” is heavily dependent on its foundry partners in Taiwan, making the region a critical operational linchpin rather than a modest revenue slice. Thus, AMD’s exposure is a single‑digit‑percent revenue share, while Qualcomm’s business is fundamentally tied to Taiwanese foundries for its core chip supply.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: AMD's $1.84 billion in revenue from Taiwan in 2023 matches the original $1,841 million (equivalent), and the 8% of total sales is accurate when calculated as $1.84B / $22.68B. The total revenue figure ($22.68B) is not in the original answer but is consistent with AMD's 2023 10-K and improves context without introducing error. (2) Entity accuracy is strong: AMD and QCOM (Qualcomm) are correctly identified, with correct attribution of revenue exposure vs. supply chain dependency, and the year 2023 is properly referenced. (3) Reasoning is sound: the LLM correctly contrasts AMD’s revenue exposure (downstream customer sales) with Qualcomm’s operational dependency on Taiwanese foundries (upstream supply chain), highlighting the differing nature and criticality of Taiwan exposure. (4) The answer is semantically equivalent to the original, capturing the dual risk theme—though it omits the explicit mention of 'geopolitical conflict involving China and Taiwan' and the phrase 'material adverse impact,' which slightly reduces completeness. However, the core multi-hop synthesis—comparing revenue vs. supply chain exposure to Taiwan under geopolitical risk—is well executed and contextually relevant. Minor deduction from 10 to 9 due to omission of the severity language around conflict impact, but overall factual and conceptual accuracy is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 404,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does the expected impact of the 15% global minimum tax under OECD's Pillar 2 on SBUX's consolidated financial statements compare to MCD's assessment, given the phased implementation timelines across jurisdictions?",
      "original_answer": "SBUX notes that the global minimum tax under Pillar 2 will not be effective for the company until fiscal 2025 and is not expected to result in a material impact on its consolidated financial statements. Similarly, MCD states that while numerous countries have enacted Pillar 2 with an effective date for taxable years beginning after December 31, 2023, it also does not expect a material impact on its consolidated financial statements. Both companies are monitoring regulatory developments and await further guidance, as the implementation of Pillar 2 varies across jurisdictions and could evolve over time.",
      "llm_answer": "Starbucks says that the 15 % OECD “Pillar 2” minimum‑tax rules will not apply to the company until fiscal 2025 and that, even when they do, the change is not expected to be material to its consolidated financial statements. McDonald’s makes a similar conclusion – it notes that Pillar 2 is being introduced on a staggered, jurisdiction‑by‑jurisdiction basis and, because the earliest effective dates are after 2023, the company does not expect a material impact on its consolidated results in the near term, with any effect only potentially material in later years once the later‑adopting jurisdictions come into force.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: SBUX expects Pillar 2 to apply from fiscal 2025 with no material impact; MCD acknowledges staggered implementation starting after 2023 and also expects no near-term material impact. The 15% OECD Pillar 2 reference is correctly stated. (2) Quantitative elements—fiscal 2025 for SBUX, post-2023 effective dates for MCD—are factually aligned with the original answer. No calculations are required, and all dates/percentages are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (SBUX and MCD), compares their assessments, and contextualizes the phased implementation across jurisdictions. The only minor shortcoming is that the LLM slightly overemphasizes the possibility of future materiality for MCD ('potentially material in later years'), which is not explicitly stated in the original answer—both companies simply state they do not expect a material impact and are monitoring developments. However, this does not contradict the source and is a reasonable inference. (4) The answer is fully relevant, directly addressing the comparative impact on consolidated financial statements in light of implementation timelines. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth with only negligible interpretive expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 395,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does JPMorganChase's risk governance framework, which emphasizes firmwide ownership of risk assessment, influence its approach to stress testing methodologies compared to Goldman Sachs, which explicitly ties stress testing to capital adequacy assessments?",
      "original_answer": "JPMorganChase's risk governance framework emphasizes firmwide ownership of risk assessment, with Risk Management and Compliance functions overseeing risk identification and escalation across business lines and corporate functions. This structured governance leads to a comprehensive approach to risk, where stress testing is likely embedded within broader risk identification and mitigation processes. In contrast, Goldman Sachs explicitly uses stress testing to assess capital adequacy and quantify exposure to tail risks, performing firmwide stress tests regularly to evaluate vulnerabilities across financial and nonfinancial risks. The difference in emphasis—JPMorganChase’s governance-driven risk ownership versus Goldman Sachs’s scenario-based capital adequacy focus—suggests that while both firms use stress testing as a core risk tool, the integration and ultimate purpose of stress testing within their risk frameworks differ significantly.",
      "llm_answer": "JPMorgan Chase’s governance model places the responsibility for identifying, measuring and testing risk on each line‑of‑business, with the independent IRM function providing firm‑wide oversight and challenge (see pages 93‑95, 94). Because risk assessment is owned throughout the firm, its stress‑testing is treated as a tool for the business units and the Market‑Risk group to validate limits and exposures rather than as a direct input to capital‑adequacy calculations.  \n\nGoldman Sachs, by contrast, describes firm‑wide stress tests as a core element of its capital‑planning process and explicitly uses the results to gauge capital adequacy (see pages 99‑101, 111). Thus, Goldman’s methodology is tied to meeting regulatory capital requirements, while JPMorgan’s is driven by a firm‑wide ownership framework that emphasizes risk‑management oversight independent of capital‑adequacy assessments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: JPMorganChase's firmwide ownership model, the role of independent Risk Management (IRM), and the decentralized yet overseen approach to risk are accurately described. The contrast with Goldman Sachs’ use of stress testing for capital adequacy and regulatory planning is also correctly presented. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or the answers, so quantitative accuracy is not applicable in a numerical sense—however, the citation of page numbers (e.g., 93–95, 99–101) is consistent with document-based reasoning and does not introduce factual errors, thus scoring full marks. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in governance frameworks and links them to divergent stress testing purposes—JPMorgan’s integration into risk oversight vs. Goldman’s alignment with capital adequacy. The conclusion that both use stress testing but for different primary purposes is logically derived and matches the ground truth. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'validate limits and exposures' not in original), the core meaning about integration into risk management rather than capital planning is preserved. One minor point preventing a perfect 10 is that the LLM slightly downplays the breadth of Goldman Sachs’ stress testing (e.g., 'nonfinancial risks' mentioned in original is omitted), but the central capital-adequacy linkage is correctly emphasized. Overall, the answer is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 467,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does XOM's asset exposure in Kazakhstan compare to CVX's financial stake in Tengizchevroil, considering CVX's equity ownership and loan contributions to the joint venture?",
      "original_answer": "XOM had $8,463 million in long-lived assets in Kazakhstan as of 2021, while CVX holds a 50% equity interest in Tengizchevroil (TCO), which operates in the same country. In addition to its equity stake, CVX provided a $4,500 million loan to TCO to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This indicates that CVX's financial exposure to Tengizchevroil in Kazakhstan includes both its proportional equity value and a significant direct loan, potentially exceeding the magnitude of XOM's reported asset base in the country when combined.",
      "llm_answer": "ExxonMobil’s balance‑sheet shows about **$8.5 billion of long‑lived assets in Kazakhstan** (non‑U.S. long‑lived assets of $8,463 million in 2021)【page_123】.  \n\nChevron’s stake in the same country is through its **50 percent equity ownership of Tengizchevroil**, recorded at a carrying value of roughly **$23.7 billion**, plus an **approximately $4.5 billion loan** to the joint‑venture to fund field development【page_78】.  \n\nThus, while Exxon’s direct asset exposure in Kazakhstan is about $8.5 billion, Chevron’s financial commitment—half‑ownership valued at $23‑24 billion together with a $4.5 billion loan—is materially larger.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $8,463 million in long-lived assets for XOM in Kazakhstan (rounded to $8.5 billion) is correct as per 2021 data. CVX's 50% equity ownership in Tengizchevroil and the $4.5 billion loan are accurately reported. However, the LLM introduces a carrying value of $23.7 billion for CVX’s equity stake, which is not present in the original answer. While this figure may be factually correct based on external data, it was not included in the ground truth, making it an addition rather than a misstatement. (2) The original answer emphasizes that CVX’s exposure includes both equity and loan, potentially exceeding XOM’s asset base—this logic is preserved and well-articulated in the LLM response. (3) Multi-hop reasoning is sound: the model correctly synthesizes XOM’s direct asset exposure with CVX’s indirect financial stake via equity and debt in the same country. (4) Entity names (XOM, CVX, Tengizchevroil), years (2021), and financial terms (long-lived assets, equity ownership, loan contributions) are correct. The only minor deviation is the inclusion of the $23.7 billion carrying value, which enhances detail but isn’t in the original; this doesn’t harm accuracy but slightly exceeds the provided truth. Overall, the answer is factually strong, contextually relevant, and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 383,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might geopolitical tensions involving Taiwan impact both QCOM's chipset supply and NVDA's supply continuity, given their reliance on foundry partners operating in the region?",
      "original_answer": "QCOM's business depends on receiving consistent chipset supply from foundry partners, particularly in Taiwan, and a significant geopolitical conflict involving Taiwan could severely limit or prevent QCOM from receiving this supply, which would have a material adverse impact on its business. Similarly, NVDA notes that geopolitical tensions involving Taiwan and China, where it has critical suppliers, contract manufacturers, and assembly partners, could have a material adverse impact on its supply continuity. Both companies rely on foundry partners operating in Taiwan, and any disruption due to geopolitical instability could lead to supply constraints, affecting QCOM's ability to manufacture products and NVDA's ability to fulfill customer orders on time, ultimately harming their revenues and market positions.",
      "llm_answer": "Qualcomm notes that its “business depends on our ability to receive consistent and reliable chipset supply from our foundry partners, particularly in Taiwan,” and that a “significant or prolonged military or other geopolitical conflict involving China and Taiwan could severely limit or prevent us from receiving chipset supply from Taiwan” – a material adverse impact on its business. Nvidia similarly warns that “geopolitical tensions, such as those involving Taiwan and China, which comprise a significant portion of our revenue and where we have suppliers, contract manufacturers, and assembly partners…could have a material adverse impact on us,” threatening the continuity of its GPU and AI‑chip supply chain.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or the ground truth, so quantitative accuracy is not applicable—no errors present. (2) The LLM correctly identifies both QCOM and NVDA, their reliance on foundry partners in Taiwan, and the potential material adverse impact of geopolitical tensions involving Taiwan and China. It accurately reflects that QCOM's chipset supply and NVDA's supply continuity are at risk due to disruptions in Taiwan, where both have critical manufacturing partners. (3) The multi-hop reasoning is sound: the model synthesizes information about both companies' supply chain dependencies and correctly links geopolitical risk in Taiwan to supply chain vulnerabilities for both firms. (4) The LLM uses direct quotes and paraphrasing that preserve the original meaning, demonstrating strong qualitative accuracy and contextual relevance. Wording differs slightly but conveys the same core risks and dependencies as the ground truth. All aspects of the question are addressed thoroughly and correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 330,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might Southern Company's environmental compliance costs, driven by regulatory requirements, affect electricity demand from industrial customers, and how does this potential demand shift compare to Duke Energy's exposure to industrial customer demand volatility as outlined in their risk factors?",
      "original_answer": "Southern Company estimates that compliance with environmental regulations could result in increased costs that are recovered through regulated rates, but this may contribute to reduced demand for electricity and natural gas from industrial customers. Many of these industrial customers may also face their own compliance costs under the same environmental requirements, further reducing their energy consumption. Duke Energy, on the other hand, explicitly notes that declines in industrial production due to economic conditions will reduce electricity and natural gas consumption, directly impacting their revenues and cash flows. Both companies are exposed to industrial demand shifts, but Southern Company's exposure is tied to regulatory cost pass-through effects, while Duke Energy highlights direct economic sensitivity of industrial customers.",
      "llm_answer": "Southern notes that the large capital and operating outlays required to meet new environmental rules – most of which must be recovered through retail rates – “could contribute to reduced demand for electricity and natural gas” and that “many commercial and industrial customers may … have the potential to reduce their demand for electricity or natural gas”【page_26】.  \n\nDuke’s risk‑factors warn that its results are vulnerable to “declines in demand for electricity or natural gas … especially as industrial customers reduce production and therefore consumption” – a volatility that is tied to broader economic‑cycle swings rather than a specific cost‑recovery issue【page_28】.  \n\nThus, Southern’s compliance costs could directly suppress industrial electricity use via higher rates, while Duke’s exposure to industrial demand volatility stems from macro‑economic fluctuations that can cause abrupt drops in industrial consumption.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: Southern Company's environmental compliance costs are tied to rate recovery and may reduce industrial demand due to higher costs, with industrial customers also facing their own compliance burdens. Duke Energy's exposure is correctly characterized as stemming from economic-cycle-driven declines in industrial production, not regulatory cost pass-through. (2) There are no numeric values in the question or answers that require verification (e.g., dollar amounts, percentages, years), so quantitative accuracy is not compromised—no figures are misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes risk factor disclosures from both companies, contrasting Southern’s regulatory-cost-driven demand risk with Duke’s macroeconomic sensitivity. The use of page references (26, 28) suggests accurate sourcing from the 10-Ks. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'macro-economic fluctuations' vs 'economic conditions'), the meaning is identical. The only minor shortcoming is that the LLM omits the explicit point that industrial customers may face their own compliance costs under the same regulations—a nuance present in the original answer—but this does not undermine the core accuracy. Overall, the response is complete, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 404,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the $9.9 billion notional amount of foreign exchange cash flow hedges used by NKE compare to MCD's foreign currency net asset exposures in managing cross-border financial risk?",
      "original_answer": "NKE utilizes $9.9 billion in notional foreign exchange cash flow hedges to manage transactional exposures from product costs, external sales, and other foreign currency-denominated assets and liabilities. These hedges, primarily in euros, Canadian dollars, Japanese yen, British pounds, and Chinese yuan, are designed to offset earnings fluctuations from currency movements. Meanwhile, MCD manages its foreign currency risk by maintaining diversified net asset exposures across a broad basket of currencies. While NKE actively hedges forecasted transactions and exposures through derivatives, MCD's approach focuses on balancing foreign currency assets and liabilities directly on its balance sheet, reflecting differing strategies to mitigate cross-border financial risk.",
      "llm_answer": "Nike’s foreign‑exchange risk program designates net cash‑flow‑hedge contracts with a total notional amount of **$9.9 billion** (as of September 28 2024)【page_121】.  \nMcDonald’s reports its largest foreign‑currency net‑asset exposures at year‑end 2024 as Australian $1.48 bn, British $1.15 bn, Polish $0.64 bn, Chinese $0.33 bn and Hong Kong $0.23 bn – together about **$3.8 billion**【page_24】.  \n\nThus, Nike’s hedging notional is roughly two‑to‑three times the magnitude of McDonald’s net‑asset exposures, indicating that Nike relies on a substantially larger hedge program to manage its cross‑border currency risk, while McDonald’s exposure is managed primarily through the underlying net‑asset positions themselves.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies NKE's $9.9 billion notional amount for foreign exchange cash flow hedges, which matches the ground truth. However, the MCD net asset exposure figures are not present in the original answer — the ground truth does not provide specific dollar amounts for MCD’s exposures (e.g., Australian $1.48 bn, etc.), nor does it state a total of $3.8 billion. These numbers appear to be fabricated or extracted from a source not reflected in the ground truth, making them factually inaccurate. (2) The calculation of MCD’s total exposure as $3.8 billion is mathematically correct based on the provided figures, but since those figures are not in the original answer or contradicted by it, the quantitative basis is flawed. The comparison that Nike’s hedge notional is 'two-to-three times' MCD’s exposure relies on unsupported data. (3) The multi-hop reasoning is logically sound — the model attempts to compare NKE’s active hedging strategy with MCD’s balance sheet-level net asset management approach — and correctly infers differing risk management strategies. This aligns with the qualitative insight in the ground truth about differing approaches. (4) Despite incorrect specific numbers for MCD, the overall conclusion about differing strategies (active hedging vs. net asset balancing) is consistent with the original answer, preserving semantic relevance. However, the inclusion of false quantitative data reduces the correctness score. The model adds specificity not present in the ground truth, which harms factual accuracy even if the direction of reasoning is valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 440,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the exposure of The Coca-Cola Company through Coca-Cola HBC's operations in Ukraine compare to Procter & Gamble's direct reliance on Ukraine for its manufacturing and supply chain stability?",
      "original_answer": "The Coca-Cola Company relies on Coca-Cola HBC for bottling and distribution operations in Ukraine, which is part of a broader network contributing to 41% of Coca-Cola's global unit case volume through its top five bottlers. Meanwhile, Procter & Gamble reports that its Ukraine-related assets account for less than 1% of net assets, with potential risks including physical damage to its two manufacturing facilities in Ukraine and disruptions in raw material sourcing or product distribution. While Coca-Cola's exposure is indirect through a key bottler, P&G's exposure is more direct but smaller in scale, with both companies facing similar regional supply chain risks tied to geopolitical instability.",
      "llm_answer": "Coca‑Cola’s exposure to Ukraine comes only through its independent bottler Coca‑Cola HBC, which lists Ukraine among the many countries it serves but the filing does not quantify the share of Coca‑Cola’s revenue or earnings that derives from those sites. In contrast, Procter & Gamble actually operates two manufacturing plants in Ukraine; the company states that the Ukraine business represents **less than 1 percent of consolidated net sales and net earnings** for fiscal 2022, making its reliance direct but still a very small portion of the overall company.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures that Coca-Cola's exposure is indirect through Coca-Cola HBC, while P&G has direct operations via two manufacturing plants in Ukraine. The key quantitative point that P&G's Ukraine business represents 'less than 1 percent' of net sales and net earnings is correctly reported, matching the ground truth's statement about assets (though the ground truth refers to 'net assets' while LLM cites 'net sales and net earnings'). This is a minor discrepancy in metric specificity but does not materially misrepresent the scale of exposure. (2) The LLM correctly notes that no specific revenue or volume from Ukraine is quantified in the filings for Coca-Cola, which is consistent with the original answer’s implication that exposure is part of a broader 41% contribution from top bottlers without isolating Ukraine. However, the LLM omits the multi-hop synthesis that Coca-Cola HBC is one of the top five bottlers contributing to 41% of global unit case volume—a key contextual metric in the original answer that strengthens the assessment of indirect exposure. (3) The reasoning is sound: it distinguishes indirect vs. direct exposure and correctly assesses the relative scale. The omission of the 41% bottler network context slightly weakens the completeness of the multi-hop analysis. (4) Despite this, the answer remains factually accurate, relevant, and well-reasoned, with only minor qualitative and quantitative omissions preventing a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 423,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What is the combined exposure of MET and BAC to commercial mortgage-backed securities (CMBS), and how does MET's fair value of CMBS compare to BAC's amortized cost for the same category as of December 31, 2023?",
      "original_answer": "MET's fair value exposure to CMBS was $4,551 million as of December 31, 2023, while BAC's amortized cost for commercial mortgage-backed securities was $10,922 million. The combined exposure of both companies to CMBS totals $15,473 million. MET's CMBS, as part of its Structured Securities portfolio, are reported at fair value, whereas BAC reports its CMBS at amortized cost, reflecting different accounting treatments for similar asset classes.",
      "llm_answer": "MetLife reported $10.4 billion of commercial‑mortgage‑backed securities (CMBS) at fair value, while Bank of America carried $10.9 billion of CMBS at amortized cost.  Together the two companies have roughly $21.3 billion of CMBS exposure, and MetLife’s fair‑value amount is a little lower than Bank of America’s amortized‑cost amount.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers. According to the ground truth, MET's fair value exposure to CMBS was $4,551 million ($4.551 billion), not $10.4 billion as stated in the LLM answer. BAC's amortized cost of $10,922 million ($10.922 billion) is approximately correct (rounded to $10.9 billion). The combined exposure is therefore $15,473 million ($15.473 billion), not $21.3 billion as claimed. The LLM overstates MET's exposure by more than double, leading to a severely inflated total. (2) Calculations are incorrect: $10.4B + $10.9B = $21.3B is mathematically correct based on the LLM's inputs, but the inputs themselves are wrong. The correct sum of $4.551B + $10.922B = $15.473B. (3) The multi-hop reasoning is partially sound in structure—identifying both companies, the CMBS category, and attempting to compare fair value vs. amortized cost—but fails due to incorrect data retrieval for MET. The model correctly identifies that MET reports at fair value and BAC at amortized cost, showing understanding of accounting differences. (4) The contextual relevance is fair because the answer addresses the right entities, time frame (implied), and concept of comparing CMBS exposure with accounting treatment noted. However, the severe quantitative inaccuracies—especially the incorrect MET value—undermine the core of the answer, warranting a low correctness score despite some structural adequacy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 400,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How do cyber intrusion risks at nuclear power plants impact the financial obligations and operational strategies of both Duke Energy and Southern Company, given their respective exposures to decommissioning trusts and compliance costs?",
      "original_answer": "Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida have significant obligations tied to decommissioning nuclear plants, with funded trusts subject to market fluctuations that could increase funding requirements if asset values decline. Southern Company's nuclear units, operated by Southern Nuclear, are subject to compliance costs related to cyber intrusion risks, which could increase licensing or security expenditures. Both companies face potential financial strain: Duke Energy may need to inject additional capital if decommissioning trusts underperform, while Southern Company could face higher operational costs due to mandatory cybersecurity standards and potential threats, both of which could materially affect their financial positions and cash flows.",
      "llm_answer": "Both companies say that a successful cyber intrusion at a nuclear site would force them to spend substantially more on security, regulatory compliance and possible penalties. For Duke Energy, those extra costs would come on top of the already‑uncertain returns on its nuclear de‑commissioning trust funds (NDTF), so a breach could require additional cash contributions to the trusts and pressure the registrants’ liquidity and capital‑allocation strategy. For Southern Company, the breach would add to its already‑significant compliance‑cost base (environmental, safety and rate‑recovery expenses) and would compel the firm to divert resources to enhanced cyber‑defenses, shaping its operational plan around higher security spending and tighter cost‑recovery assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: both Duke Energy and Southern Company face increased financial and operational impacts from cyber intrusion risks at nuclear plants. Duke Energy's exposure through decommissioning trusts is accurately described, including the risk of needing additional contributions if trust performance declines. Southern Company's heightened compliance and security costs due to cyber risks are also correctly portrayed. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not compromised—no calculations or figures to verify. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes cyber risk impacts with company-specific financial structures—decommissioning trusts for Duke and compliance costs for Southern—drawing logical conclusions about liquidity, capital allocation, and operational strategy. (4) Semantic equivalence is strong; while the LLM uses slightly different phrasing (e.g., 'NDTF', 'registrants’ liquidity'), the meaning matches the original. The only minor shortcoming is that the LLM does not explicitly name Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida, nor Southern Nuclear as the operator, slightly reducing entity specificity. However, the core entities (Duke Energy and Southern Company) and their respective risk channels are correctly identified and linked. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 434,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the treatment of dividend equivalents on unvested restricted stock units at HD influence the issuance of additional shares, and how does this compare to LOW's delivery of additional shares under its ASR agreements in fiscal 2021?",
      "original_answer": "At HD, dividend equivalents accrue on unvested restricted stock units and are paid out in the form of additional shares upon vesting. This mechanism increases the total number of shares ultimately delivered to employees. For example, HD's 2022 10-K shows that dividend equivalents are reinvested and paid out as additional shares when RSUs vest. This practice results in a higher share count over time, as unvested units continue to accrue dividends. In contrast, LOW delivered additional shares in the context of accelerated share repurchase (ASR) agreements. In fiscal 2021, LOW executed ASR agreements in Q1, Q4, and Q2, under which it received additional shares at settlement—0.2 million, 1.6 million, and 4 million shares respectively—depending on the final calculation of the stock price during the settlement period. Therefore, while HD's additional shares arise from reinvested dividend equivalents tied to employee compensation, LOW's additional shares are a byproduct of its capital return strategy through ASR agreements.",
      "llm_answer": "Home Depot’s restricted‑stock units accrue dividend equivalents while the units are unvested, and those equivalents are settled as **additional shares of common stock on the vesting date** of the RSUs 【page_69】.  \n\nLowe’s, by contrast, receives **additional shares from its Accelerated Share Repurchase (ASR) contracts** when the contracts settle; in fiscal 2021 the company received roughly 0.2 M (Q1) + 4 M (Q2) + 1.7 M (Q3) + 1.6 M (Q4) ≈ 7.5 million extra shares 【page_64】.  \n\nThus, HD’s extra shares arise from dividend‑equivalent payouts tied to RSU vesting, whereas LOW’s extra shares stem from the settlement mechanics of its ASR agreements, delivering about 7½ million shares in FY 2021.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the mechanism at HD—dividend equivalents on unvested RSUs are paid out as additional shares upon vesting—and contrasts it with LOW's ASR-related receipt of additional shares. The core reasoning and entity identification (HD vs. LOW, RSUs vs. ASR) are accurate and well-synthesized. (2) However, there is a quantitative inaccuracy in the LOW share totals: the LLM states Q3 delivery was 1.7 million shares, but the ground truth does not mention a Q3 ASR delivery; instead, it specifies deliveries in Q1 (0.2M), Q4 (1.6M), and Q2 (4M). The LLM incorrectly adds a Q3 tranche not present in the original answer and miscalculates the total (7.5M vs. correct total of 5.8M). This affects the precision of the numerical claims. (3) The multi-hop reasoning is sound—correctly linking HD’s employee compensation practice with LOW’s capital return strategy via ASR—and the contrast is logically and contextually appropriate. (4) Despite the numerical error in LOW’s quarterly breakdown and total, the qualitative and contextual understanding is strong, warranting a high correctness score, but the quantitative inaccuracy prevents a 9 or 10. The answer remains semantically close and relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 351,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does AT&T's use of sensitivity analyses in auditing its $67,854 million goodwill balance compare to Netflix's application of similar analyses in evaluating content amortization assumptions, given both companies are audited by the same firm?",
      "original_answer": "AT&T utilized sensitivity analyses to evaluate the goodwill impairment testing for its $67,854 million goodwill balance, focusing on assumptions like terminal growth rates and weighted average cost of capital. Netflix, on the other hand, applied sensitivity analyses to assess the impact of changes in estimated viewing patterns on content amortization, a key accounting estimate given its content licensing and production model. Both companies are audited by the same firm, which performed these sensitivity analyses as part of their audit procedures to evaluate the reasonableness and robustness of management’s assumptions in each case.",
      "llm_answer": "Ernst & Young performed independent sensitivity‑analysis procedures for both companies, but the focus of the tests differed. For AT&T, the auditors “performed independent sensitivity analyses” on the key assumptions (terminal growth rates, long‑term EBITDA margins and weighted‑average cost of capital) used in the discounted‑cash‑flow and market‑multiple models that determine the fair value of its $67,854 million goodwill balance. For Netflix, the auditors “performed sensitivity analyses to evaluate the potential changes in the content amortization recorded that could result from changes in the assumptions,” testing how variations in historical and forecasted viewing‑hour patterns would affect the timing and amount of content amortization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T's $67,854 million goodwill balance is accurately cited, and the use of sensitivity analyses on terminal growth rates, WACC, and EBITDA margins for goodwill impairment testing is correctly described. For Netflix, the focus on sensitivity analyses around viewing-hour patterns affecting content amortization is also accurate. (2) Quantitative accuracy is perfect: the dollar amount ($67,854 million) matches exactly, and no other numerical errors are present. Format is consistent and precise. (3) Multi-hop reasoning is sound: the answer correctly synthesizes that both companies are audited by the same firm (implied as Ernst & Young, which matches external knowledge and aligns with the original answer’s intent), and that while the audit firm applied similar methodological procedures (sensitivity analyses), the application differed based on the accounting estimate—goodwill for AT&T vs. content amortization for Netflix. (4) The only minor shortcoming is that the LLM answer names Ernst & Young explicitly, while the original answer refers to 'the same firm' without naming it. However, this is a reasonable inference given public knowledge and does not detract from factual correctness. The core comparison—differences in the focus of sensitivity analyses despite the same auditor—is clearly and accurately conveyed. Semantic equivalence is maintained, with slightly more detail in the LLM response. All parts of the question are addressed: AT&T’s use, Netflix’s use, and the shared auditor context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 440,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does Mastercard's concern about disintermediation from fintech-developed payment platforms compare to Visa's strategic partnership approach with fintechs in the context of regulatory-driven competition in the digital payments ecosystem?",
      "original_answer": "Mastercard expresses concern that fintechs could develop platforms or networks that disintermediate them from digital payments, especially when sharing data under partnerships, which could give fintechs a competitive advantage. This aligns with the broader risk that fintechs may develop competitive products that replace Mastercard’s offerings. In contrast, Visa actively partners with fintechs and emphasizes leveraging local financial institutions and tailored solutions to maintain a competitive edge. Visa sees fintechs as both partners and potential competitors, but strategically integrates them into its 'network of networks' approach. The regulatory environment, particularly in the EEA with PSD2, exacerbates these dynamics by enabling third-party providers to route transactions away from traditional networks like Mastercard, while Visa adapts by strengthening partnerships to remain central in the evolving digital payments ecosystem.",
      "llm_answer": "Mastercard flags the risk that fintech‑built payment platforms could bypass its four‑party network – especially as regulations such as Europe’s PSD2 give third‑party providers direct access to issuer data and enable “account‑to‑account” or issuer‑direct routing that would disintermediate Mastercard’s role【page_31】. In contrast, Visa treats the same regulatory thrust as a catalyst for collaboration, expanding a suite of fintech‑focused programs (Fintech Fast‑Track, Fintech Partner Connect, Everywhere Initiative) and making strategic acquisitions (Currencycloud, Tink) to embed its network within fintech offerings and turn potential competitors into partners【page_14】【page_15】. Thus, Mastercard is primarily defensive about fintech‑driven disintermediation, whereas Visa pursues a partnership‑driven strategy to stay competitive in a regulator‑shaped digital‑payments landscape.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies Mastercard's concern about disintermediation due to fintech platforms and regulatory changes like PSD2 in the EEA, which enable third-party access and alternative routing that bypass traditional networks. (2) It accurately contrasts Visa's proactive, partnership-driven strategy, citing specific programs (Fintech Fast-Track, Fintech Partner Connect, Everywhere Initiative) and acquisitions (Currencycloud, Tink) that embed Visa into fintech ecosystems. (3) The multi-hop reasoning is sound: it synthesizes regulatory impact (PSD2), competitive dynamics, and strategic responses across two companies, correctly framing Mastercard as defensive and Visa as collaborative. (4) All entities (Mastercard, Visa, fintechs, PSD2, EEA), strategic approaches, and regulatory context are correctly identified and logically connected. No numeric inaccuracies are present, and while no explicit numbers appear, the qualitative financial and strategic concepts are correctly conveyed. The answer fully addresses the comparative strategic posture of both companies in the context of regulatory-driven competition, matching the depth and nuance of the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 356,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the expected impact of the 15% global minimum tax under Pillar 2 differ between MCD and SBUX, considering the OECD's framework and the earliest effective dates for implementation?",
      "original_answer": "MCD stated that while the global minimum tax under Pillar 2 was enacted in several countries with the earliest effective date for taxable years beginning after December 31, 2023, it does not expect a material impact on its consolidated financial statements. SBUX, on the other hand, noted that Pillar 2 will not be effective for the company until fiscal 2025 and also does not expect a material impact to its consolidated financial statements. The OECD's framework proposes a 15% global minimum tax applied on a country-by-country basis, and although many countries are incorporating Pillar 2 model rule concepts into domestic laws, differences in implementation timelines and domestic tax adjustments may affect the tax's impact on multinational companies like MCD and SBUX differently.",
      "llm_answer": "Both companies say the OECD‑mandated 15% “Pillar 2” minimum tax is not expected to be material to their consolidated results, but the timing differs. McDonald’s notes that many jurisdictions have already enacted Pillar 2 with the earliest effective date for taxable years beginning after December 31 2023, so any effect could begin in 2024 (though it still expects no material impact). Starbucks, by contrast, states the tax will not become effective for it until fiscal 2025 and likewise anticipates no material impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: both MCD and SBUX expect no material impact from the 15% global minimum tax under Pillar 2; MCD acknowledges implementation in jurisdictions with effective dates for taxable years after December 31, 2023 (i.e., starting in 2024); SBUX states it will not be affected until fiscal 2025. These dates and expectations match the original answer. (2) Quantitative accuracy is perfect: the 15% rate, December 31, 2023, and fiscal 2025 are all correctly reported. No calculations are required, but temporal references are precise and semantically equivalent. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information across two companies, their respective timelines, and the OECD framework, noting differences in implementation timing while affirming similar financial impact conclusions. (4) The only minor omission is that the LLM does not explicitly mention the OECD’s country-by-country application or domestic implementation variations, which slightly reduces qualitative completeness but does not affect the core correctness. However, the focus of the question is on the differing impact and timing between MCD and SBUX, which is fully addressed. Wording differs but meaning is preserved. Contextual relevance is excellent as all content directly addresses the comparative impact and timing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 388,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the capital adequacy position of BlackRock Institutional Trust Company (BTC) as of December 31, 2024, compare to American Express's (AXP) regulatory capital ratios, given both entities are subject to U.S. banking regulatory requirements?",
      "original_answer": "As of December 31, 2024, BlackRock Institutional Trust Company (BTC) exceeded its applicable capital adequacy requirements, including minimum Common Equity Tier 1 (CET1), Tier 1 leverage, and risk-based capital ratios. Similarly, American Express (AXP) met all capital requirements and maintained regulatory capital ratios above the thresholds to qualify as 'well capitalized' under Federal Reserve and OCC guidelines. Both entities are subject to U.S. banking regulatory capital requirements, with BTC regulated by the Office of the Comptroller of the Currency (OCC) and AXP supervised by the Federal Reserve and its subsidiary AENB also regulated by the OCC.",
      "llm_answer": "BlackRock Institutional Trust Company (BTC) reported a total capital ratio of **153.2 % of risk‑weighted assets** (Common‑Equity Tier 1 151.9 %) at 31 Dec 2024—far above the regulatory minima of 8 % total capital and 4.5 % CET1.  \n\nAmerican Express’s banking subsidiaries, by contrast, posted CET1, Tier 1 and total‑capital ratios of roughly **10‑12 % (CET1 ≈ 10.5 % for the holding company and 11.6 % for the national bank; Tier 1 ≈ 11 %; total capital ≈ 13 %)**—also above the required floors but dramatically lower than BTC’s >150 % ratios.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The reported capital ratios for BlackRock Institutional Trust Company (BTC)—153.2% total capital and 151.9% CET1—are grossly exaggerated and not plausible for any bank, as typical regulatory minimums are in the single digits (e.g., 8% total capital). These numbers are orders of magnitude higher than realistic or reported levels, suggesting a potential misinterpretation of data (e.g., basis points or non-risk-adjusted figures). In contrast, the original answer states only that BTC 'exceeded' requirements without specifying exact percentages, which aligns with typical disclosures, but does not support the extreme figures cited. For American Express (AXP), the LLM provides approximate ratios (CET1 ≈ 10.5%–11.6%, Tier 1 ≈ 11%, total ≈ 13%), which are reasonable and consistent with typical 'well-capitalized' banks, though not explicitly confirmed in the ground truth. (2) The calculation and comparison between BTC and AXP are flawed due to the implausible BTC numbers. The claim that BTC’s ratios are 'dramatically lower' than AXP’s >150% is factually incorrect and misleading, as no U.S. bank reports CET1 or total capital ratios above 150% of risk-weighted assets. (3) The multi-hop reasoning is partially sound—both entities are correctly identified as subject to U.S. banking regulation, with BTC under the OCC and AXP under the Federal Reserve/OCC. The intent to compare capital adequacy is appropriate. However, the synthesis fails due to reliance on incorrect numerical data. (4) The contextual relevance is high—the answer addresses the comparison of capital adequacy between BTC and AXP as of December 31, 2024, and correctly identifies regulatory frameworks. However, the extreme numerical inaccuracies severely undermine factual correctness, warranting a low correctness and quantitative accuracy score despite reasonable structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 523,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the $88.4 million in construction loans provided by SPG to joint ventures compare to AMT's utilization of the 2021 Multicurrency Credit Facility for acquisitions, and what does this reveal about their respective financing strategies for growth?",
      "original_answer": "SPG provided $88.4 million in construction loans to joint ventures as of December 31, 2021, indicating a strategy of internally financing development through joint ventures. In contrast, AMT borrowed $7.8 billion under the 2021 Multicurrency Credit Facility, including €2.4 billion ($2.9 billion), to fund major acquisitions like the Telxius and CoreSite deals. This reveals that AMT pursued a more aggressive, acquisition-driven growth strategy backed by large-scale credit facilities, while SPG focused on smaller-scale development financing through joint venture partnerships.",
      "llm_answer": "Simon Property Group’s construction‑loan portfolio to its joint‑venture partners was only $88.4 million at year‑end 2021 (see SPG page 116).  By contrast, American Tower borrowed about $7.8 billion under its 2021 Multicurrency Credit Facility during 2021 to fund the Telxius and CoreSite acquisitions (see AMT page 111).  The comparison shows that SPG relies on relatively modest, JV‑specific debt to support property development, whereas American Tower uses a large revolving credit facility to finance sizable acquisition deals, reflecting a far more debt‑intensive growth strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies SPG's $88.4 million in construction loans to joint ventures as of year-end 2021 and AMT's $7.8 billion borrowing under the 2021 Multicurrency Credit Facility for acquisitions, specifically naming Telxius and CoreSite. These figures match the ground truth exactly, with acceptable formatting variations (e.g., $7.8 billion vs $7.8B). The LLM also correctly attributes the sources to SPG page 116 and AMT page 111, indicating accurate sourcing. (2) Quantitatively, all numbers are correct: $88.4 million and $7.8 billion are accurately reported. While the ground truth includes the additional detail of €2.4 billion ($2.9 billion) within the $7.8 billion, this is a minor omission and does not invalidate the overall accuracy of the total amount cited. No calculations were required beyond comparison, which is handled appropriately. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two different companies (SPG and AMT), two different financial instruments (construction loans vs. multicurrency credit facility), and links them to distinct growth strategies—SPG’s joint venture–based development financing versus AMT’s acquisition-driven, debt-intensive strategy. The conclusion about differing financing intensities and strategic focus is logically derived and semantically equivalent to the ground truth. (4) The answer is contextually fully relevant, directly addressing both parts of the question: the quantitative comparison and the strategic implication. The only reason for not scoring a 10 is the omission of the €2.4 billion / $2.9 billion breakdown within AMT’s total drawdown, which adds granularity but does not alter the core correctness. Thus, the answer is highly accurate, well-reasoned, and complete for the primary correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 499,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the $0.5 billion interest rate swap held by CSCO to hedge its fixed-rate senior notes compare with AVGO's exposure to $56.3 billion in fixed-rate senior notes in terms of sensitivity to interest rate fluctuations?",
      "original_answer": "CSCO uses a $0.5 billion interest rate swap to hedge a portion of its fixed-rate senior notes, converting the fixed interest rate to a floating rate based on SOFR, thereby reducing interest rate risk for that specific liability. In contrast, AVGO holds $56.3 billion in fixed-rate senior notes as of November 3, 2024, and a 50 basis point interest rate increase would decrease the fair value of these notes by $1.7 billion. This indicates that AVGO has significant interest rate exposure on its fixed-rate debt, while CSCO has mitigated part of its exposure through active hedging.",
      "llm_answer": "Cisco’s $0.5 billion interest‑rate swap is a fair‑value hedge that converts the fixed‑rate interest on a small slice of its senior notes to a floating rate, so only the $0.5 billion notional (and the associated fair‑value change) is protected from interest‑rate moves.  \n\nBroadcom, by contrast, carries $56.3 billion of fixed‑rate senior notes; a 50‑basis‑point shift in market rates would alter the fair value of that entire portfolio by about $1.7 billion, showing a far larger sensitivity to interest‑rate fluctuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: CSCO's $0.5 billion interest rate swap hedges a portion of its fixed-rate debt by converting fixed to floating rates (SOFR implied by context), and AVGO has $56.3 billion in fixed-rate senior notes with a $1.7 billion fair value sensitivity to a 50 bps rate change. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect—dollar amounts, notional values, and sensitivity figures are all correct and properly contextualized. (3) The reasoning correctly contrasts CSCO’s active hedging (limiting interest rate risk to unhedged portions) with AVGO’s large unhedged exposure, showing sound multi-hop synthesis across two companies and financial instruments. (4) The only minor shortcoming is that the LLM does not explicitly name SOFR as the floating rate index (though this is implied in 'floating rate'), and slightly less detail on the purpose of the hedge (e.g., 'reducing interest rate risk') compared to the original. However, the semantic meaning and financial implications are preserved. The answer is fully relevant, directly addressing the comparison of interest rate sensitivity between the two firms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 352,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the use of option contracts by NKE to hedge foreign currency exposures compare to TSLA's exposure to foreign currency assets, given the impact of such hedging instruments on deferred gains and losses in other comprehensive income?",
      "original_answer": "NKE actively uses option contracts as part of its foreign currency risk management program to hedge exposures from product costs, external sales, and other costs, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024. These contracts are designated as cash flow hedges, with mark-to-market gains and losses deferred in AOCI, including $99 million in net deferred gains expected to mature in the next twelve months. In contrast, TSLA does not typically hedge foreign currency risk and instead experiences significant fluctuations in foreign exchange gains and losses from period to period, particularly on intercompany balances, which flow through 'Other income (expense), net.' This highlights a more proactive hedging strategy by NKE versus TSLA’s reactive exposure to foreign currency assets.",
      "llm_answer": "Nike’s foreign‑exchange program includes the use of currency‑option contracts that are accounted for as cash‑flow hedges; the resulting unrealised gains or losses are recorded in accumulated other‑comprehensive income (AOCI) and are only re‑classified to earnings when the underlying transaction occurs. Tesla likewise hedges its foreign‑currency assets, liabilities and forecast‑transactions with option (and forward) contracts that are designated as cash‑flow hedges, and it reports the unrealised result in OCI – a net loss of $‑97 million in OCI for 2024 (with $99 million of deferred gains for contracts maturing in the next twelve months). Thus, both companies defer the impact of their currency‑hedge instruments to OCI, but Tesla’s filing quantifies the OCI effect, whereas Nike’s filing describes the practice without providing a specific OCI amount.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitatively, it incorrectly states that Tesla uses option and forward contracts to hedge foreign currency risk and reports a net loss of $-97 million in OCI for 2024, with $99 million in deferred gains maturing in the next twelve months. The ground truth confirms that TSLA does *not* typically hedge foreign currency risk, and the $99 million deferred gain figure belongs to NKE, not Tesla. This misattribution of key financial figures severely compromises accuracy. (2) The answer fails on completeness and entity accuracy by falsely claiming Tesla employs a hedging strategy with designated cash flow hedges, which contradicts the ground truth that Tesla experiences FX fluctuations due to lack of hedging, especially on intercompany balances, and reports these in 'Other income (expense), net' rather than deferring gains/losses in OCI. (3) The reasoning is flawed: it concludes both companies defer hedge impacts to OCI, but this is not true for Tesla, breaking the multi-hop comparison. The only correct element is that NKE uses option contracts as cash flow hedges with gains/losses deferred in AOCI. However, the LLM omits NKE’s $9.9 billion notional amount and incorrectly implies Nike doesn’t disclose OCI amounts, when in fact it does ($99 million in deferred gains). (4) While the response addresses the general topic of hedging and OCI treatment, its core claims about Tesla are factually wrong, leading to a low correctness score. Contextual relevance is moderate because it attempts the right comparison framework but applies it to incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 450,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's use of Citibank in its 5-Year Facility, particularly in terms of Citibank's role and the amendment timelines?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, lists Citibank, N.A. as the administrative agent. Similarly, Caterpillar's Third Amended and Restated Credit Agreement (5-Year Facility), dated September 1, 2022, also names Citibank, N.A. as the Agent. Both companies rely on Citibank in a leadership capacity—Boeing in a dual role as administrative agent and joint lead arranger, and Caterpillar as Agent. Boeing’s amendment occurred in August 2022, while Caterpillar’s Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, showing staggered but comparable timelines for credit agreement adjustments.",
      "llm_answer": "Boeing’s five‑year credit documents name **Citibank, N.A. as the “administrative agent”** (and also a joint lead arranger) – the original agreement was executed on Oct. 30 2019 and was later amended on Aug. 25 2022 (with a new five‑year agreement again dated Aug. 24 2023). In contrast, Caterpillar’s five‑year (actually a 2023 364‑day) facility lists **Citibank, N.A. simply as “agent”** and the credit agreement was dated Aug. 31 2023, with no amendment to that facility shown in the filing.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual inaccuracies affecting overall correctness. (1) Correct elements: Boeing's original agreement date (Oct 30, 2019) and amendment date (Aug 25, 2022) are accurate, as is Citibank’s role as administrative agent and joint lead arranger. Caterpillar’s Aug 31, 2023 agreement date and Citibank’s role as 'Agent' are also correct. (2) Quantitative errors: The LLM incorrectly states that Boeing had a 'new five-year agreement dated Aug 24, 2023' — this is not supported by the ground truth, which only notes an amendment in 2022. This introduces a false data point. Additionally, the LLM claims Caterpillar’s facility is a '2023 364-day' facility, which is not mentioned in the original answer or implied by the ground truth — this misrepresents the nature of Caterpillar’s 5-Year Facility. (3) Qualitative/multi-hop reasoning: The comparison of Citibank’s roles is partially correct — Boeing has a dual role, Caterpillar a simpler 'Agent' role — but the LLM fails to note that Caterpillar’s agreement is the 'Third Amended and Restated' version, missing a key detail about its amendment history. The original answer notes Caterpillar’s Amendment No. 1 on Aug 31, 2023, but the LLM incorrectly states 'no amendment' was shown, which contradicts the ground truth. (4) Contextual relevance is high — the response directly addresses the question’s focus on roles and timelines — but due to key factual errors in dates and amendment status, the correctness score is limited to 5. The answer is partially right but contains critical inaccuracies in both quantitative and qualitative dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 454,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the difference in voting rights per share between Netflix's common stock and Meta's Class B common stock compare, given the structure of voting rights tied to different stock classes as disclosed by both companies?",
      "original_answer": "Netflix's common stock provides one vote per share, while Meta's Class B common stock provides 10 votes per share, reflecting a significant disparity in shareholder voting power between the two companies' stock structures.",
      "llm_answer": "Netflix’s common stock carries **one vote per share** (see Netflix 10‑K, “Voting Rights” – one vote per share). Meta’s Class B common stock carries **ten votes per share** (see Meta 10‑K, “Class A and Class B Common Stock…”, “Each share of Class B common stock is entitled to 10 votes per share”). Thus, a Meta Class B share has ten‑times the voting power of a Netflix common share.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, it accurately states that Netflix’s common stock provides one vote per share and Meta’s Class B common stock provides ten votes per share—both figures are factually correct and match the original answer. (2) The comparison is complete and correctly framed: a Meta Class B share has ten times the voting power of a Netflix common share, which is a valid interpretation of the disparity. (3) The multi-hop reasoning is sound—information from two different companies (Netflix and Meta) is correctly synthesized to compare their voting rights structures. (4) Entity accuracy is perfect: both companies are correctly identified, and the stock classes (common stock vs. Class B) are accurately referenced. (5) The answer is semantically equivalent to the ground truth, with slightly more detailed phrasing and proper sourcing references. No errors in logic, calculation, or fact. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 295,
        "total_tokens": 1465
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does BMY's reliance on Cardinal Health for 23% of its distribution in 2023 intersect with CVS’s financial consolidation of Red Oak Sourcing, given Cardinal Health’s 50% ownership stake in the same generic pharmaceutical sourcing entity?",
      "original_answer": "BMY relies on Cardinal Health, Inc. for 23% of its distribution network as of 2023, making Cardinal a critical third-party logistics partner. At the same time, CVS co-owns Red Oak Sourcing, LLC with Cardinal Health (each holding a 50% stake), and consolidates Red Oak’s operations into its financial statements due to its role as the primary beneficiary. This creates a complex interdependency where BMY’s supply chain is partially dependent on a company (Cardinal Health) that is structurally and financially tied to CVS through Red Oak Sourcing. The quarterly payments from Cardinal to CVS, totaling $183 million annually, influence CVS’s cost of goods sold, which could indirectly affect the pricing or efficiency of Cardinal’s distribution services to BMY.",
      "llm_answer": "BMS reported that 23 percent of its U.S. product sales in 2023 were shipped through Cardinal Health (the third‑largest wholesaler)【page_80】. Cardinal Health jointly owns Red Oak Sourcing, LLC with CVS (each holding 50 percent) and CVS has determined it is the primary beneficiary, so it consolidates Red Oak in its financial statements【page_136】【page_20】. Thus, a sizable slice of BMS’s distribution passes through a partner that co‑owns a generic‑sourcing venture that CVS fully reports, linking BMS’s reliance on Cardinal Health to CVS’s consolidated exposure to the same sourcing entity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that BMS (BMY) relies on Cardinal Health for 23% of its U.S. product distribution in 2023, matching the ground truth. It accurately states that Cardinal Health and CVS each own 50% of Red Oak Sourcing, and that CVS consolidates Red Oak due to being the primary beneficiary. All key entities, percentages, and relationships are correct. (2) Quantitatively, the 23% distribution share and 50% ownership stakes are accurate and properly cited. The LLM does not include the $183 million annual payment from Cardinal to CVS mentioned in the ground truth, which is a minor omission affecting completeness but not core correctness. (3) The multi-hop reasoning is sound: the LLM correctly links BMY’s distribution dependency on Cardinal Health to the structural relationship between Cardinal and CVS via Red Oak Sourcing, and notes the financial consolidation impact. It captures the interdependency, though it does not explicitly explore the potential indirect effects on pricing or efficiency as in the original answer. (4) The answer is semantically equivalent in key aspects, with only slight reduction in depth. Wording differences are acceptable, and no factual errors are present. The score is 9/10 due to the omission of the financial flow ($183M) and its implications, which are part of the full intersection described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 385,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does MetLife's exposure to interest rate scenarios in its Retirement and Income Solutions segment affect its Life Insurance product line, and how does this compare to AIG's experience with Life Insurance reserve updates under similar interest rate dynamics?",
      "original_answer": "MetLife's Retirement and Income Solutions segment includes life insurance products and is exposed to interest rate scenarios that could compress gross margins due to minimum crediting rate guarantees and reinvestment risks. In declining rate environments, this leads to margin compression, while rising rates allow for reinvestment in higher-yielding assets. Similarly, AIG experienced a $106 million favorable impact in 2021 from actuarial assumption updates in Life Insurance, driven by policy fee modeling, but also faced margin pressures from lower projected investment earnings. Both companies show sensitivity in their Life Insurance lines to interest rate dynamics, with MetLife managing through ALM strategies and AIG adjusting reserves and assumptions.",
      "llm_answer": "MetLife’s Retirement‑and‑Income‑Solutions (RIS) business is highly sensitive to U.S. interest‑rate moves: under its “declining‑rate” scenario the RIS segment adds about $15 million of adjusted earnings in 2022 (but turns negative in later years), whereas a “rising‑rate” scenario drags RIS earnings down $10 million in 2022 but then contributes $15‑$10 million in 2023‑24.  Because RIS products share the same long‑duration liability profile as MetLife’s traditional life‑insurance contracts, the same rate shifts that compress RIS margins also pressure life‑insurance reserves—lower rates increase the discount‑rate used to value liabilities and compress margins, while higher rates reduce reserve levels and improve profitability.  \n\nAIG experiences the impact more directly through actuarial‑assumption updates to its life‑insurance reserves: a 2021 update produced a $106 million favorable adjustment (mainly from universal‑life modeling) while a 2020 update generated a $101 million adverse impact, both driven by changes in projected investment returns and mortality assumptions that mirror the effect of interest‑rate changes on reserve valuations.  Thus, MetLife’s RIS exposure translates into indirect margin swings for its life‑insurance line, whereas AIG records explicit reserve‑adjustment gains or losses of roughly $100 million when interest‑rate‑related assumptions shift.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains several incorrect quantitative details not present in the ground truth. Specifically, it introduces specific dollar impacts for MetLife's RIS segment under interest rate scenarios—$15 million gain in declining rates and $10 million drag in rising rates in 2022, with future contributions in 2023–24—that are not found in the original answer and cannot be verified from the provided ground truth. These numbers are likely hallucinated. The original answer does not provide any such figures for MetLife’s earnings impact by year or scenario. (2) The only correct quantitative element is the $106 million favorable impact for AIG in 2021, which matches the ground truth exactly. However, the LLM adds an unsupported $101 million adverse impact in 2020 for AIG, which is not mentioned in the original answer, making this a factual overreach. (3) Qualitatively, the reasoning is sound: the LLM correctly identifies that MetLife’s RIS segment affects its life insurance line through margin pressures due to interest rate sensitivity, particularly via reinvestment risk and discount rate effects on liabilities. It also correctly notes that AIG adjusts reserves directly via actuarial assumption updates tied to investment return projections. The comparison between indirect margin effects (MetLife) vs. explicit reserve adjustments (AIG) aligns well with the original answer’s intent. (4) Contextual relevance is high—the response directly addresses both parts of the multi-hop question: MetLife’s exposure and its effect on life insurance, and a comparative analysis with AIG under similar interest rate dynamics. Despite strong structure and logical flow, the inclusion of fabricated numerical data significantly undermines factual correctness, warranting a moderate score of 6 for overall correctness. Quantitative accuracy is low (4) due to unsupported figures, while qualitative and contextual scores are higher due to valid conceptual synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 529,
        "total_tokens": 2095
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What specific battery supply agreements exist between Tesla and Panasonic Corporation, and how do these agreements compare to known battery sourcing dependencies reported by General Motors?",
      "original_answer": "Tesla has multiple agreements with Panasonic Corporation for battery supply, including the 2011 Supply Agreement, its 2019 and 2021 Pricing Agreements for Japan-sourced cells, and the 2020 Pricing Agreement for Gigafactory 2170 cells. These agreements are supported by ongoing amendments, investment letters, and shared facility leases that indicate a deep strategic partnership. In contrast, General Motors’ filings only state a general dependency on batteries without specifying agreements or suppliers, making Tesla’s battery sourcing strategy with Panasonic more explicitly defined and contractually secured.",
      "llm_answer": "Tesla’s 2023 filing lists a series of long‑term Panasonic contracts – the original 2011 Supply Agreement (Exhibit 10.25), its 2013 amendment (10.26), a 2014 supply agreement (10.27), the 2014 General Terms and Conditions (10.28), an Investment Letter Agreement (10.33), a Production‑Pricing Agreement (10.32) and subsequent pricing amendments for Japan‑cell and Gigafactory‑2170 cell production (Exhibits 10.35‑10.37, 10.31).  These agreements create a dedicated, multi‑year source of lithium‑ion cells and related factory‑lease arrangements for Tesla’s vehicles.\n\nIn contrast, General Motors’ 2023 filing shows its EV battery supply is tied to its joint‑venture Ultium Cells Holdings LLC, which “provides battery cells for our EVs” and to which GM has made committed capital contributions (see Note 8 and Note 12).  Thus, while Tesla relies on a suite of direct supply and pricing contracts with Panasonic, GM’s battery sourcing is dependent on its own Ultium Cells joint venture rather than a single external supplier.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several inaccuracies in dates and agreement specifics compared to the ground truth, affecting quantitative accuracy. It references a 2013 amendment, a 2014 supply agreement, and multiple exhibit numbers (e.g., 10.26, 10.27, 10.28, 10.31–10.37), which are not mentioned in the original answer and appear to be fabricated or misattributed. The ground truth specifies the 2011 Supply Agreement, 2019 and 2021 Pricing Agreements for Japan-sourced cells, and the 2020 Pricing Agreement for Gigafactory 2170 cells—none of which are accurately reflected in the LLM response. The LLM incorrectly implies these agreements are all listed in a '2023 filing,' while the original answer does not specify the filing year. This introduces factual errors in both dates and document references. However, the qualitative reasoning is partially sound: the LLM correctly identifies Tesla’s deep contractual relationship with Panasonic involving supply, pricing, and production arrangements, and contrasts it with GM’s reliance on its Ultium Cells joint venture. The comparison captures the essence that Tesla has explicit supplier contracts while GM depends on an internal JV, aligning with the ground truth’s claim that GM does not specify external suppliers. While the core contrast is logically synthesized and contextually relevant, the incorrect dates, fabricated exhibit numbers, and mismatched agreement names undermine factual correctness. Thus, the answer is partially correct in structure and reasoning but flawed in key factual details, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 434,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How does MDLZ's use of commodity futures, which are classified as Level 1 financial assets, compare to COST's disclosure about holding no Level 1 financial assets, in the context of their respective risk management strategies involving financial instruments?",
      "original_answer": "MDLZ actively uses commodity futures, which are categorized as Level 1 financial assets based on quoted market prices, as part of its hedging strategy to manage exposure to input cost fluctuations such as cocoa, sugar, and energy. In contrast, COST disclosed that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different approach to financial risk management that does not involve exchange-traded futures. This contrast highlights that while MDLZ relies on Level 1 commodity futures for price risk mitigation, COST does not utilize such instruments in its financial strategy.",
      "llm_answer": "Mondelez International reports that it holds commodity futures and listed options that are classified as Level 1 financial assets—exchange‑traded contracts whose fair value is based on quoted market prices—and uses them to hedge the price risk of key raw‑material inputs such as cocoa, sugar, wheat and oil (see MDLZ Note 10, where commodity contracts have a $161 million Level 1 fair‑value component). Costco, by contrast, states that it did not hold any Level 1 (or Level 3) financial assets or liabilities measured at fair value on a recurring basis, indicating that it does not employ exchange‑traded commodity futures as part of its risk‑management strategy. Thus, MDLZ actively uses Level 1 commodity futures for hedging, while COST relies on other instruments and holds no such Level 1 assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that MDLZ uses commodity futures classified as Level 1 financial assets for hedging key raw materials, including cocoa, sugar, wheat, and oil—consistent with the original answer, which mentions cocoa, sugar, and energy (wheat and oil are plausible extensions based on MDLZ's business). The inclusion of a $161 million Level 1 fair-value component from MDLZ Note 10 is factually correct and adds precision not in the original answer, but does not contradict it. (2) Quantitatively, the $161 million figure is accurate per MDLZ disclosures and appropriately cited to Note 10. No dates are incorrect—the original answer references COST’s disclosure as of August 28, 2022, which the LLM omits but implies by referencing the same fair value classification context. This is a minor omission but does not affect factual correctness. (3) The multi-hop reasoning is sound: the model correctly contrasts MDLZ’s active use of Level 1 exchange-traded instruments with COST’s explicit disclosure of holding no Level 1 or Level 3 financial assets, concluding that COST does not use such futures. This synthesis across two companies’ filings is accurate and logically presented. (4) The answer is contextually relevant, directly addressing the comparison of risk management strategies involving financial instruments. The only minor shortcoming is the slightly expanded list of hedged commodities (wheat and oil not explicitly mentioned in the original), but these are reasonable inferences for MDLZ and do not constitute errors. Overall, the answer is factually robust, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 467,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the adoption of Rule 10b5-1(c) trading plans by Apple executives compare with Broadcom's use of similar plans in terms of volume and timing of potential stock sales?",
      "original_answer": "Apple executives Deirdre O'Brien and Jeff Williams entered into Rule 10b5-1(c) trading plans in August 2024, covering the sale of shares vesting between April 1, 2025, and October 1, 2026 (O'Brien) and up to 100,000 shares plus additional vesting shares through October 1, 2025 (Williams), with expiration dates in 2025 and 2026. Broadcom director Diane M. Bryant adopted a similar plan in September 2024, allowing for the sale of up to 15,000 shares of Broadcom common stock contingent on market price thresholds, expiring September 12, 2025. Both companies utilize Rule 10b5-1(c) plans to structure insider trading in compliance with SEC regulations, but Apple’s plans involve significantly larger volumes and longer time horizons.",
      "llm_answer": "Apple’s disclosures show two senior executives adopting Rule 10b5‑1(c) plans in late August 2024.  Jeff Williams’ plan permits the sale of up to 100,000 shares (with the shares to vest between April 1 2025 and October 1 2025 and the plan expiring Dec 15 2025), while Deirdre O’Brien’s plan covers the sale of the shares that will vest from April 1 2025 through October 1 2026 (expiring Dec 31 2026).  By contrast, Broadcom’s only disclosed 10b5‑1(c) plan – adopted by board member Diane M. Bryant on Sept 23 2024 – allows the sale of at most 15,000 shares and runs until Sept 12 2025, indicating a much smaller volume and a shorter sales window than the Apple executives’ arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Correct individuals are identified: Deirdre O'Brien and Jeff Williams for Apple, Diane M. Bryant for Broadcom. (2) Quantitative accuracy: The number of shares is correct—100,000 for Williams, 15,000 for Bryant. O'Brien's plan covers vesting shares from April 1, 2025, to October 1, 2026, which is correctly stated. The LLM specifies Williams’ plan expiration as December 15, 2025, and O'Brien’s as December 31, 2026—slightly different from the ground truth, which does not specify exact expiration dates but confirms they expire in 2025 and 2026 respectively. These specific dates may not be in the source or may be inferred; since they are plausible and within the correct years, this is a minor discrepancy. (3) The adoption timing is accurate: August 2024 for Apple executives, September 23, 2024, for Bryant (ground truth says September 2024—LLM adds precision). (4) The comparison of volume and timing is sound: Apple’s plans involve larger volumes (100k+ shares vs 15k) and longer durations (up to 2026 vs 2025), which the LLM correctly highlights. (5) The reasoning is multi-hop and valid—comparing across companies, individuals, share volumes, time horizons, and regulatory context. (6) Semantic equivalence is strong: the core conclusion that Apple’s plans are larger in volume and longer in duration is preserved. Only minor deviations in expiration dates prevent a perfect 10. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 419,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the involvement of JPMorgan Chase Bank, N.A. as syndication agent in both 3M's May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement reflect a shared banking relationship in their respective credit facilities?",
      "original_answer": "JPMorgan Chase Bank, N.A. serves as syndication agent in both 3M’s May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement, indicating a shared banking relationship where JPMorgan plays a key coordinating role in managing the syndicate of lenders for both companies’ credit facilities. This suggests that both companies rely on JPMorgan Chase Bank, N.A. to help structure and administer large-scale financing arrangements, potentially reflecting a strategic alignment in how they access syndicated credit markets.",
      "llm_answer": "Both 3M’s five‑year credit agreement dated May 11 2023 (exhibit 10.29) and Honeywell’s amended and restated five‑year credit agreement dated March 20 2023 (exhibit 10.68) name JPMorgan Chase Bank, N.A. as the syndication agent 【page 114】. This common designation shows that the two companies rely on the same bank to arrange and distribute their revolving‑credit facilities, indicating a shared banking relationship across their credit programs【page 125】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that JPMorgan Chase Bank, N.A. serves as syndication agent in both 3M’s May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement. The dates, entity names, and roles are factually accurate and match the ground truth. (2) All quantitative elements—dates (May 11, 2023; March 20, 2023), document types (Five-Year Credit Agreement), and role (syndication agent)—are correct with no calculation errors. Format variations (e.g., spacing in 'five‑year') do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two separate credit agreements from different companies and identifies the shared role of JPMorgan as syndication agent, leading to the conclusion of a shared banking relationship. The reasoning is slightly less detailed than the original answer in explaining JPMorgan’s coordinating function in syndicate management and strategic alignment in credit market access, but the core logic and synthesis are valid. (4) The answer is contextually relevant, directly addressing the question about shared banking relationships through the common syndication agent. The inclusion of exhibit numbers and page references (e.g., page 114, 125) suggests grounding in source documents, enhancing credibility. Minor deduction in qualitative accuracy due to less elaboration on JPMorgan’s strategic role, but overall factual correctness and completeness warrant a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 422,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the EU and U.S. sanctions targeting the tobacco sector in Belarus impact Coca-Cola HBC's operations in the country, and what implications could this have for The Coca-Cola Company's overall unit case volume given its reliance on Coca-Cola HBC as a key bottler?",
      "original_answer": "The EU and U.S. sanctions targeting the tobacco sector in Belarus, including restrictions on trade of goods used for tobacco production, could disrupt local supply chains and economic activity, potentially affecting Coca-Cola HBC's operations in the country. Since Coca-Cola HBC is a major independent bottler representing 41% of The Coca-Cola Company’s total worldwide unit case volume in 2021 and operates in Belarus, any operational constraints or economic instability in Belarus could reduce its production and distribution capacity. This, in turn, could negatively impact The Coca-Cola Company’s overall unit case volume, especially since non-U.S. markets accounted for 83% of the company’s total volume in 2021 and bottlers like Coca-Cola HBC are contractually required to purchase concentrates from KO, forming a critical link in the supply chain.",
      "llm_answer": "The EU‑ and U.S. sanctions that bar the trade of goods used to make tobacco products in Belarus could force Coca‑Cola HBC to curtail or suspend its bottling, distribution or sales activities in that market, because the company’s Belarus operations fall under the same legal restrictions that apply to any business dealing with the tobacco sector.  Since Coca‑Cola HBC accounts for roughly 17 percent of The Coca‑Cola Company’s worldwide unit‑case volume (it is one of the five largest bottlers that together represent 41 percent of total volume), any loss of shipments from Belarus would shave a small but measurable amount off the Company’s overall case volume.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claim that Coca-Cola HBC accounts for 'roughly 17 percent' of The Coca-Cola Company’s unit case volume. The ground truth states that Coca-Cola HBC alone represented 41% of KO’s total volume in 2021, not 17%. The 17% figure appears to be a misinterpretation—possibly confusing Coca-Cola HBC’s share with an average of the top five bottlers or misreading the data. This is a major error affecting the core of the answer. (2) The statement that 'the five largest bottlers together represent 41%' is consistent with the original answer, but the implication that Coca-Cola HBC is one of them and contributes only 17% contradicts the ground truth, which clearly attributes the full 41% to Coca-Cola HBC alone. No source supports the 17% figure. (3) The reasoning chain is partially sound: the LLM correctly infers that sanctions on the tobacco sector in Belarus could indirectly affect Coca-Cola HBC’s operations due to broader economic or legal restrictions, and that disruption to a major bottler could impact KO’s overall volume. This reflects appropriate multi-hop logic (sanctions → Belarus operations → HBC capacity → KO volume). However, the flawed percentage undermines the conclusion’s accuracy. (4) Contextually, the answer addresses both parts of the question—impact on HBC in Belarus and implications for KO’s volume—and uses correct entities (Coca-Cola HBC, The Coca-Cola Company, Belarus, sanctions). Wording and structure are clear and relevant. While the direction of impact (negative, measurable but small) is plausible, the characterization of the impact as 'small' contradicts the 41% figure in the ground truth, which would make HBC a major contributor, not a minor one. Thus, the qualitative and quantitative scores are reduced, but contextual relevance remains high due to correct framing and entities.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 514,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the proposed 28%-30% reduction in U.S. debit interchange rate caps impact Capital One’s interchange fee income, given its exposure to Mastercard’s four-party network and the ongoing legal challenges involving interchange fees that Visa and Mastercard face?",
      "original_answer": "The proposed 28%-30% reduction in U.S. debit interchange rate caps by the Federal Reserve could significantly lower Capital One’s interchange fee income, as COF relies on interchange fees from transactions processed through four-party networks like Mastercard. This impact could be exacerbated by the fact that merchants continue to pursue legal actions against Mastercard and Visa, as seen in the ongoing multidistrict litigation where interchange fee practices remain under scrutiny. Mastercard, being subject to regulatory oversight and interchange fee limitations, may be forced to further reduce fees or face additional settlements, which would directly affect Capital One’s revenue model tied to those networks.",
      "llm_answer": "The Federal Reserve’s October 2023 proposal to cut the U.S. debit‑card interchange‑fee cap by about 28%‑30% would directly shrink the fee that Capital One can earn on the debit transactions it processes through Mastercard’s four‑party network, a source the company itself calls a “meaningful source of revenue” (COF 10‑K p. 38‑39).  That downward pressure is amplified by the broader antitrust litigation facing Visa and Mastercard—settlements and court orders already require caps on U.S. credit‑interchange rates and could lead to additional fee reductions—so Capital One’s overall interchange‑fee income (both debit and credit) could be materially reduced as the caps are imposed and as further legal outcomes force lower fees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and percentages are correct: the 28%-30% reduction in debit interchange fees is accurately cited (with the additional precision of October 2023, which is consistent with public record), and no incorrect figures are introduced. The reference to Capital One’s 10-K (pp. 38–39) adds verifiable support. (2) The answer correctly identifies the key entities: Capital One (COF), Mastercard’s four-party network, and the antitrust litigation involving both Visa and Mastercard. It accurately reflects that interchange fees are a 'meaningful source of revenue' for COF, as stated in its filings. (3) The multi-hop reasoning is sound: it connects the Federal Reserve’s proposed rule change → impact on debit interchange income for Capital One via Mastercard’s network → amplification due to ongoing litigation and existing settlements affecting credit interchange → potential broader impact on both debit and credit fee income. This synthesis across regulatory and legal domains is logically coherent. (4) The only minor shortcoming is that the original answer emphasizes the multidistrict litigation specifically around debit interchange practices, while the LLM answer generalizes to credit interchange outcomes. While credit litigation is relevant, the primary regulatory and legal pressure on debit fees is more directly tied to the Durbin Amendment and related merchant lawsuits, which the LLM could have specified. However, the overall conclusion—that interchange income could be materially reduced—is correct and well-supported. Wording differs but semantic equivalence is maintained. No factual errors; minor deduction in qualitative accuracy for slight overgeneralization of litigation scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 486,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does Duke Energy's exposure to LIBOR-indexed financial contracts influence its adoption timeline for ASU 2020-04 compared to Southern Company's approach, given both companies' assessments of the regulation's financial impact?",
      "original_answer": "Duke Energy is assessing LIBOR-indexed financial arrangements and evaluating the optional expedients in ASU 2020-04 for contracts extending beyond the LIBOR phase-out in 2023, with the transition not expected to have a material impact on its financial statements. Southern Company, similarly, is evaluating the provisions of ASU 2020-04 and the impact of transitioning to alternative rates, though the ultimate outcome remains uncertain. Both companies are applying the guidance as it relates to contract modifications and hedge accounting under the reform, but Duke Energy had until December 31, 2022, to apply the optional expedients, suggesting a time-bound evaluation window compared to Southern Company's ongoing assessment.",
      "llm_answer": "Duke Energy notes that a sizable portion of its variable‑rate debt and interest‑rate swaps are tied to LIBOR and, because the contracts that extend beyond the LIBOR phase‑out may need amendment, the company is still evaluating the optional expedients in the new reference‑rate‑reform guidance and had **not yet adopted ASU 2020‑04 as of December 31 2021**. In contrast, Southern Company states that it **has elected to apply the ASU 2020‑04 amendments to debt‑modification and hedging arrangements** (including its LIBOR‑referenced contracts) within the elective window (March 12 2020 – December 31 2022) and expects no material impact. Thus, Duke’s LIBOR exposure is causing a more cautious, later‑stage adoption, while Southern Company is already implementing the guidance earlier, despite both firms concluding the impact will be immaterial.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and timelines are correct: Duke Energy had not adopted ASU 2020-04 as of December 31, 2021, and Southern Company applied the guidance within the elective window ending December 31, 2022. These dates match the original answer’s implication of Duke’s time-bound evaluation window and Southern’s earlier implementation. (2) The LLM correctly identifies that both companies have LIBOR-indexed contracts and are assessing or applying ASU 2020-04’s optional expedients related to contract modifications and hedge accounting. It accurately notes that both expect no material financial impact. (3) The multi-hop reasoning is sound: it contrasts Duke’s cautious, delayed adoption due to ongoing evaluation with Southern’s proactive election to apply the guidance early, which is consistent with the original answer’s characterization of Southern’s approach as more advanced. (4) The only minor shortcoming is that the original answer emphasizes Duke’s evaluation window was *until* December 31, 2022 (same as Southern’s deadline), but the LLM implies Duke had not adopted it by end-2021 without explicitly confirming whether adoption occurred later. However, this does not contradict the truth and is a reasonable inference. Wording differs but semantic meaning and factual content are equivalent. All entities (Duke Energy, Southern Company, ASU 2020-04, LIBOR) and financial concepts are correctly used.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 412,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does the application of the Black-Scholes-Merton model for stock option valuation at KO compare to the use of weighted-average assumptions in pension plan cost calculations at CL, particularly in terms of the specific inputs and their financial reporting implications?",
      "original_answer": "KO uses the Black-Scholes-Merton model to estimate the fair value of stock option awards, with the weighted-average fair value of options granted in 2023 being calculated using assumptions such as volatility, risk-free interest rate, and expected term. These weighted-average assumptions are a key input in the model. CL also utilizes weighted-average assumptions, but in the context of pension plan cost calculations, where factors like discount rate (5.66% in 2023), expected long-term rate of return on plan assets (6.25% in 2023), and compensation increase (3.50% in 2023) directly impact the reported net periodic benefit cost. While both companies rely on weighted-average assumptions, KO applies them in equity compensation valuation using a formal pricing model, whereas CL integrates them into actuarial estimates for pension liabilities, highlighting different financial reporting applications of similar statistical inputs.",
      "llm_answer": "The Coca‑Cola Company values its stock options with a Black‑Scholes‑Merton model that inputs the grant‑date dividend yield (≈ 3 %), expected volatility (≈ 17‑18 %), the U.S. Treasury risk‑free rate (≈ 0.9‑4.1 % depending on year) and an expected term of six years; the resulting fair‑value per option is then expensed on a straight‑line basis over the four‑year vesting period and appears in SG&A (with a related tax benefit). In contrast, Colgate‑Palmolive determines its pension‑plan cost using weighted‑average actuarial assumptions—primarily a discount rate (≈ 5.4‑5.66 % for U.S. plans), an expected long‑term return on plan assets (≈ 6.5‑6.25 %), compensation‑increase rates (≈ 3.5 %), and other rates such as medical‑cost trend and interest‑crediting—which drive the components of net periodic benefit cost (service cost, interest cost, expected return, etc.) and the reported pension expense and liability on the balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) It correctly identifies KO (Coca-Cola) using the Black-Scholes-Merton model for stock option valuation and CL (Colgate-Palmolive) using weighted-average assumptions in pension cost calculations. The specific inputs for both companies are accurately described. (2) Quantitatively, the LLM provides ranges for key assumptions: expected volatility (~17-18%), risk-free rate (0.9-4.1%), expected term (6 years), discount rate (~5.4-5.66%), expected return on assets (~6.5-6.25%), and compensation increase (~3.5%). These align closely with the ground truth, which specifies 5.66% (discount rate), 6.25% (return), and 3.50% (compensation) for CL in 2023. The LLM’s use of ranges is reasonable and reflects multi-year disclosures, though the ground truth focuses on 2023 point estimates. Minor imprecision in specifying KO’s 2023 volatility or risk-free rate as ranges rather than point estimates does not constitute a factual error. (3) The reasoning is sound: the LLM correctly distinguishes between the application of weighted-average assumptions in a financial option pricing model (KO) versus actuarial pension cost modeling (CL), and explains the financial reporting implications—expensing of stock options in SG&A versus pension expense and liability recognition. (4) The answer is semantically equivalent to the ground truth, with added detail (e.g., vesting period, tax treatment, balance sheet impact) that enhances completeness without introducing errors. The only reason for not scoring 10 is the use of approximate ranges instead of the exact 2023 values emphasized in the ground truth, but this does not undermine correctness. All entities, models, and financial reporting impacts are accurately identified and contrasted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 483,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does AMT's use of subsidiary equity interests as collateral for the $525.0 million Series 2015-2 Notes compare with SPG's strategy of monetizing equity interests through disposals, particularly in light of SPG's $18.8 million gain from such transactions?",
      "original_answer": "AMT utilized the equity interests in its subsidiary GTP Acquisition Partners as part of the collateral structure for the $525.0 million Series 2015-2 Notes, which were secured by a security interest in substantially all of the personal property of the GTP Entities, including GTP Acquisition Partners' equity interests in its subsidiaries. This approach allowed AMT to securitize cash flows from specific communications sites while retaining control over excess cash flows. In contrast, SPG pursued a strategy of actively monetizing its equity interests through disposals, as evidenced by a $18.8 million gain from the sale of equity interests in 2021, indicating a more direct capital realization approach. The comparison highlights different financial strategies: AMT leveraged equity interests for secured financing, while SPG liquidated equity interests for immediate financial gain.",
      "llm_answer": "American Tower did not sell any equity; it pledged the equity interests that its wholly‑owned subsidiary GTP Acquisition Partners holds in its own subsidiaries as collateral for the $525 million Series 2015‑2 secured revenue notes (the notes are backed by mortgages on the tower sites and by a security interest in those equity holdings)【page_117】【page_118】.  \n\nSimon Property Group, by contrast, has been converting equity stakes into cash – disposing of non‑core equity interests – and recorded an $18.8 million gain from those sales in 2021【page_63】.  \n\nThus, AMT’s strategy is to use equity as a lock‑up security for debt, whereas SPG’s strategy is to monetize equity through outright disposals that generate realized gains.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: AMT pledged equity interests in subsidiaries of GTP Acquisition Partners as collateral for the $525.0 million Series 2015-2 Notes, and SPG recorded an $18.8 million gain from disposals of equity interests in 2021. The dollar amounts ($525 million and $18.8 million) and year (2021) match the original answer exactly—minor formatting difference ($525M vs $525.0 million) is acceptable. (2) Quantitative accuracy is perfect: both figures are correctly cited with proper context. (3) The multi-hop reasoning is sound—correctly contrasting AMT’s secured financing strategy (retaining control while leveraging equity) with SPG’s monetization via disposal (realizing gains). The LLM correctly identifies that AMT used equity as collateral (non-dilutive financing) while SPG sold equity for direct capital realization. (4) The only minor shortcoming is that the LLM answer does not explicitly mention AMT retaining control over excess cash flows, which is a nuanced but important point in the original answer that highlights the strategic benefit of the collateral approach. However, this omission does not undermine the overall correctness. The comparison is logically structured, entities are accurately identified, and the synthesis across two companies and strategies is clear and relevant. Hence, a high score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 399,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does ConocoPhillips' operational exposure in Nigeria compare to ExxonMobil's reliance on production-sharing contracts in terms of reserve reporting and contractual term structures?",
      "original_answer": "ConocoPhillips operates in Nigeria, where exploration and production activities are governed by production-sharing contracts (PSCs) with a typical term of 30 years, including a 10-year exploration period and a 20-year production period that may be extended under the Petroleum Industry Act. ExxonMobil reports that 12% of its total proved reserves (on an oil-equivalent basis) in 2021 were associated with PSC arrangements, where reserve volumes fluctuate inversely with price changes due to the fiscal terms of these contracts. This indicates that while both companies are exposed to PSCs in Nigeria, ExxonMobil's reserve reporting methodology must account for the dynamic nature of PSC-based reserves, whereas ConocoPhillips must manage its operations under fixed-term contractual obligations that include partial relinquishment requirements.",
      "llm_answer": "ConocoPhillips’ 2022 filing makes no specific reference to Nigeria; its only disclosed PSC‑related reserves are the ≈ 4 % of proved reserves that sit under production‑sharing contracts in the Asia‑Pacific/Middle‑East region, suggesting that any Nigerian assets are not material to its reserve reporting. In contrast, ExxonMobil’s 2022 filing describes its Nigerian deep‑water assets as being held almost entirely under 30‑year production‑sharing contracts (a 10‑year exploration phase followed by a 20‑year production phase that can be extended), and those PSCs are explicitly accounted for under the “economic‑interest” method in its reserve estimates. Thus, ExxonMobil’s reserve figures are directly tied to long‑term PSCs in Nigeria, whereas ConocoPhillips shows little or no operational exposure to Nigeria in its reserve disclosures.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but diverges significantly from the ground truth in key factual and inferential aspects. (1) Quantitatively, the LLM correctly states that ExxonMobil’s Nigerian PSCs have a 30-year term with a 10-year exploration and 20-year production phase, matching the ground truth. It also accurately notes that ExxonMobil uses the economic-interest method (implied in ground truth via dynamic reserve reporting under PSCs). However, it incorrectly claims ConocoPhillips has no disclosed exposure to Nigeria and attributes its ≈4% PSC reserves to Asia-Pacific/Middle East—this contradicts the ground truth, which explicitly states ConocoPhillips operates in Nigeria under PSCs with 30-year terms. The 4% figure is not in the original answer and appears to be fabricated or misattributed. (2) The original answer emphasizes that *both* companies are exposed to PSCs in Nigeria, but the LLM incorrectly concludes ConocoPhillips has little or no exposure, undermining the comparative analysis. (3) The reasoning is flawed in its multi-hop synthesis: while it correctly identifies ExxonMobil’s reliance on PSCs and their impact on reserve reporting, it fails to recognize the shared Nigerian PSC exposure and instead draws an incorrect contrast. (4) The ground truth highlights that ExxonMobil’s reserves fluctuate with prices under PSCs, while ConocoPhillips faces fixed-term obligations with relinquishment—this contractual and reporting distinction is entirely missing in the LLM answer. Instead, the LLM invents a regional reserve split not present in the source. Thus, while the answer is contextually relevant and attempts a valid comparison, it is factually incorrect on ConocoPhillips’ Nigerian operations and introduces unsupported data, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 492,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does IBM's focus on generative AI innovation compare with QCOM's investment in edge-based generative AI and cloud computing, particularly in terms of their respective strategies for commercializing AI technologies in high-performance, low-power computing environments?",
      "original_answer": "IBM is actively investing in generative AI as part of its broader innovation initiatives, emphasizing cutting-edge R&D to differentiate itself in hybrid cloud and AI markets, with the goal of attracting a developer ecosystem and maintaining market share. In contrast, QCOM is embedding generative AI capabilities directly into edge devices, such as smartphones and PCs, to optimize performance, privacy, and personalization while coordinating with cloud applications. QCOM's cloud computing processing initiative supports this strategy by enabling intelligent data sharing between edge devices and cloud systems. While IBM focuses on enterprise-level AI innovation and ecosystem development, QCOM is commercializing generative AI through high-performance, low-power mobile platforms, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024.",
      "llm_answer": "IBM is betting on generative‑AI as a cloud‑first, software‑driven service that runs on its hybrid‑cloud platform, emphasizing enterprise‑scale performance, security and the ability to scale AI workloads across data‑center and on‑premise environments. Qualcomm, by contrast, is commercializing generative AI through its Snapdragon‑based silicon—custom Oryon CPUs, Kryo cores and Hexagon NPUs—that deliver high‑performance inference at very low power on edge devices, while also building a cloud‑processing initiative (QSI) to complement the on‑device engine. Thus IBM’s strategy centers on AI‑enabled cloud and software offerings, whereas Qualcomm’s strategy centers on edge‑centric, low‑power hardware plus a supporting cloud layer.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its portrayal of IBM and Qualcomm's (QCOM) strategies regarding generative AI, with strong qualitative and contextual alignment to the original answer. It correctly identifies IBM's cloud-first, enterprise-focused approach centered on hybrid cloud and software services, and contrasts it with Qualcomm's edge-centric model leveraging Snapdragon silicon (e.g., NPUs, CPUs) for low-power, high-performance on-device AI. The mention of Qualcomm's cloud-processing initiative (QSI) aligns with the original answer's reference to cloud coordination, though QSI is not explicitly named in the ground truth. Crucially, the LLM answer omits the specific quantitative projection from the original answer: that generative AI-capable smartphones will rise from 19% in 2024 to 46% in 2027. This is a key commercialization metric directly tied to QCOM’s strategy and represents a meaningful omission affecting completeness. However, no incorrect facts are presented, and the reasoning across both companies’ approaches is logically sound and semantically equivalent to the ground truth. All entities (IBM, QCOM/Qualcomm, generative AI, edge/cloud computing) are correctly identified and contrasted. The absence of the 19% and 46% figures is the primary reason the correctness score is not higher, as it misses a concrete data point that strengthens the commercialization comparison. Wording differences (e.g., 'cloud-first' vs 'enterprise-level') are acceptable under semantic equivalence. No calculation errors are present, hence full marks for quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 435,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Duke Energy's exposure to nuclear decommissioning funding risks compare to NextEra Energy's financial risk management for nuclear generation, given both companies' reliance on market performance for trust-funded obligations?",
      "original_answer": "Duke Energy Carolinas, Progress, and Florida have significant obligations tied to decommissioning nuclear plants, with trust assets subject to market fluctuations that could increase funding requirements if returns fall below projections. Similarly, NextEra Energy and FPL maintain decommissioning funds and insurance coverage, but the cost of decommissioning could exceed available funds. Both companies are exposed to financial risks stemming from nuclear power plants, particularly as market performance directly affects their ability to meet long-term decommissioning obligations.",
      "llm_answer": "Duke Energy’s nuclear decommissioning risk is tied directly to the market‑value of its Nuclear Decommissioning Trust Fund (NDTF) assets – a decline in market prices could force the Carolinas, Progress and Florida subsidiaries to fund additional cash outlays, which would hurt results of operations and cash flow【page_35】. NextEra Energy also must maintain nuclear decommissioning trusts, but it stresses that its broader financial‑risk‑management program (including hedging, capital‑market access and liquidity buffers) is intended to offset the impact of market‑performance swings on those trusts, even though a poor market could still erode fund values【page_32】. Thus, Duke’s exposure is more concentrated on trust‑asset volatility, whereas NextEra relies on active risk‑management tools to mitigate a similar market‑dependent funding risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: both Duke Energy and NextEra Energy face nuclear decommissioning funding risks tied to market performance, with trust assets subject to market fluctuations. The subsidiaries of Duke Energy (Carolinas, Progress, Florida) and NextEra’s FPL are correctly identified. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that both companies rely on trust-funded obligations affected by market performance, but distinguishes Duke’s more direct exposure to trust volatility from NextEra’s broader financial risk management (hedging, liquidity, capital access), which is a nuanced and valid interpretation supported by the context. This added layer of comparison (Duke more exposed due to less mitigation) goes beyond the original answer but is logically consistent and plausible based on the cited pages. (4) Semantic equivalence is maintained—the core message about market-dependent decommissioning risks is preserved, with enhanced clarity on risk management differences. Only a minor deduction in qualitative accuracy due to the slight interpretive extension about NextEra’s active risk management, which, while reasonable, is less explicitly detailed in the ground truth. Overall, the response is contextually relevant, complete, and factually sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 423,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does CAT's application of hedging relationship accounting under ASU 2020-04 compare to UPS's adoption of the same standard, particularly in terms of their respective derivative contract management strategies and transition timelines?",
      "original_answer": "CAT formally documents and designates derivatives as either fair value or cash flow hedges, using foreign currency forward and option contracts to manage up to five years of anticipated foreign currency cash flow exposure. Under ASU 2020-04, CAT applied optional expedients for contract modifications affected by reference rate reform through December 31, 2024, though the adoption did not have a material impact. In contrast, UPS transitioned its affected debt instruments and contracts to SOFR as the alternative reference rate by December 31, 2023, but did not elect to apply the practical expedients provided under ASU 2020-04, continuing to assess potential impacts through 2024. Both companies applied the standard to manage derivative and debt contract modifications, but CAT leveraged the extended relief period while UPS opted for direct transition without using the optional relief.",
      "llm_answer": "- **Transition timing** – Both companies applied the reference‑rate‑reform update (ASU 2020‑04) as part of their 2023 year‑end reporting. Caterpillar (CAT) says that, as of 31 Dec 2023, it had fully transitioned all affected debt and contracts to the Secured Overnight Financing Rate (SOFR) in accordance with the ARRC recommendations and will continue to monitor any residual impact in 2024. UPS likewise reports that the ASU 2020‑04 changes were effective for its 2023 financial statements, with the transition to alternative reference rates completed by the end of 2023 and no material impact expected thereafter.\n\n- **Derivative‑contract management** – CAT’s hedge program is built around a “match‑funding” policy: it uses fixed‑to‑floating, floating‑to‑fixed and floating‑to‑floating interest‑rate swaps that are designated as **fair‑value hedges** (fixed‑to‑floating) or **cash‑flow hedges** (floating‑to‑fixed) to align the interest‑rate profile of its debt with the cash‑flow profile of its receivables. Foreign‑currency forwards and options are generally designated as cash‑flow hedges, while commodity forwards are kept **undesignated**. UPS, by contrast, relies on a broader set of foreign‑currency forwards, options and cross‑currency swaps to hedge currency exposure and uses interest‑rate swaps primarily as **cash‑flow hedges** (with some fair‑value hedges) but does not describe a match‑funding framework; its commodity‑related hedges are also kept undesignated.  \n\nThus, while both firms adopted ASU 2020‑04 at the same point in time, CAT couples the standard with a structured match‑funding hedge strategy that explicitly designates interest‑rate swaps for fair‑value or cash‑flow hedging, whereas UPS applies the standard to a more conventional portfolio of cash‑flow‑designated currency and interest‑rate derivatives without a dedicated match‑funding policy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly regarding transition timelines and the application of ASU 2020-04 expedients, which undermines its correctness. (1) Quantitatively, the LLM incorrectly states that CAT fully transitioned to SOFR by December 31, 2023, while the ground truth indicates CAT used optional expedients through December 31, 2024, and did not complete a full transition by 2023. Conversely, UPS completed its transition by December 31, 2023, but the LLM incorrectly aligns CAT with this timeline. Additionally, the LLM claims both companies adopted ASU 2020-04 in 2023, but the original answer clarifies that CAT applied the extended relief period through 2024, indicating a different implementation approach. (2) The LLM incorrectly asserts that CAT transitioned to SOFR in line with ARRC recommendations, which is not stated in the ground truth; instead, CAT used expedients for contract modifications without material impact. UPS, per the original, did not use the expedients—this is misrepresented in the LLM answer, which implies both adopted the standard similarly. (3) Qualitatively, the reasoning is partially sound in describing derivative management strategies—CAT’s use of fair value and cash flow hedges and UPS’s broader derivative use are plausible—but the introduction of a 'match-funding policy' for CAT is not supported in the ground truth and represents an unsupported inference. The comparison hinges on a fabricated strategic framework. (4) Contextually, the answer is well-structured and addresses the core dimensions of the question (transition timelines, hedging strategies, use of expedients), so relevance is high. However, due to major errors in key facts—especially the reversal of CAT’s and UPS’s approaches to expedients and transition dates—the overall correctness is low. The LLM conflates the two companies’ strategies, reversing who used the relief provisions and who transitioned directly, which constitutes a critical multi-hop reasoning failure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1715,
        "completion_tokens": 542,
        "total_tokens": 2258
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's dual-class stock structure, particularly in terms of control implications given Alphabet's significant share repurchase activity in Classes A and C?",
      "original_answer": "Comcast has no voting rights in Atairos and only certain consent rights, which means it lacks control over Atairos’s activities despite a remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet maintains a dual-class stock structure where Class B shares have 10 votes per share, allowing key stakeholders to retain outsized voting power. Despite repurchasing $62.0 billion in Class A and Class C shares in 2024 alone, Alphabet has preserved the Class B structure, which ensures concentrated control while reducing public float in the lower-vote and no-vote classes.",
      "llm_answer": "Comcast’s investment in Atairos gives it only economic exposure – it holds no voting rights and therefore cannot direct Atairos’s activities (see CMCSA 10‑K p. 85‑86). In contrast, Alphabet’s capital structure is dual‑class: Class B shares carry ten votes each, while Class A carries one vote and Class C carries none, and the company has been actively repurchasing large amounts of Class A and Class C stock (see GOOGL 10‑K p. 82). Those repurchases reduce the pool of low‑ or non‑voting shares, thereby concentrating voting power in the Class B holders and preserving the founders’ control over Alphabet.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that Comcast has no voting rights in Atairos, only economic exposure and consent rights, aligning with the original answer’s emphasis on lack of control despite a $1.4 billion unfunded commitment. While the LLM does not explicitly mention the $1.4 billion figure, this is the only minor omission. (2) Regarding Alphabet, the LLM accurately describes the dual-class structure (10 votes for Class B, 1 for Class A, 0 for Class C) and correctly notes the repurchase of Class A and C shares, which reduces public float and concentrates voting power. The $62.0 billion repurchase amount in 2024 from the ground truth is not mentioned in the LLM answer, which is a quantitative shortcoming. (3) The multi-hop reasoning is sound: the model correctly synthesizes Comcast’s lack of control with Alphabet’s preserved control via structural mechanisms, even amid share buybacks. (4) Wording differs but semantic meaning matches—e.g., 'concentrating voting power in Class B holders' captures the essence of Alphabet’s control preservation. The answer is contextually excellent, directly addressing the comparison of control implications. Deduction is only for missing two specific dollar amounts ($1.4B commitment, $62B repurchases), but the conceptual and qualitative analysis is complete and correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 388,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the extension of reference rate reform accounting relief under ASU 2022-06 impact the transition timelines for both UPS and FedEx, given that UPS had already transitioned its affected debt to SOFR by December 31, 2023, while FedEx continued monitoring its contracts through May 31, 2024?",
      "original_answer": "The deferral of the sunset date of ASU 2020-04 from December 31, 2022, to December 31, 2024, via ASU 2022-06, allowed both UPS and FedEx to extend their evaluation and application of reference rate reform accounting relief. UPS had already transitioned its affected debt instruments and contracts to SOFR by December 31, 2023, and did not elect to apply the practical expedients under Topic 848, but continued to assess potential impacts through 2024. FedEx, on the other hand, had not experienced any material effect from reference rate reform as of May 31, 2024, and continued to monitor its contracts and transactions for potential application of ASUs 2020-04 and 2022-06. The extension provided FedEx additional time to evaluate whether to apply the optional expedients, while UPS used the period to ensure full alignment with the new rates and assess any residual effects.",
      "llm_answer": "The ASU 2022‑06 relief now runs through December 31, 2024. UPS had already finished moving all of its LIBOR‑linked debt to SOFR by the end of 2023, so the extension does not change its timeline. FedEx, by contrast, is still evaluating the impact of the reform and will continue to monitor its contracts at least through May 31, 2024, giving it the full remainder of the extended period to complete any required transitions before the 2024 deadline.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all dates and timelines are accurate: ASU 2022-06 extends relief to December 31, 2024; UPS completed transition by December 31, 2023; FedEx continued monitoring through May 31, 2024. These match the original answer exactly. (2) The answer correctly identifies that the extension did not alter UPS’s timeline since it had already transitioned, which is consistent with the ground truth stating UPS did not elect Topic 848 expedients but continued assessing impacts. (3) For FedEx, the LLM correctly notes ongoing evaluation and monitoring through May 31, 2024, and implies the extended period allows more time for action—this matches the original answer’s point about FedEx having not experienced material effects and continuing to monitor for potential application of the ASUs. (4) Minor omission: the LLM does not mention that UPS continued to assess potential residual impacts through 2024, nor does it reference the practical expedients under Topic 848 or ASU 2020-04 explicitly, which are part of the multi-hop synthesis in the original. However, the core reasoning and factual content—especially regarding timelines and entity-specific actions—are sound and semantically equivalent. The answer is highly relevant and correctly interprets the impact of the extension on both companies’ transition strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 387,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does PepsiCo's beverage revenue concentration in Africa, Middle East, and South Asia (29% in 2023) compare with Target's beverage sales geographic exposure, given that Target's merchandise segments only describe domestic operations in the U.S.?",
      "original_answer": "PepsiCo generated 29% of its beverage revenue from the Africa, Middle East, and South Asia (AMESA) region in 2023, indicating a significant international presence in this sector. In contrast, Target's 2023 10-K filing only describes its beverage offerings as part of grocery sales within its U.S. operations, with no mention of international retail presence or beverage sales outside the United States. This suggests that Target's beverage sales are entirely domestic, while PepsiCo maintains a substantial international footprint in beverages, particularly in the AMESA region.",
      "llm_answer": "PepsiCo reports that beverages made up 29 % of net revenue in its Africa‑Middle East‑South Asia (AMESA) division in 2023, showing a sizable share of its beverage business tied to those regions【page_72】. In contrast, Target notes that it operates as a single, domestic segment and that “nearly all of our revenues are generated in the United States,” so its food‑and‑beverage sales are essentially confined to the U.S. market【page_46】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that PepsiCo generated 29% of its beverage revenue in the Africa-Middle East-South Asia (AMESA) region in 2023, matching the ground truth. It also accurately notes that Target operates as a single domestic segment with nearly all revenues from the U.S., which aligns with the absence of international beverage sales disclosure. (2) Quantitatively, the 29% figure and the characterization of Target’s revenue as almost entirely U.S.-based are factually correct and consistent with the original answer. No calculations were required, and all numbers are accurate. (3) The multi-hop reasoning is sound: the model correctly contrasts PepsiCo’s international beverage revenue concentration with Target’s domestic-only operations by synthesizing information from both companies’ 10-Ks. The only minor shortcoming is that the LLM says 'beverages made up 29% of net revenue in its AMESA division' rather than '29% of its beverage revenue came from the AMESA region'—a subtle but notable distinction in meaning. The former could imply that beverages are 29% of AMESA’s revenue, while the latter (correct in the ground truth) means AMESA accounts for 29% of global beverage revenue. However, given the context and citation, this is likely a rephrasing issue rather than a factual error, and the overall intent is preserved. (4) The answer is highly relevant, directly addressing the comparison of geographic exposure in beverage sales. Scores reflect high accuracy with a minor deduction in qualitative accuracy due to the slight ambiguity in revenue interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 438,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the absence of the Countercyclical Capital Buffer impact the minimum capital requirements for SCHW compared to GS's TLAC to RWAs requirement, given both are subject to multi-layered regulatory buffers?",
      "original_answer": "For SCHW, the absence of the Countercyclical Capital Buffer (which was set to zero) still results in a minimum Common Equity Tier 1 Risk-Based Capital ratio of 7.0%, Tier 1 Risk-Based Capital ratio of 8.5%, and Total Risk-Based Capital ratio of 10.5%, inclusive of other buffers like the 2.5% stress capital buffer. For GS, the TLAC to RWAs requirement includes a 18% minimum, a 2.5% buffer, and also incorporates the Countercyclical Capital Buffer (also set to zero), along with a 1.5% G-SIB surcharge. Therefore, even without the Countercyclical Capital Buffer, both firms face layered capital requirements, but GS's baseline (18%) is significantly higher due to its global systemic importance and TLAC framework.",
      "llm_answer": "Schwab’s capital rules show that its counter‑cyclical capital buffer (CCyB) was **zero** for both 2023 and 2024. Consequently, the minimum capital ratios it must hold are just the regulatory minimum plus the other required buffers (2.5 % stress‑capital buffer and 2.5 % capital‑conservation buffer), giving overall minimum ratios of roughly **7 % CET1, 8.5 % Tier 1 and 10.5 % total risk‑based capital**【page_118】.  \n\nGoldman Sachs’ TLAC‑to‑RWAs requirement is calculated as the sum of an 18 % baseline, a 2.5 % buffer, a **zero CCyB**, and a 1.5 % G‑SIB surcharge, which yields a **22 % TLAC‑to‑RWAs** target (the same figure is shown in the TLAC table)【page_93】.  \n\nThus, the absence of a CCyB does not add any extra cushion for either firm; Schwab’s minimum capital requirement stays at the modest 7‑10.5 % range, while Goldman Sachs must still meet a much higher 22 % TLAC‑to‑RWAs requirement because that metric already incorporates all other required buffers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers are correct: SCHW's CET1 (7.0%), Tier 1 (8.5%), and Total Risk-Based Capital (10.5%) ratios match the original answer. GS's TLAC components—18% baseline, 2.5% buffer, 0% CCyB, and 1.5% G-SIB surcharge—are correctly identified, and the sum (22%) is accurate. (2) Quantitative accuracy is perfect: calculations are correct, and the absence of CCyB (set to zero) is properly reflected for both firms. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both firms are subject to layered buffers, and despite the absence of CCyB, GS faces a much higher requirement due to TLAC and G-SIB status. (4) Minor qualitative discrepancy: the LLM mentions a '2.5% capital-conservation buffer' for SCHW, which is not mentioned in the ground truth—instead, the original answer specifies a 2.5% stress capital buffer. While both are regulatory buffers, conflating them slightly affects precision. However, the overall capital ratios are correct, so this is a minor issue. (5) Contextual relevance is excellent: the answer directly addresses the comparative impact of CCyB absence on minimum capital requirements for both firms within their respective regulatory frameworks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 355,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does Dalton's $5.3 million reimbursement from Georgia Power for Plant Vogtle construction reflect its involvement in self-owned generation facilities, and how does this ownership model contrast with NEE's approach to revenue generation through long-term contracts covering 94% of its capacity?",
      "original_answer": "Dalton receives $5.3 million in reimbursements from Georgia Power for its share of Plant Vogtle Units 3 and 4 construction costs, indicating its partial ownership stake in this nuclear generation facility. This aligns with Dalton’s broader strategy of serving its energy requirements through self-owned generation assets, some of which are jointly owned with Georgia Power. In contrast, NEE generates revenue by contracting 94% of its net generating capacity under long-term bilateral agreements, focusing on full-output commitments rather than joint ownership of facilities. This highlights a structural difference: Dalton participates in shared infrastructure ownership to meet its load needs, while NEE monetizes its generation assets through extensive contractual commitments in competitive markets.",
      "llm_answer": "Dalton’s $5.3 million reimbursement from Georgia Power (page 189) is a payment for Dalton’s proportional share of the Plant Vogtle construction costs, reflecting that Dalton meets its own load through self‑owned (and partly jointly‑owned) generation assets – it “serves its requirements from self‑owned generation facilities, some of which are jointly‑owned with Georgia Power” (page 191). By contrast, NextEra Energy Resources (NEE) does not rely on self‑owned plants for revenue; instead, about 94 % of its net generating capacity is already contracted under long‑term power purchase agreements, providing a predictable revenue stream (page 19). Thus, Dalton’s model is based on ownership‑based cost‑sharing of a specific nuclear project, whereas NEE’s model is based on selling the output of its owned assets through extensive long‑term contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Dalton receives $5.3 million from Georgia Power for its share of Plant Vogtle construction costs, reflecting its partial ownership in self-owned/jointly-owned generation assets. NEE contracts 94% of its net generating capacity under long-term agreements. These numbers and entities (Dalton, Georgia Power, Plant Vogtle, NEE) are correctly identified. (2) Quantitative accuracy is perfect: $5.3 million and 94% are correctly reported with no calculation errors. Format variations (e.g., $5.3 million) are acceptable. (3) Multi-hop reasoning is sound—LLM correctly synthesizes Dalton’s ownership model (cost-sharing via joint ownership to meet load needs) versus NEE’s revenue model (long-term contracts for output sales), drawing a clear structural contrast. (4) The only minor shortcoming is slight imprecision in stating that NEE 'does not rely on self-owned plants for revenue'—while NEE does own the plants, it monetizes them via contracts rather than using them for in-house load, which could be misinterpreted. However, the overall semantic meaning and intent match the original answer. Wording differences are acceptable under semantic equivalence. Contextual relevance is excellent, addressing all parts of the multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 373,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do RTX and BA differ in their approaches to managing customer financing obligations, particularly regarding RTX's $7.0 billion in credit facilities versus BA's long-term lease structures?",
      "original_answer": "RTX manages its customer financing obligations by leveraging its strong liquidity position, including $7.0 billion in available credit facilities, which provides flexibility for funding such obligations without relying on short-term commercial paper borrowings. In contrast, BA structures its customer financing through long-term lease arrangements, with terms ranging from 1 to 12 years, often including options to extend, terminate, or purchase the underlying asset. These lease-based financing strategies reflect BA's capital-intensive model, particularly in its BCC segment, and are accounted for under operating or finance leases, impacting both asset and liability balances on its balance sheet. The differing approaches highlight RTX's reliance on liquidity buffers versus BA's use of extended lease terms to manage financing commitments.",
      "llm_answer": "RTX keeps its customer‑financing capacity on its balance sheet by maintaining a $7 billion pool of revolving credit facilities (a $5 billion revolving line plus a $2 billion supplemental line) that it can draw on as needed to fund operations or extend credit to customers【page_52†L13-L20】. In contrast, Boeing satisfies customer‑financing demand through long‑term lease arrangements – sales‑type/finance leases and operating leases with terms of 1‑12 years, optional extensions and residual‑value guarantees – and records the resulting financing receivables and lease assets on its books rather than relying on a credit line【page_93†L1-L4】【page_94†L1-L9】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all figures are correct: RTX's $7.0 billion in credit facilities is accurately broken down into a $5 billion revolving line and $2 billion supplemental line, matching the source. Boeing's lease terms of 1–12 years are correctly stated. (2) The answer correctly identifies RTX’s use of credit facilities to fund customer financing without relying on commercial paper, and contrasts it with BA’s use of long-term lease structures (sales-type/finance and operating leases), including key features like extensions and residual-value guarantees. (3) Multi-hop reasoning is sound—information is synthesized across RTX and BA, correctly contrasting their financing models: RTX relies on liquidity buffers (credit lines), while BA uses on-balance-sheet lease receivables and lease assets. (4) The only minor omission is that the original answer notes BA’s BCC segment as particularly capital-intensive, which adds contextual depth not fully captured in the LLM response. However, this does not detract from the core factual accuracy. Wording differs but semantic meaning is equivalent. All entities (RTX, BA, credit facilities, lease types) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 354,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do Coca-Cola and Philip Morris differ in their application of weighted-average assumptions within their financial reporting frameworks?",
      "original_answer": "Coca-Cola uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, with the weighted-average assumptions applied specifically to these stock options granted during the years ended December 31, 2023, 2022, and 2021. In contrast, Philip Morris applies weighted-average assumptions to determine net pension and postretirement healthcare costs, which is a different financial reporting framework focused on employee benefits beyond stock compensation. The difference in application highlights how the same accounting methodology is used for distinct compensation components—equity-based incentives at Coca-Cola versus retirement and healthcare liabilities at Philip Morris.",
      "llm_answer": "Coca‑Cola’s weighted‑average assumptions are used in its equity‑compensation accounting – the company applies a weighted‑average fair‑value of stock‑option grants (dividend yield, volatility, risk‑free rate and expected term) and spreads the $267 million of unrecognized stock‑based compensation over a weighted‑average period of 1.7 years.  \n\nPhilip Morris, by contrast, applies weighted‑average assumptions to its post‑retirement benefit calculations – it uses weighted‑average discount rates, expected return on plan assets, compensation‑increase rates, interest‑crediting rates and health‑care cost‑trend rates to determine pension and post‑retirement cost and liability measurements.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the core distinction in how Coca-Cola and Philip Morris apply weighted-average assumptions: Coca-Cola uses them for equity-based compensation (specifically stock options), while Philip Morris applies them to post-retirement benefit accounting. This aligns perfectly with the ground truth and demonstrates accurate multi-hop reasoning across two different companies and financial reporting frameworks. The qualitative accuracy is excellent—entities (Coca-Cola, Philip Morris), financial concepts (weighted-average assumptions, stock compensation, pension/post-retirement benefits), and context (financial reporting frameworks) are all correctly identified and contrasted. Contextual relevance is strong as the response directly addresses the comparative application of the methodology. On quantitative accuracy, the LLM introduces specific figures—$267 million in unrecognized stock-based compensation and a 1.7-year amortization period—that are not present in the original ground truth. While these numbers may be factually correct based on Coca-Cola’s actual filings, they go beyond the provided knowledge graph and cannot be verified against the ground truth. This introduces unverified specifics, slightly reducing confidence in quantitative fidelity. However, since the model does not misstate any ground truth numbers (it adds rather than distorts), and the core reasoning remains sound, the overall correctness score remains high at 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 405,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does the expiration timeline of regulatory exclusivity for Merck's Januvia family of products compare to Gilead's U.S. regulatory exclusivity expiration in 2032, and what impact might this have on their respective market positions given the role of exclusivity in delaying generic competition?",
      "original_answer": "Merck's Januvia family of products is expected to lose U.S. market exclusivity in May 2026 (Januvia and Janumet) and July 2026 (Janumet XR), while Gilead has a U.S. regulatory exclusivity that expires in 2032. According to the evidence, regulatory exclusivity provides a period during which generic competitors cannot rely on the innovator’s data for approval, thus delaying market entry of generics. Since Gilead benefits from a significantly longer exclusivity period, it may maintain a more protected market position through 2032, whereas Merck will face substantial sales declines starting in 2026 due to generic competition and pricing pressures, as seen in other markets post-expiry.",
      "llm_answer": "Merck says that, because of a later‑expiring patent on the sitagliptin salt form, its Januvia/Janumet family will retain U.S. market exclusivity only until May 2026 (Januvia/Janumet) and July 2026 (Janumet XR)【page_58】. Gilead’s 10‑K notes that the U.S. regulatory exclusivity for its key product(s) does not expire until 2032【page_9】. Consequently, Merck will face generic competition several years earlier, likely accelerating sales declines for Januvia, whereas Gilead’s later exclusivity date should allow it to preserve market share and pricing power for a longer period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the U.S. market exclusivity expiration dates for Merck's Januvia family as May 2026 (Januvia/Janumet) and July 2026 (Janumet XR), matching the ground truth. It also accurately states that Gilead’s U.S. regulatory exclusivity expires in 2032. These dates are critical quantitative elements and are correct. (2) All numeric values—specifically the years 2026 and 2032 and the months May and July—are factually accurate and consistent with the original answer. There are no calculation errors, and the temporal comparison (Gilead’s exclusivity lasting significantly longer) is correctly interpreted. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (Merck and Gilead), correctly compares their exclusivity timelines, and draws a logical conclusion about the impact on market position. It correctly infers that earlier loss of exclusivity will lead to earlier generic competition and sales decline for Merck, while Gilead benefits from prolonged protection. The reasoning about pricing power and market share preservation aligns with the ground truth. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the mechanism of regulatory exclusivity—i.e., that it prevents generics from relying on innovator data—though it implies the consequence (delayed generic entry). This slight omission in explanatory depth prevents a perfect 10 on qualitative accuracy, but the core reasoning and factual content remain highly accurate. Overall, the answer is semantically equivalent to the ground truth, with excellent contextual relevance and precise quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 459,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does Intel's amortization expense for developed technology used in cybersecurity compare with Cisco's revenue recognition timing for its cloud security offerings?",
      "original_answer": "Intel reported $1,283 million in amortization expenses for developed technology in 2021, which includes technology used for cybersecurity solutions like cloud security. Cisco recognizes revenue for its cloud security offerings ratably over the contract term, aligning with the ongoing delivery of updates and upgrades critical to the software’s performance. This contrasts with Intel’s cost recognition pattern, where developed technology is amortized over a 9-year weighted average useful life, reflecting a more fixed cost structure compared to Cisco’s recurring revenue model.",
      "llm_answer": "Intel’s identified intangible “developed technology” – which includes its cyber‑security products – generates an amortization charge of roughly **$1.3 billion per year** ( $1,283 million in 2021, $1,211 million in 2020) 【page_95】.  \n\nCisco, by contrast, does **not expense the technology up front**; for its cloud‑security (and other security‑software) offerings it treats the software license or SaaS as a single performance obligation and **recognizes the revenue ratably over the contract term** rather than at the point of sale 【page_75】.  \n\nThus, Intel records a large annual amortization expense on its cyber‑security intangibles, while Cisco spreads revenue from its cloud‑security contracts evenly over the life of each contract.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Intel's amortization expense for developed technology used in cybersecurity, citing $1,283 million in 2021 (matching the ground truth) and even adding $1,211 million from 2020 for context, which is accurate and enhances completeness. The figure is correctly labeled as an annual amortization charge and associated with cybersecurity-related intangibles. Cisco's revenue recognition policy is accurately described: revenue for cloud security offerings is recognized ratably over the contract term, consistent with the ground truth. The contrast between Intel’s cost (amortization) and Cisco’s revenue (ratable recognition) is logically drawn. (2) All numeric values are correct and properly attributed to the right years and companies. Format variations (e.g., $1.3 billion vs $1,283 million) are acceptable and common. No calculation errors. (3) Multi-hop reasoning is sound: the model synthesizes Intel’s expense recognition (from its intangible asset amortization) with Cisco’s revenue recognition policy (from its SaaS contracts), correctly contrasting cost versus revenue timing across two different business models. The reasoning captures the core of the comparison: fixed annual amortization vs. recurring revenue recognition. (4) The only minor shortcoming is that the LLM does not explicitly mention the 9-year weighted average useful life of Intel’s developed technology, which is part of the ground truth and adds nuance to the amortization pattern. However, this does not undermine the overall correctness. The answer remains semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 446,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the adoption of ASU 2022-02 affected MET's loan modification disclosures compared to JPM's reporting under the legacy TDR guidance, particularly in terms of the types and financial impact of modifications made to borrowers experiencing financial difficulty?",
      "original_answer": "MET adopted ASU 2022-02 on January 1, 2023, which eliminated the TDR accounting framework and introduced the concept of Financial Difficulty Modifications (FDMs), requiring expanded disclosures. MET reported that the adoption did not have a material impact on its financial statements, but it now discloses FDMs instead of TDRs. JPM, under the legacy TDR guidance prior to 2023, reported $362 million in new TDRs for 2022, with modifications typically involving interest rate reductions, term extensions, and payment delays. In 2023, under FDM reporting, JPM noted $136 million in FDMs, predominantly term extensions and rate reductions, which extended the weighted-average life of loans by 20 years and reduced the weighted-average interest rate from 7.21% to 4.44%. This shift reflects a more principles-based approach under ASU 2022-02, focusing on financial difficulty rather than concession-based criteria, resulting in more consistent and transparent reporting of loan modifications across both institutions.",
      "llm_answer": "MetLife’s adoption of ASU 2022‑02 moved all borrower‑difficulty modifications out of the “troubled‑debt‑restructuring” (TDR) framework and into a new “financial‑difficulty modification” (FDM) category.  The firm says the types of concessions – principally term extensions and interest‑rate cuts – have not changed, but the 2023 FDM portfolio was only $136 million (mostly extensions and rate reductions that lengthened the weighted‑average life by 20 years and cut the contractual rate from 7.21 % to 4.44 %) and generated no additional lending commitments, with trial‑modifications ($69 million) and Chapter 7 loans ($9 million) reported separately as TDRs.  \n\nBy contrast, JPMorgan still reports modifications under the legacy TDR rules; its 2022 TDRs total $362 million (2021 $866 million) and include a broader mix of concessions—interest‑rate reductions, extensions, principal/interest deferrals and forgiveness—and show tangible financial effects such as $1 million of charge‑offs, $16 million of principal deferred, $2 million forgiven and $147 million of loans that re‑defaulted within a year.  Thus MetLife’s new reporting is more streamlined and shows a smaller, less‑impactful modification pool, whereas JPMorgan’s legacy TDR disclosures detail larger, more varied concessions and associated losses.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the attribution of data. It incorrectly assigns JPM's 2023 FDM data (specifically $136 million in FDMs, 20-year extension, rate drop from 7.21% to 4.44%) to MetLife (MET), while the ground truth states that these figures belong to JPM, not MET. Additionally, the LLM claims MET reported a $136 million FDM portfolio in 2023 with specific rate and term impacts, but the original answer states that MET adopted ASU 2022-02 but did not report material financial impact or specific FDM figures—only that it now discloses FDMs instead of TDRs. The $136 million figure, rate reduction, and loan life extension are explicitly tied to JPM in 2023 under FDM reporting in the ground truth, not MET. The LLM also incorrectly states that JPM 'still reports under legacy TDR rules'—but the original answer implies JPM transitioned to FDM in 2023, meaning it no longer uses legacy TDR for new reporting. (2) Quantitative accuracy is low: the $136 million, 7.21% to 4.44% rate drop, and 20-year extension are correct numbers but misattributed to the wrong company. The LLM invents trial-modifications ($69 million) and Chapter 7 loans ($9 million) for MET that are not in the ground truth. JPM’s 2022 TDR of $362 million is correct, but the additional details like $1 million charge-offs, $16 million deferred, etc., are not in the original answer and appear fabricated. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize across entities and time—confusing MET’s adoption with JPM’s reported FDM data and misrepresenting both firms’ reporting frameworks. It incorrectly contrasts MET’s 'streamlined' reporting with JPM’s 'legacy' system, when in fact both are post-transition or transitioning, and JPM had already adopted FDM in 2023. (4) Contextual relevance is high—the answer addresses loan modifications, disclosures, types of concessions, and financial impact as asked. However, due to severe factual and attribution errors, especially in quantitative data and entity mapping, the correctness score is low despite relevant structure and terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1610,
        "completion_tokens": 576,
        "total_tokens": 2187
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does CVX's upstream position in South American natural gas reserves compare with XOM's downstream footprint across the broader Americas region?",
      "original_answer": "CVX reported 329 billion cubic feet of natural gas reserves in South America as of December 31, 2022, reflecting its upstream exposure in the region. South America is geographically included within the broader 'Americas' reporting segment, which encompasses both North and South America. XOM maintains a large downstream presence across the Americas, with integrated refining, marketing, and logistics operations focused on delivering refined products like gasoline, diesel, and synthetic motor oils. While CVX's position centers on upstream resource extraction in South America, XOM's downstream operations span the entire Americas region, highlighting complementary but distinct strategic focuses within the energy value chain.",
      "llm_answer": "- Chevron’s upstream portfolio includes roughly **455 billion cubic feet of proved natural‑gas reserves in South America (“Other Americas”)** at year‑end 2021, showing a material but region‑specific resource base.  \n\n- ExxonMobil’s downstream business, on the other hand, is a **broad, integrated footprint that covers the whole Americas (both North and South America)** with refining, marketing, logistics and trading assets; it produced about **$791 million of non‑U.S. downstream earnings in 2021**, reflecting a much wider geographic scope than Chevron’s South‑American gas reserve position.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies: it reports Chevron's (CVX) South American natural gas reserves as 455 billion cubic feet as of year-end 2021, whereas the ground truth states 329 billion cubic feet as of December 31, 2022. This is both a numerical and temporal discrepancy—neither the amount nor the year matches. Additionally, the LLM introduces a figure of $791 million in non-U.S. downstream earnings for XOM in 2021, which is not present in the original answer and cannot be verified against the provided ground truth. 2) The original answer does not include any earnings data for XOM’s downstream operations, so this number appears to be hallucinated or sourced from outside the knowledge graph. While the general characterization of XOM’s downstream footprint as broad and integrated across the Americas aligns with the ground truth, the inclusion of an unsupported financial figure undermines quantitative accuracy. 3) Qualitatively, the reasoning correctly identifies the multi-hop contrast—CVX’s upstream focus in South America vs. XOM’s broader downstream presence across the Americas—and correctly interprets the geographic scope of 'Americas' as including both North and South America. The entity identification (CVX, XOM, upstream vs. downstream) is accurate, and the conceptual comparison is sound. 4) Contextually, the answer is relevant and addresses the core of the question by contrasting strategic positions in the energy value chain. However, due to incorrect reserve numbers, wrong reporting year, and an unsupported earnings figure, the correctness score is limited to 5—partially correct but with major factual flaws that affect reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 460,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the $25 million commercial paper exposure of Duke Energy Ohio compare with Tesla's $470 million commercial paper holdings in terms of their short-term liquidity strategies?",
      "original_answer": "Duke Energy Ohio reports a $25 million commercial paper exposure as part of its short-term liabilities, reflecting its reliance on modest short-term borrowing for operational needs. In contrast, Tesla holds $470 million in commercial paper as part of its short-term investments, indicating a cash deployment strategy rather than a funding need. This comparison highlights two distinct uses of commercial paper: Duke Energy utilizes it as a financing tool, while Tesla treats it as an investment to optimize liquidity returns.",
      "llm_answer": "Duke Energy Ohio carries only $25 million of commercial paper, which the company classifies as long‑term debt because it is back‑stopped by a master credit facility and can be refinanced on a longer horizon (the weighted‑average maturity of its CP program is about 15‑23 days). In contrast, Tesla reports $470 million of commercial paper as part of its cash‑equivalents and short‑term investments, meaning it is held as a highly liquid asset that can be drawn on immediately to meet short‑term cash needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $25 million commercial paper exposure for Duke Energy Ohio and Tesla's $470 million commercial paper holdings, matching the ground truth numerically. These values are accurately reported with correct units and entity associations.\n\n2) Quantitatively, all numbers are correct: $25 million and $470 million are consistent with the original answer. No calculations are required, but the comparison in magnitude is implied and accurate.\n\n3) The qualitative reasoning is mostly sound but contains a subtle inaccuracy: the LLM states that Duke Energy Ohio classifies its commercial paper as 'long-term debt' due to back-stopping by a credit facility. While technically possible under accounting rules (e.g., if refinancing capacity exists), the original answer frames the $25 million as a short-term liability, emphasizing its role in short-term financing. The LLM’s focus on classification as long-term could mislead about the nature of the exposure. Additionally, the original answer makes a clear conceptual contrast—Duke uses commercial paper as a financing tool (liability), while Tesla holds it as an investment (asset). The LLM captures this distinction but slightly misrepresents Duke’s classification, potentially weakening the conceptual clarity.\n\n4) The LLM answer addresses both entities and the core contrast in liquidity strategies—Duke as a borrower and Tesla as an investor in commercial paper. It correctly interprets Tesla’s holdings as part of cash equivalents and short-term investments. However, it omits the explicit framing of Duke’s use as reflecting 'modest short-term borrowing for operational needs' and Tesla’s strategy as 'cash deployment to optimize liquidity returns,' which are key conceptual points in the ground truth.\n\n5) Despite minor issues in framing and emphasis, the answer is contextually relevant, factually accurate in numbers, and conveys a largely correct interpretation of the two companies’ opposing roles in the commercial paper market. The reasoning is strong but not fully aligned with the precise financial characterization in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 572,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the voting power structure of META's Class A common stock compare to GOOGL's Class B common stock in terms of shareholder influence, given the dual-class stock structures described in their filings?",
      "original_answer": "META's Class A common stock has limited voting power compared to its Class B common stock, where a single shareholder (Mr. Zuckerberg) retains significant control, with Class B shares requiring majority approval for change-in-control transactions until they represent less than 35% of combined voting power. In contrast, GOOGL's Class B common stock provides 10 votes per share, significantly more than the 1 vote per share for Class A, though Class B shares automatically convert to Class A upon sale or transfer. CMCSA's example shows a similar dual-class structure where Class A holds 66 2/3% of voting power with 1 vote per share and Class B holds 33 1/3% with 15 votes per share, illustrating a pattern of concentrated voting control in dual-class structures like those of META and GOOGL.",
      "llm_answer": "Meta’s Class A shares carry only one vote each and, because the company’s dual‑class structure gives its Class B shares ten votes per share, Class A holders own a small fraction of the total voting power and cannot meaningfully influence corporate actions. Alphabet’s (Google’s) Class B shares, by contrast, also have ten votes per share, giving their holders a disproportionately large share of voting power and the ability to control board elections and other shareholder‑approved matters.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core voting structure of both META and GOOGL: META's Class A has 1 vote per share and Class B has 10 votes per share, and GOOGL's Class B also has 10 votes per share versus 1 for Class A. This aligns with the ground truth and captures the essence of disproportionate voting power in dual-class structures. However, the LLM omits key details present in the original answer that affect completeness and qualitative accuracy. Specifically: (1) It does not mention that META's Class B shares are controlled by Mark Zuckerberg and that they require majority approval for change-in-control transactions until below 35% voting power—a critical element of shareholder influence; (2) It fails to note that GOOGL's Class B shares automatically convert to Class A upon sale or transfer, which limits long-term entrenchment and is a key constraint on voting power; (3) While not required, the original answer includes CMCSA as a comparative example to illustrate a broader pattern, which the LLM omits, reducing contextual depth. Quantitatively, all vote ratios (1 vs 10) are correct, so numerical accuracy is high. The reasoning is logically sound in comparing voting power across classes and companies, but lacks full multi-hop synthesis (e.g., control mechanisms, transfer restrictions). The answer remains contextually relevant and conveys the main idea of concentrated voting power, but misses nuances that affect shareholder influence dynamics. Thus, correctness is partially reduced due to omissions in critical structural details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 427,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the dividend structure for non-voting share classes at Mastercard and Charles Schwab impact the alignment of shareholder returns between voting and non-voting equity holders, given Mastercard's explicit distinction in dividend rights for B Class Shares and Charles Schwab's statement that dividend rights are identical across voting and nonvoting stock classes?",
      "original_answer": "At Mastercard, both A Class (voting) and B Class (non-voting) shares have dividend rights, indicating equal treatment in shareholder returns through dividends despite differences in voting power. In contrast, Charles Schwab explicitly states that dividend and liquidation rights are identical between its voting and nonvoting stock classes, ensuring full alignment in shareholder returns across share types. This means that while both companies provide dividend rights to non-voting shares, Charles Schwab maintains a stronger structural alignment in returns between share classes, whereas Mastercard preserves dividend parity but separates voting control.",
      "llm_answer": "Mastercard’s charter creates two equity classes: Class A shares carry one vote **and** the right to receive dividends, while Class B shares are expressly “non‑voting Dividend rights” (Note 16 – Classes of Capital Stock) and receive the same per‑share dividend amount that is declared each year. Because Class B holders cannot vote on the company’s dividend policy, their cash return is tied to the decisions of the voting shareholders, producing a weaker alignment of interests between the two groups. In contrast, Charles Schwab states that “the participation rights, including dividend and liquidation rights, are identical between the voting and nonvoting stock classes” (Notes 20/26), so both classes earn the same dividend per share, keeping the economic return of voting and non‑voting shareholders fully aligned.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that Mastercard's Class A and Class B shares have equal dividend rights despite differences in voting power, and that Charles Schwab explicitly states identical dividend and liquidation rights across share classes. The characterization of alignment—stronger in Schwab due to identical participation rights, weaker in Mastercard due to non-voting holders' lack of influence on policy—is logically sound and consistent with the original answer. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not compromised; all referenced disclosures (Note 16 for Mastercard, Notes 20/26 for Schwab) are plausibly cited and contextually appropriate. (3) Multi-hop reasoning is correctly applied: the model synthesizes information across two companies, compares their dividend structures, and draws a valid conclusion about shareholder return alignment. The only minor shortcoming is a slightly stronger emphasis on control asymmetry at Mastercard than the original answer, which could imply a greater divergence in returns than actually exists—dividend parity is maintained, so economic returns are aligned even if governance control is not. This nuance is acknowledged but could be clearer. (4) The answer is fully relevant, directly addressing the impact of dividend structures on shareholder return alignment as requested. Overall, the response is excellent, with high factual and reasoning fidelity to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 435,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How might the implementation of the OECD's Pillar Two global minimum tax differently affect Microsoft's and Oracle's effective tax rates, given Microsoft's expectation of no material impact and Oracle's concern about materially increased international tax costs?",
      "original_answer": "Microsoft expects no material impact from the OECD's Pillar Two global minimum tax due to its current operations not being concentrated in jurisdictions with tax rates below the 15% threshold. In contrast, Oracle explicitly notes that the adoption of Pillar Two in many jurisdictions could materially increase its international tax costs. While both companies are subject to the same global regulatory framework, their differing geographic footprints and tax planning strategies appear to lead to divergent expectations about the financial impact of the new rules.",
      "llm_answer": "Microsoft says that the OECD Pillar Two rules will begin to apply to it in FY 2025, but it “does not currently estimate a material impact” on its consolidated statements, so its effective tax rate is expected to remain essentially unchanged. In contrast, Oracle notes that the same Pillar Two framework “may materially increase the level of income tax on our international profits,” indicating that the new 15 % minimum tax could push Oracle’s effective tax rate higher.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key details are correct: Microsoft’s expectation of no material impact starting in FY 2025 and Oracle’s concern about materially increased international tax costs under Pillar Two are factually consistent with the original answer. The 15% minimum tax threshold is correctly referenced. (2) The answer correctly identifies both companies and their respective stances, satisfying entity accuracy. (3) The reasoning is sound: it contrasts Microsoft’s stable effective tax rate with Oracle’s potential increase due to differing exposures, reflecting the multi-hop synthesis of company-specific disclosures under the same regulatory framework. (4) The only minor limitation is that the LLM does not explicitly mention the reason Microsoft expects no impact (i.e., its operations are not concentrated in low-tax jurisdictions), which is included in the original answer and adds explanatory depth. However, the omission does not undermine the core factual correctness. Wording differs slightly but maintains semantic equivalence. Overall, the response is complete, relevant, and accurately conveys the divergent impacts on the two companies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 344,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How do GM's and LOW's applications of Level 3 valuation techniques differ in their financial reporting, particularly regarding the unobservable inputs and methodologies used for fair value measurements?",
      "original_answer": "GM utilizes Level 3 valuation techniques primarily for marketable debt securities and finance receivables, relying on pricing models, discounted cash flow models, and industry-standard pricing models with unobservable inputs such as economic forecasts, including unemployment rates, interest rate spreads, disposable personal income, and GDP growth rates. LOW, on the other hand, applies Level 3 valuation specifically to contingent consideration from the fiscal 2022 sale of its Canadian retail business, using an income approach with unobservable inputs like total equity value, volatility, and expected term. While both companies use Level 3 valuations, GM focuses on macroeconomic assumptions across a range of financial instruments, whereas LOW applies it to a specific long-term investment with performance-based metrics.",
      "llm_answer": "- General Motors: GM explicitly applies Level 3 valuation to a performance‑based contingent‑consideration liability.  The fair‑value is set with an income‑approach/option‑pricing model that relies on unobservable inputs such as the total equity value of the sold business, assumed volatility, expected term and a risk‑adjusted discount rate.  \n\n- Lowe’s: Lowe’s fair‑value note only restates the three‑level hierarchy and defines Level 3 as using unobservable inputs, but it does not identify any specific assets or liabilities measured at Level 3.  Consequently, Lowe’s reporting suggests it relies on Level 1 or Level 2 observable inputs and provides no disclosed Level 3 methodology.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct elements but fundamentally misrepresents the Level 3 applications for both GM and LOW, leading to a low correctness score. (1) For GM, the LLM incorrectly states that GM uses Level 3 valuation for a 'performance-based contingent-consideration liability' with an option-pricing model. However, the ground truth indicates GM applies Level 3 primarily to marketable debt securities and finance receivables using pricing and discounted cash flow models based on macroeconomic forecasts (e.g., unemployment, GDP growth), not contingent consideration. This is a significant factual error in entity and methodology. (2) For LOW, the LLM claims no Level 3 disclosures are made, which contradicts the ground truth: LOW does apply Level 3 valuation to contingent consideration from the fiscal 2022 sale of its Canadian retail business, using an income approach with unobservable inputs like total equity value, volatility, and expected term—precisely the type of model the LLM incorrectly attributes to GM. Thus, the roles are reversed and misrepresented. (3) Multi-hop reasoning fails: the question asks for a comparative analysis of Level 3 usage, but the LLM misassigns the use cases and misses the core contrast—GM’s broad use across financial instruments with macroeconomic inputs vs. LOW’s narrow use for a specific contingent consideration. (4) Quantitative accuracy is scored higher because there are no explicit numbers to verify, and the general structure of valuation approaches (e.g., income approach, unobservable inputs) is plausibly described, even if misattributed. (5) Contextual relevance is moderate because the response addresses fair value hierarchy and unobservable inputs, but incorrect entity mapping undermines usefulness. Overall, major factual and qualitative inaccuracies result in a correctness score of 3.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 501,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential conversion dynamics of Class A shares, especially in light of Alphabet's aggressive share repurchase strategy involving Class A and Class C shares?",
      "original_answer": "At CMCSA, Class B common stock holds 33 1/3% of the voting power, with each share entitled to 15 votes, and this voting power is non-dilutable under the company's articles of incorporation. This structure creates a concentrated voting control that could influence decisions regarding potential conversions of Class A shares, as Class B shares can be converted share-for-share into Class A under certain restrictions. Meanwhile, Alphabet (GOOGL) has been actively repurchasing Class A and Class C shares, spending $62.2 billion in 2023 alone and maintaining $36.3 billion in remaining authorization as of year-end. This aggressive repurchase strategy could reduce the number of outstanding shares in similar classes, potentially increasing the proportional influence of remaining shareholders, including those holding voting shares like CMCSA's Class B. The combination suggests that while CMCSA's Class A shareholders may see increased influence through potential Class B conversion, GOOGL's repurchase activity could further concentrate ownership and influence within its own capital structure.",
      "llm_answer": "Comcast’s charter gives the nine‑million shares of Class B stock a “super‑voting” weight – each share carries 15 votes and the Class B tranche permanently controls about one‑third (33 %) of the company’s total voting power, a share that cannot be diluted by any future issuance of other classes【page_91】.  Because every Class B share can be converted, share‑for‑share, into a ordinary Class A share (which carries only one vote), any conversion would shift that 33 % voting bloc into the much larger pool of Class A shares and thereby dilute the former holder’s voting influence, making conversion unattractive unless the economic upside outweighs the loss of control.  Alphabet’s aggressive buy‑back program, which has retired hundreds of millions of Class A and Class C shares and left only $36.3 billion of repurchase capacity remaining【page_81】, illustrates how a large‑scale reduction in outstanding shares can boost per‑share value; that same price‑gain incentive could tempt Comcast’s Class B owners to convert to Class A to capture the upside, even though doing so would erode the protected 33 % voting power they currently enjoy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All quantitative details are correct: the 33 1/3% voting power (rounded to 33% is acceptable), 15 votes per Class B share, $36.3 billion remaining repurchase authorization for Alphabet—all match the original. The $62.2 billion repurchase amount in 2023 is not mentioned in the LLM answer, but the reference to 'hundreds of millions' is a minor understatement, though not factually incorrect since the total retired shares could sum to that scale over time; however, the dollar volume is under-specified. (2) Entity accuracy is strong: CMCSA and Alphabet (GOOGL) are correctly identified, share classes (A, B, C) are accurately referenced, and the conversion mechanism (share-for-share from B to A) is correctly described. (3) Reasoning is sound and multi-hop: the answer connects CMCSA’s voting structure to conversion incentives and contrasts it with Alphabet’s repurchase strategy, drawing a logical parallel on how share reduction can increase per-share value and potentially influence conversion decisions. (4) The LLM adds insight not in the original—specifically, that conversion would dilute the Class B holder’s voting influence, making it unattractive unless economic gains compensate—this enhances the analysis. The only minor gap is the lack of explicit mention of Alphabet’s $62.2B spent in 2023, which slightly reduces completeness. Overall, the answer is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1583,
        "completion_tokens": 413,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the difference in remaining securities available for future issuance under equity compensation plans between MDLZ and CL, based on their 2022 10-K disclosures?",
      "original_answer": "MDLZ reported 48,932,017 securities remaining available for future issuance under equity compensation plans, while CL reported 37,028,000 securities (in thousands). The difference between the two companies' remaining issuance capacity is 11,904,017 securities.",
      "llm_answer": "- Mondelēz International reported that **≈ 44,000 thousand** shares were still available for future issuance under its equity‑compensation plans.  \n- Colgate‑Palmolive reported that **37,028 thousand** shares were still available for future issuance under its equity‑compensation plans (see CL 10‑K, Item 12 table)【page_61】.  \n\n**Difference:** Mondelēz has about **6,972 thousand (≈ 7 million) more** shares available for future issuance than Colgate‑Palmolive.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the key numeric values. It reports ≈44,000 thousand (i.e., 44 million) shares available for MDLZ, but the ground truth is 48,932,017, which is approximately 48.9 million. This is a material error of about 4.9 million shares. Colgate-Palmolive's value is correctly reported as 37,028 thousand (37,028,000), matching the ground truth. (2) The calculated difference is incorrect due to the wrong MDLZ figure: the LLM computes a difference of ~6,972 thousand (~6.97 million), but the correct difference is 11,904,017. This is a major calculation error stemming from incorrect input data. (3) The multi-hop reasoning is structurally sound—the model identifies both companies, the correct metric (securities available for future issuance), and attempts the subtraction—but the conclusion fails due to the inaccurate MDLZ number. It also cites the correct source (CL 10-K, Item 12) for Colgate, but provides no source for MDLZ, and the number used does not align with the actual 2022 10-K. (4) Contextual relevance is high—the answer addresses the right question, uses appropriate terminology, and attempts the correct comparison. However, the quantitative inaccuracy severely undermines the correctness. While the format 'thousands' is acceptable and commonly used in SEC filings, the value for MDLZ is simply wrong. Thus, the correctness score is low due to the critical error in a core data point and the resulting incorrect difference.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 415,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the impact of Illinois' Clean Energy Law on ComEd's transmission rate structure compare to Tesla's exposure to state-level regulatory challenges in markets with direct sales restrictions?",
      "original_answer": "Illinois' Clean Energy Law directly affects ComEd's transmission rate structure by requiring a new four-year multi-year plan to establish rates after the expiration of its performance-based distribution formula rate, and accelerating the amortization of ComEd's unprotected excess deferred income taxes over approximately 39.5 years. These regulatory changes introduce uncertainty around ComEd’s rate of return on equity, which is currently set at 11.50% with a 50-basis-point incentive adder as a RTO member. In contrast, Tesla faces state-level regulatory challenges related to its direct-to-consumer sales model, where certain U.S. states have laws interpreted to restrict its ability to sell vehicles through company-owned stores or obtain dealer licenses. While ComEd’s exposure centers on rate-setting mechanisms and compliance with decarbonization mandates, Tesla’s risk is tied to legal interpretations of motor vehicle industry laws and potential legislative pushback from dealer associations. Both face significant regulatory uncertainty, but the financial implications differ: ComEd’s are embedded in its cost recovery and capital structure, while Tesla’s affect its go-to-market strategy and expansion potential.",
      "llm_answer": "The Illinois Clean Energy Law changes ComEd’s transmission pricing by creating a new rider that forces the utility to purchase carbon‑mitigation credits (CMCs) and recover those costs through its transmission formula rate – a direct, regulatory‑driven adjustment to the rate structure (see EXC 10‑K p. 219‑220). In contrast, Tesla’s exposure is not to a rate‑setting mechanism but to state‑level rules that may bar or limit its direct‑to‑consumer sales model; the company warns that such laws and dealer‑association challenges could restrict where it can sell cars and could hurt its financial results (see TSLA 10‑K p. 27). Thus, the Clean Energy Law reshapes ComEd’s revenue‑requirement and transmission rates, whereas Tesla faces uncertain regulatory barriers that could limit sales but do not alter a rate‑based cost structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general contrast between ComEd's regulatory-driven rate structure changes and Tesla's state-level sales restrictions, maintaining contextual relevance. However, it contains significant factual inaccuracies that reduce correctness. The Illinois Clean Energy Law does not introduce a 'rider' for carbon-mitigation credits (CMCs) as claimed; instead, it mandates a new four-year multi-year rate plan and accelerates amortization of excess deferred income taxes over ~39.5 years—neither of which is mentioned. The LLM incorrectly characterizes the mechanism as a CMC purchase and cost recovery via transmission formula rates, which is not supported by the ground truth. Additionally, ComEd’s 11.50% ROE with a 50-basis-point incentive adder is omitted, weakening the financial impact analysis. For Tesla, while the restriction on direct sales is correctly noted, the answer lacks depth on the legal interpretation of motor vehicle laws and dealer association pushback highlighted in the original. The multi-hop reasoning is partially sound—comparing regulatory uncertainty across utilities and automakers—but synthesizes incorrect details for ComEd. Quantitative accuracy is moderate: no explicit numbers are wrong, but key figures (e.g., 39.5-year amortization, 11.50% ROE) are missing or replaced with unsupported claims. Qualitative accuracy suffers due to incorrect mechanisms and incomplete entity representation. Contextual relevance remains high as the core theme of regulatory exposure is addressed appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 422,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How will the IRA-driven Medicare Part D redesign, which imposes manufacturer discounts and price caps starting in 2025, affect the gross-to-net rebate accruals for both AMGN's ENBREL and BMY's Medicare Part D-dependent products, given AMGN's regulatory exposure and BMY's accounting for GTN adjustments based on payer channel mix and contract prices?",
      "original_answer": "The IRA-driven Medicare Part D redesign, which introduces manufacturer discounts and caps beneficiary out-of-pocket costs starting in 2025, will increase the gross-to-net (GTN) rebate accruals for both AMGN and BMY. For AMGN, the redesign compounds the impact of the set price for ENBREL starting in 2026, which is significantly lower than current pricing, and the potential inclusion of Otezla in the next round of Medicare price setting in 2027. This will likely reduce profitability and necessitate larger GTN adjustments. For BMY, which depends on Medicare Part D and accounts for GTN rebates using assumptions like payer channel mix and contract prices, the new obligations under the IRA will increase rebate liabilities, particularly in the catastrophic phase where manufacturers absorb more costs. The combined effect will be a material adverse impact on both companies' revenues and financial reporting accuracy, as they must adjust accruals to reflect the new regulatory environment and pricing pressures.",
      "llm_answer": "The IRA‑driven Medicare Part D redesign forces manufacturers to provide mandatory discounts and to honor price caps beginning in 2025; for Amgen this means the GTN (gross‑to‑net) rebate accrual for ENBREL will rise sharply as the company must record larger “mandatory‑discount” and inflation‑penalty liabilities that are already highlighted as a regulatory exposure in its 10‑K. Bristol‑Myers Squibb’s GTN accounting already builds the rebate accrual on payer‑channel mix and contract‑price assumptions, so the same IRA‑mandated discounts and caps will increase the estimated U.S. Medicare Part D rebate liability for its Part D‑dependent products, producing higher GTN adjustments on its balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information in the ground truth with strong factual and semantic alignment. (1) All entities are correct: AMGN (Amgen), BMY (Bristol-Myers Squibb), ENBREL, Medicare Part D, GTN (gross-to-net) rebates, payer channel mix, contract prices, and the 2025 start date for IRA provisions are all accurately referenced. (2) Quantitative accuracy is excellent: the LLM correctly identifies 2025 as the start year for IRA-driven changes, which matches the ground truth. No specific dollar amounts, percentages, or calculations are provided in either answer, so no discrepancies exist. (3) Reasoning is sound and reflects multi-hop synthesis: the LLM correctly links the IRA’s mandatory discounts and price caps to increased GTN accruals for both companies, connects AMGN’s regulatory exposure (as noted in its 10-K) to larger liabilities for ENBREL, and explains that BMY’s existing GTN methodology—based on payer mix and contract pricing—will result in higher estimated rebate liabilities under the new rules. (4) The only minor omission is that the ground truth includes forward-looking impacts beyond 2025, such as AMGN’s set price for ENBREL in 2026 and potential Otezla price setting in 2027, as well as the specific mention of increased manufacturer responsibility in the catastrophic phase of Part D. These details enrich the original answer but are not critical to the central conclusion. The LLM captures the primary financial impact—increased GTN adjustments due to IRA mandates—accurately and concisely. Wording differs but meaning is semantically equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 475,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How do AIG's and MET's differing accounting treatments for structured securities impact the valuation and reporting of ABS & CLO assets in their respective financial statements?",
      "original_answer": "AIG applies the effective yield method to structured securities, recalculating yields based on expected cash flows and adjusting amortized cost accordingly, with changes in expected cash flows either charged or credited to net investment income. MET, on the other hand, classifies ABS & CLO as available-for-sale (AFS) and measures them at estimated fair value, including those valued using Level 3 inputs, which are disclosed in recurring fair value measurements. These differing approaches—AIG's yield-based adjustments versus MET's fair value measurement—result in different financial statement presentations and sensitivity to market changes, affecting how investors assess the valuation and risk profile of each company's structured securities portfolio.",
      "llm_answer": "AIG classifies its ABS and CLO holdings as “available‑for‑sale” fixed‑maturity securities that are measured at fair value using mainly Level 3 (unobservable) inputs; the company does not set an allowance for credit loss at initial recognition but instead updates the securities’ effective yields for expected cash‑flow changes, so any fair‑value changes flow through other‑comprehensive income (OCI) and affect the amortised‑cost basis via yield adjustments.  \n\nMetLife also reports ABS and CLOs as AFS securities, but it records an explicit allowance for credit losses on the bond portfolio (including the CLO/ABS line) and recognises unrealised gains and losses in AOCI; the allowance reduces the carrying amount and is reflected in net investment income, resulting in a lower net fair‑value figure after credit‑loss adjustments compared with AIG’s approach.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding AIG's accounting treatment. The ground truth states that AIG applies the effective yield method and adjusts amortized cost based on expected cash flows, with changes impacting net investment income. However, the LLM incorrectly claims AIG classifies ABS and CLO as 'available-for-sale' and measures them at fair value with changes flowing through OCI — this contradicts the original answer, which emphasizes AIG’s yield-based (amortized cost) approach, not fair value through OCI. This is a critical error in accounting methodology. For MET, the LLM correctly identifies AFS classification and fair value measurement using Level 3 inputs, and correctly notes unrealized gains/losses go to AOCI. However, the claim that MET records an 'explicit allowance for credit losses on the bond portfolio' and reduces carrying amount accordingly is not mentioned in the ground truth and introduces unverified detail, potentially conflating CECL implementation with disclosed practices. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable — score reflects absence of numerical errors. (3) The multi-hop reasoning is partially sound: the model attempts to compare AIG and MET’s treatments and links them to financial statement impacts. However, the core distinction — AIG using effective yield (amortized cost) vs. MET using fair value (AFS) — is misrepresented by incorrectly assigning AFS treatment to AIG. This undermines the synthesis and leads to an incorrect basis for comparison. (4) Contextual relevance is high because the response addresses valuation, reporting, and implications for ABS/CLO assets as asked. Despite incorrect accounting models, it engages with the right concepts (fair value, OCI, yield adjustments, credit loss). The qualitative accuracy is low due to fundamental misrepresentation of AIG’s model, which is central to the question. Correctness score is moderate because while some elements (MET’s AFS treatment) are accurate, the key contrast is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 564,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the percentage of Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) compare with ExxonMobil's (XOM) operational exposure in Nigeria, given Nigeria's reliance on PSCs for deepwater offshore exploration and production?",
      "original_answer": "Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) accounted for 8% of its consolidated reserves in 2021. ExxonMobil (XOM) operates in Nigeria, where deepwater offshore exploration and production are governed by PSCs with terms typically lasting 30 years, including a 10-year exploration period and a 20-year production period. This indicates that both companies are exposed to PSC frameworks, but while CVX quantifies its PSC exposure directly in terms of reserves, XOM's exposure in Nigeria is structural and long-term, embedded in the regulatory framework of a key operational region.",
      "llm_answer": "Chevron’s proved reserves that are tied to production‑sharing contracts are modest – only 7 percent of its consolidated‑company reserves in 2021 (9 percent in 2020 and 11 percent in 2019)【page_106】.  \n\nExxonMobil’s Nigerian deep‑water assets are all held under PSCs with the Nigerian National Petroleum Corporation, so its operational exposure in Nigeria is essentially 100 percent PSC‑based【page_31】.  \n\nThus, Chevron’s PSC‑linked reserves are a single‑digit share of its total portfolio, whereas ExxonMobil’s Nigerian operations are wholly dependent on PSCs.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Chevron's PSC-linked reserves are a small portion of its total reserves and that ExxonMobil's Nigerian operations are fully under PSCs. However, there is a discrepancy in the quantitative value: the LLM states Chevron's 2021 PSC-linked reserves were 7%, while the ground truth reports 8%. This minor numerical inaccuracy affects precision but not the overall conclusion. The LLM also provides additional context (7% in 2021, 9% in 2020, 11% in 2019), which is not in the original answer and may be accurate but cannot be verified against the provided ground truth. (2) The calculation of percentages is not required in this question, but the reporting of Chevron’s 2021 percentage is off by one point. ExxonMobil’s 100% PSC exposure in Nigeria aligns with the ground truth’s description of structural, long-term exposure under PSCs, so this qualitative inference is sound. (3) The multi-hop reasoning is strong: the model connects Chevron’s global reserve exposure to PSCs with ExxonMobil’s operational structure in Nigeria, where PSCs govern deepwater assets, and synthesizes a valid comparison between portfolio-level exposure (CVX) and region-specific operational dependency (XOM). (4) The contextual relevance is excellent—the answer directly addresses the comparative exposure question and highlights the structural nature of PSC reliance for each company. The qualitative accuracy is high due to correct entity identification (CVX, XOM, Nigeria, PSCs), proper time frame (2021), and logical comparison. The correctness score is 8 because the core facts and reasoning are accurate, but the 7% vs 8% error prevents a higher score on quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 467,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Tesla's fixed share reservation under the 2019 Plan compare with HD's approach to stock appreciation rights in terms of long-term equity compensation flexibility, given Tesla's 49.0 million reserved shares and HD's forfeiture-adjusted vesting methodology?",
      "original_answer": "Tesla's 2019 Plan establishes a fixed reservation of 49.0 million shares for equity incentives including stock appreciation rights (SARs), indicating a structured long-term approach to compensation with defined capacity. In contrast, HD's SAR program incorporates estimated forfeitures into its compensation expense calculation and recognizes value on a straight-line basis as restrictions lapse, allowing for dynamic adjustment based on actual retention of talent. While both companies utilize SARs, Tesla's approach suggests greater predictability and constraint in equity issuance, whereas HD's method provides flexibility in response to workforce attrition and vesting outcomes.",
      "llm_answer": "Tesla’s 2019 Equity Incentive Plan caps the equity that can be issued at a fixed pool of 49.0 million shares reserved for stock options, RSUs, SARs and other awards, so the company’s long‑term equity‑compensation capacity is limited to that amount. Home Depot, by contrast, does not set a hard‑cap on SARs; instead it adjusts the number of SARs that remain outstanding for vesting based on estimated forfeitures, allowing the ultimate grant size to expand or contract with employee turnover and thus giving the company greater flexibility in shaping long‑term equity compensation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the 49.0 million share reservation for Tesla's 2019 Plan is correctly stated. No numerical errors are present. (2) The comparison between Tesla’s fixed share pool and HD’s forfeiture-adjusted vesting methodology is accurately represented: Tesla has a hard cap, while HD adjusts SARs based on estimated forfeitures, allowing dynamic flexibility. (3) The multi-hop reasoning is sound—linking Tesla's fixed reservation to predictability and constraint, and HD's forfeiture adjustments to flexibility in long-term compensation planning. (4) Minor difference: the LLM says HD 'does not set a hard-cap on SARs,' which is semantically close but slightly stronger than the original's focus on expense recognition and straight-line vesting with forfeiture adjustments. However, this does not distort the meaning, as HD’s method inherently avoids rigid caps by adjusting for attrition. Wording differs slightly but the factual and conceptual alignment is strong. No irrelevant content; fully contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 316,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Chevron's financial exposure to Tengizchevroil in Kazakhstan, including its $4,500 million loan for the FGP/WPMP development, compare to ExxonMobil's reported long-lived asset value in Kazakhstan of $8,463 million as of 2021?",
      "original_answer": "Chevron holds a 50% equity stake in Tengizchevroil (TCO), which operates major oil fields in Kazakhstan, and has extended a $4,500 million loan to TCO specifically for the FGP/WPMP development. In 2021, Chevron's upstream earnings from TCO contributed positively to its income from equity affiliates. Meanwhile, ExxonMobil reported a total long-lived asset value in Kazakhstan of $8,463 million as of 2021. This suggests that while Chevron's exposure is primarily through equity investment and project-specific financing, ExxonMobil's presence is reflected in substantial asset holdings, indicating differing capital deployment strategies in the same geographic region.",
      "llm_answer": "Chevron’s equity stake in Tengizchevroil was carried at about **$23.7 billion** at year‑end 2021, and the company also has a **$4.5 billion loan** to TCO for the FGP/WPMP development (Note 15, page 78). Together this represents roughly **$28 billion of exposure** in Kazakhstan, which is more than **three times** the **$8.463 billion** of long‑lived assets Exxon Mobil reported for Kazakhstan in 2021 (Long‑lived assets table, page 123).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the claimed $23.7 billion equity stake value for Chevron in Tengizchevroil, which is not present in the original answer or supported by the ground truth. The original answer states Chevron holds a 50% equity stake and mentions positive upstream earnings from TCO but does not provide a carrying value of $23.7 billion. This figure appears to be fabricated or misattributed. The $4.5 billion loan amount is correct and matches the ground truth ($4,500 million). The ExxonMobil long-lived asset value of $8,463 million is correctly cited. However, the LLM’s calculation of $28 billion total exposure (sum of $23.7B + $4.5B) is based on an incorrect equity value and thus invalid. (2) Quantitative accuracy is low because while the $4.5 billion loan and $8.463 billion ExxonMobil asset value are correct, the $23.7 billion equity carrying value is unsupported and likely erroneous. There is no verification in the original answer or context for this number. The comparison claiming Chevron’s exposure is 'more than three times' ExxonMobil’s is therefore factually wrong. (3) The multi-hop reasoning is partially sound—comparing Chevron’s financial exposure to ExxonMobil’s asset value in Kazakhstan is appropriate—but the synthesis fails due to reliance on an incorrect data point. The original answer emphasizes differing strategies (equity/financing vs. asset holdings) without quantifying total exposure, suggesting a more nuanced interpretation than the LLM’s numerical aggregation. (4) Contextual relevance is high as the LLM addresses the core comparison between Chevron and ExxonMobil in Kazakhstan and references project-specific financing and asset values. However, the inclusion of an unverified, high-magnitude number severely undermines factual correctness, leading to a low overall correctness score despite relevant structure and some accurate data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 526,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How do Duke Energy's PPA negotiations for renewable facilities compare to Southern Power's PPA structures in wind facilities, particularly in terms of cash flow implications given Southern Power's utilization of production tax credits through 2024?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, where these agreements significantly influence the economic performance of its renewable energy VIEs. Southern Power, on the other hand, acts as a lessor in PPAs related to wind facilities, which are accounted for as operating leases with terms up to 25 years. These PPAs directly affect Southern Power's cash flows through lease income, which is further enhanced by production tax credits (PTCs) tied to the first 10 years of energy production from these wind facilities. Southern Power had approximately $0.8 billion in unutilized PTCs at the end of 2021, expected to be fully utilized by 2024. This creates a distinct cash flow dynamic: while Duke's PPAs are central to the performance of its consolidated VIEs, Southern Power's PPAs are structured to align with tax credit monetization strategies, directly shaping its lease income and tax equity partnership returns.",
      "llm_answer": "Duke Energy’s renewable‑project VIEs are described as “VIEs … because Duke Energy issues guarantees … The activities that most significantly impacted the economic performance of these renewable energy facilities were decisions associated with siting, **negotiating PPAs** and EPC agreements” (DUK 10‑K p. 202).  The filing does not detail the terms of those PPAs or any tax‑credit‑related cash‑flow benefit; the impact is simply noted as a factor that could affect the VIE’s economics.\n\nSouthern Power’s wind PPAs are structured differently.  The company’s wind PPAs “do not have a capacity charge; customers either purchase the energy output … or provide a fixed price” and the purchaser retains the renewable‑energy credits (Southern Power 10‑K p. 96).  Southern Power’s cash‑flow from wind is therefore tied to the amount of energy produced **and to the production‑tax‑credits (PTCs) that it expects to use for the first 10 years of production**, which the filing says are “expected to be fully utilized by 2024” and have “a material impact on Southern Power’s cash flows and net income” (Southern Power 10‑K p. 97).  \n\nThus, while Duke Energy is still in the negotiation stage with PPAs that could affect VIE economics but without disclosed cash‑flow benefits, Southern Power’s wind PPAs are already in place, lack capacity charges, and are bolstered by PTCs that will generate cash‑flow through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Duke Energy's PPA negotiations influence the economic performance of its renewable VIEs due to guarantees and decision-making involvement; Southern Power structures its wind PPAs as operating leases without capacity charges, with cash flows tied to energy output and PTCs expected to be fully utilized by 2024. The $0.8 billion in unutilized PTCs at end-2021 from the original answer is not mentioned in the LLM response, which is a minor omission but does not distort the overall picture since the utilization timeline and material impact are correctly noted. (2) Quantitative accuracy is strong: 'expected to be fully utilized by 2024' matches the ground truth, and no incorrect numbers are presented. The absence of the $0.8 billion figure reduces completeness slightly but doesn't affect correctness. (3) Multi-hop reasoning is sound—LLM correctly contrasts Duke’s role in negotiating PPAs for VIEs (affecting consolidation and economics) with Southern Power’s lessor model where PPAs generate lease income enhanced by PTCs. It accurately links PTCs to cash flow and notes their 10-year window and expiration of utilization by 2024. (4) Contextual relevance is excellent: the response directly addresses the comparison of PPA structures and their cash flow implications, especially regarding tax credits. Wording differs but meaning is semantically equivalent. The only reason for not scoring a 10 is the omission of the specific $0.8 billion unutilized PTC amount, which is a factual detail present in the ground truth and relevant to cash flow implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1613,
        "completion_tokens": 453,
        "total_tokens": 2066
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does LOW's receipt of additional shares through ASR agreements compare to HD's issuance of additional shares via dividend equivalents in deferred share awards for non-employee directors?",
      "original_answer": "LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, where the final share delivery depends on the difference between the maximum notional amount paid and the final notional value of shares repurchased. In contrast, HD issues additional shares to non-employee directors through dividend equivalents that accrue on deferred shares and are paid out in stock upon termination of board service. While LOW's additional shares result from share repurchase efficiency, HD's additional shares are a structured compensation element tied to deferred share awards.",
      "llm_answer": "Low Inc. used accelerated‑share‑repurchase (ASR) contracts that required it to pre‑pay for a set number of shares (15.4 million shares in FY 2024) and, at settlement, the company could receive **additional shares** from the counter‑party based on the VWAP of the stock.  \n\nHome Depot, by contrast, does not receive shares through a repurchase; instead it **issues additional shares** to non‑employee directors as dividend‑equivalent shares that accrue on its deferred‑share awards (19 000 deferred shares were granted in FY 2023, and the dividend equivalents are paid out as extra shares when the awards vest).  \n\nThus, Low’s ASR agreements generate extra shares for the company as a by‑product of a share‑repurchase, whereas Home Depot’s deferred‑share awards generate extra shares that are **issued** to directors as dividend equivalents.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core distinction between LOW's receipt of additional shares through ASR agreements and HD's issuance of shares via dividend equivalents on deferred share awards. It accurately describes that LOW receives extra shares from counterparties based on VWAP at settlement of ASRs, which aligns with the variable notional structure in the ground truth. HD's issuance of shares as dividend equivalents to non-employee directors is also correctly characterized, including the payout upon vesting/termination. The qualitative reasoning and multi-hop synthesis across two companies and distinct financial mechanisms are sound and semantically equivalent to the original answer. However, the LLM introduces specific quantitative figures—15.4 million shares for LOW in FY2024 and 19,000 deferred shares for HD in FY2023—that are not present in the original ground truth answer. Since the ground truth does not include these numbers, their inclusion introduces unverifiable data, reducing quantitative accuracy slightly. There is no indication these numbers are incorrect, but their absence in the source truth means they cannot be confirmed, making the response over-specific. This does not undermine the overall correctness but prevents a perfect score. Contextual relevance is excellent, as all parts of the question are addressed with appropriate focus on mechanism comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 387,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does Boeing's equity income from ULA in 2024 correlate with Lockheed Martin's commercial satellite launch revenue, given ULA's role in serving both government and commercial customers?",
      "original_answer": "Boeing reported equity income of $125 million from ULA in 2024, reflecting its stake in the joint venture. ULA, co-owned by Boeing and Lockheed Martin, provides expendable launch services to both the U.S. Government and commercial customers. Lockheed Martin’s Space segment includes revenue from commercial satellite launches facilitated through ULA. Additionally, Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes payments related to ULA’s commercial launch services. Therefore, Boeing’s equity income from ULA is directly tied to the revenue Lockheed Martin recognizes from commercial satellite launches via ULA’s dual customer base.",
      "llm_answer": "Boeing reported **$125 million of equity‑method income from its 50 % stake in United Launch Alliance (ULA) for 2024** (see BDS loss from operations, page 42). The Lockheed Martin filing does not break out a specific “commercial satellite‑launch” figure in the pages provided, so a precise dollar‑for‑dollar comparison cannot be made. Nevertheless, both companies’ results are tied to ULA’s mixed‑customer business—Boeing’s equity income reflects ULA’s overall launch activity, while Lockheed Martin’s commercial‑launch revenue (where disclosed) would stem from the same ULA operations that serve both government and commercial customers.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Boeing's $125 million equity income from ULA in 2024, which matches the ground truth exactly. This figure is accurately cited with a reference to page 42 and correctly attributed to Boeing’s 50% stake in ULA. However, the LLM states that Lockheed Martin’s filing does not break out a specific 'commercial satellite-launch' figure, which partially contradicts the ground truth: while a line-item may not be explicitly labeled as such, the original answer confirms that Lockheed Martin’s Space segment includes revenue from commercial satellite launches via ULA and specifically reports $665 million in receivables from commercial customers as of December 31, 2024, tied to ULA’s services. The LLM fails to mention this $665 million receivable, a key quantitative and qualitative link in the correlation. (2) Quantitatively, all numbers provided by the LLM ($125 million) are correct and properly formatted; no calculation errors. The missing $665 million does not invalidate the numbers it does report, but omits a critical data point. (3) The reasoning is sound in recognizing that both companies benefit from ULA’s dual customer base and that Boeing’s equity income reflects overall ULA performance. However, the multi-hop synthesis is incomplete: it does not connect Boeing’s income to Lockheed Martin’s commercial receivables through ULA’s shared operations, weakening the causal correlation asserted in the original answer. (4) The correctness score is 7 because core facts (Boeing’s income) are accurate and contextually well-placed, but the answer lacks completeness in synthesizing the full relationship due to omission of Lockheed Martin’s $665 million commercial receivables. Quantitative accuracy is perfect where data is presented, hence 10. Qualitative accuracy is reduced due to incomplete entity linkage and reasoning synthesis. Contextual relevance remains high as the response directly addresses the question’s framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 534,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does the loss of market exclusivity for LLY's pharmaceutical products, influenced by patent rights and regulatory data protection, compare to MRK's exposure to patent-related risks, particularly in light of the varying durations of exclusivity in major markets such as the U.S., Europe, and Japan?",
      "original_answer": "LLY faces a severe and rapid revenue decline when pharmaceutical products lose effective market exclusivity, which is often tied to patent expiration. However, LLY may retain exclusivity through later-expiring patents on formulations or methods of use, or through regulatory data protection, such as 12 years for biologics in the U.S., 10 years in Europe, and 8 years in Japan. This market exclusivity is determined by both patent rights and regulatory protections, as noted in the BMY evidence, which explains that patent coverage and data exclusivity (e.g., orphan drug exclusivity for 7 years or pediatric exclusivity for 6 months) are the two key determinants of exclusivity. MRK similarly depends on patent rights for market exclusivity and faces material adverse impacts if those rights are invalidated or circumvented. MRK frequently engages in patent litigation to defend its exclusivity, especially against generic manufacturers seeking to enter the market before patent expiration. Thus, both companies are highly exposed to patent-related risks, but LLY may have more nuanced opportunities to extend exclusivity through regulatory mechanisms, while MRK emphasizes legal defense of its patents as a core strategy.",
      "llm_answer": "Lilly notes that its products lose market exclusivity when the combination of patent term‑restorations and statutory data‑protection expires – five years of data protection in the United States, roughly ten years in Europe and eight years in Japan – and that the loss of either patent or data exclusivity typically produces a rapid and material decline in sales (LLY 10‑K pp. 8‑10). Merck’s filing, by contrast, stresses that its business “is dependent on its patent rights” and that any invalidation or circumvention of those patents would cause a swift loss of exclusivity and sales, but it does not enumerate the differing regional exclusivity periods, indicating that Merck’s risk is framed more around generic‑patent challenges than the specific statutory data‑exclusivity timelines that Lilly highlights.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core comparison between LLY and MRK regarding patent and data exclusivity risks and correctly identifies that both companies face significant revenue declines upon loss of exclusivity. It appropriately highlights that LLY emphasizes statutory data protection periods and their regional variation, while MRK focuses more on patent rights and litigation. However, there are critical quantitative inaccuracies: the LLM incorrectly states that the U.S. provides only five years of data protection for pharmaceuticals, whereas the ground truth specifies 12 years for biologics in the U.S., which is a major factual error. Additionally, the LLM omits key regulatory exclusivity types mentioned in the original answer, such as orphan drug exclusivity (7 years) and pediatric exclusivity (6 months), which are important nuances in understanding how companies extend exclusivity. The answer also fails to mention that LLY may extend exclusivity via later-expiring formulation or method-of-use patents, a key strategic difference. While the qualitative reasoning is sound in framing MRK’s reliance on patent litigation and LLY’s use of regulatory mechanisms, the incorrect U.S. data protection duration undermines the quantitative accuracy. The contextual relevance is high, as the response directly addresses the comparative exposure to patent-related risks across major markets. Despite correct regional references for Europe (~10 years) and Japan (8 years), the U.S. error significantly affects the correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 420,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How do the potential financial impacts of cyber intrusion-related compliance costs at Southern Company's nuclear facilities compare to Duke Energy's decommissioning trust fund funding risks given both companies' exposure to nuclear power plant operations?",
      "original_answer": "Southern Company highlights that cyber intrusions could result in increased nuclear licensing or compliance costs that are difficult to predict, particularly at its nuclear facilities where Alabama Power and Georgia Power hold ownership interests representing 26% and 28% of their total KWH generation in 2021, respectively. These compliance costs could rise unpredictably due to threats of cyber intrusions or physical attacks. Meanwhile, Duke Energy notes that a decline in the market value of assets in its Nuclear Decommissioning Trust Funds (NDTF) could increase funding requirements for decommissioning its nuclear plants. Both companies face distinct financial risks tied to nuclear power plant operations—Southern Company through potential cyber-related compliance costs and Duke Energy through market-dependent decommissioning funding obligations.",
      "llm_answer": "Southern Company warns that actual or potential cyber‑intrusions at its nuclear plants could trigger “substantial operating and capital expenditures” to meet heightened NRC licensing and security requirements, but the size of those compliance costs is uncertain and may only become material if a breach occurs. By contrast, Duke Energy notes that a decline in the market value of its nuclear‑decommissioning trust‑fund assets could force the company to inject additional cash to meet decommissioning obligations, a risk that also could be material but is tied to funding shortfalls rather than regulatory‑compliance spending. Thus, both firms face potentially significant, yet uncertain, financial impacts from their nuclear exposure—Southern’s from unpredictable cyber‑related compliance costs, and Duke’s from possible under‑funded decommissioning trusts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Southern Company faces uncertain compliance costs due to cyber intrusion risks at its nuclear facilities, and Duke Energy faces funding risks if its Nuclear Decommissioning Trust Fund (NDTF) assets decline in market value. The LLM correctly identifies the nature of the financial risks—Southern's tied to potential regulatory and security expenditures, Duke's to market-dependent funding shortfalls. (2) Quantitative accuracy is perfect: while no specific dollar amounts are cited in either answer, the LLM does not introduce any incorrect numbers, and the absence of the 26% and 28% generation percentages from the original is a minor omission but not a factual error. These percentages provide contextual detail about the scale of nuclear exposure but are not essential to answering the comparative risk question. (3) Multi-hop reasoning is sound: the model correctly synthesizes risk types across two companies, linking Southern’s cyber-related compliance uncertainty with Duke’s decommissioning trust funding volatility, and contrasts the sources of financial impact appropriately. (4) Semantic equivalence is strong—wording differs (e.g., 'substantial operating and capital expenditures' vs. 'increased nuclear licensing or compliance costs'), but meaning is preserved. The LLM uses slightly more precise regulatory language (e.g., NRC) not in the original but consistent with context. Only a 9 on correctness due to the omitted generation percentages, which add material context about Southern’s nuclear reliance, but the core comparison remains valid and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 462,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of dividend equivalents on deferred stock units granted to non-employee directors in 2023 by Lowe's compare with Home Depot's policy on dividend equivalents related to deferred shares, particularly in terms of vesting schedules and payout structure?",
      "original_answer": "Lowe's provides dividend equivalents on deferred stock units granted to non-employee directors, which vest either on the first anniversary of the grant date or the day before the next Annual Meeting of Shareholders, with immediate vesting for awards granted prior to 2022. In contrast, Home Depot pays dividend equivalents on deferred shares granted to non-employee directors that accrue and are paid out in additional shares upon termination of service, with the fair value expensed immediately upon grant. This shows differences in both vesting timing and payout mechanisms between the two companies’ deferred compensation structures.",
      "llm_answer": "Lowe’s 2023 deferred‑stock‑unit awards to non‑employee directors vest on the earlier of the first anniversary of the grant date or the day before the next annual meeting of shareholders, and the units accrue dividend equivalents that are paid when the units vest. By contrast, Home Depot’s deferred‑share awards to non‑employee directors do not vest on a set calendar date; they vest only when the director’s board service terminates, at which time the accrued dividend equivalents are paid out as additional shares of stock. Thus Lowe’s provides a short‑term, calendar‑based vesting schedule with payout at vesting, whereas Home Depot ties vesting to service termination and pays the equivalents in shares at that later payout.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that Lowe's 2023 deferred stock units for non-employee directors vest on the earlier of the first anniversary or the day before the next Annual Meeting, with dividend equivalents paid upon vesting. This matches the original answer. It also correctly states that Home Depot’s dividend equivalents accrue and are paid out in additional shares upon termination of service, which aligns with the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or answers, so quantitative accuracy is based on correct dates and timing—both are accurately represented. (3) The multi-hop reasoning is sound: the model correctly synthesizes policies from two companies (Lowe’s and Home Depot), compares their vesting schedules (calendar-based vs. service termination) and payout structures (cash/units at vesting vs. shares upon termination). The only minor omission is that the original answer notes Lowe’s awards granted prior to 2022 have immediate vesting, which the LLM answer does not mention—this is a small completeness gap but does not undermine the core accuracy regarding 2023 grants, which is the focus of the question. (4) The answer is contextually relevant, directly addressing both vesting and payout differences as asked. Wording differs but semantic meaning is equivalent. Thus, correctness is high but not perfect due to the omitted pre-2022 detail, though it does not affect the 2023 comparison central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 433,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the potential loss of 12-year biologic data exclusivity in the U.S. impact AMGN's competitive position compared to MRK's strategy of leveraging compound patents and pediatric exclusivity extensions?",
      "original_answer": "The potential removal of the 12-year biologic data exclusivity in the U.S., as highlighted in AMGN's 10-K, could expose AMGN to earlier biosimilar competition, particularly for products like EPOGEN, which is sold almost exclusively to a concentrated customer base. In contrast, MRK's strategy, as outlined in its 10-K, relies on a layered approach to market exclusivity, including compound patents, pediatric exclusivity extensions (which can add six months), and regulatory data protection. This layered approach allows MRK to maintain commercial control even after initial patent expiration, giving it a more diversified defense against generic erosion compared to AMGN's reliance on regulatory exclusivity.",
      "llm_answer": "Amgen’s biologics depend largely on the statutory 12‑year data‑exclusivity provision; if that period is shortened, biosimilar competitors could enter the market earlier, eroding Amgen’s market share and revenue because its later‑expiring patents, process patents and other IP may not be sufficient to block biosimilar entry (see AMGN pages 44‑46). Merck, by contrast, builds a layered patent estate of compound, formulation and use patents and routinely adds six‑month pediatric‑exclusivity extensions, which can extend protection beyond the basic data‑exclusivity term and therefore makes its products less vulnerable to a loss of the 12‑year biologic exclusivity (see MRK pages 18‑20). Thus, a reduction in the 12‑year exclusivity would weaken Amgen’s competitive position more than Merck’s, whose strategy relies on multiple patent layers and pediatric extensions to preserve market exclusivity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 12-year biologic data exclusivity period is accurately referenced, and the potential impact on AMGN (earlier biosimilar entry, revenue erosion) is correctly described. The reference to pediatric exclusivity adding six months is factually correct and matches the original answer. (2) Quantitative elements—'12-year' exclusivity and 'six-month' pediatric extension—are precisely stated and consistent with the ground truth; no calculations are required, but the comparison in timing and protection duration is sound. (3) The multi-hop reasoning is strong: the model correctly contrasts AMGN’s reliance on regulatory exclusivity with MRK’s layered strategy involving compound patents, pediatric extensions, and other IP protections, synthesizing information across both companies’ 10-Ks. (4) The LLM adds slightly more detail (e.g., mention of formulation and use patents, process patents) not explicitly in the ground truth, but these are plausible extensions of MRK’s strategy and do not contradict it. The only minor gap is the absence of a specific reference to EPOGEN or AMGN’s concentrated customer base, which are part of the original answer’s risk context—this is a small omission but doesn’t undermine the core correctness. Overall, the answer is semantically equivalent, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 394,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of the countercyclical capital buffer under TLAC requirements for GS compare with SCHW's application of the same buffer, particularly in light of GS's 18% minimum TLAC to RWAs threshold and SCHW's 2.5% stress capital buffer?",
      "original_answer": "Goldman Sachs (GS) includes the countercyclical capital buffer as part of its TLAC to RWAs requirement, which the Federal Reserve has set to zero percent, within the broader 18% minimum TLAC threshold (as stated in GS's 10-K filing). In contrast, Schwab (SCHW) is also subject to a countercyclical capital buffer above the minimum risk-based capital ratios, which was zero percent as of December 31, 2024 (as disclosed in SCHW's 10-K). However, SCHW specifically maintains a 2.5% stress capital buffer, indicating a differentiated approach to regulatory capital planning despite both institutions operating under a zero percent countercyclical buffer.",
      "llm_answer": "Goldman Sachs’ TLAC calculation treats the counter‑cyclical buffer as a component of the TLAC‑to‑RWA requirement, but the Federal Reserve has set that buffer to **zero**; the TLAC ratio therefore consists of the **18 % statutory minimum**, the 2.5 % capital‑conservation buffer, the 1.5 % G‑SIB surcharge and any other buffers, but no additional counter‑cyclical add‑on.  \n\nCharles Schwab, by contrast, does not apply a counter‑cyclical buffer in its TLAC‑type calculations; instead its regulatory capital framework includes a **2.5 % stress‑capital buffer** (plus a 2.5 % capital‑conservation buffer) while the counter‑cyclical buffer is also **zero**. Thus, GS’s TLAC rule hinges on an 18 % minimum threshold with a zero counter‑cyclical component, whereas Schwab’s capital regime relies on a separate 2.5 % stress buffer and likewise has no counter‑cyclical buffer.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in both quantitative and qualitative aspects. (1) Quantitatively, all key percentages are accurate: GS's 18% minimum TLAC to RWAs, the zero percent countercyclical capital buffer (as set by the Federal Reserve), and SCHW's 2.5% stress capital buffer are all correctly reported. The mention of the 2.5% capital-conservation buffer and 1.5% G-SIB surcharge for GS adds detail not in the original answer but is contextually plausible and does not contradict the ground truth. However, the original answer does not specify the composition of GS’s TLAC beyond the 18% threshold, so including these additional buffers (capital-conservation, G-SIB) introduces elements not confirmed in the source, which slightly affects precision. (2) The countercyclical buffer being zero for both firms as of the relevant period (implied as 2024 in the original) is correctly stated. (3) Qualitatively, the reasoning correctly distinguishes GS’s inclusion of the countercyclical buffer within its TLAC framework (even though set to zero) from SCHW’s application of a separate stress capital buffer, capturing the differentiated regulatory approaches. However, the LLM incorrectly implies that Schwab does not apply a countercyclical buffer in TLAC-type calculations due to not being a G-SIB; in reality, the original answer confirms SCHW *is* subject to the countercyclical buffer (set to zero), just like GS. This mischaracterization slightly undermines the reasoning. (4) Contextually, the response is highly relevant, directly addressing the comparison of buffer treatments under TLAC-like requirements. Despite minor over-specification of GS’s buffer components and a slight misrepresentation of SCHW’s buffer applicability, the core facts and comparative insight are preserved, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 495,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does XOM's asset exposure in Kazakhstan compare with CVX's stake in TCO's operations in the region?",
      "original_answer": "XOM reported $7,728 million in long-lived assets in Kazakhstan in 2023, reflecting its operational exposure in the region. Meanwhile, CVX holds a significant stake in TCO, which operates major oil fields like Tengiz and Korolev under a concession agreement expiring in 2033. TCO achieved mechanical completion of the Future Growth Project (FGP) in 2023, with start-up expected in the first half of 2025, and is also advancing the Karachaganak Expansion Project, with Stage 1A expected to complete in 2024. CVX’s involvement through TCO demonstrates its strategic positioning in Kazakhstan’s upstream sector, despite not directly owning long-lived assets like XOM.",
      "llm_answer": "ExxonMobil’s 2023 balance sheet shows roughly **$7.7 billion of long‑lived assets** located in Kazakhstan. In contrast, Chevron reports that it owns **a 50 % equity interest in the Tengizchevroil (TCO) affiliate**, which operates the major oil and gas fields in Kazakhstan.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly reports XOM's $7.7 billion (i.e., $7,728 million) in long-lived assets in Kazakhstan in 2023, matching the ground truth in both amount and year (format variation accepted: $7.7 billion ≈ $7,728 million). It also accurately states CVX's 50% equity interest in Tengizchevroil (TCO), which aligns with Chevron’s actual stake. However, the LLM omits key qualitative details present in the original answer, such as the TCO concession expiration in 2033, the Future Growth Project (FGP) mechanical completion in 2023 and expected start-up in H1 2025, and the Karachaganak Expansion Project timeline (Stage 1A completion in 2024). These omissions reduce completeness and qualitative depth.\n\n2) Quantitatively, the numbers are accurate: $7.7 billion is a valid rounding of $7,728 million, and the 50% stake in TCO is factually correct. No calculations were required, but the reporting of financial figures and ownership percentages is precise.\n\n3) The multi-hop reasoning is partially sound: the model correctly identifies that XOM has direct asset exposure (via reported long-lived assets) while CVX has indirect exposure via an equity stake in TCO. This contrast addresses the core of the comparison. However, it fails to fully synthesize the strategic implications of CVX’s involvement through TCO’s major projects and concession timeline, which are critical to understanding the nature and future of CVX’s exposure.\n\n4) The answer is contextually relevant and correctly frames the comparison between direct asset ownership (XOM) and indirect equity participation (CVX). The omission of project-level developments and timelines weakens the qualitative accuracy and overall correctness, but the core facts are present and correctly stated. Hence, a score of 7 is justified: factually sound on key numbers and entities, but incomplete in delivering the full scope of the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 512,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does Southern Company's uncertainty around the financial impact of transitioning from LIBOR to alternative rates under ASU 2020-04 compare with NextEra Energy's disclosure that it is applying the same standard to its interest rate contracts, given that both companies rely on reference rate reform guidance to manage derivative exposures?",
      "original_answer": "Southern Company explicitly states that the 'ultimate outcome of the transition [from LIBOR] cannot be determined at this time,' indicating uncertainty in assessing the financial impact of ASU 2020-04. In contrast, NextEra Energy affirms that it is applying the guidance under ASU 2020-04 to manage its interest rate contracts affected by reference rate reform. Both companies are subject to the same regulatory framework and are actively navigating the transition from LIBOR to alternative rates, but NEE demonstrates a more definitive implementation stance compared to SO's ongoing evaluation.",
      "llm_answer": "Southern Company notes that, although it has elected to apply the ASU 2020‑04 amendments to its debt‑related modifications, “the ultimate outcome of the transition cannot be determined at this time” and the company will continue to evaluate the impact of moving from LIBOR to an alternative rate (page 195). In contrast, NextEra Energy states that it is also applying the ASU 2020‑04 guidance to its debt and derivative contracts, has begun using the permitted election options, and, while the full impact is still unknown, “to date there has not been a material impact” (page 79). Both firms therefore rely on the reference‑rate‑reform guidance to manage their derivative exposures, but Southern Company emphasizes greater uncertainty about the eventual financial effect, whereas NextEra Energy reports that the transition has so far been immaterial.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures Southern Company's (SO) uncertainty, quoting the key phrase 'the ultimate outcome of the transition cannot be determined at this time,' and contrasts it with NextEra Energy's (NEE) more definitive implementation stance, including the statement 'to date there has not been a material impact.' These characterizations match the original answer's core comparison. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or ground truth, so quantitative accuracy is not applicable in a numerical sense—however, the LLM correctly references page numbers (195 and 79), which supports traceability and implies accurate sourcing; no calculation errors exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosures from two companies regarding their application of ASU 2020-04 and reference rate reform, compares their levels of certainty, and contextualizes both within the same regulatory framework. The only minor gap is that the LLM answer emphasizes 'debt and derivative contracts' for NEE, while the original answer focuses on 'interest rate contracts'—a slight difference in specificity, but derivatives and interest rate contracts are closely related in this context, so the meaning remains semantically equivalent. (4) The answer is fully relevant, directly addressing the comparative uncertainty in financial impact assessment between SO and NEE under the same standard. The LLM adds useful detail (e.g., 'has begun using the permitted election options') not in the original but consistent with a more advanced implementation stance, enhancing clarity without introducing error. Overall, the answer is factually correct, well-reasoned, and contextually appropriate—just shy of perfect due to slight variation in contract terminology, but not enough to affect correctness meaningfully.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 525,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the dual-class stock structure and voting rights limitations in META's Class A Common Stock compare to GOOGL's governance framework under their respective Certificates of Incorporation, particularly in terms of protecting minority shareholder interests?",
      "original_answer": "GOOGL's Certificate of Incorporation ensures equal dividend and liquidation rights across all stock classes and mandates unanimous board approval before amendments affecting stockholder rights can be proposed, with affected classes requiring to approve such changes. This provides a structural safeguard for minority shareholders. In contrast, META's Class A Common Stock is subject to a controlled company structure where the board is not required to be majority independent, and key governance decisions require approval from Class B stockholders, who hold superior voting rights. META's Certificate of Incorporation also includes anti-takeover provisions that require a two-thirds majority vote for certain amendments once Class B voting power drops below 35%, further entrenching control and potentially limiting minority shareholder influence.",
      "llm_answer": "**Meta (META)** – Meta’s charter creates three classes of equity. Class A shares carry one vote per share, while Class B shares carry ten votes per share and together with the founder‑CEO give a controlling voting bloc. Class A holders can vote on all ordinary matters, but the concentration of voting power in Class B “will limit or preclude” their ability to influence corporate decisions (Meta 10‑K p. 49). The certificate of incorporation (and Delaware law) requires that any amendment that would adversely affect a class of stock be approved by the class that is harmed and by the board’s unanimous consent, which provides a procedural safeguard for minority shareholders (Meta 10‑K p. 50‑52).\n\n**Alphabet (GOOGL)** – Alphabet’s charter also has three classes. Class A shares have one vote per share, Class B shares have ten votes per share, and Class C shares have no voting rights except as required by law (Alphabet 10‑K p. 81). Like Meta, the charter (and Delaware law) mandates that any amendment that would negatively alter the rights, powers or preferences of a given class must be approved by that class and by the board’s unanimous consent before a stock‑holder vote, giving minority Class A shareholders a similar procedural protection (Alphabet 10‑K p. 81).\n\n**Comparison** – Both companies use a dual‑class structure that concentrates control in a small group of super‑voting shareholders, limiting the practical influence of ordinary (Class A) investors. Each charter, however, embeds the Delaware‑law requirement that amendments harming a class must be ratified by the affected class and by unanimous board approval, offering a comparable, though not absolute, safeguard for minority shareholders in both Meta and Alphabet.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in its qualitative analysis and synthesis, particularly in misrepresenting key differences between META and GOOGL's governance frameworks. (1) Quantitatively, the voting rights (1 vote for Class A, 10 for Class B) and structural descriptions are accurate for both companies, and references to Delaware law requirements are correctly stated, earning high marks for quantitative accuracy. (2) However, the LLM incorrectly equates the governance safeguards in both companies, stating they offer 'comparable' protections due to the Delaware-law-based requirement for class and unanimous board approval of harmful amendments. This contradicts the ground truth: GOOGL’s Certificate of Incorporation *affirmatively mandates* unanimous board approval *before proposing* amendments affecting stockholder rights, and requires affected classes to approve changes—this is a structural, charter-based safeguard. In contrast, while Delaware law generally requires class approval for adverse amendments, the LLM misattributes this as a feature of the charter rather than default law, and fails to note that META’s charter *adds anti-takeover provisions* (e.g., two-thirds vote requirement when Class B voting power drops below 35%) that entrench control—information absent in the LLM response. (3) The multi-hop reasoning is flawed: the question asks for a comparison in terms of *protecting minority shareholder interests*, but the LLM concludes the safeguards are 'comparable' when the ground truth shows GOOGL has stronger, affirmative charter-level protections while META’s structure actively limits minority influence through controlled company provisions and supermajority amendment barriers. (4) The answer is contextually relevant and well-structured, but omits critical differentiating factors, leading to an incorrect overall conclusion. Thus, while factually sound on surface-level structures, it fails on deeper governance distinctions essential to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1676,
        "completion_tokens": 544,
        "total_tokens": 2220
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How might the implementation of the OECD's global minimum tax framework impact the effective tax rates of both PepsiCo and Altria, given their differing U.S. tax burdens and exposure to international tax changes?",
      "original_answer": "The implementation of the OECD's global minimum tax framework could increase PepsiCo's effective tax rate due to its international operations and exposure to countries implementing the 15% minimum tax, as noted in PepsiCo's 10-K. Altria, which reported $2,346 million in federal tax payments in the U.S. and minimal foreign tax liabilities, may not face the same upward pressure on its effective tax rate, as its tax burden is more concentrated domestically. The U.S. tax legislation context suggests that multinational corporations with significant overseas earnings, like PepsiCo, are more likely to see tax increases under the new framework, while companies like Altria with limited international exposure may remain relatively unaffected.",
      "llm_answer": "PepsiCo already benefits from a relatively low‑average tax rate because a large share of its earnings is taxed abroad at rates that are often below the U.S. statutory 21 percent.  If the OECD “Pillar Two” rules force those jurisdictions to impose a 15 percent minimum tax, PepsiCo’s foreign‑tax expense will rise and its overall effective tax rate will increase modestly, although the company still expects the U.S. provision to remain the larger component of its tax bill.  \n\nAltria, by contrast, carries a higher U.S. tax burden (its 2023 effective tax rate was about 25.6 percent) and has relatively limited foreign earnings; the global minimum tax would lift foreign rates to the 15 percent floor and could reduce the value of any foreign‑tax credits, thereby pushing Altria’s already‑high effective tax rate higher, but the incremental impact is likely smaller in absolute terms than for PepsiCo.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly regarding Altria's tax profile and the direction of impact from the OECD global minimum tax. While the assessment of PepsiCo is largely correct—highlighting its international exposure and the likelihood of an increased effective tax rate due to higher foreign taxes under Pillar Two—the analysis of Altria is flawed. The LLM claims Altria's effective tax rate was 25.6% in 2023 and suggests the global minimum tax could increase it further by reducing the value of foreign tax credits. However, the ground truth states that Altria has minimal foreign tax liabilities and $2,346 million in federal tax payments in the U.S., indicating very limited international exposure. With negligible foreign earnings, Altria would not meaningfully benefit from foreign tax credits, so the minimum tax would have little to no upward impact on its effective rate. Thus, the LLM incorrectly infers a tax increase for Altria due to reduced foreign tax credit value, which contradicts the original answer’s conclusion that Altria would be 'relatively unaffected.' The 25.6% effective tax rate is not corroborated in the ground truth and appears to be fabricated or misattributed. Additionally, while the LLM correctly identifies the mechanism of Pillar Two affecting PepsiCo, it introduces unsupported details (e.g., expectations about U.S. tax remaining the larger component) not present in the original. Quantitative accuracy is low due to the unsupported percentage and lack of citation for Altria’s rate. Qualitative reasoning is partially sound for PepsiCo but fails in cross-entity comparison due to incorrect logic for Altria. Contextual relevance is high as the response addresses the multi-hop nature of the question and discusses both companies in relation to OECD rules.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 494,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the extension of market exclusivity through orphan drug designation in the U.S. impact AbbVie's risk of generic competition, given Eli Lilly's reliance on the same regulatory mechanism to protect its products beyond compound patent expiration?",
      "original_answer": "In the U.S., orphan drug designation grants seven years of market exclusivity, which runs in parallel with any applicable patents and can extend beyond the expiration of compound patents, as noted in Eli Lilly's 2023 10-K. This exclusivity period prevents the FDA from approving another application for the same drug product for the same orphan use, as described in the regulatory overview. For AbbVie, the loss or weakening of such exclusivity—whether through patent challenges, regulatory changes, or compulsory licensing—could accelerate generic competition and significantly reduce revenues, as stated in AbbVie's 2023 10-K. Therefore, the strength and duration of orphan drug exclusivity directly influence AbbVie’s exposure to market erosion, especially in the context of competitors like Eli Lilly leveraging the same protections to maintain market control beyond traditional patent life.",
      "llm_answer": "In the United States an NDA or BLA that receives orphan‑drug designation grants a seven‑year “orphan exclusivity” that bars the FDA from approving any other application for the same drug‑product for the same orphan indication (see § U.S. RDP rules, page 6 and page 10). Because this exclusivity runs in parallel with, and can extend beyond, the underlying compound‑patent term, it effectively shields the product from generic (or biosimilar) launches for the duration of the orphan period, thereby lowering AbbVie’s exposure to generic competition on its orphan‑indicated medicines—just as Eli Lilly relies on the same mechanism to protect its own products beyond the expiration of their compound patents.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the seven-year orphan exclusivity period is correctly stated, and the explanation that it runs in parallel with and can extend beyond compound patents aligns with the original answer. No calculations are required, and all factual assertions about regulatory timelines and exclusivity rules are correct. (2) The answer correctly identifies both AbbVie and Eli Lilly as companies relying on orphan drug exclusivity to delay generic competition beyond patent expiration, satisfying the multi-hop requirement across entities. (3) The reasoning is sound: it explains how orphan exclusivity blocks FDA approval of competing applications for the same drug and indication, thereby reducing generic competition risk for AbbVie—mirroring the logic in the original answer. (4) Minor deduction in qualitative accuracy due to slightly less explicit emphasis on the risk to AbbVie if exclusivity is weakened (e.g., through legal challenges or regulatory changes), which is a key point in the original answer. However, the core synthesis—linking Eli Lilly’s use of the mechanism to AbbVie’s strategic exposure—is present and logically coherent. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 368,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Coca-Cola FEMSA's operational footprint in Argentina in 2021 influence KO's equity investee sales exposure compared to PEP's direct exposure to Argentina's economic volatility during the same period?",
      "original_answer": "KO reported net sales to equity method investees, including Coca-Cola FEMSA, of $14,471 million in 2021, which were influenced by recovery from the pandemic. Coca-Cola FEMSA operated in Argentina's federal capital and surrounding areas in 2021, contributing to KO's indirect exposure in that market. Meanwhile, PEP directly operated in Argentina and faced economic volatility, including currency controls and inflationary pressures, which posed risks to their financial results. Therefore, while KO's exposure to Argentina was indirect through Coca-Cola FEMSA's operations and tied to equity investee sales, PEP faced direct exposure to Argentina's macroeconomic instability in 2021.",
      "llm_answer": "Coca‑Cola FEMSA – in which The Coca‑Cola Company owns about a 19 % equity‑method stake – runs bottling and distribution in Argentina (the Buenos Aires metropolitan area) 【page_7】.  Because the Company’s Argentine exposure is carried through the equity‑method investment, KO’s “sales to equity‑method investees” (‑ $14.5 bn in 2021) reflects the Argentine market only indirectly and is smoothed by the equity‑method accounting and its net‑investment hedges 【page_89】.  \n\nPepsiCo, by contrast, lists Argentina among the countries whose “volatile economic, political and social conditions” create direct foreign‑exchange risk to its own operations 【page_41】.  Thus PEP’s revenue is directly exposed to Argentina’s economic swings, whereas KO’s exposure is indirect and buffered through its equity‑investee (Coca‑Cola FEMSA) rather than being a direct line‑item.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $14.5 billion figure for KO's sales to equity-method investees in 2021 matches the original $14,471 million (rounded appropriately), and the 19% equity stake in Coca-Cola FEMSA is consistent with known data. No calculation errors are present. (2) The answer correctly identifies Coca-Cola FEMSA's operations in the Buenos Aires metropolitan area (equivalent to 'federal capital and surrounding areas'), and correctly contrasts KO's indirect exposure via equity-method accounting with PEP's direct exposure. (3) The reasoning is sound: it explains how equity-method accounting and hedges buffer KO's exposure, while PEP faces direct foreign-exchange risk due to operating in volatile economies like Argentina—this synthesizes multi-hop information across entities (KO, PEP, Coca-Cola FEMSA) and accounting treatments. (4) The only minor shortcoming is that the original answer mentions pandemic recovery as a factor influencing KO's equity investee sales, which the LLM omits; however, this does not detract significantly from the core comparison about exposure type. All key entities, years (2021), and financial concepts are accurate. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as it directly addresses the comparative exposure question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 381,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does AbbVie's reliance on patent rights for emraclidine through its acquisition of Cerevel Therapeutics influence its market exclusivity strategy compared to Merck's experience with Januvia's patent expiration and regulatory exclusivity timeline?",
      "original_answer": "AbbVie's acquisition of Cerevel Therapeutics included an exclusive global license under certain Pfizer patent rights, which were critical for developing and commercializing emraclidine. However, despite this licensing arrangement, AbbVie recorded a $4.5 billion intangible asset impairment charge related to emraclidine, suggesting that the expected market exclusivity or commercial viability did not materialize as anticipated. Patent rights are a key determinant of market exclusivity in the pharmaceutical industry, often supplemented by regulatory exclusivity periods that can extend beyond patent terms. In contrast, Merck was able to extend its market exclusivity for Januvia and Janumet in the U.S. until May 2026 and for Janumet XR until July 2026 due to favorable court rulings and settlement agreements around a later-expiring patent on the sitagliptin salt form, despite the core compound patent expiring in January 2023. This demonstrates that while AbbVie's strategy relied heavily on patent licensing to secure exclusivity, it faced significant financial consequences when that exclusivity or market uptake failed to deliver expected returns, unlike Merck, which successfully leveraged later-stage intellectual property strategies to delay generic competition.",
      "llm_answer": "AbbVie’s strategy for emraclidine hinges on the exclusive global patent licence it inherited from Cerevel’s pre‑acquisition agreement with Pfizer—giving AbbVie sole rights to develop, manufacture and commercialise the molecule and tying future payments to regulatory and commercial milestones (see page 68). In contrast, Merck’s Januvia story shows how the loss of its core patent in January 2023 immediately opened the market, leaving the company to depend on a later‑expiring sitagliptin‑salt patent and the statutory five‑year regulatory exclusivity that only extends U.S. protection to May 2026 (with additional price‑setting provisions through 2027) (see page 58). Thus, AbbVie is building market exclusivity on a newly‑acquired, enforceable patent portfolio, whereas Merck is coping with an already‑expired primary patent and a limited, time‑bound exclusivity window.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core contrast between AbbVie's reliance on patent licensing for emraclidine and Merck's post-patent-expiration strategy for Januvia, showing relevant contextual understanding. However, it omits a critical fact from the ground truth: AbbVie recorded a $4.5 billion intangible asset impairment charge related to emraclidine, indicating that the expected market exclusivity or commercial viability failed to materialize. This omission significantly undermines the completeness and qualitative accuracy of the response, as it fails to convey the financial consequence that demonstrates the risk in AbbVie's strategy. While the LLM correctly notes Merck’s core patent expiration in January 2023 and regulatory exclusivity until May 2026 (and mentions 2027 for price-setting), the original answer specifies that Janumet XR exclusivity extends to July 2026 via a later-expiring salt patent—details only partially reflected here. The LLM also incorrectly frames Merck as 'coping' with expired patents without acknowledging the successful extension via litigation and settlement, which is a key point in the ground truth. Entity accuracy is strong—AbbVie, Merck, Cerevel, Pfizer, emraclidine, Januvia, Janumet, sitagliptin—are all correctly identified. The multi-hop reasoning is partially sound, linking acquisition, patent rights, and exclusivity timelines, but fails to fully synthesize the outcome (impairment charge) that validates the comparison. Quantitative accuracy is acceptable but incomplete: dates like January 2023 and May 2026 are correct, but the $4.5 billion impairment—a central financial metric—is missing. Overall, the answer is contextually relevant and semantically aligned in direction, but lacks key factual depth and outcome-based reasoning needed for full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 488,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does Chevron's investment in the Caspian Pipeline Consortium (CPC) influence its crude oil export capacity, and how does this compare to ConocoPhillips' reliance on crude oil production for its upstream operations?",
      "original_answer": "Chevron's 15% interest in the Caspian Pipeline Consortium (CPC) enables it to export approximately 1.2 million barrels of crude oil per day from Kazakhstan, which is critical for transporting output from the Tengiz and Karachaganak fields. The CPC pipeline's debottlenecking project, completed in January 2023, increased throughput capacity, directly supporting Chevron's Future Growth Project (FGP) expected to ramp up in early 2025. In contrast, ConocoPhillips' upstream operations are fundamentally dependent on crude oil production, as evidenced by its 2023 filings, where crude oil remains a core component of its asset base and revenue generation. Therefore, Chevron's exposure to crude oil export capacity is mediated through its stake in CPC, while ConocoPhillips has a more direct operational dependency on crude oil production.",
      "llm_answer": "Chevron’s 15 % ownership of the Caspian Pipeline Consortium gives it a direct outlet for roughly 1.4 million barrels of crude oil per day – about 1.2 million b/d from Kazakhstan and 0.2 million b/d from Russia (page 16). In contrast, ConocoPhillips’ upstream business is centered on producing crude itself; at the end of 2023 it reported about 2.3 billion barrels of oil‑equivalent proved reserves, the bulk of which is crude oil (page 147). Thus Chevron’s CPC stake translates into a specific export‑capacity figure, whereas ConocoPhillips’ upstream reliance is reflected in the scale of its crude‑oil reserves rather than a dedicated export pipeline.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. The ground truth states Chevron's CPC stake enables export of approximately 1.2 million barrels per day from Kazakhstan, but the LLM claims 1.4 million b/d (1.2 from Kazakhstan and 0.2 from Russia), introducing unverified data about Russian volumes not present in the original. There is no mention in the ground truth of Russian contributions to Chevron's CPC export capacity, nor is there support for splitting the 1.2 million b/d into two sources. Additionally, the LLM cites ConocoPhillips' proved reserves (2.3 billion barrels of oil-equivalent) as evidence of crude oil production reliance, which is contextually relevant but not equivalent to stating that crude oil is a core component of revenue and operations as in the original answer. While reserves are related, the original emphasizes operational dependency and revenue, not just reserve size. (2) The quantitative accuracy is compromised: the 1.4 million b/d figure is incorrect (should be ~1.2 million b/d), and the attribution of 0.2 million b/d from Russia lacks support. The 2.3 billion BOE reserves figure may be accurate in isolation but is used in a way that misaligns with the original comparison—export capacity vs. production dependency—by substituting reserves for current production or revenue reliance. (3) The reasoning is partially sound: the LLM correctly identifies that Chevron’s exposure is through export infrastructure (CPC) while ConocoPhillips is more directly involved in production. This multi-hop synthesis—comparing indirect export capacity to direct production reliance—is conceptually valid and reflects an understanding of the structural difference. However, it fails to mention the CPC debottlenecking project (completed Jan 2023) and its link to Chevron’s Future Growth Project (FGP) ramp-up in 2025, a key element in the original answer showing forward-looking strategic impact. (4) Contextual relevance is high—the answer addresses both companies and the core contrast between infrastructure-based export access and production-based operations. Despite incorrect numbers and missing strategic context, the overall framing aligns with the question’s intent. Thus, correctness is reduced primarily due to significant quantitative errors and incomplete synthesis, warranting a score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 636,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Oracle's integration of generative AI in MySQL HeatWave compare with Qualcomm's strategic vision for on-device generative AI in edge computing, given both companies' investments in cloud computing infrastructure?",
      "original_answer": "Oracle integrates generative AI into its MySQL HeatWave cloud service, combining transactions, real-time analytics, machine learning, and generative AI in one managed service to enhance data processing and decision-making capabilities. Meanwhile, Qualcomm envisions generative AI becoming ubiquitous across industries, with a focus on running complex models on edge devices such as smartphones and PCs to improve immediacy, privacy, and personalization. Qualcomm expects that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024, and sees cloud computing as a complementary enabler of these edge AI capabilities. Both companies are investing in cloud computing—Oracle through its Oracle Cloud Infrastructure (OCI) and Autonomous Database offerings, while Qualcomm supports cloud-edge coordination through its cloud computing processing initiative within its QSI segment.",
      "llm_answer": "Oracle embeds generative‑AI directly into its MySQL HeatWave offering, positioning the AI‑enhanced analytics and machine‑learning functions as a managed cloud service that runs on OCI’s infrastructure (“Oracle MySQL HeatWave combines transactions, real‑time analytics, machine learning and generative AI in one managed cloud service”). Qualcomm, by contrast, is betting that generative AI will be executed primarily on‑device at the edge—using its AI Engine, Hexagon NPU and Snapdragon platforms—to deliver low‑latency, private AI while still leveraging its cloud for model training and orchestration (“we believe … generative AI must run on‑device … we expect continued advancement in the generative‑AI capabilities of edge devices”). Thus, Oracle’s approach is cloud‑centric AI‑as‑a‑service within a database, whereas Qualcomm’s vision is edge‑centric, embedding generative AI in devices that are supported by its broader cloud‑computing investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Oracle integrates generative AI into MySQL HeatWave as a managed cloud service on OCI, combining transactions, analytics, ML, and AI. Qualcomm focuses on on-device generative AI using its Snapdragon platforms and AI Engine, emphasizing edge computing for low latency, privacy, and personalization. (2) Quantitative accuracy is perfect: while the LLM answer does not explicitly mention the 19% (2024) and 46% (2027) smartphone adoption figures, this omission does not detract from the core correctness, as the key trend (growth in on-device AI-capable smartphones) is implied through Qualcomm's strategic vision. The absence of exact percentages is a minor completeness gap but not a factual error. (3) Multi-hop reasoning is sound: the model correctly synthesizes Oracle's cloud-centric AI integration in databases with Qualcomm's edge-first AI strategy, and acknowledges both companies' cloud investments—Oracle via OCI and Autonomous Database, Qualcomm via cloud-edge coordination in its QSI segment. (4) Semantic equivalence is strong: the contrast between 'cloud-centric AI-as-a-service' and 'edge-centric on-device AI' accurately captures the strategic divergence. The answer is fully relevant and addresses all aspects of the question, with only a slight reduction in completeness due to missing specific forecast numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 396,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Walmart's use of firm commitments for inventory and utility purchases compare to Colgate-Palmolive's use of option contracts in managing financial exposure, given the role of such instruments in mitigating cash flow risks?",
      "original_answer": "Walmart has $15.9 billion in firm commitments due within one year, primarily for inventory, utilities, and capital expenditures, which represent legally binding contracts that lock in future cash outflows. These obligations are managed through operational cash flows and are not typically hedged with financial derivatives. In contrast, Colgate-Palmolive actively uses option contracts as part of its foreign exchange risk management strategy to hedge forecasted transactions, protecting against currency fluctuations. Both companies aim to reduce cash flow volatility, but Walmart focuses on operational liquidity planning while Colgate employs financial instruments like options to manage exposure. This distinction reflects differing approaches to financial risk mitigation aligned with their respective business models.",
      "llm_answer": "Walmart’s “firm‑commitment” purchases are ordinary supply contracts that obligate the retailer to buy a set amount of inventory or utilities at agreed‑upon terms.  By locking in quantity, price and timing, these contracts give Walmart a predictable cash‑outflow schedule and help it plan working‑capital needs, but they are not derivative hedges.  \n\nColgate‑Palmolive, by contrast, uses option contracts (along with forwards and swaps) as cash‑flow hedges for foreign‑currency and commodity exposures.  The options are designated as hedges so that gains or losses on the contracts offset changes in the dollar value of the underlying purchases, directly reducing cash‑flow volatility.  \n\nThus, Walmart relies on contractual certainty through firm commitments, whereas Colgate‑Palmolive relies on market‑based option contracts to hedge and smooth cash‑flow risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor omissions. (1) Quantitatively, the LLM does not include the specific $15.9 billion figure for Walmart's firm commitments, which is present in the original answer. However, the absence of this number does not distort the meaning, as the focus is on the nature and role of the instruments rather than exact amounts. All other factual claims are correct. (2) The LLM correctly identifies Walmart’s use of firm commitments for inventory and utilities as non-derivative, operationally binding contracts that create predictable cash outflows. It accurately contrasts this with Colgate-Palmolive’s use of option contracts as cash-flow hedges for foreign exchange and commodity risks. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies and two types of financial instruments (firm commitments vs. options), correctly comparing their roles in managing cash flow volatility. (4) The answer is contextually relevant and directly addresses the question about how each company manages financial exposure and cash flow risk. The only reason for not scoring a 10 is the omission of the $15.9 billion figure, which is a factual detail from the ground truth. However, since the question emphasizes the comparative mechanism rather than specific dollar amounts, this omission does not significantly detract from correctness. Wording differences are semantically equivalent and acceptable.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 416,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Morgan Stanley's use of credit default swaps (CDS) to hedge default risk relate to Capital One's reliance on default rate assumptions in valuing their net derivative assets, given the sensitivity of both institutions to credit event outcomes?",
      "original_answer": "Morgan Stanley actively uses credit default swaps (CDS) to hedge against the risk of default on debt obligations, entering into contracts where it receives or provides protection against credit events such as bankruptcy or failure to pay. The firm manages exposure through risk mitigation strategies and monitors aggregate market risk limits. Meanwhile, Capital One values its net derivative assets using discounted cash flow models that depend heavily on unobservable inputs, including a weighted average default rate assumption of 4% with a range of 53–163%. The connection between the two lies in the systemic sensitivity both institutions have to default outcomes: Morgan Stanley’s CDS contracts are triggered by defaults, directly affecting its derivative liabilities, while Capital One’s valuation models depend on projected default rates, meaning actual deviations from these assumptions would materially impact the fair value of its derivative assets. Thus, both firms are indirectly exposed to the same macroeconomic or sector-specific credit events that could simultaneously affect their derivative positions.",
      "llm_answer": "Morgan Stanley manages its exposure to credit‑event risk by buying and selling credit‑default swaps – the firm’s fair‑value tables (e.g., page 111) show a $5 billion net derivative liability that is driven by CDS protection and is marked to market based on the likelihood of a credit event. Capital One, by contrast, does not use CDS for hedging but values its net derivative assets and liabilities at Level 3 using unobservable inputs that include a “default‑rate” assumption (see page 208, where default is a key input ranging 53‑163% with a 4 % weighted average). Thus, both firms are highly sensitive to the same credit‑event outcomes: Morgan Stanley offsets that risk through CDS contracts, while Capital One’s fair‑value of derivatives moves directly with the default‑rate assumptions embedded in its valuation models.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Correctly identifies Morgan Stanley's use of CDS to hedge credit risk and Capital One's reliance on default rate assumptions in valuing Level 3 derivative assets. The core connection — both firms' sensitivity to credit event outcomes — is accurately synthesized. (2) Quantitatively, the LLM states a '4% weighted average' default rate and a '53–163%' range, matching the original answer (note: '53–163%' in the original is likely a typo or misformatting, as default rates over 100% are nonsensical; the LLM reproduces this faithfully, so no penalty). The $5 billion net derivative liability for Morgan Stanley is not in the original answer, but since it's presented as contextual detail (possibly from a real filing page 111) and doesn't contradict the ground truth, it doesn't reduce accuracy. (3) Multi-hop reasoning is sound: the model correctly contrasts Morgan Stanley’s active hedging via CDS (market-driven, mark-to-market) with Capital One’s model-based valuation (assumption-driven), and links both to systemic credit event sensitivity. (4) Minor deduction in quantitative accuracy due to the unverified $5B figure and the reproduction of the implausible >100% default rate range without comment, though this reflects the source data. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 386,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How do Duke Energy's natural gas distribution assets in Georgia compare to Southern Company Gas's investment in SNG in terms of capital scale and contribution to regional infrastructure reliability, given their respective exposures to Georgia's energy market?",
      "original_answer": "Duke Energy operates 28,000 miles of natural gas distribution and transmission pipelines in Georgia, directly contributing to local infrastructure reliability by delivering gas to end-users. Southern Company Gas holds a 50% interest in SNG, a 7,000-mile pipeline system that connects supply basins in the Gulf Coast to markets including Georgia, underpinning supply-side reliability. While Duke’s assets are focused on distribution with direct customer delivery, SNG serves as a backbone transmission system feeding regional utilities, including those in Georgia like Duke, creating an integrated infrastructure network. Southern Power’s 97% investment coverage ratio through 2028 indicates strong contracted revenue stability for SNG-related assets, while Duke’s localized pipeline miles reflect a high dependency on regional demand and regulatory frameworks governing distribution rates and returns.",
      "llm_answer": "Duke Energy’s natural‑gas system consists of roughly 35,700 miles of distribution and transmission pipelines (28,800 miles of service lines) that serve its own territories, but none of those assets are located in Georgia, so Duke’s exposure to the Georgia market is essentially limited to the broader regional gas market rather than to local infrastructure reliability. In contrast, Southern Company Gas’s 50 % stake in the Southern Natural Gas (SNG) pipeline is part of a $1.8 billion construction program and a 7,000‑mile pipeline that delivers gas into Georgia, making it a multi‑billion‑dollar capital investment that directly underpins the reliability of Georgia’s natural‑gas supply.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors, particularly regarding Duke Energy's presence in Georgia. The original answer states Duke Energy operates 28,000 miles of natural gas pipelines in Georgia, but the LLM claims Duke has no assets in Georgia and that its 35,700 miles of pipelines are not located there—this directly contradicts the ground truth. The 28,800 miles of service lines figure is fabricated and not in the original. While the LLM correctly identifies Southern Company Gas's 50% stake in SNG and the 7,000-mile pipeline, it introduces a '$1.8 billion construction program' not mentioned in the original, which lacks any dollar figures for capital investment. (2) Quantitative accuracy is partially correct: 7,000 miles for SNG is accurate, but Duke’s pipeline miles are misrepresented (35,700 vs 28,000), and the $1.8 billion figure is unsupported. The original mentions Southern Power’s 97% investment coverage ratio through 2028, which the LLM omits entirely. (3) Multi-hop reasoning fails: the LLM incorrectly concludes Duke has no Georgia infrastructure, undermining the comparison of capital scale and reliability contributions. It misses the integrated nature of SNG feeding utilities like Duke in Georgia, and fails to contrast Duke’s distribution focus with SNG’s transmission role as described in the original. (4) Contextual relevance is moderate—the answer addresses capital scale and reliability in Georgia, but due to factual inaccuracies and omission of key synthesis points (e.g., Duke relying on SNG-fed supply), the overall correctness is low. The introduction of unverified financial figures and incorrect asset locations severely undermines reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 466,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the enactment of Louisiana's corporate tax rate reduction legislation in 2024 impact Union Pacific's deferred tax expense, and how does this compare to the impact from similar legislation in Arkansas during the same year?",
      "original_answer": "Louisiana's enactment of corporate tax rate reduction legislation in 2024 resulted in a $34 million reduction in Union Pacific's deferred tax expense. This mirrors a similar impact from Arkansas, which also enacted tax rate reductions, contributing to a comparable adjustment. Together, these state-level legislative changes reflect a broader regional shift in corporate tax policy affecting Union Pacific's financial position.",
      "llm_answer": "In 2024 Union Pacific said that the corporate‑tax‑rate‑cut bills enacted in **Louisiana** (together with a similar bill in **Arkansas**) reduced its deferred tax expense by **$34 million** for the year. The filing does not break out the $34 million between the two states, so the Arkansas legislation is reflected in the same $34 million reduction – there is no separate amount disclosed for Arkansas alone.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $34 million reduction in deferred tax expense due to Louisiana and Arkansas legislation in 2024 is accurately reported. The format ($34 million) matches the original answer. (2) The LLM correctly identifies that the $34 million reflects the combined impact of both states and explicitly notes that the filing does not break out the amounts by state—this is a key nuance not present in the original answer but factually sound and adds clarity. (3) Entity accuracy is strong: Union Pacific, Louisiana, Arkansas, 2024, deferred tax expense—all are correctly identified and contextually used. (4) The reasoning is logically sound: the LLM synthesizes the multi-hop elements (two states, same year, same company, same financial impact) and correctly infers that the $34 million is a combined figure, which is consistent with the original answer’s statement that Arkansas had a 'comparable adjustment' but not a separate disclosed amount. The only minor shortcoming is that the original answer suggests Arkansas had a 'comparable' impact, implying a similar magnitude, while the LLM correctly clarifies that the total is $34M without separation—this is actually more precise. Thus, the LLM answer is factually correct, slightly more transparent about disclosure limitations, and fully contextually relevant. A score of 9 is given because while the LLM does not explicitly say the Arkansas impact was 'comparable' (as in the original), it avoids overstatement and sticks strictly to what is disclosed, which is a strength.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 448,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does the difference in voting rights between META's Class B Common Stock and GOOGL's Class A Common Stock influence their respective corporate governance structures, particularly in light of the specified voting limitations tied to Class B shares in merger scenarios?",
      "original_answer": "META's Class B Common Stock has no voting rights except in specified merger or consolidation scenarios, where they receive voting power proportional to their conversion rate. This limits shareholder influence outside of exceptional corporate actions. In contrast, GOOGL's Class A Common Stock provides one vote per share, offering more consistent voting influence to shareholders. This structural difference means that at META, decision-making control is more concentrated among holders of shares with superior voting rights (e.g., Class A), while at GOOGL, Class A shareholders have a steadier role in corporate governance. The specified voting limitations in META's charter for Class B shares in merger scenarios create a tailored influence mechanism that only activates under specific corporate events, unlike GOOGL's ongoing voting rights for Class A shares.",
      "llm_answer": "Meta’s Class B common shares carry no ordinary voting rights; they may vote only on a narrow set of matters – for example, a decision to exit the core payments business, certain amendments to the charter, and **any consolidation, merger or similar transaction**, where the Class B holders vote together as a single class and their votes equal the number of shares multiplied by the conversion rate (Meta 10‑K p. 90).  \n\nAlphabet’s (Google’s) Class A common stock, by contrast, is a fully‑voting class (one vote per share) that votes on **all** shareholder matters, including mergers (Alphabet 10‑K p. 82). Thus, Meta’s Class B shareholders have a very limited, event‑specific role in corporate governance, especially in merger scenarios, whereas Google’s Class A shareholders retain broad, ongoing voting power over the company’s governance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Meta's Class B shares have no ordinary voting rights and only vote in specified scenarios, including mergers, with voting power based on the conversion rate—consistent with the original answer. It accurately contrasts this with Alphabet's (GOOGL) Class A shares, which carry one vote per share and full voting rights on all matters, including mergers. (2) There are no numeric values (e.g., percentages, dollar amounts, dates) in the question or ground truth, so quantitative accuracy is not applicable in a traditional sense, but all referenced document locations (10-K pages) are correctly cited and consistent with source data, indicating strong factual grounding. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance differences between two companies (Meta and Alphabet), compares their share structures, and draws a valid conclusion about the concentration of control vs. ongoing shareholder influence. (4) The only minor shortcoming is that the LLM answer adds specific examples not in the original answer (e.g., 'decision to exit the core payments business'), which, while plausible and potentially accurate, are not present in the ground truth and slightly exceed the scope of the provided information. However, this does not detract from correctness, as the core structural comparison remains factually aligned. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 429,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How might U.S. payer restrictions on high-cost therapies like Repatha impact Pfizer's revenue recognition strategy for similar cardiovascular products, given both companies face challenges with formulary placement and patient affordability?",
      "original_answer": "U.S. commercial payer actions have significantly restricted access to high-cost therapies like Repatha through formulary exclusions, prior authorization requirements, and increased patient cost-sharing, which has directly limited sales despite price reductions. Pfizer faces similar risks, as it notes challenges in obtaining or maintaining favorable formulary placement and pricing for its products amid managed care and healthcare cost containment trends. Gilead's revenue recognition strategy accounts for these payer dynamics through complex gross-to-net deductions that factor in expected payer mix, rebate levels, and patient affordability trends. Therefore, if Pfizer markets similar high-cost cardiovascular therapies, it would likely face comparable pressures requiring careful estimation of rebates and chargebacks to align with payer realities and maintain revenue integrity.",
      "llm_answer": "U.S. payers are increasingly requiring steep discounts, rebates and utilization‑management steps for high‑cost drugs such as Repatha, and they are limiting patient out‑of‑pocket affordability. Pfizer notes that it “actively engages…with patients, physicians and payers to…evaluate pricing arrangements and contracting methods to minimize adverse impact on our revenues” (p. 11) and that its product‑sale revenue is recorded “net of estimated government and other rebates and chargebacks” with those estimates updated each period (p. 48). Consequently, if similar cardiovascular products face the same formulary‑placement and affordability hurdles, Pfizer will likely increase discount/rebate offers, lower list‑price options and tighten its gross‑to‑net assumptions—recognizing revenue more conservatively and adjusting timing to reflect the higher probability of payer‑driven price reductions and potential reversals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the impact of U.S. payer restrictions on high-cost therapies like Repatha, including formulary limitations, rebates, and patient affordability issues. It accurately reflects Pfizer's challenges with formulary placement and pricing, citing direct quotes from its filings about revenue recognition practices (e.g., net of rebates, updated estimates). (2) There are no numeric values in the original or LLM answer requiring calculation verification, so quantitative accuracy is not compromised—no figures are misstated. (3) The multi-hop reasoning is sound: it connects payer dynamics observed with Repatha to potential impacts on Pfizer’s cardiovascular products, then links this to revenue recognition strategy via gross-to-net deductions, consistent with Gilead’s approach mentioned in the ground truth. The LLM infers conservative revenue recognition and dynamic rebate estimation as strategic responses, which is logically supported. (4) The only minor gap is that the LLM does not explicitly mention Gilead’s revenue strategy as a benchmark (though it implies similar industry practices), slightly reducing qualitative completeness. However, the core synthesis across payer behavior, company risk, and accounting response is correct and contextually rich. Wording differs but semantic meaning matches. Thus, high scores across all dimensions with a 9 on correctness due to near-complete alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 411,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does Chevron's 15% ownership stake in TCO's Kazakhstan crude oil operations influence its exposure to TCO's planned production ramp-up from the FGP project starting in 2025, especially when compared to COP's broader dependence on crude oil as a raw material?",
      "original_answer": "Chevron's 15% ownership in TCO provides it with partial exposure to TCO's planned production ramp-up from the FGP project in Kazakhstan, which is expected to start-up in the first half of 2025 and ramp up to full production within three months. This production increase will flow through the Caspian Pipeline Consortium (CPC), in which Chevron also holds a 15% interest, enabling increased throughput capacity. In contrast, COP has a direct and full dependency on crude oil as a raw material, indicating a more concentrated exposure to crude oil supply dynamics. Chevron’s partial ownership in TCO creates a more indirect exposure to crude oil production volumes and timelines in Kazakhstan, as opposed to COP’s direct reliance on crude oil for its operations.",
      "llm_answer": "Chevron’s exposure to the Tengizchevroil (TCO) Future Growth Project (FGP) is limited to its 15 % working interest in the Caspian Pipeline Consortium (CPC) that carries TCO’s crude – so only about one‑fifteenth of the additional barrels that TCO expects to bring on‑line in the first half of 2025 will flow through assets in which Chevron has a direct economic stake【page_16】. By contrast, ConocoPhillips’ balance sheet shows a much larger portfolio of crude‑oil‑based proved reserves (over 4 billion barrels of oil‑equivalent in 2023) and its operations are broadly tied to crude oil as a raw material, making the company far more exposed to any overall increase or decline in crude‑oil production and pricing【page_146】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several critical inaccuracies that undermine its correctness. (1) Quantitative inaccuracy: The claim that Chevron's 15% stake means 'only about one-fifteenth of the additional barrels...will flow through assets in which Chevron has a direct economic stake' is incorrect. 15% is approximately one-seventh, not one-fifteenth—this is a major calculation error. (2) Misattribution of ownership: The LLM incorrectly states Chevron has a 15% working interest in the Caspian Pipeline Consortium (CPC)—while this part is factually correct (Chevron does hold 15% in CPC)—it frames Chevron’s exposure solely through CPC, ignoring the original answer’s key point that Chevron has a 15% ownership stake in TCO itself, which is the primary source of exposure to production ramp-up. The LLM conflates pipeline throughput exposure with equity ownership exposure, downplaying the direct equity link. (3) Entity and reasoning issues: While COP’s broader crude oil dependence is correctly noted with a reference to proved reserves, the comparison is weakened by focusing on reserves rather than operational dependence as emphasized in the ground truth. The original answer highlights COP’s 'direct and full dependency on crude oil as a raw material'—a structural operational point—whereas the LLM shifts to balance sheet reserves, which, while relevant, is a different concept. (4) Contextual relevance is strong: the answer addresses Chevron’s limited exposure, the 2025 timeline, and contrasts with COP’s crude dependence, so it remains on-topic. However, due to the significant error in interpreting Chevron’s ownership stake and flawed quantitative reasoning, the overall correctness is compromised. The multi-hop synthesis (Chevron → TCO → FGP → CPC → exposure vs. COP’s crude reliance) is partially correct but misprioritizes pipeline interest over equity ownership, distorting the exposure mechanism.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 514,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does Goldman Sachs' exposure to hotel-related commercial real estate loans compare to MetLife's investment in real estate funds focused on hotels, given the role of real estate funds in both companies' strategies?",
      "original_answer": "Goldman Sachs has significant credit exposure to commercial real estate loans secured by hotels, as detailed in their 2024 10-K filing, which highlights the importance of this asset class in their lending portfolio. These loans are often channeled through or connected to real estate funds, which are also a key vehicle for investment in hotel assets. MetLife, on the other hand, holds $13.3 billion in real estate investments as of December 31, 2024, including interests in real estate funds that invest in hotel properties. While both companies are exposed to hotel real estate, Goldman Sachs' involvement is primarily through lending, whereas MetLife participates through direct ownership stakes in funds. This distinction reflects different risk profiles and strategic approaches to the hotel sector within the broader commercial real estate market.",
      "llm_answer": "Goldman Sachs’ commercial‑real‑estate portfolio totals $34.8 billion, and hotels (listed as “hospitality”) make up about 5 % of that mix – roughly **$1.7 billion** of loan and commitment exposure to hotel‑related properties.  \n\nMetLife’s real‑estate‑fund holdings, which include hotel assets, are reported at a carrying value of **$3.46 billion** (the full amount of its real‑estate fund investments).  \n\nThus, MetLife’s investment in real‑estate funds that target hotels is roughly **twice the size** of Goldman Sachs’ direct hotel‑related loan exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. First, the claim that Goldman Sachs has $1.7 billion in hotel-related loan exposure (5% of $34.8B) is not supported by the original answer, which states Goldman has 'significant credit exposure' to hotel CRE loans but does not provide a specific dollar amount or percentage. The $34.8B total CRE portfolio figure and the 5% allocation to hospitality are fabricated or misattributed, as they do not appear in the ground truth. Second, the LLM asserts MetLife’s real estate fund investments total $3.46B, but the original answer states MetLife holds $13.3B in total real estate investments, including interests in funds that invest in hotels—without specifying how much is allocated to hotel-focused funds. Thus, the $3.46B figure is unsupported, and the conclusion that MetLife’s investment is 'twice the size' of Goldman’s exposure is based on incorrect data and invalid comparison. While the LLM correctly identifies the qualitative distinction in strategy—Goldman via lending, MetLife via fund investments—it fails to accurately represent the scale or sourcing of these exposures. The reasoning is logically structured but built on false numerical premises. The entities (Goldman Sachs, MetLife, hotel real estate funds) and general strategic roles are correctly identified, and the answer addresses the comparative aspect of the question, maintaining contextual relevance. However, the unsupported figures and erroneous calculations severely reduce factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 426,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How do the liquidity risk profiles of BA's limited partnership investments compare with UPS's pension fund commitments in real estate, particularly regarding the 10–15 year partnership terms and UPS's $3.3 billion in unfunded obligations?",
      "original_answer": "Both BA and UPS hold investments through limited partnerships, which expose them to long-term liquidity risks due to the structural characteristics of these vehicles. BA invests in limited partnerships that focus on real estate and private assets, with investment durations typically spanning 10–15 years, limiting liquidity until the end of the partnership term. Similarly, UPS has $3.3 billion in unfunded commitments to limited partnerships as of December 31, 2023, with redemption provisions restricted until the end of the fund’s life, also generally 10–15 years from inception. This shared structure implies both companies face limited short-term liquidity and are exposed to market risks over extended periods without the ability to exit early without discounts.",
      "llm_answer": "BA’s pension‑plan assets that are held in limited‑partnership vehicles are described as “ill‑iquid” because the partnership agreements generally do not allow redemption until the fund’s term ends – typically a 10‑ to 15‑year horizon. UPS makes the same point for its real‑estate, private‑debt and private‑equity fund interests, noting that “redemption … is not permitted … until the end of the term of the partnerships, typically ranging between 10 and 15 years” and that it carries “unfunded commitments to such limited partnerships totaling approximately $3.3 billion … to be contributed over the remaining investment period, typically ranging between three and six years” (UPS 10‑K, p. 89).  \n\nThus, both companies face long‑dated liquidity risk from these partnership holdings, but UPS explicitly quantifies a large near‑term cash‑outflow exposure ($3.3 bn of unfunded commitments) that BA does not disclose, suggesting UPS’s real‑estate commitments are materially more liquidity‑constrained than BA’s limited‑partnership investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: both BA and UPS have limited partnership investments with 10–15 year terms causing liquidity constraints; UPS has $3.3 billion in unfunded commitments as of December 31, 2023 (implied by context and explicitly stated in the LLM answer with citation to UPS 10-K, p. 89). The dollar amount, time horizon (10–15 years), and nature of the liquidity risk are all factually correct. (2) Quantitative accuracy is perfect: $3.3 billion is correctly reported, and the 10–15 year partnership term is accurately reflected for both companies. The LLM also correctly notes that UPS’s unfunded commitments are to be contributed over a 3–6 year investment period, a detail consistent with typical fund dynamics and adds nuance not in the original answer but not contradictory. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across BA and UPS, comparing their liquidity risks and highlighting that UPS discloses a quantified near-term cash obligation while BA does not—this is a valid inference and adds analytical value. (4) The only minor shortcoming is that the original answer emphasizes the shared structural liquidity risk more symmetrically, while the LLM concludes that UPS’s commitments are 'materially more liquidity-constrained,' which, while reasonable, introduces a comparative strength not explicitly in the ground truth. However, this is a defensible interpretation given the lack of disclosed obligations from BA. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 446,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at META compare to the voting structure at CMCSA, particularly in terms of control concentration and shareholder influence?",
      "original_answer": "At META, the dual-class structure gives Class B common stockholders, primarily Mark Zuckerberg, outsized control, requiring a majority of Class B shares to approve change-of-control transactions until they represent less than 35% of combined voting power. In contrast, CMCSA's structure grants Class A common stockholders 66 2/3% of the combined voting power, with each Class B share having 15 votes, but Class B stock is non-dilutable and owned entirely by Brian L. Roberts. This means both companies use dual-class structures to concentrate control, but META's governance rules and anti-takeover provisions make it harder for investors to influence corporate decisions compared to CMCSA, where Class A shareholders collectively hold significant voting influence.",
      "llm_answer": "Meta’s dual‑class structure gives its Class B shares ten votes each and its Class A shares one vote each, and the holders of Class B (Mark Zuckerberg, the board chair and CEO) control a **majority of the combined voting power** (they can dictate outcomes as long as Class B represents only about 9 % of the total shares) – effectively limiting the influence of ordinary Class A shareholders【page_49†L13-L20】.  \n\nComcast also has a dual‑class system, but the single holder of Class B (Brian L. Roberts) controls **about one‑third of the total voting power** (each Class B share carries 15 votes and represents 33 ⅓ % of voting power), while Class A shareholders retain roughly two‑thirds of the vote【page_33†L9-L13】.  \n\nThus, Meta’s voting power is more heavily concentrated in its Class B stock (a controlling majority), whereas Comcast’s concentration is lower (a substantial but not majority block), giving Meta’s non‑controlling shareholders far less ability to affect corporate decisions than Comcast’s Class A shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the dual-class structures at both META and CMCSA and accurately attributes concentrated control to insiders (Zuckerberg and Roberts). It correctly contrasts the degree of control concentration, noting that META’s Class B holds a majority of voting power while CMCSA’s Class B holds about one-third. However, there are key quantitative inaccuracies: the claim that META Class B needs only ~9% of total shares to maintain control is not in the original answer (which states control persists until Class B falls below 35% of combined voting power, not 9% of total shares). This is a significant error. Additionally, the original specifies that CMCSA Class B has 66 2/3% voting power, not Class A as implied in the LLM answer — the LLM incorrectly swaps the voting power distribution, stating Class A has two-thirds when it is actually Class B (owned by Roberts) that holds 66 2/3%. 2) The numbers are partially correct: META’s 10 votes per Class B share and CMCSA’s 15 votes per Class B share are accurate, but the 9% threshold for META and the 33 1/3% voting power for CMCSA Class B are incorrect — the original states CMCSA Class B has 66 2/3% of voting power, not 33 1/3%. The LLM likely confused voting power with ownership or misread the structure. 3) The multi-hop reasoning is sound in intent — comparing control concentration and shareholder influence across two companies using dual-class structures — and the conclusion that META’s structure gives less influence to non-controlling shareholders is logically supported and aligns with the original. However, the flawed quantitative foundation weakens the reasoning. 4) Despite the numerical errors, the answer addresses all parts of the question, uses correct entities (META, CMCSA, Zuckerberg, Roberts), and provides a relevant, structured comparison. The qualitative insight about greater control concentration at META is valid, even if the supporting numbers are imprecise. Hence, correctness is reduced due to critical percentage errors, but not severely penalized because the directional conclusion remains supportable.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 566,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the allocation of PEP's U.S. qualified defined benefit plan assets to government securities compare with the investment profile of COST's short-term holdings in government and agency securities, particularly in terms of risk management and expected return strategy?",
      "original_answer": "PEP's U.S. qualified defined benefit plans allocated $1.812 billion to government securities in 2023 as part of a diversified investment strategy aiming for a 7.4% long-term return, while COST holds short-term investments in government and agency securities primarily for capital preservation with a focus on low volatility and effective maturities of three months to five years. PEP's approach includes active management and use of derivatives to mitigate risk, whereas COST limits exposure to interest rate fluctuations by investing in fixed-rate, short-duration instruments.",
      "llm_answer": "PEP’s U.S. qualified defined‑benefit plan holds about **$1.8 billion of government securities** (≈15 % of the $11.7 billion U.S. plan assets reported in 2023) 【page 99】.  The plan’s investment policy calls for a **well‑diversified mix of high‑quality debt and equity**, targeting a **7.4 % long‑term return** while using derivatives to hedge interest‑rate and currency risk, thereby balancing return expectations with volatility control 【page 97】【page 98】.  \n\nCostco’s short‑term portfolio is limited to **U.S. government and agency securities, repurchase agreements, money‑market funds and insured bank balances**, with maturities of three months to five years; the primary goal is **preservation of principal and a modest yield**, and the company expressly avoids speculative or leveraged positions, reflecting a more conservative, liquidity‑focused risk‑management approach 【page 31】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct and aligns well with the ground truth. It accurately reports PEP's $1.8 billion allocation to government securities (rounded from $1.812 billion), which is consistent within acceptable rounding limits. The mention of a 7.4% long-term return target and use of derivatives for risk mitigation matches the original. For COST, the description of short-term holdings in government and agency securities with maturities of three months to five years, focused on capital preservation and low volatility, is fully accurate.\n\n2) Quantitative accuracy is excellent: $1.8 billion is a valid rounding of $1.812 billion. The contextual addition of total U.S. plan assets ($11.7 billion) and the implied ~15% allocation is not in the original but is a correct inference and adds value without introducing error. No calculations were required beyond this, and all figures match or are sensibly derived from ground truth.\n\n3) Multi-hop reasoning is sound — the LLM correctly synthesizes information across PEP and COST filings, contrasting PEP’s long-term, return-oriented, actively managed strategy with COST’s short-term, liquidity- and preservation-focused approach. The distinction in risk management (derivatives and diversification vs. short-duration, fixed-rate instruments) is clearly and correctly articulated.\n\n4) The only reason for not awarding a perfect 10 is minor: the LLM introduces the percentage allocation (~15%) and total plan size ($11.7B) not present in the original answer, though these are accurate and enhance understanding. Since the original answer did not include these details, this represents a slight deviation in focus, though not an error. Otherwise, semantic equivalence is strong, and all key elements of risk management and return strategy are correctly compared.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 493,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Southern Company's actual allocation to mortgage-backed securities within its fixed income portfolio compare to NextEra Energy's target allocation framework for fixed income investments, given that both classify mortgage-backed securities under fixed income assets?",
      "original_answer": "Southern Company had only $9 million allocated to mortgage-backed securities as part of its $6,154 million in fixed income investments measured using significant other observable inputs (Level 2), representing less than 0.15% of its fixed income portfolio. In contrast, NextEra Energy's pension plan targets 32% allocation to fixed income investments as part of its broader pension asset strategy, which explicitly includes mortgage-backed securities under its fixed income classification. Both companies classify mortgage-backed securities under fixed income investments, with Southern Company valuing them at yields on comparable securities and NextEra Energy utilizing a combination of directly held securities and commingled investment arrangements.",
      "llm_answer": "Southern Company’s 2020 fair‑value schedule shows that mortgage‑ and asset‑backed securities total **$9 million** within a fixed‑income portfolio of about **$3.4 billion**, i.e., roughly **0.3 % of its fixed‑income holdings**.  \n\nNextEra Energy’s pension‑plan policy, on the other hand, targets **32 % of total assets** to be invested in fixed‑income securities (the target allocation framework for the whole fixed‑income category, not a specific MBS slice).  \n\nThus, Southern Company’s actual MBS exposure is a tiny fraction of its fixed‑income mix, whereas NextEra Energy’s plan aims for roughly one‑third of its assets to be in fixed income overall.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains key factual inaccuracies in the quantitative details. While it correctly states Southern Company's $9 million allocation to mortgage-backed securities (MBS), it incorrectly reports the total fixed income portfolio as $3.4 billion instead of the correct $6,154 million (~$6.15 billion) from Level 2 assets. This leads to an erroneous percentage calculation: 0.3% (based on $9M / $3.4B) vs. the correct ~0.15% (based on $9M / $6,154M). The $3.4 billion figure does not align with the ground truth and appears to be a misinterpretation or use of incomplete data. (2) The LLM correctly identifies NextEra Energy's 32% target allocation to fixed income as part of its pension plan strategy and correctly clarifies that this is a target for the entire fixed income category, not MBS specifically. This aligns with the original answer. (3) The multi-hop reasoning is partially sound: the model correctly contrasts Southern Company's actual MBS allocation with NextEra's broader fixed income target, recognizing that both classify MBS under fixed income. However, the flawed portfolio size undermines the accuracy of the comparison. (4) Despite the numerical error, the qualitative conclusion—that Southern’s MBS exposure is minimal compared to NextEra’s strategic fixed income target—is directionally correct and contextually relevant. The answer omits some details from the ground truth (e.g., valuation methods: yields on comparable securities vs. commingled arrangements), but these are secondary. The primary deduction is for the significant quantitative inaccuracy in the denominator of the percentage calculation, which affects factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 460,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What specific pricing agreements and supply arrangements did Tesla and Panasonic Corporation formalize in their Gigafactory partnership, and how does GM’s dependency on batteries compare in terms of supplier integration and contractual depth?",
      "original_answer": "Tesla and Panasonic Corporation formalized multiple pricing agreements and supply arrangements under their Gigafactory partnership, including the Amended and Restated General Terms and Conditions for Gigafactory (June 10, 2020), the 2020 Pricing Agreement (Gigafactory 2170 Cells), and the 2021 Pricing Agreement (Japan Cells). These agreements establish detailed pricing mechanisms, production responsibilities, and shared facility leasing arrangements. In contrast, GM’s dependency on batteries is noted without equivalent supplier integration details or specific contractual commitments in the evidence provided, indicating a less transparent or structured supplier partnership compared to Tesla’s explicit agreements with Panasonic.",
      "llm_answer": "Tesla and Panasonic formalized a long‑term Gigafactory supply framework that includes a 2011 Supply Agreement (and its 2013 amendment), a 2014 General Terms and Conditions, a 2015 Letter Agreement adding co‑parties, an Investment Letter Agreement (Oct 1 2014), and a Production Pricing Agreement (Nov 7 2014) that set fixed cell‑price terms.  The partnership was later refined with a series of “Pricing Agreements” – a 2019 Japan‑cell pricing deal, a 2020 Gigafactory 2170‑cell pricing deal, and a 2021 Japan‑cell pricing deal – each establishing per‑kWh pricing and volume commitments for Panasonic‑produced cells supplied to Tesla’s Gigafactory.\n\nBy contrast, GM’s battery supply is tied to its equity stake in Ultium Cells Holdings LLC, a joint‑venture that provides cells for GM EVs but gives GM no voting or direct control over the venture’s operations.  GM reports only equity earnings from the JV (see GM 10‑K p. 76) and notes it “lacks the power … to direct the activities of these entities” (GM 10‑K p. 79), indicating a shallower, less contract‑driven integration than the detailed, multi‑year pricing and supply contracts Tesla has with Panasonic.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core of the multi-hop comparison between Tesla-Panasonic and GM's battery supply arrangements. However, there are minor inaccuracies in dates and agreement names that affect quantitative accuracy. The ground truth specifies the 'Amended and Restated General Terms and Conditions for Gigafactory' on June 10, 2020, the 2020 Pricing Agreement (Gigafactory 2170 Cells), and the 2021 Pricing Agreement (Japan Cells). The LLM incorrectly references a 2019 Japan-cell pricing deal, a 2014 Production Pricing Agreement (Nov 7, 2014), and a 2015 Letter Agreement, which are not in the ground truth. While the general structure of multiple pricing agreements is correct, the specific dates and titles do not fully align. The LLM correctly contrasts this with GM’s lack of control over Ultium Cells LLC, citing accurate 10-K page references (pp. 76, 79) and correctly noting GM’s lack of voting power and operational control, which supports the conclusion of shallower integration. The reasoning is sound and synthesizes across entities (Tesla/Panasonic vs. GM/Ultium), and the qualitative assessment that Tesla has deeper contractual integration is valid and contextually relevant. The answer exceeds the original in detail but introduces some unverified specifics. Thus, the correctness score is reduced slightly for factual overreach in agreement dates and names, though the overall conclusion remains accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 400,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Chevron's ongoing tax audit exposure in Nigeria compare to Exxon's production-sharing contract risk in the same country, given the specific terms of Nigeria's PSCs and Chevron's unresolved tax positions?",
      "original_answer": "Chevron faces unresolved tax audits in Nigeria with $5,288 million in unrecognized tax benefits at year-end 2021, where the latest audit finalized was for the year 2007, leaving over a decade of tax exposure open to scrutiny. Meanwhile, Exxon operates in Nigeria under production-sharing contracts (PSCs) that typically last 30 years, with a 10-year exploration period followed by a 20-year production period, which may be extended subject to relinquishment provisions. Exxon also reports that 12% of its total proved reserves in 2021 were under PSC arrangements, where production volumes fluctuate inversely with price changes. Therefore, while Chevron's risk in Nigeria is tied to legacy tax liabilities and regulatory uncertainty, Exxon's exposure is more operational and tied to the fiscal terms and duration of its PSCs, which are sensitive to commodity price volatility.",
      "llm_answer": "Chevron’s 2021 filing shows it still has ≈ $5.3 billion of unrecognised tax benefits, with the Nigeria audit still open (the most recent year examined there was 2007) and the outcome and timing of resolution described as “highly uncertain.” Exxon’s 2022 filing notes that its Nigerian assets are held under 30‑year production‑sharing contracts that include a 10‑year exploration phase, a 20‑year production phase and any extension is subject to the partial‑relinquishment provision of the 2021 Petroleum Industry Act, creating a contractual‑extension risk rather than a tax‑audit exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with only minor omissions. (1) Quantitatively, all numbers and dates are correct: Chevron's $5.3 billion in unrecognized tax benefits (matching $5,288 million in the original, rounded appropriately), the Nigeria audit last finalized for 2007, and Exxon's 30-year PSC structure with 10-year exploration and 20-year production phases are all correctly reported. The reference to the 2021 Petroleum Industry Act aligns contextually, even if not explicitly in the original answer. (2) The LLM correctly identifies the entities (Chevron, Exxon), the relevant financial metric (unrecognized tax benefits), and the contractual framework (PSCs with relinquishment provisions). (3) The multi-hop reasoning is sound: it contrasts Chevron’s tax-audit risk with Exxon’s contractual/operational risk under PSCs, accurately differentiating the nature of exposure. (4) The only minor shortcoming is the omission of Exxon’s 12% of proved reserves under PSCs and the inverse relationship between production volumes and price changes, which adds nuance to the fiscal sensitivity. However, the core comparison of risk types (tax vs. contractual) is preserved. Wording differs but semantic meaning is equivalent. Thus, the answer is factually correct and contextually relevant, meriting a 9 for correctness and qualitative accuracy, with full marks for quantitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 401,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does Tesla's use of commercial paper compare to companies with significant operations in Ohio, such as Duke Energy Ohio?",
      "original_answer": "Tesla reported $470 million in commercial paper holdings as of December 31, 2023, as part of its short-term investment strategy. In contrast, Duke Energy Ohio, a major company operating in the state, had $25 million in commercial paper outstanding as disclosed in its financial details. This comparison highlights different approaches to short-term financing and liquidity management between Tesla, a technology and automotive company, and Duke Energy Ohio, a utility provider.",
      "llm_answer": "Tesla reported $470 million of commercial paper on its balance sheet at 12/31/2023, whereas Duke Energy’s Ohio subsidiary carried only $25 million of commercial paper (see Duke Energy Ohio’s $25 million figure in the “Commercial paper” line of the debt tables). Thus Tesla’s commercial‑paper borrowing is roughly 20 times larger than the amount used by the Ohio‑based utility, and Duke Energy Ohio’s paper is a very short‑term facility (average maturity about 23 days).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Tesla's commercial paper as $470 million as of December 31, 2023, and Duke Energy Ohio's as $25 million, matching the ground truth exactly. These figures are presented with acceptable formatting variations (e.g., '12/31/2023' vs 'December 31, 2023'). The comparison stating Tesla’s commercial paper is 'roughly 20 times larger' is accurate (470 / 25 = 18.8, which rounds to ~20), and this quantitative assessment is reasonable. (2) All numbers and dates are correct. The calculation of relative size is logically sound and appropriately rounded. The additional detail about average maturity (~23 days) is not present in the ground truth but does not contradict it and may be inferred from Duke Energy’s short-term facility practices; however, since this detail is not confirmed in the original answer, it introduces a minor overreach. (3) The multi-hop reasoning is solid: the model correctly identifies Tesla and Duke Energy Ohio as the relevant entities, retrieves the correct financial metric (commercial paper), and synthesizes across the two companies to make a meaningful comparison. The conclusion about differing financing strategies is implied in the original answer and reasonably expanded upon. (4) The answer is highly relevant, complete, and factually aligned with the ground truth. The only reason for not scoring a 10 is the inclusion of the 23-day maturity detail, which, while plausible, is not supported by the provided ground truth and thus slightly reduces qualitative accuracy. Overall, the answer is excellent and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 445,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does JPMorgan's exposure to transition risk, as outlined in its climate risk management framework, influence its compliance risk profile compared to Morgan Stanley's experience with regulatory scrutiny tied to climate-related disclosures?",
      "original_answer": "JPMorgan acknowledges transition risk as a key component of climate risk, which may amplify compliance risk due to increased regulatory scrutiny tied to climate-related disclosures. JPMorgan has established a Climate Risk Management function that integrates climate risk into its broader risk management framework, including developing metrics and stress testing mechanisms to assess potential financial impacts. According to Morgan Stanley’s disclosures, compliance risk includes exposure to legal sanctions or reputational damage from failure to meet climate-related regulatory requirements, such as increased disclosure mandates or carbon taxes. Furthermore, Morgan Stanley notes that transition risk can lead to reputational, compliance, and litigation risks due to heightened legal and regulatory scrutiny. Therefore, both firms recognize that transition risk directly influences compliance risk, but JPMorgan emphasizes proactive integration into risk frameworks, whereas Morgan Stanley highlights the regulatory enforcement dimension.",
      "llm_answer": "JPMorgan’s climate‑risk framework treats transition risk as a direct source of compliance risk – the firm notes that the financial, policy‑ and technology‑driven changes of a low‑carbon transition can “expose us to … compliance and/or litigation risk due to increased legal and regulatory scrutiny” (see JPM 10‑K p. 78). Because transition risk is built into its enterprise‑wide risk‑governance, JPMorgan’s compliance profile is shaped by an internal, scenario‑driven assessment of how policy or market shifts could trigger regulatory actions.  \n\nMorgan Stanley, by contrast, highlights that it has already attracted regulator attention over the adequacy of its climate‑related disclosures, indicating that its compliance risk is being driven more by external enforcement and scrutiny of its reporting practices rather than by an internal transition‑risk modelling process.  This makes Morgan Stanley’s compliance risk profile more reactive to regulator actions, whereas JPMorgan’s is proactively managed through its transition‑risk framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: JPMorgan's integration of transition risk into its risk governance framework and its acknowledgment of compliance and litigation risks due to regulatory scrutiny are accurately represented, including the reference to page 78 of its 10-K, which is consistent with disclosed content. Morgan Stanley’s experience with actual regulatory scrutiny over climate disclosures is correctly contrasted as more reactive, emphasizing enforcement rather than internal modeling. (2) There are no numerical values, dates, or financial metrics requiring verification, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across both firms’ risk disclosures, comparing JPMorgan’s proactive, scenario-based internal framework with Morgan Stanley’s externally driven compliance risk profile. The distinction between proactive integration and reactive exposure is logically derived and matches the original answer’s conclusion. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'reactive to regulator actions' vs. 'highlights regulatory enforcement dimension'), the meaning is consistent. The only minor shortcoming is that the LLM does not explicitly mention Morgan Stanley’s linkage of transition risk to reputational and litigation risks, which slightly reduces completeness. However, the core comparison on compliance risk is fully accurate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 430,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What implications does Nigeria's 30-year production-sharing contract framework have for both ConocoPhillips' deepwater operations and Chevron's reserve accounting practices in the region?",
      "original_answer": "Nigeria's regulatory framework for deepwater offshore exploration establishes 30-year production-sharing contracts (PSCs) that include a 10-year exploration period followed by a 20-year production period, which may be extended under certain conditions. Since ConocoPhillips operates in Nigeria, this structure directly influences its long-term planning and investment decisions in the region. Chevron, which reports that 8-10% of its reserves are tied to PSCs like those in Nigeria, must align its reserve accounting and production forecasts with the specific terms of these contracts, including the partial relinquishment provisions under Nigeria's Petroleum Industry Act. Both companies must therefore manage exploration timelines, commercial discovery requirements, and reserve disclosures in accordance with this regulatory framework.",
      "llm_answer": "Nigeria’s production‑sharing contracts are written for a 30‑year term (10 years of exploration followed by a 20‑year production period, with possible extensions). For ConocoPhillips, this long‑term PSC framework gives the company the contractual certainty it needs to invest in and operate deep‑water projects in the Niger Delta, because the exploration window and the guaranteed production period align with the long‑horizon capital commitments typical of deep‑water development 【page 154】. For Chevron, the same PSC regime means that the Nigerian volumes are recorded under the “economic‑interest” method; PSC‑related reserves make up a material share of its reserve portfolio (7 %‑11 % of consolidated reserves in recent years) and therefore directly affect how Chevron reports and values its proved reserves in the region 【page 106】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all key numbers and timeframes are correct: the 30-year PSC structure (10-year exploration + 20-year production) matches the original. The percentage of Chevron's reserves tied to PSCs is reported as 7%-11% in the LLM answer versus 8%-10% in the original; this is a minor variation but within a reasonable range, possibly reflecting different reporting years or rounding, and does not constitute a factual error. (2) The LLM correctly identifies that ConocoPhillips benefits from long-term contractual certainty for deepwater operations, which supports investment planning—this is consistent with the original's emphasis on long-term planning and investment. (3) For Chevron, the LLM accurately notes the impact on reserve accounting, specifying the 'economic-interest' method and materiality of PSCs to its reserve base, which reflects proper synthesis of accounting implications under PSC frameworks. It also correctly ties this to reserve disclosures, though it omits explicit mention of 'partial relinquishment provisions' under Nigeria's Petroleum Industry Act—a minor omission that slightly reduces completeness but does not undermine the core accuracy. (4) The reasoning is sound: the LLM connects the PSC duration to capital planning for ConocoPhillips and links the same framework to Chevron’s reserve recognition methodology, demonstrating correct multi-hop synthesis across regulatory structure, company operations, and accounting practices. (5) Contextual relevance is excellent—the answer directly addresses both companies and the implications for operations and accounting as required. Overall, the answer is factually strong, well-reasoned, and semantically equivalent to the ground truth with only negligible differences in reserve percentage range and a minor omission of relinquishment rules.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 512,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does Boeing's exposure to U.S. government contract modifications influence its application of ASU 2022-06, and how does this compare to FedEx's use of the same standard in managing reference rate reform impacts on their contracts?",
      "original_answer": "Boeing faces significant risk from U.S. government contract modifications, which could impact 37% of its revenues earned under government contracts. While Boeing must apply accounting standards like ASU 2022-06, which extends relief for contract modifications related to reference rate reform (e.g., LIBOR), the evidence shows Boeing did not experience material impacts from such modifications. Similarly, FedEx, though not directly exposed to government contract risk like Boeing, also applies ASU 2022-06 to manage contract modifications related to reference rate reform, with no material effect on its financial condition or results of operations as of May 31, 2024. Both companies benefit from the extended sunset date of ASU 2022-06 through 2024, easing the burden of contract adjustments.",
      "llm_answer": "Boeing notes that a large share of its revenue (about 37 percent) comes from U.S. government contracts that can be modified, curtailed or terminated at the government’s discretion; because such modifications often require changes to the contract’s reference‑rate terms, Boeing says it will rely on the optional expedients in ASU 2022‑06 to lessen the accounting impact of those modifications. FedEx, by contrast, only references ASU 2022‑06 as a tool it is watching for contracts and hedging relationships affected by LIBOR reform and states that, to date, the standard has had no material effect on its financial results. Thus Boeing’s exposure to government‑contract changes drives a more proactive use of the ASU, while FedEx’s use is limited to monitoring and has been immaterial.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, the 37% figure for Boeing's revenue exposure to U.S. government contracts is accurate, and the mention of ASU 2022-06’s relevance to contract modifications is correct. The fiscal cutoff (May 31, 2024) is not explicitly mentioned in the LLM answer, but the general timeline implied by the use of the standard through 2024 is consistent. (2) The LLM correctly identifies both Boeing and FedEx as applying ASU 2022-06, and accurately states that neither has experienced material financial impact—this matches the ground truth. (3) The reasoning is mostly sound: Boeing’s exposure to government contract modifications does create a context where ASU 2022-06 is relevant, and the LLM correctly infers a more proactive use. However, the ground truth clarifies that Boeing did *not* experience material impacts, while the LLM implies Boeing is actively relying on the expedients—this is a subtle but important distinction. The ground truth does not confirm active reliance, only that the standard applies and no material impact occurred. (4) FedEx’s use is accurately portrayed as immaterial and observational. The LLM slightly overstates Boeing’s proactive application, which isn’t fully supported in the original answer. Despite this, the core facts, entities, and synthesis are correct, warranting a high score but not perfect due to the overinterpretation of Boeing’s actions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 403,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does ExxonMobil's offshore acreage in Angola compare to Chevron's stake in Angola LNG, given Chevron's reported upstream earnings contributions from that asset in 2021?",
      "original_answer": "ExxonMobil held 2.9 million net offshore acres in Angola at year-end 2021, while Chevron reported a stake in Angola LNG, which contributed to upstream-related earnings improvements in 2021 due to higher performance from equity affiliates like Angola LNG. Chevron's volumes in Angola reflect its share of production through affiliates, including Angola LNG.",
      "llm_answer": "ExxonMobil reported that at the end of 2021 it held **about 2.9 million offshore acres in Angola** (ExxonMobil’s net acreage in Angola was 3.0 million acres, of which 2.9 million were offshore)【page_24】.  \n\nChevron, by contrast, does not own acreage in Angola; its exposure comes from an **equity interest in the Angola LNG joint‑venture** that was singled out as a contributor to its 2021 upstream earnings (the filing notes “higher upstream‑related earnings … from … Angola LNG”【page_42】). Thus, ExxonMobil’s presence is measured in millions of offshore acres, whereas Chevron’s involvement is a percentage‑based ownership stake in the LNG project that generated upstream earnings, not a land‑acre holding.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, it correctly states ExxonMobil's offshore acreage in Angola as 2.9 million at year-end 2021. The slight mention of 3.0 million total net acres (with 2.9 million offshore) adds context not in the original answer but does not contradict it—this nuance is acceptable and may reflect additional detail from the source filing. Chevron’s lack of acreage ownership and its equity stake in Angola LNG are correctly described. (2) The LLM accurately captures that Chevron’s upstream earnings in 2021 were positively impacted by Angola LNG, citing the exact phrase from the filing (‘higher upstream-related earnings … from … Angola LNG’), confirming fidelity to the source. (3) The multi-hop reasoning is sound: it contrasts ExxonMobil’s physical asset (acreage) with Chevron’s financial stake in a joint venture, correctly synthesizing information across two companies and asset types. (4) The answer is semantically equivalent to the original, with enhanced clarity in distinguishing asset types (acreage vs. equity stake). The only minor deviation is the extra detail about total net acres (3.0 million), which is not in the ground truth but is not factually incorrect. Thus, the answer earns a 9/10 for correctness—excellent, with negligible discrepancy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 371,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Accenture's $6.6 billion investment in 46 strategic acquisitions in fiscal 2024, focused on scaling industry solutions, compare to Microsoft's revenue from enterprise and partner services—which includes industry solutions—in the same period?",
      "original_answer": "Accenture invested $6.6 billion across 46 strategic acquisitions in fiscal 2024 to scale its industry solutions, while Microsoft reported $7.594 billion in revenue from 'Enterprise and partner services'—a category that includes 'Industry Solutions'—during the same fiscal year. This indicates that while Accenture is heavily investing in expanding its industry-specific offerings through acquisitions, Microsoft is generating substantial revenue from its own industry solutions and enterprise services, suggesting differing strategic approaches to growth in the enterprise technology space.",
      "llm_answer": "Accenture spent **$6.6 billion** on **46 strategic acquisitions** in fiscal 2024 to scale its industry‑solution offerings【page_6】. In the same year, Microsoft reported **$7.594 billion** of revenue from “Enterprise and partner services,” which includes its industry‑solution business【page_93】. Thus, Accenture’s acquisition investment was slightly lower than Microsoft’s enterprise‑partner services revenue for fiscal 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: Accenture's $6.6 billion investment in 46 acquisitions in fiscal 2024 and Microsoft's $7.594 billion in 'Enterprise and partner services' revenue for the same period. The numbers match the ground truth exactly, with acceptable formatting (e.g., $6.6 billion, $7.594 billion). (2) Quantitative accuracy is perfect—both dollar amounts and the count of acquisitions (46) are correct, and the comparison stating Accenture’s investment was 'slightly lower' than Microsoft’s revenue is factually sound (6.6B < 7.594B). (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two different companies and financial contexts (investment vs. revenue) and draws a valid comparative conclusion. The only minor shortcoming is that the LLM answer omits the broader strategic interpretation present in the original answer—i.e., that the contrast reflects differing growth strategies (investment vs. revenue generation)—which slightly reduces qualitative depth. (4) Despite this omission, the answer is factually complete, contextually relevant, and semantically equivalent in conveying the core comparison. Hence, high scores across all categories with a 9 in correctness and qualitative accuracy due to slightly less interpretive richness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 367,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How might Duke Energy's experience with maintaining a 30% equity threshold under FERC-approved dividend policies inform Southern Company's financial planning for its 50% cost share in the $3 billion SNG pipeline project requiring similar FERC approval?",
      "original_answer": "Duke Energy Ohio was required to maintain equity, adjusted to remove push-down accounting impacts, at no less than 30% of total capital as part of FERC and PUCO approval for dividend policies. Southern Company Gas has a 50% cost share in a $3 billion pipeline project through its stake in SNG, which also requires FERC approval. Given this regulatory overlap, Southern Company may reference Duke Energy's equity management strategies to structure its capital allocation and ensure compliance with potential FERC equity requirements for the SNG pipeline project.",
      "llm_answer": "Duke Energy’s Ohio subsidiary was allowed to pay dividends only after it pledged that its adjusted equity would never drop below a 30 % capital‑to‑equity ratio – a condition that forced the company to tightly monitor retained earnings, limit cash‑outflows and, where needed, rely on its regulatory‑asset balances to shore up equity. Southern Company can apply the same discipline to its $3 billion SNG pipeline, using ongoing equity‑ratio tracking, retained‑earnings preservation and the strategic use of its regulatory assets and long‑term debt capacity to ensure its 50 % cost‑share meets the FERC‑mandated equity threshold.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Duke Energy's 30% equity threshold, Southern Company's 50% cost share in the $3 billion SNG pipeline, and the reference to FERC approval are all factually consistent with the original answer. There are no calculation errors. (2) The LLM correctly identifies the key entities: Duke Energy Ohio (implied via context), Southern Company Gas, the SNG pipeline, and FERC regulatory oversight. While it refers to 'capital-to-equity ratio'—a slightly imprecise term—the intended meaning (equity as 30% of capital) matches the ground truth. (3) The multi-hop reasoning is sound: the model connects Duke Energy’s regulatory experience with dividend policies to Southern Company’s need for FERC compliance on capital structure for a jointly funded pipeline project. It appropriately infers that equity management strategies (retained earnings, regulatory assets, debt capacity) could be transferable. (4) The answer is semantically equivalent to the original, adding actionable detail (e.g., 'ongoing equity-ratio tracking') not in the ground truth but logically consistent. One minor point: the original specifies that Duke’s equity adjustment removes push-down accounting impacts, which the LLM omits—this is a small but relevant regulatory nuance, preventing a perfect 10. Overall, the response is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 410,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the use of matrix pricing for corporate debt instruments differ between UPS's fair value hierarchy disclosures and MMM's valuation methodologies, given that both companies rely on this pricing technique when broker quotes are unavailable?",
      "original_answer": "UPS categorizes its corporate debt instruments under Level 2 inputs in the fair value hierarchy and utilizes matrix pricing when broker quotes are not available, as seen in its 2022 disclosures. Similarly, MMM also applies matrix pricing for corporate debt instruments when broker quotes are unavailable, valuing them based on yields from comparable securities or discounted cash flow models. Both companies depend on matrix pricing as a fallback method for valuing these instruments, though MMM specifically notes adjustments for non-observable risks like credit and liquidity, unlike UPS, which does not mention such adjustments. This reveals a nuanced difference in how each company applies matrix pricing depending on the complexity of risk factors considered.",
      "llm_answer": "Both companies turn to matrix pricing when broker quotes are not available, but they present it in different contexts. UPS reports that corporate bonds priced with matrix pricing are measured using **Level 2** inputs in its fair‑value hierarchy, emphasizing that the technique is part of its observable‑input valuation tier. MMM, by contrast, describes matrix pricing as one of the observable‑input methods used to value corporate debt in its **valuation methodology narrative**, but it does not explicitly tie that pricing to a specific fair‑value level in the hierarchy.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that both UPS and MMM use matrix pricing for corporate debt instruments when broker quotes are unavailable, and accurately states that UPS categorizes these under Level 2 inputs in the fair value hierarchy. This aligns with the ground truth and reflects correct entity and contextual understanding. However, the LLM incorrectly claims that MMM does not explicitly tie matrix pricing to a specific fair-value level, which contradicts the original answer stating that MMM applies matrix pricing within its valuation methodology and implies its use under observable inputs—though not explicitly labeled by level. More critically, the LLM omits a key differentiating point highlighted in the ground truth: MMM adjusts for non-observable risks such as credit and liquidity, while UPS does not. This omission significantly weakens the comparative analysis and fails to capture the nuanced difference in how each company applies the technique. While the reasoning is logically structured and contextually relevant, the failure to report this critical qualitative distinction results in partial correctness. All entities (UPS, MMM, corporate debt, matrix pricing, Level 2) and concepts are accurate, and there are no numerical inaccuracies (no numbers involved). Thus, quantitative accuracy is perfect, but qualitative accuracy is reduced due to incomplete synthesis across the multi-hop requirement of comparing both methodology and risk adjustment practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 408,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the $2.8 billion upfront payment from Vertical Bridge REIT, LLC to VZ in 2024 compare to T's prior tower transaction with Crown Castle in 2013, particularly in terms of the financing structure and the retained operational control over the towers?",
      "original_answer": "The $2.8 billion upfront payment from Vertical Bridge to VZ in 2024 was primarily recorded as prepaid rent ($2.0 billion) and a financing obligation ($830 million), reflecting the retained operational control and right-of-use for a portion of the towers. In contrast, T's 2013 transaction with Crown Castle resulted in a $4.827 billion cash payment, which was fully accounted for as a financing obligation, with T retaining control and continuing to depreciate the tower assets ($608 million at the end of 2024). Both companies maintained ownership on their balance sheets and depreciated the assets, but VZ's arrangement included a dual treatment of prepaid rent and financing, while T's was entirely structured as a financing obligation with interest at approximately 3.9%.",
      "llm_answer": "The Verizon‑Vertical Bridge deal was structured as a hybrid lease‑sale: Verizon received a $2.8 billion cash payment that it recorded partly as **pre‑paid rent ($2.0 billion)** and partly as a **financing liability ($830 million)**, while it kept the towers on its balance sheet, depreciated them and only leased back a portion of the capacity for a 10‑year term (with renewal options).  \n\nIn AT&T’s 2013 Crown Castle transaction, the $4.8 billion cash received was **treated entirely as a financing obligation** (interest‑bearing liability at about 3.9 %), the towers remained on AT&T’s books, and AT&T **sub‑leased space** to Crown Castle for roughly 20 years, ceding the exclusive lease‑and‑operate rights to Crown Castle.  \n\nThus, Verizon’s arrangement mixes prepaid‑rent and debt and retains more operational use of the towers, whereas AT&T’s earlier deal was a pure financing‑obligation sale‑leaseback that transferred operational control to Crown Castle.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $2.8 billion upfront payment from Vertical Bridge to VZ in 2024 is correctly broken into $2.0 billion in prepaid rent and $830 million in financing obligation; the AT&T-Crown Castle 2013 transaction amount is accurately reported as $4.8 billion (approximating the exact $4.827 billion, which is acceptable within rounding); the 3.9% interest rate is correctly noted. (2) Quantitative accuracy is excellent—minor rounding of $4.827B to $4.8B is reasonable and common in financial reporting. The sum $2.0B + $830M = $2.83B is slightly over $2.8B, but this is within typical reporting tolerance and likely reflects timing or rounding in disclosures. (3) The qualitative analysis correctly identifies the structural differences: VZ’s hybrid treatment (prepaid rent + financing) vs. T’s pure financing obligation, both retaining ownership and depreciation, and both keeping towers on balance sheet. The LLM correctly notes VZ leased back only a portion (right-of-use), while T subleased space to Crown Castle. However, the claim that AT&T 'ceded exclusive lease-and-operate rights' slightly overstates the ground truth, which emphasizes retained control and depreciation but does not explicitly state 'exclusive' operational transfer—this is a minor overinterpretation. (4) The multi-hop reasoning is sound, synthesizing across two companies, two transactions, years, accounting treatments, and operational outcomes. The comparison is well-structured and contextually relevant, directly addressing financing structure and retained control. Only a minor deduction in qualitative accuracy due to the slight overstatement on operational control transfer; otherwise, the answer is factually robust and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 497,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the potential tax liability from MRK's TCJA-related IRS examination compare with MDT's BEAT-related tax impact in 2024, given the TCJA's introduction of BEAT as a minimum tax?",
      "original_answer": "MRK faces a potential significant tax liability if the IRS disagrees with its transition tax position under the TCJA, which includes BEAT as a component of its minimum tax framework. The TCJA introduced BEAT as a minimum tax based on cross-border service payments, directly linking it to the broader tax reform that both MRK and MDT are subject to. In 2024, MDT reported a 0.3% increase in effective tax rate due to BEAT, indicating a measurable but relatively small impact. Comparatively, MRK's exposure could be more substantial if the IRS challenges its TCJA transition tax calculations, potentially reversing unrecognized tax benefits that stood at $2.3 billion as of December 31, 2024. Thus, while MDT's BEAT impact is quantifiably modest, MRK's TCJA-related risk remains high and contingent on IRS resolution.",
      "llm_answer": "Merck (MRK) notes that the IRS is currently examining its 2017‑2018 returns, including the one‑time transition‑tax payment required under the 2017 Tax Cuts and Jobs Act, and that a disagreement could “result in a significant tax liability,” but the filing does not quantify that amount. In contrast, Medtronic (MDT) reports that the Base‑Erosion Anti‑Abuse Tax (BEAT) component of the TCJA added only 0.5 % to its 2024 income‑tax provision – roughly $7 million (0.5 % of the $1.47 billion provision). Thus, MRK’s potential liability is described as potentially large and uncertain, whereas MDT’s BEAT impact is modest and explicitly measured.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies MRK's potential significant tax liability due to the IRS examination of its TCJA transition tax and MDT's BEAT impact in 2024. However, there are key quantitative discrepancies. The ground truth states MDT's BEAT caused a 0.3% increase in effective tax rate, while the LLM claims a 0.5% increase in the income-tax provision—this is a different metric and conflicts with the original. Additionally, the LLM calculates this as ~$7 million based on 0.5% of a $1.47 billion tax provision, but this figure and calculation are not present in the ground truth and appear to be fabricated. The ground truth mentions MRK's unrecognized tax benefits of $2.3 billion as of December 31, 2024, which the LLM omits entirely, a significant omission given the comparative nature of the question. (2) The dates (2017–2018 IRS examination) are accurate, but the 0.5% and $7 million figures are incorrect or unsupported. The $1.47 billion tax provision is not mentioned in the ground truth, making the calculation speculative. (3) The multi-hop reasoning is generally sound—linking TCJA, BEAT, MRK’s IRS exposure, and MDT’s impact—but fails in full synthesis by missing the $2.3 billion unrecognized tax benefit, which is central to comparing the scale of MRK’s risk versus MDT’s measured impact. (4) The contextual relevance is perfect—the answer addresses the comparison, the TCJA framework, and the uncertainty vs. measured impact. Qualitative accuracy is high due to correct entity identification and logical structure, but quantitative accuracy is reduced due to incorrect percentages and invented figures. Correctness score is 7 because the core comparison (MRK’s uncertain large liability vs. MDT’s small impact) is preserved, but key numbers are wrong or missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 489,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Nigeria's 30-year production sharing contract framework influence both ConocoPhillips' operational footprint and Chevron's reserve disclosures in Africa?",
      "original_answer": "Nigeria's regulatory framework establishes 30-year production sharing contracts (PSCs) with a 10-year exploration period followed by a 20-year production period, requiring partial relinquishment at the end of exploration (from hop2_evidence). ConocoPhillips operates in Nigeria under this framework (from hop1_evidence), which shapes its exploration timelines and asset management strategy. Chevron's 2021 reserves in Africa totaled 106 million barrels (from hop3_evidence), indicating continued exposure to jurisdictions like Nigeria where regulatory terms directly affect reserve life and development planning. The 30-year PSC duration influences both companies' capital allocation decisions, reserve booking practices, and long-term operational strategies in the region.",
      "llm_answer": "Nigeria’s 30‑year production‑sharing contracts give operators long‑term rights to develop and produce offshore assets, which lets ConocoPhillips maintain a permanent operating presence in the country – the company cites “improved field performance at Sonam in Nigeria” as a driver of its 42 million‑barrel increase in African proved reserves. Chevron’s 10‑K shows that a distinct portion of its African reserve balance is classified as PSC‑related (about 8 %‑10 % of consolidated reserves in 2021‑2019), so the same contract framework directly shapes the amount of African reserves it must disclose.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and unsupported claims. The ground truth states that Chevron's 2021 reserves in Africa totaled 106 million barrels, but the LLM claims that 8%-10% of Chevron's *consolidated* reserves (not African reserves) are PSC-related, which is a misrepresentation — the original answer does not specify this percentage or link it to Nigeria’s PSCs directly. Additionally, the LLM claims ConocoPhillips cited 'improved field performance at Sonam' as a driver of a 42 million-barrel increase in African proved reserves, but this specific detail is not present in the ground truth and cannot be verified from the provided evidence. (2) Quantitative accuracy is low: the 42 million-barrel increase and 8%-10% PSC-related reserve figures are not in the original answer and appear fabricated or misattributed. The only correct number is Chevron’s 2021 African reserves (106 million barrels) indirectly referenced via context, but even this is not explicitly stated in the LLM response. (3) Multi-hop reasoning is partially sound — the model attempts to link Nigeria’s 30-year PSC framework to both ConocoPhillips’ operations and Chevron’s reserve disclosures — but fails to accurately represent how the framework influences them. The original answer emphasizes the 10-year exploration + 20-year production structure and relinquishment requirements shaping operational timelines and capital decisions, which the LLM omits entirely. (4) Contextual relevance is high because the answer addresses the core question about regulatory influence on both companies. Qualitative accuracy is moderate due to correct entity identification (ConocoPhillips, Chevron, Nigeria, PSCs) and general direction of reasoning, but undermined by unsupported specifics. Correctness score is 5 due to partial factual alignment but significant hallucination of data and missed structural details of the PSC framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 524,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the limited voting rights structure attached to AT&T's Series C Preferred Stock influence potential restructuring decisions compared to Netflix's one-share-one-vote governance model?",
      "original_answer": "AT&T's Series C Preferred Stockholders have no voting rights except in specific restructuring scenarios such as mergers or consolidations where their equity treatment might change, requiring their separate approval. This constraint limits their influence on broader corporate decisions but protects their interests in defined high-impact events. In contrast, Netflix grants one vote per share to common stockholders on all matters, enabling broader shareholder participation in governance and strategic direction. This difference means Netflix’s shareholders have more consistent influence over corporate decisions, whereas AT&T’s Series C Preferred Stockholders only exert influence in narrowly defined restructuring contexts.",
      "llm_answer": "AT&T’s Series C preferred shares do not vote on ordinary corporate matters; they only cast votes – equal to the number of shares they hold – on a narrow set of “limited matters” such as a merger, consolidation or other transaction that would give the preferred holders different consideration than the Class A common shareholders (see page 90). Because any restructuring that changes conversion terms or the relative rights of the preferred stock would require the affirmative vote of the Series C holders, AT&T must negotiate with that single‑class of preferred investors before pursuing a deal. Netflix, by contrast, operates under a pure one‑share‑one‑vote structure, so restructuring decisions are decided solely by the majority of common‑stock owners without a separate privileged class, making the process more straightforward and less constrained by special‑voting rights.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that AT&T’s Series C Preferred Stockholders have no voting rights except in specific restructuring scenarios like mergers or consolidations where their equity treatment differs, which aligns with the original answer. It also accurately contrasts this with Netflix’s one-share-one-vote model. (2) There are no numeric values (e.g., dates, dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance differences between AT&T’s dual-class voting structure for preferred shares and Netflix’s uniform voting rights, and infers the implications for restructuring decisions. The mention of 'page 90' suggests sourcing from a filing, adding credibility, though not required. (4) The only minor shortcoming is a slight lack of explicit mention that AT&T’s preferred shareholders have *no voting rights at all* outside those limited matters—though this is implied. The original answer makes this more explicit. Otherwise, the semantic meaning, factual content, and reasoning are equivalent. All entities (AT&T, Netflix, Series C Preferred Stock, Class A common shareholders) are correctly identified. The answer is fully relevant and directly addresses the comparative governance impact on restructuring decisions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 399,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the expiration timeline of key patent protections for Enbrel impact Pfizer's long-term revenue strategy for the product, particularly given AbbVie's broader approach to patent term restoration and regulatory exclusivity for biologics?",
      "original_answer": "Enbrel (etanercept) has multiple U.S. patents expiring at different points: fusion protein composition in 2028, DNA encoding the fusion protein in 2029, and formulations in 2037. This staggered expiration allows Pfizer to maintain some level of market protection until 2037, though biosimilar competition could begin as early as 2028. AbbVie, in contrast, actively pursues patent protection and patent term restoration under the Hatch-Waxman Act, which can extend exclusivity by up to five years, with total post-approval exclusivity potentially reaching 14 years. Given that AbbVie emphasizes both patent and regulatory exclusivity strategies for its biologics, Pfizer may need to adopt a similarly aggressive lifecycle management approach—such as filing secondary patents or seeking regulatory extensions—to preserve Enbrel's revenue stream beyond its core patent expirations.",
      "llm_answer": "Pfizer’s 2024 filing shows that the three core U.S. patents covering Enbrel (etanercept) do not expire until 11 Nov 2028, 24 Apr 2029 and, most importantly, 19 Oct 2037 (see Pfizer Patents table, page 11).  Because Enbrel is listed among Pfizer’s “Inflammation & Immunology” brands (outside the U.S. and Canada) (page 10), the company’s long‑term revenue plan hinges on preserving those patent shields well beyond the next decade.  AbbVie’s 10‑K explains that biologics can obtain up to five years of patent‑term restoration and a statutory 12‑year BPCIA regulatory exclusivity (plus possible pediatric extensions) to extend market protection (see AbbVie Intellectual‑Property section, page 9).  By relying on similarly extended patent and exclusivity periods, Pfizer expects Enbrel’s protected life‑cycle to mirror AbbVie’s broader strategy of using patent‑term restoration and biologic exclusivity to sustain high‑margin revenue into the late 2030s.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key patent expiration dates are correctly stated: Nov 11, 2028 (fusion protein), Apr 24, 2029 (DNA encoding), and Oct 19, 2037 (formulations), matching the staggered timeline in the original answer. These dates are more precise than the ground truth’s year-only format, but this is an improvement, not an error. (2) The explanation of AbbVie’s strategy accurately reflects the Hatch-Waxman Act (patent term restoration up to 5 years) and BPCIA’s 12-year regulatory exclusivity, with mention of pediatric extensions—details consistent with the knowledge graph. (3) The reasoning correctly synthesizes multi-hop information: it links Pfizer’s patent timeline to its revenue strategy and draws a valid comparison to AbbVie’s broader lifecycle management approach. (4) The conclusion that Pfizer may aim to extend Enbrel’s exclusivity into the late 2030s via similar tactics is logically sound and semantically equivalent to the original answer’s recommendation. The only minor shortcoming is that the LLM implies Pfizer is actively pursuing patent-term restoration (‘Pfizer expects Enbrel’s protected life-cycle to mirror AbbVie’s strategy’), while the original answer frames this as a necessary future consideration rather than an already expected outcome. This slight overstatement reduces qualitative accuracy by one point, but does not undermine overall correctness. All entities (Pfizer, AbbVie, Enbrel, biologics, patent types) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 426,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the ethylene production capacity of ExxonMobil's Singapore facility compare to the ethylene manufacturing capacity that Chevron indirectly supports through its ownership stake in the Map Ta Phut Olefins joint venture in Thailand?",
      "original_answer": "ExxonMobil's Singapore facility has an ethylene production capacity of 1.9 million metric tons per year. Chevron indirectly owns a 32.77% stake in the Map Ta Phut Olefins Company Limited in Thailand, which manufactures ethylene, although the exact ethylene capacity attributable to Chevron is not specified in the evidence provided.",
      "llm_answer": "ExxonMobil’s Singapore complex is listed with an ethylene capacity of **about 1.9 million metric tons per year** (see the capacity table for Singapore).  \n\nChevron’s 10‑K only notes that it holds a **32.8 % interest in the Map Ta Phut Olefins joint‑venture in Thailand**, which “manufactures propylene and ethylene,” but the filing does not disclose the amount of ethylene that plant can produce.  \n\nTherefore, while ExxonMobil’s Singapore site is quantified at roughly 1.9 Mt / yr, the ethylene capacity that Chevron indirectly supports through its Map Ta Phut stake is not provided in the supplied documents, precluding a direct numerical comparison.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: ExxonMobil's Singapore ethylene capacity is accurately reported as 1.9 million metric tons per year, and Chevron's ownership stake in Map Ta Phut Olefins is correctly stated as 32.8% (a rounded version of the 32.77% in the original answer—this minor rounding is acceptable and common in reporting). (2) The answer correctly notes that while ExxonMobil’s capacity is explicitly quantified, the ethylene capacity attributable to Chevron’s stake is not disclosed in the available documents, which matches the original answer’s conclusion. (3) The multi-hop reasoning is sound: the model correctly identifies two separate facilities (Singapore vs. Thailand), associates them with the correct companies (ExxonMobil directly, Chevron via joint venture), and synthesizes the information to conclude that a direct numerical comparison cannot be made due to missing data. (4) The only minor shortcoming is the slight rounding of 32.77% to 32.8% without explicit acknowledgment, but this does not affect the factual integrity. Otherwise, the answer is complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 346,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How does the financial impact of Southern Company's disallowance of capital investments at Nicor Gas in Illinois compare to the scale of infrastructure assets that NextEra Energy operates in the same state?",
      "original_answer": "Southern Company recorded a pre-tax charge of $96 million related to the disallowance of capital investments at Nicor Gas, which operates in Illinois and serves approximately 2.3 million customers across 34.7 thousand miles of gas pipelines. Meanwhile, NextEra Energy operates 90 thousand miles of transmission lines in Illinois, Indiana, Kentucky, New Hampshire, and New York combined, with Illinois being a part of this footprint. This comparison highlights the relative scale of infrastructure assets under regulatory scrutiny versus those actively operated by NextEra in the same state.",
      "llm_answer": "Southern Company recorded a pre‑tax charge of roughly **$96 million** (about $72 million after tax) tied to the disallowance of capital investments at its Illinois‑based Nicor Gas utility. By contrast, NextEra Energy’s physical footprint in Illinois is limited to **about 90 miles of rate‑regulated transmission lines and five substations** (as shown in its 10‑K), a modest infrastructure scale relative to the multi‑tens‑of‑millions‑dollar financial hit faced by Southern Company.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. While it correctly states Southern Company's $96 million pre-tax charge related to Nicor Gas in Illinois, it drastically misrepresents NextEra Energy's infrastructure footprint. The LLM claims NextEra operates 'about 90 miles of rate-regulated transmission lines' in Illinois, which is incorrect. The ground truth states that NextEra operates 90 thousand miles of transmission lines across five states (Illinois, Indiana, Kentucky, New Hampshire, and New York combined), not 90 miles. This is a 1,000-fold error in scale. (2) Quantitative accuracy is severely compromised: '90 miles' vs '90,000 miles' is a critical numerical error. The after-tax figure of $72 million is not in the original answer and is an unsupported addition. (3) Multi-hop reasoning fails: the comparison should contrast a financial penalty (Southern's $96M charge) with the scale of infrastructure assets (NextEra's 90,000-mile regional transmission network, partially in Illinois). Instead, the LLM incorrectly minimizes NextEra's footprint, reversing the intended comparison. (4) Contextual relevance is moderate because the answer attempts the right comparison framework (financial impact vs. infrastructure scale), but the factual foundation is so flawed that the conclusion is misleading. The entity names and general context are correct, but the core quantitative comparison is invalid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 395,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "What percentage of KO's equity method investments as of December 31, 2021, was represented by its stake in CCEP, and how does this relate to CCEP's operational presence in Iceland, where COST also operates?",
      "original_answer": "KO owned approximately 19% of CCEP as of December 31, 2021. CCEP operates in Iceland, which is also a market where COST operates through its wholly owned subsidiaries. This shared presence in Iceland indicates both companies have exposure to the same geographic market, with KO indirectly participating in the Icelandic beverage market through its equity stake in CCEP, while COST directly operates retail warehouses there.",
      "llm_answer": "Coca‑Cola’s equity‑method stake in Coca‑Cola Europacific Partners plc (CCEP) accounted for about **19 % of the Company’s total equity‑method investments as of December 31 2021**【page_88】. CCEP’s bottling and distribution footprint includes **Iceland**【page_7】—the same country where Costco (COST) reports operating its membership‑warehouse business, indicating that both companies have a presence in the Icelandic market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that KO's equity-method stake in CCEP accounted for about 19% of KO's total equity-method investments as of December 31, 2021, which matches the ground truth. The mention of CCEP operating in Iceland and COST also operating there is accurate. (2) Quantitatively, the 19% figure is correct and properly attributed to the right date and entity; no calculations were required beyond accurate reporting. (3) The multi-hop reasoning is sound: the model correctly links KO’s indirect presence in Iceland via its equity stake in CCEP with COST’s direct operations there, showing awareness of both companies’ exposure to the Icelandic market. However, the LLM slightly misses the nuance that KO’s participation is indirect through a bottler (CCEP), while COST operates retail warehouses directly—this distinction is implied but not explicitly clarified as in the original answer. (4) The answer is highly relevant, factually correct, and synthesizes across entities and documents effectively. The only minor shortcoming is the lack of explicit clarification on the nature of KO’s indirect vs. COST’s direct operations, which slightly affects qualitative depth. Hence, a 9 on correctness and qualitative accuracy is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 353,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does Duke Energy's direct exposure to electricity price volatility compare with Southern Company's indirect exposure through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of capacity from Alabama Power under a 2021 agreement?",
      "original_answer": "Duke Energy directly manages exposure to electricity price volatility through fuel adjustment clauses, formula-based contracts, and hedging programs that defer cost differences as regulatory assets or liabilities. In contrast, Southern Company's exposure is indirect through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of year-round capacity service from Alabama Power starting in 2024 under a 2021 agreement. This arrangement, combined with a 10-year coordinated planning and operations agreement, allows Southern Company to mitigate some volatility through shared dispatch and cost-offsetting mechanisms, rather than direct hedging. While Duke Energy actively hedges its exposure using financial instruments, Southern Company's risk is mediated through contractual agreements and operational coordination with PowerSouth.",
      "llm_answer": "- Duke Energy’s filings state that the registrants are “exposed to the impact of changes in the prices of electricity …” and they manage that risk with a large portfolio of commodity‑derivative contracts (e.g., $609 million of commodity‑derivative liabilities and $5.0 billion of notional commodity contracts as of 12/31/2023) 【page 179】. This reflects a **direct** exposure to electricity‑price volatility that the company hedges on its own balance sheet.  \n\n- Southern Company’s exposure to electricity‑price risk comes **indirectly** through its subsidiaries’ ownership of PowerSouth. The 2023 filing notes that PowerSouth owns more than 1,600 MW of generation, including an **8.16 % ownership interest in Alabama Power’s Plant Miller**, and that, under a 2021 agreement, Alabama Power provides **approximately 100 MW of year‑round capacity service to PowerSouth** 【page 17】. Southern’s risk is therefore limited to the portion of PowerSouth’s generation and the 100 MW capacity arrangement, not to the full market price swings that Duke Energy faces directly.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies Duke Energy's direct exposure to electricity price volatility and its use of commodity derivatives to hedge this risk, citing specific figures ($609 million in liabilities and $5.0 billion notional value) from its 2023 filing. These numbers are accurate and contextually relevant. For Southern Company, it correctly notes the indirect exposure via subsidiary ownership in PowerSouth and the 100 MW capacity agreement with Alabama Power under a 2021 agreement, which aligns with the ground truth. However, the LLM introduces an 8.16% ownership interest in Alabama Power’s Plant Miller and PowerSouth’s 1,600 MW generation capacity—details not present in the original answer and not directly relevant to the comparison of exposure mechanisms. While not factually incorrect, they distract from the core contrast in risk management approaches.\n\n2) Quantitatively, all cited numbers (e.g., $609 million, $5.0 billion, 100 MW, 8.16%) are presented accurately as per the source material referenced. The date of the agreement (2021) is correct, and the capacity amount (100 MW) matches. However, the original answer specifies the capacity service starts in 2024, which the LLM omits—a minor but notable temporal detail affecting completeness.\n\n3) The multi-hop reasoning is mostly sound: the LLM correctly infers that Duke Energy manages risk directly via financial instruments while Southern Company’s exposure is indirect through PowerSouth. It captures the essence of the structural difference. However, it fails to mention the 10-year coordinated planning and operations agreement or the shared dispatch and cost-offsetting mechanisms emphasized in the original answer, which explain *how* Southern mitigates volatility indirectly. This omission reduces qualitative accuracy.\n\n4) Despite missing some key explanatory mechanisms from the original, the LLM answer conveys the central contrast: direct vs. indirect exposure and differing risk management strategies. The added details about Plant Miller and generation capacity slightly dilute focus but don’t contradict facts. Overall, the answer is factually solid, contextually appropriate, and semantically close to the ground truth, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 602,
        "total_tokens": 2107
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering that Taiwan is included within the Greater China geographic segment?",
      "original_answer": "Starbucks reported a net increase of 21 stores in Taiwan from fiscal year 2021 to 2022, bringing its total store count in Taiwan to 544. Nike, which includes Taiwan within its Greater China segment, reported total revenues of $7.547 billion from that region in fiscal year 2022. Given that Greater China includes mainland China, Hong Kong, and Taiwan, Starbucks’ store presence in Taiwan is a component of the broader regional market that contributes to Nike’s revenue, though the specific revenue contribution from Taiwan alone is not disclosed by Nike.",
      "llm_answer": "Starbucks added 21 licensed stores in Taiwan during fiscal 2022 (the count rose from 523 stores on Oct 3 2021 to 544 stores on Oct 2 2022). In the same year, Nike’s Greater China geographic segment generated roughly **$7.5 billion** in total revenue. Thus, while Starbucks’ Taiwan footprint grew by a few dozen locations, Nike’s contribution from the broader Greater China region amounted to multi‑billion‑dollar sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct on all key quantitative points: Starbucks' store count increased from 523 to 544 in Taiwan during fiscal 2022, a net increase of 21 stores, which matches the ground truth. Nike’s Greater China revenue is reported as $7.5 billion, which is a rounded but accurate representation of the exact $7.547 billion in the original answer. 2) All numbers are correct or acceptably rounded; the store count change is accurately calculated (544 - 523 = 21), and the fiscal year alignment is appropriate. Minor formatting differences (e.g., 'roughly $7.5 billion' vs $7.547 billion) are permissible under semantic equivalence. 3) The multi-hop reasoning is sound: the model correctly identifies that Starbucks’ Taiwan store growth and Nike’s Greater China revenue are related through geographic overlap (Taiwan included in Greater China), and it appropriately notes the difference in scope (store count vs. regional revenue). It does not falsely attribute Nike’s revenue to Taiwan alone, which is correct given the lack of disclosure. 4) The answer is highly relevant and synthesizes across entities and metrics. The only minor shortcoming is that the LLM does not explicitly state that Taiwan is part of the Greater China segment (though it is implied), and it omits the clarification that Nike does not disclose Taiwan-specific revenue. However, the core facts, calculations, and reasoning are accurate and complete enough to score highly. Thus, correctness is 9/10 due to slight incompleteness in contextual nuance, but quantitative accuracy is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 431,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How do the supplier finance disclosures required by ASU 2022-04 affect the visibility of 3M's $0.3 billion in confirmed invoice obligations, and how does FedEx's adoption of the same standard compare in terms of transparency?",
      "original_answer": "ASU 2022-04 significantly enhances the visibility of 3M's supplier finance obligations, which stood at $0.3 billion as of December 31, 2024, by mandating detailed disclosures such as key terms, balance sheet presentation, and roll-forward information. This requirement was adopted by 3M starting in 2023, with full roll-forward reporting effective in 2024. Similarly, FedEx adopted ASU 2022-04 effective June 1, 2023, and also included disclosures related to its supplier finance program obligations. Both companies now provide stakeholders with clearer insights into their supplier finance activities, aligning their reporting practices under the new standard to enhance transparency.",
      "llm_answer": "ASU 2022‑04 forces 3M to disclose its supplier‑finance program in a dedicated footnote, where the $0.3 billion of confirmed invoices is shown as a separate balance‑sheet line (included in accounts payable) together with a roll‑forward of the $1.5 billion of invoices confirmed and paid during the year, making the obligation fully visible to users. FedEx’s adoption of the same update yields a similarly transparent presentation—a Supplier Finance note that lists the outstanding balance ($94 million at year‑end) and provides a detailed roll‑forward of beginning balance, invoices confirmed, invoices paid and translation adjustments—so while the disclosed amount is smaller, the standard gives comparable, explicit visibility into its supplier‑finance liabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While the ground truth states that 3M has $0.3 billion in confirmed invoice obligations as of December 31, 2024, the LLM incorrectly claims that $1.5 billion of invoices were confirmed and paid during the year — a figure not present in the original answer and unsupported by the provided context. Additionally, the LLM introduces a specific number for FedEx — $94 million at year-end — which is not mentioned in the original answer; the ground truth does not provide any dollar amount for FedEx’s obligations, only confirming that it adopted the standard and included disclosures. (2) The dates of adoption are partially correct: the LLM does not specify 3M’s adoption timeline (starting in 2023, full roll-forward in 2024), but correctly implies post-adoption reporting. However, it fails to mention FedEx’s exact adoption date (June 1, 2023), though this is a lesser omission. (3) The multi-hop reasoning is qualitatively sound — the model correctly infers that ASU 2022-04 improves transparency for both companies through enhanced disclosures like roll-forwards and balance sheet presentation — and it draws a reasonable comparison between the two firms’ transparency levels. However, the introduction of fabricated numerical data undermines the factual integrity of the response. (4) Despite these errors, the LLM captures the core concept that ASU 2022-04 increases visibility into supplier finance programs for both companies, aligning with the original answer’s main point about improved transparency. Thus, while the reasoning and structure are strong, the incorrect financial figures significantly reduce the correctness score, particularly on quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 477,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How might the dual-class stock structures at CMCSA and META, particularly the 15-vote-per-share advantage for Class B stockholders at CMCSA and the 35% Class B voting power threshold for blocking change-of-control transactions at META, similarly expose minority shareholders to governance risks?",
      "original_answer": "At CMCSA, Class B common stockholders, led by Brian L. Roberts, hold 33⅓% of the combined voting power due to a 15-vote-per-share advantage, which can influence corporate decisions disproportionately relative to their economic stake. Similarly, at META, Class B stockholders control key governance decisions, including blocking change-of-control transactions, as long as they hold at least 35% of the combined voting power. Both structures concentrate decision-making authority in a small group, potentially undermining minority shareholder influence and making the companies less attractive to investors, which could depress stock valuations.",
      "llm_answer": "Both companies give a tiny group of insiders outsized voting power. Comcast’s Class B shares carry 15 votes each and, even though they represent only about 9 % of the total shares outstanding, they control roughly one‑third of the combined voting power, allowing those holders to dictate the result of any shareholder vote 【page_33】. Meta’s charter likewise creates a dual‑class system in which the Class B holders must retain at least 35 % of the total voting power to block a change‑of‑control transaction, giving the founder and a small cohort the ability to veto mergers or other major actions 【page_49】. In each case, minority Class A shareholders are left with limited ability to influence corporate governance, exposing them to the risk that their interests can be overridden by the controlling shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, it correctly states that CMCSA's Class B shares have 15 votes per share and control approximately one-third (33⅓%) of the voting power despite representing only about 9% of shares outstanding—this matches the known structure and is consistent with the ground truth. It also accurately notes META’s 35% Class B voting power threshold for blocking change-of-control transactions. While the exact phrase '33⅓%' is rounded to 'roughly one-third', this is semantically acceptable. (2) The answer addresses all parts of the question: both companies’ dual-class structures, the specific voting advantages (15:1 at CMCSA, 35% blocking threshold at META), and the resulting governance risks to minority shareholders. (3) Entities (CMCSA, META, Class A/B shares, controlling shareholders) are correctly identified. (4) The reasoning is sound: it synthesizes how concentrated voting power in insiders limits minority influence, creating governance risks—this is the core multi-hop insight. The only minor shortcoming is not explicitly naming Brian L. Roberts as the lead Class B holder at CMCSA, but this detail is not critical to the central comparison. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 365,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What percentage of V's U.S. pension plan assets classified as Level 2 in 2022 consists of investments in collective investment funds, and how does this allocation strategy compare to COF's use of 'other securities' in terms of investment focus and yield profile?",
      "original_answer": "In 2022, V reported $319 million in collective investment funds under Level 2 assets, out of a total of $960 million in U.S. pension plan assets, representing approximately 33.2%. These funds are described as unregistered investment vehicles that commingle assets from multiple fiduciary clients to invest in portfolios of stocks, bonds, or other securities, including equity and debt instruments. In contrast, COF held $2,834 million in 'other securities' as part of its available-for-sale securities, with a weighted-average yield of 1.57%. While V's collective investment funds focus on diversified portfolios for institutional investors, COF's 'other securities' likely reflect a different risk-return profile given the lower yield and potentially different asset composition.",
      "llm_answer": "In Visa’s U.S. pension plans, collective‑investment funds made up $319 million of the $733 million of Level 2 assets at September 30 2022 – roughly **43 % of the plan’s Level 2 holdings**【page_87】.  \n\nCapital One’s “other securities” (primarily asset‑backed, foreign‑government and supranational bonds) represent only about **3 % of its total investment‑securities portfolio** (≈$2.8 billion of $95 billion) and are priced at a **weighted‑average yield of about 1.6 %** for the whole portfolio【page_160】【page_162】.  \n\nThus, Visa’s Level 2 strategy leans heavily toward diversified collective funds that seek higher equity‑and‑debt returns, whereas Capital One’s “other securities” are a modest, lower‑yielding slice of its portfolio focused on fixed‑income‑type assets.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. It states that collective investment funds were $319 million out of $733 million in Level 2 assets (43%), but the ground truth specifies $319 million in collective investment funds out of $960 million in total U.S. pension plan assets, not Level 2 assets. The LLM incorrectly uses $733 million as the total Level 2 assets, which is not supported by the ground truth. The correct percentage is ~33.2% of total U.S. pension assets, not 43% of Level 2 holdings. This is a critical error in both denominator and interpretation of the asset base.\n\n2) The COF data is partially accurate: $2.8 billion in 'other securities' and a yield of 1.6% (close to 1.57%) are acceptable given rounding. However, the LLM introduces a claim that 'other securities' represent 3% of COF’s total investment portfolio (~$95 billion), which is not in the original answer or ground truth. This extrapolation is unsupported and introduces new, unverified data.\n\n3) Entity and year accuracy are correct: V (Visa) and COF (Capital One) are properly identified, and 2022 is the correct year. The qualitative description of investment focus (diversified collective funds vs. fixed-income-type assets) is reasonable and aligns with the ground truth’s contrast in investment strategy.\n\n4) Multi-hop reasoning is partially sound: the model attempts to compare allocation strategies and yield profiles, but the flawed quantitative foundation undermines the validity of the comparison. The conclusion about differing risk-return profiles is plausible but based on incorrect or invented numbers.\n\n5) Semantic equivalence is compromised due to incorrect calculations and invented totals. While the direction of the comparison (V focused on diversified funds, COF on lower-yielding fixed income) is consistent, the factual basis is unsound. The LLM also cites page numbers not present in the original context, raising concerns about source fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 532,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How do Adobe's compliance costs related to Saudi Arabia's data localization laws compare to Microsoft's financial exposure from similar regulations, and what does this reveal about their respective cloud service strategies?",
      "original_answer": "Adobe faces significant compliance costs due to its global operations, including exposure to Saudi Arabia's data localization requirements, which could 'adversely impact our business and our enterprise customers' business, our financial condition and our results of operations in those jurisdictions' (ADBE_10k_2024.pdf). Saudi Arabia is explicitly mentioned as one of the jurisdictions implementing data localization requirements that mandate data to remain stored within national borders (MA_10k_2024.pdf). Microsoft discloses that such localization laws globally 'may require changes in services, business practices, or internal systems that result in increased costs, lower revenue, reduced efficiency' and specifically references compliance engineering costs that 'involve substantial expense and the diversion of engineering resources from other projects' (MSFT_10k_2024.pdf). The comparison reveals Adobe's vulnerability through its enterprise customer contracts in Saudi Arabia, while Microsoft faces broader systemic challenges due to its cloud infrastructure and AI services that rely heavily on cross-border data flows.",
      "llm_answer": "Adobe says that the Kingdom of Saudi Arabia’s data‑localisation requirements are among the “specific legal requirements … that could involve significant costs” for its cloud services (see Adobe 10‑K p. 30). Microsoft, by contrast, warns that similar cross‑border‑data rules “could result in substantial financial exposure” and higher compliance expenses for its Azure cloud (see Microsoft 10‑K p. 29). The contrast shows Adobe is budgeting for localized compliance as a core part of a region‑focused cloud strategy, while Microsoft’s more globally‑scaled cloud model leaves it more exposed to costly regulatory changes.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both Adobe and Microsoft's exposure to data localization laws, particularly in Saudi Arabia, and cites relevant 10-K disclosures with correct page numbers (p.30 for Adobe, p.29 for Microsoft), which aligns with the ground truth. There are no numeric values in the question or answers that require verification, so quantitative accuracy is not compromised. (2) The answer accurately reflects that Adobe faces significant compliance costs and Microsoft faces substantial financial exposure due to cross-border data rules, which is consistent with the original answer. However, the LLM mischaracterizes the strategic implications: it claims Adobe is pursuing a 'region-focused cloud strategy' and budgeting for localized compliance as a 'core part', but the ground truth does not state or imply that Adobe has such a strategic orientation—rather, it emphasizes Adobe's vulnerability through enterprise customer contracts. Conversely, the LLM understates Microsoft's systemic challenges related to AI and cloud infrastructure, instead generalizing about a 'globally-scaled cloud model' without referencing the specific engineering cost disclosures and resource diversion mentioned in the ground truth. (3) The multi-hop reasoning is partially sound—linking both companies’ regulatory exposures is correct—but the synthesis of their strategic differences is speculative and slightly misaligned with the source. The ground truth emphasizes Microsoft's need to modify internal systems and services due to AI and cloud scale, while Adobe’s risk is more contractual and jurisdictional. The LLM flips this nuance into a strategic choice by Adobe rather than a compliance vulnerability. (4) Despite these reasoning gaps, the answer remains contextually relevant and factually grounded in the cited documents, earning high marks for relevance and qualitative accuracy, though not perfect. Minor but important misrepresentation of strategy reduces correctness score to 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 541,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Duke Energy's divestiture of KO Transmission's pipeline facilities impact its FERC regulatory exposure, and how does this contrast with Southern Company's ongoing capital expenditure risks tied to FERC rule changes?",
      "original_answer": "Duke Energy Ohio divested all of KO Transmission's pipeline facilities on February 1, 2023, for approximately book value, which reduces its direct exposure to FERC-regulated interstate pipeline operations. This contrasts with Southern Company’s ongoing capital expenditure programs, which are subject to FERC rule changes that could materially affect construction costs and recovery of investments. Southern Company specifically notes uncertainty in recovering costs related to capital expenditures due to potential changes in FERC regulations. While Duke Energy has mitigated its FERC-related risk in the pipeline business through divestiture, Southern Company remains exposed to regulatory shifts that could impact its construction programs and cost recovery.",
      "llm_answer": "Duke Energy eliminated its direct FERC‑regulated natural‑gas‑pipeline business when KO Transmission sold its 90‑mile pipeline and related real‑property to Columbia Gas Transmission on Feb. 1 2023; because the pipeline was an interstate asset subject to FERC certification, siting and rate rules, the divestiture removes that line of regulatory oversight and therefore lowers Duke’s exposure to future FERC actions on that asset【page_24】.  \n\nIn contrast, Southern Company’s capital‑expenditure program still carries “capital‑expenditure risks” that stem from possible changes to FERC rules and regulations (including the proposed ELG Supplemental Rule and other environmental‑related FERC actions), which could raise construction costs, alter required compliance spending, or affect the timing of projects【page_104】.  \n\nThus, Duke’s sale reduces its FERC regulatory risk, whereas Southern Company remains vulnerable to FERC rule changes that could increase its future capex requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Duke Energy Ohio divested KO Transmission's pipeline facilities on February 1, 2023, which were FERC-regulated interstate assets, reducing its regulatory exposure. This date and event are correctly stated. The sale was for approximately book value in the original answer, and while the LLM does not mention 'book value,' it correctly identifies the buyer (Columbia Gas Transmission) and the nature of the divestiture, which is consistent with the knowledge graph. (2) Quantitative accuracy is perfect: the date (Feb 1, 2023) is correct, and no financial figures are misstated. The LLM adds detail (90-mile pipeline) not in the original but does not contradict it. (3) Multi-hop reasoning is sound: the model correctly contrasts Duke’s reduced FERC exposure post-divestiture with Southern Company’s ongoing capex risks due to FERC rule changes, including specific references to environmental rules like the ELG Supplemental Rule. The synthesis across two companies and regulatory outcomes is logically structured. (4) The only minor omission is the lack of explicit mention that the sale was 'for approximately book value,' which is a small detail affecting completeness but not the core conclusion. Otherwise, the answer captures the essential contrast in regulatory risk exposure. Wording differs but semantic meaning matches. Contextual relevance is excellent, directly addressing both parts of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 418,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $2.7 billion in unfunded commitments to private debt and private equity funds reported by UPS compare to Caterpillar's allocation of $55 million in NAV-measured assets for its other postretirement benefit plans, in terms of liquidity and investment strategy?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private debt and private equity funds, which are illiquid and typically have redemption restrictions for 10–15 year terms, indicating a long-term investment horizon. In contrast, Caterpillar allocates $55 million in NAV-measured assets for its other postretirement benefits, which include less complex instruments like U.S. corporate bonds and short-term instruments, suggesting a more liquid and conservative investment approach. The difference highlights UPS's focus on alternative investments for long-term growth versus Caterpillar's preference for liquidity and stability in managing postretirement obligations.",
      "llm_answer": "UPS reports roughly $2.7 billion of unfunded commitments to private‑debt and private‑equity funds, which are ill‑iquid partnership interests that cannot be redeemed for 10‑15 years and therefore represent a large, long‑term exposure in its pension‑plan portfolio. By contrast, Caterpillar’s other post‑retirement benefit plans hold only about $55 million of assets measured at NAV—a tiny fraction of the total plan assets—indicating a modest, comparatively more liquid allocation to alternative investments and a more conservative investment strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $2.7 billion for UPS's unfunded commitments and $55 million for Caterpillar's NAV-measured assets. These match the original answer exactly, with acceptable formatting (e.g., $2.7 billion = $2.7 billion). (2) The answer correctly identifies both companies—UPS and Caterpillar—and the relevant financial metrics: unfunded commitments for private debt/equity funds and NAV-measured assets for postretirement plans. (3) The reasoning is sound: it correctly characterizes UPS's investments as illiquid with 10–15 year lockups, reflecting a long-term, alternative investment strategy, while contrasting Caterpillar’s smaller, more liquid allocation as conservative. The only minor shortcoming is that the LLM does not explicitly name the types of instruments in Caterpillar’s portfolio (e.g., U.S. corporate bonds and short-term instruments) as in the original answer, slightly reducing completeness in qualitative detail. However, the core contrast in liquidity and investment strategy is clearly and correctly conveyed. (4) The answer fully addresses the multi-hop comparison between two companies’ investment strategies in the context of liquidity and commitment structure, making it contextually relevant and well-reasoned. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 407,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Alphabet's selective repurchase of Class A and Class C shares, while retaining Class B shares with enhanced voting rights, contrast with Netflix's uniform voting rights structure, and what might this imply about Alphabet's governance strategy?",
      "original_answer": "Alphabet selectively repurchased $62.2 billion of Class A and Class C shares in 2023 while retaining Class B shares, which carry 10 votes per share, suggesting a strategy to maintain concentrated voting control. In contrast, Netflix provides one vote per share across all common stock, indicating a more egalitarian governance approach. This contrast implies that Alphabet's repurchase strategy may be designed to preserve the influence of stakeholders holding Class B shares, which could include insiders or long-term investors, rather than diluting their control through broader ownership.",
      "llm_answer": "Alphabet’s capital structure is dual‑class: each Class A share gets one vote, each Class B share gets ten votes and each Class C share has no voting rights, and the company’s repurchase program is limited to Class A and Class C shares, leaving the high‑voting Class B stock untouched 【page_81】. In contrast, Netflix’s 2023 filing states that every share of its common stock carries a single vote on all shareholder matters 【page_61】. This suggests Alphabet is using its share‑repurchase authority to return capital to non‑controlling shareholders while preserving concentrated voting power in the hands of insiders, whereas Netflix follows a uniform‑voting model that distributes control more evenly among all owners.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Alphabet's selective repurchase of Class A and Class C shares (non-voting or low-voting) while retaining Class B shares with 10 votes per share is accurately described. Netflix's uniform voting structure (one vote per share) is correctly stated. (2) Quantitative accuracy is perfect: although the $62.2 billion repurchase figure from 2023 in the original answer is not explicitly mentioned in the LLM response, this omission does not constitute a factual error—rather, it is a minor completeness gap. The LLM correctly identifies the structural and strategic aspects without misstating any numbers. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Alphabet’s and Netflix’s capital structures and infers the governance implications—Alphabet preserving insider control vs. Netflix’s egalitarian model. (4) Semantic equivalence is strong: the LLM conveys the same core conclusion as the original answer, namely that Alphabet’s repurchase strategy supports concentrated voting power, especially for insiders holding Class B shares, while Netflix distributes voting power uniformly. The only minor shortcoming is the absence of the specific $62.2 billion figure, which slightly reduces completeness but does not affect the correctness of the reasoning or qualitative accuracy. Hence, a score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 420,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the Tax Reform Act's GILTI provisions impact Coca-Cola's 2022 effective tax rate, and how does this compare to Philip Morris International's 2021 effective tax rate benefit from the corporate income tax reduction enacted in the Philippines where it operates and completed business combinations?",
      "original_answer": "The Tax Reform Act's GILTI provisions impacted Coca-Cola's 2022 effective tax rate by requiring the company to account for these taxes in the period subject to such tax, contributing to a $431 million net tax expense (4.4% impact on effective tax rate). For Philip Morris International, the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a 0.1 percentage point decrease in its 2021 effective tax rate, which stood at 21.8%. This tax benefit occurred in a jurisdiction where PMI completed business combinations, including in the Philippines, as part of its global expansion strategy.",
      "llm_answer": "- **Coca‑Cola (2022)** – The Tax Reform Act’s Global Intangible Low‑Taxed Income (GILTI) rules required Coca‑Cola to include the earnings of its foreign subsidiaries that exceed a return on tangible assets in its U.S. tax return.  The company elected to recognize the GILTI tax expense in the period in which it is incurred, and that expense was reflected in the full‑year provision, pushing the 2022 effective tax rate above the 21 % U.S. statutory rate by roughly one percentage point (the GILTI component added about 0.8 %‑1.0 % to the effective rate).\n\n- **Philip Morris International (2021)** – PMI’s 2021 effective tax rate was 21.8 % (up 0.1 percentage point from 2020).  The increase was largely due to GILTI‑related foreign‑tax‑credit limitations, but it was partially offset by the corporate‑income‑tax reduction that the Philippines enacted in the first quarter of 2021 (where PMI operates and completed business combinations).  That Philippine tax cut contributed roughly a 0.5 %‑0.8 % benefit, helping keep the overall effective rate only marginally higher than the prior year.  \n\n**Comparison:** Coca‑Cola’s GILTI exposure raised its 2022 effective tax rate by about a full percentage point, whereas PMI’s 2021 effective tax rate was only modestly higher because the Philippines tax reduction provided a comparable offset, limiting PMI’s net increase to just 0.1 percentage point.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. According to the ground truth, Coca-Cola's GILTI provisions caused a $431 million net tax expense, which had a 4.4% impact on its effective tax rate. However, the LLM claims the GILTI component added only '0.8%–1.0%' to the effective tax rate—this is off by a factor of over four times and completely misrepresents the magnitude of the impact. This is a major error in both dollar amount and percentage effect. (2) For Philip Morris International (PMI), the ground truth states that the Philippines' corporate income tax reduction contributed to a 0.1 percentage point *decrease* in PMI’s 2021 effective tax rate. In contrast, the LLM incorrectly frames the Philippine tax cut as providing a '0.5%–0.8%' benefit and claims the overall rate *increased* by 0.1 percentage point due to GILTI-related issues. While it correctly notes the 2021 effective tax rate was 21.8%, it misattributes the direction and size of the Philippines tax benefit. The ground truth says the benefit was small (0.1 pp decrease), but the LLM exaggerates it to 0.5–0.8% and incorrectly positions it as offsetting an increase, rather than being one of several factors in a complex calculation. (3) The multi-hop reasoning is partially sound—the model attempts to compare the tax impacts across two companies in different jurisdictions and links PMI’s operations and business combinations in the Philippines. However, the synthesis fails because the core numbers and directional impacts are wrong. The comparison section builds on incorrect premises, rendering the conclusion invalid. (4) Despite these serious errors, the answer is contextually relevant and uses correct entities (Coca-Cola, PMI, GILTI, Philippines tax changes, correct years). It also correctly identifies that GILTI affects foreign subsidiary earnings and that tax reforms in the Philippines influenced PMI. These elements support a moderate contextual relevance and partial qualitative accuracy, but the severe quantitative inaccuracies dominate the evaluation, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 577,
        "total_tokens": 2120
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $3.1 billion in mortgage loans sold by BAC to GSEs in 2023 influence the risk exposure of MET's $12.392 billion portfolio of pass-through mortgage-backed securities, given that these securities are directly secured by mortgage loans serviced by institutions like BAC?",
      "original_answer": "BAC sold $3.1 billion in mortgage loans to GSEs in 2023, which are part of the broader pool of loans that can be securitized into pass-through mortgage-backed securities (MBS). MET holds $12.392 billion in such pass-through MBS as of 2023, which are directly secured by mortgage loans—often serviced by institutions like BAC. If BAC, as a servicer, experiences issues in fulfilling its obligations (e.g., due to cybersecurity incidents or servicing breaches), this could lead to disruptions in cash flows or increased credit risk for the underlying loans, which in turn affects the value and performance of MET’s pass-through MBS portfolio.",
      "llm_answer": "BAC’s 2023 filing notes that it “sold approximately $3.1 billion of loans to GSEs, primarily Freddie Mac (FHLMC)”【page_18】. MET’s RMBS table shows that its pass‑through mortgage‑backed securities – which are “secured by a mortgage loan or collection of mortgage loans” that are serviced by banks such as BAC – have an estimated fair value of $12.392 billion【page_98】. Because the loans BAC sold to the GSEs are removed from the pool of mortgages it continues to service, the sale trims the amount of underlying credit that could affect MET’s pass‑through securities; however, the $3.1 billion represents roughly 25 % of MET’s $12.4 billion pass‑through exposure, so the impact is modest and MET’s overall risk remains tied to the broader mortgage‑backed‑securities market and the continued performance of the GSE‑guaranteed loans.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "1) The LLM correctly identifies the $3.1 billion in mortgage loans sold by BAC to GSEs in 2023 and MET's $12.392 billion portfolio of pass-through MBS. However, it introduces a critical error by claiming the $3.1 billion represents 'roughly 25% of MET’s $12.4 billion pass-through exposure'—this is factually incorrect and unsupported. The $3.1 billion refers to loans sold by BAC to GSEs, not loans underlying MET’s MBS portfolio. There is no evidence in the ground truth or logic that these are directly overlapping pools, so this percentage calculation is invalid and misleading. 2) Quantitatively, the dollar amounts ($3.1 billion and $12.392 billion) are accurate and correctly attributed. The year 2023 is correct. However, the 25% calculation is erroneous because it assumes proportionality between two unrelated figures: BAC’s loan sales and MET’s MBS holdings. This misrepresents the scale of influence. 3) The reasoning is flawed in the multi-hop synthesis. The LLM incorrectly assumes that because BAC services loans in MET’s MBS pool, and BAC sold $3.1B in loans to GSEs, those specific loans were part of the securities backing MET’s portfolio. The ground truth emphasizes risk exposure via servicing risk (e.g., cybersecurity, servicing breaches), not direct pool overlap. The LLM shifts focus to a quantitative reduction in risk due to loan removal from the servicing pool, which is not supported. 4) Contextually, the answer is relevant and cites correct document locations and definitions. It recognizes the link between servicers like BAC and MBS performance. However, it fails to convey the actual mechanism of risk—servicing disruption affecting cash flows—not portfolio size reduction. Thus, while some facts are right, the core reasoning and conclusion are significantly off, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 494,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the valuation complexity of NKE's embedded derivatives, which result in Level 3 classification, compare to LOW's use of unobservable inputs for fair value measurements, particularly in terms of reliance on non-market-based assumptions?",
      "original_answer": "NKE disclosed $5 million in embedded derivatives as of May 31, 2022, which resulted in Level 3 classification due to the use of significant unobservable inputs such as extrapolation beyond observable limits and policyholder behavior assumptions. Similarly, Level 3 classifications—as described in MET_10k_2022—rely on non-market-based assumptions like actuarial inputs for policyholder behavior and mortality, which cannot be corroborated by observable market data. LOW, however, reported no material fair value measurements on a nonrecurring basis and emphasized that its financial assets and liabilities not measured at fair value on a recurring basis (such as long-term debt) primarily use observable inputs like quoted market prices or discounted cash flow analyses with incremental borrowing rates, indicating a lesser reliance on unobservable assumptions compared to NKE's Level 3 embedded derivatives.",
      "llm_answer": "Nike’s embedded derivatives are valued with option‑pricing and income‑approach models that require many inputs that cannot be observed in the market – such as actuarial assumptions for mortality, lapse and utilization, extrapolated swap‑yield curves, risk‑margin and non‑performance adjustments – so they are classified in Level 3 of the fair‑value hierarchy【page_84】.  Lowe’s 10‑K notes that Level 3 measurements are those that use unobservable inputs, but the company’s recurring fair‑value assets are largely Level 1 or Level 2 and, where unobservable inputs are used, they are limited to standard estimates (e.g., credit spreads, volatility) rather than the extensive actuarial and behavioral assumptions required for Nike’s embedded derivatives【page_55】【page_56】.  Consequently, Nike’s valuation relies far more heavily on non‑market‑based assumptions and is considerably more complex than the relatively modest use of unobservable inputs disclosed by Lowe.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, no specific dollar amounts or dates are misstated—the original answer mentions NKE's $5 million in embedded derivatives as of May 31, 2022, but the LLM answer does not include this figure. However, the omission is not a factual error, just a lack of specificity on the amount and date, which were present in the ground truth. Since the question does not explicitly ask for the dollar value or date, and the focus is on valuation complexity and reliance on unobservable inputs, this omission does not undermine the core correctness. (2) The LLM correctly identifies that NKE uses significant unobservable inputs such as actuarial assumptions (mortality, lapse, utilization), extrapolated curves, and risk margins, leading to Level 3 classification—this matches the ground truth. (3) For LOW, the LLM accurately states that its recurring fair value measurements are primarily Level 1 or 2, and when Level 3 inputs are used, they are limited (e.g., credit spreads, volatility), contrasting with NKE’s more complex assumptions. This reflects the ground truth that LOW has no material nonrecurring fair value measurements and relies on observable inputs for items like long-term debt. (4) The multi-hop reasoning is sound: the model correctly synthesizes information across NKE and LOW filings, compares their use of unobservable inputs, and draws a valid conclusion that NKE’s valuation is more complex and reliant on non-market-based assumptions. (5) Semantic equivalence is strong—while the LLM references MET_10k_2022 implicitly through actuarial concepts, it correctly attributes similar methodologies to NKE and contrasts them with LOW’s approach. The only minor gap is the absence of the explicit $5M and May 31, 2022, reference, but this does not affect the qualitative comparison central to the question. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 533,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "As defense industry peers managing significant pension assets, how do GD's and LMT's approaches to Level 3 asset valuations differ, given GD's use of valuation models with observable inputs for fixed-rate notes versus LMT's reliance on unobservable inputs for its $4,951 million private equity fund holdings?",
      "original_answer": "GD values its Level 3 assets, including fixed-rate notes, using valuation models that incorporate observable inputs such as interest rates and quoted prices for similar assets. In contrast, LMT's $4,951 million in private equity funds, which are also Level 3 assets, are valued using NAV based on valuation models that rely on unobservable inputs not corroborated by verifiable market data. This highlights a key difference in their fair value accounting methodologies for similar asset classifications, with GD relying on more market-validated inputs while LMT uses internally-derived assumptions for its private equity investments.",
      "llm_answer": "General Dynamics values the assets that fall in the Level 3 tier – such as its fixed‑rate notes – by applying market‑based valuation models that use observable inputs (e.g., current interest rates, bond yields and quoted prices for comparable securities). Lockheed Martin, by contrast, classifies its $4.951 billion of private‑equity fund holdings as Level 3 and measures them at NAV using valuation models that rely on significant unobservable inputs that cannot be corroborated by market data. Thus GD’s Level 3 valuations are grounded in observable market information, while LMT’s Level 3 valuations depend on internal, non‑observable assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: GD uses observable inputs (interest rates, quoted prices) for its Level 3 fixed-rate notes, while LMT values its $4,951 million (correctly rendered as $4.951 billion) in private equity funds using unobservable inputs via NAV. The dollar amount is accurate and properly converted between million and billion formats. (2) Quantitative accuracy is perfect—$4,951 million = $4.951 billion, and no other numbers are misstated. (3) The multi-hop reasoning is sound: the model correctly contrasts two companies' Level 3 valuation methodologies, linking GD’s use of market-validated models with LMT’s reliance on internal assumptions for similar classifications. (4) The only minor shortcoming is a slight reduction in detail compared to the original—specific mention of 'valuation models not corroborated by verifiable market data' in the ground truth is paraphrased as 'cannot be corroborated by market data,' which is semantically equivalent but slightly less precise. However, this does not affect factual correctness. Overall, the answer is factually complete, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 349,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the legal exposure from Slack's shareholder litigation, including the timeline and procedural history of the motion to dismiss, compare to Disney's recent antitrust litigation strategy involving motions to dismiss in the Biddle and Fendelander actions?",
      "original_answer": "Slack faced a multi-year shareholder litigation process beginning in 2019, with the motion to dismiss filed in January 2020, partial denial in April 2020, and eventual reversal by the Ninth Circuit on February 10, 2025, leading to dismissal with prejudice. In contrast, Disney filed motions to dismiss in both the Biddle and Fendelander actions on January 31, 2023, which were granted in part and denied in part by September 30, 2023. Disney then filed another motion to dismiss the consolidated amended complaint on December 1, 2023, which was also granted in part and denied in part on June 25, 2024. While Slack’s litigation reached the U.S. Supreme Court and resulted in a definitive dismissal, Disney’s antitrust cases remain ongoing with class certification deadlines set for March 27, 2026.",
      "llm_answer": "Slack’s shareholder suits began in September 2019 and the company’s first motion to dismiss was filed in January 2020. After a series of district‑court rulings, interlocutory appeals, a Ninth Circuit affirmation, a petition to the U.S. Supreme Court and a remand, the Ninth Circuit finally ordered the complaint dismissed with prejudice on February 10 2025—effectively ending the exposure.  \n\nBy contrast, Disney’s antitrust actions (the Biddle and Fendelander putative class actions) were filed in November 2022; Disney moved to dismiss them on January 31 2023, received a mixed “grant in part/deny in part” order on September 30 2023, consolidated the cases, and again moved to dismiss the consolidated complaint on December 1 2023, receiving another partial grant/deny on June 25 2024. The cases remain alive (class‑certification deadline March 27 2026, trial set for October 6 2025), so Disney’s exposure is still ongoing, whereas Slack’s exposure has been largely resolved through a final dismissal.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key dates and procedural milestones are correct: Slack's motion to dismiss in January 2020, partial denial in April 2020 (implied by 'series of rulings'), Ninth Circuit dismissal with prejudice on February 10, 2025. Disney's motions to dismiss on January 31, 2023, and December 1, 2023, with rulings on September 30, 2023, and June 25, 2024, are all correctly stated. The class-certification deadline of March 27, 2026, is also accurate. (2) Quantitative accuracy is perfect: all dates and timelines match the original answer. The mention of the U.S. Supreme Court petition and remand aligns with the ground truth's reference to the Supreme Court, even though the original does not detail the procedural path. (3) The multi-hop reasoning is sound—correctly contrasting Slack’s fully resolved litigation with Disney’s ongoing exposure. The synthesis across two companies, multiple cases, and procedural stages is well-executed. (4) The only minor omission is that the original specifies the April 2020 partial denial of the motion to dismiss for Slack, which the LLM implies but does not explicitly state. However, this does not undermine the overall correctness. The LLM adds contextual detail (e.g., trial date October 6, 2025) not in the original but consistent with ongoing status. Semantic equivalence is maintained, and the answer fully addresses the comparative legal exposure, timeline, and procedural history as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 413,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Intel's tax benefit from operations in Hong Kong compare to Apple's revenue contribution from the Greater China region, considering the inclusion of Hong Kong within Apple's Greater China reporting?",
      "original_answer": "Intel reported deriving effective tax rate benefits from operations in Hong Kong, where statutory tax rates range from 12.5% to 24.0%, as part of its broader non-US tax strategy. Meanwhile, Apple reported $74.2 billion in net sales from the Greater China region in 2022, which includes Hong Kong. This indicates that while Intel leverages Hong Kong for tax optimization, Apple generates significant revenue from the broader Greater China region, which encompasses Hong Kong.",
      "llm_answer": "Intel says that the “effective‑tax‑rate benefit attributed to non‑U.S. income taxed at different rates … primarily from our operations in Hong Kong, Ireland, Israel and Malaysia” lowered its effective tax rate to **8.5 % in 2021** (down from the 21 % statutory rate, a roughly 12.5‑percentage‑point benefit)【page_90】.  \n\nApple’s “Greater China” segment – which **includes Hong Kong** – produced **$74.2 billion of net sales in 2022**【page_52】.  \n\nThus, Intel’s Hong Kong‑derived advantage is a modest tax‑rate reduction, whereas Apple’s Hong Kong‑included Greater China region contributes tens of billions of dollars in revenue, far larger in absolute monetary terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Intel's effective tax rate benefit tied to Hong Kong operations and Apple's $74.2 billion net sales from the Greater China region in 2022, which includes Hong Kong. All numeric values—Intel’s 8.5% effective tax rate in 2021, the 12.5-percentage-point reduction from the 21% U.S. statutory rate, and Apple’s $74.2 billion—are factually accurate and match the context. The mention that Apple’s Greater China segment includes Hong Kong is correctly stated. (2) Quantitative accuracy is perfect: the dollar amount, percentages, and years are all correct. The implied calculation of the tax benefit (21% - 8.5% = 12.5 percentage points) is accurate. (3) The multi-hop reasoning is sound: the model synthesizes Intel’s tax strategy involving Hong Kong with Apple’s revenue reporting for a region that includes Hong Kong, and correctly contrasts a tax benefit (a percentage-rate reduction) with a direct revenue figure (in billions). The conclusion that Apple’s revenue contribution is far larger in absolute monetary terms than Intel’s tax benefit is logically valid, though it compares different metrics (tax rate vs. revenue), which is acceptable given the question’s comparative framing. (4) The only minor limitation is that the original answer notes Hong Kong’s statutory tax rate range (12.5%–24.0%), which the LLM omits. However, this detail is contextual and not central to the comparison asked. All key entities—Intel, Apple, Hong Kong, Greater China, correct years (2021 for Intel, 2022 for Apple), and financial metrics—are accurately identified and used. The answer is highly relevant and factually aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 460,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does the 70% CO₂ emissions reduction target set by North Carolina's HB 951 impact Duke Energy's Carolinas Resource Plan, and how does this regulatory requirement compare with NextEra Energy's operational exposure in North Carolina?",
      "original_answer": "North Carolina passed HB 951 in 2021, directing the NCUC to develop and approve a carbon reduction plan targeting a 70% reduction in CO₂ emissions from Duke Energy Progress' and Duke Energy Carolinas' electric generation by 2030. In response, Duke Energy filed its 2023 Carolinas Resource Plan, recommending Portfolio 3 as the most prudent path forward, which includes retiring coal by 2035 and leveraging nuclear and energy storage to meet the emissions targets. Meanwhile, NextEra Energy operates in North Carolina, exposing it to the same regulatory environment, though it is not directly subject to HB 951. This creates a differentiated regulatory burden and transition pathway between the two companies in the same state.",
      "llm_answer": "North Carolina’s HB 951 mandates a 70 % cut in CO₂ emissions from public‑utility generation, so Duke Energy’s 2023 Carolinas Resource Plan was built around “Portfolio 3” – a path that retires remaining coal plants by 2035, extends nuclear and pumped‑hydro capacity, and adds storage and demand‑response to meet the state‑required emissions‑reduction goal. By contrast, NextEra Energy’s 2023 Form 10‑K makes no mention of generation assets, regulatory filings or emissions targets in North Carolina, indicating that the company has little or no operational exposure in the state compared with Duke’s regulated, emissions‑driven transition.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy regarding NextEra Energy's operational exposure in North Carolina, which undermines the comparison. (1) Quantitatively, the 70% CO₂ reduction target, HB 951 (2021), 2030 deadline, coal retirement by 2035, and reference to Duke Energy’s 2023 Carolinas Resource Plan and Portfolio 3 are all accurate. The mention of nuclear, storage, and demand-response aligns with the ground truth. (2) However, the claim that NextEra Energy has 'little or no operational exposure' based on its 2023 Form 10-K is incorrect. The ground truth states that NextEra *does* operate in North Carolina and is exposed to the same regulatory environment, even if not directly subject to HB 951. This is a critical error in entity and contextual understanding. (3) The multi-hop reasoning fails in the comparison step: while correctly identifying Duke’s regulatory obligations, it incorrectly infers absence of exposure from lack of mention in the 10-K, which is not logically or factually sound—companies may operate in a state without detailing every jurisdiction in their filings. (4) The answer is well-structured and contextually relevant, addressing both parts of the question, but the core comparison is flawed, reducing correctness and qualitative accuracy. A score of 6 reflects accurate numbers and partial reasoning but major error in a key factual claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 391,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How do MDLZ's use of weighted-average assumptions for measuring postretirement healthcare costs differ from KO's application of these assumptions in the Black-Scholes-Merton model for stock option valuation?",
      "original_answer": "MDLZ uses weighted-average assumptions to determine its net periodic postretirement healthcare costs, which resulted in costs of $14 million in 2021, $12 million in 2022, and a benefit of $5 million in 2023. These assumptions are applied to liability cash flows using spot rates along a yield curve to measure service and interest costs. In contrast, KO uses weighted-average assumptions as inputs in the Black-Scholes-Merton option-pricing model to estimate the fair value of stock options granted, which are then expensed on a straight-line basis over a four-year vesting period. The key difference lies in the financial valuation context: MDLZ applies the assumptions for postretirement benefit accounting, while KO uses them for equity compensation valuation.",
      "llm_answer": "Mondelez (MDLZ) applies weighted‑average actuarial assumptions – a discount rate and a health‑care cost‑trend rate (e.g., 5.53 % discount and 7.0 % cost trend for U.S. plans in 2023) – to project the cash‑flow timing of its post‑retirement health‑care obligations and to measure the service and interest components of the net periodic cost.  \n\nCoca‑Cola (KO), by contrast, uses weighted‑average market‑based inputs – risk‑free rate, expected option life, expected volatility and dividend yield (e.g., 4.18 % risk‑free, 20.97 % volatility, 2.32 % dividend yield for 2023) – in the Black‑Scholes‑Merton model to calculate the fair value of stock options.  \n\nThus, MDLZ’s assumptions are actuarial parameters for benefit valuation, while KO’s are option‑pricing parameters for equity compensation valuation.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly distinguishes MDLZ's use of weighted-average actuarial assumptions (discount rate and healthcare cost-trend rate) for postretirement healthcare cost measurement from KO's use of weighted-average inputs in the Black-Scholes-Merton model for stock option valuation. The specific 2023 assumption examples (5.53% discount, 7.0% cost trend for MDLZ; 4.18% risk-free, 20.97% volatility, 2.32% dividend yield for KO) are consistent with typical disclosures, though the original answer does not include these exact percentages—these are plausible and contextually appropriate, so their inclusion enhances rather than detracts. (2) The original answer includes dollar amounts for MDLZ's net periodic costs: $14M (2021), $12M (2022), and a $5M benefit (2023). These specific figures are missing in the LLM response, which prevents a perfect quantitative match—hence quantitative accuracy is marked at 9 rather than 10. However, the LLM correctly describes the application of spot rates to liability cash flows for service and interest cost measurement, which is a key technical point. (3) The multi-hop reasoning is sound: the model correctly synthesizes that MDLZ applies assumptions in a postretirement benefit context (actuarial, liability-focused), while KO uses them in an equity compensation context (option-pricing, fair value estimation). (4) The semantic meaning and key differentiators are fully preserved. The LLM adds helpful detail (specific assumption inputs) not in the original, without introducing inaccuracies. Minor omission of exact dollar figures prevents a 10 on correctness, but the core conceptual and qualitative analysis is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 471,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does JPMorgan Chase's exposure to derivatives under the Dodd-Frank Act compare to Bank of America's resolution planning obligations under the Orderly Liquidation Authority, particularly in terms of liquidity risk management during financial distress?",
      "original_answer": "JPMorgan Chase is subject to Dodd-Frank regulations that govern its use of derivatives through enforceable set-off and close-out netting provisions under ISDA Master Agreements, which are constrained by the Orderly Liquidation Authority (OLA) under Title II of Dodd-Frank. Similarly, Bank of America must submit resolution plans under the OLA that outline a 'single point of entry' strategy, restricting liquidity flows from subsidiaries to the parent company during financial distress. Both firms face regulatory constraints on liquidity: JPMorgan through enforceable netting limitations and Bank of America through intercompany liquidity contribution arrangements that prioritize subsidiary solvency over parent company funding needs.",
      "llm_answer": "JPMorgan Chase reports a “large portfolio of … derivatives” that can trigger “additional collateral or … increased funding costs” if market stress or a credit‑rating downgrade occurs, and the Dodd‑Frank Act’s margin‑and‑close‑out‑netting rules require the firm to post extra cash or securities that could strain its liquidity in a crisis. By contrast, Bank of America’s resolution‑planning obligations under the FDIC’s Orderly‑Liquidation Authority require the parent to keep sufficient capital and liquidity at each subsidiary and, in a distress scenario, may bar the parent from drawing on subsidiary funds or force it to contribute assets to a bridge holding company—an approach that limits liquidity outflows but still hinges on maintaining enough liquidity to meet the plan’s “single‑point‑of‑entry” requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies JPMorgan Chase's exposure to derivatives under Dodd-Frank, emphasizing liquidity risks from margin and close-out netting requirements during stress, which matches the original answer's focus on enforceable set-off and close-out netting constrained by the Orderly Liquidation Authority (OLA). It also accurately describes Bank of America's resolution planning obligations under OLA, including the 'single point of entry' strategy and restrictions on intercompany liquidity flows. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes how Dodd-Frank impacts JPMorgan’s derivatives liquidity risk and contrasts it with Bank of America’s structural liquidity constraints under resolution planning. The only minor gap is that the LLM does not explicitly mention ISDA Master Agreements or the term 'enforceable netting limitations' as in the original, but it captures the functional impact (e.g., posting extra collateral). (4) The answer is contextually precise, directly addressing the comparison of liquidity risk management during distress for both institutions under the relevant regulatory frameworks. Wording differs but semantic meaning and factual content are equivalent. One point deducted from qualitative accuracy for slight omission of technical terminology, but core reasoning and facts remain intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 424,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Ohio's continued reliance on coal influence the contrasting energy transition strategies of XOM and CVX, particularly considering XOM's European coal tax burden and CVX's 2024 renewable natural gas investments in the state?",
      "original_answer": "XOM faced a significant $1.8 billion after-tax charge in 2022 due to the EU's new tax on coal and other energy sectors, which targeted companies with surplus profits, signaling regulatory pressure to reduce fossil fuel dependency. Meanwhile, Duke Energy Ohio, a subsidiary operating in the state, held only $23 million in coal inventory as of December 31, 2024, suggesting a cautious but ongoing reliance on coal. In contrast, CVX made targeted investments in Ohio through Brightmark RNG Holdings LLC, achieving commercial operations at renewable natural gas projects in 2024, aligning with a cleaner energy transition. This divergence highlights how regulatory penalties in Europe are pushing XOM toward compliance, while CVX is proactively investing in low-carbon alternatives like RNG in coal-reliant states such as Ohio.",
      "llm_answer": "Ohio’s power system still leans on coal – Duke Energy’s Ohio inventory shows a $23 million coal balance in 2024 (see Duke Energy Ohio inventory, page 124) – so any oil‑major that sells coal‑linked products there faces a market that is carbon‑intensive.  ExxonMobil’s 2024 filing notes that the EU’s new “surplus‑profits” tax on coal‑related earnings imposed a $1.8 billion after‑tax charge on its European results (EU coal tax discussion, page 115), underscoring the fiscal drag a coal‑dependent portfolio creates for its transition.  Chevron, by contrast, is deploying renewable natural gas in Ohio in 2024 through Brightmark’s dairy‑biomethane facilities (RNG projects in Ohio, page 19), using low‑carbon fuel to offset the state’s coal reliance and signal a more aggressive shift away from coal‑based generation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Duke Energy Ohio's $23 million coal inventory as of 2024 and XOM's $1.8 billion after-tax EU coal tax charge in 2022 (the LLM incorrectly cites 2024 for the tax charge, but the original answer does not specify the year in the sentence about the charge—however, the knowledge graph ground truth correctly dates it to 2022, so this is a minor error). The LLM attributes the EU tax to 2024, which is incorrect; the charge was recognized in 2022. (2) Quantitative accuracy is otherwise perfect: $23 million and $1.8 billion figures match exactly, and formats are consistent. (3) Multi-hop reasoning is sound: the model correctly links Ohio’s coal reliance (via Duke Energy) to broader energy transition strategies, contrasts XOM’s regulatory penalty in Europe with CVX’s proactive RNG investments in Ohio via Brightmark, and contextualizes these moves as divergent transition strategies. (4) The mention of Brightmark’s dairy-biomethane facilities adds detail not in the original but is consistent with CVX’s 2024 RNG investments and enhances relevance. The only substantive issue is the misattribution of the timing of XOM’s EU tax charge to 2024 instead of 2022, which slightly affects qualitative accuracy but does not undermine the overall correctness. Semantic equivalence is maintained, and the answer fully addresses the contrast in strategies influenced by Ohio’s coal use and external regulatory pressures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 416,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How does the structure of MS's CLNs, which embed credit protection sold by the issuer, compare with JPM's credit-related notes in terms of payout mechanics upon a credit event, given that both instruments involve the transfer of credit risk on reference entities?",
      "original_answer": "Morgan Stanley structures CLNs as hybrid instruments where it purchases credit protection from the issuer, and if a credit event occurs with the reference entity, the principal balance of the note may not be repaid in full. JPMorgan, on the other hand, sells credit protection through credit-related notes, where the issuer pays the investor the difference between the par value and the fair value of the defaulted reference obligation upon a credit event. Both instruments transfer credit risk on reference entities, but MS acts as the buyer of protection while JPM often acts as the seller, affecting payout obligations differently based on their respective positions in the transaction.",
      "llm_answer": "Morgan Stanley’s credit‑linked notes are structured so that the issuer (the SPE) sells protection on a reference asset and, if a credit event occurs, the SPE delivers the underlying collateral securities to the firm – the note’s principal is therefore reduced to the value of the collateral received. JPMorgan’s credit‑related notes work like a funded CDS: the investor pays par up‑front, receives periodic coupon payments and, at maturity, the issuer repays par unless a credit event occurs, in which case the issuer pays only the shortfall (par minus the fair‑value of the defaulted reference obligation). Thus, MS CLNs settle a credit event by transferring collateral assets, whereas JPM’s notes settle by paying the cash shortfall between par and the reference obligation’s fair value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor differences in emphasis. (1) The key factual elements are correct: MS's CLNs involve the issuer selling credit protection, and upon a credit event, the principal is reduced based on the value of delivered collateral (i.e., not repaid in full), which aligns with the ground truth. JPM's notes are correctly described as functioning like a funded CDS where the payout upon a credit event is the shortfall between par and the fair value of the defaulted obligation. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly identifies the opposing roles (MS as buyer of protection, JPM as seller) and links this to different payout mechanics—physical or in-kind settlement (collateral transfer) vs. cash settlement of the loss amount. The LLM uses slightly different phrasing (e.g., 'SPE sells protection' vs. 'MS purchases protection') but this is semantically equivalent. (4) The only reason for not scoring a 10 is that the LLM does not explicitly state that MS 'buys' protection and JPM 'sells' it in the same direct comparative way as the ground truth, though this is implied in the payout mechanics. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 397,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the application of the reduced disclosure format differ between Georgia Power Company (a subsidiary of Southern Company) and Florida Power & Light Company (a subsidiary of NextEra Energy) in their respective 2022 Form 10-K filings, particularly in terms of their compliance with General Instruction I.(1)(a) and (b) of Form 10-K?",
      "original_answer": "Georgia Power Company, as part of Southern Company's consolidated 10-K filing, explicitly states that it meets the conditions in General Instructions I(1)(a) and (b) of Form 10-K and therefore uses the reduced disclosure format specified in General Instructions I(2)(b), (c), and (d). Similarly, Florida Power & Light Company also asserts compliance with General Instruction I.(1)(a) and (b), qualifying for the reduced disclosure format in its 2022 Form 10-K filing. However, while Georgia Power is one of multiple registrants in a combined filing with Southern Company, Florida Power & Light Company is one of only two registrants in its combined filing, the other being NextEra Energy, Inc., which holds all 1,000 shares of its common stock. Both companies file information only on their own behalf and disclaim responsibility for the other registrants’ data.",
      "llm_answer": "Both subsidiaries qualify for the “reduced‑disclosure” filing, but the way the qualification is described differs.  \n\n* **Georgia Power Company** (a Southern Company subsidiary) states that it “meets the conditions set forth in General Instructions I.(1)(a) and (b) of Form 10‑K and is therefore filing this Form 10‑K with the reduced‑disclosure format specified in General Instructions I.(2)(b), (c) and (d).” This language appears in the combined Southern Company 10‑K, which includes separate filings for each subsidiary.  \n\n* **Florida Power & Light Company** (a NextEra Energy subsidiary) simply notes that it “meets the conditions set forth in General Instruction I.(1)(a) and (b) of Form 10‑K and is therefore filing this Form with the reduced disclosure format.” The statement is in the combined NextEra Energy 10‑K and does not reference the specific I.(2) subsections.  \n\nThus, while both companies rely on the same General Instruction I.(1)(a)‑(b) eligibility, Georgia Power’s filing explicitly cites the additional I.(2)(b)‑(d) reduced‑disclosure requirements, whereas Florida Power & Light’s filing affirms eligibility without citing those subsections.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. Both Georgia Power Company and Florida Power & Light Company are correctly identified as qualifying for the reduced disclosure format under General Instruction I.(1)(a) and (b) of Form 10-K in their 2022 filings. The LLM correctly notes that Georgia Power explicitly references the specific reduced-disclosure subsections I.(2)(b), (c), and (d), while Florida Power & Light affirms eligibility without citing those subsections—this distinction is accurate and directly addresses the question about differences in application. The entities, years, and regulatory instructions are all correctly identified (entity accuracy: 10). There are no numerical values in the question or answer, so quantitative accuracy is not applicable in a numerical sense, but all factual assertions (e.g., filing structure, citation practices) are correct, warranting a 10. The qualitative accuracy is high, though the LLM omits a minor but relevant detail from the ground truth: that Florida Power & Light files in a combined form with NextEra Energy, Inc., which owns all 1,000 shares of its common stock, and that both companies disclaim responsibility for each other’s disclosures. This contextual nuance about ownership and joint filing structure adds depth to the comparison and was not included, slightly reducing completeness. However, the core of the question—how the application of the reduced disclosure format differs in terms of compliance language—is well addressed. The reasoning is sound and the answer is semantically equivalent to the ground truth in intent and substance, with only minor omissions. Contextual relevance is perfect, as the response directly focuses on the regulatory citation differences between the two companies’ 10-Ks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 488,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does RTX's revenue recognition timing on U.S. government fixed-price contracts, influenced by FAR guidelines, compare to GD's cost allocation practices under the same regulatory framework, particularly in relation to performance-based payments and contract modifications?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to performance-based payments (PBPs) or progress payments, where the customer retains a portion of the contract price until completion. This practice is guided by the Federal Acquisition Regulation (FAR), which outlines allowable cost structures and payment mechanisms. Similarly, GD operates under the FAR and Cost Accounting Standards (CAS), which regulate cost allowability and allocation across contracts. GD's cost allocation practices are subject to audits and reviews by the government, ensuring that costs charged to contracts comply with FAR stipulations. Both companies must manage contract modifications and revenue or cost adjustments in response to FAR-mandated acquisition phases, including planning, competition, and contractor qualifications, though RTX specifically highlights the impact of these regulations on contract assets and liabilities, while GD emphasizes compliance and auditability under FAR and CAS.",
      "llm_answer": "RTX says that its U.S. government fixed‑price contracts are governed by the FAR and are “priced based on estimated or actual costs” (page 78) and that the contracts are paid through performance‑based payments or progress payments. Because the government retains a portion of the price until contract completion, RTX recognises revenue on a percentage‑of‑completion/over‑time basis, often ahead of billings and records the excess as contract assets (page 79).  \n\nGeneral Dynamics, by contrast, notes that the FAR (and the Cost Accounting Standards) “address the allowability of our costs, while the CAS addresses the allocation of those costs to contracts” (page 19). Its practice therefore focuses on allocating allowable costs to each contract rather than timing revenue, with cost‑type contracts paid shortly after costs are incurred and any contract modifications reflected in the cost allocation rather than in early revenue recognition.  \n\nThus, RTX’s FAR‑driven policy accelerates revenue recognition relative to billings via PBPs and modification‑adjusted catch‑up accounting, whereas GD’s FAR‑driven approach emphasizes cost‑allowability and cost allocation, matching costs to contract performance without front‑loading revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to performance-based or progress payments, using a percentage-of-completion method, resulting in contract assets—this matches the original answer. GD’s cost allocation practices under FAR and CAS are correctly described, emphasizing cost allowability and allocation rather than revenue timing. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or the original answer, so quantitative accuracy is not compromised; the LLM does not introduce any incorrect figures. (3) The multi-hop reasoning is sound: the LLM correctly contrasts RTX’s revenue recognition timing (FAR-influenced, PBP-driven, over-time recognition) with GD’s cost-focused, allocation-oriented approach under the same regulatory framework, synthesizing across both companies and regulatory mechanisms (FAR, CAS). (4) The LLM adds slight document page references (e.g., 'page 78', 'page 19') not in the original answer—these may be plausible but are not verifiable from the ground truth; however, they don’t affect factual correctness. The core distinction—RTX accelerates revenue recognition relative to billings, while GD focuses on cost allocation and compliance—is semantically equivalent to the original. Only a minor deduction in qualitative accuracy due to unverifiable page citations, but reasoning and synthesis remain strong. Contextual relevance is perfect: all parts of the question (revenue timing, cost allocation, PBPs, contract modifications, FAR influence) are addressed directly and accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1595,
        "completion_tokens": 468,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the difference in voting rights structure between Class A and Class B shares at GOOGL compare to CMCSA's disclosure regarding its lack of voting rights in Atairos, and what implications does this have for corporate governance control in both entities?",
      "original_answer": "At GOOGL, Class A shares carry one vote per share while Class B shares carry ten votes per share, creating a dual-class structure that concentrates voting power among holders of Class B shares. This structure allows certain shareholders to maintain control over corporate decisions despite owning a minority of shares. In contrast, CMCSA explicitly discloses that it has no voting rights in Atairos, which is accounted for as an equity method investment, limiting its influence over Atairos’s operations. While GOOGL uses differentiated voting rights to preserve control through a structured share class system, CMCSA lacks such control mechanisms entirely in its investment in Atairos, affecting its corporate governance influence in that entity.",
      "llm_answer": "Alphabet’s charter creates a dual‑class structure: each Class A share carries one vote, while each Class B share carries ten votes (Class C has no voting rights)【page 82】. In contrast, Comcast’s investment in Atairos is explicitly described as having “no voting rights and only certain consent rights”【page 85】, meaning Comcast cannot direct Atairos’s policies or operations. Consequently, control of Alphabet is concentrated in the hands of the relatively few Class B shareholders, whereas Comcast’s stake in Atairos is essentially passive, giving it little or no governance influence over that entity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies the voting rights structure at GOOGL (Class A: 1 vote/share; Class B: 10 votes/share), noting the concentration of control among Class B shareholders, and accurately contrasts this with CMCSA's lack of voting rights in Atairos, citing 'no voting rights and only certain consent rights'—which aligns with the original answer’s claim of limited influence. (2) There are no numerical inaccuracies; the vote ratios are correctly stated, and no calculations are required beyond accurate qualitative comparisons. (3) The multi-hop reasoning is sound: the model synthesizes information across two distinct entities (GOOGL and CMCSA/Atairos), correctly interpreting the implications of dual-class shares versus passive equity investments on corporate governance control. (4) The answer is contextually precise, directly addressing the comparison of voting structures and their governance implications. Minor additions (e.g., mention of Class C shares, citation of page numbers) enhance clarity without introducing error. All key elements—control concentration at GOOGL, absence of control at CMCSA, and the resulting governance implications—are fully and correctly covered.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 356,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does Amgen's reliance on McKesson Corporation for 33% of its gross product sales in 2021 compare to Merck's risk disclosures about pharmaceutical product distribution concentration, given Amgen's specific exposure to wholesaler distribution risks outlined in its 2022 filing?",
      "original_answer": "Amgen's 2022 filing reveals that McKesson Corporation accounted for 33% of its gross product sales in 2021, highlighting a significant dependency on a single wholesaler. This concentration risk is explicitly acknowledged in Amgen's disclosure that the substantial majority of its U.S. product sales are made to just three distributors, including McKesson, and that financial or operational difficulties at any of these could significantly disrupt its business. Merck's 2022 filing similarly warns that 'pharmaceutical products can develop unexpected safety or efficacy concerns' and that 'reliance on third-party relationships and outsourcing arrangements could materially adversely affect the business,' reinforcing the industry-wide sensitivity to distribution chain vulnerabilities. Together, these disclosures underscore the material financial and operational risk both companies face from overreliance on a concentrated pharmaceutical distribution network.",
      "llm_answer": "Amgen’s 2022 filing spells out that a single wholesaler—McKesson Corporation—accounted for 33 percent of the company’s total gross product sales in 2021 (and 82 percent of gross revenues came from its three largest customers), explicitly linking that concentration to credit‑risk monitoring and potential revenue impact. Merck’s 2022 risk factors similarly warn that “the substantial majority” of its U.S. product sales are made to three wholesale distributors (McKesson, AmerisourceBergen and Cardinal Health) and that a financial or operational problem at any of them could materially disrupt its business, but it does not quantify the exposure to a single distributor. Thus, Amgen’s disclosure quantifies a higher, single‑customer reliance, whereas Merck’s disclosure acknowledges comparable concentration in broader terms without a specific percentage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers are correct: Amgen's 33% exposure to McKesson in 2021 is accurately cited, and the additional detail that 82% of gross revenues came from the top three customers is factually consistent with Amgen’s 2022 filing (though not in the original answer, it is a valid supporting detail). Merck’s lack of a specific percentage for individual distributor reliance is correctly noted. (2) The entity identification is accurate—McKesson, AmerisourceBergen, and Cardinal Health are correctly named as Merck’s key distributors. The years (2021 sales data, 2022 filings) are correct. (3) The multi-hop reasoning is sound: the model correctly compares Amgen’s quantified single-distributor risk to Merck’s broader but unquantified concentration risk, synthesizing disclosures from both companies. (4) The LLM adds value by specifying the three major distributors for Merck, which strengthens the comparison. The only minor shortcoming is that the original answer emphasizes Merck’s warning about 'unexpected safety or efficacy concerns' as part of its risk framework, which the LLM omits—however, this is not central to the distribution concentration comparison. The LLM instead focuses more precisely on distribution chain risks, arguably improving relevance. Thus, the answer is factually superior in some aspects, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 418,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "What is ConocoPhillips' financial exposure from its ownership in Alba Plant LLC, given Chevron's production of condensate and the plant's role in processing natural gas from the Alba Unit in Equatorial Guinea?",
      "original_answer": "ConocoPhillips has a 56.0% ownership interest in EG LNG and a 52.2% interest in Alba Plant LLC, which processes natural gas from the Alba Unit and extracts condensate and LPG for sale at market prices. According to COP's 2024 10-K, ConocoPhillips has $116 million in maximum potential future payments related to guarantees for Alba Plant LLC’s agreements to process third-party gas. This exposure is tied to Chevron’s upstream production of condensate, which feeds into the Alba Unit’s gas stream, and the downstream monetization through the LPG plant and EG LNG’s liquefaction facility.",
      "llm_answer": "ConocoPhillips’ exposure tied to its 52.2 % stake in Alba Plant LLC is reflected in the “Equatorial Guinea Guarantees” – the company is liable for up to **about $116 million** of potential future payments on those guarantees (the carrying amount of the related liability was about **$4 million** at 31 Dec 2024).【page_102】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: $116 million in maximum potential future payments and $4 million carrying amount of the liability as of December 31, 2024, match the source data. The ownership stake of 52.2% in Alba Plant LLC is correctly stated. (2) The mention of 'Equatorial Guinea Guarantees' correctly contextualizes the exposure, and the reference to page 102 supports traceability. (3) The multi-hop reasoning is sound: the answer links ConocoPhillips’ ownership to financial exposure via guarantees tied to third-party gas processing, which is consistent with the plant’s role in processing gas from the Alba Unit—fed in part by Chevron’s condensate production. (4) While the LLM does not explicitly mention Chevron’s condensate feeding the gas stream or the connection to EG LNG’s liquefaction facility, it captures the core financial exposure accurately. These omissions reduce completeness slightly but do not undermine the factual correctness of the primary query about financial exposure. Hence, the answer earns a 9/10 for correctness and qualitative accuracy due to minor contextual omissions, but full marks for quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 348,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does the use of valuation models incorporating observable market inputs by General Dynamics' Level 2 assets compare with Union Pacific's disclosure of real estate funds at NAV, given that real estate funds are typically valued using unobservable inputs over 8-10 year terms?",
      "original_answer": "General Dynamics values its Level 2 fixed-income assets using valuation models with observable inputs like interest rates and bond yields, contrasting with Union Pacific's $30 million allocation to real estate funds that are valued at NAV based on unobservable inputs according to LMT's explanation of real estate fund valuation practices which involve long-term valuations over 8-10 year periods.",
      "llm_answer": "General Dynamics says its Level 2 assets are measured using a market‑approach valuation model that relies on observable inputs such as interest‑rate curves, bond yields and quoted prices for comparable securities【page_83】. Union Pacific, by contrast, reports its real‑estate fund holdings at net‑asset value, noting that those NAVs are derived from valuation models and periodic appraisals that use primarily unobservable inputs and reflect long‑term (8‑10‑year) investment terms【page_88】. Thus, GD’s Level 2 valuations are based on market‑observable data, while UNP’s real‑estate funds are valued using less‑observable, longer‑horizon assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core contrast between General Dynamics' use of observable market inputs for Level 2 assets and Union Pacific's use of NAV for real estate funds based on unobservable inputs over 8-10 year terms. All entities—General Dynamics (GD), Union Pacific (UNP), Level 2 assets, real estate funds, NAV, observable vs. unobservable inputs—are accurately identified and correctly contextualized. (2) Quantitatively, while the original answer mentions Union Pacific's $30 million allocation to real estate funds, the LLM answer omits this specific dollar amount. This is a minor omission but does not affect the overall correctness of the comparison, as the focus of the question is on valuation methodology rather than magnitude. No calculations are required, and all referenced inputs (interest rates, bond yields, quoted prices, appraisals) are correctly attributed. (3) The multi-hop reasoning is sound: the model correctly synthesizes valuation practices across two companies (GD and UNP), links them to appropriate asset types (Level 2 fixed-income vs. real estate funds), and contrasts observable vs. unobservable inputs in the context of long-term valuation horizons. It also correctly references LMT’s explanation implicitly by aligning real estate fund valuation practices with long-term unobservable inputs, even if not explicitly naming LMT—this is acceptable given the semantic flow. (4) The answer is contextually precise, directly addressing the comparison asked. The omission of the $30M figure prevents a perfect score, but the reasoning, entity accuracy, and qualitative synthesis are otherwise excellent, warranting a 9/10 on correctness and qualitative accuracy, and full marks on quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 483,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "Given Citibank's co-branding role in Costco's credit card program and its administrative role in Colgate's five-year credit agreement, how does the nature of Citibank's involvement differ in these two financial arrangements?",
      "original_answer": "Citibank's involvement with Costco is characterized by a co-branded credit card program that has undergone twelve amendments since 2015, most recently on October 11, 2023, indicating an ongoing consumer financial product partnership. In contrast, Citibank's role with Colgate is as administrative agent and arranger for a five-year credit agreement most recently amended on November 4, 2022, which represents a corporate lending facility rather than a consumer credit product. The Costco relationship centers on a retail financial service partnership while the Colgate arrangement involves managing a syndicated corporate credit facility.",
      "llm_answer": "Citibank’s role with Costco is that of a **co‑branded credit‑card partner** – it issues and services a Costco‑branded card under a “Citibank, N.A. Co‑Branded Credit Card Agreement” (see Exhibit 10.8 in Costco’s filing)【page_68】.  \n\nWith Colgate‑Palmolive, Citibank is not a card issuer but the **administrative agent and arranger** for a syndicated loan, acting only to manage and coordinate the five‑year credit agreement (see Exhibit 10‑I in Colgate’s filing)【page_67】.  \n\nThus, Citibank’s involvement with Costco is a marketing‑oriented, consumer‑facing card partnership, whereas with Colgate it is a back‑office, financing‑administration function for a corporate loan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential differences between Citibank's roles in the Costco and Colgate arrangements. (1) It correctly identifies Citibank as a co-branded credit card partner with Costco and as administrative agent and arranger for Colgate's credit agreement, aligning with the ground truth. (2) There are no numeric values, dates, or financial figures in the LLM answer that conflict with the ground truth; while the original answer mentions specific amendment dates (October 11, 2023 for Costco, November 4, 2022 for Colgate), the LLM answer does not include them but also does not contradict them—this omission is minor and does not affect core correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two different companies and financial arrangements, distinguishing consumer-facing card partnerships from corporate lending administration. (4) The semantic meaning matches the ground truth: 'marketing-oriented, consumer-facing card partnership' corresponds to the 'ongoing consumer financial product partnership', and 'back-office, financing-administration function' aligns with 'managing a syndicated corporate credit facility'. The only minor shortcoming is the lack of mention of the number of amendments or the most recent amendment dates, which are present in the ground truth and could enhance completeness. However, since the question focuses on the nature of involvement rather than historical amendment activity, this does not significantly detract from correctness. Overall, the answer is factually sound, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 446,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What is Chevron's net daily crude oil production contribution from its stake in QatarEnergy LNG, considering the average daily net production and Chevron's ownership percentage in 2023?",
      "original_answer": "Chevron's net daily crude oil production from its stake in QatarEnergy LNG in 2023 was 3.9 MBD (thousand barrels per day), calculated as 30% ownership of the 13 MBD average daily net crude oil production from QatarEnergy LNG.",
      "llm_answer": "Chevron’s share of the QatarEnergy N3 LNG project produces about **13 thousand barrels of crude oil per day** on a gross basis (ConocoPhillips 10‑K, page 12).  Chevron owned **approximately 30 %** of the joint venture in 2023 (Chevron 10‑K, page 111).  Multiplying the gross figure by Chevron’s ownership yields a net contribution of roughly **3.9 thousand barrels of crude oil per day** (≈ 4 MBD).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's 30% ownership in the joint venture and the 13 thousand barrels per day (MBD) gross production, matching the ground truth. The net production is accurately calculated as 3.9 thousand barrels per day (30% of 13 MBD), which aligns with the original answer. The rounding to approximately 4 MBD is noted as an approximation and does not detract from accuracy. (2) All numeric values—30%, 13 MBD, and 3.9 MBD—are factually correct and properly formatted; calculations are mathematically sound. (3) The multi-hop reasoning is logically structured: it pulls ownership from Chevron’s 10-K and production data from ConocoPhillips’ 10-K (a plausible proxy if Chevron does not report it directly), then synthesizes them correctly. However, attributing the 13 MBD figure to ConocoPhillips’ 10-K may raise sourcing concerns since the production should be tied to QatarEnergy LNG and Chevron’s stake, though this is a minor issue given the likely shared project data. (4) The answer is semantically equivalent to the ground truth, with only slight wording differences and a reasonable approximation. The contextual relevance is perfect, addressing all parts of the question. A score of 9 is given due to potential sourcing ambiguity, but quantitative and factual accuracy is fully preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 373,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does Caterpillar's use of pricing models for valuing Level 3 non-U.S. pension assets compare to Lockheed Martin's valuation methodology for fixed income investments categorized as Level 3, particularly in terms of the inputs and approaches used?",
      "original_answer": "Caterpillar values its Level 3 non-U.S. pension assets, which include insurance contracts, using pricing models that reflect management's judgment of assumptions a market participant would use. In contrast, Lockheed Martin categorizes fixed income investments as Level 3 when observable inputs are unavailable and uses discounted cash flow approaches or indicative quotes from vendors and brokers, with significant inputs including projected annuity payments and discount rates. Both companies rely on unobservable inputs for Level 3 assets, but Caterpillar focuses on pricing models based on management assumptions, while Lockheed Martin employs a broader set of valuation techniques including discounted cash flows and third-party indicative quotes.",
      "llm_answer": "Caterpillar values its Level 3 non‑U.S. pension assets – which are primarily insurance contracts – with internal pricing models that incorporate the assumptions a market participant would use, such as projected annuity cash‑flows, discount rates, current insurance‑market pricing, market rates and inflation. Lockheed Martin’s Level 3 fixed‑income valuations also use pricing models, but when observable inputs are unavailable the trustee relies on indicative broker or vendor quotes and a discounted‑cash‑flow approach, with the key inputs being projected cash‑flow payments and the discount rate applied to those payments. Thus, Caterpillar’s models are driven by insurance‑specific market assumptions, whereas Lockheed Martin’s models are driven by market‑derived quotes and generic DCF inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Caterpillar uses internal pricing models for Level 3 non-U.S. pension assets (insurance contracts) based on management's judgment of market participant assumptions, including annuity cash flows, discount rates, inflation, and insurance-market pricing. Lockheed Martin uses discounted cash flow models and indicative quotes from brokers/vendors for its Level 3 fixed income investments when observable inputs are lacking, with key inputs being projected cash flows and discount rates. These points match the original answer. (2) There are no numeric values, dates, or calculations in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense, but the description of inputs is precise and consistent—thus scored as 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes valuation approaches across two different companies, asset types (pension vs. fixed income), and methodologies (pricing models vs. DCF and quotes), drawing a valid contrast. The only minor shortcoming is that the LLM slightly emphasizes 'insurance-specific market assumptions' for Caterpillar and 'market-derived quotes' for Lockheed Martin, which adds interpretive nuance not explicitly in the ground truth, but this does not distort the facts and is a reasonable inference. (4) The answer is fully contextually relevant, directly addressing the comparison of inputs and approaches for Level 3 assets at both firms. Overall, the response is factually correct, comprehensive, and semantically equivalent to the original answer, warranting a 9/10 due to slight interpretive phrasing but no material errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 472,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How might the expiration of Enbrel's formulation patents in 2037 impact Pfizer's Specialty Care segment revenue concentration risk, especially considering Bristol Myers Squibb's external innovation strategy focused on future pipeline assets?",
      "original_answer": "Enbrel remains a key product in Pfizer's Specialty Care segment, where it is listed among major inflammation & immunology offerings. The expiration of its formulation patents in 2037 could expose Pfizer to increased generic competition, potentially exacerbating revenue concentration risk if other pipeline or partnered products have not sufficiently diversified the segment's portfolio by then. Meanwhile, Bristol Myers Squibb's external innovation strategy, which emphasizes acquiring and developing disruptive therapies beyond internal R&D, may position it to enter the post-patent market with new assets, assuming favorable clinical and regulatory outcomes. This dynamic could shift competitive positioning in the inflammation & immunology space if BMY successfully brings alternative therapies to market ahead of the 2037 timeline.",
      "llm_answer": "Enbrel (etanercept) is listed as one of the core inflammation‑and‑immunology products in Pfizer’s Specialty Care portfolio, and its U.S. formulation patents do not expire until 10 October 2037 (see Pfizer 10‑K page 11).  When those patents lapse, Pfizer will lose the exclusivity that currently protects a sizable share of Specialty Care revenue, heightening the segment’s exposure to a smaller set of remaining products and therefore increasing its revenue‑concentration risk (Item 1A‑Risk Factors).  By contrast, Bristol Myers Squibb explicitly emphasizes an “external‑innovation” model that leans on collaborations and future pipeline assets to broaden its product base, a strategy that mitigates its own concentration risk and underscores the pressure on Pfizer to diversify beyond Enbrel as its patent protection ends (BMY 10‑K pages 9‑13).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Enbrel is a core product in Pfizer's Specialty Care segment, its formulation patents expire on October 10, 2037 (specific date and year match factual data), and this expiration will increase revenue concentration risk due to loss of exclusivity. The reference to Pfizer’s 10-K page 11 and BMY’s 10-K pages 9–13 adds document-level precision. (2) Quantitative accuracy is perfect: the date 'October 10, 2037' is correctly cited, and no other numbers (e.g., revenue figures) are claimed, avoiding overstatement. Format and specificity meet or exceed ground truth. (3) Multi-hop reasoning is sound: the model correctly links Enbrel’s patent cliff to Pfizer’s revenue concentration risk and contrasts it with Bristol Myers Squibb’s external innovation strategy as a mitigating approach to similar risks. It infers competitive implications without overreaching. (4) The only minor gap is that the LLM does not explicitly state that BMY could enter the post-patent market with new assets before 2037, which is a nuanced but important point in the original about shifting competitive dynamics. However, the core insight — that BMY’s strategy positions it better against concentration risk — is preserved. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent, directly addressing all parts of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 403,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How do AIG's market risk stress testing practices compare with COF's credit loss forecasting methods in terms of their reliance on scenario-based modeling and sensitivity analysis?",
      "original_answer": "AIG employs stress testing as part of its market risk management to evaluate the impact of adverse market developments, including through sensitivity analysis and scenario analysis, which are aligned with its corporate risk appetite. This includes analyzing the effects of hypothetical shocks to interest rates, credit spreads, and equity prices. On the other hand, COF uses scenario-based forecasting models to estimate its allowance for credit losses (ACL), which totaled $13.0 billion as of December 31, 2024, incorporating both quantitative forecasts and qualitative adjustments for current and forward-looking economic conditions. Both firms rely on scenario and sensitivity analysis, but AIG applies these techniques to market risk exposures while COF integrates them into credit risk modeling for consumer loan portfolios.",
      "llm_answer": "AIG’s market‑risk framework is built around extensive scenario‑based stress testing. It runs firm‑wide stress tests, separate sensitivity analyses (single‑factor shocks) and multi‑factor scenario analyses to gauge the impact of both moderate and severe market moves (see Goldman Sachs 10‑K pages 111‑113). In contrast, Capital One’s credit‑loss allowance is generated primarily from quantitative loss‑forecasting models that use statistical analyses and economic‑condition forecasts, supplemented by qualitative management judgments, rather than a formal scenario‑or sensitivity‑analysis regime (see COF 10‑K page 135). Thus AIG relies heavily on scenario‑based modeling and sensitivity testing, whereas COF’s credit‑loss methodology leans on statistical forecasting with limited use of explicit scenario or sensitivity analysis.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains no explicit numeric values, so quantitative accuracy is not applicable—however, since there are no incorrect numbers, it does not detract from accuracy. The core issue lies in qualitative inaccuracy: the LLM incorrectly states that COF (Capital One) does *not* use scenario or sensitivity analysis in its credit loss forecasting, directly contradicting the ground truth, which confirms that COF *does* use scenario-based forecasting models for ACL estimation, incorporating forward-looking economic conditions. The LLM also incorrectly cites the Goldman Sachs 10-K (pages 111–113) as a source for AIG’s practices, which is a clear factual error—this undermines entity and source accuracy. While the LLM correctly identifies that AIG uses scenario and sensitivity analysis for market risk, it fails to accurately represent COF’s methodology, leading to an incorrect comparative conclusion. The ground truth emphasizes that *both* firms use scenario and sensitivity analysis, albeit in different risk domains (market vs. credit), but the LLM falsely differentiates them by claiming COF lacks such practices. This represents a critical failure in multi-hop reasoning and synthesis, as the comparison is central to the question. Contextual relevance is moderate—the response addresses the right topic areas but misrepresents a key entity’s practices due to incorrect sourcing and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 388,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Qualcomm's exposure to EAR regulations on advanced semiconductor technologies compare with AMD's specific constraints on exporting Versal VC2602 and VE2602 FPGAs to China, given both companies' involvement in high-performance computing markets?",
      "original_answer": "Qualcomm's business and products, including those of its customers and licensees, are subject to a broad range of regulations, including the U.S. Export Administration Regulations (EAR), which govern the export and re-export of advanced technologies, potentially affecting its business operations and results. In contrast, AMD faces specific export constraints under EAR, including requirements to file a Notified Advanced Computing (NAC) notification 25 days before shipping certain Versal VC2602 and VE2602 FPGAs to China or to customers outside the U.S. whose ultimate parent is headquartered in a D5 country, including China. These FPGAs are part of AMD's Data Center segment, which includes Field Programmable Gate Arrays (FPGAs) and other adaptive computing products. While both companies are impacted by EAR regulations, AMD's exposure is more directly constrained in terms of specific product lines and geographic markets, particularly affecting its ability to serve Chinese customers without prior regulatory approval, whereas Qualcomm's exposure is more diffuse across its broader regulatory risk profile.",
      "llm_answer": "Qualcomm’s risk discussion notes that its chips and related services are covered by the U.S. Export Administration Regulations (EAR) – the same rules that govern “advanced semiconductor technologies” – so any change in the interpretation or enforcement of the EAR could affect the export of many of its products and require new licences or compliance programmes (see QCOM 10‑K p. 35).  \n\nAMD, by contrast, is subject to very specific BIS controls on a handful of high‑performance computing items: the Instinct MI250/MI300‑class GPUs and the Versal VC2802/VE2802 FPGAs cannot be shipped to China (or to customers whose ultimate parent is in a D5 country) without a licence, and shipments of the Versal VC2602 and VE2602 FPGAs must be preceded by a Notified Advanced Computing (NAC) filing that could result in a prohibition or licence requirement (see AMD 10‑K p. 33).  \n\nThus Qualcomm faces a broader, technology‑wide exposure to EAR rules, whereas AMD’s exposure is limited to a defined set of FPGA and GPU products that require explicit licences or advance notifications before export to China.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core distinction between Qualcomm's broad exposure to EAR regulations and AMD's specific product-level constraints. It correctly identifies that Qualcomm faces a wide-ranging regulatory risk under EAR affecting many products, while AMD has targeted restrictions on certain FPGAs and GPUs. However, there is a minor factual inaccuracy: the LLM incorrectly states that the Versal models subject to NAC filing are VC2602 and VE2602 (correct in ground truth), but then references VC2802/VE2802 as the non-ship items, which are not mentioned in the original answer. This appears to be a mix-up or typo, though the overall regulatory mechanism (NAC filing requirement for VC2602/VE2602) is accurately described. The mention of Instinct MI250/MI300-class GPUs is additional context not in the original answer but is factually plausible and does not contradict it. The reasoning is sound, with proper multi-hop synthesis between the two companies' 10-K disclosures and correct interpretation of EAR implications. The answer is semantically equivalent in intent and meaning, with only the specific FPGA model numbers slightly off, which slightly affects quantitative and qualitative accuracy but not the overall correctness. Contextual relevance is excellent, directly addressing the comparative exposure question with appropriate detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 381,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does CMCSA's relinquishment of voting rights in Hulu contrast with META's dual-class stock structure in terms of control retention strategies?",
      "original_answer": "CMCSA relinquished substantially all voting rights associated with its investment in Hulu in 2019, including board seats, in exchange for a put/call arrangement with Disney that guaranteed a minimum equity value of $27.5 billion for its interest and resulted in an $8.6 billion payment from Disney in 2023. This contrasts with META's dual-class stock structure where Class B shares carry 10 votes per share compared to 1 vote for Class A shares, allowing certain stockholders to maintain significant voting power while owning a minority of economic interests. CMCSA's approach involved transferring control to Disney in exchange for financial guarantees, whereas META retains internal control differentiation through its stock classification framework.",
      "llm_answer": "Comcast’s 2019 agreements with Disney required it to give up its board seats and “substantially all voting rights” in Hulu, handing full operational control to Disney while retaining only an economic stake and a put‑call option to sell the interest later 【page_85】. In contrast, Meta’s charter creates three share classes in which Class B shares carry ten votes per share and can be converted to one‑vote Class A shares, allowing insiders to keep a disproportionate voting bloc while issuing non‑voting Class C shares to the market 【page_82】. Thus, Comcast relinquished voting power to cede control, whereas Meta deliberately structures its equity to preserve control through super‑voting shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: CMCSA relinquished voting rights and board seats in Hulu in 2019, retained only economic interest and a put/call option, and Disney assumed control. META's dual-class structure with 10 votes per Class B share versus 1 for Class A is accurately described. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or dollar amounts are stated. While the $27.5B minimum equity value and $8.6B payment from Disney in 2023 are omitted, these are specific financial details not strictly necessary to answer the contrast in control strategies. Their absence prevents a perfect 10 on correctness but does not undermine the factual core. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across CMCSA’s Hulu divestiture of control and META’s internal governance structure to highlight contrasting control retention strategies—ceding control for financial guarantees vs. maintaining control via super-voting shares. (4) Semantic equivalence is strong; wording differs but meaning aligns. The LLM mentions Class C shares (non-voting), which adds slight detail beyond the original but is factually correct and enhances the explanation. Only minor incompleteness prevents full marks, hence 9/10 on correctness and qualitative accuracy. Contextual relevance is perfect—directly addresses the question with precise, relevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 407,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Goldman Sachs' $113.9 billion in broker-dealer assets influence its approach to managing conflicts of interest under Regulation Best Interest, compared to Morgan Stanley's compliance framework for the same regulatory obligations?",
      "original_answer": "Goldman Sachs manages $113.9 billion in broker-dealer assets as of December 2024, which necessitates a robust compliance framework under Regulation Best Interest to ensure recommendations align with retail customers' best interests, especially given the SEC's requirement that broker-dealers avoid placing their own interests ahead of clients. This asset size increases the complexity of conflict management, particularly in areas like variable insurance product sales and investment strategy recommendations. Similarly, Morgan Stanley explicitly states it is subject to Regulation Best Interest, which governs its broker-dealer sales practices and customer relationships, including conflict mitigation. Both firms must maintain stringent internal controls, but Goldman's larger broker-dealer asset base may require more extensive monitoring and disclosure protocols to satisfy the same impartial conduct standards outlined in the regulation, particularly as both firms face potential litigation and regulatory scrutiny tied to compliance.",
      "llm_answer": "Goldman Sachs reports that its “major broker‑dealer subsidiaries” hold roughly **$113.9 billion** of assets (see the GCLA table on page 106).  Because such a large broker‑dealer balance sheet is integral to the firm’s overall liquidity and capital framework, Goldman Sachs manages potential conflicts of interest by embedding the R‑Best‑Interest requirements within its broader risk‑limits, liquidity‑outflow models and subsidiary‑funding policies that restrict the use of broker‑dealer funds unless legally permitted and free of regulatory or tax constraints (see the discussion of liquidity limits and inter‑company funding on pages 104‑107).  \n\nMorgan Stanley, by contrast, addresses Regulation Best Interest through a more discrete compliance program for its broker‑dealer units (MS Co. and MSSB), explicitly describing the need to disclose services, standards of conduct and conflicts to retail customers and to follow SEC, FINRA and state‑level best‑interest rules (see the R‑Best‑Interest description on page 9).  Thus, Goldman Sachs’ massive broker‑dealer asset base leads it to manage conflicts as part of its enterprise‑wide liquidity and capital governance, whereas Morgan Stanley relies on a dedicated broker‑dealer compliance framework that focuses on disclosure and fiduciary‑standard enforcement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $113.9 billion figure for Goldman Sachs' broker-dealer assets is correct and matches the original answer. No other numerical values are present, and the reference to December 2024 in the ground truth is implied contextually though not explicitly stated in the LLM response—this is a minor omission but does not detract from accuracy. (2) The LLM correctly identifies both Goldman Sachs and Morgan Stanley as subject to Regulation Best Interest and accurately contrasts their compliance approaches. It adds specific detail about Goldman embedding conflict management within enterprise liquidity and capital governance (referencing pages 104–107), and Morgan Stanley using a more discrete, disclosure-focused compliance framework (referencing page 9), which reflects deeper document insight. (3) The multi-hop reasoning is sound: it synthesizes asset size with regulatory obligation and infers differing structural responses between the two firms. While the original answer emphasizes litigation risk and impartial conduct standards, the LLM substitutes this with operational mechanisms (e.g., risk limits, inter-company funding), which are valid and consistent with the regulation’s intent. (4) The semantic meaning is equivalent: both answers conclude that Goldman’s larger asset base leads to a more integrated, systemic approach to conflict management, while Morgan Stanley employs a dedicated compliance framework. The LLM enhances the response with document-specific page references, suggesting fidelity to source material. Only a minor lack of explicit mention of 'retail customers' or 'SEC impartial conduct standards' prevents a perfect 10, but these are implied in context. Thus, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1610,
        "completion_tokens": 499,
        "total_tokens": 2110
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How might Intel's IDM 2.0 strategy, which includes expanding manufacturing capacity with the aim of attracting foundry customers, be affected by Samsung's development of in-house integrated circuits, and what implications could this have for Qualcomm's semiconductor business given its reliance on external integrated circuit customers?",
      "original_answer": "Intel's IDM 2.0 strategy involves significant capital expenditures to expand manufacturing capacity with the goal of attracting foundry customers (chunk 1). However, Samsung, a key potential customer for Intel's foundry services, is developing its own integrated circuit products, which it may increasingly use in its own devices and potentially sell to third parties in competition with others in the market (chunk 2). This vertical integration by Samsung could limit Intel's ability to secure foundry business from Samsung, making Intel's IDM 2.0 capacity investments riskier and potentially leading to underutilized facilities or increased pricing pressure to attract other customers. Qualcomm, which derives a significant portion of its revenues from sales of its own integrated circuit products to OEMs (chunk 3), could face intensified competition if Samsung's in-house chips gain market traction, particularly in segments like mobile and automotive. Additionally, if Intel responds by lowering prices to attract other foundry clients, it could indirectly affect the broader semiconductor pricing environment, potentially impacting Qualcomm's cost structure or competitive positioning.",
      "llm_answer": "Intel’s IDM 2.0 plan hinges on adding fab capacity to sell “foundry‑as‑a‑service” wafer runs to other chip makers.  Samsung’s push to design and produce its own integrated circuits directly cuts into that addressable market—Intel will face a smaller pool of external customers and greater risk of under‑utilized capacity as Samsung competes both as a customer and as a rival foundry (Intel 10‑K p.53‑p.54).  Because Qualcomm’s semiconductor business (QCT) relies on selling chips to third‑party OEMs and licensees, Samsung’s vertical integration could strip away a key buyer, pressuring Qualcomm’s revenue and margins (Qualcomm 10‑K p.19‑p.20).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core multi-hop reasoning required by the question. (1) All factual elements are correct: Intel's IDM 2.0 strategy involves expanding manufacturing capacity to attract foundry customers; Samsung's development of in-house ICs reduces its reliance on external foundries, thereby limiting Intel's potential customer base and increasing risk of underutilized capacity; Qualcomm's semiconductor business (QCT) depends on selling chips to OEMs, making it vulnerable to Samsung's vertical integration. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The reasoning is sound: the LLM correctly synthesizes information across Intel and Qualcomm 10-Ks, identifying the competitive dynamics between foundry strategy, vertical integration, and market competition. It accurately infers that Samsung acts both as a potential customer and competitor, which aligns with the ground truth. (4) The only minor omission is that the original answer notes the broader implication that Intel might lower prices to attract other foundry clients, potentially affecting the overall pricing environment and indirectly impacting Qualcomm’s cost structure or positioning. This layer of indirect pricing pressure is missing in the LLM response, slightly reducing completeness in qualitative synthesis. However, the core logic and entities are correctly identified and linked. Thus, correctness and qualitative accuracy are slightly docked to 9, but contextual relevance remains perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 434,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How does VZ's monetization of wireless tower infrastructure through exclusive arrangements with American Tower Corporation compare to NFLX's reliance on exclusive content rights in terms of upfront capital impact and long-term strategic control?",
      "original_answer": "VZ received an upfront payment of $5.0 billion from American Tower Corporation in 2015 for exclusive rights to 11,300 wireless towers, while retaining operational control through subleased capacity and continuing depreciation of the towers. This allowed VZ to monetize infrastructure assets while maintaining network usage flexibility. In contrast, NFLX pursues exclusive content rights to differentiate its service, which requires ongoing licensing costs and exposes the company to risks of content withdrawal and increased programming expenses. Unlike VZ's capital-generating tower arrangement, NFLX's exclusive content strategy represents a cost center rather than a revenue source, with no upfront payments received and instead involves financial commitments to secure programming advantages.",
      "llm_answer": "Verizon’s tower‑monetization deals involve a single, large cash outlay – $5 billion paid to American Tower in 2015 and a $2.8 billion upfront payment to Vertical Bridge in 2024 – that is recorded as prepaid rent and a financing obligation, but give Verizon a 10‑year (with renewal options) lease‑back of capacity and an option to acquire the towers after the lease, preserving long‑term control of a critical network asset. Netflix’s exclusive‑content model, by contrast, requires substantial upfront licensing and production spend (the filing notes that Netflix “focuses on securing certain exclusive rights” and that costs are rising), but the control is limited to the term of the license and can be lost if rights are withdrawn, offering less durable strategic control than Verizon’s tower arrangement.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. It incorrectly states that VZ received a $5 billion payment *from* American Tower in 2015 (correct per ground truth), but then adds a $2.8 billion upfront payment to Vertical Bridge in 2024, which is not mentioned in the original answer and introduces unsupported new data. The ground truth does not reference any 2024 transaction or Vertical Bridge, making this a factual error. Additionally, the characterization of the $5 billion as a 'cash outlay' is incorrect — it was an *inflow* to VZ, not an outlay. The LLM misrepresents the direction of cash flow.\n\n2) Quantitatively, only the $5 billion figure from 2015 is accurate and correctly attributed. The addition of the $2.8 billion payment introduces false precision and undermines the factual basis of the response. There are no calculations required, but the misuse of financial direction (outlay vs inflow) is a critical error.\n\n3) Qualitatively, the reasoning about strategic control is sound: the LLM correctly contrasts VZ’s retained operational control and lease-back structure with NFLX’s time-limited content rights and vulnerability to withdrawal. It captures the core contrast in strategic durability. However, it mischaracterizes VZ’s arrangement as a 'financing obligation' and 'prepaid rent', which are not in the original and may reflect misinterpretation of accounting treatment, though such details could be present in filings beyond the scope of the ground truth.\n\n4) Contextually, the answer is highly relevant, addressing both the capital impact and strategic control dimensions of the question. It attempts a direct comparison between VZ’s infrastructure monetization and NFLX’s content strategy. However, due to the incorrect inclusion of a second transaction and reversal of cash flow direction, the factual foundation is compromised. While the qualitative insight about control is strong, the quantitative inaccuracies reduce overall correctness. The answer would have scored higher if limited to the 2015 American Tower deal and correctly framed as a capital-generating event.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 567,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the Tax Reform Act's GILTI provisions impact KO's effective tax rate in 2022, and how does this contrast with the effect of the corporate income tax rate reduction in the Philippines on PEP's operations in that market?",
      "original_answer": "KO's effective tax rate in 2022 was impacted by the Tax Reform Act's GILTI provisions, which required the inclusion of foreign subsidiaries' excess earnings in U.S. income tax returns, contributing to a 1.2% impact on KO's effective tax rate through pretax charges of $710 million related to equity method investee impairments. In contrast, PEP's operations in the Philippines experienced low-single-digit growth, and the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a favorable impact on PEP's effective tax rate, lowering it by an unspecified but notable amount. This illustrates how the same U.S. tax reform had divergent effects—raising KO's tax burden through GILTI while enabling PEP to benefit from lower local corporate taxes.",
      "llm_answer": "The Tax Reform Act’s GILTI rules forced Coca‑Cola (KO) to recognize the U.S. tax on excess earnings of its foreign subsidiaries in the year the earnings were earned, which pushed the company’s full‑year provision upward and lifted its 2022 effective tax rate (the GILTI impact is reflected in the provision for that year). In contrast, the Philippines’ reduction of its corporate income‑tax rate lowered the tax burden on PepsiCo (PEP) in that market, offsetting other upward pressures (such as GILTI‑related repatriation costs) and helping to keep PEP’s effective tax rate lower in the Philippines.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the impact of GILTI on KO's effective tax rate in 2022 and the favorable effect of the corporate tax rate reduction in the Philippines on PEP. However, it omits key quantitative details from the ground truth: the 1.2% impact on KO's effective tax rate and the $710 million pretax charge related to equity method investee impairments. These are significant omissions in a multi-hop financial question requiring precise data. The LLM mentions 'lifted its 2022 effective tax rate' but does not quantify it, reducing quantitative accuracy. (2) The Philippines tax rate reduction was enacted in Q1 2021 (per ground truth), but the LLM does not mention this date, instead focusing on the ongoing effect in 2022. While the general direction of impact is correct, the lack of specific numbers and dates lowers precision. (3) The reasoning is sound: the model correctly contrasts U.S. GILTI provisions increasing KO's tax burden with local tax cuts benefiting PEP, showing proper multi-hop synthesis between U.S. tax policy and foreign operations. It also notes that PEP's lower local taxes helped offset GILTI-related costs, which aligns with the contrast implied in the original answer. (4) Despite missing specific figures, the LLM captures the core qualitative contrast and entities (KO, PEP, GILTI, Philippines tax cut, 2022). Wording differs but meaning is semantically close. Scores reflect strong reasoning and relevance but partial quantitative inaccuracy due to missing metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 421,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does the $1.3 billion in restricted retained earnings at Nicor Gas impact Southern Company's ability to receive dividends from its subsidiaries, given that Nicor Gas is a key subsidiary under Southern Company Gas?",
      "original_answer": "Nicor Gas, as a regulated subsidiary under Southern Company Gas, has $1.3 billion in retained earnings that are restricted from being distributed as dividends or loans to affiliates. This restriction directly limits Southern Company's ability to receive dividend payments from Nicor Gas, which in turn affects the consolidated cash flows and financial flexibility of Southern Company, especially since Southern Company relies on equity earnings and dividends from its subsidiaries for a significant portion of its income.",
      "llm_answer": "The filing notes that, by regulation, Nicor Gas may distribute dividends or make loans only out of the portion of its retained earnings that is **not** restricted, and it is prohibited from making “money‑pool” loans to affiliates. At 12/31/2021, $1.3 billion of Southern Company Gas’s subsidiary retained earnings were classified as restricted for dividend payment, meaning that amount cannot be paid out to Southern Company. Consequently, Southern Company’s ability to receive dividends from Nicor Gas (and therefore from Southern Company Gas) is capped at the unrestricted earnings – the $1.3 billion restriction directly limits the dividend cash flow that can flow to the parent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $1.3 billion restricted retained earnings figure is correctly stated, and the date (12/31/2021) is precise and consistent with typical SEC filing disclosures. While the original answer does not specify the date, the LLM adds this detail without contradicting the ground truth—this is a minor enhancement rather than an error. (2) The explanation correctly identifies that Nicor Gas, as a regulated subsidiary under Southern Company Gas, cannot distribute restricted earnings as dividends or loans to affiliates, directly limiting Southern Company's dividend inflows. (3) The multi-hop reasoning is sound: it connects Nicor Gas’s regulatory constraints → restricted retained earnings → impact on dividend capacity → effect on Southern Company’s cash flow, which matches the logical chain in the original answer. (4) The only minor gap is that the LLM does not explicitly mention Southern Company’s reliance on subsidiary dividends for income (a nuance in the original), but it does convey the core financial limitation. Wording differs slightly but maintains semantic equivalence. All entities—Nicor Gas, Southern Company Gas, Southern Company—are correctly identified and hierarchically accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 360,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How do Tesla's and GM's compliance costs related to evolving vehicle safety standards compare, given the increasing regulatory complexity under the National Traffic and Motor Vehicle Safety Act?",
      "original_answer": "Tesla faces rising compliance costs due to evolving international vehicle safety standards, particularly for its Autopilot and FSD (Supervised) features, which must meet varying requirements across jurisdictions and may delay or restrict functionality. GM similarly notes that compliance with the National Traffic and Motor Vehicle Safety Act is costly, with global regulatory divergence—especially between North American and UN-ECE based standards—adding complexity and expense to vehicle development. Both companies emphasize the financial burden of maintaining compliance as safety standards evolve and expand globally, with GM specifically highlighting the lack of harmonization as a key driver of increased costs.",
      "llm_answer": "Tesla’s filing only notes that the “rapidly changing” vehicle‑safety and autonomous‑driving regulations – including the patchwork of standards created by the National Traffic and Motor Vehicle Safety Act – could generate “substantial … expenses, delays or fines,” but it does not quantify those costs. In contrast, GM’s filing spells out the dollar impact of meeting evolving safety‑related standards, reporting that it spent **$2.0 billion (2024), $0.5 billion (2023) and $1.0 billion (2022) on credits** and recorded **$1.0 billion, $0.7 billion and $0.5 billion** as compliance‑related costs in automotive cost of sales. Thus, GM provides concrete, multi‑hundred‑million‑dollar compliance cost figures, whereas Tesla’s costs are described only qualitatively.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The dollar amounts cited for GM—$2.0 billion (2024), $0.5 billion (2023), $1.0 billion (2022) on credits, and $1.0 billion, $0.7 billion, $0.5 billion in compliance-related costs—are not present in the original answer (ground truth). The ground truth does not provide any specific financial figures for either Tesla or GM; it only states that both companies face rising compliance costs due to regulatory complexity. Therefore, the LLM fabricates precise multi-billion-dollar figures and assigns them to specific years and line items (e.g., 'credits', 'automotive cost of sales'), which are unsupported by the source. (2) Completeness: While the question asks for a comparison of Tesla’s and GM’s compliance costs related to evolving safety standards, the LLM incorrectly implies that GM quantifies these costs in its filings, which the ground truth does not confirm. Thus, the answer fails to accurately reflect the available information. (3) Entity Accuracy: The companies (Tesla, GM) and regulatory framework (National Traffic and Motor Vehicle Safety Act) are correctly identified, and the mention of Autopilot/FSD for Tesla aligns with the original. However, the introduction of 'UN-ECE based standards' and 'credits' is absent from the original and not verified. (4) Reasoning: The multi-hop reasoning is flawed because the LLM invents a quantitative contrast (GM provides numbers, Tesla doesn’t) that is not grounded in the truth data. The original answer makes no such distinction in reporting practices—both describe costs qualitatively. (5) Semantic Equivalence: The LLM answer diverges significantly in meaning by introducing false precision and a misleading comparison. While it captures the general theme of rising compliance costs and regulatory complexity, the fabricated data renders the response factually incorrect. The contextual relevance is moderate because it addresses the right topic and companies, but the invented figures severely compromise reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 560,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does General Dynamics' deferral of $305 million in other contract costs under FAR regulations compare to Raytheon Technologies' exposure to cost overruns under its fixed-price U.S. government contracts, given the differing financial risk profiles associated with these contract cost management approaches?",
      "original_answer": "General Dynamics defers $305 million in other contract costs under FAR regulations that govern cost allowability and allocation to U.S. government contracts, with recovery expected through existing backlog and follow-on contracts. These costs are not currently allocable but are maintained as assets pending future allocation. In contrast, Raytheon Technologies faces financial risk on its fixed-price contracts, particularly firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns without reimbursement. This creates a more direct financial exposure compared to General Dynamics’ deferred cost model. The difference in risk stems from the fact that FAR-regulated cost recovery allows General Dynamics to defer recognition of certain costs until allocable, while Raytheon must absorb overruns on fixed-price contracts, which constitute a significant portion of its U.S. government contract portfolio.",
      "llm_answer": "General Dynamics’ 2021 financial statements show that it has deferred $305 million of “other contract costs” because, under the Federal Acquisition Regulation, those costs cannot yet be charged to U.S. government contracts and will be recovered only as the contracts are performed. In contrast, Raytheon Technologies discloses that it is exposed to roughly $2 billion (≈ $1.5‑$2.0 billion) of potential cost overruns on its fixed‑price U.S. government contracts, meaning that a much larger portion of its earnings could be eroded if actual costs exceed contract estimates. Thus, General Dynamics’ deferred‑cost amount is modest relative to Raytheon’s far larger cost‑overrun exposure, reflecting a comparatively lower financial‑risk profile for GD’s contract‑cost management approach.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies General Dynamics' deferral of $305 million in other contract costs under FAR regulations and explains that these costs are not currently allocable but will be recovered as contracts are performed—this aligns with the ground truth. However, the LLM introduces a figure of approximately $1.5–$2.0 billion in potential cost overruns for Raytheon Technologies, which is not present in the original answer and lacks sourcing or confirmation from the knowledge graph. This number appears to be fabricated or hallucinated, significantly undermining quantitative accuracy. (2) The $305 million figure for General Dynamics is accurate and correctly contextualized within FAR and cost recovery expectations. But the Raytheon cost-overrun exposure of ~$2 billion is not supported by the original answer, which only states that Raytheon bears full burden of overruns on firm fixed-price (FFP) contracts without specifying a dollar amount. This is a major factual deviation. (3) The reasoning is partially sound: the LLM correctly contrasts deferred cost recovery (lower immediate risk) with fixed-price contract exposure (higher risk), and draws a logical comparison in terms of financial risk profiles. It synthesizes the differing implications of cost-type vs fixed-price contracts appropriately. However, the introduction of an unsupported $2 billion exposure figure breaks the multi-hop chain’s reliability, as it adds a false quantitative comparison. (4) The contextual relevance is high—the answer addresses the core contrast in risk profiles and contract management approaches. Qualitative accuracy is moderate because the conceptual framework is correct, but quantitative accuracy is low due to the invented Raytheon figure. Correctness score is reduced to 6 due to this significant factual error, despite otherwise solid reasoning and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 512,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the compound annual growth rate (CAGR) of Intel's Taiwan revenue from 2019 to 2021 compare to Apple's Greater China segment revenue growth over the same period, given that Taiwan is included within Apple's Greater China reporting?",
      "original_answer": "Intel's Taiwan revenue grew from $10,058 million in 2019 to $13,461 million in 2021, representing a CAGR of approximately 15.6%. Apple's Greater China revenue increased from $40,308 million in 2019 to $68,366 million in 2021, yielding a CAGR of approximately 30.8%. Therefore, Apple's Greater China segment revenue grew at more than double the rate of Intel's Taiwan-specific revenue during this period.",
      "llm_answer": "Intel’s Taiwan revenue grew from $10,058 million in 2019 to $13,461 million in 2021, giving a compound annual growth rate of roughly **15‑16 %** (CAGR ≈ 15.7 %).  \n\nApple’s Greater China net sales rose from $40,308 million in 2019 to $74,200 million in 2021, producing a CAGR of about **35‑36 %** (CAGR ≈ 35.7 %).  \n\nThus, Apple’s Greater China segment grew at more than twice the annual rate of Intel’s Taiwan revenue over the same period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in Apple's 2021 Greater China revenue and the resulting CAGR calculation. The ground truth states Apple's Greater China revenue was $68,366 million in 2021, but the LLM incorrectly reports $74,200 million. This leads to an erroneous CAGR of approximately 35.7% instead of the correct 30.8%. Intel's figures ($10,058M to $13,461M) are accurate, and its CAGR is correctly approximated (~15.6% vs LLM's 15.7%). (2) Calculations: Intel's CAGR is accurate (CAGR = (13,461/10,058)^(1/2) - 1 ≈ 15.6%). Apple's correct CAGR is (68,366/40,308)^(1/2) - 1 ≈ 30.8%, but LLM computes it as ~35.7% based on incorrect input. This is a major quantitative error. (3) Multi-hop reasoning: The model correctly identifies the need to calculate CAGRs for both companies over 2019–2021 and compare them. It also acknowledges that Taiwan is part of Apple’s Greater China segment, which is contextually appropriate. However, due to the incorrect Apple revenue figure, the conclusion that Apple grew at 'more than twice' the rate is exaggerated (30.8% vs 15.6% is about 1.97x, not 'more than double'). (4) Scores justified: Correctness is 4 due to major financial data inaccuracy affecting core comparison; Quantitative accuracy is low (3) due to wrong dollar amount and CAGR; Qualitative accuracy is moderate (5) — reasoning structure is sound but based on flawed data; Contextual relevance is high (8) — addresses the right entities, time frame, and comparative intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 416,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "Given Alphabet's $70 billion share repurchase authorization targeting Class A and Class C shares in 2024, how might the repurchase activity influence Class B shareholders' decisions to convert shares to Class A, especially in light of Meta's disclosure of a significantly larger Class A share base compared to Class B outstanding shares?",
      "original_answer": "Alphabet's $70 billion share repurchase program, which includes Class A shares, could reduce the supply of Class A shares in the market, potentially increasing their relative value. This may incentivize Class B shareholders—who hold shares with 10x voting rights but often face restrictions on holding Class A shares after conversion—to convert and sell Class A shares before further scarcity and price appreciation occur. However, Meta's 2024 disclosure shows that it has 2,189,898,148 Class A shares and only 343,761,117 Class B shares outstanding, indicating a much larger float of Class A shares in the market. This abundance of Class A shares at Meta may temper conversion urgency compared to Alphabet, as Class A shares at Meta are likely more liquid and less affected by repurchase-induced scarcity.",
      "llm_answer": "Alphabet’s board approved an additional $70 billion program to buy back Class A and Class C shares (with $44.7 billion still available at year‑end 2024) and its charter allows every Class B share to be converted 1‑for‑1 into a Class A share 【page 82】.  By removing a sizable amount of Class A stock from the market, the repurchase can lift the price of the remaining Class A shares, making conversion attractive to Class B holders who want to capture that premium even though they would give up the ten‑vote per‑share voting advantage.  Meta’s filing shows a far larger pool of Class A shares (≈2.19 billion) versus Class B shares (≈0.34 billion)【page 1】, indicating that a substantial Class A base can coexist with control‑preserving structures and suggesting that Alphabet’s Class B owners may feel comfortable converting without jeopardizing governance while benefiting from the buy‑back‑driven price uplift.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Alphabet's $70 billion share repurchase includes Class A and Class C shares; Class B shares can be converted 1-for-1 to Class A; Meta has approximately 2.19 billion Class A shares and 0.34 billion Class B shares outstanding—these match the ground truth values (2,189,898,148 and 343,761,117). The mention of $44.7 billion remaining at year-end 2024 is additional context not in the original answer but does not contradict it and may come from the source document. (2) Quantitative accuracy is perfect: numbers are correctly reported or appropriately rounded (e.g., ≈2.19 billion), and no calculation errors are present. (3) Reasoning is sound: the LLM correctly infers that reducing Class A supply via buybacks could increase their price, incentivizing Class B holders to convert and capture gains despite losing voting power. It appropriately contrasts Alphabet’s situation with Meta’s, noting that Meta’s large Class A float suggests such conversions can occur without destabilizing control—this supports the idea that Alphabet’s Class B holders may feel similarly secure. (4) The only minor shortcoming is that the LLM slightly reframes the Meta comparison as evidence that conversion doesn’t threaten governance, while the original emphasizes Meta’s large Class A base as a reason why scarcity effects (and thus conversion urgency) would be *less* pronounced at Meta than at Alphabet. This nuance is present but less clearly articulated. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop reasoning across companies and share structures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 459,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the treatment of dividend equivalents in RSU awards differ between PepsiCo and Philip Morris International in terms of vesting conditions and financial obligations as of 2023?",
      "original_answer": "PepsiCo accrues dividend equivalents during the vesting period for both RSUs and PSUs, which are paid out in cash when the award vests. Philip Morris International also accrues dividend equivalents on RSU awards, but its RSUs generally vest on the third anniversary of the grant date and do not carry voting rights. As of December 31, 2023, PMI had $160 million of total unrecognized compensation costs related to non-vested RSU awards, which are being amortized over the restriction period or upon specific life events.",
      "llm_answer": "PepsiCo’s RSU (and PSU) awards accrue dividend‑equivalent cash payments throughout the vesting period, and because those rights are non‑forfeitable they are treated as “participating securities” and are included in earnings‑per‑share calculations; the awards vest after the service period (generally three years) or earlier on death, disability or reaching age 58, and the company carries $441 million of unrecognized compensation cost for the non‑vested awards that will be expensed over a weighted‑average two‑year period【page_92】【page_90】.  \n\nPhilip Morris International’s RSU awards also earn dividend equivalents, but the cash is paid only when the RSU actually vests (typically on the third anniversary of the grant, or earlier on death, disability or age 58); the firm records $160 million of unrecognized compensation cost for non‑vested RSUs, which is expected to be recognized over roughly 17 months (or upon the same early‑termination events)【page_110】【page_110】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both PepsiCo and Philip Morris International (PMI) accrue dividend equivalents on RSU awards, with cash paid upon vesting. It accurately notes PMI’s $160 million of unrecognized compensation cost as of 2023 (matching the ground truth), and correctly states that PMI RSUs typically vest on the third anniversary of the grant date. However, the LLM introduces additional details about PepsiCo’s $441 million unrecognized cost and a weighted-average two-year amortization period, which are not present in the original answer and cannot be verified against the ground truth. While these figures may be accurate, they go beyond the provided truth and introduce unverified quantitative claims. (2) The $160 million figure for PMI is correct and matches the ground truth. The PepsiCo $441 million figure is plausible but not confirmed in the original answer, which does not mention PepsiCo’s compensation cost—making this an over-specification. The '17 months' amortization period for PMI is more precise than the ground truth’s general 'amortized over the restriction period or upon specific life events,' but not contradicted by it. (3) The multi-hop reasoning is sound: the model correctly differentiates between the two companies’ treatment of dividend equivalents and links vesting conditions and financial obligations. It synthesizes vesting triggers (death, disability, age 58) and payout timing correctly for both firms. (4) The answer is contextually excellent, directly addressing vesting conditions and financial obligations. The qualitative reasoning is strong, but the correctness score is reduced slightly due to the unverified PepsiCo financial figure, which affects quantitative accuracy. Overall, the core facts are correct, but the addition of unsupported specifics prevents a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 502,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does DHR's use of NAV and discounted cash flow in valuing private investments compare to LLY's reliance on fair value estimation for acquired intangible assets, considering the inherent subjectivity in both approaches as highlighted in their respective disclosures?",
      "original_answer": "DHR utilizes NAV based on fund manager inputs and applies discounted cash flows, earnings multiples, and third-party appraisals to estimate the fair value of private investments, acknowledging that these methods may not reflect net realizable value or future fair values. LLY, on the other hand, applies fair value estimation to acquired intangible assets such as IPR&D, which required $3.80 billion in charges in 2023 alone, and admits that final valuations may change significantly as fair values are finalized within one year post-acquisition. Both companies recognize the subjectivity involved in fair value estimation, with DHR noting that different methodologies can yield materially different results and LLY emphasizing the need for considerable judgment in determining the fair value of acquired assets, especially under limited access to pre-acquisition data.",
      "llm_answer": "Danaher (DHR) values its venture‑capital, partnership and other private‑investment holdings by using the funds‑manager‑provided net‑asset‑value (NAV) as a practical expedient, and then applies a mix of discounted‑cash‑flow models, earnings multiples, third‑party appraisals or quoted market prices to adjust that NAV — a process the company notes can yield fair‑value estimates that may differ materially depending on the assumptions used. Eli Lilly (LLY), by contrast, records acquired intangible assets at their estimated fair value, which the company says requires “significant estimates and assumptions” about future cash flows and market inputs; this valuation is likewise subjective. Thus, both firms rely on judgment‑laden methods, but DHR’s approach blends NAV with explicit DCF‑type techniques for private assets, whereas LLY’s approach hinges on a broader fair‑value estimate for intangibles that also depends on management’s assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core comparison between DHR and LLY in their use of valuation methods with appropriate emphasis on subjectivity. (1) All factual elements are correct: DHR uses NAV as a practical expedient and supplements it with discounted cash flows, earnings multiples, and third-party appraisals; LLY applies fair value estimation to acquired intangible assets requiring significant judgment. The LLM correctly notes the subjectivity in both approaches. (2) Quantitatively, while the LLM answer does not include the specific $3.80 billion charge for LLY in 2023 mentioned in the ground truth, this is a minor omission that does not undermine the overall correctness. No incorrect numbers are presented, so quantitative accuracy remains high. (3) The multi-hop reasoning is sound: the model correctly synthesizes DHR's private investment valuation approach with LLY's intangible asset valuation, contrasting their methodologies while highlighting the shared reliance on judgment and assumptions. (4) The answer is contextually relevant and directly addresses the question about comparative use of valuation techniques and their inherent subjectivity. The only reason for not scoring a 10 is the omission of the concrete $3.80 billion figure for LLY’s 2023 charges, which adds specificity in the ground truth. However, the semantic meaning and qualitative accuracy remain very strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 391,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does NVIDIA's revenue from Taiwan in 2022 compare to Apple's reported revenue from the Greater China segment, given that Apple's geographic reporting includes Taiwan within Greater China?",
      "original_answer": "NVIDIA reported $8,544 million in revenue from Taiwan in 2022, while Apple reported $74,200 million in net sales from the Greater China segment in the same year. Since Apple explicitly includes Taiwan within its Greater China geographic reporting, NVIDIA's Taiwan-specific revenue constitutes a subset of the broader regional revenue that Apple reports, reflecting different levels of geographic granularity in their respective segment disclosures.",
      "llm_answer": "NVIDIA’s 2022 Form 10‑K does not break out revenue by individual countries, so a specific “Taiwan” figure is not disclosed. Apple’s 2022 10‑K reports net sales of **$74.2 billion** for the “Greater China” segment, which explicitly includes Taiwan (see Note 11, “Segment Information and Geographic Data”). Therefore, while Apple’s Greater China revenue—including Taiwan—is $74.2 billion, NVIDIA’s Taiwan‑only revenue cannot be directly compared because it is not separately reported.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that NVIDIA's 2022 10-K does not break out revenue by Taiwan. According to the ground truth, NVIDIA *did* report $8,544 million in revenue from Taiwan in 2022, which directly contradicts the LLM's claim. This is a major factual error. Apple's reported $74.2 billion (i.e., $74,200 million) in Greater China revenue is correctly cited, matching the original answer. (2) Quantitative accuracy is low because the LLM fails to report NVIDIA's actual Taiwan revenue figure ($8,544 million), instead asserting it is not disclosed. This omission invalidates the comparison. The Apple number is correct and matches the ground truth. (3) The reasoning is partially sound in noting that Apple includes Taiwan in its Greater China segment, which is accurate and relevant. However, the LLM incorrectly concludes that a comparison cannot be made due to lack of disclosure, when in fact the data *is* available for NVIDIA. This breaks the multi-hop synthesis required: comparing NVIDIA’s Taiwan-specific revenue to Apple’s broader regional revenue that includes Taiwan. The model fails to perform this valid comparison due to an incorrect assumption about data availability. (4) Scores reflect the severity of the factual error: correctness is very low (2/10) because the core claim (non-disclosure) is false; quantitative accuracy is similarly low due to missing the key number; qualitative accuracy is slightly higher because the understanding of Apple’s geographic reporting is correct; contextual relevance is moderate as the response addresses the right companies and region, but with flawed execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 453,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the concentrated voting power in CMCSA's Class B common stock compare to the shareholder structure disclosed for GOOGL's Class A common stock in terms of control and ownership distribution?",
      "original_answer": "CMCSA's Class B common stock, held entirely by Brian L. Roberts, represents 33⅓% of the combined voting power with each share carrying 15 votes, creating significant control concentration. In contrast, GOOGL's Class A common stock, with 300,754,904 shares outstanding as of January 25, 2022, is broadly distributed among non-affiliates, with voting rights presumably more dispersed given the large number of shares and absence of similar super-voting structures described for CMCSA. This indicates a stark difference in governance dynamics, with CMCSA maintaining centralized control through Class B shares, while GOOGL's structure suggests more distributed shareholder influence.",
      "llm_answer": "Comcast’s dual‑class structure gives the company a built‑in concentration of voting power: every Class B share carries 15 votes and all 44.6 million Class B shares are owned by a single person, Brian L. Roberts, which translates into roughly one‑third (33 ⅓ %) of the total voting power even though Class B holders represent only about 12 % of the total shares outstanding【page_38†L23-L30】.  \n\nAlphabet’s Class A common stock, by contrast, is a single‑vote‑per‑share security that is listed on the Nasdaq Global Select Market and is held by a broad base of public investors; the filing does not identify any single shareholder or group that controls a comparable share of voting power【page_1†L9-L15】.  \n\nThus, Comcast’s Class B shares concentrate control in one individual (≈33 % of votes), whereas Alphabet’s Class A shares are widely held with no comparable concentration of ownership or voting influence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the 33⅓% voting power for CMCSA's Class B stock, 15 votes per share, and the fact that Brian L. Roberts holds all Class B shares are accurately reflected. While the LLM adds a specific number (44.6 million Class B shares) not in the original answer, this is consistent with external knowledge and does not contradict the ground truth. Alphabet's Class A stock being broadly held with single voting rights is correctly described. The original answer mentions 300,754,904 shares outstanding as of January 25, 2022—a specific figure absent in the LLM response—but this omission does not detract significantly from the core comparison about control distribution. (2) Calculations are not required beyond proportional understanding (e.g., 33⅓% voting power), which is correctly conveyed. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance structures across CMCSA and GOOGL, contrasting concentrated control (via super-voting shares held by one individual) with dispersed control (broad public ownership, no super-voting concentration). (4) The LLM omits the exact share count for GOOGL, which slightly reduces completeness, but the qualitative conclusion about dispersed voting power remains valid and well-supported. Wording differs but semantic equivalence is strong. No factual errors; minor omission prevents a perfect 10. Contextual relevance is excellent—directly addresses control and ownership distribution as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 430,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the ratio of securities remaining available for future issuance to those issuable upon exercise of outstanding options differ between UnitedHealth Group and Johnson & Johnson under their respective equity compensation plans approved by security holders?",
      "original_answer": "For UnitedHealth Group, the ratio is approximately 9.64 (241 million remaining available / 25 million issuable upon exercise), while for Johnson & Johnson, the ratio is approximately 1.79 (240,344,013 remaining available / 133,794,708 issuable upon exercise). This indicates that UnitedHealth Group has a significantly higher proportion of remaining available securities compared to those already issuable, relative to Johnson & Johnson.",
      "llm_answer": "- **UnitedHealth Group (UNH)** – The 2020 Stock Incentive Plan (shareholder‑approved) shows 25 million securities that would be issued on exercise of outstanding options and 241 million securities still available for future issuance. The ratio is **241 ÷ 25 ≈ 9.6 to 1**.\n\n- **Johnson & Johnson (JNJ)** – The shareholder‑approved 2005 and 2012 Long‑Term Incentive Plans show about 133.8 million securities that would be issued on exercise of outstanding options and 240.3 million securities still available for future issuance. The ratio is **240.3 ÷ 133.8 ≈ 1.8 to 1**.\n\nThus, UNH’s “available‑to‑exercisable” ratio is roughly **9.6 to 1**, far higher than JNJ’s **1.8 to 1**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with minor rounding differences. (1) Quantitatively, all numbers are correct within acceptable rounding: UnitedHealth Group's 25 million and 241 million match exactly; Johnson & Johnson's 133.8 million (vs. 133,794,708) and 240.3 million (vs. 240,344,013) are appropriately rounded. The calculated ratios—9.6 (vs. 9.64) and 1.8 (vs. 1.79)—are rounded to one decimal place but remain factually sound. (2) Completeness is strong: the answer addresses both companies, their shareholder-approved plans, the two key metrics (securities remaining available and issuable upon exercise), and computes the required ratios. (3) Entity accuracy is correct: company names (UnitedHealth Group and Johnson & Johnson), tickers (implied), and plan types (shareholder-approved equity plans) are properly identified. (4) Reasoning is sound: the multi-hop synthesis—pulling data from two different companies’ compensation plans and calculating comparative ratios—is logically executed and clearly explained. The conclusion that UnitedHealth has a significantly higher ratio is valid. The only minor shortcoming is the slight rounding of the JNJ ratio (1.8 vs. 1.79), which does not affect interpretation. Thus, the answer is semantically equivalent and highly accurate, warranting a 9/10 for correctness and quantitative accuracy, with full marks for contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 396,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does AMD's reliance on third-party motherboard suppliers compare to Intel's dependency on Dell Inc. as a major customer, particularly in terms of revenue concentration risk?",
      "original_answer": "AMD depends on third-party companies for the design, manufacture, and supply of motherboards that support its microprocessor, GPU, and APU offerings, making it vulnerable to supply chain disruptions. In contrast, Intel reports that Dell Inc. accounted for 21% of its net revenue in 2021, highlighting a significant revenue concentration risk tied to a single customer. While AMD's risk centers on supply chain limitations that could prevent product delivery, Intel's exposure is tied directly to customer dependency, with Dell representing a substantial portion of both revenue and accounts receivable.",
      "llm_answer": "AMD’s 2022 filing notes that it “depends on third‑party companies for the design, manufacture and supply of motherboards, graphics cards, software, memory and other components” (p. 28).  The risk is therefore tied to the availability of many suppliers rather than to any one customer’s purchases.  \n\nBy contrast, Intel disclosed that Dell accounted for 21 percent of its net revenue in 2021, and the three largest customers together represented 43 percent of revenue (p. 87).  This makes Intel’s revenue more concentrated in a single customer, creating a higher concentration‑risk exposure than AMD’s more diversified supplier‑based reliance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Intel's disclosure that Dell accounted for 21% of net revenue in 2021 matches the original answer. The additional detail that Intel's top three customers represented 43% of revenue is not in the original answer but does not contradict it and adds context without introducing error. (2) The entity identification is accurate—AMD, Intel, Dell Inc., and the correct fiscal year (2021) are all properly referenced. (3) The reasoning correctly distinguishes between AMD's supply-side reliance on third-party suppliers and Intel's demand-side revenue concentration risk with Dell, which is the core of the multi-hop comparison. The LLM accurately synthesizes risk types: supply chain disruption vs. customer concentration. (4) The only minor shortcoming is that the LLM does not explicitly mention Intel's accounts receivable exposure to Dell, which is part of the original answer and adds depth to the revenue concentration risk. However, this omission does not undermine the central comparison. Wording differs but semantic meaning is equivalent. The answer is contextually relevant, directly addressing the comparison of revenue concentration risk between the two companies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 358,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How do Louisiana's corporate tax rate reductions impact the financial exposure of both Boeing and Union Pacific, given Boeing's dependence on federal appropriations influenced by broader legislative dynamics and Union Pacific's direct operations in the state?",
      "original_answer": "Louisiana enacted legislation to reduce its corporate income tax rate for future years, resulting in a $34 million reduction of Union Pacific’s deferred tax expense in 2024. Union Pacific directly benefits from this tax reduction due to its operational presence in Louisiana, as evidenced by its major classification yard in Livonia. Boeing, on the other hand, does not directly benefit from Louisiana’s tax changes but faces exposure to broader legislative uncertainty, particularly in terms of federal appropriations for the U.S. Department of Defense and other government agencies. A lapse or delay in federal funding could disrupt Boeing’s operations, delay aircraft certifications, or impact future orders. Therefore, while Union Pacific experiences a quantifiable financial benefit ($34 million reduction in deferred tax expense) from Louisiana’s tax legislation, Boeing’s exposure is indirect and tied to the uncertainty of federal budget dynamics influenced by the same legislative environment.",
      "llm_answer": "Louisiana’s corporate‑tax cuts shave about $34 million off Union Pacific’s deferred‑tax expense, directly lowering the railroad’s state‑tax liability and thus reducing its overall tax‑related financial exposure in the state【page_29】. By contrast, Boeing’s 10‑K notes that its earnings are far more sensitive to the timing and level of U.S. government defense appropriations and other federal‑budget legislation, not to state‑level tax rates, so the Louisiana tax reduction does not materially affect Boeing’s exposure; its risk remains tied to broader federal‑legislative dynamics【page_10】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $34 million reduction in Union Pacific’s deferred tax expense is correctly stated, matching the original answer exactly. No other numbers or dates are involved, and the figure is presented accurately. (2) The answer correctly identifies that Union Pacific benefits directly due to its operations in Louisiana, citing the tax cut’s impact on deferred tax expense, and references a major operational asset (implied by context, though not explicitly naming the Livonia yard). (3) For Boeing, the LLM correctly states that its exposure is not to state tax changes but to federal appropriations, particularly defense funding, which matches the original answer’s emphasis on legislative uncertainty affecting federal budgets. The reasoning correctly synthesizes multi-hop information: Louisiana’s tax policy affects Union Pacific directly due to in-state operations, while Boeing is exposed to broader federal dynamics, not state-level changes. (4) The only minor omission is the lack of explicit mention of Union Pacific’s physical presence (e.g., Livonia classification yard) as evidence of operational footprint, which slightly weakens the qualitative justification but does not affect factual correctness. Wording differs but semantic equivalence is preserved. All key entities (Boeing, Union Pacific, Louisiana tax changes, deferred tax expense, federal appropriations) are correctly identified and logically connected. The answer is fully relevant and responsive to the multi-part, multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 436,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does Netflix's one-vote-per-share governance model contrast with Meta's dual-class stock structure, particularly in relation to Charter Communications' disclosure about the link between Class A common stock and voting rights?",
      "original_answer": "Netflix operates under a one-vote-per-share governance model for its common stock, as explicitly stated in its 2024 10-K filing. In contrast, Charter Communications' 2024 financial statements clarify that its Class A common stock carries one vote per share, while its Class B common stock has variable voting rights tied to A/N's economic interests. Meta's 2024 10-K filing discloses the existence of both Class A and Class B common stock, a dual-class structure that suggests differentiated voting rights similar to Charter's framework, though Meta does not specify the exact voting power of each class in the provided chunk. This creates a contrast between Netflix's egalitarian voting model and the more complex, tiered voting structures used by both Charter and Meta.",
      "llm_answer": "Netflix’s proxy statement says that every share of its common stock carries **one vote per share** – a straight‑forward, one‑share‑one‑vote governance model. In contrast, Meta’s 10‑K describes a **dual‑class structure** in which Class A shares have limited voting rights while a separate Class B series carries super‑voting power, separating control from economic ownership. Charter Communications’ filing makes the same point for its own equity, noting that **Class A common stock is entitled to one vote per share**, highlighting how Netflix (and Charter’s Class A) treat voting uniformly, whereas Meta’s voting is split between two classes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core contrast in governance models as described in the ground truth. (1) It correctly identifies Netflix's one-vote-per-share model and cites it as a straightforward governance approach, aligning with the original answer. It accurately describes Meta's dual-class structure, noting differentiated voting rights between Class A and Class B shares, which matches the ground truth's assertion of a dual-class system. It also correctly references Charter Communications' disclosure that its Class A common stock carries one vote per share, which is factually consistent. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct citation of 'one vote per share'—which is consistently and correctly reported across all entities. (3) The multi-hop reasoning is sound: the model synthesizes information across Netflix, Meta, and Charter Communications, correctly contrasting Netflix’s egalitarian model with the tiered structures of Meta and Charter. However, the LLM slightly overreaches by stating that Meta’s Class B shares have 'super-voting power'—while this is likely true, the ground truth explicitly notes that Meta’s 10-K 'does not specify the exact voting power of each class in the provided chunk,' so this detail is not confirmable from the given data. This minor assumption prevents a perfect score. (4) The answer is contextually relevant, directly addressing the question’s focus on governance contrasts and Charter’s disclosure. Overall, the answer is factually strong, well-reasoned, and semantically equivalent to the ground truth, with only a small overstatement regarding Meta’s voting rights detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 475,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does the daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing impact the valuation methodology used by MDLZ for its Level 1 financial liabilities, given that both companies rely on quoted market prices from commodity exchanges?",
      "original_answer": "The daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing aligns with the valuation methodology used by MDLZ for its Level 1 financial liabilities, which are also based on quoted market prices from commodity exchanges. PEP notes that exchange-traded commodity futures are 'cashsettled on a daily basis' and therefore not included in the balance sheet table as of year-end, indicating a standard market practice. MDLZ explicitly states that the fair value of its Level 1 financial assets and liabilities 'is determined based on quoted market prices on commodity exchanges.' This shows that the market standard of daily cash settlement directly informs MDLZ's valuation approach for Level 1 liabilities, as both companies are subject to the same pricing and settlement mechanisms in commodity futures markets.",
      "llm_answer": "PEP notes that exchange‑traded commodity futures are “cash‑settled on a daily basis and, therefore, not included in the table” because the contracts are settled each day and do not remain on the balance sheet as open liabilities. MDLZ’s Level 1 financial liabilities are defined as “exchange‑traded commodity futures and listed options” whose fair value is measured “based on quoted market prices on commodity exchanges.” Because the futures are settled daily, MDLZ can value those Level 1 liabilities directly at the current quoted price—no additional modeling or accrual is required—mirroring PEP’s treatment that daily settlement removes the need to carry the contracts as outstanding liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) All factual elements are correct: PEP's 2022 filing notes daily cash settlement of exchange-traded commodity futures and their exclusion from year-end balance sheet tables due to settlement; MDLZ uses quoted market prices on commodity exchanges to value its Level 1 financial liabilities, which include exchange-traded commodity futures. There are no numeric values (e.g., dollar amounts, percentages) in the question or answers, so quantitative accuracy is not applicable beyond correct referencing of concepts like 'Level 1' and 'daily cash settlement,' which are accurately cited. (2) The answer addresses all parts of the multi-hop question: it connects PEP’s description of settlement mechanics to MDLZ’s valuation methodology, explaining how daily settlement enables direct use of quoted prices without modeling or accruals. (3) Multi-hop reasoning is sound: the model correctly infers that because futures are settled daily, they do not persist as liabilities, allowing fair value to be based purely on observable market prices—this aligns with both PEP’s and MDLZ’s disclosures and reflects an understanding of market practice. (4) Semantic equivalence is strong: while the LLM answer phrases the conclusion slightly differently (emphasizing operational impact on valuation), it captures the essential logic that daily settlement supports the use of Level 1 pricing. The only minor shortcoming is a slightly less explicit statement about 'market standard' or 'common practice' compared to the original answer, which more clearly generalizes the alignment between the two companies as evidence of industry-wide norms. However, this does not detract significantly from correctness. Overall, the response is factually precise, contextually appropriate, and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 506,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Apple's 2022 net sales performance in the Greater China region, which includes Taiwan, compare with AMD's 2022 sales in Taiwan alone, given both companies' exposure to the technology market in that geographic area?",
      "original_answer": "Apple reported $74,200 million in net sales in the Greater China region in 2022, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales specifically in Taiwan for the same year. This indicates that while Apple has a significantly larger overall presence in the broader Greater China region, AMD's direct sales in Taiwan are much smaller in scale.",
      "llm_answer": "Apple reported $74.2 billion in net sales for its Greater China segment (which includes Taiwan) in fiscal 2022【page_25】.  \nAMD’s 2022 10‑K shows sales to external customers in Taiwan of $2.091 billion【page_78】.  \n\nThus Apple’s Greater China revenue was roughly thirty‑five times larger than AMD’s Taiwan‑only sales.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Apple's $74.2 billion (i.e., $74,200 million) in Greater China and AMD's $2.091 billion (i.e., $2,091 million) in Taiwan are correctly reported, with appropriate unit conversions (billion vs. million) preserved. The comparison stating Apple's revenue was 'roughly thirty-five times larger' is mathematically sound: 74.2 / 2.091 ≈ 35.48, which rounds to ~35x. (2) The answer is complete, addressing both companies' sales figures, the relevant geographic areas (Greater China for Apple, Taiwan-only for AMD), and the implied comparison of scale. (3) Entities are correctly identified: Apple and AMD, 2022 fiscal year, and the appropriate financial metric (net sales). (4) The multi-hop reasoning—synthesizing data from two different 10-K filings across companies and geographies—is logically sound and clearly articulated. (5) The semantic meaning is equivalent to the original answer, with slightly more concise phrasing and the addition of a helpful multiplicative comparison that enhances clarity without introducing error. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 334,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Duke Energy's exposure to environmental remediation liabilities compare to Southern Company's ability to recover similar costs through regulatory mechanisms, given that Duke Energy's remediation costs are typically expensed as incurred unless recovery is probable, while Southern Company Gas' natural gas utilities specifically include environmental remediation in their approved cost recovery mechanisms?",
      "original_answer": "Duke Energy faces environmental remediation liabilities at multiple sites, with costs typically expensed as incurred unless regulatory recovery is deemed probable. In contrast, Southern Company Gas explicitly includes environmental remediation among the costs eligible for recovery through regulatory riders in its natural gas distribution utilities. This means that while Duke may bear these costs directly unless recovery is approved, Southern Company has a more structured pathway to recover such expenses through approved rate mechanisms, reducing its direct financial exposure to environmental remediation liabilities.",
      "llm_answer": "Duke Energy records its environmental‑remediation costs as operating expenses when incurred, and only treats them as recoverable if a regulator has already indicated that recovery is probable (see Duke remediation note, page 163). In contrast, Southern Company’s natural‑gas utilities are expressly allowed to include environmental‑remediation expenses in the cost‑recovery riders that regulators approve for rates (see Southern Company Gas cost‑recovery discussion, page 22). Thus, Duke bears the remediation liability largely as an unrecoverable expense, whereas Southern Company can largely offset similar costs through regulated rate recoveries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly states that Duke Energy expenses environmental remediation costs as incurred unless recovery is probable, while Southern Company Gas has explicit regulatory mechanisms allowing recovery of such costs through approved riders. These facts align with the original answer. (2) There are no numeric values (e.g., dollar amounts, dates, percentages) in either the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes contrasting regulatory treatment between Duke Energy and Southern Company Gas, drawing from distinct disclosures (e.g., referencing specific pages for each company’s policy). The conclusion that Southern has a structured recovery path while Duke bears more direct financial risk is logically derived. (4) Minor wording differences exist (e.g., 'unrecoverable expense' slightly overstates Duke’s position since recovery can be probable later), but the semantic meaning remains equivalent. No entity errors—company names and regulatory mechanisms are correctly identified. The answer fully addresses the comparative exposure and recovery mechanisms, making it contextually complete and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 367,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does LOW's use of broker/dealer quotes for Level 2 fair value measurements compare to GM's reliance on valuation models for product warranty reserves, given the role of industry-standard models in both companies' financial reporting?",
      "original_answer": "LOW uses broker/dealer quotes as inputs to Level 2 fair value measurements for financial assets when quoted prices in active markets are not available, relying on third-party pricing models with observable market inputs like issuer spreads and benchmark securities. GM, on the other hand, applies valuation models to estimate product warranty reserves, incorporating significant assumptions such as warranty claims frequency, average cost per claim, and historical claims data. Both companies utilize industry-standard valuation models, but LOW's approach is market-driven with observable inputs (Level 2), while GM's involves more management judgment and forward-looking assumptions. This highlights different applications of valuation models: LOW's fair value measurements are more directly tied to current market data, whereas GM's depend on internal forecasts and historical performance.",
      "llm_answer": "Lowe’s Level 2 fair‑value measurements are derived from pricing models that use observable market inputs—most notably recent broker‑dealer quotes on the same or similar securities—so the fair value is anchored to current market prices (see LOW Note 3 and the Level 2 discussion of corporate‑debt securities). In contrast, General Motors does not use market quotes for its warranty reserves; it estimates those liabilities with actuarial valuation models that rely on historical claim frequency, average claim cost and other assumptions about future experience (see GM Note 12 and the audit description of the warranty‑reserve models). Both companies therefore depend on industry‑standard models, but Lowe’s leans on observable market quotes within those models, whereas GM’s models are driven by internal, actuarial assumptions rather than external price data.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: LOW uses broker/dealer quotes as observable inputs in pricing models for Level 2 fair value measurements, particularly for corporate-debt securities, which is consistent with market-based, observable inputs. GM uses actuarial valuation models for warranty reserves based on historical data and assumptions like claim frequency and cost per claim. These are correctly contrasted in terms of reliance on market data (LOW) vs. internal forecasts (GM). (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LOW and GM), two distinct financial reporting areas (fair value measurements vs. warranty reserves), and two types of valuation approaches (market-observable vs. assumption-driven). It accurately references appropriate disclosures (e.g., Note 3 for LOW, Note 12 for GM), demonstrating proper grounding in typical 10-K footnote structures. (4) The only minor shortcoming is a slight reduction in completeness compared to the original answer: the LLM does not explicitly state that both companies use 'industry-standard models'—though it implies this by referencing 'pricing models' and 'actuarial valuation models'—and the phrase 'industry-standard' is a key linking concept in the original. However, the semantic meaning is preserved, and the core contrast in input types (observable market data vs. internal assumptions) is clearly and correctly articulated. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 497,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How would the implementation of the Basel III Finalization Proposal's Expanded Risk-Based Approach impact both Capital One and Citigroup's regulatory capital requirements, considering the phased-in effective date of July 1, 2025, and the requirement to use the lower of the two calculated risk-based capital ratios?",
      "original_answer": "The Basel III Finalization Proposal introduces a new Expanded Risk-Based Approach that would require both Capital One and Citigroup to calculate their risk-based capital ratios under both this new framework and the existing Basel III standardized approach, using the lower of the two ratios for compliance. For Capital One, this includes a three-year transition period starting July 1, 2025, during which risk-weighted assets under the Expanded Risk-Based Approach would be phased in. Citigroup has indicated that, if the proposal is finalized as written, it would materially increase its required regulatory capital. Both banks must also comply with all capital buffer requirements regardless of which approach yields the lower ratio, further constraining capital flexibility.",
      "llm_answer": "Both Capital One and Citigroup would have to calculate their risk‑weighted assets under the new “Expanded Risk‑Based Approach” as well as under the existing Basel III standardized approach and, for each capital ratio, be bound by the lower (i.e., more capital‑intensive) result.  Because the expanded approach is expected to produce higher RWA for large banks, the lower‑ratio outcome would raise the CET1, Tier 1 and total‑capital percentages that each firm must hold, and the increase would be phased in over the three‑year transition that begins on July 1 2025.  Consequently, the firms’ regulatory capital requirements will climb gradually during the 2025‑2028 transition period, with the expanded‑approach calculation becoming the binding constraint once fully phased in.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and reasoning. (1) It accurately describes the requirement for both Capital One and Citigroup to calculate risk-based capital ratios under both the new Expanded Risk-Based Approach and the existing Basel III standardized approach, using the lower of the two for compliance. It correctly notes the July 1, 2025 effective date and the three-year phase-in period through 2028, which matches the ground truth. (2) Quantitatively, all dates (July 1, 2025) and timeframes (three-year transition) are correct. There are no specific numerical values (e.g., exact capital ratios or dollar amounts) in either answer, so no calculation errors are present. The LLM correctly infers that the Expanded Approach will likely result in higher risk-weighted assets (RWA), leading to higher capital requirements—a point supported by Citigroup’s own disclosures referenced in the ground truth. (3) The multi-hop reasoning is sound: it connects the regulatory requirement, the phase-in period, the impact on capital ratios (CET1, Tier 1, total capital), and the expectation that the expanded approach will become binding. However, the LLM omits a specific mention of Citigroup’s explicit statement that the rule would 'materially increase' its required capital, which is a notable qualitative point in the original. It also does not mention that capital buffer requirements apply regardless of which approach yields the lower ratio—a key constraint on capital flexibility emphasized in the ground truth. (4) Despite these minor omissions, the answer is contextually highly relevant, clearly structured, and factually accurate on all major points. The omission of Citigroup’s forward-looking statement and the capital buffers prevents a perfect score, but the core regulatory mechanics are correctly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 506,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does ConocoPhillips' exposure to condensate production through its ownership in Alba Plant LLC compare to Chevron's direct condensate production volumes in 2024, given Chevron reports zero condensate reserves in its 2024 10-K filing?",
      "original_answer": "ConocoPhillips holds a 52.2% interest in Alba Plant LLC, which extracts condensate from the Alba Unit natural gas stream and sells it at market prices, with COP's share reflected in 'Equity in earnings of affiliates.' In contrast, Chevron's 2024 10-K shows no condensate production or reserves across all categories, including both consolidated and affiliated companies. This indicates that while COP has exposure to condensate through its Alba Plant investment, Chevron had no direct condensate production in 2024.",
      "llm_answer": "ConocoPhillips is indirectly exposed to condensate because it owns 52.2 percent of Alba Plant LLC – a joint‑venture processing plant that “extracts condensate and LPG from the natural‑gas stream and sells it at market prices” (Conoco 10‑K, page 12). Chevron, by contrast, reports no condensate reserves or production in its 2024 filing – the “Crude Oil Condensate” column is blank (‑) for both consolidated and affiliated companies in the reserves table (page 109 of Chevron 10‑K). Thus Conoco’s exposure is through a processing‑plant stake, whereas Chevron’s direct condensate output in 2024 is effectively zero.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the 52.2% ownership stake in Alba Plant LLC is accurately reported, and the statement that Chevron reports zero condensate reserves and production is correctly derived from the 2024 10-K, with the detail that the 'Crude Oil Condensate' column is blank (-) for both consolidated and affiliated companies. (2) The answer is complete, addressing both ConocoPhillips' indirect exposure via its equity stake and Chevron's lack of direct production or reserves. (3) Entity accuracy is perfect: both companies are correctly identified, the Alba Plant LLC is accurately described, and the reference to the correct 10-K pages (12 for Conoco, 109 for Chevron) adds verifiability. (4) The multi-hop reasoning is sound—synthesizing Conoco's indirect exposure through a joint venture with Chevron's absence of condensate data across its operations—and correctly concludes that Conoco has exposure while Chevron does not. (5) The semantic meaning is equivalent to the original answer, with slightly more detail (e.g., mentioning LPG and page numbers) that enhances clarity without introducing error. All formatting and factual claims align with the knowledge graph ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 353,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the application of ASU 2020-04 to contract modifications impact both AVGO's revenue recognition practices and ORCL's financial reporting, particularly in relation to reference rate reform?",
      "original_answer": "AVGO evaluates contract modifications to determine whether additional products or services should be accounted for as a separate contract or part of the existing contract, using standalone selling prices adjusted for specific contract circumstances. ORCL adopted ASU 2020-04 related to reference rate reform, which allowed optional expedients for contract modifications affected by changes in reference rates such as LIBOR. According to the evidence, AVGO uses standalone selling prices to allocate consideration in bundled arrangements, and modifications are accounted for prospectively, cumulatively, or a combination depending on the nature of the change. ASU 2020-04 applied to contract modifications made between March 12, 2020, and December 31, 2024, and both AVGO and ORCL reported no material impact on their consolidated financial statements from applying this guidance. ORCL finalized its adoption of ASU 2020-04 in Q1 of fiscal 2024, with no material effect on its financial statements or notes.",
      "llm_answer": "- **Broadcom (AVGO)** – The company’s ASC 606 policy treats a contract modification as either a new, separate contract or as part of the existing contract. When the modification’s price reflects a standalone selling price, the added products or services are accounted for as a **separate contract**; when it does not, the amendment is accounted for **prospectively, on a cumulative‑catch‑up basis, or a mix of both**. This approach, described in the “Contract modifications” paragraph (AVGO p. 63), changes the timing of when the incremental revenue is recognized but does not alter the overall revenue‑recognition framework.\n\n- **Oracle (ORCL)** – Oracle adopted **ASU 2020‑04, Reference Rate Reform** in the first quarter of fiscal 2024. The filing (ORCL p. 72) states that the adoption “had no material impact to our consolidated financial statements or notes thereto,” meaning the reference‑rate‑reform expedients and exceptions did not materially affect Oracle’s revenue‑recognition or other financial‑reporting amounts.  \n\nThus, while Broadcom’s application of ASU 2020‑04 influences *how* and *when* revenue from contract modifications is booked, Oracle’s adoption of the same update was essentially neutral to its financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AVGO's treatment of contract modifications under ASC 606, including the use of standalone selling prices and prospective/cumulative catch-up accounting, is accurately described. ORCL's adoption of ASU 2020-04 in Q1 of fiscal 2024 with no material impact is correctly reported. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not compromised; dates (fiscal 2024) and timeframes (no mention of March 12, 2020–December 31, 2024 in LLM answer) are partially omitted but not critical to the core conclusion. (3) The multi-hop reasoning is sound: the model correctly synthesizes how ASU 2020-04 affects AVGO’s revenue recognition timing and ORCL’s financial reporting neutrality. (4) The only minor omission is that the LLM does not explicitly state that ASU 2020-04 applied to modifications between March 12, 2020, and December 31, 2024, nor that both companies reported no material impact—though ORCL’s case is covered. Also, AVGO’s use of standalone selling prices in bundled arrangements is mentioned in the ground truth but only implied in the LLM answer. These omissions are minor and do not affect the overall correctness. Wording differs but meaning is semantically equivalent. Contextual relevance is perfect—directly addresses both companies and the impact on revenue and financial reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1574,
        "completion_tokens": 409,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the dual-class stock structure at META, which negatively impacts the attractiveness of its Class A Common Stock, compare to CMCSA's Class B Common Stock convertibility policy in terms of governance control and shareholder influence?",
      "original_answer": "META's dual-class structure gives disproportionate voting control to Class B shareholders like Mark Zuckerberg, requiring a majority of Class B shares to approve change-of-control transactions until they fall below 35% of combined voting power. In contrast, CMCSA allows Class B Common Stock (with 15 votes per share) to convert share-for-share into Class A Common Stock, maintaining a non-dilutable 33⅓% aggregate voting power for Class B shares. While both structures concentrate governance influence, META's system entrenches control more rigidly through class-vote requirements, whereas CMCSA enables gradual dilution through conversion.",
      "llm_answer": "Meta’s dual‑class system gives its 9 % of Class B shares ten votes each, while Class A carries only one vote, so the founder‑led Class B holders control a majority of the voting power and can effectively block or dictate any shareholder‑approved action – making the publicly‑traded Class A stock unattractive because ordinary investors have little influence (Meta 10‑K pp. 49‑50).  \n\nComcast’s Class B shares also carry super‑voting rights (15 votes per share, about 33 % of total voting power that is non‑dilutable) but are convertible, share‑for‑share, into Class A stock (which has one vote), giving B‑shareholders the option to relinquish their extra votes; thus, while B‑holders retain strong governance control, the convertibility provides a mechanism that can moderate that concentration of power (Comcast 10‑K pp. 91‑92).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: META's Class B shares have 10 votes per share (LLM states this), CMCSA's Class B has 15 votes per share and represents approximately 33⅓% of voting power (LLM correctly notes ~33%, which is semantically equivalent). The convertibility of CMCSA Class B to Class A on a share-for-share basis is accurately described. (2) Quantitative accuracy is perfect: no incorrect numbers, percentages, or vote counts; minor rounding of 33⅓% to 'about 33%' is acceptable and common. (3) Multi-hop reasoning is sound: the answer correctly contrasts META’s entrenched control (via disproportionate voting power and class-vote requirements implied by 'block or dictate') with CMCSA’s more flexible structure due to convertibility. While the LLM does not explicitly mention META’s 35% threshold for change-of-control transactions, this is a minor omission that doesn’t undermine the central comparison on governance control and shareholder influence. (4) The answer is contextually relevant, directly addressing governance control, shareholder influence, and the impact on Class A stock attractiveness. Wording differs slightly but meaning aligns with the original. One point deducted from correctness and qualitative accuracy for missing the specific 35% trigger condition in META’s structure, though the overall logic remains intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 399,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does PEP's use of exchange-traded commodity futures, which are cash-settled daily, compare with COST's disclosure regarding the absence of Level 1 financial assets measured at fair value on a recurring basis, given that Level 1 financial assets typically include exchange-traded commodity futures?",
      "original_answer": "PEP utilizes exchange-traded commodity futures that are cash-settled daily to manage market risk, and these are excluded from the fair value table as of December 25, 2021. These commodity futures fall under Level 1 financial assets, as defined by MDLZ's disclosure, which includes exchange-traded commodity futures valued at quoted market prices. However, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a distinct difference in financial instrument usage between PEP and COST.",
      "llm_answer": "PepsiCo (PEP) notes that it does use exchange‑traded commodity futures, but because those contracts are cash‑settled each day they are **not included in its Level 1 fair‑value tables** (see Note 10, “Exchange‑traded commodity futures are cash‑settled on a daily basis, therefore not included in the table” – page 107).  \n\nCostco (COST), by contrast, explicitly discloses that **it held no Level 1 (or Level 3) financial assets or liabilities measured at fair value on a recurring basis** (page 51), which means it does not have any exchange‑traded commodity futures on its balance sheet.  \n\nThus, while PEP’s futures exist but are excluded from Level 1 reporting, COST reports the absence of any such Level 1 assets altogether.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that PEP uses exchange-traded commodity futures that are cash-settled daily and are excluded from the fair value table, consistent with the original answer referencing exclusion as of December 25, 2021. While the LLM does not explicitly name the date, it correctly cites the accounting treatment and source (Note 10, page 107), which implies the correct reporting period. (2) It accurately reflects COST's disclosure as of August 28, 2022, that it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, matching the ground truth. (3) The multi-hop reasoning is sound: it correctly synthesizes that exchange-traded commodity futures are typically Level 1 assets (as confirmed by MDLZ’s disclosure in the ground truth), explains why PEP’s are excluded (due to daily cash settlement), and contrasts this with COST’s complete absence of such assets. (4) The only minor shortcoming is that the LLM does not explicitly mention MDLZ’s role in defining Level 1 assets, which supports the classification logic in the ground truth. However, the LLM still reaches the correct conclusion about the classification and contrast between PEP and COST. All entities (PEP, COST), financial instruments, and disclosures are correctly identified. Wording differs slightly but maintains semantic equivalence. Quantitative elements (dates, values) are not numerically specified but are contextually accurate based on correct citation of notes and pages. No calculation errors. The answer is fully relevant and directly addresses the comparative aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 460,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the value of securities loaned with maturities of 31-90 days at Goldman Sachs compare to the total securities loaned value reported by Morgan Stanley, and what does this suggest about their relative exposure to short-term securities lending risk?",
      "original_answer": "Goldman Sachs reports $1,634 million in securities loaned with maturities of 31-90 days, while Morgan Stanley reports a total of $281 million in securities loaned (U.S. and Non-U.S. combined). This suggests that Goldman Sachs has a significantly higher exposure to short-term securities lending risk compared to Morgan Stanley.",
      "llm_answer": "Goldman Sachs reports $1.634 billion of securities loaned that mature in 31‑90 days (see the “31‑90 days” line in the securities‑loaned table on page 187).  \nMorgan Stanley’s 2024 filing shows total securities‑loaned balances of $9.499 billion (U.S.) + $6.853 billion (non‑U.S.) = $16.352 billion (page 148).  \n\nThus, Goldman Sachs’ short‑term (31‑90 day) loaned securities are roughly one‑tenth the size of Morgan Stanley’s entire securities‑loaned portfolio, suggesting that Goldman Sachs has far less exposure to short‑term securities‑lending risk than Morgan Stanley.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer contains major factual and quantitative errors. First, it incorrectly states that Morgan Stanley's total securities loaned amount to $16.352 billion ($9.499 billion U.S. + $6.853 billion non-U.S.), which directly contradicts the ground truth value of $281 million. This calculation appears to be based on a misreading of the filing, possibly confusing securities lending with other balance sheet items. Second, while the LLM correctly identifies Goldman Sachs' 31-90 day securities loaned as $1.634 billion (equivalent to $1,634 million), it then draws the opposite conclusion of the ground truth: claiming Goldman has *less* exposure, when in fact $1,634 million is significantly larger than Morgan Stanley’s total of $281 million. The reasoning is therefore flawed and leads to an incorrect interpretation. The multi-hop synthesis fails because the LLM uses incorrect data for Morgan Stanley. Even allowing for format variation, the numbers are orders of magnitude off. The contextual relevance is low due to reliance on incorrect data, and the conclusion is semantically opposite to the truth. All downstream reasoning is invalid due to the initial data error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 330,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What percentage of PowerSouth's owned generating capacity comes from its undivided interest in Alabama Power's Plant Miller Units 1 and 2, and how does this compare to Duke Energy's total electricity generation in GWh for 2021?",
      "original_answer": "PowerSouth owns an undivided 8.16% interest in Alabama Power's Plant Miller Units 1 and 2, which contributes to its total generating capacity of over 1,600 MWs. In comparison, Duke Energy generated a combined total of 22,344 GWh of electricity in 2021 across all its operating segments. This comparison highlights the relative scale of PowerSouth’s partial ownership in a specific plant versus Duke Energy’s full system-wide electricity generation.",
      "llm_answer": "PowerSouth’s 8.16 % undivided stake in Alabama Power’s Plant Miller Units 1‑2 represents roughly 174 MW (8.16 % × 2,133 MW).  With PowerSouth owning a little over 1,600 MW of name‑plate capacity, that interest accounts for about **11 % of PowerSouth’s owned generating capacity**.  \n\nDuke Energy’s 2021 electricity generation was **approximately 34,700 GWh** (22,344 GWh + 1,681 GWh + 10,688 GWh across its main segments).  \n\nSo, PowerSouth’s Plant Miller share is about 11 % of its capacity, whereas Duke Energy produced roughly 34.7 thousand GWh of electricity in 2021.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies PowerSouth's 8.16% undivided interest in Plant Miller Units 1 and 2, which matches the ground truth. However, it introduces a calculated figure of 174 MW (8.16% × 2,133 MW) and claims this represents about 11% of PowerSouth’s total owned capacity (~1,600 MW). While the percentage calculation is roughly accurate (174 / 1,600 ≈ 10.875%), this level of precision is not supported by the original answer, which only states that the interest 'contributes to' PowerSouth’s over 1,600 MW capacity without quantifying its exact share. More critically, the LLM fabricates Duke Energy’s 2021 generation as approximately 34,700 GWh by summing 22,344 GWh + 1,681 GWh + 10,688 GWh — these additional values are not present in the ground truth. The original answer clearly states Duke Energy generated 22,344 GWh in total in 2021. This results in a significant quantitative error. (2) The calculation for PowerSouth’s share is mathematically sound but based on an assumed total capacity denominator not explicitly confirmed in the source. The Duke Energy total is completely incorrect: 34,700 GWh vs. the correct 22,344 GWh — a major factual deviation. (3) The multi-hop reasoning is partially correct — the model attempts to compare PowerSouth’s partial ownership to Duke Energy’s system-wide generation — but fails due to incorrect data aggregation for Duke. It assumes multiple segments with unverified generation values, breaking the chain of accurate synthesis. (4) The contextual relevance is high because the structure and intent align with the question, and the qualitative identification of entities (PowerSouth, Plant Miller, Duke Energy, 2021) is correct. However, the correctness score is low due to the critical error in Duke Energy’s generation figure, and quantitative accuracy is severely penalized for the fabricated sum.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 506,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does NIKE's exposure to interest rate risk in its $11.6 billion portfolio of fixed-income investments compare to McDonald's sensitivity to market inputs like interest rate yield curves, given both companies rely on pricing models that use observable market data for valuation?",
      "original_answer": "NIKE holds $11.6 billion in short-term investments, including investment-grade fixed-income securities, which are exposed to interest rate risk. These investments are valued using pricing models that incorporate observable market data such as interest rates and yield curves. Similarly, McDonald’s discloses that its derivatives are valued using pricing models that rely on observable market parameters, including interest rate yield curves. While NIKE’s risk stems from changes in interest rates affecting investment returns, McDonald’s exposure is tied to derivative valuations that reflect market fluctuations. Both companies depend on observable inputs for fair value measurements, though the nature and magnitude of risk differ based on the type of financial instrument involved.",
      "llm_answer": "Nike’s balance sheet shows a $11.6 billion pool of cash, short‑term investments and other investment‑grade fixed‑income securities that “are exposed to both credit and interest‑rate risk” (NIKE 10‑K p. 50). By contrast, McDonald’s does not hold a comparable fixed‑income portfolio; its interest‑rate exposure comes from derivatives that are valued with Level‑2 pricing models that use observable market inputs such as interest‑rate yield curves (McDonald’s 10‑K p. 46). Thus Nike’s interest‑rate risk is tied to a large $11.6 billion fixed‑income holding, whereas McDonald’s sensitivity is limited to the valuation of its derivatives, which depend on changes in yield‑curve inputs rather than a sizable bond portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $11.6 billion figure for NIKE's fixed-income investments is correct and matches the original answer. The reference to observable market inputs like interest-rate yield curves for McDonald’s derivatives is also factually consistent. (2) The LLM correctly identifies that NIKE’s interest rate risk arises from a large portfolio of fixed-income securities, while McDonald’s exposure is derivative-based and valued using Level 2 inputs (pricing models with observable parameters such as yield curves), which is consistent with the original answer. (3) The multi-hop reasoning is sound: it contrasts the nature of interest rate risk between two companies by synthesizing information about their respective financial instruments and valuation methods from separate 10-K filings. (4) Minor deduction in qualitative accuracy due to slightly narrower framing—while the LLM emphasizes McDonald’s lack of a comparable fixed-income portfolio (which is correct), it doesn’t explicitly note that both companies still rely on similar observable market data for fair value measurements, a key point of comparison in the original answer. However, this does not undermine the core correctness. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is perfect—directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 391,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class A common stock potentially influence their respective shareholder governance dynamics, given Netflix's uniform one-vote-per-share policy and Alphabet's multi-class structure with differential voting rights?",
      "original_answer": "Netflix's common stock provides each share with one vote, promoting a more egalitarian shareholder governance model. In contrast, Alphabet's multi-class structure, where Class A common stock grants one vote per share while Class B common stock grants 10 votes per share, concentrates voting power among holders of Class B shares. This structural difference means Alphabet's governance is more susceptible to control by a smaller group of insiders or major shareholders, while Netflix maintains a more evenly distributed voting environment.",
      "llm_answer": "Netflix’s charter gives every share the same voting power – one vote per share (see NFLX 10‑K p. 60) – so all shareholders have an equal ability to influence board elections and corporate actions. Alphabet, by contrast, issues three classes of equity: Class A shares receive one vote per share, but Class B shares carry ten votes per share and Class C shares carry no votes (see Alphabet 10‑K p. 82). This multi‑class structure concentrates voting control in the hands of insiders who hold Class B stock, allowing them to steer governance and strategic decisions even when public‑market (Class A) shareholders collectively own a large economic stake.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies Netflix's one-vote-per-share policy and contrasts it with Alphabet's multi-class structure, accurately describing Class A (1 vote), Class B (10 votes), and Class C (no votes) shares. These details align with the original answer, which emphasizes the concentration of voting power in Alphabet's Class B shares. (2) All quantitative elements are correct: the 1:1 and 10:1 voting ratios are accurately reported, and no calculations are required beyond these ratios, which are properly cited. (3) The multi-hop reasoning is sound—comparing governance models across two companies based on their capital structures—and the synthesis correctly infers that Alphabet's structure concentrates control among insiders (typically founders or executives holding Class B shares), while Netflix's structure ensures more equal shareholder influence. (4) The answer is fully relevant, directly addressing how voting rights differences affect shareholder governance dynamics. Minor additions (e.g., mention of Class C shares and page citations) enhance completeness without introducing error. Wording differs slightly but preserves and accurately expands on the core meaning of the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 360,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How might the IRA's price-setting provisions for Medicare Part D drugs like Imbruvica and XARELTO differently impact AbbVie and Johnson & Johnson's revenue strategies, given their respective exposure to the Medicare program?",
      "original_answer": "The IRA's price-setting provisions for Medicare Part D drugs will likely impact AbbVie and Johnson & Johnson differently due to their distinct product portfolios and revenue strategies. AbbVie has Imbruvica selected for price-setting starting in 2026, which could significantly affect its revenue stream, especially if more high-revenue products are selected in the future. Johnson & Johnson has XARELTO selected under the same program, a major anticoagulant with substantial Medicare utilization. Both companies face uncertainty around the final government-set prices, but J&J has already filed litigation challenging the constitutionality of the IRA’s pricing mechanism, suggesting a more aggressive stance to protect revenue. AbbVie, on the other hand, is more focused on evaluating the broader strategic impact of the IRA, including potential acceleration of revenue erosion prior to patent expirations. The differing responses reflect their respective risk exposure and strategic priorities within the Medicare program.",
      "llm_answer": "The IRA will impose a government‑set ceiling on the Medicare Part D price of the drugs that appear on the “selected‑drug” list.  AbbVie’s Imbruvica is one of the first ten medicines slated for price‑setting (effective 2026) and AbbVie explicitly warns that the IRA “will have the effect of reducing prices and reimbursements for certain of our products” (see AbbVie 10‑K p. 19), so the company will likely have to accept lower Medicare margins or accelerate new‑product launches to offset the erosion.  Johnson & Johnson’s Xarelto is also on the list, but J&J’s filing notes the provision only as a regulatory risk (see J&J 10‑K p. 11) and does not flag a material revenue concentration, implying that the price‑cap will bite less heavily on its overall Medicare exposure and can be absorbed within its broader portfolio strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Imbruvica (AbbVie) and XARELTO (Johnson & Johnson) are both selected for IRA price-setting starting in 2026, which matches the original answer. The LLM correctly cites the 2026 effective date and references the appropriate 10-K disclosures (p.19 for AbbVie, p.11 for J&J), supporting its claims with direct evidence. (2) There are no numeric inaccuracies—no specific dollar amounts or percentages are misstated, and the qualitative financial impact is described appropriately without overstatement. (3) The reasoning is sound: the LLM correctly infers that AbbVie perceives a more direct financial threat due to explicit warnings in its 10-K about reduced prices and reimbursements, while J&J treats the IRA as a general regulatory risk without flagging material revenue concentration, suggesting lower relative exposure. This reflects a correct synthesis across both companies’ filings and strategic postures. (4) The LLM omits J&J’s litigation challenge mentioned in the original answer—a notable but not critical omission, as the core of the question (differential revenue strategy impact) is still well addressed. The absence of this detail slightly reduces qualitative completeness but does not undermine factual correctness. Overall, the answer is semantically equivalent in substance, with excellent contextual relevance and precise entity and date accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 403,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does Citi's governance structure for managing compliance risk specifically address the potential amplification of credit and liquidity risks stemming from transition climate risks as outlined in Morgan Stanley's risk disclosures?",
      "original_answer": "Citi's governance structure includes the Board and Executive Management Team, which oversee enterprise risk management (ERM) and hold management accountable for the effectiveness of internal controls and compliance with legal and regulatory requirements. This includes ensuring that compliance risk is effectively managed across the organization. Transition climate risks, as outlined in Morgan Stanley's disclosures, may amplify credit and liquidity risks by reducing customers' operating income or the value of their assets. These risks also expose firms to reputational, compliance, and litigation risks due to increased legal and regulatory scrutiny. Citi’s Internal Audit, which reports functionally to the Chair of the Citi Audit Committee, provides independent assurance over the effectiveness of governance, risk management, and controls, including those addressing climate-related risks. This structure ensures that compliance risk management processes are aligned with evolving regulatory expectations, such as those related to climate risk, which Morgan Stanley notes are increasingly focused on disclosure and regulation of carbon emissions.",
      "llm_answer": "Citi’s compliance‑risk governance is built around the Independent Compliance Risk Management (ICRM) function, which is led by the Group Chief Compliance Officer, reports directly to the Board’s Risk Management Committee and sits on the Risk Management Executive Council alongside the CRO.  ICRM, together with the Group Business Risk and Control Committee, monitors and escalates compliance issues that arise from climate‑transition regulations, and feeds those alerts to the Independent Risk Management (IRM) team that sets credit‑ and liquidity‑risk limits.  By embedding climate‑transition compliance monitoring into the same oversight chain that governs credit and liquidity risk, Citi’s structure is expressly designed to curb the amplification of credit‑ and liquidity‑risk exposures that Morgan Stanley notes can result from transition‑related policy, legal and market changes.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and addresses the core of the multi-hop question by linking Citi's governance structure to the management of compliance risks related to climate transition, and how this connects to credit and liquidity risks as highlighted in Morgan Stanley's disclosures. There are no numeric values in either the ground truth or the LLM answer, so quantitative accuracy is 10 by default. The LLM introduces specific structural elements—ICRM, Group Chief Compliance Officer, Risk Management Executive Council, and IRM—that are not explicitly mentioned in the original answer but are plausibly consistent with Citi’s governance framework. While the original answer emphasizes the Board, Executive Management, and Internal Audit (reporting to the Audit Committee), the LLM focuses on ICRM and its integration with risk oversight bodies. This represents a difference in emphasis but not necessarily inaccuracy. The key multi-hop reasoning—connecting Citi’s compliance governance to the amplification of credit and liquidity risks from transition climate risks as noted by Morgan Stanley—is correctly synthesized and logically sound. The LLM accurately reflects that regulatory changes tied to climate transition can impact financial risks and that Citi’s structure is designed to monitor and escalate such risks across compliance, credit, and liquidity domains. However, the original answer includes an important point about reputational, compliance, and litigation risks due to increased regulatory scrutiny, and the role of Internal Audit in providing independent assurance—elements missing in the LLM response. These omissions reduce completeness slightly, justifying a correctness score of 8 rather than 9 or 10. Overall, the LLM answer is factually aligned, contextually relevant, and semantically equivalent in intent and substance, though less comprehensive in coverage of control functions like Internal Audit.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 520,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does QCOM's reliance on Chinese OEMs for 30% of its licensing revenue create different supply chain risks compared to TXN's strategy of expanding internal 300mm wafer fabrication capacity?",
      "original_answer": "QCOM derives a significant portion of its licensing revenues from Chinese OEMs, with 30% of total licensing revenue coming from this group of manufacturers. Delays or disputes in license agreements with these OEMs can directly impact QCOM's revenue and cash flows. In contrast, TXN is expanding internal 300mm wafer fabrication capacity through investments in RFAB2, LFAB1, and SM1 facilities, aiming to achieve greater supply chain control and reduce dependency on external foundries. While QCOM's business model depends heavily on maintaining licensing agreements with external manufacturers, particularly in China, TXN's strategy reduces exposure to external supply chain disruptions by vertically integrating manufacturing. This creates different risk profiles: QCOM faces higher exposure to geopolitical and contractual risks in China, while TXN mitigates manufacturing risks through capital investments in internal capacity.",
      "llm_answer": "Qualcomm’s licensing stream is heavily tied to a handful of Chinese OEMs that together generate about 30 % of its royalty income. Because Qualcomm does not control those OEMs’ product‑development, sales or cash‑flow cycles, it is exposed to geopolitical and trade‑policy actions, possible payment defaults and the risk that the OEMs will vertically integrate or switch to competitors – all of which can abruptly cut or curtail licensing revenue (see QCOM pages 19‑20).  \n\nIn contrast, Texas Instruments is reducing supply‑chain exposure by expanding its own 300 mm wafer‑fab capacity (RFAB2, LFAB1, SM1/SM2, LFAB2 – pages 6‑7), which gives it greater control over manufacturing lead times, raw‑material costs and capacity constraints and limits reliance on external foundries, making its risk profile centered on internal production execution rather than on external customer or geopolitical disruptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 30% figure for QCOM's licensing revenue from Chinese OEMs is correctly stated. No other numerical values are present, and all are accurate. Format variations (e.g., 300 mm vs 300mm) are acceptable and do not affect meaning. (2) The answer addresses all parts of the multi-hop question: it contrasts QCOM's reliance on Chinese OEMs for licensing revenue with TXN's internal 300mm wafer fab expansion, correctly identifying the differing supply chain risk profiles. (3) Entity accuracy is strong: QCOM and TXN are correctly identified, and the facilities mentioned (RFAB2, LFAB1, SM1) match the ground truth; SM2 and LFAB2 are additional but not incorrect—likely reflecting updated or supplementary info from the source (pages 6–7 cited), so not penalized. (4) Reasoning is sound: the LLM correctly synthesizes that QCOM faces geopolitical and contractual risks due to external dependencies, while TXN reduces external supply chain risks through vertical integration. The only minor shortcoming is that the original answer emphasizes TXN’s goal of reducing dependency on external foundries more explicitly, and the LLM slightly underemphasizes the contrast in business models (licensing vs. manufacturing). However, the core multi-hop logic—linking QCOM’s revenue model to geopolitical risk and TXN’s capex to supply chain control—is intact and semantically equivalent. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 454,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does Southern Company's evaluation of ASU 2020-04 in relation to interest rate derivatives compare with Duke Energy's assessment of the same accounting standard's impact on its LIBOR-indexed financial contracts?",
      "original_answer": "Southern Company continues to evaluate the provisions of ASU 2020-04 and its impact on transitioning to alternative interest rates, particularly in relation to its interest rate derivatives as noted in Note 14, while Duke Energy is assessing the optional expedients provided by the same standard to manage contractual amendments or terminations for LIBOR-indexed financial arrangements, including variable-rate debt and interest rate swaps, which may extend beyond the 2023 LIBOR phase-out. Both companies recognize the uncertainty around the ultimate financial impact, with Duke Energy specifically noting it is not expected to be material.",
      "llm_answer": "Southern Company says it has elected to apply the ASU 2020‑04 amendments to any debt‑modification transactions that fall within the guidance and is continuing to evaluate the transition to an alternative rate, but it does not expect a material impact on its statements. Likewise, Duke Energy is reviewing its LIBOR‑indexed swaps and other contracts, considering the optional expedients in ASU 2020‑04, and also concludes that the transition is unlikely to have a material effect on its financial results.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the essential comparison between Southern Company and Duke Energy regarding their assessments of ASU 2020-04. (1) Both companies are accurately described as evaluating the standard’s impact on interest rate derivatives and LIBOR-indexed contracts, with correct mention of ongoing evaluation and expectations of immaterial financial impact. (2) There are no numeric values, dates, or percentages in the original or LLM answer that conflict—both correctly avoid asserting specific figures, and no calculation errors exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both firms are assessing ASU 2020-04 in the context of derivatives and debt transitions, though the LLM omits some detail from the ground truth—specifically, Southern Company's reference to Note 14 and Duke Energy's focus on optional expedients for contractual amendments or terminations, including variable-rate debt and interest rate swaps extending beyond 2023. (4) Despite these minor omissions, the core meaning and comparison are preserved, and the conclusion about materiality aligns exactly. The LLM slightly simplifies Duke Energy's broader scope of assessment but still correctly states it is reviewing LIBOR-indexed swaps and contracts. Thus, while not fully complete in contextual detail, the answer remains factually accurate and contextually relevant, warranting a high score but not perfect due to missing nuances in the scope of each company's evaluation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 415,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the exposure of AMZN's foreign currency assets to British Pounds and Euros compare to NKE's reliance on option contracts for managing similar currency risks, given their differing approaches to foreign exchange risk management?",
      "original_answer": "AMZN holds foreign currency assets in British Pounds, Euros, and other currencies, and is exposed to foreign exchange risk due to fluctuations that may materially impact translated values of these assets. NKE actively manages its foreign exchange risk using option contracts, specifically hedging exposures related to product costs, external sales, and other costs denominated in currencies like the British Pound and Euro. While AMZN discloses its exposure to these currencies, it does not specify the use of derivative instruments like options to hedge this risk. In contrast, NKE explicitly states its use of option contracts as part of its foreign currency risk management program to hedge forecasted transactions and balance sheet exposures. This suggests that NKE takes a more proactive and structured approach to mitigating foreign exchange impacts through financial instruments, while AMZN's strategy remains less transparent in terms of derivative usage.",
      "llm_answer": "Amazon’s 10‑K notes that it “holds cash equivalents and/or marketable securities in foreign currencies such as British Pounds … and Euros,” so a portion of its balance‑sheet assets is directly exposed to movements in those currencies (no hedging instruments are described). Nike, by contrast, states that it “may also elect to use currency forward and **option contracts** to hedge the remaining effect of exchange‑rate fluctuations” on its product‑cost, sales and other exposures, making options a core tool of its foreign‑exchange risk‑management program. Thus, Amazon’s risk comes from un‑hedged GBP/EUR holdings, while Nike relies on option contracts (along with forwards) to offset similar currency risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly identifies that AMZN holds foreign currency assets in British Pounds and Euros without disclosing the use of hedging instruments, while NKE explicitly uses option contracts (along with forwards) to manage foreign exchange risk. The characterization of AMZN's exposure as unhedged and NKE's approach as proactive and instrument-based is consistent with the ground truth. (2) There are no numerical values in the question or answers requiring calculation, so quantitative accuracy is not applicable in a numerical sense; however, all factual assertions (e.g., types of currencies, use of options) are correct, earning full marks. (3) The multi-hop reasoning—comparing two companies' approaches to FX risk management across their 10-K disclosures—is sound: the model correctly synthesizes AMZN's asset exposure without derivative hedging disclosure and contrasts it with NKE's explicit use of options for hedging forecasted transactions and balance sheet items. (4) The only minor shortcoming is that the LLM slightly simplifies NKE’s program by not mentioning 'hedging exposures related to product costs, external sales, and other costs' in full detail, and omits the explicit reference to 'forecasted transactions' in the hedging objective. However, the core meaning and comparative insight remain intact. Wording differences are acceptable under semantic equivalence. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 458,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the dynamic relationship between share class voting rights?",
      "original_answer": "At META, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders hold 33 1/3%, with each share of Class B having 15 votes. In contrast, at GOOGL, each share of Class A has one vote and each share of Class B has 10 votes, with no specific percentage provided for their distribution. This indicates that META grants significantly more voting influence to Class B shares relative to Class A compared to GOOGL's structure.",
      "llm_answer": "Meta Platforms’ 10‑K (see the filing summary) shows that the company has two voting‑share classes: each Class A share carries **one vote**, while each Class B share carries **ten votes**.  Because the number of Class B shares is small, the bulk of the company’s voting power is concentrated in the Class B stock.\n\nAlphabet (Google) describes the same split in its 10‑K (Note 11): **Class A = 1 vote per share**, **Class B = 10 votes per share**, and **Class C = no voting rights**.  Like Meta, Alphabet’s Class B shares may be converted at the holder’s option (and automatically convert on transfer) into Class A shares, so the voting‑power concentration can change if conversions occur.\n\n**Thus, Meta’s voting‑power distribution (1‑vote A vs 10‑vote B) mirrors Google’s dual‑class structure, with the added nuance at Google of a non‑voting Class C and the same conversion mechanism that can alter the effective voting balance.**",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the voting rights assigned to Meta's share classes. According to the ground truth, Meta's Class B shares have 15 votes per share, not 10 as stated in the LLM answer. Additionally, the ground truth specifies exact voting power distribution percentages: Class A holds 66 2/3% and Class B holds 33 1/3% of combined voting power at Meta. The LLM answer omits these percentages entirely and incorrectly implies a symmetric 1 vs 10 vote structure like GOOGL, which distorts the comparative analysis. For GOOGL, the LLM correctly identifies Class A as 1 vote and Class B as 10 votes, and correctly notes the existence of non-voting Class C shares and conversion mechanics, which aligns with the ground truth.\n\n(2) Quantitatively, the LLM fails on the most critical number: Meta’s Class B votes per share (reports 10 instead of 15). This error directly impacts the comparison, as the ground truth emphasizes that Meta grants *significantly more* voting influence to Class B relative to GOOGL, due to the 15:1 ratio versus 10:1. The absence of the 66 2/3% and 33 1/3% voting power split further undermines quantitative accuracy. While GOOGL numbers are correct, the Meta data is not, leading to a low quantitative accuracy score.\n\n(3) The reasoning is partially sound in recognizing the dual-class structure and conversion mechanisms at both companies, and in attempting a structural comparison. However, the multi-hop synthesis fails because the incorrect vote ratio leads to a flawed conclusion that the structures 'mirror' each other. In reality, Meta’s 15-vote Class B shares (with concentrated ownership) create a different balance of power than GOOGL’s 10-vote Class B, especially given the explicit voting power percentages in Meta’s case. The LLM does not capture this key distinction.\n\n(4) Contextual relevance is high because the answer addresses the core question about voting power distribution and compares both companies’ structures, including conversion rules and non-voting shares. But due to major factual errors in Meta’s voting rights and missing quantitative distribution, the correctness score is limited to 4—partially correct but with significant omissions and inaccuracies that affect the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 607,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Southern Company's (SO) investment in SNG and SNG's need for FERC approval on its pipeline project compare to Duke Energy Ohio's (DUK) experience with FERC approval in terms of regulatory constraints and capital implications?",
      "original_answer": "Southern Company's (SO) investment in SNG was $1,245 million as of December 31, 2024. SNG is developing a $3 billion pipeline project requiring FERC approval, with Southern Company Gas owning 50% of the project. This regulatory dependency could delay the project until 2029 if approvals are not met. Similarly, Duke Energy Ohio (DUK) requires FERC and PUCO approval to pay dividends from specific equity accounts, with a condition to maintain equity at no less than 30% of total capital. Both entities face regulatory constraints from FERC, but while SNG's challenge centers on project execution and timing, DUK's is tied to capital structure and dividend policy.",
      "llm_answer": "Southern Company’s equity‑method investment in Southern Company Gas includes a 50 % stake in SNG’s proposed $3 billion pipeline – a project that cannot move forward until all required regulator sign‑offs, including FERC approval, are obtained (page 92). By contrast, Duke Energy Ohio does not rely on FERC for project or rate approvals; its capital actions are constrained by state‑level PUC O rules that limit dividend payments and require a minimum equity‑to‑capital ratio, rather than a specific FERC pipeline permit (page 147). Consequently, Southern’s exposure is tied to a large, FERC‑dependent capital outlay, whereas Duke’s constraints are regulatory limits on earnings distribution and capital structure imposed by the state commission.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Southern Company's 50% stake in SNG's $3 billion pipeline project and the necessity of FERC approval, aligning with the ground truth. However, it omits the specific investment amount of $1,245 million in SNG as of December 31, 2024, which is a key quantitative fact from the original answer. Additionally, the LLM incorrectly states that Duke Energy Ohio does not rely on FERC for project or rate approvals — this contradicts the ground truth, which explicitly states that DUK requires both FERC and PUCO approval for dividend payments from specific equity accounts. While the focus on PUCO rules is correct, the dismissal of FERC's role in DUK’s regulatory constraints is inaccurate. (2) The $3 billion project cost and 50% ownership are correctly reported. However, the missing $1,245 million investment figure and the incorrect denial of FERC involvement for DUK reduce quantitative accuracy. There are no calculation errors, but key numbers are omitted or misrepresented. (3) The reasoning correctly contrasts Southern Company’s project-level FERC dependency with Duke Energy Ohio’s capital structure constraints. It synthesizes the different types of regulatory exposure — project execution vs. dividend policy — which reflects sound qualitative understanding. However, the failure to acknowledge FERC’s actual role in DUK’s approval requirements undermines the multi-hop comparison. (4) The answer is contextually relevant and well-structured, addressing both regulatory and capital implications. Despite the omission and error, the core contrast in regulatory nature (project vs. capital structure) is preserved, warranting high marks for relevance and qualitative reasoning. The correctness score is 7 due to accurate framing but significant omissions and one key factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 498,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Lowe's share repurchase activity through financial institutions in 2021-2022 compare with Home Depot's use of dividend equivalents in terms of shareholder value distribution mechanisms?",
      "original_answer": "Lowe's authorized $13.0 billion in additional share repurchases in December 2021, bringing total authorization to $28.0 billion since 2020, and executed a $3.0 billion accelerated share repurchase (ASR) with a financial institution, receiving 11.9 million shares. Meanwhile, Home Depot pays dividend equivalents on unvested restricted stock units and performance shares, which accrue and are paid out in the form of additional shares upon vesting or payout. This shows Lowe's prioritized direct share reduction through financial intermediaries, while Home Depot focused on equity-based dividend equivalent compensation aligned with vesting timelines.",
      "llm_answer": "Lowe’s returned shareholder value in fiscal 2021‑2022 primarily through direct buy‑backs, repurchasing $13.1 billion of common stock and, in November 2021, entering into an accelerated‑share‑repurchase (ASR) agreement with a third‑party financial institution that involved a $3 billion cash payment for an immediate delivery of shares. In contrast, Home Depot’s distribution mechanism is indirect: its stock‑based compensation plans grant dividend equivalents on performance shares, restricted stock units and other awards, which are paid as additional shares when the awards vest or are settled, rather than through cash‑based share repurchases.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Lowe's use of share repurchases, including the $3.0 billion ASR with a financial institution, and contrasts it with Home Depot's use of dividend equivalents on unvested equity awards. However, the LLM states Lowe's repurchased $13.1 billion of stock in fiscal 2021–2022, which conflates execution with authorization. The ground truth specifies that Lowe's *authorized* an additional $13.0 billion in December 2021 (not executed), bringing total authorization since 2020 to $28.0 billion. The $13.1 billion figure does not appear in the ground truth and appears to be a factual error or misattribution. (2) The ASR amount ($3 billion) and timing (November 2021 vs. December 2021 in ground truth) are close but slightly off in date—minor discrepancy. The ground truth notes 11.9 million shares received, which the LLM omits. (3) The qualitative reasoning is strong: the LLM correctly synthesizes that Lowe’s uses direct share reduction via financial intermediaries (ASR), while Home Depot uses indirect, vesting-aligned dividend equivalents paid in shares. This reflects accurate multi-hop reasoning across companies and mechanisms. (4) Contextual relevance is excellent—the response directly addresses the comparison of shareholder value distribution mechanisms. Despite minor quantitative inaccuracies in execution vs. authorization and missing share count, the core contrast is well-articulated, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 410,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure of supplier finance program obligations for both Caterpillar and Honeywell, particularly in terms of the rollforward requirement effective in 2024?",
      "original_answer": "Caterpillar and Honeywell both adopted ASU 2022-04, which mandates enhanced disclosures for supplier finance programs. The guidance requires annual disclosure of key terms, balance sheet presentation, and a rollforward of obligations, with the rollforward specifically becoming effective on January 1, 2024. Caterpillar included the rollforward in its 2024 disclosures, showing $830 million in obligations at year-end. Honeywell also adopted the rollforward requirement for 2024, aligning with the new standard. Both companies now provide more transparent reporting of their supplier finance obligations, which were $830 million for Caterpillar and would be similarly detailed for Honeywell under the new rules.",
      "llm_answer": "Both Caterpillar and Honeywell have adopted ASU 2022‑04, which requires a buyer that uses a supplier‑finance program to (i) describe the program’s key terms, (ii) state where the related amounts appear on the balance sheet, and (iii) provide a roll‑forward of the “confirmed‑as‑valid” obligations. The standard became effective for the roll‑forward element on January 1 2024, and each company now discloses the obligations in Accounts Payable and presents a table showing the beginning‑of‑period balance, invoices confirmed during the year, invoices paid, and the ending‑of‑period balance. Honeywell’s 10‑K includes this roll‑forward in Note 19 (Supplier Finance Programs) with the 2024 figures ($803 m beginning, $5,140 m confirmed, $5,113 m paid, $830 m ending) and a schedule of future payments; Caterpillar’s filing contains a comparable roll‑forward in its supplier‑finance note, reflecting the same required elements under the ASU.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative description of ASU 2022-04 and its impact on Caterpillar and Honeywell, accurately outlining the three key disclosure requirements and correctly stating that the rollforward requirement became effective on January 1, 2024. It correctly identifies that both companies now disclose supplier finance obligations within Accounts Payable and provide a rollforward with beginning balance, invoices confirmed, payments, and ending balance. However, there is a quantitative discrepancy: the LLM claims Honeywell had an $803 million beginning balance and $830 million ending balance in 2024, with $5,140 million confirmed and $5,113 million paid. The ground truth only confirms that Caterpillar reported $830 million in obligations at year-end and does not provide specific rollforward figures for Honeywell. The LLM introduces detailed numerical data for Honeywell not present in the original answer, which risks overprecision or fabrication. While the structure and reasoning are sound and the Caterpillar figure aligns (implied $830 million ending balance), the inclusion of Honeywell-specific numbers not in the ground truth reduces quantitative accuracy. The multi-hop reasoning—linking ASU 2022-04 to both companies and the 2024 rollforward requirement—is well-executed and contextually appropriate. Semantic equivalence is mostly preserved, but the added Honeywell figures go beyond the original answer’s scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 401,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the $49,549 million in credit card loans due within 1 year reported by Company C compare to Visa's strategy of driving growth through credit card issuance, given the $20 trillion global opportunity they identify in converting non-card payments to digital credentials?",
      "original_answer": "Company C reports holding $49,549 million in credit card loans due within 1 year, indicating a significant portion of short-term consumer credit exposure. This aligns with Visa's strategic focus on expanding credit card usage to capture a share of the $20 trillion global opportunity in converting non-card payments to digital credentials on their network. Visa's emphasis on growing credit card programs through financial institution partnerships suggests a continued push to increase the volume and velocity of credit card transactions, which would likely feed into larger short-term loan balances across institutions like Company C.",
      "llm_answer": "Company C (Citi) reports $49.5 billion of credit‑card loans that mature within one year (see C page 86).  Visa’s 2024 filing says it is pursuing growth by expanding credit‑card issuance and digital credentials to capture “more than $20 trillion” of global opportunity to convert non‑card payments into card‑based transactions (see V pages 8‑9).  Thus, Citi’s near‑term $49.5 billion loan balance represents only a tiny fraction—roughly 0.25 %—of the $20 trillion market that Visa is targeting with its credit‑card growth strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Company C (Citi) holding $49,549 million (~$49.5 billion) in credit card loans due within 1 year, matching the ground truth. It accurately references Visa's $20 trillion global opportunity figure and their strategy of expanding credit card issuance and digital credentials. The calculation of Citi's loan balance as ~0.25% of the $20 trillion market ($49.5 billion / $20 trillion = 0.002475) is mathematically correct and adds a quantitative perspective not in the original answer but logically sound. (2) All numbers are accurate: $49.5 billion is a valid rounding of $49,549 million; $20 trillion is correctly cited; the 0.25% fraction is precise. Formatting variations (billion vs. million) are acceptable and correctly converted. (3) The multi-hop reasoning is strong: it connects Citi’s short-term credit exposure to Visa’s broader growth strategy, synthesizing data from both companies’ filings. The added comparative percentage enhances the analysis and aligns with the strategic context. (4) The only reason for not scoring a 10 in qualitative accuracy is that the original answer emphasizes the systemic alignment between institutional loan growth and Visa’s network strategy, while the LLM focuses more on scale comparison. However, the LLM’s interpretation is still valid and adds value. Overall, the answer is factually correct, well-reasoned, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 396,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the impact of weather conditions on Southern Company's gas distribution revenues compare to the exposure of NextEra Energy's electricity demand, considering their respective risk mitigation strategies?",
      "original_answer": "Southern Company Gas' earnings are affected by customer consumption patterns that are largely a function of weather conditions and natural gas price levels. For example, in 2023, Southern Company Gas experienced a 6.2% decrease in net income compared to 2022, partly due to lower gas volumes sold driven by weather patterns. However, the company utilizes mechanisms like weather normalization and weather derivative instruments to limit exposure to typical weather variations. In contrast, NextEra Energy (NEE) faces more direct and severe operational risks from weather conditions, such as hurricanes, extreme temperatures, and disruptions to power generation from wind and solar facilities. NEE's Florida-based operations are particularly vulnerable to hurricanes, which can cause power outages, infrastructure damage, and increased costs for service restoration. While NEE also seeks cost recovery through regulatory mechanisms, its exposure to unpredictable weather events poses a more immediate threat to both operations and financial performance compared to Southern Company Gas' structured risk management approach.",
      "llm_answer": "Southern Company’s gas‑distribution earnings are weather‑sensitive because customer heating consumption rises and falls with temperature, but the company cushions that exposure with regulatory “weather‑ and revenue‑normalization” mechanisms and weather‑derivative contracts that limit the impact of typical weather swings (see SO 10‑K pp. 86‑87). In contrast, NextEra Energy’s electricity demand is directly driven by weather—extreme heat, cold, hurricanes and other events can sharply alter load and revenue—and the filing only cites broad hedging and risk‑management tools, without the same dedicated weather‑normalization instruments, leaving its demand more exposed to weather‑related volatility (see NEE 10‑K pp. 26‑28).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies the key differences between Southern Company and NextEra Energy regarding weather exposure and mitigation strategies. (1) There are no numeric inaccuracies: while the LLM does not mention the specific 6.2% net income decrease for Southern Company in 2023, this omission does not introduce inaccuracy—only incompleteness. All other qualitative assertions about risk mitigation mechanisms are consistent with the ground truth. (2) Quantitatively, no incorrect numbers are presented; the absence of the 6.2% figure is a minor gap but does not affect the correctness of what is stated. (3) The multi-hop reasoning is sound: the model correctly synthesizes that Southern Company uses weather normalization and derivatives (citing SO 10-K pp. 86–87), while NextEra Energy faces more direct weather impacts (especially hurricanes in Florida) and lacks dedicated weather-normalization instruments, relying instead on broader risk management (citing NEE 10-K pp. 26–28). This aligns with the ground truth’s emphasis on NEE’s operational vulnerability versus SO’s structured financial mitigation. (4) The answer is contextually highly relevant, directly comparing both companies’ exposure and strategies as required. The main limitation is the lack of specific financial impact data (e.g., the 6.2% decline), which slightly reduces completeness but does not undermine the overall correctness. Hence, a score of 8 is justified—core facts and reasoning are correct, but minor detail omission prevents a 9–10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 430,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does McDonald's revenue model relying on affiliates compare to General Motors' production strategy for crossovers through nonconsolidated affiliates, particularly in terms of revenue contribution and operational structure?",
      "original_answer": "McDonald's generates revenue from affiliates through royalty payments based on a percentage of sales, along with initial fees, as part of its franchise model. This structure allows McDonald's to maintain a steady income stream tied directly to the performance of affiliate-operated restaurants. In contrast, General Motors produces crossovers through nonconsolidated affiliates involved in development, manufacturing, and marketing, where GM engages in purchasing and selling transactions with these entities. While McDonald's affiliate model centers on brand licensing and royalty income, GM's affiliate relationships focus on vehicle production and distribution. This results in distinct revenue contributions: McDonald's sees recurring revenue from affiliate royalties, whereas GM's revenue from affiliates is transactional and tied to the volume of crossover production and sales.",
      "llm_answer": "McDonald’s earns most of its revenue from the restaurants it owns **and** from the royalties, rent and initial‑fee payments it receives from franchisees, developmental licensees and other affiliates – amounts that are calculated as a percentage of each outlet’s sales and are **not** consolidated because the company does not have voting control over those entities (see MCD 10‑K pages 46‑48).  \n\nBy contrast, General Motors produces many of its trucks, cross‑overs and cars through joint‑venture affiliates (primarily its China JVs) that are **non‑consolidated**; the only revenue that flows to GM from those affiliates is the modest “automotive sales and revenue” of about **$90 million** in 2024 and the equity‑method earnings, which were a loss of **$4.4 billion** (see GM 10‑K pages 103‑104, 77). Thus, McDonald’s affiliate‑based model contributes a sizable, ongoing percentage‑of‑sales stream to total revenue, whereas GM’s crossover production through non‑consolidated affiliates contributes only a tiny slice of total sales and is reflected mainly through equity‑method gains/losses rather than direct revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies McDonald's revenue model as being based on royalties, rent, and initial fees from franchisees and affiliates, tied to sales percentages, and notes these are nonconsolidated due to lack of voting control—consistent with MCD 10-K pages 46–48. For GM, it accurately describes production through nonconsolidated joint ventures (especially in China), with minimal direct revenue ($90 million in automotive sales) and significant equity-method losses ($4.4 billion), citing GM 10-K pages 103–104 and 77. (2) The quantitative figures—$90 million in direct revenue and $4.4 billion equity loss—are factually correct and contextually appropriate for 2024 (as reported in the filings). While the ground truth does not specify exact numbers, the LLM adds precision from actual filings, enhancing rather than contradicting the original answer. (3) The multi-hop reasoning is sound: it synthesizes across two companies, their distinct use of nonconsolidated affiliates, and contrasts revenue contribution (recurring royalty-based vs. transactional/equity-based). It correctly infers that McDonald’s affiliate model contributes directly and significantly to revenue, while GM’s contribution is minimal and primarily reflected in equity earnings, not sales. (4) Minor deduction in correctness and quantitative accuracy due to the addition of specific numbers not in the original answer (e.g., $90M, $4.4B), which, while accurate, go beyond the scope of the provided ground truth; however, since they are correct and improve precision, the impact is minimal. Overall, the answer exceeds the original in detail without introducing errors, making it semantically equivalent and contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 483,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the voting power dilution protection for Class B Common Stock at CMCSA compare with the automatic conversion provisions for Class B Common Stock at GOOGL, particularly in light of CMCSA's share-for-share conversion restriction and GOOGL's voluntary and transfer-triggered conversion policy?",
      "original_answer": "At CMCSA, the Class B Common Stock has a non-dilutable 33 1/3% aggregate voting power, which cannot be diluted by additional issuances of any other class of common stock, and is convertible share-for-share into Class A Common Stock, subject to certain restrictions. In contrast, at GOOGL, Class B Common Stock is entitled to 10 votes per share and can be voluntarily converted to Class A Common Stock at any time, with automatic conversion upon sale or transfer. This means CMCSA’s Class B shares maintain structural voting protection unaffected by issuance volumes, while GOOGL’s Class B shares lose enhanced voting rights upon transfer, making CMCSA's Class B shares more resilient to voting dilution.",
      "llm_answer": "Comcast’s charter locks the voting power of its Class B shares at a fixed one‑third of total votes and expressly states that this aggregate voting power “cannot be diluted by additional issuances of any other class of common stock.” Its Class B shares can be converted share‑for‑share into Class A stock, but only under the “certain restrictions” set out in the certificate of incorporation, which limit when and how the conversion can occur. In contrast, Alphabet’s charter gives each Class B share ten votes and permits holders to convert at any time voluntarily, while also triggering an automatic conversion to Class A shares whenever a Class B share is sold or transferred—providing no comparable voting‑power dilution protection.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: CMCSA's Class B shares have a fixed 33 1/3% (one-third) aggregate voting power that cannot be diluted by additional stock issuances, and are convertible share-for-share into Class A shares subject to restrictions. GOOGL's Class B shares have 10 votes per share, can be voluntarily converted to Class A at any time, and automatically convert upon sale or transfer. (2) Quantitative accuracy is perfect: 'one-third' correctly represents 33 1/3%, and '10 votes per share' matches the ground truth. No calculations are required, but comparative statements are accurate. (3) Multi-hop reasoning is sound: the answer correctly contrasts CMCSA’s structural, non-dilutable voting protection with GOOGL’s transfer-triggered loss of enhanced voting rights, highlighting that CMCSA’s Class B shares are more resilient to voting dilution. (4) The response is fully contextually relevant, directly addressing the comparison of voting dilution protections and conversion mechanisms. Wording differs slightly but meaning is preserved with high precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 326,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does AXP's valuation methodology for Level 3 investment securities expose it to the risks of illiquid market conditions, and how might this impact MS's ability to manage market risk during periods of asset devaluation?",
      "original_answer": "AXP relies on internal credit models and third-party valuations for its Level 3 investment securities, which include debt securities from Community Development Financial Institutions and an embedded derivative in GBT JerseyCo Limited valued using Monte Carlo simulations. These valuation techniques are sensitive to changes in market inputs and assumptions, particularly in illiquid market conditions where observable data is scarce. JPM_10k_2024.pdf confirms that illiquid markets make it extremely difficult to value financial instruments, and valuations may materially change when market conditions shift, leading to potential losses upon disposition. MS_10k_2024.pdf further states that during periods of market volatility and illiquidity, the firm faces challenges in valuing and monetizing financial instruments, which can negatively affect its results of operations and risk management strategies, including hedging inefficiencies and increased counterparty risk.",
      "llm_answer": "American Express values its Level 3 investment securities using unobservable, internally‑generated inputs – essentially its own discounted‑cash‑flow models and credit‑risk assumptions – because there is no active market for those securities (see the Level 3 definition on page 145 and the discussion of the internal credit model for Community Development Financial Institution debt on page 146). When market liquidity dries up, those models may diverge sharply from any observable price, so the fair‑value estimates can swing dramatically and may not reflect the price that could actually be realized. If such Level 3 assets were to be de‑valued, Morgan Stanley’s market‑risk framework would be strained, since, as it notes on page 13, illiquid market conditions make it difficult to value and monetize positions and can limit the firm’s ability to hedge or offset losses, thereby impairing its capacity to manage market risk during periods of asset devaluation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) It correctly identifies AXP's use of internal models (discounted cash flow and credit risk assumptions) for valuing Level 3 securities, specifically mentioning Community Development Financial Institution debt, which aligns with the ground truth. It also references the lack of active markets, linking this to reliance on unobservable inputs. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: it connects AXP's valuation methodology to risks in illiquid markets, then explains how that could impact MS's market risk management. It correctly cites MS's challenges in valuing and monetizing positions during illiquidity (aligned with MS_10k_2024.pdf) and mentions hedging limitations. The only minor omission is the specific mention of the embedded derivative in GBT JerseyCo Limited valued via Monte Carlo simulations, which is present in the original but absent in the LLM response. This reduces completeness slightly but does not undermine the overall correctness. (4) The answer is contextually fully relevant, directly addressing both parts of the question: how AXP’s methodology creates risk in illiquid markets, and how that affects MS’s risk management. Wording differs but semantic meaning is equivalent. Minor deduction from 10 to 9 due to omission of Monte Carlo example, but all key mechanisms and implications are accurately captured.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 437,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the valuation approach for Chevron's Level 2 derivatives compare to Exxon's use of discounted cash flow models in valuing upstream assets acquired from Pioneer, particularly in terms of observable market inputs and management judgment?",
      "original_answer": "Chevron classifies its derivatives as Level 2 when valued using third-party broker quotes, industry pricing services, and exchanges, relying on observable market data like interest rates and foreign exchange rates, with minimal adjustments. In contrast, Exxon used discounted cash flow models incorporating management judgment and unobservable inputs—such as projected production volumes, commodity prices based on third-party industry experts, and risk-adjusted discount rates—to determine the fair value of upstream assets acquired from Pioneer. While Chevron's Level 2 derivatives rely on largely consistent and observable inputs, Exxon's valuation required significant assumptions about future market conditions and asset performance, reflecting a higher degree of subjectivity and forward-looking judgment.",
      "llm_answer": "Chevron classifies its Level 2 commodity swaps, options and forwards at fair value using third‑party broker quotes, industry pricing services and exchange‑derived data—observable market inputs that the company applies “as‑is” with no material adjustments. Exxon, by contrast, valued the Pioneer upstream assets with discounted‑cash‑flow models that use observable price averages from third‑party experts but also depend heavily on management‑derived estimates of production, costs and risk‑adjusted discount rates, so the valuation involves considerably more judgment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies Chevron's use of Level 2 derivatives valued via third-party broker quotes, industry pricing services, and exchange data, emphasizing observable inputs with no material adjustments—consistent with the original answer. It contrasts this with Exxon's use of discounted cash flow (DCF) models for valuing upstream assets from Pioneer, correctly noting the inclusion of management-derived estimates (production, costs, discount rates) and reliance on third-party expert price averages. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense; however, the qualitative descriptors (e.g., 'observable', 'management-derived', 'no material adjustments') are factually correct and consistent. (3) The multi-hop reasoning—comparing Chevron’s derivative valuation approach to Exxon’s asset valuation methodology across different contexts—is sound and synthesizes the correct entities (Chevron, Exxon, Pioneer, Level 2 derivatives, DCF models). (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'unobservable inputs' or 'forward-looking assumptions about commodity prices' as clearly as the original, slightly downplaying the extent of subjectivity in Exxon’s model compared to Chevron’s. However, the phrase 'considerably more judgment' effectively captures the higher degree of subjectivity. Overall, the answer is semantically equivalent, contextually precise, and factually correct with only slight nuance missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 451,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does Duke Energy's negotiation of PPAs for renewable facilities compare with Southern Power's investment in solar facilities in terms of financial structure and tax credit utilization, given the role of PPAs in financing solar assets?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, which significantly influences the economic performance of its renewable energy VIEs, particularly through siting, PPA negotiation, and ongoing operations. These PPAs are also central to Southern Power's financial structure, where they are accounted for as operating leases with terms up to 25 years for solar facilities. Southern Power utilizes federal tax credits (ITCs and PTCs), with $1.2 billion of unutilized credits at the Southern Company level as of December 31, 2021, largely tied to solar and wind investments. This indicates that while both companies rely on PPAs in the development and operation of solar facilities, Southern Power integrates tax equity partnerships and federal incentives more directly into its investment model, affecting cash flows and net income differently than Duke’s VIE and guarantee-based financing.",
      "llm_answer": "Duke Energy’s renewable‑project VIEs are built around the **negotiation of long‑term PPAs** that generate the cash‑flows needed to service the debt guarantees the company provides; the PPAs are therefore a core financing tool, and the VIEs also incorporate tax‑equity partnerships that allow a third‑party tax partner to take most of the federal ITC and PTC benefits (see pages 203‑204). Southern Power, by contrast, **invests directly in solar facilities** and relies on **tax‑equity structures** to monetize its ITCs (about $0.8 billion of un‑used credits expected to be fully used by 2024) while the PPAs it signs for those solar assets provide revenue but carry no capacity charge and the buyer retains the renewable‑energy credits (see pages 96‑97, 270). Thus, Duke uses PPAs chiefly to underpin debt‑financed VIEs, whereas Southern Power uses PPAs for revenue while the financing of its solar builds is driven primarily by tax‑equity arrangements that capture the ITC.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative analysis and captures the core contrast between Duke Energy and Southern Power in terms of financial structure and tax credit utilization. It correctly identifies that Duke Energy uses PPAs as a core financing mechanism for its VIEs, supported by debt guarantees and tax-equity partnerships where third parties capture most ITC/PTC benefits. It also accurately notes that Southern Power invests directly in solar facilities and relies on tax-equity structures to monetize ITCs. However, there is a quantitative discrepancy: the LLM states Southern Power has 'about $0.8 billion of un-used credits expected to be fully used by 2024', while the ground truth reports '$1.2 billion of unutilized credits at the Southern Company level as of December 31, 2021'. This is a material difference in amount and lacks the specific date reference. Additionally, the LLM introduces a detail not in the original — that Southern Power's PPAs 'carry no capacity charge and the buyer retains the renewable-energy credits' — which, while possibly accurate, is not supported by the ground truth and adds unsupported specifics. Despite this, the multi-hop reasoning is sound: the model correctly synthesizes information across entities (Duke vs. Southern Power), financial structures (VIEs vs. direct investment), and tax credit mechanisms. The semantic meaning aligns well with the original, and the core conclusion — that Duke uses PPAs for financing VIEs while Southern Power uses them for revenue with tax equity driving financing — is accurate and well-supported. Hence, the answer earns a high score but is penalized for the incorrect dollar figure and minor addition of unsupported details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 468,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the concentration of voting power in NKE's Class A Common Stock, which elects three-quarters of the Board of Directors, compare with HD's treatment of voting rights for restricted stock awards in terms of governance influence?",
      "original_answer": "NKE's Class A Common Stockholders elect three-quarters of the Board of Directors, consolidating governance control within a single class of shares. In contrast, HD grants voting rights to recipients of restricted stock awards at the grant date, allowing them to vote on matters even before the restrictions lapse. This indicates that HD distributes voting influence more broadly across equity compensation recipients, while NKE centralizes it among Class A shareholders. Neither company allows Class B or C common stockholders to vote on most matters, but HD’s approach introduces earlier voting participation through restricted shares.",
      "llm_answer": "Nike’s dual‑class structure gives the holders of its Class A common stock the power to elect three‑quarters of the board of directors, concentrating a decisive share of governance control in that one class. In contrast, Home Depot’s equity‑based awards – such as restricted‑stock units and performance shares – carry **no voting rights until the underlying shares are actually issued after vesting**, so they do not provide any immediate influence over board composition or other governance matters.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that NKE's Class A Common Stock elects three-quarters of the board, which matches the ground truth and is quantitatively accurate. However, it makes a critical factual error regarding HD's treatment of restricted stock awards: the LLM claims that HD's equity awards (e.g., restricted stock units) carry no voting rights until shares are issued after vesting, which contradicts the ground truth stating that HD grants voting rights at the grant date, even before restrictions lapse. This is a major qualitative inaccuracy that undermines the comparison. The reasoning is therefore flawed in the multi-hop synthesis—instead of contrasting NKE's centralized control with HD's broader early distribution of voting rights, the LLM incorrectly portrays HD as restricting voting influence, which inverts the actual governance dynamic. While the entities (NKE, HD) and the general concept of dual-class vs. equity awards are correctly identified, the core contrast in governance influence is misrepresented. The answer is contextually relevant and well-structured but fails on a key factual point essential to the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 324,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the foreign exchange risk exposure of Netflix's forecasted revenue transactions compare to Disney's VAR model estimates, given both companies' use of financial instruments to hedge against currency fluctuations?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on forecasted revenue transactions denominated in non-U.S. dollar currencies, while Disney employs a VAR model that excludes forecasted transactions from its risk estimation. Netflix's foreign currency transactions resulted in a $293 million loss in 2023, indicating volatility in unhedged positions, whereas Disney's VAR estimate for maximum one-day loss decreased to $255 million in 2024 from $284 million in 2023 due to lower interest rate volatility. This suggests that while both companies manage FX risk, Disney's modeled approach excludes certain forecasted exposures that Netflix explicitly hedges.",
      "llm_answer": "Netflix explicitly hedges the foreign‑currency component of its forecasted subscription‑revenue stream with forward contracts, and the company’s translation of those non‑U.S. revenues has produced swings of a $293 million loss to $403 million gains in recent years. By contrast, Disney’s market‑risk model values its currency‑sensitive exposure at only about $40 million at fiscal‑year‑end (up to $57 million at its peak). Thus, Netflix’s foreign‑exchange risk tied to forecast revenue is materially larger than the amount Disney quantifies in its VAR estimate.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that Netflix's foreign exchange swings include a $293 million loss and a $403 million gain, but the ground truth only mentions a $293 million loss in 2023—there is no mention of a $403 million gain. More critically, the LLM claims Disney’s VAR estimate is 'about $40 million at fiscal-year-end (up to $57 million at its peak)', which directly contradicts the ground truth: Disney’s VAR estimate was $255 million in 2024 and $284 million in 2023. These numbers are completely different in magnitude and context. (2) The quantitative inaccuracies are severe: the LLM invents a $403M gain not present in the original, and replaces Disney’s actual VAR figures ($255M and $284M) with fabricated ones ($40M–$57M). These are not formatting differences but entirely incorrect values. (3) The reasoning is partially sound in structure—comparing Netflix’s hedging of forecasted revenues to Disney’s VAR model—but fails on multi-hop synthesis. The original answer emphasizes that Disney’s VAR model *excludes* forecasted transactions, which is a key qualitative distinction. The LLM omits this critical point and instead fabricates quantitative comparisons, undermining the logical foundation. (4) The contextual relevance is moderate because the answer addresses the right companies and general topic (FX risk, hedging, VAR), but the qualitative and quantitative inaccuracies severely degrade correctness. The conclusion that 'Netflix’s risk is materially larger' is unsupported due to incorrect data. Thus, correctness is low despite some relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 446,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How do the Value at Risk (VAR) calculations for MDLZ and PM differ in terms of the time periods used to estimate expected return distributions under normal market conditions, and what does this imply about their respective risk assessment horizons?",
      "original_answer": "MDLZ uses the prior quarter's interest rate, currency exchange, and commodity price movements to estimate return distributions for VAR calculations at year-end (December 31, 2024 and 2023), and the four prior quarters for average VAR amounts. In contrast, PM primarily uses the preceding quarter for year-end VAR calculations and the four preceding quarters for average, high, and low VAR amounts. This indicates that while both companies rely on recent market data, MDLZ explicitly applies a multi-quarter approach for average VAR, suggesting a slightly more extended risk assessment horizon compared to PM.",
      "llm_answer": "Both Mondelēz (MDLZ) and Philip Morris International (PM) build their VAR models on **the same time‑frames**: they use market movements observed **in the most recent quarter** to estimate the expected‑return distribution for the point‑in‑time VAR at year‑end, and they use **the four most recent quarters (a full year)** to compute the average (and high/low) VAR figures for the year. Because both firms rely on a one‑day holding‑period, 95 % confidence VAR that is calibrated to only the last three months of data (and a rolling‑year for averages), their risk‑assessment horizon is short‑term – a daily loss estimate – but it is grounded in very recent market behavior, with an additional view of how that risk has behaved over the past year.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant inaccuracies in the comparison between MDLZ and PM's VAR time periods, despite correctly identifying some general practices. (1) The LLM claims both companies use 'the same time-frames', stating that both use the most recent quarter for year-end VAR and four quarters for averages. However, the ground truth specifies that MDLZ uses the prior quarter for year-end VAR and four prior quarters for averages, while PM uses the preceding quarter for year-end VAR *and also* the four preceding quarters for average, high, and low VAR amounts. The LLM incorrectly concludes equivalence, missing the nuance that MDLZ explicitly applies a multi-quarter approach for average VAR, which implies a slightly extended risk assessment horizon—a key differentiator highlighted in the original answer. (2) Quantitatively, the LLM does not introduce incorrect numbers (e.g., 'one quarter', 'four quarters' align roughly), but it fabricates a 'one-day holding-period' and '95% confidence' level not mentioned in the ground truth, introducing unsupported specifics. These additions misrepresent the source data and reduce quantitative accuracy. (3) The multi-hop reasoning is flawed: the question asks how the time periods differ and what that implies about risk horizons. The LLM fails to identify the subtle but important difference in how each company uses the four-quarter data (MDLZ for average VAR only vs. PM for average, high, and low), and incorrectly concludes no difference exists, undermining the comparative analysis. (4) Contextually, the answer is relevant and addresses VAR timeframes and risk implications, but the erroneous equivalence claim and invented model parameters (holding period, confidence level) severely compromise factual correctness. While the general idea of 'recent data + rolling year' is directionally correct, the lack of differentiation and added inaccuracies justify a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 522,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 relate to the auditor's evaluation of significant assumptions, and how does this compare to the auditor's approach in testing significant assumptions at NFLX related to content amortization estimates?",
      "original_answer": "The $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 was directly tied to the fair value assessment of the entertainment linear networks reporting unit, which relied on significant assumptions such as future revenues, operating margins, terminal growth rates, and discount rates. The auditor, PricewaterhouseCoopers LLP, evaluated the reasonableness of these assumptions by comparing them to historical performance, external market data, and evidence obtained elsewhere in the audit. Similarly, at NFLX, the auditor (also PricewaterhouseCoopers LLP) tested significant assumptions used in content amortization estimates, including forecasted viewing hour consumption and historical viewing patterns, by comparing them to current trends and prior actual results. Both audits involved sensitivity analyses and the use of professionals with specialized skills to assess the impact of changes in these assumptions on financial outcomes.",
      "llm_answer": "The $0.6 billion goodwill impairment that Disney recorded for fiscal 2024 was the result of management’s quantitative fair‑value test of its linear‑networks and DTC reporting units, and the auditors treated the assessment as a critical audit matter, performing extensive procedures to test the controls over the impairment model and to evaluate the reasonableness of the key assumptions – future revenues, operating expenses, margins, terminal growth rates and discount rates – used in the discounted‑cash‑flow valuation. Netflix’s auditors addressed a similarly complex, judgment‑heavy area – the amortization of content – by obtaining an understanding of, and testing the operating effectiveness of, controls over the amortization process and by scrutinizing the significant assumptions that drive estimated viewing patterns (historical and forecasted viewing hours), comparing them to current trends and running sensitivity analyses. Thus, both firms’ auditors focused heavily on testing management’s significant assumptions, but Disney’s work centered on DCF‑based goodwill‑impairment inputs, whereas Netflix’s work centered on viewing‑hour assumptions underlying content amortization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $0.6 billion goodwill impairment charge for DIS in fiscal 2024 is correctly stated, with no numerical errors. (2) The entities—DIS, NFLX, PricewaterhouseCoopers LLP (implied as the common auditor, though not explicitly named in the LLM answer)—are correct, and the fiscal year 2024 is accurately referenced. (3) The reasoning correctly identifies the multi-hop connection: both audits involve significant assumptions tested by auditors, with DIS focusing on DCF-based inputs (revenues, margins, growth rates, discount rates) for goodwill impairment, and NFLX on viewing-hour assumptions for content amortization. The LLM accurately notes auditor procedures such as sensitivity analyses, control testing, and evaluation of assumptions against trends and historical data. (4) The only minor shortcoming is that the LLM does not explicitly name the auditor (PricewaterhouseCoopers LLP) for both companies, which is included in the ground truth and strengthens the comparison. However, this omission does not undermine the factual or logical accuracy. The answer demonstrates strong synthesis across both companies and audit areas, with semantically equivalent and contextually appropriate content. Thus, the correctness score is 9 due to this slight omission, but quantitative accuracy and contextual relevance remain perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1570,
        "completion_tokens": 392,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the cost-sharing structure between Gilead and Merck for long-acting HIV injectable products compare to Gilead's other collaboration agreements, such as the one with Arcellx, in terms of financial commitment and milestone-based payments?",
      "original_answer": "Gilead and Merck share global development and commercialization costs for long-acting HIV injectable products at 60% and 40%, respectively, with no material expenses recognized under the agreement through 2024. This contrasts with Gilead's collaboration with Arcellx, where Gilead made a $313 million upfront payment and a $299 million equity investment in 2023, and paid $68 million in development milestones in 2024. Unlike the Merck agreement, which involves shared costs and revenue splits upon approval, the Arcellx collaboration includes significant upfront and milestone-based payments, profit sharing in the U.S., and royalties outside the U.S., indicating a more financially committed and risk-shared structure with Arcellx compared to the cost-sharing model with Merck.",
      "llm_answer": "The Merck‑Gilead HIV collaboration is structured mainly as a cost‑share: Gilead bears about 60 % of development and commercialization expenses and the partners split product revenue equally (with Gilead’s share rising to 65 % above a $3.5 billion sales threshold), and the filing notes no material upfront or milestone payments. By contrast, the Arcellx deal required a $313 million upfront cash payment (recorded as an in‑process R&D charge) plus a $299 million equity investment, and it provides for performance‑based development and regulatory milestones of up to $1.5 billion (with $68 million already paid in 2024) together with a 50/50 U.S. profit split and royalties on sales. Thus, the Merck arrangement involves a modest, ongoing cost‑sharing commitment, whereas the Arcellx collaboration carries a large upfront financial commitment and substantial milestone‑based payment potential.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $313 million upfront payment, $299 million equity investment, and $68 million milestone payment to Arcellx in 2024, which aligns with the ground truth. However, it incorrectly states that Gilead and Merck have an equal revenue split (50/50), with Gilead’s share increasing to 65% above a $3.5 billion threshold. The original answer does not mention any revenue split or sales threshold—only that costs are shared 60/40 (Gilead/Merck) and that there are no material expenses recognized through 2024. This is a significant factual error in the Merck agreement terms. Additionally, the LLM introduces a $1.5 billion potential milestone cap for Arcellx, which is not present in the ground truth and cannot be verified from the provided information. (2) Quantitative accuracy is partially compromised: while the Arcellx figures ($313M, $299M, $68M) are correct, the $1.5B potential milestones and the revenue-sharing thresholds for Merck are unsupported. The 60/40 cost share is correctly attributed, but the revenue split is fabricated. (3) The multi-hop reasoning is sound in comparing the nature of the two agreements—highlighting upfront/milestone payments for Arcellx versus cost-sharing for Merck—but the conclusion is based on incorrect assumptions about the Merck deal. The synthesis captures the contrast in financial commitment style but misrepresents the Merck arrangement. (4) Contextual relevance is high as the response directly addresses the comparison of financial commitment and milestone-based payments. Qualitative accuracy is good due to correct identification of entities and general structure, but quantitative accuracy is reduced due to unsupported numbers and incorrect revenue splits. Correctness score is 7 because core facts about Arcellx are accurate and the overall contrast is valid, but key details about the Merck agreement are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 518,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How do Tesla's multi-year pricing agreements with Panasonic for Gigafactory 2170 and Japan-sourced battery cells compare to GM's battery procurement cost exposure in terms of contractual stability and long-term cost predictability?",
      "original_answer": "Tesla has structured long-term pricing agreements with Panasonic Corporation for both Gigafactory 2170 cells (executed June 9, 2020) and Japan-sourced cells (executed December 29, 2020), providing multi-year cost predictability. In contrast, GM's 2023 10-K filing on page 78 indicates a dependency on battery procurement costs without equivalent visibility into long-term pricing agreements, suggesting greater exposure to market volatility. This creates a differentiated risk profile where Tesla has locked in pricing through 2020+ agreements while GM's battery cost structure appears more variable.",
      "llm_answer": "Tesla’s 2020‑2021 pricing agreements with Panasonic lock in the price of Gigafactory‑2170 cells and of Japan‑sourced cells for several years, creating a long‑term, fixed‑price supply contract that gives Tesla a stable cost base and high predictability for its battery expenses. In contrast, GM does not have comparable fixed‑price contracts; its battery cost exposure stems from its equity ownership and committed capital contributions to Ultium Cells Holdings LLC (the joint‑venture that supplies its Ultium cells), which is reflected only as an equity investment and a maximum loss‑exposure amount, leaving GM’s battery procurement costs more variable and less predictable.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) Quantitatively, the LLM correctly identifies Tesla's multi-year agreements with Panasonic for both Gigafactory 2170 and Japan-sourced cells, though it generalizes the execution dates as '2020–2021' rather than citing the specific dates (June 9, 2020, and December 29, 2020) from the original. This is a minor omission but does not affect factual correctness. (2) The LLM accurately contrasts Tesla's fixed-price, long-term contracts with GM's lack of equivalent visibility, correctly interpreting GM's exposure through its equity investment in Ultium Cells Holdings LLC and referencing the appropriate risk—variable and less predictable battery costs. While the original answer cites GM’s 2023 10-K page 78 for lack of long-term pricing visibility, the LLM infers this correctly but does not explicitly reference the source document detail. (3) The multi-hop reasoning is sound: the model synthesizes Tesla’s contractual agreements with Panasonic and contrasts them with GM’s joint-venture-based procurement model, correctly concluding that Tesla has greater cost predictability while GM faces more variability. (4) Semantically, the LLM answer matches the original in meaning—Tesla has contractual stability; GM does not—and uses accurate financial and strategic terminology. The only slight gap is the lack of explicit mention of 'market volatility' and the specific 10-K citation, but the implication is preserved. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 445,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Coca-Cola's use of non-derivative instruments to hedge foreign exchange risk compare to Procter & Gamble's exposure to foreign exchange fluctuations, given that both operate in similar international markets such as the United Kingdom and Germany?",
      "original_answer": "Coca-Cola actively uses non-derivative instruments, such as foreign currency-denominated third-party debt, to hedge foreign exchange risk related to its net investments in foreign subsidiaries, with these instruments designated in hedging relationships to offset currency exposure. In contrast, Procter & Gamble discloses that it is significantly exposed to foreign exchange fluctuations due to its international operations — particularly in the United Kingdom and Germany, which are among its largest markets — and while it employs strategies to manage these risks, it explicitly acknowledges that exchange rate movements have historically negatively impacted its net sales, earnings, and cash flows. Therefore, while Coca-Cola appears to have a more structured hedging approach, Procter & Gamble reports a more direct and material financial sensitivity to FX volatility.",
      "llm_answer": "Coca‑Cola explicitly uses **non‑derivative instruments** – chiefly its foreign‑currency‑denominated senior notes – as “net‑investment hedges,” placing the resulting gains or losses in AOCI until the underlying investment is sold or liquidated【page_81】. By contrast, Procter & Gamble reports a **large foreign‑exchange exposure** (its UK, Germany and other overseas markets represent about 20 % of net sales) that lowered net earnings by roughly $589 million in 2024, but its filing does not describe a comparable non‑derivative hedging program; the discussion focuses on translation and transaction exposures rather than specific non‑derivative hedges【page_21】【page_23】.  \n\nThus, Coca‑Cola actively mitigates currency risk with designated non‑derivative hedges, whereas P&G’s exposure is disclosed without a parallel non‑derivative hedging strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Coca-Cola uses non-derivative instruments—specifically foreign-currency-denominated senior notes—as net-investment hedges, with gains/losses recorded in AOCI, which matches the original answer's description of designated hedging relationships. (2) For Procter & Gamble, the LLM accurately states its significant foreign exchange exposure, particularly in the UK and Germany, and quantifies the impact of FX fluctuations as a $589 million reduction in net earnings in 2024. While the original answer does not include this exact dollar figure or year, the LLM’s inclusion of specific data from its source (pages 21, 23) enhances precision without contradicting the ground truth. The 20% of net sales from overseas markets is consistent with P&G’s international footprint. (3) The reasoning correctly synthesizes multi-hop information: comparing Coca-Cola’s structured non-derivative hedging approach to P&G’s lack of a comparable non-derivative program, focusing instead on exposure and derivative or operational risk management. (4) Minor deduction in quantitative accuracy due to the introduction of a specific $589M figure and 2024 year not present in the original answer—though not necessarily incorrect, they are unverifiable against the ground truth and could reflect over-specificity. However, this does not undermine the overall correctness. The answer is contextually excellent, directly addressing the comparison of hedging strategies and exposure in similar markets.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 432,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Amgen's exposure to state-level drug affordability regulations in Maryland, through PDAB laws, compare to Gilead's operational risks in the same state, particularly in relation to their respective biopharma manufacturing and pricing strategies?",
      "original_answer": "Amgen is subject to Maryland’s PDAB laws that grant authority to set upper payment limits on certain drugs for in-state patients, payers, and providers, which affects its pricing strategy and rebate obligations under Medicaid and the 340B Drug Pricing Program. These laws are part of a broader regulatory framework that includes the Inflation Reduction Act’s Medicare price-setting provisions, which began with ENBREL being selected among the first ten drugs for Medicare price negotiation. Meanwhile, Gilead operates a CAR T-cell therapy manufacturing facility in Maryland, exposing it to operational risks such as quality control, production delays, and regulatory compliance. Unlike Amgen, whose primary risk in Maryland is regulatory and pricing-related, Gilead faces logistical and manufacturing risks tied to the complexity of cell therapy production and delivery. Both companies are impacted by Maryland’s healthcare ecosystem, but through different risk vectors—Amgen through pricing regulation and Gilead through manufacturing execution.",
      "llm_answer": "Amgen’s risk in Maryland is two‑fold: the company runs an in‑house CAR‑T cell‑therapy manufacturing site in Maryland 【page_19】 and, like many states, Maryland has enacted a Prescription‑Drug‑Affordability‑Board (PDAB) law that can impose upper payment limits on drugs sold in‑state 【page_18】. Thus Amgen’s manufacturing operations and the price it can charge for those products are directly exposed to Maryland’s PDAB caps.\n\nGilead’s filing does not identify any Maryland‑based manufacturing facilities; its Maryland‑related risk is limited to the broader state‑level pricing and affordability legislation that could force price caps or additional rebates on its products 【page_21】. Consequently, Gilead’s exposure in Maryland is primarily a pricing/reimbursement risk, whereas Amgen faces both a pricing‑cap risk and a direct operational risk tied to its Maryland manufacturing footprint.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error that undermines its correctness: it incorrectly states that Amgen operates a CAR-T cell therapy manufacturing site in Maryland, which directly contradicts the ground truth. According to the original answer, it is Gilead—not Amgen—that operates a CAR T-cell therapy manufacturing facility in Maryland. This misattribution reverses the core risk profiles of the two companies. The ground truth clearly distinguishes that Amgen’s exposure is primarily regulatory and pricing-related due to Maryland’s PDAB laws affecting its pricing strategy and rebate obligations, especially in the context of ENBREL being subject to Medicare price negotiation. In contrast, Gilead faces operational and manufacturing risks due to its physical production presence in the state. The LLM answer flips this relationship, assigning manufacturing risk to Amgen and only pricing risk to Gilead, which is factually incorrect. There are no numerical values in the question or answers, so quantitative accuracy is not applicable—no numbers are present to be wrong or right, hence a score of 10 by default. The qualitative accuracy is low because the model fails in the essential multi-hop reasoning task of correctly attributing entity-specific risks based on operational footprint and regulatory exposure. While the answer correctly identifies the existence of PDAB laws and their impact on drug pricing, and acknowledges different types of risks (pricing vs. operational), the incorrect assignment of the manufacturing site severely distorts the comparison. Contextual relevance is high because the response addresses the structure of the question—comparing Amgen and Gilead’s risks in Maryland—and discusses both pricing regulations and manufacturing, even if the synthesis is flawed. Overall, the answer appears plausible but is substantively incorrect in its key claim, warranting a correctness score of 4 due to partial factual alignment but major entity and reasoning errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 537,
        "total_tokens": 2047
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does AIG's use of separate accounts for policyholder-directed investments compare to MET's utilization of investment management firms in managing ERISA plan assets, particularly in terms of asset diversification strategies and risk mitigation through sub-advisory discretion?",
      "original_answer": "AIG discloses that its separate accounts are legally segregated funds where investment gains and losses accrue directly to policyholders who bear the investment risk, with assets primarily including fixed maturity securities, equity securities, and derivatives. MET utilizes separate accounts backed by similar asset classes (cash, fixed maturities, equities, derivatives, real estate, and private equity) for its ERISA pension and postretirement plans, engaging investment management firms with discretionary authority to manage these assets. Both companies emphasize diversification across asset categories and multiple managers to minimize risk concentration, with MET explicitly stating that its investment policies aim to maximize funded status and minimize volatility, aligning with the long-term nature of benefit obligations. The use of derivatives is restricted to risk mitigation and duration management in both contexts.",
      "llm_answer": "AIG’s separate‑account structure gives each policyholder‑directed investment its own legally‑segregated pool of assets that is carried at fair value and bears the investment risk of the individual policyholder; diversification is achieved by offering a variety of separate accounts, each with its own investment objective, but risk mitigation rests mainly on the segregation of assets from AIG’s other businesses. In contrast, MetLife’s ERISA‑plan assets are held in insurance separate accounts that are managed by external investment‑management firms that act as sub‑advisors with full discretion over buying and selling; the plans are deliberately spread across many asset classes, managers and alternative‑security vehicles to minimize concentration risk, using that sub‑advisory discretion as a key risk‑mitigation tool.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, though it omits a few key details. (1) Correctly identifies AIG's use of separate accounts where policyholders bear investment risk and assets are legally segregated, and notes diversification through multiple accounts with different objectives. It accurately contrasts this with MetLife's (MET) use of external investment management firms with discretionary authority over ERISA plan assets. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across AIG and MET regarding separate accounts, sub-advisory discretion, and risk mitigation strategies. However, the LLM answer misses specific asset classes mentioned in the original answer (e.g., real estate and private equity for MET), and does not mention that both companies restrict derivatives to risk mitigation and duration management—a key point in the comparison. Also, while it notes MET’s use of multiple managers, it fails to highlight MET’s explicit goal of maximizing funded status and minimizing volatility, which ties into long-term benefit obligations. (4) Despite these omissions, the core comparison on diversification and risk mitigation via sub-advisory discretion is accurate and relevant. Wording differs but meaning is semantically close. Minor completeness gaps prevent a perfect score, but overall the response is factually sound and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 426,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How might the structural differences in voting rights between NKE's Class B Common Stock, which grants no voting rights except on certain defined matters, and HD's restricted stock awards, which grant voting rights from the grant date, impact investor influence on corporate governance decisions such as board composition or takeover defenses?",
      "original_answer": "NKE's Class B Common Stockholders have limited voting rights, only participating on certain defined matters such as exiting the core payments business or major corporate transactions, and do not influence the election of the Board of Directors, which is controlled by Class A Common Stockholders. In contrast, HD's restricted stock recipients are granted voting rights immediately upon grant, allowing them to influence governance matters throughout the vesting period. This structural difference means that NKE's Class B investors have significantly less influence over corporate governance, including board composition and takeover defenses, compared to HD shareholders who hold restricted stock and can exercise voting rights from the outset.",
      "llm_answer": "Nike’s Class B common stock is essentially a non‑voting share – the company’s charter creates two classes that “vote separately on certain issues” and holders of Class B have “no right to vote on any matters, except for certain defined matters” (Nike 10‑K p. 27). Because Class B investors cannot vote on ordinary director elections or proxy contests, they have little ability to shape board composition or to mobilize a vote against a hostile takeover. In contrast, Home Depot’s restricted‑stock awards give recipients voting rights as soon as the award is granted (Home Depot 10‑K p. 67), so those award‑holders can participate in director elections and other shareholder votes, giving them a direct voice in governance decisions and a potential check on takeover attempts.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies that NKE's Class B Common Stock has no voting rights except on certain defined matters, explicitly noting the lack of influence on director elections and takeover defenses, while HD's restricted stock awards grant immediate voting rights upon grant. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not applicable but not deficient. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance structures from two different companies (NKE and HD), compares their voting rights frameworks, and draws a valid conclusion about differential investor influence on corporate governance. (4) The answer addresses all parts of the question—board composition, takeover defenses, and the structural differences in voting rights—with precise references to the 10-K filings (page numbers provided), demonstrating high contextual relevance and qualitative accuracy. Minor wording differences (e.g., 'non-voting share' vs 'limited voting rights') do not affect meaning and are acceptable under semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 343,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the voting structure for Class B common stock at META compare to NFLX's general voting rights framework, considering the specific limitations outlined in the voting rights policies of both companies?",
      "original_answer": "NFLX provides one vote per share to all common stockholders on all matters, while META restricts voting rights for Class B common stockholders to specific defined matters such as amendments to the certificate of incorporation affecting Class B or C stock, decisions to exit the core payments business, or certain consolidation or merger transactions. In these limited cases, Class B stockholders vote together either as a single class or alongside Class A stockholders, but they do not have voting rights on all matters like NFLX's common stockholders.",
      "llm_answer": "Meta Platforms’ Class B common stock is essentially non‑voting: holders “have no right to vote on any matters, except for certain defined matters… (i) a decision to exit the core payments business, (ii) a merger or similar transaction, and (iii) amendments to the certificate of incorporation that affect the terms of Class B or C stock” (Meta 10‑K p. 90). In contrast, Netflix’s charter gives every share of its sole class of common stock “one vote per share on all matters submitted to a vote of the stockholders” with no special exclusions (Netflix 10‑K p. 59). Thus, Meta’s Class B shares are limited to voting only in narrowly‑specified situations, whereas Netflix’s shareholders enjoy full, unrestricted voting rights on every corporate matter.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that NFLX provides one vote per share on all matters with no exclusions, while META Class B stockholders only vote on specific matters: exiting the core payments business, merger/consolidation transactions, and amendments affecting Class B or C stock. These points match the original answer exactly. (2) There are no numeric values requiring calculation (e.g., percentages, dollar amounts, dates), so quantitative accuracy is not applicable beyond correct referencing of document pages (p. 90 for Meta, p. 59 for Netflix), which are contextually appropriate and consistent with source documentation. (3) The multi-hop reasoning is sound: the model correctly synthesizes voting rights frameworks from two different companies (META and NFLX) across their respective 10-K filings, compares them accurately, and draws a valid contrast between restricted vs. unrestricted voting rights. (4) The answer is fully relevant, directly addressing the comparative voting structure question with precise, sourced distinctions. Wording differs slightly but meaning is preserved and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 333,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the use of the parametric delta-gamma approximation technique under normal market conditions by PM compare to MDLZ's application of the same method in their VAR model for estimating potential one-day losses in pre-tax earnings?",
      "original_answer": "PM uses the parametric delta-gamma approximation technique under normal market conditions to estimate the risk of underlying positions in its portfolio, observing interest rate and forward currency rate movements primarily over the preceding quarter for determining value at risk (VAR) at year-end. Similarly, MDLZ applies the same technique to estimate the expected return distribution in interest rates, currencies, and commodity prices for calculating VAR, also observing movements over the prior quarter for year-end calculations. Both companies estimate potential one-day losses using a 95% confidence interval and a one-day holding period, with MDLZ specifically reporting the estimated potential one-day loss in pre-tax earnings from currency and commodity instruments as part of its VAR computation.",
      "llm_answer": "Philip Morris International’s filing says it uses a Value‑at‑Risk computation to estimate the potential one‑day loss in the fair value of its interest‑rate‑sensitive and foreign‑currency/commodity derivative instruments, but it does **not** describe the calculation as a “parametric delta‑gamma” approximation.  \n\nMondelez International, by contrast, explicitly states that its VAR model (which also assumes normal market conditions, a 95 % confidence interval and a one‑day holding period) **uses a parametric delta‑gamma approximation** to generate the expected‑return distributions for interest rates, currencies and commodities, and then quantifies the resulting one‑day pre‑tax‑earnings impact.  \n\nThus, PM’s VAR approach is described more generally, whereas MDLZ specifically applies the parametric delta‑gamma technique in its VAR analysis.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite being contextually relevant and well-structured. (1) The key error is the claim that PM does *not* use the 'parametric delta-gamma' approximation technique, which directly contradicts the ground truth stating that PM *does* use this method under normal market conditions. The original answer explicitly states both PM and MDLZ apply the same technique, making the LLM's central comparison invalid. (2) Quantitatively, the LLM correctly identifies the 95% confidence interval and one-day holding period for MDLZ, which aligns with the ground truth, earning partial credit. However, it fails to mention that PM also uses these same parameters, weakening completeness. (3) The reasoning is flawed because it builds a contrast (PM general vs. MDLZ specific) that is not supported by the ground truth—both companies use the same method with similar implementation details (prior quarter observations, one-day pre-tax loss estimation). The multi-hop synthesis fails because it misrepresents PM’s methodology. (4) While the LLM correctly identifies MDLZ’s use of the technique and its application to pre-tax earnings, the incorrect characterization of PM’s approach leads to an inaccurate overall comparison. The answer is semantically different from the ground truth due to this core factual error, warranting a low correctness score despite some accurate elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 400,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the application of the 2.5% Capital Conservation Buffer for Bank of America under the Advanced Approach compare with American Express's reliance on the Stress Capital Buffer under the Standardized Approach for meeting Basel III regulatory requirements?",
      "original_answer": "Bank of America applies a 2.5% Capital Conservation Buffer under the Advanced Approach as part of its CET1 capital regulatory minimum to meet Basel III requirements, while American Express uses the Stress Capital Buffer under the Standardized Approach, which is also a component of its Basel III compliance framework. The two institutions thus rely on different buffer mechanisms depending on their regulatory frameworks, with BAC using the Capital Conservation Buffer and AXP referencing the Stress Capital Buffer as part of their respective capital adequacy strategies.",
      "llm_answer": "Bank of America’s Basel III CET1 minimum is met by adding the 2.5 % **capital‑conservation buffer** that is required under the **Advanced Approach** (the buffer is built into the CET1 regulatory minimum shown in its capital‑ratio table).  \n\nAmerican Express, by contrast, satisfies the Basel III minimums under the **Standardized Approach** by relying on the **stress‑capital buffer (SCB)** – a separate buffer (e.g., 5.4 % in 2023) that is added to the CET1 minimum, rather than the 2.5 % CCB used by Bank of America.  \n\nThus, BofA’s compliance hinges on the 2.5 % CCB in the Advanced framework, while Amex’s compliance depends on the SCB prescribed for the Standardized framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that Bank of America uses the 2.5% Capital Conservation Buffer (CCB) under the Advanced Approach, while American Express relies on the Stress Capital Buffer (SCB) under the Standardized Approach—this matches the original answer's key distinction. (2) The mention of a 5.4% SCB in 2023 is an additional detail not present in the ground truth; however, since the original answer does not specify a value for the SCB, this plausible figure (which aligns with public SEC filings from American Express in 2023) does not make the response incorrect—it adds context without contradicting the known facts. (3) The reasoning correctly synthesizes multi-hop information: it contrasts two companies, two regulatory approaches (Advanced vs. Standardized), and two distinct buffer mechanisms (CCB vs. SCB) as part of Basel III compliance. (4) Minor deduction in quantitative accuracy due to the introduction of a specific SCB percentage (5.4%) not confirmed in the ground truth, though it is factually reasonable. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative and logical fidelity to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 352,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does LMT's use of a discounted cash flow approach in valuing certain fixed income investments compare with HON's application of the same methodology in testing goodwill and intangible asset impairments, particularly in terms of the significance and sensitivity of the discount rate assumptions used?",
      "original_answer": "LMT applies the discounted cash flow approach to value certain Level 3 fixed income investments, where significant inputs include projected annuity payments and the discount rate applied to those payments. This valuation method introduces sensitivity due to the reliance on unobservable inputs. Similarly, HON uses a discounted cash flow approach to estimate the fair value of goodwill and indefinite-lived intangible assets during impairment testing, incorporating strategic and annual operating plans with terminal value assumptions. HON also acknowledges the sensitivity of these valuations to changes in assumptions, particularly the discount rate, and performs sensitivity analyses to address uncertainty. Both companies rely on the discounted cash flow method with key assumptions around discount rates, making the valuation outcomes at both firms sensitive to changes in these inputs, though applied in different asset contexts—fixed income investments at LMT and intangible assets at HON.",
      "llm_answer": "Lockheed Martin applies a discounted‑cash‑flow model only to a limited set of Level 3 fixed‑income assets, where the discount rate is listed as a “significant input” together with projected annuity payments, but the filing does not indicate that modest changes in that rate would materially alter the valuation. Honeywell, by contrast, uses a discounted‑cash‑flow approach for goodwill and indefinite‑life intangible‑asset impairment testing and explicitly states that the discount‑rate (along with growth and terminal‑value assumptions) is a key driver; the company performs sensitivity analyses and notes that even small changes in the rate could materially affect the fair‑value conclusions and therefore its financial condition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that LMT uses the discounted cash flow (DCF) approach for certain Level 3 fixed income investments, with the discount rate and projected annuity payments as significant inputs. It also accurately states that HON applies DCF to goodwill and indefinite-lived intangible assets for impairment testing, incorporating strategic plans and terminal value assumptions. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The LLM adds a nuanced but plausible detail not explicitly in the ground truth: that LMT does not indicate material sensitivity to modest changes in the discount rate, while HON explicitly acknowledges that small changes in the discount rate could materially affect valuation and performs sensitivity analyses. This inference is consistent with typical SEC filing language and represents a reasonable interpretation of comparative sensitivity, though the original answer does not make this explicit contrast. This prevents a perfect 10 on qualitative accuracy. (4) The response is fully contextually relevant, directly addressing the comparison of DCF use and the significance and sensitivity of discount rate assumptions at both firms. The synthesis across two companies and applications (fixed income vs. intangibles) is sound and well-articulated. Minor deduction from 10 to 9 on correctness due to the slight interpretive leap about LMT’s lack of stated sensitivity, but overall the answer is factually sound and semantically equivalent in substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 458,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential impact of share repurchases on voting control, given Alphabet's dual-class share structure where Class B shares convert to Class A with voting dilution?",
      "original_answer": "At CMCSA, holders of Class B common stock maintain a non-dilutable 33 1/3% of the voting power, with each Class B share entitled to 15 votes, whereas voting rights for Class A shares fluctuate based on the number of shares outstanding. This contrasts with Alphabet (GOOGL), where Class B shares convert to Class A shares with a 10:1 voting dilution, and repurchases of Class A and Class C shares totaled $62.0 billion in 2024. Since CMCSA’s Class B shares are convertible share-for-share into Class A stock, but retain a fixed voting percentage, repurchases of Class A shares could increase the relative voting power of Class B holders, unlike Alphabet’s structure where repurchases of Class A and C shares do not create a similar fixed voting skew due to the dilutive conversion mechanism.",
      "llm_answer": "CMCSA’s charter gives the nine outstanding Class B shares a fixed one‑third (≈33 ⅓ %) of the total voting power, and that share‑of‑voting is “generally non‑dilutable” because Class B votes cannot be reduced by issuing additional Class A shares【page_91】. Consequently, when CMCSA repurchases or retires Class A (or Class C) shares, the proportion of votes held by the Class B holders either stays the same or rises, so share‑buybacks have little risk of eroding the Class B voting bloc. By contrast, Alphabet’s Class B stock carries ten votes per share but is convertible, share‑for‑share, into voting‑equal Class A stock; each conversion adds many one‑vote shares and therefore dilutes the voting weight of the remaining Class B shares【page_82】. Thus, CMCSA’s protected one‑third voting stake limits the impact of repurchases on control, whereas Alphabet’s convertible Class B structure means that conversions (not repurchases) can materially dilute Class B voting power.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core distinctions between CMCSA and Alphabet's dual-class structures with respect to voting power and share repurchases. (1) All factual elements are correct: CMCSA’s Class B shares hold a fixed 33 1/3% non-dilutable voting power, each Class B share has 15 votes (implied by structure, though not explicitly stated in LLM answer, but not contradicted), and repurchases of Class A/C shares do not dilute Class B voting control. Alphabet’s Class B shares convert 1:1 into Class A with loss of 10:1 voting advantage, causing dilution of remaining Class B voting weight—this is correctly explained. (2) Quantitatively, all percentages and structural ratios are accurate. The $62.0 billion repurchase amount by Alphabet in 2024 from the ground truth is missing in the LLM answer, which is a minor omission affecting completeness but not the core reasoning. (3) The multi-hop reasoning is sound: the model correctly synthesizes how share repurchases affect voting control differently due to structural differences—CMCSA’s fixed voting bloc vs. Alphabet’s conversion-driven dilution. (4) The answer is contextually fully relevant, directly addressing the influence of repurchases on voting control. The only reason for not scoring a 10 is the omission of Alphabet’s $62.0B repurchase figure, which was part of the original answer’s factual content, though it does not undermine the logical comparison made.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 398,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does TGT's beverage sales mix compare to PEP's beverage revenue contribution in the APAC region, given both companies' exposure to this market?",
      "original_answer": "TGT includes beverages as part of its grocery segment, which is a key category within its retail operations. PEP, on the other hand, reports that beverages contribute 23% of its revenue in the APAC region. Additionally, PEP's APAC segment generated $10 million in reported revenue for 2024. This indicates that while both companies operate in the beverages category in APAC, PEP provides a specific quantification of its beverage exposure in the region, whereas TGT does not break down beverage sales separately from its broader grocery offering.",
      "llm_answer": "Target’s “Food & beverage” category accounts for about **$23.8 billion of its $106.6 billion total net sales – roughly 22 % of the company’s overall revenue**【page_49】.  \n\nPepsiCo reports that **beverage sales represent 23 % of net revenue in its APAC division** (the remainder is convenient‑food sales)【page_73】.  \n\nThus, Target’s overall beverage mix (≈22 %) is essentially on par with, and just a touch below, PepsiCo’s beverage contribution in the APAC market (23 %).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that PEP's beverage sales represent 23% of its APAC revenue, it fabricates data for TGT by claiming that 'Food & beverage' accounts for $23.8 billion (22%) of TGT's $106.6 billion in net sales. The original answer (ground truth) explicitly states that TGT does not break out beverage sales separately from its broader grocery segment, making this specific quantification unsupported and incorrect. (2) The quantitative accuracy is partially correct for PEP (23% beverage contribution in APAC is accurate), but the TGT figures ($23.8B, 22%) are not present in the ground truth and appear to be invented. The ground truth does not provide any specific revenue breakdown for TGT’s beverage sales, nor does it mention total net sales of $106.6 billion or a food & beverage category value. (3) The multi-hop reasoning is flawed because the model incorrectly assumes that TGT's food & beverage category can be directly compared to PEP's beverage revenue contribution in APAC. The ground truth emphasizes that TGT does not disclose beverage-specific sales, so no direct comparison is possible. The LLM falsely creates a numerical comparison that the source data does not support. (4) Despite the incorrect data, the answer attempts to address the core question and correctly identifies PEP’s 23% beverage contribution. It also draws a logical conclusion based on its (erroneous) inputs, which preserves some contextual relevance. However, due to the fabrication of TGT financials and failure to reflect the lack of disclosed beverage data for TGT, the overall correctness and qualitative accuracy are low.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 463,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How might the Medicare price negotiation under the IRA, which will apply to Otezla starting in 2027, impact Amgen's $5.2 billion intangible asset valuation for Otezla, considering that Bristol-Myers Squibb (BMY) also markets Otezla under a licensing agreement?",
      "original_answer": "The Medicare price negotiation under the IRA, which will apply to Otezla starting January 1, 2027, introduces regulatory and financial risk that could impair Amgen's $5.2 billion intangible asset valuation for Otezla. Since BMY also markets Otezla under a licensing agreement, the negotiated price could affect overall revenue from the drug, further influencing Amgen's ability to recover the carrying value of the asset. Amgen has explicitly stated that future changes in estimates related to IRA price negotiations could unfavorably impact the intangible asset's recoverability.",
      "llm_answer": "Amgen says the developed‑product‑technology right for Otezla is recorded at $5.2 billion, but it “expects future changes to the Company’s estimates of the impact of the price negotiations under the IRA… could unfavorably impact the Company’s ability to recover the carrying value of the related intangible asset”【page_137】.  Because Otezla is also marketed by Bristol‑Myers Squibb under a licensing/co‑promotion agreement (the product is listed with BMS as a competitor‑marked product on Amgen’s product‑competitor table)【page_15】, any Medicare‑price‑setting that lowers Otezla’s reimbursed price will reduce the royalty or profit‑sharing payments Amgen receives from BMS, further eroding the cash‑flow assumptions that support the $5.2 billion valuation and increasing the risk of an impairment charge.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Amgen's $5.2 billion intangible asset valuation for Otezla, the risk of impairment due to IRA price negotiations starting in 2027, and the licensing/co-promotion agreement with Bristol-Myers Squibb (BMS) are all accurately represented. (2) Quantitative accuracy is perfect: the $5.2 billion figure is correctly cited, and no calculations are required beyond accurate reporting of financial estimates. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across entities—linking the IRA's impact on pricing, the effect on BMS's sales, and the resulting reduction in Amgen’s expected cash flows through royalties or profit-sharing, which underpin the asset valuation. (4) The answer adds contextual detail not in the original (e.g., reference to Amgen’s product-competitor table and specific mention of page citations), enhancing clarity without introducing error. Wording differs but meaning fully aligns with the ground truth. All aspects of the question are addressed with precise, relevant, and logically structured reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 332,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does AMD's production of FPGAs for hyperscale data centers compare to Altera's FPGA offerings, given Intel's strategic decision to operate Altera as a standalone business?",
      "original_answer": "Altera, now operated as a standalone business by Intel, offers programmable semiconductors primarily FPGAs, targeting embedded, communications, and cloud and enterprise markets. Intel is pursuing monetization opportunities with Altera, including a potential IPO. Meanwhile, AMD produces FPGAs and Adaptive SOCs that are directly incorporated into servers and data center appliances used by hyperscale customers, including for AI workloads such as generative AI models. This positions both companies in competitive yet distinct roles within the FPGA market, with AMD directly serving hyperscale data centers and Intel seeking to unlock value through Altera's standalone structure.",
      "llm_answer": "AMD manufactures its own FPGA families – Virtex, Kintex, Spartan and the newer UltraScale+ and Versal lines – and markets them directly to hyperscale data‑center customers as part of its data‑center, GPU‑accelerator and Adaptive‑SoC portfolio (see AMD 10‑K pages 9‑13). In contrast, Intel’s Altera business is a separate, stand‑alone programmable‑semiconductor unit that sells FPGAs for a broad set of markets (embedded, communications, cloud and enterprise) and is being run as an independent subsidiary rather than as an integrated Intel product line (see Intel 10‑K pages 23‑25, 68‑70).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies AMD's FPGA product lines (Virtex, Kintex, Spartan, UltraScale+, Versal) and their use in hyperscale data centers, particularly within AI and data center portfolios, which matches the original answer's emphasis on AMD directly serving hyperscale customers. It also accurately describes Altera as a standalone unit under Intel, targeting multiple markets including cloud and enterprise, consistent with the ground truth. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about AMD’s integrated approach to FPGAs in data centers versus Intel’s strategic separation of Altera as a standalone business, referencing appropriate sections of the 10-K filings. The only minor shortcoming is that the LLM answer does not explicitly mention Intel’s potential IPO or monetization plans for Altera, which is part of the original answer and Intel’s strategic intent. This omission slightly affects completeness but does not distort the overall comparison. (4) The answer is contextually relevant, directly addressing the comparison between AMD and Altera (Intel) in the FPGA market for hyperscale data centers. Wording differs but semantic meaning is equivalent. Thus, high scores across all dimensions with a 9/10 on correctness due to the missing IPO/monetization point.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 418,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the ownership structure of Class A common stock at GOOGL, given the relative number of shares outstanding and holder concentration?",
      "original_answer": "At CMCSA, the Class B common stock represents 33⅓% of the combined voting power, with all shares beneficially owned by Brian L. Roberts, and only 3 record holders as of December 31, 2021. In contrast, GOOGL’s Class A common stock had 300,754,904 shares outstanding as of January 25, 2022, with a much broader base of non-affiliate ownership contributing to a market value of approximately $1,451.1 billion as of June 30, 2021. Both structures tie voting rights to distinct stock classes, but CMCSA’s Class B shares grant concentrated control to a single individual, while GOOGL’s Class A shares are more widely distributed.",
      "llm_answer": "Comcast’s Class B shares, which carry 15 votes each, account for about 33 ⅓ % of the company’s total voting power even though only a handful of shares exist – all of them are beneficially owned by Mr. Brian L. Roberts (the filing lists just three record holders). In contrast, Alphabet’s Class A shares are the sole voting class, with roughly 300.8 million Class A shares outstanding and held by a broad base of investors, so voting power is widely dispersed rather than concentrated in a single insider.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively: The 33⅓% voting power for CMCSA Class B stock is correctly stated. The number of Class A shares outstanding at GOOGL is reported as 'roughly 300.8 million', which aligns with the ground truth figure of 300,754,904 (rounding is acceptable). The $1,451.1 billion market value from June 30, 2021, is omitted, but the broad ownership and wide dispersion are correctly emphasized. (2) The statement that CMCSA Class B shares are 'beneficially owned by Brian L. Roberts' with only three record holders matches the original. (3) The reasoning correctly contrasts concentrated control (Roberts) vs. dispersed voting in GOOGL, capturing the multi-hop comparison of ownership concentration and voting power distribution across two companies. (4) Minor omission: the LLM does not explicitly mention that GOOGL Class A shares are the sole voting class (though implied), and omits the specific market value figure, but these do not undermine the core correctness. Wording differs but semantic equivalence is strong. No factual errors. Thus, high scores across all categories with a 9/10 on correctness due to slight incompleteness on GOOGL's market value context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 352,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the change in Keytruda royalty structure post-2023 impact Bristol-Myers Squibb's revenue dependency on Merck, considering Merck's co-development and financial obligations tied to Keytruda in combination therapies?",
      "original_answer": "The royalty rate Merck pays to Bristol-Myers Squibb (BMS) and Ono for Keytruda drops from 6.5% to 2.5% starting January 1, 2024, which will reduce BMS’s royalty income from Merck. This is significant because Merck co-develops Keytruda-based combination therapies like V940 (mRNA-4157) with Moderna, where Merck bears 50% of development costs and receives 50% of any future profits. Since BMS's revenue from Merck is partly tied to Keytruda's global sales through this licensing agreement and has been a growing component of BMS's income (noted by the 2023 increase in royalties), the reduced royalty rate may diminish the financial upside BMS experiences from Keytruda's continued use in these new combination regimens.",
      "llm_answer": "The 2023 10‑K states that the Keytruda patent‑license royalty drops from 6.5 % of worldwide Keytruda sales through 31 Dec 2023 to 2.5 % for 2024‑2026 (‑75/25 split with Ono)【page_90】, and BMS’s reported Keytruda‑related royalty impact fell from $1.0 billion in 2022 to $1.2 billion in 2023【page_90】. Because the royalty rate is cut by 4 percentage points, BMS’s cash flow from Merck’s Keytruda sales will be materially lower, reducing its overall revenue dependence on Merck; however, Merck continues to fund extensive co‑development programs (e.g., the $250 million Moderna V940‑Keytruda combo and multi‑billion‑dollar Daiichi Sankyo ADC collaborations) that generate separate R&D and continuation‑payment obligations, so BMS still benefits from the partnership but the direct royalty stream is now smaller.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key royalty rate change from 6.5% to 2.5% starting in 2024, aligning with the ground truth. It accurately references the time-bound reduction (2024–2026) and notes the 75/25 split with Ono, which is consistent with BMS’s reporting. However, the dollar amounts for Keytruda-related royalties are partially inaccurate: the LLM states royalties increased from $1.0 billion in 2022 to $1.2 billion in 2023, but the ground truth does not specify these exact figures—only that royalties were a growing component of income in 2023. While plausible, this specific quantification is not confirmed in the original answer and introduces unverified precision. (2) The mention of the $250 million Moderna V940 collaboration is plausible but not explicitly stated in the ground truth; the original answer notes Merck’s 50% cost/profit sharing in V940 but not the dollar value. Similarly, the Daiichi Sankyo collaboration is not mentioned in the ground truth and may be extraneous or misattributed. (3) The multi-hop reasoning is sound: the LLM correctly links the reduced royalty rate to lower direct revenue from Merck, acknowledges the continued value from co-development programs, and infers reduced revenue dependency despite ongoing partnership benefits. This reflects proper synthesis of licensing terms and development obligations. (4) The answer is contextually excellent—directly addressing the impact on BMS’s revenue dependency, the structural change in royalties, and Merck’s ongoing financial obligations. The core conclusion (reduced royalty stream but continued indirect benefits) matches the ground truth. The score is reduced due to unsupported numerical claims and minor entity overreach, but the central logic and factual framework are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 488,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the adoption of ASU 2022-06, which CAT has listed as applicable to its financial reporting, impact the treatment of contract modifications under U.S. government agreements that BA identified as a material risk in its 2023 disclosures?",
      "original_answer": "ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform through December 31, 2024. This allows companies like BA to apply simplified accounting treatments for contract modifications made in response to reference rate changes, such as replacing LIBOR, during that period. BA, which reported that 37% of its 2023 revenues came from U.S. government contracts—where modifications can occur without prior notice—benefits from reduced operational complexity and financial impact when adjusting contracts affected by reference rate reform. CAT, in its 2023 10-K, listed ASU 2022-06 under recently adopted accounting standards, confirming its applicability and alignment with broader corporate practices around reference rate reform.",
      "llm_answer": "CAT notes that it has adopted ASU 2022‑06 (Reference‑rate reform). That update gives the company optional expedients that reduce the accounting and financial impact of contract‑modification‑related reference‑rate changes (e.g., replacing LIBOR) and extends those relief measures through Dec. 31, 2024. Accordingly, any U.S.‑government contract modifications that involve such rate changes are treated with less‑burdensome accounting, but CAT also states the adoption “did not have a material impact on the Company’s consolidated financial statements,” so the mitigation is limited to accounting treatment and does not eliminate the material risk Boeing flagged for its government contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: ASU 2022-06 extends optional expedients for reference rate reform through December 31, 2024 (correct date), applies to contract modifications involving reference rate changes like LIBOR replacement, and reduces accounting burden. The statement that CAT’s adoption 'did not have a material impact' matches typical disclosure language and is consistent with the original answer’s implication that the benefit is procedural rather than financial. (2) Quantitatively, all dates (Dec 31, 2024) are correct; while the original answer includes BA’s 37% revenue from U.S. government contracts, this specific percentage is not mentioned in the LLM response—this is a minor omission but does not affect correctness since the question does not require repeating that number in the impact explanation. (3) Multi-hop reasoning is sound: the model correctly links CAT’s adoption of ASU 2022-06 to the accounting treatment of contract modifications, connects it to reference rate reform (e.g., LIBOR), and acknowledges BA’s identification of government contract modifications as a material risk—even noting that the relief is limited to accounting treatment, not elimination of operational risk. (4) Semantic equivalence is strong: though the LLM does not explicitly name Boeing (BA) or restate the 37% figure, it correctly refers to 'Boeing flagged for its government contracts', showing proper entity linkage. The omission of the 37% revenue detail prevents a perfect score, but the core multi-hop logic—how ASU 2022-06 affects treatment of modifications in government contracts that BA sees as risky—is accurately synthesized and conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 471,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the $4.8 billion transaction with Crown Castle in 2013 compare to Verizon's 2024 $2.8 billion deal with Vertical Bridge REIT in terms of asset treatment and financing obligations, particularly given both companies retained depreciation responsibilities and structured payments as financing obligations?",
      "original_answer": "Both AT&T’s 2013 transaction with Crown Castle and Verizon’s 2024 deal with Vertical Bridge REIT involved transferring exclusive rights to operate wireless towers while retaining depreciation responsibilities on their balance sheets. AT&T received $4.827 billion from Crown Castle, accounted for as a financing obligation with an effective interest rate of ~3.9%, and continues to sublease space on the towers. Similarly, Verizon received $2.8 billion from Vertical Bridge, of which $830 million was recorded as a financing obligation related to the towers Verizon continues to use, with the remainder treated as prepaid rent. Both arrangements reflect a structured financing model where the original owner maintains accounting control and depreciation charges, rather than achieving sale-leaseback treatment.",
      "llm_answer": "Both deals left the tower assets on the seller’s balance sheet and kept depreciation on those assets. In the 2013 AT&T‑Crown Castle transaction AT&T recorded the $4.8 billion cash received as a financing liability (interest‑accrued at about 3.9 %) while continuing to carry the towers in PP&E and depreciate them; the lease‑back of space is treated as a sub‑lease payment. In Verizon’s 2024 deal with Vertical Bridge, the $2.8 billion upfront payment is split into $2.0 billion of prepaid rent and an $830 million financing obligation, the towers also remain in PP&E‑net and are depreciated, and Verizon has a 10‑year lease‑back (with renewal options) for capacity on the towers.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: both deals kept towers on the sellers' balance sheets, retained depreciation, and structured payments as financing obligations. The $4.8 billion AT&T-Crown Castle deal and $2.8 billion Verizon-Vertical Bridge deal are correctly cited. (2) Quantitatively: the $4.8B (vs. $4.827B in original) is acceptably rounded; Verizon's $2.8B split into $2.0B prepaid rent and $830M financing obligation matches the ground truth ($2.0B + $830M = $2.83B, minor rounding difference is acceptable). The 3.9% effective interest rate is correctly noted. (3) Multi-hop reasoning is sound: the model correctly synthesizes asset treatment (PP&E and depreciation), financing structures, and lease-back arrangements across two different companies and years. (4) The only minor omission is that the original answer specifies AT&T 'subleases' space, while LLM says 'lease-back', which is slightly less precise but semantically close. Also, the LLM does not explicitly state that the financing obligation was only for the portion Verizon continues to use, though implied. Wording differences are acceptable under semantic equivalence. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 362,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does PEP's direct operational presence in New Zealand's beverage market compare to KO's financial influence through its 19% stake in CCEP, which bottles and distributes Coca-Cola products in the same region?",
      "original_answer": "PEP operates in New Zealand through its APAC regional structure, selling branded beverages and convenient foods directly and through partners. CCEP, in which KO holds a 19% stake, is responsible for bottling and distributing Coca-Cola products in New Zealand under a bottler's agreement. KO's financial stake allows it to influence CCEP's operations indirectly, while PEP maintains full operational control over its New Zealand beverage activities. This creates two distinct models—direct operation for PEP and equity influence for KO through CCEP—both active in the New Zealand beverage market.",
      "llm_answer": "PepsiCo’s “Asia Pacific, Australia and New Zealand and China” (APAC) segment is listed as one of its geographic operating units and the segment description says it “makes, markets, distributes and sells beverage concentrates, fountain syrups and finished goods … in certain markets … operates its own bottling plants and distribution facilities” 【page_5】【page_6】—so PepsiCo has a direct, on‑the‑ground bottling and distribution footprint in New Zealand.  \n\nCoca‑Cola’s exposure to the same market comes only from its equity‑method investment in Coca‑Cola Europacific Partners (CCEP), in which it owns about 19 % of the bottler that bottles and distributes Coca‑Cola products in New Zealand, generating equity‑income of $1.44 billion in 2021 but giving Coca‑Cola no direct operating control 【page_88】【page_89】.  \n\nThus, PepsiCo operates its own bottling and distribution assets in New Zealand, whereas Coca‑Cola’s influence is financial‑only through a minority 19 % stake in the CCEP bottler.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies PEP's direct operational presence in New Zealand through its APAC segment, including ownership of bottling plants and distribution facilities, which matches the original answer's claim of 'direct, on-the-ground' operations. (2) It accurately states KO's 19% stake in CCEP as a financial (equity-method) investment without direct control, consistent with the original answer's description of 'financial influence' and 'indirect influence.' (3) The $1.44 billion equity income figure from CCEP in 2021 is a specific numeric addition not in the original answer but does not contradict it; assuming it's correctly extracted from the cited pages, it enhances detail without error. (4) The core distinction—PEP has direct operational control, KO has financial influence via minority stake—is correctly synthesized and mirrors the multi-hop comparison required. (5) Minor deduction in quantitative accuracy due to introducing a number ($1.44B) not in the ground truth, which cannot be independently verified here, though it doesn't appear incorrect. (6) All entities (PEP, KO, CCEP, APAC) and their relationships are correctly identified. (7) The reasoning is sound, clearly contrasting operational vs. financial models in the same market. (8) Semantic equivalence is strong—wording differs but meaning matches. No significant omissions or inaccuracies; only slight caution on unsourced financial figure prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 417,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does AIG's use of internal valuation models for mortgage-backed securities compare to SCHW's reliance on broker/dealer quotes for similar asset classes like commercial mortgage-backed securities in determining fair value?",
      "original_answer": "AIG utilizes internal valuation models and third-party asset managers to determine fair values for mortgage-backed securities, subject to management review to ensure model reasonableness. These models incorporate inputs like interest rates, borrower creditworthiness, collateral, and market pricing for comparable loans. In contrast, SCHW primarily relies on broker/dealer quotes and third-party pricing services for similar asset classes such as commercial mortgage-backed securities, using observable market data like trades, spreads, and maturity information to validate pricing. GILD’s evidence further supports that broker/dealer quotes are commonly used alongside valuation models with observable inputs for fair value estimation, indicating a shared industry practice that bridges AIG's internal modeling and SCHW's external pricing reliance.",
      "llm_answer": "AIG prices its residential‑ and commercial‑mortgage‑backed securities primarily with its own valuation models (supplemented by dealer quotations and discounted‑cash‑flow analyses) and incorporates credit‑risk inputs directly into those models. In contrast, Schwab determines the fair value of comparable assets such as non‑agency CMBS chiefly from independent third‑party pricing services that rely on observable trades, broker‑dealer quotes and market‑based discounted‑cash‑flow calculations, adjusting the quoted prices only when they appear inconsistent with fair‑value definitions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that AIG uses internal valuation models, incorporating credit-risk inputs, and supplements them with dealer quotations and discounted-cash-flow analyses—consistent with the original answer's mention of internal models, third-party managers, and inputs like interest rates and borrower creditworthiness. (2) For SCHW, the LLM accurately states reliance on third-party pricing services using broker/dealer quotes and observable market data (trades, spreads, etc.), aligning with the ground truth. It also correctly notes that Schwab adjusts quotes only when inconsistent with fair value, which adds a nuance not explicitly in the original but does not contradict it. (3) The multi-hop reasoning is sound: the comparison between AIG’s model-centric approach and SCHW’s external-data reliance is correctly synthesized. (4) The only minor shortcoming is the absence of the GILD evidence mentioned in the original answer, which provides broader industry context linking both approaches. While this omission slightly reduces completeness, it does not affect the core factual accuracy. No numbers, entities, or financial terms are incorrect. All terminology (e.g., non-agency CMBS, third-party pricing) is contextually appropriate. Thus, the answer is semantically equivalent with high qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 395,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does AVGO's valuation methodology for Level 2 securities compare to ADBE's reliance on matrix pricing, given the use of observable market inputs like yield curves and benchmark rates in their fair value determinations?",
      "original_answer": "AVGO categorizes its investments, including equity and short-term money market instruments, as Level 2 securities when they are valued using inputs such as interest rates, yield curves, and broker quotes. These inputs are observable but not quoted prices in active markets, distinguishing them from Level 1 securities. Matrix pricing, which is used for Level 2 securities like corporate bonds and asset-backed securities, relies on observable market data such as yield curves to estimate fair value. ADBE also categorizes its fixed income available-for-sale debt securities as Level 2 and explicitly uses matrix pricing techniques that incorporate benchmark yields, issuer spreads, interest rates, and U.S. Treasury or swap curves to determine fair value. Both companies rely on similar observable inputs, indicating a shared dependence on market-derived data rather than direct quotations for active trading in valuing their Level 2 portfolios.",
      "llm_answer": "Both Broadcom (AVGO) and Adobe (ADBE) classify their corporate‑bond, asset‑backed and municipal‑bond holdings as Level 2 and price them with observable market data. AVGO states that Level 2 securities are valued using “market‑corroborated pricing, matrix pricing or other models that utilize observable inputs such as yield curves and benchmark rates,” whereas Adobe explicitly says it relies on “matrix‑pricing valuation techniques … that use quoted prices for identical or comparable assets and observable inputs including benchmark yields, issuer spreads and Treasury or swap curves.” Thus, AVGO’s methodology and Adobe’s matrix‑pricing approach are essentially the same in that each uses observable yield‑curve and benchmark‑rate inputs to determine fair value, with Adobe simply emphasizing the matrix‑pricing process as its primary tool.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: both AVGO and ADBE classify their fixed-income securities as Level 2, and both use observable inputs like yield curves, benchmark rates, and issuer spreads. The LLM correctly notes that AVGO uses matrix pricing among other observable-input-based methods, while ADBE explicitly emphasizes matrix pricing. (2) There are no numeric values in the question or answer requiring calculation, so quantitative accuracy is not applicable in terms of sums or percentages; however, the absence of numerical errors and correct handling of financial concepts supports a score of 10. (3) The multi-hop reasoning is sound—comparing AVGO’s valuation methodology to ADBE’s reliance on matrix pricing using observable inputs—and correctly synthesizes the shared dependence on market-derived data despite different phrasing in disclosures. (4) The answer is contextually precise, directly addressing the comparison of valuation methodologies and the role of observable inputs. The only minor limitation is that the LLM slightly downplays AVGO’s use of broker quotes (mentioned in the original) as an input, but this does not detract from the core accuracy. Overall, the answer is semantically equivalent and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 366,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "What percentage of Coca-Cola's non-U.S. unit case volume is managed by Coca-Cola HBC, and in how many of its operational countries—including the Czech Republic—does it coordinate distribution for Coca-Cola's trademark beverages?",
      "original_answer": "Coca-Cola HBC manages 17% of Coca-Cola's non-U.S. unit case volume and coordinates distribution for Coca-Cola's trademark beverages in 30 countries, including the Czech Republic.",
      "llm_answer": "Coca‑Cola HBC handles roughly **20 % of the Company’s non‑U.S. unit‑case volume**.  It coordinates the distribution of Coca‑Cola trademark beverages in **28 countries** – the full list of its operating territories includes the Czech Republic.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer is partially correct but contains key factual inaccuracies. The percentage of Coca-Cola's non-U.S. unit case volume managed by Coca-Cola HBC is stated as 20%, while the ground truth is 17%. The number of countries where distribution is coordinated is given as 28, but the correct number is 30. Both figures are close but incorrect. The inclusion of the Czech Republic as part of the operating territories is correctly noted, which addresses a specific part of the question.\n\n2) Quantitatively, the percentage (20% vs 17%) and country count (28 vs 30) are both inaccurate. These are not minor rounding differences but represent measurable deviations from the ground truth. No calculations were required, but direct recall of figures failed on both key metrics.\n\n3) The reasoning structure is sound—LLM identifies the right entity (Coca-Cola HBC), the correct metric (non-U.S. unit case volume), and the distribution role in operational countries including the Czech Republic. It correctly interprets the multi-hop nature of the question (linking Coca-Cola HBC's role to volume share and geographic scope), but fails in precise data retrieval.\n\n4) Despite incorrect numbers, the answer remains contextually relevant and well-structured. It addresses both sub-questions and correctly identifies the relationship between the entities. However, the two quantitative errors significantly reduce factual correctness, warranting a moderate score. A score of 6 reflects partial credit for correct framing and entity identification, but penalizes the critical factual inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1125,
        "completion_tokens": 434,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How do Duke Energy's 50% equity stake in Hardy Storage in West Virginia and NextEra Energy's 31.9% ownership in a 303-mile pipeline under construction in the same region reflect divergent strategic approaches to natural gas infrastructure investment, particularly in light of regulatory and market challenges?",
      "original_answer": "Duke Energy's 50% equity stake in Hardy Storage, an interstate underground natural gas storage facility in West Virginia, indicates a strategic focus on stable, long-term infrastructure assets that support regulated gas operations. This aligns with Duke's broader approach of investing in FERC-regulated infrastructure such as Pine Needle and Hardy Storage to ensure reliable supply and service. In contrast, NextEra Energy's 31.9% ownership in a 303-mile pipeline project in West Virginia and Virginia reflects a more ambitious and risk-exposed strategy aimed at expanding transportation capacity into new markets, despite facing regulatory delays and legal challenges. While both companies are investing in West Virginia's natural gas ecosystem, Duke's approach emphasizes secure, operational assets, whereas NextEra's involvement in a pipeline under construction—subject to permitting and legal hurdles—suggests a higher tolerance for uncertainty in pursuit of future capacity and market access.",
      "llm_answer": "Duke Energy’s 50 % stake in the Hardy underground storage facility (regulated by FERC) gives it a mature, rate‑regulated asset that generates a predictable return and shields the company from construction‑related risk 【page_19】. In contrast, NextEra Energy’s 31.9 % interest in a 303‑mile interstate pipeline that is still being built in West Virginia and Virginia exposes it to the uncertainty of obtaining final FERC approvals and overcoming legal challenges before the asset can generate revenue 【page_18】. Thus, Duke is pursuing a low‑risk, regulated‑return storage strategy, while NextEra is betting on growth‑oriented, higher‑risk pipeline development despite the regulatory and market hurdles.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Duke Energy's 50% stake in Hardy Storage and NextEra Energy's 31.9% ownership in a 303-mile pipeline project in West Virginia and Virginia are accurately reported. The characterization of Hardy Storage as FERC-regulated is correct and matches the original answer. (2) Quantitative accuracy is perfect: percentages (50%, 31.9%), pipeline length (303 miles), and geographic scope (West Virginia and Virginia) are all correct. No calculations were required, but factual numbers are precise. (3) Multi-hop reasoning is sound: the model correctly contrasts Duke’s low-risk, regulated storage strategy with NextEra’s higher-risk, growth-oriented pipeline development, synthesizing strategic implications from ownership stakes and regulatory exposure. It correctly identifies that the pipeline is under construction and faces approval and legal risks, while Duke’s asset is operational and rate-regulated. (4) The only minor shortcoming is a slight reduction in depth compared to the original answer—specifically, the LLM does not mention Pine Needle (a supporting example in the ground truth) or elaborate on Duke’s broader strategy across regulated infrastructure. However, this does not detract from the core accuracy. The answer is semantically equivalent and contextually fully relevant, clearly addressing the divergent strategic approaches in light of regulatory and market challenges.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 409,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How does the difference in voting rights between Class A and Class B shares at META compare to GOOGL's dual-class structure, and what implications might this have on ownership concentration given META's 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding as of January 24, 2025, versus GOOGL's 10:1 voting ratio for Class B shares and $62.0 billion in 2024 share repurchases?",
      "original_answer": "META discloses two classes of stock—Class A and Class B—with the latter carrying greater voting rights, though the exact ratio is not quantified in the filing. As of January 24, 2025, META had 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding, indicating a significant concentration of voting power within Class B. In contrast, GOOGL explicitly states that each Class B share carries 10 votes, creating a defined 1:10 voting disparity. GOOGL also repurchased $62.0 billion in shares during 2024, predominantly from Class A and Class C, which may further consolidate voting control in Class B shares held by insiders. This suggests that while both companies utilize dual-class structures to concentrate voting power, GOOGL's is more explicitly weighted and reinforced through aggressive capital allocation, whereas META’s structure lacks detailed disclosure on voting disparity but similarly reflects a concentrated ownership base through disproportionate Class B shareholding.",
      "llm_answer": "Meta’s capital structure gives each Class A share one vote and each Class B share ten votes, so the 343,761,117 Class B shares outstanding on January 24 2025 represent about 3.44 billion votes versus 2.19 billion votes from the 2.19 billion Class A shares – roughly 61 % of total voting power resides in the much smaller Class B block. Google’s dual‑class system is identical in voting mechanics (Class A = 1 vote, Class B = 10 votes), but the company’s $62 billion of share repurchases in 2024 has removed a large amount of both Class A and Class C stock, thereby tightening the share base and further concentrating voting control in the remaining Class B holders. In both firms the 10‑to‑1 voting premium gives a small number of Class B shares disproportionate influence, but Meta’s concentration is already evident from the vote‑share split, while Google’s recent repurchases are likely to increase that concentration even more.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in asserting that Meta's Class B shares carry 10 votes each. The original answer (ground truth) explicitly states that Meta does not disclose the exact voting ratio between Class A and Class B shares, making the LLM's claim of a 10:1 ratio incorrect. This error undermines the entire quantitative analysis of voting power (61% of total votes in Class B), which is based on an assumed ratio not supported by the filing. All subsequent calculations—3.44 billion votes from Class B and 2.19 billion from Class A—are therefore invalid. (2) The $62 billion share repurchase figure for GOOGL in 2024 is correctly cited and contextually used. The number of shares outstanding for both Meta classes is accurately reported. However, the calculation of voting power is flawed due to the incorrect assumption of a 10:1 ratio at Meta. (3) The multi-hop reasoning is partially sound: the model correctly identifies that dual-class structures concentrate voting power and that share repurchases can amplify this effect at GOOGL. However, it fails to acknowledge the key distinction in disclosure transparency—GOOGL explicitly states its 10:1 ratio, while Meta does not—which is a central point in the original answer. By assuming parity in voting ratios, the LLM misses a critical qualitative difference between the two companies' structures. (4) The contextual relevance is high because the answer addresses the comparison between Meta and GOOGL, ownership concentration, and the impact of repurchases. However, due to the fundamental error in Meta’s voting rights structure, the qualitative and quantitative accuracy scores are low. The correctness score is 4 because while some facts (share counts, repurchase amount) are right, the core analysis is built on a false premise, leading to misleading conclusions about Meta’s ownership concentration.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 519,
        "total_tokens": 2063
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the enactment of TRAF in Switzerland impact JNJ's effective tax rate in 2020, and how does this compare to MRK's tax benefit from its Swiss tax holiday that began in 2021?",
      "original_answer": "The enactment of TRAF in Switzerland allowed JNJ to adjust the tax basis of certain assets to fair value under transitional provisions, resulting in an incremental Swiss tax deduction and contributing to a 1.9% decrease in JNJ's 2020 effective tax rate compared to 2019. Meanwhile, MRK benefited from a Swiss tax holiday for a newly active legal entity, effective through 2030, which began yielding favorable tax impacts starting in 2021. These provisions in Switzerland contributed to both companies experiencing lower effective tax rates due to localized tax incentives, albeit through different mechanisms and in different fiscal years.",
      "llm_answer": "The Swiss TRAF reform that took effect on 1 January 2020 gave Johnson & Johnson a net tax benefit of roughly **$0.4 billion, which lowered its 2020 effective tax rate by about 2.6 percentage points**.  \n\nMerck’s new Swiss “tax‑holiday” that began in 2021 produced a far larger effect – the company’s effective tax rate fell from 22.9 % in 2020 to 11.0 % in 2021, a **reduction of roughly 12 percentage points**, indicating a substantially bigger tax benefit than the TRAF‑related 2.6 % saving J&J received.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative claims. The ground truth states that JNJ's effective tax rate decreased by 1.9% due to TRAF in 2020, but the LLM claims a 2.6 percentage point reduction, which is incorrect. Additionally, the LLM cites a $0.4 billion tax benefit for JNJ, which is not present in the original answer and cannot be verified against the ground truth. For MRK, the original answer notes that the tax holiday began in 2021 and contributed to lower tax rates, but does not provide specific percentage points or a rate drop from 22.9% to 11.0%. The claimed 12 percentage point reduction is unsupported by the ground truth and introduces precise numbers that were not in the source. (2) Calculations and comparisons are flawed: the conclusion that Merck’s benefit was 'substantially bigger' relies on invented data and cannot be validated. The comparison between a 2.6% (incorrect) and 12% (unverified) reduction is not grounded in the original answer. (3) Multi-hop reasoning is partially sound—the model attempts to compare two companies’ Swiss tax incentives across different years—but fails in execution due to fabrication of numerical impacts. It correctly identifies that JNJ benefited from TRAF in 2020 and MRK from a tax holiday starting in 2021, showing some correct entity and temporal alignment. (4) Contextual relevance is high because the response addresses both parts of the question and discusses the correct mechanisms (TRAF reform and tax holiday), but correctness and quantitative accuracy are severely compromised by unsupported figures. Minor note: 'MRK' and 'JNJ' are correctly identified, and the years 2020 and 2021 are appropriately assigned, preserving some qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 481,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How do MCD's foreign currency asset hedging practices compare with NKE's transactional FX risk management strategies using options, particularly regarding notional amounts and objectives?",
      "original_answer": "MCD manages FX exposure by holding diversified foreign currency net asset positions, with its largest exposures denominated in major global currencies (chunk_1). To mitigate associated risks, MCD uses option and forward contracts to hedge forecasted foreign currency transactions, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024 (chunk_2). NKE also uses option contracts as part of its FX risk management, focusing on transactional exposures such as product costs and external sales in non-functional currencies, with hedging strategies aimed at stabilizing U.S. Dollar inventory costs amid FX fluctuations (chunk_3). While both companies use options, MCD's strategy centers on protecting existing foreign currency assets, whereas NKE's approach is more transaction-focused, targeting forecasted cash flows and cost stability.",
      "llm_answer": "McDonald’s does not disclose a specific notional amount for its foreign‑currency hedges; it says it “uses foreign‑currency debt and derivatives to hedge the foreign‑currency risk associated with certain royalties, inter‑company financings and long‑term investments in foreign subsidiaries and affiliates” and relies on natural offsets and cross‑currency swaps to smooth earnings and cash‑flow volatility.  \n\nNike, by contrast, quantifies its transactional‑FX program: at September 28 2024 it had net cash‑flow‑hedge contracts (for assets, liabilities, firm commitments and forecasted transactions) with a notional of **$9.9 billion** and additional foreign‑exchange contracts not designated as hedges with a net notional of **$3.4 billion**.  Nike’s objective is to lock in the U.S.‑dollar value of those items—using forwards and options for periods up to four years—so that earnings and cash‑flow fluctuations from currency movements are minimized.  \n\nThus, while McDonald’s describes a qualitative, asset‑focused hedging approach without a disclosed notional figure, Nike provides a quantitative transactional‑FX strategy that uses options/forwards on roughly $13 billion of notional exposure to achieve a defined earnings‑stability objective.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors, particularly in the reversal of key quantitative disclosures between MCD and NKE. According to the ground truth, MCD has $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024, while the LLM incorrectly attributes this $9.9 billion figure to Nike. Additionally, the LLM claims Nike had $3.4 billion in non-designated contracts and a total notional of ~$13 billion, which is not supported by the original answer and introduces data not present in the ground truth. The original answer does not provide any notional amount for Nike, nor does it mention $3.4 billion or a total of $13 billion in exposure. Thus, the quantitative inaccuracies are severe and central to the comparison. Regarding qualitative accuracy, the LLM correctly identifies that MCD focuses on hedging foreign currency assets and uses options/forwards, and that NKE uses options for transactional exposures like product costs and sales in non-functional currencies. The objective of stabilizing U.S. Dollar inventory costs for NKE is accurately reflected, as is MCD’s broader asset protection strategy. However, the reversal of the $9.9 billion notional amount — a core piece of evidence — undermines the validity of the comparison. The reasoning is structured logically and addresses the comparative question, but the synthesis is based on misattributed data. Contextually, the answer is relevant and attempts a direct comparison on notional amounts and objectives, but due to the inversion of key facts, the conclusion is misleading. Semantic equivalence fails on the most critical numeric claim. Minor note: both mention September 28, 2024, which matches the ground truth date, but it is tied to the wrong company in the LLM response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 486,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the exclusive use of RTX's PW800 engine on Gulfstream's G500 support General Dynamics' strategy to position the G500 as a next-generation replacement for the G450 and G550 models?",
      "original_answer": "The G500, developed by General Dynamics, is positioned as a next-generation replacement for the G450 and G550 models with a clean-sheet design that includes a new wing and advanced avionics. RTX's Pratt & Whitney Canada produces the PW800 engine, which exclusively powers the G500 (along with the G400 and G600). This exclusive engine-airframe pairing enhances the G500's performance with improved fuel efficiency, range, and speed, aligning with General Dynamics' investment in new technologies to differentiate the G500 as a modern, high-performance aircraft in the business jet market.",
      "llm_answer": "RTX’s PW800 engine is the sole powerplant for the Gulfstream G500 (and G600), delivering higher thrust with markedly lower fuel burn and emissions 【RTX page 5】. Those engine‑level gains translate directly into the G500’s “faster, more fuel‑efficient, greater‑cabin‑volume, reduced‑emissions, more‑range and improved‑flight‑controls” characteristics that General Dynamics cites as the reasons the clean‑sheet G500 (and G600) replace the older G450 and G550 models 【GD page 5】. Thus, the exclusive PW800 engine underpins the G500’s next‑generation performance and efficiency, supporting GD’s strategy to position it as the successor to the G450/G550 family.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: RTX's Pratt & Whitney Canada produces the PW800 engine, which exclusively powers the G500 (and G600), and this supports General Dynamics' strategy to position the G500 as a next-generation replacement for the G450 and G550. The answer correctly identifies the clean-sheet design, improved performance metrics (fuel efficiency, range, speed, cabin volume, emissions), and the strategic intent. (2) There are no numeric values, dates, or calculations in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly links RTX as the engine provider, the PW800 as the exclusive powerplant, and its performance benefits to General Dynamics' positioning strategy. The synthesis across entities (RTX, PW800, G500, G450/G550) is accurate. (4) The only minor shortcoming is that the LLM mentions the G600 more than the G400 (which is also powered by the PW800 per ground truth), but this does not detract from the core accuracy regarding the G500. Wording differs slightly (e.g., 'reduced-emissions' vs 'lower emissions'), but semantic equivalence is maintained. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 368,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the voting power distribution in META's dual-class structure compare to CMCSA's, particularly regarding the non-dilutable provisions under their respective articles of incorporation and the specific voting percentages allocated to Class A and Class B shareholders?",
      "original_answer": "META's Class B common stock is not publicly traded and as of December 31, 2023, there were only 23 stockholders of record of Class B common stock, suggesting concentrated voting control. In contrast, CMCSA explicitly states that holders of Class A common stock hold 66 2/3% of the combined voting power, while Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power. CMCSA's Class B common stock has 15 votes per share and its non-dilutable nature is specifically tied to the terms of its articles of incorporation, which preserves the voting power percentage regardless of additional Class A share issuances.",
      "llm_answer": "Meta Platforms uses a 2‑class structure in which each Class A share carries one vote and each Class B share carries ten votes.  Under the company’s articles of incorporation the voting power of the Class B shares is “generally non‑dilutable,” and the 23 Class B shares outstanding give the Class B holders roughly 80 % of the total voting power, leaving about 20 % to the roughly 3,098 Class A shareholders.\n\nComcast’s structure is similar but with a different weighting: each Class A share has one vote and each Class B share has fifteen votes.  The single Class B share owned by Mr. Brian L. Roberts represents about 33 ⅓ % of the combined voting power (the Class A holders own the remaining 66 ⅔ %), and the articles of incorporation also make that Class B voting power “generally non‑dilutable.”",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several key inaccuracies in quantitative details, particularly regarding voting power percentages and share structures, which significantly affect correctness. First, the claim that Class B shareholders in META hold 'roughly 80%' of voting power is incorrect and not supported by the ground truth, which does not specify a percentage—only that Class B is non-public and held by 23 stockholders as of December 31, 2023. The 80% figure is a fabrication or inference not present in the original data. Second, the LLM states there are '23 Class B shares outstanding,' which misinterprets the ground truth: it says there are 23 stockholders of record, not 23 shares—this is a critical error. META's Class B shares are held in large quantity by a small number of individuals (primarily Mark Zuckerberg), not one share per stockholder. Third, while CMCSA's voting split (66 2/3% for Class A, 33 1/3% for Class B) is correctly reported, the LLM incorrectly states there is 'a single Class B share' owned by Brian L. Roberts. The ground truth confirms he beneficially owns all Class B stock, but does not state there is only one share—this is an unjustified simplification. However, the qualitative aspects are mostly sound: the LLM correctly identifies the non-dilutable nature of both companies' dual-class structures tied to articles of incorporation, accurately notes the 10-vote and 15-vote weights (though META's 10 votes per Class B share is not in the ground truth and assumed), and correctly contrasts the concentrated control in both firms. The reasoning synthesizes the comparison well and addresses all parts of the question. Contextual relevance is high, as the response directly engages with voting power distribution, non-dilutable provisions, and shareholder classes. Despite correct framing and structure, the quantitative inaccuracies—especially the false 80% and '23 shares' claims—severely undermine factual reliability, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 532,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the risk of losing market exclusivity due to patent challenges for BMY's Revlimid in Europe compare to LLY's reliance on data protection for orphan drug designations, given that both companies depend on intellectual property frameworks to extend commercial exclusivity?",
      "original_answer": "BMY faces earlier-than-expected market exclusivity loss for Revlimid in Europe due to patent settlements allowing generic entry in the UK starting January 18, 2022, and in other European countries beginning February 18, 2022. This highlights the vulnerability of market exclusivity when patent rights are challenged or settled. In contrast, LLY leverages regulatory data protection, including orphan drug designations that provide seven years of market exclusivity independent of patent expiration. While BMY's exclusivity is determined largely by patent rights and settlements, LLY benefits from parallel regulatory protections that do not rely solely on patent enforcement, especially in markets where orphan designations apply.",
      "llm_answer": "Bristol‑Myers Squibb says that Revlimid could lose its European market exclusivity sooner than expected because generic manufacturers are already seeking patent settlements and “at‑risk” launches – it expects generic lenalidomide to enter the United Kingdom on 18 January 2022 and other EU markets on 18 February 2022 under its Supplemental Protection Certificate (page 36). Eli Lilly, by contrast, counts on the seven‑year orphan‑drug data‑exclusivity granted to certain indications to keep competitors out (page 10), so its main vulnerability is a change to or loss of that regulatory data protection rather than a direct patent challenge. Thus, BMY’s risk is a near‑term, patent‑focused threat to Revlimid in Europe, whereas LLY’s risk is a more abstract reliance on orphan‑drug data exclusivity that could be altered by regulatory changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BMY's Revlimid faces generic entry in the UK on January 18, 2022, and in other European markets on February 18, 2022, due to patent settlements—this matches the original answer exactly. The reference to the Supplemental Protection Certificate (SPC) adds context without contradicting the ground truth. For LLY, the seven-year orphan drug data exclusivity is correctly cited, and the distinction between regulatory data protection versus patent reliance is accurately drawn. (2) Quantitative accuracy is perfect: both dates (January 18, 2022, and February 18, 2022) are correct, and the seven-year exclusivity period is accurately stated. No calculations are required, but temporal comparisons are sound. (3) Multi-hop reasoning is strong: the model correctly synthesizes information across two companies (BMY and LLY), two types of IP protection (patents vs. regulatory exclusivity), and two risk profiles (imminent patent-driven generic entry vs. potential regulatory change). The conclusion that BMY faces a near-term, patent-focused threat while LLY’s risk is more abstract and regulatory is a valid interpretation of the contrast. (4) Minor deduction in qualitative accuracy due to slightly different framing—ground truth emphasizes that LLY’s protection is 'independent of patent expiration,' while LLM focuses on 'vulnerability to regulatory change'—but this is semantically consistent. No factual errors; wording differences do not affect correctness. Contextual relevance is excellent as all parts of the question are addressed with precise, targeted information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 456,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the sensitivity of MS's asset management revenues to fixed income market fluctuations compare with PYPL's exposure to market risk through its use of pricing models for derivatives and debt securities?",
      "original_answer": "MS's asset management revenues are sensitive to changes in fixed income markets due to their reliance on fee-based client assets, which include fixed income investments valued using pricing models with observable market data like interest rates and credit spreads. MS specifically notes that revenues may not fully correlate with market changes due to factors like client behavior and asset mix. Meanwhile, PYPL also depends on pricing models for valuing its derivatives and available-for-sale debt securities, using observable inputs such as currency rates, interest rate yield curves, and equity prices. However, unlike MS, PYPL has elected the fair value option for foreign currency-denominated debt securities, directly tying gains and losses to market fluctuations. Both firms face market risk through their use of pricing models, but MS's exposure is more indirect through asset management fees, while PYPL's is direct through its investment and derivative valuations.",
      "llm_answer": "Morgan Stanley notes that a portion of its Wealth‑Management and Investment‑Management revenues comes from fees on client assets that are “primarily composed of equity, fixed‑income and alternative investments” and that “these revenues … are sensitive to changes in the related markets,” meaning that a decline in fixed‑income prices can directly reduce fee income. PayPal, by contrast, does not earn fees that vary with market moves; its market‑risk exposure arises from the fact that “the majority of our derivative instruments are valued using pricing models… and our debt securities are measured using observable inputs,” so changes in the inputs to those models affect the fair‑value gains or losses recorded on its balance sheet and income statement. Thus, MS’s sensitivity is on the revenue‑generation side, while PYPL’s exposure is on the valuation‑and‑earnings side through model‑based pricing of derivatives and debt securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core distinction between MS and PYPL's exposure to market risk through pricing models and fixed income fluctuations. (1) All factual elements are correct: MS's asset management revenues are indeed sensitive to fixed income market changes due to fee-based models tied to client asset values, including fixed income; PYPL uses pricing models with observable inputs (interest rates, currency rates) for derivatives and debt securities and has elected the fair value option, leading to direct income statement impacts. The LLM correctly identifies that MS’s exposure is on the revenue-generation side (fees tied to asset values), while PYPL’s is on the valuation-and-earnings side via fair value changes. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not applicable in a traditional sense—but the absence of incorrect numbers and correct use of financial concepts supports a score of 10. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies, their revenue models, and risk exposures from different parts of the financial statements. The only minor shortcoming is that the LLM does not explicitly mention PYPL’s election of the fair value option for foreign currency-denominated debt, which is a key differentiator in the ground truth. However, it does convey the effect (fair value gains/losses impacting earnings), so the omission is more presentational than substantive. (4) The answer is fully contextually relevant, directly addressing the comparison of sensitivity and exposure as requested. Overall, the answer is semantically equivalent to the ground truth with high precision and clarity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 473,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How do Oracle's integration of generative AI in MySQL HeatWave and Qualcomm's investment in IoT applications reflect their respective strategies for on-device AI processing in enterprise and consumer markets?",
      "original_answer": "Oracle integrates generative AI into Oracle MySQL HeatWave, offering it as a managed cloud service that combines transactions, real-time analytics, machine learning, and generative AI capabilities. This enables enterprise customers to deploy AI-driven analytics and applications more efficiently. In contrast, Qualcomm is investing heavily in expanding generative AI into IoT and edge devices, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024. Qualcomm’s QCT segment develops integrated circuits for IoT applications, including consumer electronics, industrial devices, and edge networking products, emphasizing on-device processing for immediacy, privacy, and personalization. While Oracle focuses on cloud-native AI integration for enterprise database workloads, Qualcomm is driving AI capabilities into edge devices across multiple industries, particularly IoT, to capitalize on the growing demand for on-device intelligence.",
      "llm_answer": "Oracle is weaving generative‑AI directly into the data‑layer service that enterprises run – MySQL HeatWave now “combines transactions, real‑time analytics, machine learning **and generative AI** in one managed cloud service” (ORCL 12).  By embedding AI inside its database platform, Oracle is giving its enterprise customers on‑device‑style intelligence (privacy‑preserving, low‑latency analytics) while keeping the workload under the same OCI/Hybrid‑cloud infrastructure.  \n\nQualcomm, by contrast, is pouring resources into **IoT‑focused Snapdragon platforms and AI Engine hardware** (the Hexagon NPU and AI Engine that enable “high‑performance and low‑power on‑device AI” – QCT 7) and is counting on the surge in IoT demand “enabled by 5G and AI technologies, including generative AI” (QCT 8).  This investment lets Qualcomm deliver on‑device AI processing for consumer‑grade devices (smartphones, AI‑centric PCs, wearables) and industrial IoT edge nodes, emphasizing low‑power, on‑device inference rather than cloud‑based AI.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Oracle integrates generative AI into MySQL HeatWave as a managed cloud service combining transactions, analytics, ML, and generative AI—this matches the original answer. Qualcomm's investment in IoT and edge AI is accurately portrayed, including its focus on Snapdragon platforms, AI Engine hardware (Hexagon NPU), and low-power on-device inference. (2) Quantitative accuracy is perfect: although no specific numbers (like the 19% and 46% smartphone projections for 2024 and 2027) are mentioned in the LLM answer, it does not misstate any figures and avoids making up data. The omission of the exact percentages is a minor completeness gap but does not reduce factual correctness. (3) Multi-hop reasoning is sound: the model correctly contrasts Oracle’s cloud-native, enterprise-focused AI integration in databases with Qualcomm’s edge-focused, device-level AI strategy for consumer and industrial IoT markets. The synthesis across companies and use cases (enterprise vs. consumer, cloud vs. edge) is logically coherent. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'on-device-style intelligence' for Oracle, which is metaphorical since HeatWave is cloud-based), it still correctly conveys that Oracle brings AI close to data in a managed environment, preserving latency and privacy benefits akin to on-device processing. Qualcomm’s strategy is accurately grounded in hardware enablement for on-device AI. The only minor shortcoming is the lack of explicit mention of the 19% → 46% generative AI smartphone growth projection, which is part of the original answer’s quantitative emphasis. However, the core strategic contrast is fully preserved, and no incorrect claims are made. Hence, a score of 9 is justified—excellent accuracy with a small omission in quantitative detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 520,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How might the compliance costs associated with the EU AI Act, which Adobe anticipates will require costly changes to its AI development practices, affect its competitive positioning against Salesforce, which relies heavily on its AI-powered Agentforce platform for sales and service offerings?",
      "original_answer": "Adobe anticipates that the EU AI Act, which will be implemented in phases through 2030, may require costly changes to its AI development practices, including delays or halts in development, changes to monetization strategies, and increased compliance costs. Meanwhile, Salesforce relies heavily on its AI-powered Agentforce platform across sales, service, and marketing offerings to drive productivity and growth. If Adobe is forced to divert resources to comply with the new regulations, it could slow the pace of its AI innovation, potentially giving Salesforce a competitive edge through its more established and integrated AI capabilities like Agentforce for Sales and Service. The GS_10k_2024 chunk reinforces that evolving AI regulations increase compliance costs and operational risks for companies relying on AI, suggesting both firms face similar pressures, but Salesforce’s deeper integration of AI across its platform may make it better positioned to absorb such regulatory changes.",
      "llm_answer": "Adobe warns that the EU AI Act will likely force “costly changes” to its AI‑development practices and increase its compliance, governance and R&D expenses, which could “adversely impact our margins” as it continues to invest heavily in AI (see ADBE pages 23‑24). Because Salesforce’s growth strategy is built around its AI‑powered Agentforce layer that underpins its sales‑ and service‑offering (see CRM pages 5‑7), higher compliance costs could limit Adobe’s ability to fund and roll out new AI features as quickly, eroding its ability to compete with Salesforce’s more‑unencumbered, AI‑centric platform.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original ground truth. (1) All factual elements are correct: Adobe anticipates costly changes due to the EU AI Act, including increased compliance, governance, and R&D expenses, which could impact margins—this is supported by ADBE 10-K pages 23–24. Salesforce’s reliance on Agentforce for sales and service is accurately represented (CRM pages 5–7). (2) There are no numeric values, dates, or calculations in the question or answers that conflict; all references are qualitative and correctly cited. (3) The multi-hop reasoning is sound: the model correctly synthesizes that regulatory compliance costs for Adobe could slow AI innovation, potentially benefiting Salesforce due to its deeper AI integration. The only minor shortcoming is that the LLM answer does not explicitly mention the phased implementation through 2030 or the GS_10k_2024 context about both firms facing similar pressures, slightly reducing completeness. However, the core competitive dynamic is accurately captured. (4) The answer is contextually excellent—directly addressing the competitive implications of regulatory cost burdens. Thus, the correctness score is 9 due to a small omission in temporal scope and shared industry-wide risk, but all key entities, reasoning, and implications are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 369,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does the payout structure of HD's deferred shares, which includes dividend equivalents paid in additional shares, compare with LOW's receipt of additional shares through ASR agreements, in terms of stock-based value distribution to stakeholders?",
      "original_answer": "HD issues additional shares as dividend equivalents to non-employee directors upon the payout of deferred shares following termination of service, based on accrued dividends. This represents a stock-based compensation mechanism tied to director retention and long-term alignment. In contrast, LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, which are tied to repurchase efficiency and final notional value calculations. These additional shares in LOW's case are not compensation-related but are part of capital return strategy execution. Both companies issue additional shares, but the context, stakeholders, and triggers differ significantly, reflecting distinct financial strategies.",
      "llm_answer": "Home Depot’s deferred‑share awards give non‑employee directors a share of the company’s stock and, on payout, they also receive “dividend equivalents” that are issued as **additional shares** of stock – a direct, stock‑based benefit to those individual directors. Lowe’s ASR transactions, by contrast, are treasury‑stock purchases in which the company pays cash up‑front, then **receives additional shares** (or cash) from the financial institution at settlement, increasing the company’s own share inventory rather than distributing extra shares to a specific group of stakeholders. Thus, HD’s structure passes extra shares to directors as compensation, while LOW’s structure adds shares to the company’s balance sheet, indirectly affecting shareholder value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that HD issues additional shares as dividend equivalents to non-employee directors upon payout of deferred shares, which is a form of stock-based compensation. It contrasts this with LOW's ASR agreements, where the company receives additional shares from financial institutions as part of share repurchase programs, not as compensation. These points align with the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (HD and LOW), two distinct financial instruments (deferred shares with dividend equivalents vs. ASR agreements), and two stakeholder contexts (individual directors vs. the company itself). The conclusion that HD distributes shares to individuals while LOW adds them to treasury stock is logically derived and factually correct. (4) Minor deduction in qualitative accuracy due to slightly less explicit emphasis on the strategic distinction (compensation/retention vs. capital return efficiency), though the implication is clear. Overall, the answer is semantically equivalent, contextually precise, and factually correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 386,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does AT&T's adoption of ASU 2020-04, which facilitates contract modifications triggered by reference rate reform, compare to Verizon's disclosure of contract modifications in terms of impact on their respective revenue recognition timing and contract performance obligations?",
      "original_answer": "AT&T adopted ASU 2020-04, which provides optional expedients for contract modifications triggered by reference rate reform (e.g., LIBOR transition), and stated that the adoption did not materially impact its financial statements. Meanwhile, Verizon disclosed that contract modifications affect the timing and scope of performance obligations, with $25.7 billion, $18.7 billion, and $7.5 billion expected to be recognized in 2024, 2025, and beyond, respectively. The connection through ASU 2020-04 to contract modifications shows that while AT&T experienced minimal financial impact from reference rate-related modifications, Verizon's broader contract modification landscape significantly influences its future revenue recognition patterns.",
      "llm_answer": "AT&T notes that its adoption of ASU 2020‑04 – which provides optional expedients for contract modifications caused by reference‑rate reform – “does not materially impact our financial statements,” indicating that the change does not alter the timing of revenue recognition or the accounting for performance obligations. In contrast, Verizon explicitly states that contract modifications can change the “timing and scope of contracts, arising from contract modifications,” and therefore affect the estimates of remaining performance obligations and when related revenue will be recognized. Thus, AT&T’s adoption has essentially no effect on revenue‑recognition timing, whereas Verizon’s disclosed modifications can shift when revenue is recognized and reshape performance‑obligation estimates.",
      "correctness_score": 7,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the qualitative distinction between AT&T and Verizon regarding the impact of contract modifications on revenue recognition and performance obligations. It accurately states that AT&T’s adoption of ASU 2020-04 did not materially impact its financial statements, consistent with the ground truth. It also correctly notes that Verizon views contract modifications as affecting the timing and scope of performance obligations, influencing revenue recognition patterns. However, the LLM answer omits all quantitative figures provided in the original answer—specifically, Verizon’s $25.7 billion, $18.7 billion, and $7.5 billion expected to be recognized in 2024, 2025, and beyond—representing a significant omission of key numerical data required for full accuracy. (2) The absence of these dollar amounts results in a low quantitative accuracy score. These figures are central to the comparison, especially in illustrating the materiality of Verizon’s contract modifications. Their omission means the LLM answer fails to convey the scale of impact, which is a core part of the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (AT&T and Verizon), links ASU 2020-04 to contract modifications, and contrasts the financial impact on revenue timing and performance obligations. The logic and entity identification (ASU 2020-04, reference rate reform, performance obligations) are accurate. (4) The correctness score is 7 because while the core qualitative comparison is accurate and well-reasoned, the missing quantitative data limits completeness and precision. The answer remains contextually relevant and conveys the essential contrast, but the lack of numbers reduces its fidelity to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 492,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How do Union Pacific's and Lockheed Martin's pension plan disclosures reflect differences in their reliance on Level 2 valuation methodologies for municipal bonds, and what does this imply about their adherence to ASC 820 fair value measurement standards?",
      "original_answer": "Union Pacific discloses that its pension plan classifies municipal bonds as Level 2 investments, which are valued using a bid evaluation process with bid data from independent pricing sources. Lockheed Martin's pension plan also discloses the use of Level 2 valuation methodologies for fixed income securities, where indicative quotes from pricing vendors are used if corroborated. UPS's filing explicitly confirms that municipal bonds fall under Level 2, valued via market-corroborated pricing or matrix pricing models using observable inputs like yield curves. The alignment in Level 2 classification for these instruments suggests both companies are applying ASC 820 consistently for fair value measurements, though UNP provides more specificity regarding municipal bonds, while LMT focuses on general fixed income treatment.",
      "llm_answer": "- **Union Pacific (UNP)** – In the pension‑plan footnote the company states that “Bonds and debentures… including state and municipal bonds are classified as Level 2 investments” (UNP 10‑K p. 57). This shows that UNP’s pension assets rely on Level 2 fair‑value techniques for its municipal‑bond holdings, using observable market inputs (e.g., yield curves and broker quotes) consistent with ASC 820’s hierarchy requirements.  \n\n- **Lockheed Martin (LMT)** – The pension‑plan disclosure lists equity securities (Level 1) and corporate‑debt, government‑agency and GSE securities (Level 2) but does **not** include any municipal‑bond line items (LMT 10‑K p. 87). Thus LMT’s pension plan shows little or no reliance on Level 2 methods for municipal bonds; its assets are valued at Level 1 or Level 2 for other categories, and the company still complies with ASC 820 by providing the required hierarchy disclosure.  \n\n**Implication:** Both companies meet ASC 820’s fair‑value measurement standards by disclosing the level of inputs used, but UNP explicitly uses Level 2 inputs for municipal bonds, whereas LMT’s pension plan either holds no municipal bonds or values any it holds at a different level, reflecting a differing degree of reliance on Level 2 methodologies.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in that it accurately identifies Union Pacific's (UNP) use of Level 2 valuation for municipal bonds and references ASC 820 appropriately. However, it incorrectly claims that Lockheed Martin (LMT) does not disclose municipal bonds in its pension plan or relies less on Level 2 for them. The ground truth states that LMT does use Level 2 valuation methodologies for fixed income securities, including when indicative quotes from pricing vendors are corroborated — which aligns with ASC 820 and may include municipal bonds, even if not explicitly named. The LLM misinterprets the absence of an explicit 'municipal bond' line item as evidence of non-holding or non-use of Level 2 for such instruments, which is a flawed inference. Per ASC 820, companies can group similar fixed income securities (e.g., government, agency, municipal) under broader categories. Thus, LMT’s disclosure of Level 2 treatment for government and agency debt does not preclude municipal bonds being included therein. The implication drawn — that LMT shows 'little or no reliance' on Level 2 for municipal bonds — is therefore unsupported and factually incorrect. While the reasoning around UNP is sound and citations are contextually plausible (though not verifiable here), the comparison fails due to incorrect synthesis about LMT. There are no numerical inaccuracies (hence high quantitative score), but the qualitative error in multi-hop logic — comparing disclosure specificity across firms and inferring asset composition — significantly undermines the conclusion. The answer is contextually relevant and well-structured, but factually flawed in a key comparative claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 457,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How does KO's reliance on Coca-Cola FEMSA for distribution in Argentina compare to MDLZ's exposure to economic volatility in the same market, given Coca-Cola FEMSA's specific operational footprint and MDLZ's inflation-related financial impacts?",
      "original_answer": "KO relies on Coca-Cola FEMSA for distribution in parts of Argentina, specifically the federal capital of Buenos Aires and surrounding areas, as part of its broader network of equity method investees to whom it sold $14.471 billion in net sales in 2021. Coca-Cola FEMSA operates in Argentina, a market that has been classified as highly inflationary since mid-2018, which directly affects MDLZ’s operations there. MDLZ reported a $13 million remeasurement loss in 2021 due to the volatility of the Argentine peso, with Argentina contributing $401 million (1.4%) to MDLZ’s consolidated net revenues. This highlights how both companies are exposed to Argentina, but through different mechanisms: KO through a distribution dependency and MDLZ through direct financial exposure to currency and inflation risks.",
      "llm_answer": "Coca‑Cola Co. reaches Argentine consumers almost entirely through its independent bottling partner Coca‑Cola FEMSA, which operates the bottling and distribution system for the federal capital of Buenos Aires and surrounding areas — a footprint that underpins KO’s Argentine sales (about $401 million, or 1.4 % of total net revenues). In contrast, Mondelēz does not rely on a local bottler; it bears the country’s macro‑economic risk directly, recording inflation‑related remeasurement losses of $13 million in 2021 and $9 million in 2020 after classifying Argentina as a highly inflationary economy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core contrast between KO's distribution reliance on Coca-Cola FEMSA and MDLZ's direct financial exposure to Argentina's inflationary environment, which aligns well with the ground truth. However, there are key quantitative inaccuracies: the LLM incorrectly attributes the $401 million (1.4%) revenue figure to KO, when in fact this revenue contribution and percentage belong to MDLZ, not KO. The ground truth states that MDLZ earned $401 million (1.4%) from Argentina, while KO's specific Argentine sales figure is not provided. The $13 million remeasurement loss in 2021 and $9 million in 2020 for MDLZ are accurate and correctly cited. The statement that Coca-Cola FEMSA operates in Buenos Aires and surrounding areas is correct. The qualitative reasoning is sound—correctly identifying KO’s indirect exposure via a bottling partner versus MDLZ’s direct exposure to currency and inflation risks—and the multi-hop synthesis across companies and mechanisms is logically presented. Contextually, the answer is highly relevant and well-structured. The main flaw is the misattribution of financial figures, which significantly affects quantitative accuracy despite otherwise strong reasoning and contextual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 346,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the voting rights structure of META's Class B common stock influence its shareholder equity strategy compared to Alphabet's dual-class stock framework, particularly in light of Alphabet's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "META's Class B common stock grants 10 votes per share, compared to 1 vote per share for Class A, giving certain shareholders disproportionate voting power. Similarly, Alphabet follows a dual-class structure where Class B shares also carry 10 votes each, while Class A shares have one vote, and Class C shares have no voting rights. In 2024, Alphabet repurchased $62.0 billion of its Class A and Class C shares, prioritizing repurchases based on economic cost and market conditions. This suggests that both companies maintain strategic flexibility in managing shareholder equity by leveraging their dual-class structures to preserve voting control while repurchasing shares to enhance shareholder value.",
      "llm_answer": "Meta’s capital structure gives its insiders a powerful lever: each Class B share carries ten votes and can be converted into voting Class A shares, so the holders of Class B stock retain decisive control over corporate actions while still being able to buy back both voting and non‑voting shares (Meta 10‑K, Note 11 – “Class B common stock is entitled to 10 votes per share… Shares of Class B may be converted… We continued to repurchase both Class A and Class C shares”【page_82】).  \n\nAlphabet’s dual‑class system separates voting power (Class B shares, not mentioned in the repurchase) from economic interest (Class A – one vote, and Class C – no vote). Its 2024 $62 billion buyback was directed only at Class A and Class C shares, returning cash to shareholders without affecting the concentrated voting control held by the Class B owners (Alphabet 10‑K, Note 11 – “we repurchased $62.0 billion of Alphabet’s Class A and Class C shares”【page_82】).  \n\nThus, Meta’s high‑voting Class B stock lets the controlling group steer equity‑management decisions such as buybacks while preserving control, whereas Alphabet’s framework uses buybacks of the publicly‑traded classes to enhance shareholder value without diluting the voting dominance of its Class B shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: META's Class B shares have 10 votes vs. 1 for Class A, and can be converted to Class A; Alphabet’s Class B has 10 votes, Class A has 1, Class C has none. The $62.0 billion 2024 share repurchase by Alphabet targeted only Class A and C shares. These numbers and structures match the original answer exactly. (2) Quantitative accuracy is perfect: the $62.0 billion figure is correctly cited, and no calculations are required beyond accurate reporting. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across both companies’ capital structures and repurchase strategies, drawing a valid comparison that both use dual-class systems to preserve voting control while enhancing shareholder value via buybacks of lower-vote/no-vote shares. (4) The only minor shortcoming is that the LLM does not explicitly state that both companies’ strategies provide 'strategic flexibility' in managing shareholder equity—a phrase and concept in the original answer—though this idea is implied in the conclusion about preserving control while conducting buybacks. Wording differences are acceptable under semantic equivalence, and all entities (Meta, Alphabet, share classes, years, financial actions) are correctly identified. The inclusion of 10-K citations adds precision but does not affect factual scoring. Overall, this is a strong, factually correct response with only slight room for improved conceptual completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 420,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the decline in GILD's Veklury sales in 2024, influenced by the availability of alternative treatments, compare to the negative impact AMGN reports from alternative treatments in competitive therapeutic markets?",
      "original_answer": "GILD reported that Veklury sales in 2024 were $1,799 million globally, a decline from $2,184 million in 2023, attributed to reduced demand linked to the availability and uptake of alternative treatments for COVID-19. This reflects a direct impact on revenue due to competitive therapeutic options. Similarly, AMGN notes that in competitive treatment markets such as those for ENBREL, Otezla, Repatha, and Aimovig, payers and PBMs are increasingly using formulary restrictions and cost-containment measures to shift patients toward alternative treatments, which has limited Amgen's product usage and sales. Both companies experience revenue pressure from alternative treatments, though GILD’s impact is more directly tied to pandemic-related dynamics, while AMGN faces systemic payer-driven shifts in competitive markets.",
      "llm_answer": "Gilead’s COVID‑19 antiviral Veklury fell from $2.18 billion in 2023 to $1.80 billion in 2024 – a drop of roughly $385 million – because lower infection rates and the availability of newer antivirals and vaccines have given physicians and patients alternative treatment options. Amgen reports a similar, though qualitative, hit: in its competitive therapeutic markets, payer and PBM pressure is forcing doctors to turn to alternative therapies, which it says is eroding the use and sales of its own products.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with only minor deviations in numerical precision. (1) Quantitatively, the LLM reports Veklury sales declining from $2.18 billion in 2023 to $1.80 billion in 2024, which closely approximates the ground truth values of $2,184 million and $1,799 million. The calculated drop of $385 million is accurate (actual: $2,184M - $1,799M = $385M). The use of rounded figures ($2.18B, $1.80B) is acceptable and common in financial reporting. (2) The LLM correctly identifies GILD’s revenue decline as tied to alternative treatments and lower infection rates, aligning with the original answer’s attribution to reduced demand due to alternative therapies. (3) For AMGN, the LLM accurately captures the qualitative nature of the impact—payer and PBM pressure leading to shifts toward alternatives—though it omits specific drug names (ENBREL, Otezla, Repatha, Aimovig) mentioned in the ground truth. This is a minor omission that does not undermine the correctness of the synthesis. (4) The multi-hop reasoning is sound: the model correctly compares GILD’s direct revenue impact from alternative treatments in a pandemic context to AMGN’s systemic, payer-driven challenges in competitive markets. (5) Semantic equivalence is maintained; the LLM conveys the same conclusion—both companies face sales pressure from alternatives, though through different mechanisms. The only grounds for not giving a 10 are the slightly rounded sales figures and omission of AMGN’s specific product names, which marginally affect completeness but not overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 443,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does AMD's interest payment schedule on its $312 million 7.50% Senior Notes compare with QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes, particularly in terms of payment frequency and fiscal year obligations?",
      "original_answer": "AMD's $312 million 7.50% Senior Notes require semi-annual interest payments on February 15 and August 15 of each year, as stated in the indenture governing the notes. In contrast, QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes includes semi-annual payments for fixed-rate notes and quarterly payments for floating-rate notes. While AMD's interest obligations are tied to a specific fixed schedule with a final maturity in fiscal 2022, QCOM has significant upcoming principal payments starting in fiscal 2023 ($1.4 billion) and continuing through future fiscal years, with no principal due in fiscal 2026.",
      "llm_answer": "AMD’s $312 million 7.50 % senior notes require interest to be paid twice a year – on February 15 and August 15 – with the entire principal coming due in fiscal 2022 (the current portion of debt). Qualcomm’s $14.0 billion of notes is a mix of fixed‑rate and floating‑rate issues; interest on the floating‑rate notes is paid quarterly, while interest on the fixed‑rate notes is paid semi‑annually, and principal repayments are spread over several future fiscal years (2023, 2024, 2025, 2027 and beyond) rather than being concentrated in a single year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: AMD's semi-annual interest payments on February 15 and August 15, principal due in fiscal 2022; QCOM's mix of fixed-rate (semi-annual) and floating-rate (quarterly) notes; and the spread of principal repayments across multiple fiscal years (2023, 2024, 2025, 2027+). (2) Quantitative accuracy is perfect: $312 million, $14.0 billion, correct fiscal years, and payment frequencies match the original. Format variations (e.g., 'fiscal 2022' vs 'current portion of debt') are semantically equivalent. (3) Multi-hop reasoning is sound—correctly compares payment frequency and fiscal obligations across two companies' debt instruments. (4) Minor deduction in qualitative accuracy because the original specifies 'no principal due in fiscal 2026', a detail omitted in the LLM answer, though the mention of gaps (e.g., 2027 after 2025) implies this. Otherwise, the synthesis and comparison are clear, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 300,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How might the impending loss of U.S. patent protection for Prolia/XGEVA in February 2025 impact Merck's competitive position, given its reliance on strong patent rights to defend against generic competition and Amgen's own exposure to biosimilar threats in international markets?",
      "original_answer": "The loss of U.S. patent protection for Prolia/XGEVA in February 2025 will likely expose Amgen's product to biosimilar competition, reducing its market exclusivity and potentially decreasing revenue. This dynamic is particularly relevant for Merck, which emphasizes its reliance on strong patent rights to protect its portfolio from generic challenges. Given Merck's acknowledgment of increased global pricing pressure and weakened patent protection in international markets, the erosion of exclusivity for key competitors like Prolia/XGEVA could intensify biosimilar threats across markets, thereby indirectly affecting Merck’s own competitive strategy and market positioning in the therapeutic category.",
      "llm_answer": "The U.S. patents covering Merck’s denosumab antibodies (Prolia and XGEVA) expire on 2 February 2025 (see Merck 10‑K, p. 10 and the patent table on p. 11), and the company repeatedly stresses that “the patent rights that protect its products are of varying strengths and durations” and that loss of those rights “is typically followed promptly by generic or biosimilar substitutes” that would erode sales (Merck 10‑K, p. 33). Because Merck relies heavily on those patents to keep lower‑cost generics out of the market, the imminent expiry is likely to open the bone‑health franchise to rapid generic entry, weakening Merck’s competitive position and cash‑flow contribution from a historically high‑selling product line. At the same time, Amgen’s own flagship biologics are already confronting biosimilar pressure in overseas markets (Amgen 10‑K, p. 9‑13), meaning that both companies will be fighting on price‑sensitive fronts; however, Merck’s exposure is more immediate and acute because the U.S. loss occurs before Amgen’s international biosimilar challenges fully materialize, potentially shifting market share toward competitors and amplifying the competitive risk for Merck.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it incorrectly attributes Prolia and XGEVA to Merck, when these products are developed and marketed by Amgen, not Merck. This misidentification of the core entity undermines the entire response. The expiration date of February 2, 2025, for U.S. patents on Prolia/XGEVA is accurate and aligns with the ground truth, hence partial quantitative accuracy. (2) The date '2 February 2025' is correctly stated and matches the ground truth, and references to 10-K pages (p.10, p.11, p.33) may be plausible but are not verifiable without source access; however, the core financial and product attribution error overshadows these details. (3) The multi-hop reasoning is flawed because the model fails to correctly assign Prolia/XGEVA to Amgen, leading to an incorrect analysis of Merck’s exposure. The original question hinges on understanding that Amgen faces patent expiry, which may indirectly affect Merck’s competitive environment—instead, the LLM wrongly suggests Merck owns Prolia/XGEVA and will face direct generic erosion, reversing the actual dynamic. While the response correctly discusses the general risk of biosimilars post-patent expiry and notes Amgen’s international biosimilar pressures, it misapplies the primary cause-effect relationship. (4) The contextual relevance is moderate because the answer addresses patent expiry, biosimilar threats, and competitive positioning, which are thematically relevant, but the qualitative inaccuracy due to the company-product misattribution severely limits factual correctness. Thus, correctness and qualitative accuracy scores are low despite some structural and conceptual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 463,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What portion of Broadcom's VMware Cloud Foundation revenue in fiscal year 2024 was directly tied to enabling AI workloads, and how does this align with Cisco's strategic focus on providing infrastructure for AI training and inference?",
      "original_answer": "In fiscal year 2024, $1,380 million of Broadcom's $2,900 million VMware Cloud Foundation revenue was recognized, and this platform specifically enables advanced AI and machine learning workloads at enterprise scale. This aligns with Cisco's strategic focus on providing network infrastructure to power AI training and inference workloads through high-density routers and switches, improved network management, and high-performance optics, as stated in their 2024 10-K filing.",
      "llm_answer": "Broadcom’s 2024 filing does not break out a specific dollar amount or percentage of VMware Cloud Foundation (VCF) revenue that is attributable solely to “enabling AI workloads.” The filing only notes that VCF “enables advanced AI and machine‑learning workloads at enterprise scale,” but it does not quantify how much of the VCF revenue comes from that use case.  \n\nCisco’s 2024 filing, by contrast, makes AI a central pillar of its strategy, stating that it is “providing network infrastructure to power AI training and inference workloads” for both web‑scale providers and enterprise customers. Thus, while Broadcom’s disclosure does not isolate an AI‑related revenue share, Cisco explicitly aligns its product roadmap and investments with delivering the underlying connectivity and compute fabric needed for AI training and inference.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim, which directly contradicts the ground truth. The original answer states that $1,380 million of Broadcom's $2,900 million VMware Cloud Foundation revenue in fiscal year 2024 was tied to enabling AI workloads, implying a quantifiable portion. However, the LLM claims that 'Broadcom’s 2024 filing does not break out a specific dollar amount or percentage' and that it 'does not quantify how much of the VCF revenue comes from that use case.' This is factually wrong according to the ground truth, which explicitly provides the $1,380 million figure. Therefore, the quantitative accuracy is very low because the model denies the existence of a key number that is present in the correct answer. The qualitative accuracy is moderate: while the model correctly identifies Cisco’s strategic focus on AI infrastructure as stated in its 10-K, it fails to recognize or report the multi-hop link between Broadcom’s AI-related VCF revenue and Cisco’s positioning. The reasoning is flawed because it concludes no quantification exists when the ground truth clearly includes one, breaking the multi-hop synthesis required. Contextual relevance is fair—the response addresses both companies and the AI infrastructure theme, and correctly summarizes Cisco’s strategy. But by denying the key revenue figure, it fails the primary task. Semantic equivalence is not achieved due to this major factual omission and misrepresentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 402,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the $1,851 million in assets from NEE's consolidated solar VIEs compare to Southern Power's exposure through PPAs accounted for as operating leases, given both entities operate solar facilities under long-term power sales agreements?",
      "original_answer": "NEE consolidates solar VIEs with approximately $1,851 million in assets at year-end 2021, which sell electricity under long-term PPAs expiring between 2035 and 2052. Southern Power, a subsidiary of SO, operates PPAs related to solar facilities accounted for as operating leases with remaining terms of up to 25 years. While NEE's VIEs directly own the solar assets and bear construction and operational risk, Southern Power's exposure is structured as lessor under operating leases, receiving lease payments tied to energy production. Both entities demonstrate significant long-term commitments to solar generation through contractual arrangements, though NEE holds direct ownership and asset risk while SO participates through lease financing structures.",
      "llm_answer": "NextEra Energy’s consolidated solar VIEs hold about **$1.85 billion of assets**.  By contrast, Southern Power’s exposure to its renewable‑energy PPAs that are accounted for as operating leases is reflected in roughly **$652 million of undiscounted cash‑flow commitments** (the total of the operating‑lease cash‑flow schedule for Southern Power).  Thus, the solar‑VIE asset base is roughly three times larger than Southern Power’s operating‑lease PPA exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative comparison. While it correctly states NEE's consolidated solar VIE assets as $1,851 million (rounded to $1.85 billion), it incorrectly characterizes Southern Power's exposure as $652 million in 'undiscounted cash-flow commitments'—a figure not present in the ground truth and unsupported by the provided information. The original answer does not quantify Southern Power's exposure numerically, only describing its structure as operating leases with up to 25 years remaining. Thus, the claim that NEE's asset base is 'roughly three times larger' is based on a fabricated or external data point and is not derivable from the given ground truth. This constitutes a major error in quantitative accuracy. On qualitative aspects, the LLM correctly identifies NEE's ownership model through VIEs and contrasts it with Southern Power's lease-based exposure, capturing the structural difference in risk and accounting treatment at a high level. It also appropriately notes long-term PPA arrangements for both, aligning with the original's theme of long-term solar commitments. However, it fails to mention key details such as PPA expiration ranges (2035–2052) for NEE or that Southern Power receives lease payments tied to production. The reasoning attempts multi-hop synthesis but is undermined by the introduction of an unverified number. Contextually, the response stays focused on the comparison of solar exposures and remains relevant to the question. Overall, partial credit is given for correct framing and one accurate number, but major deductions are made for unsupported quantification and omission of key qualitative details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 465,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the structure of Starbucks' stock-based compensation grants under Stock Appreciation Rights compare to Tesla's use of the 2019 Plan in terms of equity instruments available and vesting timelines?",
      "original_answer": "Starbucks grants Stock Appreciation Rights as part of its equity incentive plans, though it notes that stock options have not been broadly used recently. In contrast, Tesla's 2019 Plan, adopted in June 2019, explicitly includes Stock Appreciation Rights among the equity instruments available for grant, along with stock options, RSUs, and performance shares. Tesla's stock options and RSUs generally vest over four years and are exercisable over a maximum period of 10 years from grant dates. Starbucks records compensation expense based on the fair value of awards at grant date and recognizes it over the service period, with performance-based RSUs tied to metrics like earnings per share and return on invested capital. Tesla also uses vesting schedules and forfeitures estimates but does not specify performance-based conditions in this excerpt.",
      "llm_answer": "Starbucks’ stock‑based compensation program allows SARs to be granted together with non‑qualified options, incentive options, restricted stock and RSUs, and the SARs vest on a graded service‑period schedule rather than a fixed term (the filing notes that “expense … is recognized … following a graded vesting expense schedule”). Tesla’s 2019 Equity Incentive Plan also authorizes SARs, but the plan’s standard vesting cadence is four years for the equity awards it lists (stock options and RSUs) and options may be exercised for up to ten years, so SARs under the 2019 Plan are generally subject to the same four‑year vesting timeline that applies to the other awards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) Quantitatively, all key numbers and timelines are correct: Tesla's four-year vesting period and 10-year exercise window are accurately reported. The mention of the 2019 Plan adoption (implied by '2019 Plan') is consistent, though the exact adoption date (June 2019) is omitted but not required for the comparison. (2) The LLM correctly identifies that both Starbucks and Tesla include SARs in their equity compensation plans and lists other instruments available under Tesla’s 2019 Plan (though not explicitly listing all, it references the plan’s authorization of SARs alongside standard awards). (3) The reasoning is sound: it correctly infers that SARs under Tesla’s plan likely follow the same four-year vesting as other awards, which is a reasonable conclusion based on the structure described. It also accurately notes Starbucks’ use of graded vesting schedules for expense recognition. (4) Minor omission: the original answer notes Starbucks has not broadly used stock options recently, and highlights performance-based RSUs tied to EPS and ROIC—this detail is missing in the LLM response, slightly reducing completeness. However, the core of the multi-hop comparison—equity instruments available and vesting timelines—is correctly synthesized. Wording differs but meaning is semantically equivalent. No factual errors; only slight lack of depth on Starbucks’ performance conditions. Hence, high scores across the board with a 9 on correctness due to partial omission of performance-based metrics in Starbucks’ plan.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 441,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the difference in voting rights structure between META's Class B common stock and GOOGL's Class A common stock affect the potential influence of large shareholders on corporate governance decisions at each company?",
      "original_answer": "META's Class B common stock has no voting rights except for certain defined matters, such as exiting the core payments business or specific amendments to the certificate of incorporation, limiting the influence of large shareholders on most corporate governance decisions. In contrast, GOOGL's Class A common stock provides one vote per share, allowing shareholders of this class to have a more direct say in company decisions. This structural difference means that at META, significant shareholders holding Class B shares have limited ability to impact governance outside of specific scenarios, while at GOOGL, shareholders with Class A shares can exert more consistent influence on corporate decisions through their voting power.",
      "llm_answer": "Meta’s capital‑structure gives its Class B shares essentially no voting power – the filing notes that “Class B and C common stockholders have no right to vote on any matters, except for certain defined matters” (Meta 10‑K p. 90). Consequently, even a large holder of Meta Class B stock cannot affect ordinary corporate‑governance votes; control is concentrated in the holders of Class A stock (the founders and insiders).\n\nAlphabet’s Class A shares, by contrast, carry ordinary voting rights – “each share of Class A common stock is entitled to one vote per share” (Alphabet 10‑K p. 82). Thus a large shareholder of Alphabet Class A can influence all shareholder votes, although its influence is modest compared with the super‑voting Class B holders (10 votes per share). In short, Meta’s Class B shares give large investors virtually no say in governance, while Alphabet’s Class A shares give them a standard, one‑vote‑per‑share voice.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that META's Class B shares have no voting rights except in limited circumstances, citing the correct page from the 10-K (p. 90), and accurately contrasts this with GOOGL's (Alphabet's) Class A shares, which carry one vote per share, citing the correct source (p. 82). The explanation of governance influence is sound: large shareholders in META with Class B shares have minimal influence, while those in GOOGL with Class A shares have standard voting rights, though less than Class B super-voting shareholders. The only minor shortcoming is that the LLM introduces Class C shares for Meta, which were not mentioned in the original answer and are not relevant to the question—this does not introduce inaccuracy but adds slight extraneous detail. All entities (Meta, Alphabet/GOOGL, stock classes) are correctly identified, and the reasoning across the two companies’ structures is logically synthesized. No numerical errors exist, and the semantic meaning fully captures the original answer’s intent. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 363,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the use of foreign currency derivatives in risk management activities differ between BAC and JPM, based on their respective derivative asset and liability disclosures?",
      "original_answer": "BAC includes foreign currency derivatives under 'Risk Management Activities' as part of its derivative assets and liabilities, which are presented on a gross basis before netting adjustments as of December 31, 2024, and 2023. JPM specifically states that foreign currency derivatives are used to manage foreign exchange risk associated with non-U.S. dollar-denominated assets, liabilities, and forecasted transactions, and that gains or losses on these instruments are expected to substantially offset this variability. The fair value of these derivatives is reflected in the balance sheets, either in 'Other' or shown separately under 'Risk Management Activities.'",
      "llm_answer": "Both Bank of America and JPMorgan use foreign‑currency derivatives to hedge the FX risk of non‑U.S.‑denominated assets, liabilities and forecast‑ed transactions, but they disclose the activity differently. BAC’s notes list the specific contracts (e.g., $1.8 billion of FX swaps and $3.6 billion of spot/futures forwards) and shows them split between “fair‑value” and “cash‑flow” hedge designations in its gross‑asset/‑liability tables, whereas JPMorgan’s filing groups FX derivatives into three hedge‑accounting categories—fair‑value hedges, cash‑flow hedges and net‑investment hedges—and emphasizes that a portion of its FX contracts are not designated as hedges. Thus, BAC presents detailed contract‑notional amounts by type, while JPMorgan focuses on the hedge‑accounting classification and notes that not all FX derivatives receive hedge accounting.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts—$1.8 billion in FX swaps and $3.6 billion in spot/futures forwards—that are not present in the original ground truth answer. There is no mention in the ground truth of these figures or any quantitative breakdown of derivative types or notional values for either BAC or JPM. This constitutes a significant factual inaccuracy, as these numbers appear to be fabricated or hallucinated. (2) The ground truth does not provide any numerical data about derivative positions, so any inclusion of specific dollar amounts cannot be verified and directly contradicts the absence of such data in the source. Thus, the quantitative accuracy is low due to the introduction of unsupported figures. (3) While the LLM attempts multi-hop reasoning by comparing disclosure practices between BAC and JPM, it misrepresents the nature of the disclosures. The ground truth states that BAC presents foreign currency derivatives under 'Risk Management Activities' on a gross basis before netting, but does not mention hedge designations (fair-value or cash-flow) or breakdown by contract type. Similarly, while JPM is correctly described as using foreign currency derivatives to manage FX risk and expecting offsetting gains/losses, the ground truth does not mention JPM grouping derivatives into three hedge-accounting categories or explicitly stating that some are not designated as hedges. These details, while plausible, go beyond the provided ground truth and introduce unverified qualitative claims. (4) Despite these issues, the LLM captures the general idea that BAC and JPM differ in how they disclose foreign currency derivatives—BAC with gross presentation and JPM with emphasis on risk management purpose and balance sheet classification—which aligns with the question's focus. Hence, contextual relevance is high, and some qualitative elements are directionally accurate, but the inclusion of fabricated numbers and unsupported details significantly undermines factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 547,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does Duke Energy's exposure to economic downturns through industrial customers compare to Southern Company's risk from environmental compliance costs affecting similar customer segments, given both companies' regulated rate recovery mechanisms?",
      "original_answer": "Duke Energy notes that industrial customers reducing production during economic downturns can lead to reduced electricity consumption, lowering revenues and cash flows. Southern Company, on the other hand, faces risks that increased environmental compliance costs—estimated to impact capital expenditures through 2028—could be passed through regulated rates, potentially reducing demand from commercial and industrial customers. Both companies rely on rate mechanisms for cost recovery: Duke through periodic adjustment clauses and Southern through ECO Plan, CNP Compliance, and ECCR tariff mechanisms. However, while Duke's risk centers on demand volatility from macroeconomic conditions, Southern's exposure stems from regulatory-driven cost increases that may dampen industrial customer demand despite efforts to recover those costs through rates.",
      "llm_answer": "Duke Energy’s downside comes from an economic‑downturn‑driven drop in industrial‑customer usage – lower electricity and natural‑gas sales that cut revenue and cash flow even though fuel‑cost components are subject to cost‑recovery clauses in regulated rates 【page_27】. Southern Company, by contrast, faces the risk that rising environmental‑compliance expenditures (CCR, air‑quality, GHG rules) will be passed through retail and wholesale rates, but if regulators limit recovery the higher costs could suppress demand from commercial‑ and industrial‑customers and erode earnings 【page_88‑89】【page_25‑26】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies Duke Energy's risk from reduced industrial customer demand during economic downturns, impacting revenues and cash flows despite fuel-cost recovery mechanisms. It also accurately describes Southern Company's risk from rising environmental compliance costs (specifically naming CCR, air-quality, GHG rules) that may be passed through rates but could suppress demand if not fully recovered. (2) There are no numeric values, dates, or dollar amounts in either answer requiring verification—both mention future cost impacts without specific figures, and the LLM correctly notes that Southern’s expenditures extend through 2028 in the original, though this date is omitted in the LLM response; however, since the LLM does not contradict it and the focus is on ongoing risk, this omission is minor. (3) The multi-hop reasoning is sound: the model synthesizes risks for two companies, distinguishes demand-side vs. cost-recovery drivers, and references regulated rate mechanisms (implied via 'cost-recovery clauses' and 'passed through retail and wholesale rates'). While the LLM does not name Southern’s specific tariff mechanisms (ECO Plan, CNP Compliance, ECCR), it captures their functional equivalent by describing regulated cost recovery. (4) Semantic equivalence is strong—wording differs but meaning aligns closely. The LLM slightly under-specifies the exact tariff structures but retains the essential contrast: Duke faces macroeconomic demand volatility, Southern faces regulatory cost pass-through risk. No factual errors; minor detail omission prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 459,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is fully owned by Brian Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have different voting rights?",
      "original_answer": "CMCSA's Class B common stock, which is fully owned by Brian Roberts, holds 33 1/3% of the combined voting power with each share carrying 15 votes, creating a concentrated control mechanism that is non-dilutable under the company's articles of incorporation. This contrasts with GOOGL's structure, where Class A shares have 1 vote each and Class B shares have 10 votes each, and Class B shares automatically convert to Class A upon sale or transfer. While both companies utilize dual-class structures to preserve founder control, CMCSA's system entrenches Brian Roberts' influence more securely due to the non-dilutable nature and high per-share voting weight of the Class B stock, whereas GOOGL's structure allows for more fluidity in ownership and voting power distribution.",
      "llm_answer": "Comcast’s governance is shaped by a single‑shareholder “Class B” block that carries 15 votes per share and accounts for one‑third of the company’s total voting power (the other two‑thirds belong to the widely held Class A shares) – Mr. Brian L. Roberts therefore controls a permanent, non‑dilutable 33 % voting stake that can sway board elections and key decisions even though he does not hold a majority (CMCSA 5‑31). Alphabet’s (Google’s) dual‑class system gives each Class B share ten votes versus one vote for Class A, and the insider‑held Class B stock is large enough to provide a controlling majority of the voting power, concentrating decision‑making authority with founders and executives (GOOGL 8‑82). Thus, while both companies use high‑voting‑right shares to preserve insider influence, Comcast’s Class B gives Roberts a substantial but not outright controlling block, whereas Google’s Class B shares give its insiders outright control of the board.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core differences between CMCSA's and GOOGL's dual-class structures. (1) Quantitatively, it correctly states that CMCSA's Class B stock carries 15 votes per share and accounts for one-third (33%) of total voting power, matching the ground truth's '33 1/3%'—this minor rounding is acceptable. It also accurately notes GOOGL's 10:1 voting ratio for Class B vs Class A. (2) However, the LLM incorrectly implies that Brian Roberts holds a 'substantial but not outright controlling block,' which contradicts the ground truth: with 33 1/3% voting power, Roberts does not have majority control, but the answer mischaracterizes this as non-controlling in a way that underplays the structural entrenchment. More critically, the LLM fails to mention that GOOGL’s Class B shares automatically convert to Class A upon sale or transfer—a key differentiator in governance fluidity highlighted in the original answer. (3) The reasoning is sound in comparing concentrated voting rights and insider control, but misses the multi-hop nuance that CMCSA’s structure is 'non-dilutable' by design, making Roberts’ control more permanent than GOOGL’s, where transfer-triggered conversion allows eventual dilution of founder control. (4) Despite these omissions, the answer remains factually strong on core metrics and relevant to the question, earning high marks for contextual relevance and quantitative accuracy, with a slight deduction for incomplete qualitative synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 412,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did KO's indirect exposure to Taiwan through Swire Beverages' operations compare to PEP's direct growth performance in the Taiwanese beverage market in 2022?",
      "original_answer": "KO had indirect exposure to Taiwan through Swire Beverages, one of its top five bottling partners, which operated in Taiwan and accounted for 17% of KO’s worldwide unit case volume in 2021. Meanwhile, PEP directly reported low-single-digit beverage unit volume growth in Taiwan as part of its APAC division's 34% net revenue increase in 2022. This highlights KO’s reliance on a third-party bottler versus PEP’s direct market performance in the same geography.",
      "llm_answer": "Coca‑Cola’s link to Taiwan is indirect – the company’s bottling partner Swire Beverages, which operates in Hong Kong, Taiwan and other Asian markets, provides the system’s exposure to Taiwanese sales, but the filing does not give a separate volume or growth figure for that market. PepsiCo, by contrast, reports that its own APAC operations recorded “low‑single‑digit” beverage‑unit‑volume growth in Taiwan in 2022, reflecting a modest but positive direct performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core contrast between KO's indirect exposure and PEP's direct performance in Taiwan in 2022. (1) It correctly identifies that KO's exposure is indirect through Swire Beverages and that no specific volume or growth figure is provided for Taiwan, which aligns with the ground truth. It also accurately states that PEP reported 'low-single-digit' beverage unit volume growth in Taiwan in 2022. (2) The only quantitative shortcoming is that the LLM omits the specific fact that Swire Beverages accounted for 17% of KO’s worldwide unit case volume in 2021—a key metric from the original answer that quantifies the significance of this indirect relationship. While not directly about Taiwan, it contextualizes the importance of Swire to KO globally. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across KO’s bottling partner structure and PEP’s direct reporting in the APAC region. (4) The answer is semantically equivalent in intent and conveys the strategic difference in market presence, though slightly less complete due to the missing 17% figure. Wording is clear and relevant, with no factual inaccuracies. Hence, minor deduction in correctness and quantitative accuracy, but high marks for qualitative reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 364,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How might the expiration of Trulicity's patent protection impact LLY's revenue trajectory in light of MRK's strategic reliance on strong patent protection to maintain market exclusivity and competitive positioning?",
      "original_answer": "The expiration of Trulicity's patent protection, as noted in LLY's 2024 10-K, is expected to lead to a rapid and severe decline in revenue, as seen in 2024 where Trulicity's U.S. revenue decreased by 32% due to competitive dynamics and supply constraints. This aligns with the broader risk LLY faces as products lose exclusivity, typically resulting in generic competition and steep revenue drops. Similarly, MRK acknowledges that loss of patent protection leads to generic substitutes entering the market, adversely affecting sales and cash flows. Given MRK's emphasis on actively defending patent rights to maintain market exclusivity and profitability, the erosion of Trulicity's patent protection signals a critical vulnerability for LLY, especially if it lacks a robust pipeline or alternative strategies to offset the anticipated revenue losses.",
      "llm_answer": "The 10‑K notes that Trulicity already posted a 26 % drop in 2024 revenue (to $5.3 billion) and that “Trulicity will lose significant patent and remaining data protections in the next few years,” after which “generic competition … leads to a rapid and severe decline in revenues” (LLY p.28‑29). Merck’s filing stresses that its business model depends on strong patent protection to preserve market exclusivity; loss of that protection “typically results in the entry of one or more generic competitors, leading to a rapid and severe decline in revenues” (MRK p.33‑34). Consequently, when Trulicity’s patents expire, LLY can expect a further acceleration of the product’s revenue decline—mirroring the risk Merck warns about—and will need to rely on new launches or other protected assets to sustain its overall revenue trajectory.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in substance and closely aligns with the ground truth. It accurately captures the expected revenue decline for Trulicity due to patent expiration, citing LLY's own warning about 'rapid and severe decline in revenues' post-patent expiry. It also correctly references MRK's strategic reliance on patent protection and the resulting market dynamics when exclusivity is lost. The core reasoning across both companies is sound and well-synthesized.\n\n2) Quantitative accuracy: The LLM states a 26% drop in Trulicity revenue in 2024, while the ground truth reports a 32% decrease. This discrepancy is notable but not extreme—possibly due to different reporting segments or timing within the year. The $5.3 billion figure for 2024 revenue is plausible and consistent with public disclosures, though not explicitly confirmed in the ground truth. The ground truth emphasizes the 32% U.S. revenue decline due to competitive dynamics and supply constraints, which the LLM does not fully contextualize (e.g., attributing part of the drop to supply issues). However, the LLM correctly cites the forward-looking risk from patent expiration.\n\n3) Multi-hop reasoning is strong: The model correctly links LLY’s Trulicity patent risk with MRK’s analogous exposure to generic competition upon patent loss. It draws a valid parallel between the two companies’ experiences and business logic, showing that LLY will face similar revenue erosion unless offset by new product launches or protected assets—exactly the inference supported by the knowledge graph.\n\n4) Semantic equivalence is high. While wording differs, the LLM conveys the same essential conclusion: patent expiration threatens LLY’s revenue trajectory just as MRK warns, requiring pipeline strength to compensate. Minor deduction in quantitative accuracy due to the 26% vs 32% mismatch, but overall reasoning, entity accuracy (LLY, MRK, Trulicity, patent dynamics), and contextual relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 534,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How might FedEx's operational reliance on leased retail locations at hotels, such as the 200 stores located at hotels and convention centers, compare with UPS's financial exposure to real estate funds—like the $10.1 billion in pension assets invested in real estate, private debt, and hedge funds—in terms of strategic risk during periods of real estate market volatility?",
      "original_answer": "FedEx maintains a direct operational exposure to hotels through its 200 leased retail locations at hotels and convention centers, positioning it in high-traffic hospitality venues but exposing it to lease renegotiations or relocations if hotel operators change tenants. These leases are typically for five to ten years, and FedEx's ability to maintain these locations depends on the ongoing operation of the hotels themselves. In contrast, UPS holds an indirect financial exposure to real estate through its pension and postretirement plan assets, which include $10.1 billion in investments in real estate funds, private debt, and hedge funds as of December 31, 2024. These funds may include investments in hotels and other commercial properties, meaning UPS’s exposure is tied to the performance of these funds rather than direct occupancy or lease agreements. During real estate market volatility, FedEx could face operational disruptions or increased leasing costs if hotel properties experience financial strain, while UPS could see fluctuations in the value of its pension assets, affecting long-term liability projections and funding obligations. Thus, while both companies are exposed to the real estate sector, the nature of their risk—operational for FedEx and financial for UPS—differs significantly in both timing and impact.",
      "llm_answer": "FedEx’s exposure is operational – about 200 FedEx Office stores are leased inside hotels, convention centers, hospitals and universities, so a downturn in real‑estate values would mainly affect the cost or renewal terms of those leases and the ability to replace locations if landlords pull back (the risk is confined to the lease contracts themselves). UPS, by contrast, carries a financial‑market risk of roughly $10.1 billion of pension‑plan assets invested in real‑estate, private‑debt and hedge‑fund vehicles; a volatile real‑estate market can depress the NAV of those assets and force the company to make additional pension contributions or record losses, creating a much larger balance‑sheet‑level risk than FedEx’s lease‑related exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core distinction between FedEx's operational exposure and UPS's financial exposure to real estate market volatility. (1) Quantitatively, all key figures are correct: the $10.1 billion in pension assets and the ~200 leased retail locations are accurately reported, with acceptable rounding and phrasing (e.g., 'about 200' aligns with the ground truth's '200'). The date (December 31, 2024) is not mentioned in the LLM answer, but the dollar amount is correct and contextually sufficient. (2) The answer correctly identifies both companies and the nature of their exposures—FedEx through leases, UPS through pension fund investments—and links them appropriately to real estate volatility. (3) The reasoning is sound: it distinguishes operational risk (lease renewals, location stability) from financial risk (pension asset valuation, balance sheet impact), which is the central multi-hop insight required. It correctly infers that UPS’s exposure could lead to higher pension contributions or recorded losses, a valid implication not explicitly stated in the ground truth but logically consistent. (4) Minor omission: the ground truth specifies that FedEx’s leases are typically 5–10 years and that their presence depends on hotel operations continuing—context that adds depth to the operational risk, which the LLM answer does not include. Also, the LLM broadens the locations to include hospitals and universities, which are not mentioned in the original answer; this is plausible but introduces slight entity inaccuracy. Despite these small gaps, the answer conveys semantically equivalent and factually correct information with strong reasoning and full contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1577,
        "completion_tokens": 468,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the voting rights structure of GOOGL's Class B Common Stock compare to CMCSA's disclosure around voting rights in its investment in Atairos, particularly in terms of control and influence over strategic decisions?",
      "original_answer": "GOOGL's Class B Common Stock provides its holders with 10 votes per share, significantly enhancing their influence over corporate decisions compared to Class A shares, which carry one vote per share. This structure allows holders of Class B Common Stock to maintain greater control over strategic decisions despite owning fewer shares. In contrast, CMCSA disclosed that it has no voting rights in Atairos, a VIE in which it holds a significant investment, and only retains certain consent rights. As a result, CMCSA lacks the power to direct Atairos’s activities that most significantly impact its economic performance, which limits its control and influence over strategic decisions at Atairos.",
      "llm_answer": "Alphabet’s Class B common stock carries ten votes per share, giving its holders a disproportionately strong ability to direct corporate actions and strategic decisions. In contrast, Comcast’s investment in Atairos provides it with no voting rights at all – the voting power resides entirely with the management‑company investors – so Comcast can only exercise limited consent rights and cannot control or influence Atairos’s strategic choices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, it correctly states that GOOGL's Class B shares carry ten votes per share, matching the ground truth. It also accurately notes that CMCSA has no voting rights in Atairos—both key facts are correct. (2) There are no calculations, but all stated numbers (10 votes per share, zero voting rights) are factually accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different companies (GOOGL and CMCSA) and compares their voting rights structures in relation to control over strategic decisions. It correctly infers that ten votes per share equates to strong control for GOOGL Class B holders, while CMCSA’s lack of voting rights and reliance on consent rights limits its influence. (4) The only minor shortcoming is that the LLM does not explicitly mention that Atairos is a VIE (variable interest entity) or that CMCSA’s consent rights are tied to activities that most significantly impact economic performance—details present in the original answer that add technical precision. However, the semantic meaning and practical implication (lack of control) are preserved. Wording differs slightly (e.g., 'management-company investors' is not in the original) but does not introduce inaccuracy. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 402,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the use of commercial paper financing by Duke Energy Ohio compare to PepsiCo's short-term debt strategy, given Duke Energy Ohio's specific disclosures and PepsiCo's broader commercial paper obligations?",
      "original_answer": "Duke Energy Ohio reported $25 million in commercial paper obligations as of December 31, 2023, as part of its overall short-term financing strategy. In comparison, PepsiCo disclosed $2,286 million in commercial paper obligations in 2023, representing a significant portion of its broader short-term debt obligations totaling $6,510 million. This highlights a stark contrast in the scale of commercial paper usage between the two companies, with PepsiCo relying more heavily on this form of short-term financing.",
      "llm_answer": "Duke Energy Ohio’s commercial‑paper program is tiny – only about **$25 million** of paper (plus $27 million of tax‑exempt bonds) that the company classifies as long‑term debt because it is backed by a master credit facility and can be refinanced on a longer‑term basis, with an average maturity of just **15‑23 days**. In contrast, PepsiCo relies on a **much larger short‑term‑debt platform**, issuing roughly **$2.3 billion of commercial paper** (plus $300 million of other borrowings) and uses its senior‑note issuances and $4.2 billion of revolving‑credit facilities to fund and roll over that paper.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies Duke Energy Ohio's $25 million in commercial paper as of December 31, 2023, matching the ground truth. It also accurately reports PepsiCo's commercial paper obligations as approximately $2.3 billion (ground truth: $2,286 million), which is semantically equivalent. However, the LLM introduces additional details not present in the original answer or ground truth: specifically, the $27 million of tax-exempt bonds and $300 million of other borrowings, which were not disclosed in the ground truth and may misrepresent completeness. Additionally, the claim that Duke Energy Ohio classifies its commercial paper as long-term debt due to refinancing capability, while potentially accurate from a technical accounting perspective, is not part of the original answer and adds interpretive context not requested.\n\n2) Quantitatively, the core numbers are correct: $25 million for Duke Energy Ohio and $2.3 billion (~$2,286 million) for PepsiCo. The LLM rounds $2,286 million to $2.3 billion, which is acceptable. However, the inclusion of $300 million in 'other borrowings' and references to $4.2 billion in revolving credit facilities are not in the original answer and lack verification from the provided ground truth, introducing unverified data points.\n\n3) The multi-hop reasoning is sound—comparing Duke Energy Ohio’s small-scale commercial paper use to PepsiCo’s larger short-term debt strategy is logically supported and correctly contrasts the scale. The LLM captures the essence of the comparison: PepsiCo uses commercial paper more extensively. However, it goes beyond the original answer by detailing PepsiCo’s senior-note issuances and credit facilities, which were not required for the comparison and may distract from the core focus on commercial paper.\n\n4) Despite the extra details, the LLM conveys the key takeaway: a stark contrast in commercial paper usage between the two companies, with PepsiCo relying much more heavily on it. The answer remains contextually relevant and factually aligned on the main points. The correctness score is reduced slightly (from 9 to 8) due to the introduction of unverified figures and classifications not present in the ground truth, which could mislead if taken as part of the required comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 608,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given Duke Energy's expectation of increasing commercial gas customers in the Carolinas, Ohio, and Kentucky, how might Southern Company's reliance on regulated rate recovery for environmental compliance costs be affected if commercial demand declines due to environmental regulations impacting industrial operations in these same regions?",
      "original_answer": "Duke Energy's gas utility operations expect an increase in the number of commercial and industrial customers over time, particularly in North Carolina, South Carolina, Ohio, and Kentucky. Southern Company, on the other hand, relies heavily on regulated rate recovery mechanisms to offset rising environmental compliance costs, which include upgrades to gas distribution infrastructure and compliance with GHG regulations. However, Southern Company also acknowledges that increased costs recovered through regulated rates could lead to reduced demand for natural gas from commercial and industrial customers—many of whom may be directly impacted by environmental requirements such as emission limits or carbon constraints. If these regulations lead to operational changes or reduced production among industrial users, the anticipated growth in commercial gas demand may not materialize, thereby undermining the effectiveness of rate recovery mechanisms and creating financial pressure on Southern Company's gas operations.",
      "llm_answer": "Duke Energy’s filing notes that its natural‑gas utility expects the number of commercial customers in the Carolinas, Ohio and Kentucky to grow, but also warns that higher gas prices or stricter environmental rules could cause industrial users to cut back or switch fuels. Southern Company’s 10‑K makes clear that most of its environmental‑compliance spending is intended to be recouped through retail and wholesale rates, yet it admits that if commercial‑and‑industrial demand falls, the rate‑base that supports those recoveries will shrink, making full cost recovery less certain and potentially forcing lower‑rate recoveries or additional regulatory scrutiny.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core multi-hop reasoning required. (1) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (2) The LLM correctly identifies Duke Energy’s expectation of growing commercial gas customers in the Carolinas, Ohio, and Kentucky, and links this to the risk that environmental regulations or higher prices could reduce industrial demand. It then correctly states Southern Company’s reliance on regulated rate recovery for environmental compliance costs. (3) The key multi-hop synthesis—connecting reduced commercial and industrial demand to a shrinking rate base, thereby threatening the effectiveness of rate recovery—is logically sound and aligns with the ground truth. The LLM notes the potential for lower recovery rates or regulatory scrutiny, which is consistent with Southern Company’s own risk disclosures. (4) The only minor shortcoming is that the LLM does not explicitly mention Southern Company’s gas infrastructure upgrades or GHG compliance as part of the costs being recovered, which slightly reduces completeness. However, the central causal chain—environmental rules → industrial demand decline → smaller rate base → impaired cost recovery—is correctly and clearly articulated. Wording differs but semantic meaning matches. Contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 383,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given that Comcast's Class B shares carry 15 votes each and represent 33 1/3% of the combined voting power, how does the absence of repurchase activity for these shares (only Class A shares were repurchased in 2023) impact Mr. Roberts' ownership control relative to the broader shareholder base?",
      "original_answer": "Comcast's Class B shares, which carry 15 votes per share and represent 33 1/3% of the combined voting power, are not being repurchased, while Class A shares (with fewer votes) are being actively repurchased. This selective repurchase activity reduces the number of outstanding Class A shares, thereby increasing the relative voting influence of the non-repurchased Class B shares. Since Mr. Brian L. Roberts owns all outstanding Class B shares, this dynamic strengthens his control over corporate decisions, even as the broader shareholder base sees its equity diluted through the retirement of Class A shares.",
      "llm_answer": "Comcast’s proxy statement notes that the single Class B share held by Mr. Brian L. Roberts carries 15 votes and, by itself, accounts for 33 ⅓ % of the company’s total voting power (​page 33​). The 2023 share‑repurchase table shows that only Class A shares were bought back; no Class B shares were repurchased (​page 33​). Because the number of Class A shares – which together hold the remaining 66 ⅔ % of votes – was reduced, Roberts’ unchanged 33 ⅓ % stake now represents a larger share of the voting pool, thereby strengthening his control relative to the broader shareholder base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Class B shares carry 15 votes and represent 33 1/3% of voting power; only Class A shares were repurchased in 2023; Mr. Roberts holds the Class B share. The statement that his stake now represents a larger share of the voting pool due to Class A repurchases is factually sound. (2) Quantitative accuracy is perfect: percentages (33 1/3% and 66 2/3%) are correctly cited, and the logic that reducing Class A shares increases the relative weight of Class B is mathematically valid. (3) The reasoning is strong and correctly synthesizes two pieces of information: the differential repurchase activity and its effect on voting power concentration. The only minor shortcoming is that the LLM implies there is a 'single' Class B share (likely based on a simplification in the proxy), while the ground truth refers to 'all outstanding Class B shares'—this is a nuance, but not factually incorrect given that all Class B shares are held by Roberts and may be structured as a single share with special rights. (4) The answer is fully relevant, directly addressing the impact on Mr. Roberts’ control relative to other shareholders. Thus, the answer earns a 9 for correctness and qualitative accuracy due to this slight ambiguity in share structure description, but full marks for quantitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 394,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does the contractual structure of Amgen's performance units, which are subject to specific payout simulations based on stockholder returns, compare to Bristol-Myers Squibb's exposure to financial agreements that include counterparty credit risk mitigation strategies, particularly in terms of payout or risk management predictability?",
      "original_answer": "Amgen's performance units in 2023 were valued at $121 million and are subject to payout simulations that model stockholder returns based on correlations and volatilities of comparator company stocks over the performance period, as dictated by contractual terms. This creates a structured but variable payout mechanism tied to relative performance metrics. In contrast, Bristol-Myers Squibb enters into financial agreements that include counterparty credit risk mitigation strategies such as limiting exposure to individual counterparties, using conventional instruments, and requiring high credit quality standards. These strategies are designed to ensure predictability and minimize financial risk in derivative and other financial instrument transactions. The contractual frameworks differ in that Amgen’s focus is on performance-linked payout predictability, while BMY emphasizes counterparty risk control and financial stability in its agreements.",
      "llm_answer": "Amgen’s performance‑unit awards are “contingent‑on‑stockholder‑return” awards whose payout is estimated with a Monte‑Carlo‑type simulation that incorporates the grant‑date stock price, volatility, risk‑free rate and the correlation of Amgen’s share price with a peer‑group (see AMGN 10‑K p. 126). The model produces a weighted‑average grant‑date fair value, but the actual number of units earned – and therefore the cash or share payout – will vary with the future market performance of Amgen’s stock, making the ultimate payout inherently uncertain despite the simulation.\n\nBristol‑Myers Squibb’s exposure to its financial agreements is managed through explicit counter‑party‑credit‑risk controls – limits on amounts outstanding with any one counterparty, use of standard derivative contracts, and selection of only high‑credit‑quality counterparties (see BMY 10‑K p. 97). These mitigation measures limit the variability of loss from a counter‑party default, so the risk‑management outcome is far more predictable than Amgen’s performance‑unit payouts, which depend on future equity returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, while the original answer cites Amgen's performance units as valued at $121 million in 2023, the LLM answer does not include this specific dollar amount. However, the absence of this figure does not undermine the core reasoning, as the focus is on the structure and predictability of payouts rather than total value. All other financial and modeling details (Monte Carlo simulation, inputs like volatility, correlation, risk-free rate) are correctly described. (2) The LLM accurately identifies the contractual mechanisms: Amgen’s use of stockholder return simulations tied to peer-group performance and BMY’s counterparty credit risk controls (limits, high credit quality, standard instruments). (3) Multi-hop reasoning is sound—correctly contrasting Amgen’s variable, market-dependent payout predictability with BMY’s more stable, risk-controlled financial agreements. (4) Semantic equivalence is strong: though wording differs, the LLM captures the essence that Amgen’s payouts are performance-linked and uncertain, while BMY’s risk management is structured for predictability. The only minor omission is the $121M figure, which slightly affects completeness but not the overall correctness of the comparison. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1558,
        "completion_tokens": 393,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does MetLife's exposure to derivatives governed by ISDA Master Agreements under the Orderly Liquidation Authority compare to Bank of America's resolution planning risks, given both companies' regulatory obligations under Dodd-Frank?",
      "original_answer": "MetLife manages credit risk in its derivatives transactions through ISDA Master Agreements that allow for close-out netting, which is subject to financial regulations such as the Orderly Liquidation Authority (OLA) under Dodd-Frank. This means that in the event of a counterparty's bankruptcy, MetLife can offset receivables and apply collateral without being subject to the automatic stay. Similarly, Bank of America Corporation is required to submit resolution plans to the FDIC and Federal Reserve that outline a 'single point of entry' strategy under the U.S. Bankruptcy Code or potentially the OLA. If Bank of America were resolved under the OLA, the FDIC could replace the corporation with a bridge holding company, and security holders could face significant losses. Both firms are therefore subject to Dodd-Frank provisions that alter the treatment of their financial obligations and risk profiles during insolvency, with MetLife exposed through its derivative contracts and BAC through its parent company resolution strategy.",
      "llm_answer": "MetLife’s OTC‑bilateral derivatives are covered by ISDA Master Agreements that give it a legal right, under the Orderly‑Liquidation Authority (Title II of Dodd‑Frank), to net‑set‑off receivables against payables and apply collateral if a counter‑party defaults; after netting and collateral, the company’s net derivative liability was only about **$19 million** at year‑end 2023 (page 261).  \n\nIn contrast, Bank of America’s Dodd‑Frank‑mandated resolution‑planning obligations expose it to a much broader systemic risk: if regulators deem its “single‑point‑of‑entry” resolution plan not credible, the FDIC could invoke the Orderly‑Liquidation Authority and impose stricter capital, leverage and liquidity requirements that could restrict funding to subsidiaries and jeopardize the bank’s overall liquidity and ability to meet obligations (page 13).  \n\nThus MetLife’s exposure is limited to a modest net derivative position protected by ISDA netting, whereas Bank of America faces a far‑greater resolution‑planning risk that could affect the entire firm under the same Dodd‑Frank framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer correctly identifies the core regulatory frameworks (ISDA Master Agreements, Orderly Liquidation Authority, Dodd-Frank) and contrasts MetLife's derivative-level exposure with Bank of America's firm-wide resolution planning risks. The qualitative reasoning about close-out netting, collateral application, and the 'single point of entry' strategy aligns well with the ground truth. However, the LLM introduces a specific quantitative figure—'$19 million net derivative liability at year-end 2023'—that is not present in the original answer and cannot be verified from the provided ground truth. This number may be accurate in context but is unsupported by the knowledge graph, making it a factual overreach. (2) The quantitative accuracy is compromised due to the inclusion of this unverified number. While the format ($19 million) is acceptable, the absence of any dollar amounts in the original answer means this precision creates a false sense of specificity. There is no way to confirm if $19M is correct, and its inclusion implies access to data beyond the knowledge graph. (3) The multi-hop reasoning is strong: the model correctly synthesizes MetLife’s ISDA-based protections under OLA with Bank of America’s resolution plan obligations under Dodd-Frank, and draws a valid contrast between entity-level insolvency treatment (MetLife’s contracts) vs. parent-company resolution (BAC’s systemic risk). The logic that MetLife’s exposure is more contained while BAC faces broader structural risks is sound and consistent with the original. (4) Contextual relevance is high—the answer directly addresses the comparative regulatory risk question and stays focused on the implications of Dodd-Frank for both firms. The qualitative accuracy is high due to correct entity identification and conceptual synthesis, but the unsupported number reduces overall correctness. Hence, a 7/10: core facts and reasoning are correct, but the addition of unverified quantitative data prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 538,
        "total_tokens": 2091
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does Nike's revenue from the Greater China region, which includes Taiwan, compare to Starbucks' store count in Taiwan specifically, and what might this suggest about their relative market presence in that geographic area?",
      "original_answer": "Nike generated $7,547 million in revenue from the Greater China region in 2022, which includes Taiwan along with mainland China and Hong Kong. In contrast, Starbucks operated 544 stores in Taiwan as of October 2, 2022. Given that Nike's revenue figure represents a broader regional performance across multiple countries while Starbucks' store count is specific to Taiwan, the comparison highlights different dimensions of market presence—Nike's being revenue-based across a larger geographic cluster, and Starbucks' being operationally focused with a localized footprint in Taiwan.",
      "llm_answer": "Nike reported roughly $6.7 billion (≈$7 billion) in revenue from its Greater China segment – which includes mainland China, Hong Kong and Taiwan – for fiscal 2022.  Starbucks, by contrast, operated about 544 licensed stores in Taiwan at the end of fiscal 2022.  The comparison suggests that Nike’s economic footprint in the Greater China market is far larger than Starbucks’ physical footprint in Taiwan, indicating a much stronger market presence for Nike in that region.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a quantitative inaccuracy in Nike's revenue. The ground truth states $7,547 million (i.e., $7.547 billion), while the LLM reports '$6.7 billion (≈$7 billion)', which is notably lower and outside an acceptable rounding range. This discrepancy affects the precision of the financial comparison. Starbucks' store count of 544 is correctly reported and matches the ground truth for fiscal year 2022. (2) The time period alignment is acceptable—both figures refer to fiscal 2022, though the original answer specifies October 2, 2022, as the exact date for Starbucks, which the LLM omits but not unreasonably so. (3) The reasoning and multi-hop synthesis are sound: the LLM correctly identifies that Nike's revenue covers a broader region (Greater China including Taiwan), while Starbucks' store count is specific to Taiwan, and draws a logical conclusion about differing dimensions of market presence—economic vs. operational footprint. However, the LLM overstates the implication by concluding Nike has a 'much stronger market presence' without acknowledging that the metrics are not directly comparable (revenue across a region vs. store count in one country), which the original answer carefully clarifies. (4) Despite the numerical inaccuracy and slightly overstated conclusion, the answer addresses all parts of the question, uses correct entities (Nike, Starbucks, Greater China, Taiwan, fiscal 2022), and maintains high contextual relevance. The qualitative reasoning is strong but could better reflect the nuance in comparability. Hence, correctness is reduced primarily due to the revenue figure error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 455,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does the $5.0 billion upfront payment from American Tower Corporation in March 2015 compare to the $2.8 billion received from Vertical Bridge in December 2024 in terms of Verizon's retained obligations and asset treatment related to the exclusive rights transactions?",
      "original_answer": "The $5.0 billion transaction with American Tower in 2015 and the $2.8 billion transaction with Vertical Bridge in 2024 both involved Verizon transferring exclusive rights to operate wireless towers while retaining ownership and depreciation responsibilities. In both cases, Verizon subleases capacity back from the acquiring entity and continues to include the towers in 'Property, Plant and Equipment - Net' on its balance sheet. However, the Vertical Bridge deal resulted in a $2.0 billion prepaid rent and $830 million financing obligation split based on usage, whereas the American Tower deal did not specify such a breakdown, indicating a potentially different structure in how the financing and lease obligations were allocated between the two transactions.",
      "llm_answer": "Both transactions left the towers on Verizon’s balance sheet and subject to depreciation, but the accounting treatment differed. The 2015 American Tower deal was a $5 billion upfront payment for exclusive lease‑and‑operate rights; Verizon simply sub‑leased capacity for at least ten years and kept the towers in PP&E with no separate prepaid‑rent or financing liability recorded. By contrast, the December 2024 Vertical Bridge transaction brought in $2.8 billion, of which $2.0 billion was recorded as prepaid rent and $830 million as a financing obligation, and Verizon retained the present‑value of the underlying ground‑lease obligations in its operating‑lease right‑of‑use assets and liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $5.0 billion American Tower transaction in 2015 and $2.8 billion Vertical Bridge transaction in December 2024 are correctly cited, including the $2.0 billion prepaid rent and $830 million financing obligation from the Vertical Bridge deal. These numbers match the original answer exactly, and dates are accurate. (2) The qualitative analysis is sound: both transactions kept towers on Verizon’s balance sheet under PP&E with continued depreciation, and the distinction in accounting treatment—lack of separate prepaid rent or financing liability in 2015 vs. explicit split in 2024—is correctly identified. (3) Multi-hop reasoning is strong: the model synthesizes asset treatment, lease obligations, and accounting differences across two separate transactions and time periods. (4) The only minor shortcoming is that the LLM mentions Verizon retaining 'present-value of the underlying ground-lease obligations in its operating-lease right-of-use assets and liabilities' for the Vertical Bridge deal, which adds detail not confirmed in the ground truth and slightly extends beyond the provided information. However, this does not contradict the original and may be a reasonable inference. Overall, the answer is factually correct, complete, and contextually appropriate with excellent quantitative precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 390,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does JPMorgan's operational risk capital estimation under Basel III, which includes fraud risk as a key component, compare to Citigroup's exposure to fraud-related losses in emerging markets, particularly in scenarios involving asset confiscation or loss of control in Russia?",
      "original_answer": "JPMorgan uses the Advanced Measurement Approach (AMA) under Basel III to estimate operational risk capital, incorporating internal and external losses, scenario analysis, and business environment metrics, with fraud being a key risk category. Meanwhile, Citigroup reports exposure to fraud and political instability in emerging markets, with a specific scenario in Russia involving potential losses of $1.6 billion in CTA (Cumulative Translation Adjustment) and $0.9 billion on intercompany liabilities if control of AO Citibank is lost. These figures highlight how both firms face fraud-related risks but experience them through different financial mechanisms and geographic exposures.",
      "llm_answer": "JPMorgan does not quote a single dollar figure for fraud risk; instead it quantifies fraud as one of the many operational‑risk loss drivers in its Basel III Advanced Measurement Approach, using a loss‑distribution (LDA) model that simulates the frequency and severity of operational losses (including fraud) at a 99.9 % confidence level to determine the firm’s operational‑risk capital charge. By contrast, Citi’s 10‑K spells out a concrete emerging‑market exposure to loss of control/confiscation in Russia – a potential charge‑off of roughly $1.6 billion on the subsidiary’s net investment plus about $0.9 billion on inter‑company liabilities (≈ $2.5 billion), illustrating a specific, material fraud‑related loss scenario rather than a model‑based capital estimate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $1.6 billion loss on CTA (net investment) and $0.9 billion on intercompany liabilities are accurately reported, and their sum (~$2.5 billion) is correctly implied. These match the original answer exactly, with acceptable formatting variations (e.g., '≈ $2.5 billion' is a valid inference). (2) The explanation of JPMorgan’s use of the Advanced Measurement Approach (AMA) under Basel III, including the loss distribution approach (LDA) and 99.9% confidence level, is factually sound and consistent with regulatory practice, even if the original answer did not specify LDA or confidence level—this additional detail is correct and enhances accuracy. (3) Entity accuracy is strong: both JPMorgan and Citigroup are correctly identified, with accurate reference to Russia, fraud risk, and operational risk frameworks. (4) Multi-hop reasoning is well executed: the model correctly contrasts JPMorgan’s model-based capital estimation with Citigroup’s scenario-specific exposure, synthesizing information across different risk frameworks and geographies. (5) The LLM answer conveys the same core insight as the original: JPMorgan models fraud risk quantitatively for capital purposes, while Citigroup faces a concrete, material fraud-adjacent risk in Russia due to political instability. The only minor gap is that the original explicitly names 'Cumulative Translation Adjustment (CTA)', while the LLM refers more generally to 'net investment'—a technically accurate proxy but slightly less precise in terminology. This does not affect factual correctness but slightly reduces qualitative precision. Overall, the answer is factually excellent, contextually relevant, and demonstrates strong multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 493,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact Qualcomm's chipset supply chain differently than Intel's operational footprint in the region, given Qualcomm's reliance on Taiwan-based foundry partners and Intel's $6.867 billion in 2023 revenue tied to the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan would impact Qualcomm and Intel through different mechanisms. For Qualcomm, the risk is operational, as the company explicitly states its 'business depends on our ability to receive consistent and reliable chipset supply from our foundry partners, particularly in Taiwan.' A disruption would 'severely limit or prevent us from receiving chipset supply,' directly threatening its product availability. In contrast, Intel's exposure is primarily financial, with $6.867 billion in 2023 revenue tied to Taiwan, but no explicit mention of reliance on Taiwan-based manufacturing in its disclosures. While both face risks from instability in Taiwan, Qualcomm's dependency is on supply continuity, whereas Intel's is on market demand and revenue generation in the region.",
      "llm_answer": "A prolonged China‑Taiwan conflict would threaten Qualcomm’s ability to obtain chips because the company “relies on consistent and reliable chipset supply from its foundry partners, particularly in Taiwan” and a “significant or prolonged … conflict … could severely limit or prevent us from receiving chipset supply from Taiwan” (Qualcomm 10‑K p. 35). In contrast, Intel’s exposure in the region is primarily commercial – it earned $6.867 billion of net revenue billed to customers in Taiwan in 2023 (Intel 10‑K p. 88) – so a conflict would mainly erode that sales stream rather than disrupt its own manufacturing, which is based outside Taiwan.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Qualcomm's reliance on Taiwan-based foundry partners and the risk of supply disruption is accurately quoted and cited from its 10-K (p. 35), and Intel's $6.867 billion in 2023 revenue from Taiwan is correctly stated and sourced to Intel’s 10-K (p. 88). (2) Quantitative accuracy is perfect: the dollar amount ($6.867 billion) and year (2023) match the original answer exactly. (3) The multi-hop reasoning is sound—correctly distinguishing Qualcomm’s operational/supply risk from Intel’s commercial/revenue risk, synthesizing information from both companies’ disclosures. (4) The answer addresses all parts of the question: the differing impacts on Qualcomm’s supply chain versus Intel’s operational footprint, with proper context on foundry reliance vs. regional revenue. Wording differs slightly but meaning is preserved, and citations enhance credibility. No errors in entities, metrics, or logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 293,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does RTX's valuation methodology for private equity limited partnerships differ from BA's approach to valuing Level 3 assets measured on a nonrecurring basis, given that both companies report these investments through fair value processes?",
      "original_answer": "RTX values its private equity limited partnerships on a quarterly basis using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results, financial condition, or prospects of the applicable portfolio company. In contrast, BA applies an income approach based on discounted cash flows for Level 3 assets measured on a nonrecurring basis, such as impaired customer financing assets, which include operating lease equipment and investments in finance leases valued using median collateral values from third-party aircraft publications. While RTX actively adjusts valuations quarterly based on portfolio company performance, BA relies on third-party publications and adjusts values only under specific circumstances, such as unique aircraft attributes or expected net sales prices.",
      "llm_answer": "RTX values its private‑equity limited‑partnership interests each quarter by applying a combination of discounted‑cash‑flow models, earnings multiples and market multiples to the partnership’s NAV per unit. In contrast, Boeing’s Level 3 assets that are measured only on a non‑recurring basis are valued principally with an income (discounted‑cash‑flow) approach, without the use of periodic multiples, and the valuation is performed only when an impairment or other one‑time event occurs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core differences between RTX's and BA's valuation methodologies as described in the ground truth. (1) RTX's quarterly valuation using discounted cash flows, earnings multiples, and market multiples is accurately described, including the use of NAV per unit (a detail not in the original but not incorrect). (2) BA's use of an income approach (discounted cash flows) for nonrecurring Level 3 assets is correctly stated. The answer correctly notes that BA applies this only upon triggering events like impairment, aligning with 'nonrecurring basis.' (3) The multi-hop reasoning—comparing two companies' fair value approaches across different asset types and timing—is sound and logically synthesized. However, the LLM omits key contextual details from the original answer: it does not mention BA's reliance on third-party aircraft publications, median collateral values, or specific asset types like operating lease equipment and finance leases. It also fails to note that BA may adjust values based on unique aircraft attributes or expected net sales prices. These omissions reduce completeness and qualitative accuracy, though the core factual contrast (quarterly vs. event-driven, multiples vs. DCF-only) remains valid. (4) No numbers, dates, or financial figures are incorrect—there are no quantitative inaccuracies. The answer is fully relevant to the question. Thus, a score of 8 is justified: factually sound with minor but notable omissions in detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 413,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does Netflix's use of forward contracts to manage foreign exchange risk on firm commitments compare to Disney's VAR model estimates in terms of potential one-day loss exposure, given the specific metrics disclosed in their respective financial reports?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on firm commitments related to foreign currency-denominated content assets, aiming to reduce cash flow volatility. However, Disney's Value at Risk (VAR) model estimates a maximum potential one-day loss of $255 million (as of September 28, 2024) across its interest rate, foreign exchange, commodities, and equity-sensitive instruments. While Netflix does not disclose a specific VAR metric, Disney's $255 million VAR figure provides a quantified estimate of its exposure, allowing for a comparative view of how each company assesses and manages financial risk in their operations.",
      "llm_answer": "Netflix does not disclose a dollar‑amount estimate of the loss that could arise from its foreign‑exchange forward contracts on firm commitments – it simply states that it enters into cash‑flow‑hedge forwards (generally ≤ 24 months) to offset the U.S.‑dollar value of those commitments. In contrast, Disney quantifies its market‑risk exposure with a VAR model that estimates a maximum one‑day loss of **$255 million** for the combined portfolio at fiscal‑year‑end 2024 (and a peak “highest VAR” of **$444 million**). Thus, Disney provides a concrete one‑day loss figure, whereas Netflix’s disclosure is qualitative and contains no comparable monetary metric.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Disney's one-day loss exposure is accurately reported as $255 million (fiscal-year-end 2024), and the additional 'highest VAR' of $444 million is consistent with Disney's disclosures. The date (fiscal-year-end 2024) corresponds to September 28, 2024, in the original answer. (2) The LLM correctly notes that Netflix does not disclose a specific dollar amount or VAR metric for its foreign exchange risk, only describing its use of forward contracts qualitatively—this matches the ground truth. (3) The multi-hop reasoning is sound: the model correctly contrasts Netflix’s qualitative risk management disclosure with Disney’s quantitative VAR approach, synthesizing information across both companies’ financial reports. (4) The only minor shortcoming is that the LLM introduces a 'highest VAR' of $444 million, which, while likely accurate from Disney’s report, is not mentioned in the original answer and thus adds information beyond the ground truth. However, this does not contradict it and may reflect a more complete view of Disney’s disclosures. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the original, with excellent quantitative precision and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 374,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the corporate income tax rate reduction in the Philippines enacted in Q1 2021 impact AMD's tax provision compared to Texas Instruments' operational investments in the country, given both companies' exposure to international tax regulations?",
      "original_answer": "The corporate income tax rate reduction in the Philippines enacted in Q1 2021 had a favorable impact on AMD’s effective tax rate by partially offsetting increases from other tax factors, such as GILTI-related foreign tax credit limitations. Meanwhile, Texas Instruments had $370 million in property, plant, and equipment at its two sites in the Philippines as of December 31, 2021, indicating significant operational exposure that would be directly affected by the lower tax rate. AMD’s 2021 effective tax rate increased by 0.1 percentage point to 21.8%, with the Philippines tax reduction noted as a mitigating factor, while TXN’s capital investment in the country suggests a strategic commitment that would benefit from the lower corporate tax rate.",
      "llm_answer": "AMD’s 2021 income‑tax provision was $513 million (an effective tax rate of about 14%).  The filing notes that the provision was “partially offset” by a number of foreign‑tax benefits, the most material of which was the corporate‑income‑tax‑rate reduction that the Philippines enacted in the first quarter of 2021.  In other words, the lower Philippine rate helped shrink AMD’s overall tax bill for the year.\n\nTexas Instruments, by contrast, does not cite a Philippine‑rate reduction; its 2022 filing instead emphasizes the company’s operating‑investment footprint in the Philippines.  Those capital and R&D investments generate taxable earnings in the country, which adds to TI’s overall tax expense rather than reducing it.  Consequently, while AMD’s provision was lowered by the Philippine rate cut, TI’s exposure to the Philippines comes from the tax on its operational investments, which works in the opposite direction.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. It states AMD’s effective tax rate was 'about 14%' and tax provision was $513 million, which contradicts the ground truth that AMD’s 2021 effective tax rate was 21.8% (an increase of 0.1 percentage point). These numbers are not supported by the original answer and appear fabricated or misattributed. (2) The claim that AMD’s tax provision was $513 million is unsupported in the ground truth, which does not provide a dollar amount for AMD’s tax provision—only the effective tax rate. The only correct quantitative detail is the mention of the Q1 2021 Philippines tax rate reduction, which aligns with the original answer. However, Texas Instruments’ $370 million in property, plant, and equipment in the Philippines as of December 31, 2021 is completely omitted, a major missing data point. (3) The reasoning is partially sound in that it identifies AMD benefited from the tax reduction while TI has operational investments in the country, but it incorrectly frames TI’s exposure as increasing tax expense 'rather than reducing it,' which misrepresents the impact of a lower corporate tax rate. A lower rate would reduce tax expense on earnings from operational investments, not increase it. The answer incorrectly implies TI does not benefit from the lower rate, when in fact its significant capital investment suggests it would benefit directly. (4) Contextual relevance is fair—the answer addresses both companies and the Philippines tax change, and attempts multi-hop reasoning. However, due to major factual errors in numbers and misrepresentation of tax impact on TI, the qualitative and quantitative accuracy scores are low. The core comparison is conceptually relevant but factually flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 491,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How do GM's and McDonald's different approaches to affiliate relationships reflect their respective business models, particularly in terms of vehicle production and franchise operations?",
      "original_answer": "GM engages in transactions with nonconsolidated affiliates for the development, production, and marketing of trucks, crossovers, cars, and automobile parts, which are integral to its automotive manufacturing business model. These affiliates are primarily located in China and produce vehicles under the Baojun, Buick, Cadillac, Chevrolet, and Wuling brands. In contrast, McDonald's relies on affiliates for franchise operations, where revenues are generated through royalties based on a percentage of sales and initial fees. This reflects McDonald's asset-light business model centered on franchising and brand licensing. While GM's affiliate relationships are production-focused and tied to physical goods, McDonald's approach emphasizes service-based revenue through franchisee support and brand management, highlighting the distinct operational structures of the two companies.",
      "llm_answer": "GM treats its affiliates as equity‑method or variable‑interest entities that are part of its production and financing chain – its China joint‑ventures own the plants that build Buick, Chevrolet and Cadillac models, its non‑consolidated battery‑cell partners supply EV cells, and GM Financial’s VIEs fund vehicle leases – so earnings from these affiliates are reported as “equity income” and are integral to vehicle‑manufacturing and sales (see GM 10‑K pp. 75‑77, 79).  \n\nMcDonald’s, by contrast, classifies franchisees, developmental licensees and advertising cooperatives as affiliates that it does not control; the company earns rent, royalties and advertising‑cooperative fees from them and therefore does not consolidate their operations, reflecting a franchise‑focused model that relies on third‑party operators rather than direct production (see MCD 10‑K pp. 45‑48).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: GM's use of nonconsolidated affiliates in China for vehicle production (Buick, Chevrolet, Cadillac) and its partnerships in EV battery supply and financing via GM Financial are accurately described. McDonald's franchise model involving royalties, rent, and advertising fees from third-party operators is also correctly portrayed. (2) There are no numeric values in the original or LLM answer requiring calculation, so quantitative accuracy is not compromised; all references to financial reporting (e.g., equity income) and business structures are consistent with SEC filings. (3) Multi-hop reasoning is sound: the model correctly synthesizes how GM’s production-focused affiliate relationships contrast with McDonald’s service- and brand-based franchise model, reflecting their distinct business models. (4) The LLM adds detail not in the original (e.g., mention of VIEs in leasing, battery-cell partners, GM Financial, and specific 10-K page references), which enhances accuracy without introducing error. The only minor shortcoming is that the LLM omits mention of Baojun and Wuling brands produced by GM’s Chinese affiliates—present in the original—making the response slightly less complete but not factually deficient. Overall, the answer is semantically equivalent and contextually precise, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 398,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "Given Alphabet's significant share repurchase activity of $62.0 billion in Class A and Class C shares in 2024, and the automatic conversion of Class B shares to Class A upon sale or transfer, how might the reduction in outstanding Class A shares impact the relative voting power of remaining Class B shareholders, especially in light of the fact that Class B shares carry 10 votes per share compared to 1 vote for Class A?",
      "original_answer": "Alphabet repurchased $62.0 billion of Class A and Class C shares in 2024, reducing the number of outstanding Class A shares. Since Class B shares convert automatically to Class A shares upon sale or transfer, this limits the ability of Class B holders to retain higher-vote shares if they transact. With fewer Class A shares in circulation due to buybacks, the relative voting concentration among remaining Class B shareholders—who hold 10 votes per share—would increase, potentially consolidating control among long-term holders.",
      "llm_answer": "Alphabet’s 2024 buy‑back retired $62 billion of Class A and Class C stock, cutting the number of outstanding Class A shares (see Note 11, page 82). Because each Class A share carries only 1 vote while a Class B share carries 10 votes, removing Class A shares reduces the pool of one‑vote shares and therefore raises the percentage of total voting rights held by the remaining Class B shares. Moreover, since any Class B share that is sold or transferred automatically converts to a Class A share (which may then be repurchased and retired), the conversion further shrinks the one‑vote pool, magnifying the relative voting power of the still‑held Class B stock.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Alphabet repurchased $62.0 billion of Class A and Class C shares in 2024, which reduces the number of outstanding Class A shares. The dollar amount is correctly stated (with acceptable formatting variation: $62 billion vs $62.0 billion). (2) The reasoning correctly explains the voting structure: Class B shares have 10 votes per share, Class A have 1 vote, and reducing the pool of Class A shares through buybacks increases the relative voting power of remaining Class B shares. (3) The multi-hop logic is sound: it connects share repurchases → reduction in Class A shares → increased concentration of voting power among Class B holders, and further incorporates the automatic conversion of Class B to Class A upon sale, which limits dilution of control and reinforces voting concentration. (4) The LLM adds contextual precision by referencing 'Note 11, page 82' (a realistic document citation), enhancing credibility without introducing error. No factual, numerical, or logical inaccuracies are present. The answer fully addresses all parts of the question with correct entities, accurate synthesis, and clear reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 346,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the adoption of ASU No. 2020-01 impact the accounting treatment for equity securities by both Colgate-Palmolive and The Coca-Cola Company, particularly in light of the clarification provided by the standard on the interaction between equity securities, equity method investments, and derivative contracts?",
      "original_answer": "ASU No. 2020-01 clarifies the interaction between the accounting for equity securities under Topic 321, equity method investments under Topic 323, and derivative contracts under Topic 815. Colgate-Palmolive adopted this guidance effective January 1, 2021, and concluded that it did not have a material impact on its Consolidated Financial Statements. Similarly, The Coca-Cola Company, which is also subject to the same accounting standard, applies the clarified guidance to its equity securities, including the calculation of net unrealized gains and losses recognized during the year related to equity securities still held at the end of the year (as disclosed in its financial statements). Both companies benefit from the standard’s clarification on when observable transactions should be considered before applying or upon discontinuing the equity method, and how derivatives linked to equity securities should be accounted for without considering whether the underlying securities would be accounted for under the equity method or fair value option.",
      "llm_answer": "Both Colgate‑Palmolive and The Coca‑Cola Company adopted ASU 2020‑01 on January 1 2021. The update simply reaffirmed that equity securities that are not accounted for under the equity‑method are measured at fair value (with changes recognized in earnings, or using the cost‑minus‑impairment alternative when fair value is not readily determinable) and that the accounting for forward contracts, purchase options or other derivatives is unaffected by whether the underlying security is treated under the equity‑method or the fair‑value option. In each company’s 2022 filing the board noted that the adoption had no material impact on its consolidated financial statements.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions and one potential inaccuracy in timing. (1) Quantitatively, the adoption date of January 1, 2021, is correctly stated for both companies, matching the original answer. However, the reference to the '2022 filing' is misleading—while not necessarily incorrect, the original answer does not specify the filing year, only the effective date; thus, citing 2022 introduces unverified detail. (2) The statement that adoption had 'no material impact' is accurate for Colgate-Palmolive and implied for Coca-Cola in the original, so this is reasonably supported. (3) The explanation of ASU 2020-01’s effect—clarifying that derivatives are accounted for independently of equity method considerations and that fair value measurement applies to non-equity-method securities—is semantically equivalent to the ground truth and reflects correct multi-hop synthesis across both companies and accounting topics (321, 323, 815). (4) Missing from the LLM answer is explicit mention of Coca-Cola’s disclosure of net unrealized gains/losses on equity securities still held, which is a specific application noted in the original. Also, the term 'board noted' is vague and not present in the original—management or accounting disclosures, not the board, typically make such statements. Despite these minor issues, the core facts, reasoning, and synthesis are sound, and the answer remains contextually precise and relevant to the question about ASU 2020-01's impact on both firms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 424,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the difference in the Stress Capital Buffer (SCB) components of the CET1 capital ratio requirements between Goldman Sachs and Citibank reflect their respective approaches to regulatory capital adequacy under the Standardized Capital Rules as of December 2024?",
      "original_answer": "As of December 2024, Goldman Sachs is subject to a Stress Capital Buffer (SCB) of 6.2% under the Standardized Capital Rules, while Citibank’s required CET1 capital ratio under the same rules is 7.0%, which includes the 4.5% minimum CET1 requirement and a fixed 2.5% Capital Conservation Buffer. This indicates that Goldman Sachs faces a higher SCB-driven capital requirement, suggesting a potentially more stringent stress-based capital adequacy assessment compared to Citibank, which does not explicitly include an SCB in its stated CET1 requirement under the Standardized Approach.",
      "llm_answer": "Goldman Sachs’ Standardized‑approach CET1 requirement incorporates a **6.2 % Stress Capital Buffer (SCB)** for December 2024, whereas Citibank’s Standardized‑approach CET1 requirement includes only a **4.1 % SCB** (the buffer that Citi applies to its CET1 ratio). The larger SCB at Goldman Sachs shows a more conservative, stress‑oriented stance—consistent with its G‑SIB status and a strategy of holding extra capital to absorb severe adverse scenarios—while Citibank’s smaller SCB reflects a comparatively modest stress buffer, relying mainly on the baseline capital‑conservation and regulatory minimums to meet its capital adequacy under the Standardized Capital Rules.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Goldman Sachs has a 6.2% Stress Capital Buffer (SCB), which is correct in the LLM answer, but Citibank does not have an SCB component in its CET1 requirement under the Standardized Approach. Instead, Citibank’s 7.0% CET1 ratio consists of the 4.5% minimum CET1 plus a 2.5% Capital Conservation Buffer (CCB), with no SCB applied. The LLM incorrectly states that Citibank has a 4.1% SCB, which is not supported by the original answer and is factually wrong. This misrepresents a key regulatory distinction. (2) Quantitative accuracy is low: the 4.1% SCB for Citibank is incorrect—no SCB is mentioned for Citibank in the ground truth. The correct components for Citibank are 4.5% + 2.5% = 7.0%, but this sum is not an SCB; it's the total CET1 requirement without stress-based buffers. The LLM invents a number (4.1%) not present in the source. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize that only Goldman Sachs is subject to an SCB under the rules as of December 2024, while Citibank’s requirement does not include SCB. This undermines the comparison. The conclusion that Citi has a 'smaller SCB' is invalid because it has no SCB at all in this context. (4) Despite incorrect facts, the answer is contextually relevant—it addresses the right companies, time frame, and regulatory framework, and attempts a meaningful comparison of capital adequacy approaches. However, the core quantitative and qualitative errors severely reduce correctness. The reasoning about Goldman Sachs being more conservative due to SCB is partially sound, but the contrast with Citibank is based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 469,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How do NextEra Energy's operational infrastructure investments in Indiana compare with Duke Energy Indiana's financing strategy through tax-exempt bonds as of December 31, 2023?",
      "original_answer": "NextEra Energy operates transmission infrastructure in Indiana, including 90 miles of lines and 5 substations operating at 161-345 kilovolts, as part of its broader multi-state network. Meanwhile, Duke Energy Indiana disclosed holding $285 million in tax-exempt bonds as of December 31, 2023, which represents a significant portion of its $435 million total debt portfolio. This contrast highlights different strategic focuses: NextEra's emphasis on physical infrastructure development in Indiana versus Duke Energy Indiana's reliance on tax-advantaged financing instruments to fund its operations.",
      "llm_answer": "NextEra’s Indiana presence is reflected in its physical transmission assets – about 90 miles of rate‑regulated lines and five substations that the company wholly owns and has operated since the 1950s‑2020s. By contrast, Duke Energy’s Indiana operations are funded largely through tax‑exempt debt, with roughly $285 million of tax‑exempt bonds classified as long‑term debt and an additional $352 million of longer‑maturity tax‑exempt bonds (2027‑2046) carrying a weighted‑average rate of about 3.9 %. Thus, NextEra’s focus is on owning and operating infrastructure in Indiana, while Duke relies on tax‑exempt bond financing to support its Indiana activities.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies NextEra Energy's 90 miles of transmission lines and 5 substations in Indiana, which matches the ground truth. It also correctly states Duke Energy Indiana's $285 million in tax-exempt bonds, aligning with the original answer. However, the LLM introduces an additional $352 million in longer-maturity tax-exempt bonds not present in the ground truth, which significantly misrepresents Duke Energy Indiana's debt portfolio. The ground truth specifies that the $285 million represents a portion of a $435 million total debt, but the LLM does not mention this total or correctly contextualize the $285 million within it. Instead, it fabricates a new figure ($352 million) and adds details about maturity dates (2027–2046) and a weighted-average rate of 3.9%, which are not in the original data. (2) The core number ($285 million in tax-exempt bonds) is accurate, but the addition of $352 million in other tax-exempt bonds is unsupported and incorrect. No calculation is requested, but the implied total of tax-exempt debt ($285M + $352M = $637M) contradicts the ground truth total debt of $435M. This is a major quantitative error. (3) The multi-hop reasoning is partially sound: the model correctly contrasts NextEra’s physical infrastructure focus with Duke’s financing strategy. However, the reasoning is undermined by the inclusion of fabricated financial data, weakening the validity of the comparison. (4) The answer is contextually relevant and addresses the strategic contrast asked in the question. Due to the significant quantitative inaccuracy involving Duke’s bond amounts and the introduction of unverified details, the correctness score is reduced to 7—core facts are present but key financial details are incorrect, affecting the reliability of the synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 494,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does Apple's reliance on third-party content providers for its App Store revenue model create different business risks compared to Microsoft's strategy of producing its own content, particularly in light of Apple's changes to alternative payment processing and Microsoft's emphasis on brand reputation tied to content decisions?",
      "original_answer": "Apple's App Store revenue model depends heavily on third-party content providers, with developers retaining most of the revenue while Apple keeps a commission. This model is vulnerable to changes in developer incentives and regulatory compliance, such as Apple's recent adjustments to alternative payment processing in the EU under the DMA, which could reduce commission revenue. In contrast, Microsoft produces its own content and highlights the importance of brand reputation tied to its content decisions, noting that backlash could arise from public scrutiny or dissatisfaction with product offerings. While Apple risks losing developer support due to shifting business terms, Microsoft faces brand-related risks from its own content choices, creating fundamentally different exposure points in their respective content strategies.",
      "llm_answer": "Apple’s App Store model depends on dozens of third‑party developers and content owners, and the company’s revenue is tied to the commissions it can retain.  The 10‑K notes that changes to alternative‑payment rules (e.g., the EU Digital Markets Act) and the short‑term, non‑renewable nature of many licensing agreements could force Apple to lower its commission or lose popular apps, creating a direct supply‑side risk to its App Store earnings.  By contrast, Microsoft largely creates its own software and services, so its chief exposure is reputational – a misstep in its own content or moderation decisions could damage the Microsoft brand and hurt demand, but it does not face the same third‑party licensing‑or‑commission volatility that Apple does.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Apple's reliance on third-party developers and commission-based revenue model, and contrasts it with Microsoft's in-house content creation and brand-reputation risk. The core risks—supply-side/commission volatility for Apple and reputational exposure for Microsoft—are accurately conveyed. (2) There are no numeric values (e.g., percentages, dollar amounts, dates) in either the original or LLM answer, so quantitative accuracy is not compromised; all references (e.g., EU Digital Markets Act) are factually correct. (3) The multi-hop reasoning is sound: the model synthesizes Apple’s regulatory-driven changes to alternative payment processing (specifically citing the DMA) and links it to potential revenue risk, while correctly contrasting Microsoft’s self-produced content strategy and associated brand risks. The only minor shortcoming is that the LLM does not explicitly mention 'brand reputation tied to content decisions' as a deliberate strategic emphasis by Microsoft (it implies it), slightly reducing qualitative precision. (4) The answer is fully contextually relevant, directly addressing all parts of the complex, multi-faceted question. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the original answer, warranting a high correctness score with only a slight deduction for minor omission in elaborating Microsoft's strategic emphasis on brand reputation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 416,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the potential liability from tritium leakage at Southern Company's nuclear plants compare to the decommissioning fund shortfalls highlighted in NEE's disclosures, given both companies' exposure to nuclear health risks?",
      "original_answer": "Southern Company's nuclear facilities, which contributed approximately 26% and 28% of total KWHs generated for Alabama Power and Georgia Power respectively in 2021, face health risks including potential leakage of radioactive materials like tritium. These risks expose the company to potential liabilities that could exceed decommissioning trusts or insurance coverage. Similarly, NEE discloses that the cost of decommissioning its nuclear facilities could exceed the amounts available in decommissioning funds, leaving it exposed to additional financial risks. Both companies face comparable challenges in managing nuclear health risks, with Southern Company highlighting potential tritium exposure and NEE emphasizing the risk of decommissioning shortfalls, creating parallel financial exposures despite no direct business relationship.",
      "llm_answer": "Southern Company warns that a release of tritium from any of its nuclear plants could generate liability and property‑damage costs that exceed the amount of insurance it carries, a loss that could “materially adversely affect” its business and financial condition. In contrast, NEE’s filing states that the assets in its nuclear‑decommissioning trusts may be insufficient – a decline in market value or higher‑than‑expected decommissioning costs could create a funding shortfall that would require additional contributions and could also “materially adversely affect” its liquidity and results of operations. Thus, Southern’s exposure is an accident‑related liability that could surpass insurance coverage, whereas NEE’s exposure is a potential gap between decommissioning fund assets and the future cost of shutting down its reactors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) There are no numeric values in the original or LLM answer that conflict—both correctly avoid citing specific dollar amounts, percentages, or dates beyond 2021 context, which is consistent. The LLM does not introduce any incorrect figures, so quantitative accuracy is perfect. (2) Completeness is strong: the LLM addresses both Southern Company’s tritium-related liability risks and NEE’s decommissioning fund shortfall risks, correctly contrasting accident-driven liability (Southern) vs. funding gap risk (NEE). It captures the 'materially adverse effect' language used by both companies, which is semantically equivalent to the original answer’s emphasis on financial exposure. (3) Entity accuracy is correct—Southern Company and NEE are properly identified with their respective risk disclosures. The LLM correctly distinguishes the nature of each company's exposure without implying a business relationship. (4) Reasoning is sound and reflects multi-hop synthesis: it draws from separate disclosures to compare two different types of nuclear-related financial risks. The only minor shortcoming is that the LLM omits the specific detail about Southern Company’s nuclear generation percentages (26% and 28% in 2021), which were present in the original answer and add contextual depth. However, this omission does not undermine the core comparison or conclusion. Thus, while highly accurate and contextually relevant, it loses one point on qualitative accuracy for missing a supporting detail. Overall, the answer conveys the same essential meaning with correct logic and terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 452,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the corporate income tax rate reduction in the Philippines, enacted in Q1 2021, impact both Altria's (MO) effective tax rate and Coca-Cola's (KO) capital investment strategy, given their respective exposures to the Philippine market?",
      "original_answer": "The corporate income tax rate reduction in the Philippines, enacted in Q1 2021, favorably impacted Altria's (MO) effective tax rate in 2021, contributing to a 0.1 percentage point increase to 21.8%. This suggests that Altria benefited from lower tax liabilities on its Philippine-related earnings. Meanwhile, Coca-Cola (KO) maintained a significant capital investment in the Philippines, with property, plant, and equipment in the country representing 10% of its consolidated PPE net as of December 31, 2021 and 2020. The tax cut likely improved the after-tax return on KO's Philippine operations, reinforcing its sustained capital commitment. Therefore, the tax reform positively influenced both companies’ financial positioning in the region, with MO seeing a direct tax benefit and KO maintaining a stable long-term asset base.",
      "llm_answer": "- Altria’s (MO) 2021 effective tax rate rose only 0.1 percentage point to 21.8 % because the increase was “partially offset by the corporate income‑tax‑rate reduction in the Philippines (enacted in the first quarter of 2021)” 【page_94】. In other words, the Philippine rate cut modestly reduced the overall tax burden that would otherwise have pushed the effective rate higher.  \n\n- Coca‑Cola’s (KO) bottling and other assets in the Philippines account for roughly 10 % of its consolidated property, plant and equipment 【page_124】. The lower Philippine corporate tax rate therefore improves the after‑tax return on those assets and reinforces the company’s willingness to continue its capital‑expenditure program in the market, rather than curtailing it.  ",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: Altria's effective tax rate increased to 21.8% with a 0.1 percentage point impact attributed to the Philippine tax cut, and Coca-Cola's Philippine PPE exposure is correctly stated as 10% of consolidated PPE. These match the original answer exactly. (2) The LLM correctly identifies that the tax reduction in Q1 2021 partially offset a rise in Altria’s tax rate, implying a favorable impact—consistent with the ground truth’s claim of a 'favorable impact' contributing to the 21.8% rate. (3) For Coca-Cola, the LLM correctly infers that the lower tax rate improves after-tax returns and supports continued capital investment, which aligns with the original answer’s conclusion about sustained capital commitment. (4) The only minor shortcoming is that the LLM does not explicitly state that KO’s PPE percentage was stable across 2020 and 2021, which adds nuance to the 'sustained' investment strategy. However, the core reasoning and synthesis across both companies and the tax policy impact are sound. Wording differs slightly but maintains semantic equivalence. All entities (MO, KO, Philippines, 2021, effective tax rate, PPE) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 362,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How might Samsung's dual role as a supplier to NVIDIA for semiconductor wafer production and as a competitor to Qualcomm in the integrated circuit market impact Qualcomm's $12.8 billion in multi-year capacity purchase commitments, particularly if Samsung prioritizes its own product lines over external manufacturing demand?",
      "original_answer": "Samsung plays a critical role in NVIDIA's supply chain, producing semiconductor wafers for the company (Hop 1). At the same time, Samsung develops and produces its own integrated circuit products, directly competing with Qualcomm in this space (Hop 2). Qualcomm has $12.8 billion in multi-year capacity purchase commitments tied to its integrated circuit product manufacturing (Hop 3). If Samsung prioritizes its own competitive product lines over external manufacturing obligations, including those to Qualcomm, it could lead to capacity constraints or increased costs for Qualcomm. This would put pressure on Qualcomm’s ability to meet its manufacturing needs under existing commitments, potentially requiring renegotiation of terms or impacting margins if alternative suppliers must be sourced at higher costs.",
      "llm_answer": "Samsung is one of Qualcomm’s key foundry partners – Qualcomm’s 10‑K notes that its integrated‑circuit purchase obligations total $12.8 billion of multi‑year capacity commitments and that “cancellation of outstanding purchase commitments is generally allowed but would require payment of costs incurred… and may be subject to incremental fees or loss of advance payments” if capacity is under‑utilized (QCOM Note 8, p. 82).  At the same time, NVIDIA’s filing confirms that Samsung is a wafer‑fabrication supplier for NVIDIA’s chips (NVDA 10‑K, p. 9) and that Samsung also designs and sells its own ICs that directly compete with Qualcomm’s products (QCOM Risk Factors, p. 19‑20).  If Samsung chooses to prioritize its own product lines, it could constrain the wafer capacity Qualcomm expects under its contracts, forcing Qualcomm either to pay cancellation penalties or to secure alternative, potentially more expensive, manufacturing capacity—thereby jeopardizing the timing and cost assumptions underlying its $12.8 billion commitment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Qualcomm has $12.8 billion in multi-year capacity purchase commitments, Samsung is a supplier to NVIDIA for wafer fabrication, and Samsung competes with Qualcomm in the integrated circuit market. The dollar amount is correctly stated and matches the original answer. (2) Quantitative accuracy is perfect—$12.8 billion is accurately reported with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Qualcomm’s and NVIDIA’s 10-K filings to identify Samsung’s dual role and the contractual implications for Qualcomm. It adds value by citing specific contractual terms (e.g., cancellation penalties, fees for under-utilization) from Qualcomm’s Note 8, which enhances the reasoning beyond the original answer. (4) The only minor shortcoming is that the original answer emphasizes the risk of Samsung prioritizing its own products *over external manufacturing demand*, including Qualcomm’s, while the LLM focuses slightly more on contractual penalties than on the broader strategic risk of capacity allocation. However, the core logic and implications—constrained capacity, cost increases, need for alternative suppliers—are fully captured. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent, directly addressing the impact on Qualcomm’s $12.8B commitment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 404,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the impact of Lockheed Martin's commercial customer receivables on United Launch Alliance's financial position, given Boeing's equity stake in ULA and its reported income from the joint venture?",
      "original_answer": "Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes entities like ULA. ULA is a key commercial customer for Lockheed Martin through its Space segment, where Lockheed holds a 50% ownership interest. Boeing also holds the other 50% and reported $125 million in equity income from ULA in 2024. This suggests that ULA’s financial performance is significant to both companies, and Lockheed’s exposure to ULA through receivables and ownership could influence its contract asset management and overall liquidity. Therefore, any financial strain on ULA could affect both Lockheed’s $665 million commercial receivables and Boeing’s equity income.",
      "llm_answer": "Lockheed Martin’s balance sheet shows that, as of 31 December 2024, about **$665 million** of its receivables are owed by **commercial (non‑government) customers**. Those receivables represent the commercial launch contracts that flow through its 50 % ownership of United Launch Alliance (ULA) and therefore bolster ULA’s cash‑flow and liquidity position.  \n\nBoeing, which holds the other 50 % of ULA, reported **$125 million of equity‑method earnings from the joint venture in 2024** (down from $44 million in 2023), indicating that the commercial business that generates Lockheed’s receivables is also producing earnings that are reflected in Boeing’s share of ULA’s results. In short, Lockheed’s commercial customer receivables underpin ULA’s financial strength, and that strength is reflected in the income Boeing records from its 50 % stake in the venture.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all numbers are accurate: $665 million in commercial receivables for Lockheed Martin as of December 31, 2024, and $125 million in equity income from ULA reported by Boeing in 2024. These match the original answer exactly, and date references are correct. (2) The LLM correctly identifies the entities: Lockheed Martin, Boeing, and United Launch Alliance (ULA), along with their 50/50 joint venture structure and the use of equity-method accounting for ULA by Boeing. (3) The reasoning is mostly sound: the LLM correctly links Lockheed’s commercial receivables to ULA’s operations and explains that these receivables reflect business activity that generates earnings for ULA, which in turn flows to Boeing’s equity income. However, there is a subtle but important directional mischaracterization: the original answer states that ULA is a *customer* of Lockheed Martin (i.e., ULA owes Lockheed money as part of the $665M), implying receivables *from* ULA. The LLM instead frames the receivables as *bolstering ULA’s cash flow*, which inaccurately suggests Lockheed is funding ULA or that the receivables are assets owed to ULA. This reverses the financial relationship. The correct interpretation is that Lockheed has extended credit or has contractual claims (receivables) *from* ULA as a commercial customer, so ULA’s financial health affects Lockheed’s ability to collect, not the other way around. (4) Despite this misinterpretation of the financial flow, the core multi-hop synthesis—linking Lockheed’s receivables, ULA’s role, and Boeing’s equity income—is present and mostly logical. The answer remains highly relevant and factually rich, warranting a high score, but the error in financial causality prevents a perfect score on qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 498,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the invalidation of the '190 Patent in the CAR T litigation affect Gilead's amortization expense following its acquisition of Kite?",
      "original_answer": "The invalidation of the '190 Patent in August 2021 removed the risk of ongoing 27.6% running royalties on Kite’s Yescarta sales, which had been previously awarded to Juno and SKI. This resolution likely reduced Gilead’s contingent liabilities and improved the valuation of the acquired intangible assets. As a result, Gilead’s amortization expense for finite-lived intangible assets, which included Yescarta-related rights from Kite, was $1.7 billion in 2021, up from $1.2 billion in 2020, reflecting the clearer path to monetization of these assets post-litigation.",
      "llm_answer": "The court’s decision that the “190” CAR‑T patent was invalid meant that the intangible asset Gilead had recorded for that patent after buying Kite was written‑off.  With the asset removed, Gilead no longer records its amortization, so the company’s amortization expense on the Kite acquisition fell in the periods after the ruling.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) It claims that Gilead wrote off the intangible asset related to the '190 patent and that amortization expense fell post-ruling, which directly contradicts the ground truth. The original answer states that amortization expense *increased* from $1.2 billion in 2020 to $1.7 billion in 2021, indicating higher, not lower, amortization. There are no numbers mentioned in the LLM answer, so it fails on quantitative accuracy. (2) The entity identification (Gilead, Kite, CAR-T patent) is correct, and the date of invalidation (August 2021) is contextually accurate, though not mentioned in the LLM response. However, the core financial impact is misrepresented. (3) The reasoning is flawed: the invalidation removed royalty risk (27.6% to Juno/SKI), which improved the valuation of Yescarta-related intangible assets, leading to higher amortization due to a clearer monetization path—not a write-off. The LLM incorrectly assumes patent invalidation leads to asset write-down, when in this case it reduced contingent liabilities and supported asset valuation. (4) While the answer addresses the general topic (patent invalidation affecting amortization), it draws the opposite conclusion of the ground truth, severely undermining correctness. Contextual relevance is moderate because it engages with the right concepts but arrives at an incorrect outcome.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 394,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does Apple's revenue from Greater China in 2022 compare to Intel's revenue from Taiwan in 2021, given that Greater China includes Taiwan as one of its key markets?",
      "original_answer": "Apple reported $74,200 million in net sales from Greater China in 2022, which includes Taiwan. Intel reported $13,461 million in net revenue from Taiwan in 2021. This indicates that Apple's revenue from the broader Greater China region was significantly higher than Intel's revenue specifically from Taiwan during those periods.",
      "llm_answer": "Apple reported $74.2 billion of net sales from the Greater China segment in 2022 (which includes Taiwan). Intel’s net revenue billed to customers in Taiwan was $13.5 billion for the year ended Dec 25 2021. Thus Apple’s Greater China revenue was about $60 billion (roughly 5½ times) larger than Intel’s Taiwan revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Apple's 2022 revenue from Greater China as $74.2 billion (equivalent to $74,200 million in the ground truth) and Intel's 2021 revenue from Taiwan as $13.5 billion (very close to the exact $13,461 million, or $13.461 billion, in the original answer). The rounding to $13.5 billion is acceptable and common in financial reporting. (2) The calculation comparing Apple's revenue to Intel's is accurate: $74.2B - $13.5B ≈ $60.7B difference, and $74.2B / $13.5B ≈ 5.5, so stating 'about $60 billion (roughly 5½ times) larger' is factually sound and well-reasoned. (3) The multi-hop reasoning is correct—synthesizing Apple's regional revenue (which includes Taiwan) with Intel's country-specific revenue from the same region in different years, as required by the question. The answer acknowledges the geographic overlap (Taiwan being part of Greater China) without incorrectly conflating the two figures. (4) All entities—Apple, Intel, Greater China, Taiwan, net sales/revenue, and correct fiscal years (2022 and 2021)—are accurately referenced. The only minor deduction is for rounding Intel’s revenue from $13.461B to $13.5B, which, while reasonable, introduces a small quantitative imprecision. Otherwise, the answer is complete, logically structured, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 376,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How do UPS's derivative valuation practices involving yield curves and Boeing's approach to fixed income investments compare in terms of reliance on observable market data like credit spreads and interest rates?",
      "original_answer": "UPS relies on pricing models that use observable market data such as yield curves and foreign currency exchange rates for valuing derivatives, which are classified as Level 2. Similarly, Boeing's fixed income investments, including interest rate swaps, are valued using pricing models that incorporate verifiable observable market data like interest rates, yield curves at commonly quoted intervals, and credit spreads, also categorizing them as Level 2 when observable inputs are available. Both companies emphasize the use of market-observable inputs for Level 2 classifications, though UPS focuses on derivatives tied to foreign exchange and Boeing on fixed income instruments.",
      "llm_answer": "UPS values its over‑the‑counter interest‑rate and foreign‑currency derivatives using Level‑2 pricing models that depend on market‑observable inputs such as benchmark yields, swap curves (yield curves) and other observable rates (e.g., inter‑dealer broker rates and rating‑agency data). Boeing’s fixed‑income investments are similarly valued at Level 2 when market prices are not available, using pricing models that rely on observable market data—including current interest rates, yield‑curve points and quoted credit spreads. Thus, both companies base their valuations on observable market inputs, but UPS emphasizes yield‑curve and rate inputs for derivative pricing, while Boeing’s approach also explicitly incorporates observable credit‑spread information for fixed‑income securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: both UPS and Boeing use Level 2 valuation methods relying on observable market data; UPS uses yield curves, swap curves, and other observable rates for derivative valuation; Boeing uses interest rates, yield curves, and credit spreads for fixed income investments. There are no incorrect numbers, dates, or financial metrics—this is a qualitative comparison, so no calculations are needed. (2) Quantitative accuracy is perfect: no numerical inaccuracies, and the use of terms like 'benchmark yields', 'swap curves', and 'quoted credit spreads' matches the observable inputs described in the original. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (UPS and Boeing), two types of financial instruments (derivatives vs. fixed income), and compares their reliance on observable data, noting both commonalities and distinctions. (4) The only minor shortcoming is that the original answer explicitly states that both classify these valuations as Level 2 *when observable inputs are available*, which the LLM implies but doesn't fully emphasize. Additionally, the original notes UPS focuses on foreign exchange derivatives while Boeing focuses on fixed income—this is partially reflected but could be clearer. Despite this, the LLM captures the core comparison accurately and uses semantically equivalent language. Hence, a score of 9 is justified—excellent but not perfect in qualitative nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 425,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the use of discounted cash flow models for impairment testing by META compare to DIS's application of these models in valuing Level 2 derivatives, particularly in terms of the inputs and assumptions each company relies on?",
      "original_answer": "META uses discounted cash flow (DCF) models with Level 3 inputs to estimate the fair value of impaired operating lease ROU assets and leasehold improvements, incorporating assumptions such as expected downtime, projected sublease income, and discount rates reflecting risk levels. In contrast, DIS applies internal DCF models to value Level 2 derivatives using observable inputs like interest rates, yield curves, and foreign currency exchange rates. While both companies utilize DCF models, META relies on less observable (Level 3) assumptions, whereas DIS uses more market-based (Level 2) data, reflecting different applications and risk profiles in their respective financial reporting.",
      "llm_answer": "Meta uses discounted‑cash‑flow (DCF) models for impairment testing of its lease‑related assets, relying on Level 3 inputs that are largely unobservable – chiefly management’s estimates of expected downtime before subleases begin, projected sub‑lease cash flows over the remaining lease terms, and a discount rate that reflects the risk of those future cash flows. In contrast, Disney values its Level 2 derivatives with internal DCF models that depend on observable market data (interest‑rate curves, yield curves and foreign‑exchange rates) and only modest credit‑risk adjustments, so its assumptions are market‑driven rather than the internal, risk‑adjusted forecasts that Meta employs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Meta uses DCF models with Level 3 inputs for impairment testing of lease assets, relying on unobservable assumptions like expected downtime, projected sublease income, and risk-adjusted discount rates. Disney uses internal DCF models for Level 2 derivatives based on observable market inputs such as interest rate curves, yield curves, and foreign exchange rates, with only minor credit-risk adjustments. (2) There are no numeric values to verify (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not applicable in a traditional sense—but the absence of incorrect numbers supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Meta and Disney), two applications of DCF models (impairment testing vs. derivative valuation), and two levels of fair value hierarchy (Level 3 vs. Level 2), accurately contrasting their reliance on unobservable vs. observable inputs. (4) The only reason for not scoring a perfect 10 in correctness and qualitative accuracy is minor: the LLM omits explicit mention of 'leasehold improvements' as part of Meta’s impairment testing and does not directly name 'risk profiles' in the conclusion, though these concepts are implied. However, the semantic meaning and key differentiators (Level 3 vs. Level 2 inputs, internal estimates vs. market data) are fully preserved. Contextual relevance is perfect—the response directly addresses the comparison asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 441,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the IQOS device supply constraint mentioned in PM's 2022 filing impact PM USA's ability to commercialize heated tobacco products in the U.S., considering the FDA authorization dependency and PM USA's role as a guarantor under Altria's financial structure?",
      "original_answer": "The IQOS device supply constraint due to the global semiconductor shortage, as reported in PM's 2022 filing, limited IQOS user growth in the second half of 2021 and contributed to the delay in resuming U.S. supply following the ITC import ban. PM USA, as the exclusive commercialization partner for PMI's heated tobacco products in the U.S., depends on FDA authorization for IQOS devices, including IQOS 3, which is under review. The cessation of IQOS device sales in the U.S. after November 29, 2021, due to the ITC cease-and-desist order, further disrupted PM USA’s product portfolio. Given PM USA's role as a guarantor of Altria's debt obligations, any prolonged inability to market IQOS devices could strain PM USA's financial position, particularly if it affects cash flows or dividend distributions to Altria, thereby increasing the risk of insolvency considerations under fraudulent conveyance laws.",
      "llm_answer": "The 2022 filing notes that a global semiconductor shortage left IQOS device inventory “tight” in the second half of 2021 and, after the ITC‑imposed import ban, the devices are not currently available for sale in the United States; the company expects supply to resume only in the first half of 2023 and only if the FDA’s existing PMTA/MRTP authorizations remain in force. Because PM USA is the 100 % Altria subsidiary that unconditionally guarantees Altria’s senior debt and other borrowings, a prolonged U.S. shortage that delays commercial launch would curb the cash‑flow needed to satisfy those guarantees, even though the guarantees have not yet had a material liquidity impact. Thus, the device‑supply constraint directly hampers PM USA’s ability to commercialize heated‑tobacco products in the U.S., and any delay adds financial risk to its guarantor role under Altria’s capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) Quantitatively, all dates and timeframes are correct: the semiconductor shortage affecting H2 2021, the cessation of U.S. sales post-November 29, 2021 (implied by ITC ban), and the expectation of supply resuming in H1 2023 are consistent with known timelines. The reference to FDA PMTA/MRTP authorizations aligns with regulatory context. (2) The answer correctly identifies PM USA as the 100% Altria subsidiary and guarantor of Altria’s debt, accurately reflecting its role in the financial structure. (3) The reasoning correctly links the supply constraint to delayed commercialization and explains the financial risk to PM USA’s ability to support its guarantees due to reduced cash flows—this reflects sound multi-hop logic connecting operational constraints (semiconductor shortage, ITC ban), regulatory dependency (FDA authorization), and financial structure (guarantor role). (4) Minor omission: the ground truth specifically notes that IQOS 3 is under FDA review, and the ITC cease-and-desist directly caused the end of U.S. sales, which the LLM answer implies but does not explicitly state. Also, the fraudulent conveyance risk under prolonged insolvency pressure is not mentioned, slightly reducing completeness. However, these are secondary details, and the LLM conveys the essential causal chain and financial implications accurately. Wording differs but semantic meaning is equivalent. No calculation errors. Thus, high scores across all dimensions with a 9 on correctness due to minor omissions in regulatory specificity and legal risk nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 448,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the impact of biosimilar competition on BMY's revenue outlook compare to ABBV's exposure given that Humira alone accounted for 27% of ABBV's 2023 net revenues and faces direct biosimilar pressure globally?",
      "original_answer": "BMY faces significant risk from biosimilar competition, which threatens to rapidly erode revenues for products losing market exclusivity, especially as seen with Eliquis and Revlimid. Meanwhile, ABBV's Humira, which accounted for 27% of its 2023 net revenues, is under direct global biosimilar pressure. While both companies are exposed to biosimilar threats, ABBV has a concentrated risk tied to a single product, whereas BMY faces broader portfolio risk across multiple products.",
      "llm_answer": "BMY warns that, as its patents expire, “there are usually very substantial and rapid declines in a product’s revenues” when generic or biosimilar versions enter the market (BMY 10‑K p.27‑28). In contrast, AbbVie’s revenue picture is far more concentrated: Humira alone generated about 27 % of AbbVie’s 2023 net revenues (AbbVie 10‑K p.81) and is now “facing direct biosimilar competition globally” (AbbVie 10‑K p.8). Thus, while BMY expects biosimilar entry to erode sales across several products, AbbVie’s exposure is acute because a single product that accounts for over a quarter of its sales is under biosimilar pressure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Humira accounted for 27% of AbbVie’s 2023 net revenues, which matches the original answer. The characterization of biosimilar pressure on Humira as 'global' is consistent with both the LLM and original answers. (2) Quantitative accuracy is perfect: the 27% figure is correctly cited and contextualized. No calculations are required beyond accurate reporting of percentages. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes risk exposure across two companies—BMY’s broad portfolio risk (e.g., Eliquis, Revlimid) and ABBV’s concentrated risk in Humira—drawing from appropriate 10-K disclosures. (4) The answer addresses all parts of the question: it compares BMY’s general revenue risk due to biosimilars with ABBV’s specific, high-concentration risk, using correct entities, years, and financial impact. Wording differs slightly but meaning is preserved. Citations to 10-K pages further support accuracy. No factual errors, omissions, or misinterpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 309,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between PM and PEP in terms of payout structure and vesting triggers, given PM's inclusion of dividend equivalents during vesting and PEP's cash payout upon vesting?",
      "original_answer": "PM includes dividend equivalents on RSU awards that accrue during the vesting period and are paid out as part of the RSU settlement, typically after three years or upon specific events like death, disability, or reaching age 58. PEP also accrues dividend equivalents on RSUs, but these are paid out in cash (without interest) only when the RSU vests and becomes payable. Unlike PM, which may vest RSUs upon age or disability, PEP ties payout strictly to the end of the service period or performance-based vesting for PSUs, with no mention of age-based triggers. This reflects a structural difference in how each company manages equity compensation benefits.",
      "llm_answer": "- **Philip Morris (PM)** – RSUs earn dividend‑equivalent amounts that are treated as participating securities; the equivalents are recognized in earnings (and EPS) while the award is vesting, but they are not paid out separately – they remain part of the RSU benefit until the award vests (RSUs typically vest on the third anniversary of the grant).  \n\n- **PepsiCo (PEP)** – RSUs and PSUs also accrue dividend equivalents, but those equivalents are **paid in cash (without interest) at the moment the RSU vests**.  PEP’s RSUs vest at the end of the service period, and the cash dividend‑equivalent payment is triggered only upon that vesting event.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that PM accrues dividend equivalents during vesting which are paid upon settlement (typically after three years), and that PEP pays dividend equivalents in cash at vesting. The structural differences in payout timing and form (accrued vs. cash) are accurately captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not compromised; all time references (e.g., 'third anniversary') match the ground truth's 'three years'. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in payout structure (accrual vs. cash) and vesting triggers (PM includes age 58, death, disability; PEP ties to service or performance with no age-based triggers). The only minor omission is that the LLM does not explicitly mention PM's age 58 or disability vesting triggers, which slightly reduces completeness but does not invalidate the core accuracy. (4) The answer is contextually relevant, directly addressing the comparison in payout structure and vesting triggers. Wording differs slightly but maintains semantic equivalence. Thus, a high score is justified, with a small deduction in qualitative accuracy for the partial omission of PM's specific vesting events.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 376,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does GE's $1,410 million investment in illiquid real estate funds through its run-off insurance operations compare to BA's broader real estate investment strategy, particularly in terms of liquidity risk and fund structure?",
      "original_answer": "BA invests in a diversified portfolio of global real estate, including office, retail, apartment, and industrial properties, primarily through limited partnerships or fund structures that allow for varied market exposure. These investments are part of a broader asset allocation strategy that includes private equity, hedge funds, and real assets. In contrast, GE holds $1,410 million in illiquid real estate funds through its run-off insurance operations, which are measured at net asset value and generally not eligible for redemption without the general partner's approval. Both use fund structures that limit liquidity, but GE's exposure is more concentrated and less flexible, as distributions depend on the liquidation of underlying assets at the discretion of the fund's general partner, whereas BA's approach is more diversified and integrated within a broader investment framework.",
      "llm_answer": "GE’s run‑off insurance segment holds about **$1.4 billion of limited‑partner interests in private‑equity‑style real‑estate funds** that are “generally not eligible for redemption and generally cannot be sold without the general‑partner’s approval.” These holdings are therefore **highly illiquid** and the company can receive cash only when the fund liquidates assets at the GP’s discretion.\n\nBoeing’s 10‑K shows a **much larger real‑estate exposure – roughly $3 billion‑plus of real‑estate fund interests** (carrying value $3.46 bn with $214 m of unfunded commitments) that are also **closed‑end, non‑redeemable funds**, but they are spread across many funds with varied contractual maturities (under‑5‑year, 5‑10‑year, over‑10‑year) and generate periodic distributions as underlying properties are sold. Thus, while Boeing’s real‑estate holdings are similarly illiquid in principle, the **broader, multi‑fund structure and staged maturities provide more predictable cash‑flow opportunities and lower overall liquidity risk** than GE’s single, tightly‑held illiquid block.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the $1.4 billion figure for GE matches the $1,410 million in the original answer (rounded appropriately), and Boeing's $3.46 billion carrying value with $214 million in unfunded commitments is correctly reported. The characterization of both companies' investments as non-redeemable, closed-end, or limited-partnership structures is consistent. (2) The LLM correctly identifies that GE’s investment is highly illiquid, redemption-restricted, and dependent on GP discretion—mirroring the original answer’s emphasis on lack of flexibility. (3) For Boeing, the LLM adds valuable detail not in the original—contractual maturity bands and periodic distributions—supporting the conclusion of lower liquidity risk due to diversification across funds and staggered maturities. This enhances rather than distorts the comparison. (4) The multi-hop reasoning is sound: it synthesizes structure, liquidity, and fund mechanics across two companies and correctly contrasts GE’s concentrated, inflexible exposure with Boeing’s broader, more diversified strategy. The only minor gap is that the original emphasizes BA’s real estate as part of a broader asset allocation (including private equity and hedge funds), which the LLM omits—hence not a perfect 10. However, the core comparison on liquidity risk and fund structure is thoroughly and accurately addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 397,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does BAC's exposure to equity market risk, as managed through derivative instruments, compare to MET's use of equity market derivatives in terms of notional value and sensitivity to a 10% decrease in equity prices?",
      "original_answer": "BAC discloses exposure to equity market risk through trading positions involving equity-linked instruments such as options, futures, and swaps. MET reports a notional value of $23,595 million for its equity market derivatives, with a sensitivity of $522 million to a 10% decrease in equity prices. While BAC does not specify exact notional amounts for its equity derivatives, it emphasizes the use of similar hedging tools. MET's quantified exposure highlights a direct sensitivity to equity market movements, which contrasts with BAC's broader market risk management approach that includes equity risk as one of several components.",
      "llm_answer": "- **Bank of America (BAC)** – The only quantitative equity‑market figure disclosed is the one‑day VaR for the equity component of its trading book, which averaged **$18 million** in 2023 (Table 41, page 77). The filing does not give a separate notional amount for the equity‑linked derivatives that are used to hedge this risk, implying that the bank’s equity‑derivative exposure is relatively modest.\n\n- **MetLife (MET)** – MetLife reports a **notional amount of about $23.6 billion** for its equity‑market derivative instruments (Note 12, page 129). Its sensitivity analysis shows that a **10 % decline in equity prices would reduce the fair value of those positions by roughly $522 million** (page 129).\n\n**Comparison:** MetLife’s equity‑market derivative program is far larger in scale – roughly $23.6 billion of notional versus BAC’s undisclosed but evidently much smaller exposure – and a 10 % equity‑price drop would cost MetLife about $522 million, whereas BAC’s reported equity‑related VaR is only $18 million, indicating a considerably lower potential loss.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All quantitative values are correct: MET's notional value of $23,595 million is accurately reported as ~$23.6 billion, and the $522 million sensitivity to a 10% decline in equity prices is correctly cited. BAC's one-day equity VaR of $18 million is factually accurate and properly contextualized as the only disclosed quantitative metric related to equity market risk. (2) Calculations and comparisons are sound—while no direct calculation is required, the inference that BAC’s exposure is 'modest' relative to MET’s $23.6 billion notional and $522 million sensitivity is logically supported by the disclosed VaR figure. (3) Multi-hop reasoning is strong: the model correctly synthesizes information across two companies (BAC and MET), identifies the relevant metrics (notional value, sensitivity, VaR), and draws a valid comparative conclusion about scale and risk exposure. (4) The only minor limitation is that the original answer emphasizes BAC’s use of 'similar hedging tools' without quantification, while the LLM slightly strengthens this by implying the exposure is 'relatively modest' based on VaR—this is a reasonable inference but not explicitly confirmed in the original. However, this does not constitute a factual error. Wording differs but semantic meaning and factual content are equivalent. All entities (BAC, MET, equity derivatives, 10% decrease sensitivity) are correctly identified and analyzed in context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 412,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does Microsoft's operational footprint in Greater China compare to AMD's revenue concentration in Taiwan, and what does this suggest about their respective regional market strategies in 2022?",
      "original_answer": "Microsoft operates a regional center in Singapore that supports operations in Greater China, indicating a centralized approach to managing its activities across the region, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales to Taiwan in 2022, highlighting a significant direct revenue contribution from the region. While Microsoft's presence in Greater China is part of a broader Asia-Pacific operational structure, AMD's financial data shows a more concentrated revenue exposure to Taiwan specifically, suggesting differing regional market strategies: Microsoft leans on regional hubs to support broad market access, while AMD has a pronounced financial dependency on Taiwan as a key market.",
      "llm_answer": "Microsoft’s 2022 filing notes that its Asia‑Pacific operations are coordinated from a regional centre in Singapore, which “supports … Greater China” and that the company runs data‑centres “throughout … Asia” (MS 10‑K p. 16). In contrast, AMD’s 2022 filing shows that sales billed to customers in Taiwan were $2.1 billion out of $16.4 billion total external sales – roughly 13 % of its revenue – indicating a relatively high concentration in that single market (AMD 10‑K p. 78). Together, the disclosures suggest Microsoft pursues a broadly distributed, infrastructure‑heavy presence to serve Greater China without relying on a dominant revenue share, while AMD’s business model in 2022 was more dependent on the Taiwanese market, reflecting a focused regional sales strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Microsoft's regional center in Singapore supporting Greater China and AMD's $2.1 billion in sales to Taiwan in 2022, which aligns with the ground truth value of $2,091 million (rounded appropriately). The percentage calculation (13%) is accurate: $2.1B / $16.4B ≈ 12.8%, which rounds to 13%. All entities (Microsoft, AMD, Singapore, Greater China, Taiwan), fiscal year (2022), and financial metrics (revenue concentration, operational footprint) are correctly identified. (2) Quantitative accuracy is perfect: $2.1 billion is an acceptable rounding of $2,091 million; total revenue of $16.4 billion matches AMD’s reported external sales. No calculation errors. (3) Multi-hop reasoning is sound: the model synthesizes Microsoft’s operational structure from its 10-K with AMD’s revenue breakdown to contrast strategic approaches—centralized regional support vs. concentrated revenue dependency. The conclusion that Microsoft has a distributed infrastructure model while AMD relies more heavily on Taiwan is logically supported and semantically equivalent to the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly mention that Microsoft’s operational footprint includes China mainland, Hong Kong, and Taiwan as part of Greater China, though it references 'Greater China' correctly. This slight omission in detail prevents a perfect 10, but core facts, reasoning, and implications are fully aligned. Hence, correctness is 9, with high scores across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 424,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the dual-class stock structure at META, which affects the voting rights of Class A common stockholders, compare to NFLX's approach to shareholder voting rights in terms of investor influence over corporate governance decisions?",
      "original_answer": "META's dual-class common stock structure gives disproportionate voting power to Class B stockholders, such as Mark Zuckerberg, limiting the influence of Class A common stockholders on key corporate decisions, including board composition and change-of-control transactions. This contrasts with NFLX's one-share-one-vote policy, where each share of common stock entitles the holder to one vote on all matters, ensuring equal voting influence for all shareholders. The difference in voting rights structures reflects divergent approaches to corporate governance, with META prioritizing founder control and NFLX emphasizing broad shareholder participation.",
      "llm_answer": "Meta’s dual‑class structure gives its Class B shares ten votes per share while Class A shares have only one vote, concentrating voting power in the hands of the founder, the board chair and other insiders and “will limit or preclude” Class A holders from influencing corporate matters【page_49】. In contrast, Netflix’s charter provides that “the holders of each share of common stock shall be entitled to one vote per share on all matters to be voted upon by the Company’s stockholders,” giving every shareholder equal voting rights and therefore far greater ability to affect governance decisions【page_61】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the statement that Class B shares have ten votes per share while Class A shares have one is correct and matches the known structure of Meta's dual-class stock; Netflix's one-vote-per-share policy is also accurately represented. These numbers are not in the original answer but are factual and correctly cited from the source (page_49 and page_61), enhancing precision. (2) The answer is complete, addressing both Meta’s and Netflix’s voting structures and their implications for investor influence, satisfying the comparative, multi-hop nature of the question. (3) Entity accuracy is strong: Meta (formerly Facebook) and NFLX are correctly identified, and the governance concepts (voting rights, shareholder influence) are properly applied. (4) Reasoning is sound: the contrast between founder control (Meta) and equal shareholder participation (Netflix) is logically derived and synthesizes information across both companies. The only minor shortcoming is that the LLM does not explicitly name Mark Zuckerberg or mention specific governance decisions like board composition or change-of-control transactions, which are in the original answer and add contextual depth. However, the phrase 'limit or preclude Class A holders from influencing corporate matters' effectively captures the same idea. Overall, the answer is semantically equivalent, with slightly less granular detail but no factual errors—justifying a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 425,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the expiration of patent rights for JNJ's pharmaceutical products impact their market exclusivity, and how does this compare to LLY's reliance on regulatory exclusivity extensions for maintaining competitive advantage in the U.S. market?",
      "original_answer": "JNJ notes that patent expirations are typically followed by the introduction of competing generic products, which can result in significant revenue and market share losses. Additionally, JNJ highlights that increasingly aggressive challenges to its patents may lead to a loss of market exclusivity sooner than expected. In contrast, LLY relies on regulatory exclusivity extensions—such as those granted for orphan drug designations or pediatric exclusivity—to maintain market exclusivity beyond patent terms. According to BMY’s 10-K, regulatory exclusivity can provide a market exclusivity period that expires beyond the patent term, offering a strategic buffer against generic competition. Thus, while JNJ faces declining sales due to patent erosion and legal challenges, LLY strategically leverages regulatory exclusivity to prolong its market protection.",
      "llm_answer": "Johnson & Johnson explains that the bulk of a drug’s commercial value is realized while its patents are in force; once the listed compound, formulation or use patents expire, the FDA can approve generic versions (or biosimilars for biologics) and sales typically fall sharply (see JNJ 10‑K p. 6‑7). In contrast, Eli Lilly’s filing stresses that it leans heavily on statutory regulatory exclusivities—such as seven‑year orphan‑drug protection, six‑month pediatric extensions and the 12‑year BPCIA period for biologics—to keep competitors out of the U.S. market even after patent terms run out (LLY 10‑K pp. 9‑13). Thus, JNJ’s exclusivity is primarily patent‑driven, whereas LLY’s competitive advantage is more dependent on extending regulatory exclusivity periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that JNJ faces sharp sales declines post-patent expiration due to generic/biosimilar competition, and notes the risk of early loss of exclusivity from patent challenges—consistent with JNJ’s 10-K. It also accurately characterizes LLY’s reliance on regulatory exclusivity mechanisms such as orphan drug (7 years), pediatric exclusivity (6 months), and BPCIA’s 12-year biologics exclusivity. These durations are factually correct and match regulatory standards cited in relevant filings. (2) Quantitatively, all timeframes (7-year, 6-month, 12-year) are accurate and properly attributed to the correct regulatory mechanisms. No calculations were required, but the durations are correctly stated. (3) The multi-hop reasoning is sound: the model synthesizes JNJ’s patent-centric model and LLY’s regulatory exclusivity strategy, contrasting their approaches to market exclusivity. It correctly infers that LLY uses regulatory tools to extend protection beyond patent life, which is supported by both LLY and BMY 10-K references in the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly mention BMY as a source for the general principle of regulatory exclusivity outlasting patents, though it correctly conveys the concept. This omission does not detract significantly from the overall accuracy. Wording differs but semantic meaning and factual content are equivalent to the original answer. All parts of the question are addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 431,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does AMD's reduction in interest expense from convertible debt conversions compare with Nuance's outstanding convertible senior notes liability post-acquisition by Microsoft, and what does this imply about their respective capital structure strategies?",
      "original_answer": "AMD reduced its interest expense from $47 million in 2020 to $34 million in 2021 due to conversions of its 2.125% Convertible Senior Notes due 2026, indicating a proactive approach to reducing debt. Meanwhile, Nuance, which had issued $986 million in convertible senior notes in 2015 and 2017, had redeemed $985 million of those notes by June 30, 2022, leaving only $1 million outstanding. Microsoft, having acquired Nuance, now holds this remaining liability as part of its Intelligent Cloud segment. This suggests that AMD focused on reducing debt through voluntary conversions, while Nuance’s strategy under Microsoft involved largely redeeming its convertible notes, reflecting differing capital structure management approaches between the two companies.",
      "llm_answer": "AMD’s interest expense fell from $47 million in 2020 to $34 million in 2021—a $13 million reduction that the company said resulted from holders converting its 2.125 % convertible senior notes due 2026. After Microsoft’s acquisition of Nuance, only about $1 million of Nuance’s convertible senior notes remained on Microsoft’s balance sheet (the other $985 million was redeemed). This contrast shows AMD is actively using conversions to trim debt and lower interest costs, while Microsoft effectively eliminated the target’s convertible‑note liability, reflecting a strategy of cleaning up the acquired company’s capital structure and avoiding future interest obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports AMD's interest expense reduction from $47 million in 2020 to $34 million in 2021, a $13 million decrease, accurately citing the conversion of its 2.125% Convertible Senior Notes due 2026. It also correctly states that $985 million of Nuance’s convertible notes were redeemed, leaving $1 million outstanding post-acquisition by Microsoft—matching the ground truth. All numeric values, years, and percentages are accurate. (2) Quantitative accuracy is perfect: the $13 million difference is correctly implied, and the $985 million redemption and $1 million remaining liability are precisely reported. Format variations (e.g., spacing in '$47 million') do not affect correctness. (3) The multi-hop reasoning is sound: the model synthesizes AMD’s debt management via conversions with Nuance’s note redemptions under Microsoft, correctly contrasting AMD’s proactive conversion strategy with Microsoft’s post-acquisition cleanup of Nuance’s capital structure. The implication about differing capital structure strategies is logically drawn and semantically equivalent to the original answer. (4) The only minor shortcoming is that the LLM does not explicitly mention Nuance’s original $986 million in notes issued in 2015 and 2017, which slightly reduces completeness in contextual background, though the redemption amount and remaining liability are fully accurate. This omission does not affect the core comparison or conclusion, hence a 9/10 on qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 423,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers compare to the $4.827 billion transaction Crown Castle executed in 2013 for similar exclusive rights to AT&T's towers, considering both companies retained ownership and depreciation responsibilities?",
      "original_answer": "The $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers is slightly higher than the $4.827 billion Crown Castle paid in 2013 for 9,048 AT&T towers and the purchase of 627 towers. Both Verizon and AT&T retained ownership of the towers and continued to include them in Property, Plant and Equipment - Net on their balance sheets, depreciating them accordingly. In both cases, the companies subleased capacity back from the acquiring entity (American Tower or Crown Castle) for extended terms, with Verizon leasing back for a minimum of 10 years and AT&T subleasing for an estimated original term of 20 years.",
      "llm_answer": "The 2015 Verizon‑American Tower deal gave American Tower an upfront cash payment of **$5.0 billion** for exclusive rights to about 11,300 towers, while the 2013 AT&T‑Crown Castle arrangement provided **$4.827 billion** for exclusive rights to roughly 9,000 towers. Both transactions were structured as lease‑back‑type financings—Verizon and AT&T kept legal ownership of the towers and continue to record the assets on their balance sheets and depreciate them, so the only difference is that the American Tower payment is roughly $170 million larger.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key dollar amounts ($5.0 billion and $4.827 billion), years (2015 and 2013), and companies involved (Verizon-American Tower, AT&T-Crown Castle). It accurately notes that both deals involved retained ownership and depreciation responsibilities, with lease-back structures. However, it omits specific details present in the ground truth: the exact number of AT&T towers (9,048 vs. 'roughly 9,000') and the additional purchase of 627 towers by Crown Castle, which is a material component of the 2013 transaction. It also fails to mention the differing lease-back terms (10 years for Verizon vs. 20 years for AT&T), which is a relevant qualitative difference. (2) Quantitatively, the $5.0 billion and $4.827 billion figures are correct, and the $170 million difference is accurately implied (5,000 - 4,827 = 173 million; 'roughly $170 million' is acceptable rounding). The number of Verizon towers (11,300) is correctly cited, but the AT&T tower count is approximated as 'roughly 9,000' instead of the precise 9,048 + 627, which affects completeness. (3) The multi-hop reasoning is sound—comparing two complex transactions across time, companies, and structures—but misses full synthesis by omitting the 627 purchased towers and lease duration differences. (4) Scores reflect high accuracy in numbers and core structure, with minor deductions for missing specifics that affect completeness and depth of comparison. Contextual relevance is perfect as the answer directly addresses the question's focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 425,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does Southern Power's use of tax equity partnerships for wind facilities, which are connected to long-term PPAs with up to 25-year terms, compare with Duke Energy's approach to structuring PPAs for its renewable VIEs, particularly in terms of monetizing federal tax credits like PTCs?",
      "original_answer": "Southern Power utilizes tax equity partnerships for its wind facilities, allowing a tax partner to capture most of the federal tax benefits, including PTCs tied to the first 10 years of energy production. These partnerships are consolidated using the HLBV method, and the associated PPAs have remaining terms of up to 25 years. The PPAs are critical in monetizing these tax credits through long-term revenue streams. Similarly, Duke Energy structures PPAs as part of its renewable VIEs, where it is the primary beneficiary and makes key decisions including PPA negotiations. These PPAs are also essential in monetizing tax credits, but Duke does so under a model involving third-party tax equity investors to finance eligible assets. Both companies rely on PPAs for revenue predictability, but Southern Power explicitly ties its PPA terms and tax equity structures to the PTC window, while Duke’s focus is on broader VIE financing and guarantees.",
      "llm_answer": "Southern Power builds each wind project as a tax‑equity partnership in which the third‑party tax partner receives virtually all of the federal Production Tax Credits, while Southern Power secures a long‑term (often 20‑ to 25‑year) power‑purchase agreement that guarantees the cash‑flow needed to service the partnership debt. By contrast, Duke Energy places its wind assets in renewable‑energy VIEs that are funded through tax‑equity arrangements and debt‑service guarantees; the PTCs are monetized through the VIE’s tax‑equity structure rather than through a single, long‑term PPA, and the PPAs for those VIEs are not described as having the same 25‑year, fixed‑term structure that Southern Power uses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key numbers and timeframes are correct: the 20- to 25-year PPA terms match the 'up to 25 years' in the original answer, and the focus on PTC monetization within tax equity structures is consistent. No explicit dollar amounts or percentages were provided in either answer, so no discrepancies exist. (2) The LLM correctly identifies that Southern Power uses tax equity partnerships where the tax partner captures most PTCs, and that long-term PPAs (20–25 years) provide stable cash flow to service debt—this matches the original's emphasis on HLBV consolidation and PPA role in monetization. (3) For Duke Energy, the LLM accurately states that renewable VIEs are used with tax equity financing and debt-service guarantees, and that PTCs are monetized through the VIE structure. It correctly contrasts Duke’s approach by noting that its PPAs are not described as having the same fixed, long-term (25-year) structure as Southern Power’s, which aligns with the original’s point about Duke focusing more on VIE financing than PTC-timed PPAs. (4) The only minor shortcoming is that the LLM does not explicitly mention Duke’s role as primary beneficiary or its control over PPA negotiations—details included in the original. However, it captures the essence of Duke’s model through 'funded through tax-equity arrangements and debt-service guarantees.' The reasoning is sound, multi-hop synthesis across both companies is effective, and the comparison highlights the key distinction: Southern Power ties PPA length directly to PTC window, while Duke relies on broader VIE financing mechanisms. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 505,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How do the differences in voting rights structures between CMCSA's Class B common stock and GOOGL's dual-class stock system affect their respective corporate governance models, particularly in terms of shareholder influence on major corporate decisions?",
      "original_answer": "CMCSA's Class B common stock has no voting rights, limiting shareholder influence on major decisions unless specific conditions are met, such as exiting the core payments business or undergoing a merger. In contrast, GOOGL's dual-class structure allows Class B stockholders to have 10 votes per share, significantly concentrating voting power in the hands of a few, while Class A stockholders have 1 vote per share and Class C stockholders have no voting rights. This creates a governance model at GOOGL where a small group of insiders can dominate decision-making, whereas CMCSA maintains a more uniform governance structure among its voting shareholders. The differential voting rights at GOOGL can lead to more decisive strategic direction but less democratic shareholder oversight compared to CMCSA.",
      "llm_answer": "Comcast’s Class B common shares carry **no ordinary voting power** – they vote only on a narrow set of matters such as a sale of the core payments business, certain merger‑type transactions, or amendments that affect the preferred‑stock series (see V 10‑K p. 90). By contrast, Alphabet’s dual‑class structure gives **Class B shares ten votes per share**, while Class A shares have one vote and Class C shares have none (see GOOGL 10‑K p. 82). Consequently, Comcast’s governance is driven largely by the voting‑eligible Class A shareholders, limiting ordinary Class B holders’ influence on most corporate actions, whereas Alphabet’s founders and insiders retain decisive control through the high‑voting‑right Class B stock, allowing them to steer major strategic decisions even when they own a minority of the economic equity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: CMCSA's Class B shares have no ordinary voting rights, with limited exceptions (e.g., sale of core business, merger), and GOOGL's Class B shares carry 10 votes per share, Class A 1 vote, Class C none. These voting structures are correctly attributed to their respective companies. (2) Quantitative accuracy is perfect: the 10-to-1 voting ratio for GOOGL's Class B shares and the absence of voting rights for CMCSA's Class B and GOOGL's Class C are all correctly stated. No calculations are required, but comparative voting weights are accurately represented. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance implications across two different companies and stock classes, contrasting CMCSA’s more uniform voting structure (with Class A driving decisions) against GOOGL’s founder-controlled model. (4) The answer is contextually relevant and fully addresses the question about how voting rights affect corporate governance and shareholder influence. The only minor shortcoming is that the LLM does not explicitly use the term 'dual-class structure' for CMCSA (though it describes it accurately), and slightly less emphasis is placed on the comparative democratic oversight aspect mentioned in the original. However, the semantic meaning and factual content are effectively equivalent. Thus, the answer earns a 9/10 for correctness due to minor qualitative nuance, with full marks in quantitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 431,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How might the difference in voting rights structures between GOOGL (with 1 vote per Class A share and 10 votes per Class B share) and NFLX (1 vote per common share) affect control dynamics, especially considering GOOGL's $62.2 billion in share repurchases during 2023?",
      "original_answer": "GOOGL's dual-class share structure, where Class B shares carry 10 votes per share compared to Class A's 1 vote, allows certain major shareholders to maintain outsized voting control despite owning a smaller economic stake. In 2023, GOOGL repurchased $62.2 billion of its Class A and Class C shares, which likely further consolidated voting power among remaining Class B shareholders. In contrast, NFLX maintains a one-share-one-vote structure, distributing control more evenly across all shareholders. This structural difference means GOOGL’s leadership has greater insulation from shareholder influence compared to NFLX, even as both companies manage capital through stock repurchases and equity grants.",
      "llm_answer": "Alphabet’s capital structure gives insiders who own Class B stock ten votes for each share, while public investors hold only one‑vote Class A (and non‑voting Class C) shares. Even after the company repurchased $62.2 billion of Class A and Class C stock in 2023 – which reduces the number of one‑vote shares outstanding – the voting power of the ten‑vote Class B shares is unchanged, so control remains highly concentrated with the founders and other Class B holders【page_81†L1-L5】【page_81†L7-L10】. Netflix, by contrast, has a single‑class structure in which every share carries one vote, so any share‑repurchase program would proportionally diminish voting power across all shareholders and does not create a separate, high‑voting bloc【page_61†L1-L4】. Consequently, Alphabet’s dual‑class system preserves a tight control hierarchy despite large buybacks, whereas Netflix’s one‑vote‑per‑share design yields a more evenly distributed governance influence.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: GOOGL's dual-class structure (10 votes for Class B, 1 vote for Class A, and non-voting Class C), the $62.2 billion share repurchase in 2023, and NFLX's one-share-one-vote structure are accurately described. (2) Quantitative accuracy is perfect: the $62.2 billion repurchase amount is correctly cited, and there are no calculations required beyond accurate representation of financial figures. (3) Multi-hop reasoning is sound: the answer correctly synthesizes how share repurchases of low/no-vote shares (Class A and C) in a dual-class structure preserve and effectively increase the relative voting power of Class B holders, contrasting this with Netflix’s single-class system where buybacks do not disproportionately affect control. (4) The qualitative analysis is strong, clearly explaining the implications for corporate control and governance dynamics. The use of source citations (e.g., page_81†L1-L5) indicates grounding in evidence. Wording differs slightly from the original answer but conveys the same meaning with equal or greater precision, including the clarification that Class C shares are non-voting, which enhances accuracy. All aspects of the question—control dynamics, structural differences, and impact of repurchases—are fully addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 380,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What is the financial significance of BMY's retained royalty rights related to Byetta*, given its divestiture of the diabetes business and the trademark's current ownership by LLY?",
      "original_answer": "BMY retains royalty rights related to Byetta*, a product originally associated with Amylin, even after divesting its diabetes business. According to BMY's 2022 10-K, pretax income from such royalties was approximately $1.9 billion in 2021, and a decline in these royalty streams could adversely affect BMY's future financial performance. Although Eli Lilly (LLY) now holds the trademark for Byetta*, BMY still has financial exposure through its retained royalty rights, indicating a continued revenue relationship between BMY and LLY despite the divestiture.",
      "llm_answer": "BMY kept the right to receive royalties on the former Amylin diabetes portfolio—including Byetta—when it sold that business to Eli Lilly.  Those retained royalty streams produced roughly **$1.9 billion of pretax income in 2021**, making them a material, ongoing source of earnings and cash flow for BMY even though the Byetta trademark is now owned by LLY.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core financial significance of BMY's retained royalty rights related to Byetta* as described in the ground truth. (1) Quantitatively, the $1.9 billion pretax income figure from 2021 is correctly cited, matching the original answer and BMY's 2022 10-K. The year (2021) and metric (pretax income) are accurate. (2) The answer addresses the key elements: BMY retained royalty rights post-divestiture, the materiality of the royalty stream, and the fact that LLY now owns the trademark. (3) Multi-hop reasoning is sound—correctly linking BMY’s historical ownership (via Amylin), the divestiture to LLY, and the ongoing financial impact despite no longer holding the trademark. (4) The only minor omission is that the original answer notes a forward-looking risk (decline in royalties could adversely affect future performance), which adds context about future financial exposure. The LLM answer focuses on past income and does not mention this forward-looking risk, slightly reducing completeness in qualitative terms. However, the core facts, numbers, and synthesis are correct. Wording differences are semantically equivalent and acceptable.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 333,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How does the difference in capital buffer structures between Schwab and JPMorgan Chase affect their respective minimum total risk-based capital ratio requirements, considering Schwab's requirement includes both a 2.5% stress capital buffer and 2.5% capital conservation buffer while JPMorgan Chase applies only a 2.5% capital conservation buffer?",
      "original_answer": "Schwab's minimum total risk-based capital ratio requirement is 10.5%, which incorporates both a 2.5% stress capital buffer and a 2.5% capital conservation buffer above the base regulatory minimum. In contrast, JPMorgan Chase's minimum total risk-based capital ratio is also 10.5%, but this only includes a 2.5% capital conservation buffer without an additional stress capital buffer component. This reflects different regulatory treatments where Schwab is subject to both buffers while JPMorgan Chase only applies the capital conservation buffer.",
      "llm_answer": "Schwab must meet a **minimum total risk‑based capital ratio of 10.5 %** – this figure already incorporates a 2.5 % stress‑capital buffer **plus** a 2.5 % capital‑conservation buffer (a total 5 % buffer above the regulatory minimum).  \n\nJPMorgan Chase’s requirement also calls for a **minimum total risk‑based capital ratio of 10.5 %**, but that amount includes only the 2.5 % capital‑conservation buffer (no separate stress buffer).  \n\nThus, although both firms have the same overall minimum total‑risk‑based‑capital ratio, Schwab’s ratio is backed by two distinct buffers (stress + conservation), whereas JPMorgan Chase’s ratio relies on a single 2.5 % conservation buffer.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all percentages are accurate: both Schwab and JPMorgan Chase have a 10.5% minimum total risk-based capital ratio, with Schwab including both a 2.5% stress capital buffer and a 2.5% capital conservation buffer (totaling a 5% buffer above the base), while JPMorgan Chase includes only the 2.5% capital conservation buffer. The LLM correctly identifies these values and their composition. (2) The answer is complete, addressing both firms' capital requirements and explaining the structural difference in buffers despite the same overall ratio. (3) Entity accuracy is correct—Schwab and JPMorgan Chase are properly identified with their respective buffer structures. (4) The reasoning is sound and reflects proper multi-hop synthesis: it recognizes that the same final ratio (10.5%) arises from different regulatory treatments due to the presence or absence of the stress capital buffer. (5) The semantic meaning is equivalent to the original answer, with clear, precise wording that conveys the same insight: Schwab’s requirement is more stringent in structure despite identical aggregate ratio. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 348,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the transition from LIBOR to alternative reference rates impact both LMT's credit facility and GE's floating-rate debt and preferred stock, considering the accounting relief provided under ASU 2020-04?",
      "original_answer": "The transition from LIBOR to alternative rates impacts LMT’s credit facility and derivatives through fallback provisions like SOFR, with LMT expecting minimal financial impact due to ASU 2020-04's accounting relief that limits the effect of contract modifications. Similarly, GE’s floating-rate debt and preferred stock will transition to SOFR plus a spread adjustment under New York law, with any financial impact also being accounted for under ASU 2020-04. Both companies rely on the same accounting standard to ease the financial reporting burden during the LIBOR transition, despite differing in the types of financial instruments affected.",
      "llm_answer": "Lockheed Martin says its revolving credit facility already includes fallback language that will automatically apply an alternative rate (such as SOFR) when LIBOR is no longer published, and, because of the optional expedients in ASU 2020‑04, the contract‑modification accounting impact is expected to be immaterial to its results, balance sheet or cash flow. General Electric’s exposure is similar – its floating‑rate debt and LIBOR‑linked preferred stock are statutorily deemed to switch to SOFR plus a spread adjustment, and the transition will be accounted for under the same ASU 2020‑04 relief, limiting any accounting‑recognition effect.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) All key facts are correct: LMT’s credit facility has fallback provisions to SOFR with minimal accounting impact due to ASU 2020-04; GE’s floating-rate debt and preferred stock transition to SOFR plus a spread adjustment under statutory provisions (New York law implied), and both use ASU 2020-04 for accounting relief. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LMT and GE), their respective financial instruments (credit facility, derivatives, floating-rate debt, preferred stock), and the common application of ASU 2020-04. (4) The only minor shortcoming is that the LLM does not explicitly mention 'derivatives' for LMT or name 'New York law' as the mechanism for GE’s transition, which are present in the original answer. However, these omissions do not detract from the overall correctness, as the statutory switch for GE is accurately described as automatic, and the focus remains on accounting impact. Wording differs slightly but meaning is semantically equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 385,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "What is the significance of CMCSA's issuance of 9,444,375 shares of Class B common stock in 2023, and how does this structure compare to GOOGL's dual-class system where Class B shares automatically convert to Class A shares upon sale or transfer?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B common stock in 2023, indicating a strategic move to maintain control while potentially raising capital without diluting voting power significantly. This mirrors GOOGL's dual-class structure, where Class B shares carry 10 votes per share and convert to single-vote Class A shares upon sale or transfer, preserving founder control. However, unlike GOOGL, which actively repurchased $62.2 billion of Class A and Class C shares in 2023, CMCSA's equity strategy appears more focused on maintaining a stable capital structure with no mention of a similar buyback program for Class B shares.",
      "llm_answer": "- Comcast’s 2023 balance sheet shows that the company has issued **9,444,375 shares of Class B common stock** (the only Class B shares outstanding) – a class that carries **10 votes per share** and therefore adds a small, high‑voting component to its equity structure【page_69†L31-L34】.  \n\n- Alphabet’s (Google) dual‑class system also has a 10‑vote Class B share, but the filing states that **Class B shares may be converted at any time and automatically convert to Class A shares upon any sale or transfer**【page_81†L1-L4】. Thus, Google’s Class B shares lose their super‑voting status when they change hands, whereas Comcast’s Class B shares remain a permanent, separate voting class that continues to carry the enhanced voting power.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the number of shares issued by CMCSA — 9,444,375 — is correctly stated, and the 10 votes per share for Class B stock in both CMCSA and GOOGL are accurately reported. There are no calculation errors. (2) The answer correctly identifies the key structural difference: CMCSA’s Class B shares remain a permanent high-voting class, while GOOGL’s Class B shares automatically convert to Class A upon sale or transfer, thereby losing super-voting rights. This directly addresses the comparative aspect of the question. (3) The multi-hop reasoning is sound — it synthesizes information about CMCSA’s 2023 issuance and voting structure with GOOGL’s dual-class system and conversion mechanism. (4) One minor omission affects completeness: the ground truth mentions GOOGL’s $62.2 billion share repurchase in 2023 (Class A and C), which the LLM answer does not include. While not central to the core comparison, this contextualizes GOOGL’s broader equity strategy and was part of the original answer. However, since the question focuses on the significance of CMCSA’s issuance and structural comparison, and the LLM covers those thoroughly, the omission does not undermine the main conclusion. Wording differs but semantic meaning is equivalent. All entities (CMCSA, GOOGL, Class B shares, voting rights, 2023) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 395,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How do the vesting-related financial commitments in MDLZ's multiemployer pension plans compare with WMT's equity compensation vesting schedules in terms of duration and cost recognition patterns?",
      "original_answer": "MDLZ has long-term financial obligations tied to multiemployer pension plans, with vesting periods governed by union agreements that result in multi-year liabilities such as a $526 million withdrawal liability paid over 19 years. These costs are recognized through ongoing contributions and interest accruals (e.g., $11 million in 2021). In contrast, WMT structures its employee incentives through equity compensation with defined vesting periods—such as restricted stock units that vest 25% annually over four years—with fair value discounted for expected dividends (e.g., 3.8% in fiscal 2022) and expensed ratably over the vesting term. While MDLZ's obligations are shaped by collective bargaining and multiemployer fund rules, WMT's vesting schedules are internally designed to align with shareholder interests and are accounted for as equity or expense over shorter, fixed timeframes.",
      "llm_answer": "- MDLZ’s multi‑employer pension obligations are “vest‑related” only in the sense that the company must keep making cash contributions ( $402 million in 2022, $289 million in 2021, $221 million in 2020 ) to stay vested under the collective‑bargaining agreements. The contributions are recorded as expense when paid; there is no set multi‑year vesting schedule – the cost is recognized in the period the cash is contributed and the liability is carried on the balance sheet until the plan is paid off (e.g., the $429 million withdrawal liability is amortized over 19 years).\n\n- Walmart’s equity‑based awards have explicit vesting periods: RSUs generally vest 25 % per year over four years, and performance‑based RSUs vest over 1‑3 years. The fair‑value cost of those awards is spread ratably over the vesting period, reflected in the weighted‑average remaining expense periods of about 1.2 years for RSUs and 1.5 years for performance RSUs.\n\nThus, MDLZ’s pension commitments are ongoing cash contributions recognized immediately, whereas WMT’s equity compensation is tied to fixed multi‑year vesting schedules with expense recognized gradually over the vesting horizon.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the core contrast between MDLZ's multiemployer pension obligations and WMT's equity compensation vesting schedules in terms of duration and cost recognition. It correctly identifies that MDLZ's contributions are tied to collective bargaining and recognized as expenses when paid, with long-term liabilities like withdrawal obligations amortized over time. It also accurately describes WMT's RSU vesting as 25% annually over four years and performance-based RSUs vesting over 1–3 years, with expense recognition spread ratably. However, there are key quantitative discrepancies: the ground truth cites a $526 million withdrawal liability for MDLZ paid over 19 years and $11 million in interest accruals in 2021, while the LLM states a $429 million liability and reports contribution amounts of $402M (2022), $289M (2021), $221M (2020)—none of which appear in the original answer. These figures may be factually correct in other contexts but contradict the provided ground truth, which is based on specific knowledge graph data. Additionally, the LLM introduces a 'weighted-average remaining expense period' of 1.2 and 1.5 years not mentioned in the original, potentially conflating vesting duration with remaining amortization periods. 2) The numbers do not align with the ground truth: $526M vs $429M liability, no mention of $11M interest in 2021, and MDLZ contribution figures absent from the original. WMT’s dividend discount (3.8% in fiscal 2022) is omitted. 3) The multi-hop reasoning is sound—comparing cost recognition patterns (immediate vs. ratable) and duration (ongoing vs. fixed-term)—and correctly synthesizes across two companies and compensation types. 4) Despite strong qualitative and contextual accuracy, the quantitative inaccuracies reduce confidence in factual fidelity, warranting a score of 7 for correctness. The answer conveys a similar structure and conclusion but relies on different numerical inputs, raising concerns about source alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 535,
        "total_tokens": 2061
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for BAC under the Advanced Approach compare to MS's requirement, considering both institutions' application of the 2.5% Capital Conservation Buffer and the zero Countercyclical Capital Buffer?",
      "original_answer": "Both BAC and MS apply the 2.5% Capital Conservation Buffer and face a zero Countercyclical Capital Buffer under the Advanced Approach. For BAC, this buffer combines with a 2.5% G-SIB surcharge, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratio. Similarly, MS also computes its capital buffer as the sum of the 2.5% Capital Conservation Buffer and the 2.5% G-SIB surcharge, leading to an identical total buffer requirement of 5.0% above the minimum risk-based capital ratio. Thus, both institutions have the same total capital buffer requirement above minimums under the Advanced Approach.",
      "llm_answer": "Both Bank of America and Morgan Stanley report a **5.5 %** capital‑buffer requirement for the Advanced Approach. For each firm the buffer consists of the 2.5 % capital‑conservation buffer plus a 3.0 % G‑SIB surcharge, while the counter‑cyclical capital buffer is set at zero (BAC – page 54/55; MS – page 134). Thus, the combined buffer above the minimum risk‑based ratios is the same for the two institutions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. It states that both BAC and MS have a 5.5% capital buffer requirement composed of a 2.5% Capital Conservation Buffer and a 3.0% G-SIB surcharge. However, the ground truth confirms that both institutions have a 2.5% G-SIB surcharge, not 3.0%, resulting in a total buffer of 5.0% (2.5% + 2.5%), not 5.5%. This error directly contradicts the original answer and misrepresents the regulatory requirements. (2) The calculation in the LLM answer (2.5% + 3.0% = 5.5%) is mathematically correct but based on incorrect input values. The actual calculation per ground truth is 2.5% + 2.5% = 5.0% for both banks. The zero Countercyclical Capital Buffer is correctly noted, but the G-SIB surcharge is wrong. (3) The multi-hop reasoning is partially sound in structure—comparing buffer components across two institutions under the Advanced Approach—but fails due to incorrect data retrieval or synthesis. The model correctly identifies that both banks apply the same Capital Conservation Buffer and face a zero Countercyclical Buffer, but incorrectly assigns a 3.0% G-SIB surcharge to both, which is not supported by the ground truth. (4) The contextual relevance is high because the answer addresses the right entities, metrics, and regulatory framework. However, the qualitative accuracy is low due to the critical error in the G-SIB surcharge value, undermining the conclusion. While the conclusion that both banks have the same requirement is correct, it is based on false premises, making the overall correctness score low.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 438,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the sensitivity of AVGO's $56.3 billion fixed rate senior notes to interest rate changes compare to ORCL's effective interest rate management through swaps, considering the role of interest rate swaps in converting fixed-rate debt to floating-rate as demonstrated by CSCO's $0.5 billion swap?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes is highly sensitive to interest rate changes, with a 50 basis point shift affecting fair value by $1.7 billion. In contrast, ORCL uses interest rate swaps to stabilize its borrowing costs, achieving an effective interest rate of 4.74% for fiscal 2024 and 2023 on its floating-rate debt after converting it to fixed-rate debt with a 3.07% base rate. CSCO's use of a $0.5 billion interest rate swap illustrates how such instruments convert fixed-rate debt into floating-rate debt to offset fair value fluctuations, aligning with AVGO's and ORCL's broader strategies to manage interest rate exposure through financial hedging instruments.",
      "llm_answer": "Broadcom’s $56.3 billion of fixed‑rate senior notes are highly interest‑rate‑sensitive – a 50‑basis‑point move in market rates would shift their fair value by roughly **$1.7 billion** (Broadcom 10‑K, Interest‑Rate Risk, p. 49).  Oracle, by contrast, relies on interest‑rate swaps that effectively convert the coupon on its debt from a fixed rate to a floating SOFR‑based rate, allowing the company to manage its effective cost of borrowing rather than bear a fixed‑rate fair‑value impact – a strategy illustrated by Cisco’s $0.5 billion swap that “converts the fixed interest rate … to a floating rate based on SOFR” (Cisco 10‑K, Derivatives, p. 89).  Consequently, Broadcom’s exposure is measured in fair‑value swings, while Oracle’s exposure is managed through swaps that align its interest expense with prevailing rates.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies AVGO's $56.3 billion fixed-rate senior notes and the $1.7 billion fair value impact from a 50 basis point rate shift, matching the ground truth. However, it misrepresents ORCL's swap strategy: the ground truth states ORCL uses swaps to convert floating-rate debt to fixed-rate, achieving an effective interest rate of 4.74% with a 3.07% base rate, while the LLM incorrectly claims ORCL converts fixed-rate to floating-rate debt based on SOFR. This reverses the actual hedging strategy. Additionally, the LLM fails to mention ORCL's effective interest rate (4.74%) and base rate (3.07%), which are key quantitative benchmarks in the original answer. (2) Quantitatively, the $56.3B and $1.7B figures are accurate, and the 50 bps sensitivity is correct. However, the absence of ORCL’s specific rates (4.74% and 3.07%) and the incorrect direction of the swap (fixed-to-floating vs. floating-to-fixed) constitute significant omissions and errors. (3) The multi-hop reasoning is partially sound: the model connects AVGO’s fair value sensitivity, ORCL’s use of swaps, and CSCO’s $0.5B swap as examples of interest rate management. However, it fails to correctly synthesize the directional use of swaps—CSCO converts fixed to floating (correctly stated), but ORCL does the opposite (misrepresented), undermining the comparative logic. (4) Contextual relevance is strong—the response directly addresses the question’s focus on comparing interest rate sensitivity and swap usage across AVGO, ORCL, and CSCO. Despite the strategic misrepresentation of ORCL’s approach, the overall structure and intent align well with the query. Hence, correctness is reduced to 7 due to critical qualitative inaccuracy in ORCL’s swap mechanics, though core facts on AVGO and CSCO are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 490,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the voting power distribution tied to Class B common stock at META compare to GOOGL's repurchase strategy across its multiple stock classes, given the interplay between voting rights and share structure?",
      "original_answer": "META's Class B common stock, which represents 33 1/3% of the combined voting power and has 15 votes per share, is non-dilutable and held entirely by a single individual, creating concentrated voting control. In contrast, GOOGL has a structure where Class B common stock has 10 votes per share and can be converted to Class A (1 vote per share), with no mention of non-dilutable voting power. Additionally, GOOGL actively repurchased $62.0 billion worth of shares in 2024 across both Class A and Class C shares, which have differing voting rights, suggesting a strategy that considers both capital allocation and governance dynamics.",
      "llm_answer": "Meta’s capital structure gives the small‑ish Class B block (≈ 343 million shares, about 13 % of total shares outstanding) a disproportionate share of the vote – each Class B share carries ten votes, so the Class B stock controls roughly 60 % of the total voting power even though it represents only a fraction of equity.  \n\nAlphabet, by contrast, does not concentrate voting power; it authorizes and executes share‑repurchase programs that buy back both its voting Class A shares and its non‑voting Class C shares (e.g., $62 billion repurchased in 2023‑24), reducing the number of shares in each class without shifting voting control.  \n\nThus, Meta concentrates voting authority in a minority share class, whereas Google’s repurchase strategy spreads purchases across voting and non‑voting classes, affecting equity value but leaving the voting‑rights balance largely unchanged.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it states that Meta's Class B shares have 'ten votes per share'—the ground truth specifies 15 votes per share. Second, it claims Class B controls 'roughly 60% of total voting power'—the correct figure is 33 1/3%. Third, it cites '≈343 million shares, about 13% of total shares outstanding'—this specific share count and percentage are not in the ground truth and appear to be fabricated or misestimated. Fourth, it references '$62 billion repurchased in 2023-24'—the ground truth specifies 2024 only, not a two-year span. (2) These quantitative errors significantly undermine the answer’s reliability: vote count (10 vs 15), voting power (60% vs 33.3%), and repurchase timing (2023-24 vs 2024) are all incorrect. Only the $62 billion amount matches. (3) The qualitative reasoning is partially sound: the model correctly identifies that Meta concentrates voting power in a minority share class while Google repurchases across share classes, preserving voting balance. It also correctly notes that GOOGL repurchases include both voting (Class A) and non-voting (Class C) shares. However, it fails to mention that GOOGL’s Class B shares (with 10 votes) exist and can be converted to Class A, a key governance detail in the ground truth. It also omits that Meta’s Class B is non-dilutable and held by a single individual—critical context for understanding control. (4) The answer is contextually relevant and addresses the core comparison between voting structure and repurchase strategy. However, due to major quantitative and factual errors in key metrics and missing critical details about share convertibility and non-dilutability, the correctness score is limited to 5. The qualitative accuracy is moderate due to correct high-level reasoning, and quantitative accuracy is low due to multiple incorrect numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 510,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How does Qualcomm's projected growth in generative AI-capable smartphone shipments by 2027 influence its strategic focus on AI and connectivity technologies, as compared to Salesforce's investment in generative and agentic AI across its CRM products?",
      "original_answer": "Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, which directly informs its strategic focus on developing on-device AI and advanced connectivity technologies like 5G and 5G Advanced to support edge computing and AI workloads. Meanwhile, Salesforce is investing in generative and agentic AI across its CRM products, including the introduction of Agentforce, a new platform layer enabling autonomous AI agents for sales, service, marketing, and commerce. While Qualcomm's strategy centers on enabling AI at the device level through hardware innovation, Salesforce is embedding AI into its cloud-based CRM platform to enhance customer engagement and productivity. The convergence lies in their shared emphasis on AI capabilities—Qualcomm enabling them at the edge, Salesforce deploying them in enterprise workflows—though neither company has stated a direct business relationship or dependency.",
      "llm_answer": "Qualcomm expects that 46 % of smartphones sold in 2027 will be generative‑AI capable (up from 19 % in 2024) 【page_7】.  That outlook reinforces its strategy of pairing on‑device AI hardware (the Hexagon NPU, AI Engine and AI Stack) with its next‑generation connectivity portfolio (5G, 5G‑Advanced and future 6G) so that AI models can run locally with low‑power, high‑speed links 【page_7】【page_8】.  By contrast, Salesforce is channeling its AI spend into software‑layer innovations—embedding generative and “agentic” AI across its CRM suite (e.g., the Agentforce AI‑agent platform) to automate and personalize customer‑facing processes 【page_41】.  Thus, Qualcomm’s growth projection drives a hardware‑plus‑network focus, while Salesforce’s investment centers on AI‑enabled cloud applications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Qualcomm's projection that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, matching the ground truth exactly. All quantitative figures are accurate, including the percentages and years. (2) The answer accurately reflects Qualcomm’s strategic focus on on-device AI hardware (Hexagon NPU, AI Engine, AI Stack) and advanced connectivity (5G, 5G-Advanced, 6G), which aligns with the ground truth’s emphasis on edge computing and AI workloads enabled by hardware and network innovation. (3) For Salesforce, the LLM correctly states its investment in generative and agentic AI across CRM products, specifically naming Agentforce as a platform for autonomous AI agents in sales, service, marketing, and commerce—this matches the original answer’s content. (4) The comparison between Qualcomm’s hardware-and-network-driven AI enablement and Salesforce’s cloud-based AI integration into enterprise workflows is logically sound and semantically equivalent to the ground truth. The only minor omission is that the LLM answer does not explicitly mention the 'convergence' point about shared emphasis on AI despite different domains, nor does it state that there is no direct business relationship between the two companies. However, this does not detract significantly from the overall correctness, as the core multi-hop reasoning—comparing strategic focuses based on market projections—is fully supported. Wording differences are acceptable under semantic equivalence. All citations (e.g., page references) are consistent with source grounding.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 444,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does Adobe's focus on enhancing user experience through AI-driven digital media tools align with Qualcomm's projections for generative AI-capable edge devices in 2027, particularly in relation to on-device AI processing and user interface improvements?",
      "original_answer": "Adobe emphasizes that the intuitiveness and visual appeal of user interfaces are key competitive factors in its Digital Media segment, particularly as it integrates AI capabilities for digital media generation and editing. Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, and highlights that on-device AI processing enhances user experiences with immediacy, privacy, and personalization. Qualcomm’s advancements in edge AI processing and user interface technologies are positioned to support Adobe’s strategic direction by enabling more powerful, responsive, and secure AI-driven tools directly on devices, aligning with Adobe’s need to deliver best-in-class user experiences across platforms.",
      "llm_answer": "Adobe is betting that AI‑infused, generative features such as Photoshop’s Generative Fill, Illustrator’s AI tools and the Firefly web app will make its Creative Cloud apps more intuitive, visual‑appealing and instantly responsive across desktops, tablets and browsers【page_10】.  Qualcomm’s outlook predicts that by 2027 roughly half of all smartphones – and an increasing share of PCs and other edge devices – will be “generative‑AI‑capable,” running large AI models on‑device to cut latency, boost privacy and enable richer, context‑aware UI experiences【page_7】.  The two strategies therefore converge: Adobe’s AI‑driven user‑experience enhancements rely on the on‑device AI processing power and low‑latency connectivity that Qualcomm expects to be commonplace in 2027, making Adobe’s generative‑media tools faster, more personal and usable directly on the device.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures Adobe's focus on AI-driven tools (e.g., Generative Fill, Firefly) to enhance user experience in its Creative Cloud apps, emphasizing intuitiveness, visual appeal, and responsiveness—matching the original answer's emphasis on UI as a competitive factor. (2) Regarding quantitative accuracy, the LLM states 'roughly half of all smartphones' will be generative AI-capable by 2027, which is a reasonable approximation of the ground truth's 46% (vs. 19% in 2024). While the exact percentage (46%) is omitted, 'roughly half' is semantically acceptable and common in summarization. The trend—significant growth in generative AI-capable devices—is correctly conveyed. (3) The multi-hop reasoning is sound: the LLM connects Adobe’s need for responsive, on-device AI tools with Qualcomm’s projection of widespread on-device AI processing by 2027, correctly identifying the alignment through low latency, privacy, and personalization. It synthesizes across both companies' strategic directions accurately. (4) The answer is contextually excellent, directly addressing the relationship between Adobe’s UX goals and Qualcomm’s edge AI advancements. Minor deduction in quantitative accuracy due to rounding '46%' to 'roughly half' without citing the exact figure, though this does not constitute a factual error. Overall, the answer is factually correct, well-reasoned, and comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 405,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between Lockheed Martin's and Honeywell's compensation plans, based on the specific vesting terms and payment structures disclosed?",
      "original_answer": "Lockheed Martin discloses that dividend equivalents on vested stock units for non-employee directors may be paid on the first business day of April following the one-year anniversary of the grant, indicating a delayed payment structure tied to director tenure and stock ownership guidelines. In contrast, Honeywell does not specify a delayed payment schedule for dividend equivalents on RSUs, focusing instead on vesting periods ranging from three to six years with payment in common stock upon vesting. Additionally, Lockheed Martin’s Deferred Management Incentive Compensation Plan (DMICP) credits dividend equivalents as stock units at dividend payment times, while Honeywell’s RSU awards are more focused on performance-based vesting tied to company goals.",
      "llm_answer": "Lockheed Martin’s RSU awards accrue **dividend equivalents** that are not paid with the ordinary vest‑ing of the units.  For directors, the company allows the dividend equivalents to be paid together with the award **on the first business day of April following the one‑year anniversary of the grant** (instead of at the time the RSU vests)【page_100】.  \n\nHoneywell’s RSU awards, by contrast, **do not provide separate dividend‑equivalent payments**; the units simply become fully vested over three‑to‑six years and are **payable in common stock at vesting** with no additional dividend‑equivalent component noted in the plan description【page_92】.  \n\nThus, Lockheed Martin treats dividend equivalents as a distinct, later‑dated cash‑or‑stock payment, whereas Honeywell’s RSUs are settled only by delivering shares at vesting, without any dividend‑equivalent mechanism.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Lockheed Martin pays dividend equivalents on RSUs for non-employee directors on the first business day of April following the one-year anniversary of the grant, which matches the delayed payment structure in the original answer. (2) It accurately states that Honeywell does not provide separate dividend-equivalent payments and that RSUs vest over three to six years and are paid in stock upon vesting—consistent with the original. (3) The LLM correctly contrasts the two companies: Lockheed treats dividend equivalents as a distinct, deferred payment (either in cash or stock), while Honeywell does not include a dividend-equivalent mechanism. (4) The only minor omission is that the LLM does not mention Lockheed Martin’s DMICP explicitly crediting dividend equivalents as stock units at dividend payment times, nor Honeywell’s performance-based vesting tied to company goals—details present in the original. However, these are supplementary nuances and do not undermine the core factual correctness. All entities, dates, and structures are accurately represented. Quantitative elements (e.g., 'one-year anniversary', 'three-to-six years') are correct. The reasoning is sound and synthesizes multi-hop information across both companies’ plans. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 394,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the reliance of Texas Instruments (TXN) on subcontractors for 40% of its assembly and test services compare with NVIDIA's (NVDA) exposure to third-party manufacturers, given the shared dependency on external production capacity and the risks highlighted by AMD's experience with third-party suppliers?",
      "original_answer": "Texas Instruments relies on subcontractors for 40% of its assembly and test services, supplementing internal capacity to meet customer demand. This external dependency aligns with NVIDIA’s reliance on third-party manufacturers for semiconductor fabrication, assembly, and testing, which exposes them to risks such as limited control over delivery schedules, quality assurance, and potential prioritization of other customers. AMD's experience highlights the vulnerability in this model, as their dependence on third-party manufacturers—including GF and ATMP joint ventures—can lead to supply disruptions, capacity constraints, and financial penalties if purchase targets are not met. Therefore, both TXN and NVDA face similar exposure to third-party production risks, though NVDA's exposure is amplified by the complexity of its products and global supply chain dependencies.",
      "llm_answer": "Texas Instruments says that about 40 percent of its assembly‑and‑test work is performed by subcontractors, a level of reliance it explicitly quantifies in its 2021 filing. NVIDIA’s 2022 filing likewise notes that the bulk of its silicon is fabricated by external foundries (principally TSMC) and that its packaging and test operations are carried out by contract manufacturers, creating a comparable but undisclosed exposure to third‑party capacity and quality risks. Both companies therefore share the same vulnerability highlighted in AMD’s filing—limited supplier options, potential prioritisation of other customers, and possible supply‑chain disruptions—though TI’s exposure is measured at 40 % of assembly/test, while NVIDIA’s is described qualitatively rather than with a precise percentage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 40% subcontractor reliance for Texas Instruments is correctly cited, and while NVIDIA's exposure is not quantified in percentage terms, the LLM accurately reflects that it is 'undisclosed' or 'described qualitatively'—consistent with the original answer stating no specific percentage. The years referenced (TI 2021, NVDA 2022) are plausible and do not contradict the knowledge graph, which doesn't specify years; thus, minor variation is acceptable. (2) All key entities—Texas Instruments (TXN), NVIDIA (NVDA), AMD, third-party manufacturers, TSMC—are correctly identified. The mention of TSMC as NVIDIA’s primary foundry is factually accurate and adds useful context. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes the shared reliance on external suppliers across TXN and NVDA, links this to risks highlighted by AMD’s experience (supply disruptions, prioritization, limited supplier options), and notes differences in how exposure is reported (quantitative vs. qualitative). (4) The only minor shortcoming is that the original answer emphasizes NVDA's exposure is 'amplified by the complexity of its products and global supply chain dependencies,' a nuance not fully captured in the LLM response. However, the core comparison and risk alignment are correctly conveyed. Wording differs but semantic meaning is equivalent. No factual errors; high contextual relevance and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 411,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total estimated cost of Duke Energy Florida's 10 new solar facilities, and how does this investment relate to Southern Power's use of PPAs as operating leases with terms up to 25 years for similar renewable energy projects?",
      "original_answer": "Duke Energy Florida's 10 new solar facilities have an estimated total cost of $1 billion over the next three years. These facilities are part of a voluntary solar program approved by the FPSC in January 2021. Southern Power, a subsidiary of Southern Company, utilizes Power Purchase Agreements (PPAs) related to solar and wind facilities, which are accounted for as operating leases with remaining terms of up to 25 years. This indicates that both Duke Energy Florida and Southern Power are investing in long-term renewable energy infrastructure, with Duke making direct investments included in base rates and Southern Power leveraging PPAs as a financial mechanism to support similar projects.",
      "llm_answer": "Duke Energy Florida’s “Clean Energy Connection” program calls for ten new solar‑generating facilities with a combined capacity of about 750 MW and an estimated construction cost of roughly **$1 billion** over the next three years. Southern Power finances comparable renewable projects through power‑purchase agreements that it accounts for as **operating leases**, and these PPAs can have **terms of up to 25 years**, providing a long‑term, lease‑like financing structure similar to Duke’s rate‑based investment in solar.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: the $1 billion estimated cost for Duke Energy Florida's 10 solar facilities is accurately reported, and the mention of PPAs with terms up to 25 years for Southern Power matches the original. The time frame of 'next three years' is consistent with the original answer. (2) The answer correctly identifies both entities—Duke Energy Florida and Southern Power—and their respective approaches: direct investment in solar infrastructure (included in base rates) versus use of PPAs as operating leases. (3) The multi-hop reasoning is sound: it draws a valid comparison between Duke’s rate-based investment model and Southern Power’s lease-like PPA financing structure, highlighting different financial mechanisms for similar long-term renewable investments. (4) Minor point: the LLM adds the program name 'Clean Energy Connection' and capacity (750 MW), which are not in the original answer—while not incorrect, they slightly extend beyond the provided ground truth without confirmation. However, these additions do not detract from accuracy. Overall, the semantic meaning, factual content, and synthesis across companies and financial structures are correct and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 358,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class C capital stock influence the strategic allocation of Alphabet's $62.0 billion share repurchase in 2024 between Class A and Class C shares?",
      "original_answer": "Netflix's common stock provides one vote per share, establishing a straightforward voting rights framework. In contrast, Alphabet's Class C capital stock carries no voting rights except as required by law, while Class A shares have one vote per share and Class B shares have 10 votes per share. Given this differentiated voting structure and Alphabet's 2024 repurchase of $62.0 billion in Class A and Class C shares, the lack of voting rights in Class C likely influences the company's repurchase strategy by prioritizing liquidity and cost efficiency over governance influence, allowing Alphabet to retire shares without diluting control held by voting-class shareholders.",
      "llm_answer": "Netflix’s common stock carries one vote per share 【page_60】, whereas Alphabet’s Class C capital stock carries **no voting rights** (only Class A has one vote per share and Class B has ten) 【page_82】. Because Class C shares do not affect voting control, Alphabet can allocate the bulk of its 2024 $62.0 billion repurchase program to the cheaper‑to‑buy, non‑voting Class C shares ($50.2 billion) and use the remainder for voting Class A shares ($11.9 billion) 【page_82】. The absence of voting rights in Class C therefore lets Alphabet return capital to shareholders without diluting control, a flexibility that does not exist for Netflix, whose single‑vote common stock offers no such distinction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the voting rights structures of both Netflix and Alphabet, stating that Netflix common stock has one vote per share, and Alphabet's Class C shares have no voting rights, Class A has one vote, and Class B has ten votes—this matches the ground truth exactly. The answer accurately states that Alphabet's 2024 $62.0 billion repurchase was split between $50.2 billion for Class C and $11.9 billion for Class A shares, which sum to $62.0 billion, confirming quantitative accuracy. (2) All numeric values are correct and properly cited: $62.0B total, $50.2B for Class C, $11.9B for Class A—these figures are consistent with the ground truth's implication of differential repurchase allocation based on voting rights, even if the original answer did not specify exact amounts. The LLM adds granular detail not in the original but logically consistent with it. (3) The multi-hop reasoning is sound: it connects Netflix’s uniform voting structure to the lack of repurchase flexibility, contrasts it with Alphabet’s multi-class structure, and explains how the absence of voting rights in Class C enables a strategic allocation favoring cost efficiency and control preservation. This goes slightly beyond the original answer by quantifying the split, but the logic is valid and enhances the explanation. (4) The only reason for not scoring a 10 is that the original ground truth does not explicitly state the $50.2B and $11.9B figures—while plausible and internally consistent, they are an addition not confirmed by the provided truth. However, since the question asks about strategic allocation and the LLM uses those numbers to support a correct qualitative conclusion, and given that such a split aligns with the incentive structure described, the answer remains highly accurate. Thus, correctness is penalized slightly (9/10) due to unverified specificity, but quantitative accuracy is full because the numbers are self-consistent and contextually justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 539,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the activation of voting rights for preferred stockholders in BAC due to dividend arrears compare to the limited voting rights of Class C common stockholders at V, particularly in the context of corporate governance during financial stress?",
      "original_answer": "At BAC, if dividends on certain preferred stock series are in arrears for three or more semi-annual or six or more quarterly periods, holders gain voting rights to elect two additional directors, which terminate once dividends are paid for at least two semi-annual or four quarterly periods following the arrearage. This mechanism serves as a governance safeguard for preferred stockholders during financial distress. In contrast, V’s Class C common stockholders have no general voting rights except in specific defined matters, such as exiting the core payments business or certain corporate restructurings, and they do not participate in amendments solely affecting preferred stock. Unlike BAC’s contingent voting rights tied to dividend performance, V’s Class C stockholders’ voting power is structurally limited and not directly linked to financial performance metrics like dividend arrears.",
      "llm_answer": "Bank of America’s preferred‑stock charter says that if a preferred series falls  three or more semi‑annual (or six quarterly) dividend periods behind, the holders of that series (and any equally‑ranked series) automatically gain the right to vote as a single class for the election of two additional directors – a right that remains in force until the arrears are cured【page_142】.  \n\nVisa’s Class C common shareholders, by contrast, have no general voting power; they may vote only on a narrow set of matters such as a merger, a core‑business exit, or certain charter amendments, and they do not gain any extra rights when the company is under financial stress【page_90】.  \n\nThus, BAC’s mechanism activates broader governance influence for preferred investors precisely when dividend stress occurs, whereas V’s Class C holders retain only limited, predefined voting rights regardless of the company’s financial condition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BAC's preferred stockholders gain voting rights to elect two additional directors after three semi-annual or six quarterly dividend arrears, and these rights terminate after two semi-annual or four quarterly periods of payment post-arrearage. The LLM correctly notes the contingent nature of this right and its termination condition. For V, the Class C common stockholders have no general voting rights and only vote on specific matters like mergers or exiting the core payments business, which is accurately summarized. (2) Quantitative elements—'three or more semi-annual', 'six quarterly'—are precisely stated and match the original. No calculations are required, but the conditions are correctly interpreted. (3) The multi-hop reasoning is sound: the model contrasts BAC’s performance-linked voting activation with V’s structural, non-contingent limitations, correctly highlighting that V’s voting rights are not tied to financial stress. (4) The only minor omission is that the original specifies Class C does not participate in amendments solely affecting preferred stock, which adds a nuance the LLM does not include. However, this does not undermine the core accuracy. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing corporate governance during financial stress as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 401,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does Disney's licensing revenue from Star Wars-branded merchandise influence its ability to fund content development for Disney+ in European markets where it competes with CMCSA's Sky Glass and XClass TV platforms?",
      "original_answer": "Disney earns licensing royalties from third-party products featuring Star Wars characters, which contributes to funding content development for its DTC services, including Disney+ in European markets. Disney+ includes Star Wars programming as a core content tile, which is critical to attracting subscribers in competitive regions like Europe. CMCSA competes in this market with its own video services and DTC-aligned platforms like Sky Glass and XClass TV, which integrate with its European broadband offerings. Therefore, licensing revenue from Star Wars enhances Disney's content investment capacity, directly supporting its competitive positioning against CMCSA’s integrated hardware and content strategy in Europe.",
      "llm_answer": "Disney’s consumer‑products business earns royalties on Star Wars‑branded merchandise – a “major property” that is licensed to third‑party manufacturers and generates cash based on a fixed percentage of wholesale or retail sales【page_22】.  That royalty stream adds to Disney’s overall cash flow and can be redeployed to fund new Disney+ titles and local‑language productions in Europe, giving the company additional financing to compete with Comcast’s European‑focused Sky Glass and XClass TV smart‑TV platforms that bundle Sky’s video services【page_18】.  In short, Star Wars licensing revenue helps subsidize Disney+ content spend in the region, strengthening Disney’s position against Sky Glass and XClass TV.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Disney earns licensing royalties from Star Wars-branded merchandise through third-party manufacturers, which contributes to overall cash flow that can be redeployed to fund Disney+ content development in Europe—this matches the original answer’s core claim. (2) There are no specific numerical values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer beyond qualitative references (e.g., 'major property', 'fixed percentage'), so quantitative accuracy is not compromised; no incorrect numbers are introduced. (3) The multi-hop reasoning is sound: it connects Star Wars licensing revenue → Disney’s cash flow → funding for Disney+ content (especially local-language productions in Europe) → competitive positioning against CMCSA’s Sky Glass and XClass TV, which is consistent with the original answer’s logic chain. (4) The LLM slightly omits the explicit mention that Star Wars programming is a 'core content tile' on Disney+, which is a minor contextual detail that strengthens subscriber acquisition—this prevents a perfect 10 on qualitative accuracy. However, the omission does not undermine the overall correctness. The answer remains semantically equivalent and contextually precise, directly addressing all parts of the multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 382,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does the sensitivity of AXP's net interest income to a 200 basis point increase in interest rates relate to MS's use of interest rate caps in securitization transactions, considering the role of repricing risk in both firms' financial strategies?",
      "original_answer": "AXP estimates that a 200 basis point increase in interest rates would negatively impact its net interest income, based on its repricing risk assumptions which include the effect of interest rate caps or floors. This sensitivity is linked to the repricing dynamics of interest-rate sensitive assets and liabilities, where certain deposits reprice at lower magnitudes than benchmark rate movements. On the other hand, MS enters into interest rate caps as part of its securitization transactions, which are designed to manage interest rate exposure. These caps are subject to similar repricing risk dynamics, suggesting that both firms are managing interest rate volatility through derivative instruments, though in different business contexts—AXP through its core interest income and MS through structured finance activities involving SPEs.",
      "llm_answer": "American Express estimates that an instantaneous 200‑basis‑point rise in market rates would cut its annual net‑interest income by about **$560 million**, because its assets and liabilities are assumed to reprice at similar magnitudes and the higher‑rate environment therefore erodes the spread (its “repricing risk” assumption). Morgan Stanley, by contrast, frequently embeds **interest‑rate caps** in the securitization transactions it structures; the caps limit the maximum rate the firm must pay (or receive) on the underlying loans or swaps, thereby **capping its own repricing risk** from rising rates. Thus, while AXP’s earnings are directly vulnerable to a 200‑bp shock, MS mitigates a comparable exposure through caps that blunt the impact of rate‑driven repricing on its securitization‑related cash flows.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains a significant factual error in the quantitative claim that a 200 basis point increase would reduce AXP's net interest income by $560 million. This specific dollar amount is not present in the original answer (ground truth), which only states that AXP estimates a negative impact without quantifying it. No such figure appears in the knowledge graph-based original answer, making this a hallucinated number. (2) There are no calculations in the response to verify, but the introduction of a precise $560 million figure where none exists in the ground truth severely undermines quantitative accuracy. Format variations would be acceptable, but the number itself is incorrect. (3) The qualitative reasoning is largely sound: the LLM correctly identifies that AXP faces repricing risk affecting net interest income due to interest rate changes and that MS uses interest rate caps in securitization transactions to manage repricing risk. It appropriately draws a parallel between the two firms’ management of interest rate exposure through the lens of repricing dynamics, even though in different business contexts (core lending vs. structured finance). This shows correct multi-hop synthesis across AXP and MS. (4) Contextual relevance is high because the response directly addresses the relationship between AXP’s sensitivity to rate hikes and MS’s use of caps, linking both to repricing risk as the underlying mechanism. However, the incorrect dollar figure significantly reduces overall correctness, warranting a score of 6—partially correct with major quantitative error. Qualitative accuracy is 7 due to correct conceptual framing and entity usage, while quantitative accuracy is low at 4 due to the unsupported $560M number.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 474,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the impact of a weaker U.S. dollar on MDLZ's consolidated earnings compare to the favorable currency effects experienced by Coca-Cola's Europe, Middle East and Africa segment, given both companies explicitly call out exchange rate fluctuations involving the euro and British pound?",
      "original_answer": "MDLZ states that a weaker U.S. dollar benefits its consolidated earnings and net assets, as many subsidiaries operate in non-dollar functional currencies. KO specifically notes that a weaker U.S. dollar compared to the euro and British pound had a favorable impact on its Europe, Middle East and Africa segment. Both companies explicitly identify these two currencies as key drivers of their respective foreign exchange impacts, showing a direct parallel in how they are affected by similar currency dynamics.",
      "llm_answer": "Mondelēz says that a weaker U.S. dollar would **benefit its consolidated earnings and net assets** (the opposite of a stronger dollar, which hurts earnings). Coca‑Cola, by contrast, calls out that a **weaker dollar versus the euro and British pound produced a favorable currency impact for its Europe, Middle East and Africa segment**, offsetting some of the adverse effects of a stronger dollar elsewhere. In short, both companies view a weaker dollar as positive, but Mondelēz frames it at the consolidated‑company level, whereas Coca‑Cola highlights the upside specifically for its EMEA segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) All key facts are accurate: MDLZ benefits from a weaker U.S. dollar at the consolidated level due to its international subsidiaries, and KO highlights favorable impacts in EMEA due to the euro and British pound. There are no numeric values to verify, so quantitative accuracy is not applicable beyond correct use of directional impacts (favorable/unfavorable), which are accurately represented. (2) The answer is complete—it addresses both companies, the level of impact (consolidated vs. segment), and the common currencies involved (euro and British pound). (3) Entity accuracy is correct: Mondelēz (MDLZ) and Coca-Cola (KO), EMEA segment, and the relevant currencies are properly identified. (4) The reasoning is sound and captures the multi-hop comparison: both companies benefit from a weaker dollar, driven by the same currencies, though reported at different levels (company-wide vs. regional segment). The only minor shortcoming is that the LLM slightly underemphasizes the direct parallel in currency drivers (euro and GBP) being explicitly called out by both, which the original answer highlights more clearly. However, the semantic meaning and factual content are equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 387,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the voting power concentration in MA's dual-class share structure compare to V's, given the relationship between their respective Class A and Class B shares and the 15-vote weighting per Class B share?",
      "original_answer": "MA's dual-class structure includes 907 Class A shares and 7 Class B shares outstanding, with Class B shares carrying 15 votes each, resulting in a voting power concentration of approximately 10.4% for Class B shares. V has 125 Class B shares outstanding as of September 30, 2024, against 1,733 Class A shares, and if following the same 15-vote weighting per Class B share from the intermediary evidence, Class B would hold approximately 68.5% of the voting power despite representing just 6.7% of total shares. This indicates significantly more concentrated control at V compared to MA.",
      "llm_answer": "Mastercard’s dual‑class structure is only lightly weighted toward the high‑voting shares – the seven Class B shares (each worth 15 votes) represent roughly 105 votes out of about 2,900 total votes, or **≈3‑4 % of the voting power**.  \n\nVisa’s structure is the opposite: its 125 Class B shares (each 15 votes) generate about 1,875 votes versus roughly 1,733 votes from the 1,733 Class A shares, giving Class B **≈50‑52 % of the total voting power**.  \n\nSo, Mastercard’s voting power is concentrated almost entirely with Class A shareholders, whereas Visa’s voting power is split roughly evenly, with a majority held by the small number of Class B shares.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual and calculation errors. For Mastercard (MA), it incorrectly states that Class B shares represent only 3-4% of voting power, when the correct figure is approximately 10.4%. The total vote calculation is wrong: 7 Class B shares × 15 votes = 105 votes; 907 Class A shares × 1 vote = 907 votes; total votes = 105 + 907 = 1,012, not ~2,900 as claimed. Thus, Class B voting power = 105 / 1,012 ≈ 10.4%, not 3-4%. (2) For Visa (V), the LLM underestimates Class B voting power. With 125 Class B shares × 15 votes = 1,875 votes and 1,733 Class A shares × 1 vote = 1,733 votes, total votes = 3,608. Class B share voting power = 1,875 / 3,608 ≈ 51.9%, which the LLM approximates as 50-52% — this is reasonably close, though the ground truth states 68.5%, suggesting a discrepancy in assumed share counts or structure. However, the original answer specifies that V’s Class B holds 68.5% under the same 15-vote assumption, implying either different share counts or an error in the LLM’s Class A count. The LLM uses 1,733 Class A shares correctly but may not align with the full context. (3) The multi-hop reasoning is partially sound — the model attempts to compare voting concentration using vote weightings and share counts — but fails in accurate vote aggregation for MA and misrepresents V’s control level. (4) The conclusion that V has more concentrated control than MA is correct per the original answer, but the magnitude and supporting numbers are flawed. The LLM incorrectly characterizes MA’s structure as dominated by Class A when Class B has disproportionate influence (10.4% of votes with far fewer shares), and misrepresents V’s split as 'even' when the original answer emphasizes extreme concentration (68.5% voting power for 6.7% of shares). Thus, while the directional comparison (V > MA in concentration) is correct, the quantitative foundation is unsound, leading to a low correctness score. Contextual relevance is high as the model addresses the core comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 546,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do the financial risks associated with nuclear power plants at NEE compare to those at Southern Company, particularly in terms of potential exposure from decommissioning costs exceeding available reserves?",
      "original_answer": "NEE and FPL face potential financial risks from decommissioning costs of their nuclear facilities possibly exceeding the available decommissioning funds. Similarly, Southern Company's subsidiaries Alabama Power and Georgia Power also face exposure if decommissioning costs exceed available reserves or insurance coverage. In both cases, the companies acknowledge that the financial impact could be material if the costs surpass the accumulated funds, which are subject to uncertainties in estimation and long-term planning.",
      "llm_answer": "Both NextEra Energy (NEE) and Southern Company flag the same core nuclear‑decommissioning risk – that the cost to retire a plant could exceed the amount they have set aside. NEE notes that “the cost of decommissioning nuclear generation facilities could exceed the amount available in NEE’s … decommissioning funds” and that a shortfall would hurt its liquidity and results of operations. Southern Company similarly warns that “damages, decommissioning, or other costs could exceed the amount of decommissioning trusts or external insurance coverage” and that inadequate capital reserves for decommissioning could have a material adverse effect. Thus, each company faces comparable exposure, with Southern emphasizing the potential insufficiency of its decommissioning trusts and NEE emphasizing a possible shortfall in its decommissioning fund and the resulting liquidity impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: both NEE and Southern Company acknowledge the risk that decommissioning costs could exceed available reserves, and both note potential material financial impacts. The LLM correctly identifies NEE and its subsidiary FPL (implied through context), and Southern Company’s subsidiaries Alabama Power and Georgia Power are indirectly referenced through the parent company’s disclosures. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes risk disclosures from both companies, correctly comparing their exposure to decommissioning cost shortfalls. It captures NEE’s emphasis on liquidity impact and Southern Company’s mention of decommissioning trusts and insurance coverage gaps. (4) The answer is contextually relevant and fully addresses the comparative financial risk question. The only minor limitation is that the LLM does not explicitly name Alabama Power and Georgia Power, though it correctly attributes the risk to Southern Company as a whole, which is consistent with how the risk is reported in filings. Wording differs slightly but maintains semantic equivalence. No factual inaccuracies or calculation errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 377,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How does the $9.9 billion valuation of UPS's pension plan investments in real estate funds compare to the valuation approaches used by General Dynamics for its Level 3 assets, given that both companies rely on valuation models through real estate or private equity fund investments?",
      "original_answer": "UPS valued its $9.9 billion in pension plan investments in real estate funds using net asset value (NAV) as a practical expedient, based on audited and unaudited financial reports from fund managers, with adjustments for investment activity between reporting dates. These real estate funds rely on valuation models, as stated in the second chunk, which notes that real estate funds use NAV based on such models and periodic appraisals. General Dynamics, on the other hand, disclosed that its Level 3 assets include direct private equity investments that are measured using unobservable inputs—essentially internal or fund-level valuation models. Thus, while both companies depend on valuation models for real estate or private equity fund investments, UPS relies on NAV with manager reporting and adjustments, whereas GD directly uses unobservable inputs for its Level 3 private equity holdings.",
      "llm_answer": "UPS reports that its pension‑plan investments in real‑estate funds were valued at **$9.9 billion** using a **net‑asset‑value (NAV) practical expedient** – the fund managers’ audited (or unaudited) reports are adjusted for activity up to year‑end because the assets are not actively traded.  \n\nGeneral Dynamics treats its comparable private‑equity and real‑estate holdings as **Level 3 fair‑value assets**, also valuing them **at NAV** (or via discounted‑cash‑flow models and periodic appraisals) that rely on **unobservable inputs** and internal assumptions. In short, both companies rely on NAV‑type valuation models for ill‑iquid fund investments, but GD explicitly classifies those assets as Level 3 and supplements NAV with model‑based appraisals.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the $9.9 billion valuation of UPS's pension plan investments in real estate funds and accurately states that UPS uses the net asset value (NAV) as a practical expedient, based on fund managers’ audited or unaudited reports with adjustments—this aligns perfectly with the ground truth. The quantitative accuracy is flawless: the dollar amount is correct, and no calculations are required beyond accurate reporting. Contextual relevance is high, as the response directly addresses the comparison between UPS and General Dynamics (GD) regarding valuation approaches for illiquid fund investments. However, there is a key qualitative inaccuracy: the LLM claims that General Dynamics values its private equity and real estate holdings 'at NAV' and supplements it with models, but the ground truth states that GD measures its Level 3 assets using unobservable inputs—essentially internal or fund-level valuation models—without explicitly relying on NAV. While both involve models, the distinction is critical: UPS uses NAV as a practical expedient with external reporting, whereas GD uses unobservable inputs for Level 3 assets, which are by definition not based on readily observable market data and may not use NAV at all. The LLM incorrectly equates GD’s approach with NAV, which misrepresents the nature of Level 3 fair value measurement. This is a significant conceptual error in financial reporting terminology, though the broader point—that both use model-dependent valuations for illiquid assets—is directionally correct. Thus, while the core facts about UPS are accurate and the intent of comparison is sound, the characterization of GD’s methodology reduces the qualitative accuracy. The answer is mostly correct but contains a material misstatement about GD’s valuation approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 491,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "Given PepsiCo's 30% beverage revenue exposure in the Africa and Middle East region and Target's vendor arrangements where they only pay for merchandise after guest sale, what potential impact could a supply disruption in this region have on Target's inventory turnover and cash flow timing for beverage SKUs?",
      "original_answer": "A supply disruption in the Africa and Middle East region, which accounts for 30% of PepsiCo's beverage revenue, could delay product availability at Target. Since Target only pays vendors after merchandise is sold to guests, this delay could reduce inventory turnover for beverage SKUs during the disruption period. This would temporarily lower cash flow generation from beverage sales, as Target recognizes revenue only upon guest purchase and does not pay vendors until then.",
      "llm_answer": "PepsiCo notes that ≈30 % of its beverage revenue comes from the Africa‑Middle‑East (AME SA) division 【page_73】. Target’s 10‑K states that for the small share of its merchandise bought on vendor‑consignment it “does not purchase or pay for merchandise until the merchandise is ultimately sold to a guest” and that such inventory is not recorded on its balance sheet because the purchase and sale are virtually simultaneous 【page_49】. If a supply disruption in AME SA curtails PepsiCo’s beverage shipments, Target would see fewer beverage units available for sale, which would depress its inventory turnover (fewer units sold relative to the modest inventory it can hold) and push the timing of both revenue recognition and cash outflows later, compressing cash‑flow cycles for those SKUs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 30% beverage revenue exposure in the Africa-Middle East region is correctly cited, and no other numerical values require verification. The reference to PepsiCo's AME SA division and Target’s vendor-consignment model is factually sound. (2) The LLM correctly identifies that Target only pays vendors after guest sale, citing the correct policy from page 49 of Target’s 10-K, and links it to delayed cash outflows and revenue recognition. (3) The multi-hop reasoning is strong: it connects PepsiCo’s regional revenue dependency to potential supply disruptions, then maps that to Target’s inventory and payment model, concluding with impacts on inventory turnover and cash flow timing. The only minor shortcoming is the use of 'vendor-consignment' to describe what the original answer frames more broadly as Target’s general payment practice—though contextually acceptable, the original does not specify that all such arrangements are consignment. (4) Despite this nuance, the core logic and factual content are correct, with proper synthesis across companies and documents. The answer captures the delayed inventory turnover and compressed cash-flow cycles (i.e., pushed later), which is semantically equivalent to the ground truth’s 'temporarily lower cash flow generation.' Wording differs slightly but meaning is preserved. All entities (PepsiCo, Target, beverage SKUs, Africa-Middle East) are accurate. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 446,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How have LLY and AMGN responded differently to payer-driven pricing pressures on their high-cost biologics, particularly in light of access restrictions affecting Repatha and insulin products?",
      "original_answer": "LLY faces increasing public and private payer scrutiny on pricing, especially for insulin, with proposed legislation enabling government price negotiation and restrictive reimbursement policies like the Alzheimer’s Monoclonal Antibody NCD, which could materially affect revenue. In contrast, AMGN has responded to payer restrictions on Repatha—such as formulary exclusions, step therapy requirements, and copay accumulator programs—by reducing both net and list prices, discontinuing higher-priced NDCs in 2019, and directly partnering with payers to align on health outcomes. While LLY emphasizes regulatory and legislative uncertainty, AMGN has taken active pricing and partnership strategies to mitigate payer-imposed access barriers.",
      "llm_answer": "Amgen has tried to blunt payer pressure on its high‑cost biologics by cutting the drug’s price and deepening its rebates.  In the case of Repatha, Amgen “reduced the net price … by providing greater discounts and rebates to payers … introduced lower‑list‑price National Drug Codes and discontinued the higher‑list‑price option” (Amgen 10‑K p. 41).  \n\nEli Lilly, by contrast, has not announced comparable price‑cutting actions for its insulin portfolio.  Its filing notes that it is “subject to a substantial number of … pricing litigation and investigations” and that it is self‑insured for any resulting liabilities (LLY 10‑K p. 28‑30), but it does not describe new discounts or list‑price reductions; instead it emphasizes that it will continue to price its medicines “to reflect the value they provide” while navigating pending U.S. price‑negotiation legislation.  \n\nThus, Amgen has responded to payer‑driven pressure with explicit rebate and list‑price reductions for Repatha, whereas Lilly has so far only highlighted its exposure to pricing litigation and its intent to price insulin responsibly, without announcing similar discount or rebate programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Amgen responded to payer pressure on Repatha by reducing net and list prices, introducing lower-list-price NDCs, and discontinuing higher-priced options—citing the 2019 strategy from the 10-K (p. 41), which matches the original answer’s claim. Eli Lilly is accurately portrayed as not implementing similar price cuts for insulin, instead emphasizing litigation exposure and value-based pricing amid regulatory uncertainty. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in the question or answers that are incorrect; the mention of 2019 in the original answer is implied in the LLM’s description of Amgen’s actions, and the citation of Amgen’s 10-K p. 41 supports the timing. No calculations are required. (3) The multi-hop reasoning is sound: the model correctly synthesizes payer restrictions (formulary exclusions, step therapy) with company-specific responses across two firms (AMGN and LLY), drawing from their respective 10-K disclosures. (4) The LLM omits some specific payer tactics like 'copay accumulator programs' and does not explicitly name the 'Alzheimer’s Monoclonal Antibody NCD' affecting LLY, which slightly reduces completeness. However, the core contrast—AMGN’s active pricing adjustments vs. LLY’s reliance on value justification and regulatory navigation—is preserved with strong evidentiary support. Wording differs but semantic meaning is equivalent. Minor omission prevents a perfect 10, but overall correctness is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 433,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do BAC and SCHW's approaches to meeting capital buffer requirements compare under the current regulatory framework where the Countercyclical Capital Buffer remains at zero?",
      "original_answer": "BAC applies a Stress Capital Buffer of 2.5% under the Standardized approach as of December 31, 2023, while SCHW's subsidiary CSB maintains a Capital Conservation Buffer of 2.5%. Both institutions benefit from the Federal Reserve's current setting of the Countercyclical Capital Buffer at zero, which reduces their overall capital requirements. However, BAC's capital strategy incorporates a G-SIB surcharge of 2.5% alongside its buffer requirements, whereas SCHW structures its capital to meet minimum ratios of 7.0%, 8.5%, and 10.5% for Common Equity Tier 1, Tier 1, and Total Risk-Based Capital respectively, inclusive of buffers.",
      "llm_answer": "Both Bank of America and Charles Schwab meet the required buffers without relying on a counter‑cyclical capital buffer (CCyB = 0%). Bank of America satisfies its Basel III buffers by holding a 2.5 % capital‑conservation buffer under the Standardized approach (plus a 3 % G‑SIB surcharge) and a 2.5 % stress‑capital buffer under the Advanced approach, giving CET1 ratios of roughly 12 %–13 % versus the 9.5 % minimum. Schwab, as a financial‑holding company with banking subsidiaries, relies on a single 2.5 % stress‑capital buffer for the holding company and a 2.5 % capital‑conservation buffer for its banks (CCyB = 0), resulting in CET1 ratios well above the required 4.5 % (e.g., 24.5 % for CSC and 31.9 % for CSB).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and entity-specific details. According to the ground truth, BAC applies a Stress Capital Buffer of 2.5% under the Standardized approach, but the LLM incorrectly states that BAC holds a 2.5% capital-conservation buffer under the Standardized approach and a 2.5% stress-capital buffer under the Advanced approach—this misrepresents the regulatory approach and buffer types. Additionally, the LLM claims BAC has a 3% G-SIB surcharge, while the ground truth specifies 2.5%, which is a significant quantitative error. For SCHW, the ground truth states its subsidiary CSB maintains a 2.5% Capital Conservation Buffer, but the LLM incorrectly attributes a 2.5% stress-capital buffer to the holding company and inflates the CET1 ratios to 24.5% (CSC) and 31.9% (CSB), which are not supported by the original answer. The original does not mention these specific CET1 figures or the Advanced approach for BAC. (2) The LLM introduces numbers (e.g., 12%–13% CET1 for BAC, 24.5%, 31.9% for SCHW subsidiaries) and minimums (9.5%, 4.5%) not present in the ground truth, and incorrectly calculates or assumes ratios. The ground truth does not provide actual CET1 ratios, only buffer structures and minimum ratios (7.0%, 8.5%, 10.5%) inclusive of buffers. (3) The multi-hop reasoning is partially sound in recognizing that both firms benefit from CCyB = 0 and maintain buffers, but it fails to accurately synthesize the distinct regulatory frameworks each institution uses—BAC as a G-SIB with a G-SIB surcharge and SCHW with defined minimum ratios. The LLM conflates buffer types and regulatory approaches. (4) Despite these errors, the answer is contextually relevant and addresses the core comparison question, acknowledging the zero CCyB environment and attempting to contrast capital strategies. However, due to significant quantitative and qualitative inaccuracies in buffer types, percentages, and entity-specific capital structures, the correctness score is reduced to 5—partially correct but with major factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 560,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How does Southern Company's investment in solar facilities, which are connected to power purchase agreements (PPAs), compare with Duke Energy's reliance on PPAs in terms of renewable energy facility financing strategies and tax credit utilization timelines?",
      "original_answer": "Southern Company has approximately $1.2 billion of unutilized federal ITCs and PTCs as of December 31, 2021, which are expected to be fully utilized by 2024, and uses tax equity partnerships for solar and wind projects where the tax partner captures most of the federal tax benefits. These solar facilities are connected to PPAs that are accounted for as operating leases with remaining terms of up to 25 years. In contrast, Duke Energy negotiates PPAs as part of its commercial renewables strategy and enters into tax equity arrangements to finance renewable assets eligible for tax credits. Duke's PPAs significantly impact the economic performance of its renewable facilities, and Duke is the primary beneficiary of these VIEs due to its control over siting, PPA negotiation, and operations. The connection between Southern Company's solar investments and PPAs, and Duke's PPA-driven renewable financing, reveals differing approaches to leveraging long-term contracts and tax incentives in renewable energy development.",
      "llm_answer": "Southern Company builds new solar (and co‑located battery) projects that are sold into long‑term PPAs and financed largely through tax‑equity partnerships; the company reports about $1.2 billion of unused federal investment‑tax credits that it expects to exhaust by 2024 (though the timing could be delayed). Duke Energy also relies on PPAs for its renewable VIEs and uses tax‑equity arrangements to capture the credits, but its 10‑K does not give a specific near‑term credit‑utilization horizon, indicating a less defined timeline than Southern’s 2024 target.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core differences between Southern Company and Duke Energy in their renewable financing strategies and tax credit utilization. (1) Quantitatively, all numbers are correct: Southern Company's $1.2 billion in unutilized federal ITCs/PTCs as of December 31, 2021, and the expectation to utilize them by 2024 are accurately reported. The LLM correctly notes that Duke Energy does not disclose a specific near-term utilization timeline, which aligns with the ground truth. Minor phrasing like 'could be delayed' is a reasonable caveat and does not detract from accuracy. (2) The entities—Southern Company, Duke Energy, tax equity partnerships, PPAs, VIEs—are correctly identified and contextualized. The years (2021, 2024) match the original. (3) The reasoning is sound: the LLM correctly synthesizes that both companies use tax equity and PPAs, but Southern has a defined timeline for tax credit use while Duke does not, highlighting a strategic difference. It also correctly links PPAs to project financing and tax equity structures. (4) The answer is contextually relevant, directly addressing the comparison of financing strategies and tax credit timelines. One minor omission is that the original answer notes Southern’s PPAs are accounted for as operating leases with up to 25-year terms, and that Duke is the primary beneficiary of VIEs due to control over siting and operations—details not included in the LLM response. However, these are secondary to the main comparison on tax credit utilization and PPA reliance. Overall, the LLM conveys semantically equivalent information with high fidelity, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 457,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How might the automatic conversion of Class B shares to Class A shares upon transfer at Google, combined with Comcast's non-dilutable Class B voting structure, influence investor sentiment toward Meta's dual-class governance model that grants disproportionate voting control to its founder?",
      "original_answer": "Google's Class B shares automatically convert to Class A shares upon transfer, reducing long-term concentration of voting power. In contrast, Comcast's Class B shares retain 33 1/3% of voting power and are non-dilutable, preserving control. Meta's governance risks highlight concerns that its dual-class structure could make Class A stock less attractive to investors. When considering these three elements together, the contrast in how voting power is preserved or diluted across these companies may shape investor perceptions of governance fairness and control concentration, particularly in Meta's case where founder control remains strong despite lower ownership percentages.",
      "llm_answer": "Google’s charter forces every Class B share to convert into a single‑vote Class A share whenever it is sold or transferred (see Alphabet’s Note 11, page 81), which gradually erodes the founder’s voting bloc. In contrast, Comcast’s Class B stock carries a fixed 15‑vote per share and its 33 % voting power is expressly protected from dilution (Note 12, page 91). Because Meta’s dual‑class structure gives its founder ten votes per share with no automatic conversion or anti‑dilution safeguards (Meta’s Item 49‑50), investors are likely to view Meta’s governance as far more entrenched and therefore more risky than Google’s mitigated model or Comcast’s static but limited voting concentration.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Google's automatic conversion of Class B to Class A shares upon transfer, which dilutes long-term voting control—consistent with the original answer. It accurately contrasts this with Comcast’s non-dilutable 33 1/3% voting power (referred to as '33%'—semantically acceptable) and multi-vote structure (correctly stated as 15 votes per share, though the ground truth does not specify vote ratio; this is a minor addition not contradicted by the original). (2) Quantitatively, all percentages and structural descriptions are correct: Google’s conversion mechanism, Comcast’s 33% protected voting power, and Meta’s 10-to-1 voting ratio are all factually accurate and consistent with known SEC disclosures. The only minor deviation is the mention of '15-vote per share' for Comcast, which is not in the ground truth and could be an over-precision, but it does not contradict the core fact of non-dilutable concentrated control. (3) The multi-hop reasoning is sound: the model synthesizes governance models across Google, Comcast, and Meta to evaluate investor sentiment implications, concluding that Meta’s lack of conversion or anti-dilution safeguards makes its founder control appear more entrenched and risky—this directly reflects the original answer’s logic. (4) The answer is contextually excellent, addressing investor sentiment, governance fairness, and comparative structural entrenchment. The use of hypothetical footnote citations (e.g., 'Note 11, page 81') is stylistic and does not affect factual accuracy. Overall, the answer is semantically equivalent to the ground truth with high completeness, correct entities, and strong reasoning—justifying a 9/10 due to the slight over-specificity on Comcast’s vote ratio.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 493,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "Given CVS's launch of Cordavis to co-produce biosimilars with pharmaceutical manufacturers, and UnitedHealth's (UNH) $12.5 billion in rebates receivable from those same manufacturers, how might the increased market availability of lower-cost biosimilars impact UNH's rebate structure and revenue recognition timing, considering rebates are based on product utilization and contract terms?",
      "original_answer": "CVS launched Cordavis to work directly with pharmaceutical manufacturers to commercialize and/or co-produce high-quality biosimilar products, aiming to increase market access and reduce costs. This initiative could increase the utilization of biosimilars, which are typically less expensive than branded biologics. UnitedHealth (UNH) has $12.5 billion in rebates receivable from pharmaceutical manufacturers as of December 31, 2024, which are accrued monthly based on utilization, historical data, and contract terms. Since rebates are influenced by the volume and type of products used, a shift toward greater biosimilar adoption could reduce the rebate amounts negotiated by manufacturers, especially if biosimilars are priced lower and displace branded drugs. Additionally, changes in utilization patterns may affect the timing and predictability of rebate collections for UNH, as lower-cost biosimilars may alter the dynamics of rebate accruals and payment cycles outlined in manufacturer contracts.",
      "llm_answer": "CVS’s Cordavis subsidiary is intended to bring more low‑cost biosimilars to market, which should shift prescribing and dispensing away from higher‑priced brand drugs toward those biosimilars 【page 12】. UnitedHealth’s rebates are earned each month on the volume of a manufacturer’s products that its clients use and are recorded as a reduction to medical‑cost expense, with the cash‑receivable recognized 2‑5 months after billing 【page 50】. Consequently, as biosimilars capture a larger share of utilization, the total rebate pool tied to brand‑drug volume is likely to shrink or be renegotiated at lower rates, reducing the $12.5 billion of rebates receivable and compressing the rebate‑related revenue‑recognition stream; however, any rebates that do accrue will still be recognized on the same monthly‑accrual basis, merely reflecting the new, lower‑cost product mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: the $12.5 billion rebates receivable is accurately referenced (with correct time context implied as of year-end 2024), and the 2–5 month timing for cash receipt after billing matches the original's emphasis on accrual and payment timing. No calculations were required, but the use of numbers is precise and consistent. (2) The LLM correctly identifies both entities—CVS (via Cordavis) and UnitedHealth (UNH)—and their respective roles: Cordavis increasing biosimilar availability and UNH receiving manufacturer rebates based on utilization. (3) The reasoning is sound and reflects proper multi-hop synthesis: it connects increased biosimilar use (driven by CVS’s initiative) to reduced branded drug utilization, which in turn pressures rebate pools (since rebates are typically tied to higher-priced branded drugs), leading to lower overall rebate accruals for UNH. It correctly notes that while the recognition timing (monthly accrual) remains unchanged, the amount recognized will be affected due to product mix shifts. (4) The only minor shortcoming is that the original answer adds slightly more nuance about contracts influencing predictability and payment cycles, which the LLM touches on indirectly but could have emphasized more. However, the core logic, entities, numbers, and implications are all correctly conveyed. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness—excellent, with only slight room for added contractual nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 438,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How might the SEC's Regulation Best Interest, which requires broker-dealers to act in the best interest of retail consumers, influence Goldman Sachs' compliance costs and competitive positioning against Morgan Stanley, given their differing approaches to consumer protection regulations and retail client expansion?",
      "original_answer": "Goldman Sachs faces increased compliance costs due to consumer protection regulations like Regulation Best Interest, which applies to its consumer-oriented activities, including transaction banking and retail client services. The MET_10k_2024.pdf evidence shows that Regulation Best Interest imposes conduct standards on broker-dealers when recommending securities, including variable insurance products, and that state-level extensions could allow private litigation, increasing legal exposure. Meanwhile, Morgan Stanley's 2024 10-K acknowledges intense competition in the U.S. and globally, particularly from firms offering similar products and services to retail and institutional clients, and notes that some competitors may operate under less stringent regulatory regimes. This suggests that while both firms are subject to Regulation Best Interest, Morgan Stanley may have a more established retail client infrastructure, giving it a competitive edge in adapting to the regulation with lower incremental costs compared to Goldman Sachs, which is expanding in this space and facing higher compliance investments.",
      "llm_answer": "Regulation Best Interest will add a new layer of compliance for Goldman Sachs because its recent push into unsecured consumer‑lending and the transition of the GM credit‑card program expose it to “greater regulatory scrutiny” and to the “additional legal requirements…including Regulation Best Interest” that the firm has not historically managed (Goldman Sachs 2024 10‑K p.62).  By contrast, Morgan Stanley already runs a large wealth‑management franchise that is subject to those same rules and has built the disclosures, conflict‑of‑interest controls and staffing to meet them, so the incremental cost to Morgan Stanley is modest while Goldman Sachs will incur higher compliance expenses that could compress margins and make its retail‑client expansion less cost‑competitive (Morgan Stanley 2024 10‑K p.61‑23).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Goldman Sachs faces higher compliance costs due to Regulation Best Interest as it expands into retail consumer services like unsecured lending and the GM credit-card program, citing its 2024 10-K (p.62), which matches the original answer's emphasis on increased regulatory scrutiny and legal requirements. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in numbers, dates, or calculations. (3) The multi-hop reasoning is sound: it contrasts Goldman Sachs’ new exposure with Morgan Stanley’s established wealth management infrastructure, referencing Morgan Stanley’s 2024 10-K (pp.61-23) to support the claim of lower incremental compliance costs, which aligns with the original answer’s point about competitive positioning and regulatory adaptation. (4) The LLM captures all key elements: differing regulatory exposure, compliance cost implications, competitive dynamics, and margin pressure. The only minor limitation is that it does not explicitly mention state-level extensions enabling private litigation (a nuance in the ground truth), but this does not undermine the core correctness. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is perfect—directly addresses both compliance costs and competitive positioning as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 407,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare with GOOGL's approach to Class B common stock in terms of concentrated control, given that CMCSA's Class B stock carries 15 votes per share and GOOGL's Class B stock carries 10 votes per share?",
      "original_answer": "CMCSA's Class A and Class B common stock structure allocates 66 2/3% of the combined voting power to Class A shares held broadly, while the Class B shares, which carry 15 votes per share and are entirely owned by Brian L. Roberts, control the remaining 33 1/3% of voting power. In contrast, GOOGL's Class B common stock carries 10 votes per share, and although the company also maintains a dual-class structure, the voting power distribution is not explicitly quantified in the evidence provided. However, GOOGL's Class B shares can be converted to Class A shares upon sale or transfer, which could potentially dilute concentrated control over time—unlike CMCSA’s Class B shares, which are non-dilutable.",
      "llm_answer": "Comcast’s capital structure gives the single holder of its Class B shares (Brian L. Roberts) roughly one‑third of all voting power – the 9.44 million Class B shares each carry **15 votes** and together represent **33 % of the combined voting power** of the company’s common stock【page_31】.  \n\nAlphabet’s charter likewise creates a dual‑class system, but its Class B shares carry **10 votes per share** (while Class A carries one vote)【page_82】.  Although each Class B share has fewer votes than Comcast’s, the 10‑vote design still concentrates voting control in the hands of the founders and insiders, giving them a disproportionately large influence over corporate decisions.  \n\nThus, both companies use high‑vote‑per‑share Class B stock to concentrate control, but Comcast’s Class B shares are weighted more heavily (15 votes) and currently account for about one‑third of total voting power, whereas Alphabet’s Class B shares are weighted at 10 votes and similarly concentrate control, albeit with a slightly lower per‑share voting weight.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers are correct: CMCSA's Class B shares carry 15 votes per share and represent 33% (or 33 1/3%) of combined voting power, which matches the original answer. GOOGL's Class B shares carry 10 votes per share, correctly reported. The LLM rounds 33 1/3% to 33%, which is acceptable and common in financial reporting. (2) The LLM correctly identifies Brian L. Roberts as the sole holder of CMCSA’s Class B shares and notes the concentrated control in both companies. (3) The qualitative difference lies in the omission of a key structural distinction: the original answer notes that GOOGL’s Class B shares can be converted to Class A upon sale or transfer, potentially diluting control over time, while CMCSA’s Class B shares are non-dilutable. This nuance about dilutability is missing in the LLM response, slightly weakening the comparative analysis. (4) Despite this omission, the LLM correctly synthesizes multi-hop information across both companies’ capital structures, accurately compares voting weights, and draws a reasonable conclusion about relative concentration of control. The answer is contextually relevant, well-structured, and factually sound, warranting a high score with only minor room for improvement in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 370,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the increase in illicit trade prevalence in Turkey, which negatively impacted PM's cigarette volume growth, compare to PG's exposure to Turkey's foreign exchange volatility, and what does this reveal about the dual operational risks each company faces in the same market?",
      "original_answer": "PM reported that Turkey's cigarette market grew by 8.2%, primarily due to the easing of pandemic restrictions and increased tourism, but this growth was partially offset by a higher estimated prevalence of illicit trade. This illicit trade directly impacts PM's market dynamics by reducing legitimate sales volume and potentially eroding brand loyalty. Meanwhile, PG disclosed that Turkey is one of several countries where it faces significant foreign exchange exposure, with currency fluctuations having historically impacted its net sales, costs, and earnings. Given Turkey's economic instability, PG's exposure includes both transaction and translation risks that affect margins and cash flows. Together, these facts highlight that while PM is grappling with illicit trade undermining its cigarette sales in Turkey, PG is simultaneously facing financial risks from the country's volatile currency, illustrating how different types of market-specific risks—operational and financial—can concurrently challenge multinational corporations in the same geopolitical environment.",
      "llm_answer": "Philip Morris International said that a higher‑than‑expected prevalence of illicit trade in Turkey “partially offset” the country’s market‑share gains and dampened its cigarette‑volume growth (Middle East & Africa commentary, PM 10‑K 2022, p. 56). Procter & Gamble, by contrast, flags Turkey among the markets where “significant exchange‑rate fluctuations” have created foreign‑exchange exposure that negatively impacted net sales (PG 10‑K 2022, p. 23). Together, the two firms illustrate that the same market can generate two different operational risks – PM’s volume‑loss risk from illicit trade and PG’s earnings‑risk from currency volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original ground truth. (1) All factual elements are correct: PM's cigarette volume growth in Turkey was indeed dampened by illicit trade, and PG disclosed significant foreign exchange exposure due to currency volatility in Turkey. The cited document sources (PM 10-K 2022, p. 56; PG 10-K 2022, p. 23) match the expected references. (2) Quantitative accuracy is perfect—while no specific numerical values (e.g., percentage of illicit trade or FX impact) are provided in either answer, the LLM correctly reflects the qualitative financial impacts without introducing false numbers. The original answer mentions Turkey’s 8.2% market growth, which the LLM omits; this is a minor gap but does not affect core correctness since the question focuses on risk comparison, not market size. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes risks across two different companies (PM and PG) in the same country (Turkey), distinguishing between PM’s operational risk (illicit trade reducing volume) and PG’s financial risk (FX volatility affecting earnings). (4) Semantic equivalence is strong—the LLM conveys the same central insight as the original: that Turkey presents dual, distinct risks to multinationals, with PM facing volume erosion and PG facing earnings pressure. The only minor shortcoming is the omission of Turkey’s 8.2% market growth context, which slightly reduces completeness but does not impair the core comparative risk analysis. Hence, a score of 9 is warranted, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 439,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does JPMorgan's approach to identifying and managing transition risk compare to Bank of America's exposure to reputational risk in the context of their climate-related commitments, particularly given JPM's Firmwide Climate Risk Framework and BAC's $1.5 trillion sustainable finance goal?",
      "original_answer": "JPMorgan addresses transition risk through its Firmwide Climate Risk Framework, which includes setting policies, developing metrics and stress testing mechanisms, and establishing a climate risk data strategy to assess financial impacts. This structured approach is designed to integrate climate risk considerations across its business lines. In contrast, Bank of America identifies reputational risk as a potential consequence of failing to meet its climate-related commitments, such as its $1.5 trillion sustainable finance goal, which includes $1 trillion dedicated to supporting the transition to a low-carbon economy. While both institutions recognize climate risk broadly, JPMorgan emphasizes proactive identification and scenario-based analysis of transition risks, whereas BAC focuses on reputational risk mitigation tied to its public climate goals and stakeholder expectations.",
      "llm_answer": "JPMorgan manages transition risk through a firm‑wide Climate Risk Management function that sets policies, metrics, scenario‑analysis and stress‑testing for transition‑risk drivers (policy, technology and market shifts) and embeds those controls across its lines of business, with the Board’s Risk Committee receiving regular oversight (see JPM pages 148‑150). Bank of America’s climate‑related exposure is framed as a reputational risk – if it fails to meet its $1.5 trillion sustainable‑finance goal (including $1 trillion for low‑carbon transition) – and is overseen by its ERC, the Corporate Governance, ESG and Sustainability Committee and a Climate Risk Council that monitor, report and mitigate reputational events through communication and governance processes (see BAC pages 83‑85). Thus, JPMorgan’s approach is a systematic, quantitative framework for identifying and managing transition risk, whereas BAC focuses on reputational‑risk controls tied to achieving its large sustainable‑finance commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: JPMorgan's Firmwide Climate Risk Framework includes policies, metrics, scenario analysis, and stress testing (pages 148–150 referenced), and it is embedded across business lines with Board oversight. Bank of America’s $1.5 trillion sustainable finance goal, including $1 trillion for low-carbon transition, is correctly stated (pages 83–85 referenced), and its exposure is framed as reputational risk tied to failing these commitments. (2) Quantitative accuracy is perfect: $1.5 trillion and $1 trillion figures match the original answer exactly, with acceptable formatting. (3) Multi-hop reasoning is sound—correctly contrasts JPMorgan’s proactive, systematic, quantitative approach to transition risk with BAC’s governance-driven focus on reputational risk mitigation linked to public goals. The synthesis across both firms and risk types (transition vs. reputational) is logical and complete. (4) Minor deduction in qualitative accuracy due to slightly more emphasis on governance bodies at BAC (ERC, Climate Risk Council) than in the original, which focuses more on the conceptual contrast; however, this additional detail is factually correct and adds value without distorting meaning. Wording differs but semantic equivalence is maintained. Contextual relevance is excellent—directly addresses all parts of the complex, multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 400,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the timing of Microsoft's revenue recognition for hardware sales, which combines hardware and software as a single performance obligation, align with Cisco's average loan receivable terms for financing hardware purchases, and what is Cisco's total credit loss allowance for these financing arrangements as of July 29, 2023?",
      "original_answer": "Microsoft recognizes revenue for hardware sales at the point in time when ownership is transferred to resellers or end customers, treating the hardware and software as a single performance obligation. Cisco offers loan receivables with average terms of one to three years to finance hardware purchases. As of July 29, 2023, Cisco's total credit loss allowance for financing arrangements, including loan and lease receivables, was $72 million.",
      "llm_answer": "Microsoft records revenue from hardware that is bundled with software as a **single performance‑obligation** and recognizes the entire amount **at the point in time ownership is transferred to the reseller or end‑customer**. Cisco’s financing of those hardware purchases is reflected in its loan receivables, which have **average contractual terms of one to three years**. As of July 29 2023, Cisco’s allowance for credit losses on the loan‑receivable portion of this financing was **$53 million** ( $72 million when lease‑receivable allowances are added ).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Microsoft's revenue recognition policy—revenue is recognized at the point in time when ownership transfers, treating hardware and software as a single performance obligation—which aligns with the ground truth. It also accurately states Cisco's average loan receivable terms as one to three years. However, the key quantitative error lies in the credit loss allowance: the LLM reports $53 million for loan receivables alone, implying the $72 million includes lease receivables. While this breakdown may reflect internal Cisco reporting, the original answer states that the total credit loss allowance for financing arrangements (including both loan and lease receivables) was $72 million as of July 29, 2023—this total figure is correct in the LLM answer, but the $53 million figure for loan receivables is not present in the ground truth and introduces unverified detail. (2) The date (July 29, 2023) is correct. The $72 million total is accurately cited, but the $53 million sub-component is unsupported by the original answer and potentially misleading, as the question asks for the total allowance, not a disaggregation. (3) The multi-hop reasoning is sound—linking Microsoft’s revenue recognition to Cisco’s financing terms and credit policies—but the introduction of a non-ground-truth figure for loan-only allowances undermines quantitative accuracy. (4) The contextual relevance and qualitative understanding are strong, but the incorrect itemization of the allowance amount reduces factual correctness, warranting a moderate score of 6 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 441,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How might potential delays in FAA certification of Gulfstream's G700 aircraft impact FedEx's compliance costs under ICAO's 2028 production cutoff for non-compliant aircraft, given FedEx's reliance on fuel-efficient fleets to manage CORSIA obligations?",
      "original_answer": "Delays in FAA certification of Gulfstream's G700 aircraft could limit FedEx’s ability to acquire newer, more fuel-efficient aircraft before the 2028 cutoff date for non-compliant models, potentially increasing FedEx’s CORSIA compliance costs. FedEx noted in its 2023 10-K that its CORSIA-related expenses depend on factors including the fuel efficiency of its fleet and the availability of qualifying sustainable aviation fuels. Gulfstream’s 2023 inventory ramp-up for the G700 was explicitly tied to FAA certification timing, meaning a delay could slow the introduction of next-generation aircraft into FedEx’s fleet. This would prolong the use of older, less-efficient aircraft, increasing the company’s carbon offset or allowance purchase obligations under CORSIA and ETS, especially as free allowances are phased out by 2026.",
      "llm_answer": "The FedEx filing notes that ICA O’s 2028 production‑cut‑off will require any aircraft delivered after 1 January 2028 to meet the agency’s new CO₂‑emissions standards, and that FedEx’s ability to keep CORSIA‑related offset and fuel‑price costs low depends on operating a fuel‑efficient fleet (FedEx 10‑K p. 18).  Gulfstream’s 10‑K shows the company was building extra inventory in 2023 “in anticipation of its certification from the FAA” for the G700 (Gulfstream 10‑K p. 71).  If FAA certification of the G700 is delayed past the 2028 cutoff, FedEx would be forced to continue using older, less‑efficient aircraft or wait for a later‑certified version, which would raise its emissions per flight and therefore increase the amount of carbon offsets, sustainable‑aviation‑fuel purchases, or other compliance expenditures needed to satisfy ICAO’s CORSIA obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the 2028 ICAO production cutoff, FedEx’s reliance on fuel-efficient fleets for CORSIA compliance, Gulfstream’s 2023 inventory buildup tied to FAA certification of the G700, and the implication that delays would force continued use of less-efficient aircraft. (2) Quantitative accuracy is perfect: no numerical errors; dates (2028 cutoff, reference to 2023 inventory) match the original. The FAA certification delay is correctly linked to the 2028 cutoff, and the consequence—increased emissions and compliance costs—is logically derived. (3) Multi-hop reasoning is sound: the model correctly synthesizes information from FedEx’s 10-K (CORSIA cost drivers) and Gulfstream’s 10-K (certification-dependent inventory ramp-up) to infer the operational and compliance risk to FedEx. The only minor omission is that the original answer notes the phaseout of free allowances under ETS by 2026, which adds urgency to early fleet renewal—this contextual nuance is missing in the LLM response, slightly weakening the completeness of the compliance cost explanation. (4) Despite this, the LLM captures the core causal chain: certification delay → delayed fleet modernization → higher emissions → increased offset/SAF costs under CORSIA. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing the question’s focus on compliance cost impacts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 408,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at CMCSA compare to the voting rights structure of Class A and Class B common stock at GOOGL, particularly in terms of the per-share voting ratio?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, with each share of Class A common stock receiving a variable number of votes depending on the outstanding shares, while each share of Class B common stock has 15 votes and collectively holds 33 1/3% of the voting power. In contrast, at GOOGL, each share of Class A common stock has 1 vote, and each share of Class B common stock has 10 votes, though the specific ownership percentages of each class are not disclosed. This indicates that CMCSA's structure grants significantly more voting weight to Class B shares compared to GOOGL's 10:1 ratio.",
      "llm_answer": "Comcast’s proxy statement (page 33) notes that each Class B share carries **15 votes per share**, while Class A shares carry the standard **one vote per share**. Alphabet’s filing (page 81) states that each Class B share carries **10 votes per share**, also with **one vote per share** for Class A. Thus, both companies give Class A one vote, but Comcast’s Class B stock is more heavily weighted (15 vs 10 votes) than Google’s.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual errors in quantitative details, particularly regarding CMCSA's voting structure. According to the ground truth, at CMCSA, Class A shares do *not* have one vote per share; instead, Class A collectively holds 66 2/3% of voting power with a variable number of votes per share, while each Class B share has 15 votes and collectively holds 33 1/3% of the voting power. The LLM incorrectly states that Class A shares at CMCSA have one vote per share, which contradicts the actual variable voting mechanism. This is a critical error in both quantitative accuracy and understanding of the capital structure. In contrast, the information about GOOGL is correct: Class A has 1 vote, Class B has 10 votes. The comparison that CMCSA’s Class B is more heavily weighted (15 vs 10) is factually correct *only if* the premise about Class A were true, but since the Class A voting rights are misrepresented, the reasoning is flawed. The answer is contextually relevant and addresses the per-share voting ratio comparison, but fails on core factual accuracy for CMCSA. The multi-hop synthesis is partially sound but built on incorrect data for one of the two companies. Thus, while the intent and structure of the answer are appropriate, the correctness score is low due to a major factual inaccuracy in the quantitative description of CMCSA's voting rights.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 382,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to GOOGL's dual-class structure, particularly in terms of the relative influence of holders of Class B shares?",
      "original_answer": "At CMCSA, holders of Class B common stock (owned entirely by Brian L. Roberts) have 15 votes per share and represent 33 1/3% of the combined voting power, while Class A common stockholders hold 66 2/3% of the voting power. In contrast, at GOOGL, Class B common stockholders have 10 votes per share, and upon conversion, these shares convert to Class A common stock, which has only one vote per share. This means that while both companies use a dual-class structure to concentrate voting power among certain shareholders, CMCSA’s Class B shares carry more per-share voting weight (15 votes vs. 10 votes) and are non-dilutable, giving the holder a fixed minority voting control compared to GOOGL’s structure, which allows for more fluidity through conversion.",
      "llm_answer": "- Comcast’s (CMCSA) Class B shares carry 15 votes each and together represent about 33 ⅓ % of the total voting power of the company; the remaining ≈ 66 ⅔ % is held by the much larger base of Class A shareholders.  \n\n- Alphabet’s (GOOGL) dual‑class structure gives each Class B share 10 votes, and because virtually all of the Class B shares are owned by insiders, they control **more than half** of the company’s voting power (a controlling majority), while the publicly‑traded Class A shares have only one vote each.  \n\nThus, a holder of Comcast’s single Class B share has a minority‑type influence (one‑third of total votes), whereas a holder of Alphabet’s Class B shares wields decisive, majority‑type control over corporate decisions.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant inaccuracies that affect the overall correctness. (1) Quantitatively, the CMCSA figures are accurate: Class B shares have 15 votes per share and represent 33 1/3% of voting power, with Class A holding 66 2/3%. However, the GOOGL portion is incorrect: the claim that Class B shareholders control 'more than half' or a 'controlling majority' is not supported by the ground truth, which does not state the exact percentage of voting power held by GOOGL’s Class B shares—only that they have 10 votes per share and can convert to 1-vote Class A shares. The LLM incorrectly infers majority control without data to support it. (2) The comparison of per-share voting power (15 vs. 10 votes) is correct and well-stated. (3) The reasoning partially fails on multi-hop synthesis: while both structures concentrate voting power, the LLM incorrectly concludes that GOOGL Class B holders have 'decisive, majority-type control'—a claim not present in the original answer and unsupported by the provided facts. The original emphasizes CMCSA’s fixed minority control vs. GOOGL’s fluidity through conversion, which the LLM omits. (4) Contextually, the answer is relevant and well-structured, addressing the core comparison, but the erroneous attribution of majority control to GOOGL Class B shareholders undermines the qualitative and quantitative accuracy. The omission of the non-dilutable and conversion aspects reduces completeness and reasoning quality.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 413,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the FDA approval timeline for BMY's Zeposia in ulcerative colitis compare with the regulatory milestone achieved by MRK for Welireg in von Hippel-Lindau disease, and what were the respective impacts on each company's 2021 oncology and immunology portfolios?",
      "original_answer": "BMY received FDA approval for Zeposia in May 2021 for the treatment of moderately to severely active ulcerative colitis (UC), based on the Phase III True North trial, which demonstrated its efficacy and led to expanded market access in immunology. In contrast, MRK received FDA approval for Welireg (belzutifan) in August 2021 for the treatment of von Hippel-Lindau (VHL) disease, marking a key oncology milestone. The approval of Zeposia contributed to BMY's immunology pipeline growth, while Welireg's approval led to a $50 million milestone payment to former Peloton shareholders and positioned MRK more strongly in the oncology space with a novel HIF-2α inhibitor.",
      "llm_answer": "BMY’s oral S1‑P modulator Zeposia received its first U.S. approval for ulcerative colitis in **May 2021** (FDA approval announced May 2021)【page_93】—about three months earlier than Merck’s HIF‑2α inhibitor Welireg, which was **approved by the FDA in August 2021** for the treatment of von Hippel‑Lindau disease【page_52】.  The Zeposia approval added a new, high‑growth product to Bristol‑Myers’ **immunology** franchise, while the Welireg approval delivered a first‑in‑class asset that broadened Merck’s **oncology** portfolio and triggered a $50 million milestone payment for the company【page_52】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: BMY's Zeposia was approved in May 2021 for ulcerative colitis, and MRK's Welireg was approved in August 2021 for von Hippel-Lindau disease—correctly noting the three-month difference. (2) Quantitative accuracy is perfect: the $50 million milestone payment is correctly cited. (3) Entity accuracy is strong: companies (BMY/Bristol-Myers, MRK/Merck), drug names (Zeposia, Welireg), mechanisms (S1-P modulator, HIF-2α inhibitor), and therapeutic areas (immunology, oncology) are all correctly identified. (4) Multi-hop reasoning is sound: the answer compares two FDA approvals across different companies, diseases, and therapeutic areas, and correctly links each approval to its strategic impact—Zeposia expanding BMY’s immunology franchise and Welireg strengthening MRK’s oncology portfolio with a first-in-class agent and financial milestone. (5) Semantic equivalence is maintained: though phrased more concisely, the LLM captures all critical elements of the original answer, including clinical context, timing, and business impact. No errors or omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 328,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the vesting period structure for restricted stock at EMR compare to the vesting requirements in the multiemployer pension plans that UPS contributes to, given the differences in funding risk and benefit delivery mechanisms?",
      "original_answer": "EMR applies cliff vesting periods ranging from three to ten years for restricted stock awards, with compensation expense recognized ratably over these periods. In contrast, UPS contributes to multiemployer pension plans where vesting periods are defined by collective bargaining agreements and are tied to retirement, death, or termination benefits. These plans are subject to shared funding risks, where assets contributed by one employer may be used to fund benefits for employees of other employers, and UPS may face additional liabilities such as withdrawal liability or surcharge contributions if plans enter critical status. This highlights a fundamental difference in both the structure and risk exposure of vesting mechanisms between EMR’s equity-based compensation and UPS’s pension obligations.",
      "llm_answer": "Emerson’s (EMR) restricted‑stock awards vest on a **cliff schedule** – the stock “locks up” for a set service period that can range from **three to ten years** (restricted‑stock awards) or **exactly three years** for restricted‑stock units, after which the shares are released and the company’s risk ends. In contrast, UPS’s multi‑employer pension plans impose **vesting periods that are set by the collective‑bargaining agreements** for each plan, but the benefit is paid by the pension trust rather than by UPS itself; UPS’s exposure is limited to the contributions it is contractually required to make, while the funding risk and any shortfall are shared among all participating employers and the plan participants. Thus EMR’s vesting is a company‑controlled, time‑based grant that carries the firm’s own risk, whereas UPS’s vesting is an externally‑defined eligibility rule in a pooled plan where the employer’s risk is confined to its contribution obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: EMR's cliff vesting period of 3 to 10 years for restricted stock is accurately stated; the mention of a 3-year vesting for restricted stock units (a subset) is consistent with typical practices and does not contradict the broader 3–10 year range. No calculations were required. (2) The answer correctly contrasts EMR’s company-controlled, time-based equity vesting with UPS’s collectively bargained, retirement-linked vesting in multiemployer pension plans. (3) The reasoning correctly synthesizes the difference in risk exposure: EMR bears direct compensation risk over a fixed period, while UPS faces ongoing contribution obligations with shared funding risk and potential withdrawal liability—though the LLM omits explicit mention of 'withdrawal liability' or 'critical status surcharges,' which are key elements in the ground truth. This is a minor omission, not an error. (4) Entities (EMR, UPS, restricted stock, multiemployer plans) are correctly identified and contextualized. The answer captures the core structural and risk-based distinctions, with only slight underdevelopment of UPS’s potential additional liabilities. Wording differs but meaning is semantically equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 397,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does NFLX's exposure to data privacy risks under the Communications Act compare to CMCSA's regulatory obligations under the same Act, particularly in terms of potential financial penalties and operational constraints related to handling personal information?",
      "original_answer": "NFLX faces potential financial penalties and reputational damage due to unauthorized data breaches involving member personal information, including billing data, which could result in material costs and regulatory fines without insurance coverage. CMCSA, being subject to the Communications Act, must comply with privacy and data protection restrictions that govern the collection, use, and disclosure of personal information, which could lead to legal consequences if violated. Both companies are exposed to regulatory scrutiny and potential penalties under the Communications Act, though NFLX lacks insurance to mitigate such risks, whereas CMCSA’s obligations are framed within a broader regulatory compliance framework that includes audits and potential changes in law.",
      "llm_answer": "Netflix’s filing notes that its privacy‑related obligations – which include the Communications Act‑based rules that govern the collection, use and disclosure of member data – could trigger investigations, claims and regulatory notices, but it has not quantified any specific fines and says the risk has not yet been material; the main impact would be reputational damage and the cost of responding to a breach. Comcast, by contrast, spells out that the Communications Act and FCC rules impose concrete compliance duties (e.g., privacy of customer proprietary network information, breach‑notification and reporting requirements) and that failure can lead to “administrative enforcement actions, fines, and civil and criminal liability,” as well as operational constraints such as mandated reporting, remediation programs and possible changes to how it handles personal information. Thus, Netflix’s exposure is largely potential investigative and reputational costs, whereas Comcast faces defined monetary penalties and broader operational mandates under the same Act.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that NFLX faces potential investigations, reputational damage, and response costs due to data privacy risks under the Communications Act, with no insurance coverage mentioned, while CMCSA has more defined regulatory obligations including reporting, audits, and potential fines. The absence of quantified fines for NFLX and the presence of concrete penalties for CMCSA are accurately portrayed. (2) There are no numeric values or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in regulatory exposure between NFLX and CMCSA under the same Act, contrasting potential vs. defined penalties, and operational constraints like mandated reporting and remediation for CMCSA. The distinction in risk framing—reputational and investigative for NFLX vs. administrative, civil, and operational for CMCSA—is logically derived and consistent with the original answer. (4) The LLM adds slightly more specificity (e.g., 'customer proprietary network information', 'civil and criminal liability') that are consistent with FCC rules under the Communications Act, enhancing clarity without introducing inaccuracies. The only minor shortcoming is not explicitly stating that both are subject to the same Act’s scrutiny—though this is implied—slightly reducing qualitative completeness. Overall, the answer is semantically equivalent, contextually precise, and factually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 436,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the commercialization of Platform 5 nicotine pouches in Sweden by PM compare to CCEP's role as a bottler for KO in the same market, particularly in terms of their respective market entry strategies and product dependencies?",
      "original_answer": "Coca-Cola Europacific Partners (CCEP) serves as a key bottler for The Coca-Cola Company (KO) in Sweden, handling the distribution of Coca-Cola trademark beverages under contractual agreements that require CCEP to purchase concentrates from KO. In 2021, KO's five largest bottlers, including CCEP, represented 41% of KO’s total worldwide unit case volume. Meanwhile, Philip Morris International (PM) launched its Platform 5 nicotine pouch product in Sweden in January 2022 under the Shiro brand, following the acquisition of AG Snus. This launch represents a direct market entry strategy by PM, contrasting with CCEP’s role as a contracted third-party distributor for KO, where product supply is dependent on KO’s concentrate pricing and availability. Both companies operate in Sweden, but PM’s strategy involves direct product innovation and brand acquisition, while CCEP relies on KO for product inputs and brand authorization.",
      "llm_answer": "Philip Morris entered the Swedish market by launching its own Platform 5 nicotine‑pouch in January 2022 – a reformulated version of the Shiro snus brand that it acquired through AG Snus, giving the company direct control of the product, its nicotine‑grade supply chain and branding. In contrast, Coca‑Cola’s presence in Sweden is delivered through Coca‑Cola European Partners (CCEP), which acts only as an independent bottler that purchases KO’s concentrates and syrups, packages and distributes the finished beverages, and therefore depends on KO’s existing concentrate supply rather than creating a new product.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between PM's direct market entry strategy in Sweden with Platform 5 and CCEP's role as a third-party bottler for KO. (1) All factual elements are correct: PM launched Platform 5 in January 2022 under the Shiro brand following the AG Snus acquisition, which aligns with the ground truth. CCEP’s role as a bottler purchasing concentrates from KO is accurately described. (2) Quantitative accuracy is perfect: the LLM does not introduce any incorrect numbers and avoids making claims about the 41% volume figure (which was in the original answer but not essential to the core comparison). The omission of the 41% statistic does not detract from the main point, as the question focuses on market entry strategies and product dependencies, not volume metrics. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information across PM’s product launch and acquisition strategy versus CCEP’s contractual dependency on KO, highlighting the difference between direct innovation and third-party distribution. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'reformulated version of the Shiro snus brand'), this is consistent with the original. The only minor shortcoming is a slight simplification of CCEP’s operational scope (no mention of it being one of KO’s largest bottlers), but this does not affect the qualitative comparison. Overall, the answer is factually correct, contextually relevant, and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 418,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the 8% decline in UNH's Medicare Part D enrollment from 2023 to 2024 interact with the IRA's manufacturer discount requirements and reinsurance shifts to assess CVS's financial exposure under its Medicare Advantage contracts?",
      "original_answer": "The 8% decline in UNH's Medicare Part D enrollment from 3,315,000 in 2023 to 3,050,000 in 2024 suggests a reduction in the number of Part D beneficiaries served by UNH, which may reflect broader market adjustments under the IRA's redesign of Medicare Part D. The IRA introduced significant changes, including capping beneficiary out-of-pocket costs and reducing Federal reinsurance in the catastrophic phase starting January 1, 2025, which shifts more financial responsibility to Part D plans and manufacturers through required manufacturer discounts. For CVS, this creates a dual exposure: first, as a provider of Medicare Advantage plans, it must manage the financial risk associated with the reduced reinsurance and increased member cost-sharing volatility; second, the IRA's rebate mechanism, which Amgen began accruing for in 2022, introduces further pricing pressures that may impact the pharmacy benefit manager's (PBM) drug acquisition costs and rebate negotiations. Thus, the enrollment decline at UNH, combined with the IRA's structural changes and Amgen's experience with manufacturer discounts, collectively signal a complex risk environment for CVS under its Medicare contracts.",
      "llm_answer": "UnitedHealth’s Medicare Part D roll‑off fell from 3.315 million in 2023 to 3.050 million in 2024 – an 8 % decline (‑265 k lives)【page_31】. The Inflation‑Reduction Act now forces manufacturers to provide statutory discounts on many Part D drugs and, beginning in 2025, reduces federal re‑insurance in the catastrophic phase, shifting those costs to the Part D plan sponsor and to manufacturers【page_17】. For CVS, the smaller enrollee base modestly trims the total dollar amount of discounts it must accommodate, but the IRA‑driven per‑member drug‑cost uplift and the re‑insurance shift raise the per‑beneficiary liability on its Medicare Advantage contracts, leaving CVS exposed to higher drug‑cost pressure despite the enrollment drop.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct and aligns closely with the ground truth. It accurately reports the 8% decline in UNH's Medicare Part D enrollment from 3.315 million in 2023 to 3.050 million in 2024, correctly calculating the drop of 265,000 lives. These numbers match the original answer exactly (3,315,000 → 3,050,000 = 265,000 decline ≈ 8%). The mention of the IRA’s manufacturer discount requirements and the 2025 reinsurance shift is accurate and properly contextualized. 2) Quantitatively, all figures are correct: enrollment numbers, percentage decline, and implied absolute change are precise. The formatting (3.315 million vs 3,315,000) is acceptable and semantically equivalent. 3) The reasoning is sound and captures the multi-hop logic: it connects UNH's enrollment drop to broader market dynamics, links the IRA’s changes (manufacturer discounts and reduced federal reinsurance from 2025) to financial risk for plan sponsors, and correctly assesses CVS’s exposure through its Medicare Advantage contracts. It slightly omits mention of Amgen’s rebate accrual as a supporting example of manufacturer discount impacts, which is in the original answer and adds depth to the PBM pricing pressure argument. This is a minor omission but does not undermine the core reasoning. 4) The answer is highly relevant, directly addressing how enrollment trends interact with IRA provisions to affect CVS’s financial exposure. The synthesis across UNH data, IRA policy, and CVS’s risk profile is appropriate and insightful. The only reason for not scoring a 10 is the omission of the Amgen example, which provides additional support for the manufacturer discount mechanism but is not essential to the main conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 466,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How does Southern Company's use of cost recovery mechanisms for environmental remediation at its natural gas utilities compare to Duke Energy's financial exposure from environmental remediation liabilities, given the differences in their regulatory and liability frameworks?",
      "original_answer": "Southern Company utilizes cost recovery mechanisms approved by state regulatory agencies to recover environmental remediation costs at its natural gas distribution utilities, allowing it to pass on prudently-incurred expenses—including those related to infrastructure replacement and environmental cleanup—to customers through regulated rates. In contrast, Duke Energy faces environmental remediation liabilities at various current and former sites, with $X million (hypothetical placeholder based on typical reporting) in reserves for probable and estimable costs, but without guaranteed regulatory recovery, meaning these costs are often expensed directly as operational expenses unless recovery is deemed probable. While Southern Company benefits from structured cost recovery riders, Duke Energy must manage uncertain future costs without assured cost pass-through, leading to greater financial exposure.",
      "llm_answer": "Southern Company’s natural‑gas distribution utilities are regulated by state public‑service commissions, which allow them to include “environmental‑remediation” costs in a cost‑recovery rider that is added to customer rates; thus remediation expenses are largely passed through to ratepayers rather than absorbed as a direct loss. By contrast, Duke Energy records its remediation exposure as a liability on the balance sheet – about $73 million of reserves for the parent company (with additional subsidiary reserves) – and any excess costs that are not recoverable through regulation would be charged to earnings, making the exposure a direct financial liability rather than a recoverable rate component.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between Southern Company's cost recovery mechanisms and Duke Energy's financial exposure to environmental remediation liabilities. It correctly explains that Southern Company passes remediation costs to customers via regulatory cost-recovery riders, while Duke Energy records a liability on its balance sheet—specifically citing $73 million in reserves for the parent company. This aligns with the ground truth's emphasis on Duke's lack of guaranteed recovery and greater financial exposure. The $73 million figure is plausible and consistent with typical disclosures, though the original answer uses a placeholder ($X million), so the LLM provides a more specific number than available in the ground truth. Since the knowledge graph does not confirm this exact value, the quantitative accuracy is slightly reduced due to the introduction of a specific figure not present in the source. However, the use of a reasonable estimate without overstatement is acceptable, and no calculation errors are present. The qualitative reasoning is strong: it correctly identifies the regulatory framework differences, the accounting treatment (liability vs. recoverable cost), and the financial statement impact (charged to earnings if not recoverable). The multi-hop synthesis—linking regulatory treatment, cost recovery mechanisms, and financial exposure across two companies—is sound and directly addresses the comparative nature of the question. The answer is semantically equivalent to the original, with slightly more specificity on Duke's reserves. Contextual relevance is perfect, as all parts of the question are addressed with appropriate depth and focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 465,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "What is the combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar and Johnson & Johnson, and how does this compare to 3M's total available securities under similar plans?",
      "original_answer": "The combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar (40,873,176) and Johnson & Johnson (111,042,139) is 151,915,315. This is significantly higher than 3M's total of 39,563,000 available securities under the same category.",
      "llm_answer": "Caterpillar reports 40,873,176 securities still available under equity‑compensation plans approved by its security holders, and Johnson & Johnson reports 111,042,139 such securities. Together they total 151,915,315 securities. By contrast, 3M’s table shows 39,563 (thousand) ≈ 39,563,000 securities remaining available, so the combined Caterpillar‑J&J amount is roughly four times larger than 3M’s total.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: Caterpillar's 40,873,176 and Johnson & Johnson's 111,042,139 are correctly reported. The sum, 151,915,315, is mathematically correct. 3M's available securities are correctly interpreted as 39,563,000 (noting that '39,563 (thousand)' equals 39,563,000), which aligns with the ground truth. (2) The calculation of the combined total is accurate, and the comparison to 3M's total is both numerically and qualitatively sound—stating the Caterpillar-J&J total is 'roughly four times larger' is a reasonable approximation (151,915,315 ÷ 39,563,000 ≈ 3.84, which rounds to ~4x). (3) Multi-hop reasoning is correctly executed: the model synthesizes data from three separate companies (Caterpillar, J&J, and 3M), identifies the relevant metric (securities available under shareholder-approved equity plans), computes the combined total, and makes a valid comparative statement. (4) Entity accuracy is perfect—company names, metric descriptions, and contextual details are all correctly identified. (5) Semantic equivalence is maintained: though the LLM uses slightly different phrasing (e.g., '≈ 39,563,000' and 'roughly four times larger'), the meaning is identical to the original answer. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 375,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How do Merck's Januvia and Janumet U.S. market exclusivity expiration timelines (May 2026) and IRA-imposed pricing constraints compare to Pfizer's regulatory exclusivity strategy, and what does this indicate about their respective post-2025 revenue protection mechanisms?",
      "original_answer": "Merck’s Januvia and Janumet are set to lose U.S. market exclusivity in May 2026 due to patent settlements and court rulings, with Janumet XR following in July 2026. Despite this, the IRA mandates government price-setting for Januvia starting in 2026 and for Janumet/Janumet XR in 2027, adding pricing pressure. In contrast, Pfizer relies on both patent rights and concurrent regulatory exclusivity periods upon drug approval to protect revenue beyond patent terms. This indicates that Merck is managing near-term exclusivity erosion through price adjustments and rebate reductions, while Pfizer’s strategy emphasizes regulatory exclusivity as a parallel shield alongside patents, suggesting divergent approaches to post-2025 revenue sustainability.",
      "llm_answer": "Merck’s diabetes franchise will lose its U.S. patent‑based market exclusivity in May 2026 (Janumet XR in July 2026) and, under the Inflation‑Reduction Act, will be subject to a government‑set price for Januvia beginning 1 Jan 2026 and for Janumet/Janumet XR on 1 Jan 2027, which together signal a steep post‑2025 revenue decline. By contrast, Pfizer’s 10‑K emphasizes that its key products (e.g., Comirnaty and Paxlovid) retain basic U.S. patent protection until 2041 and are backed by the standard five‑year (chemical) or twelve‑year (biologic) regulatory exclusivity periods, giving the company a much longer horizon for protecting sales after 2025. Thus, Merck faces an imminent loss of exclusivity and price caps, while Pfizer relies on far‑out patent and regulatory exclusivity to sustain revenue well beyond the mid‑2020s.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core comparison between Merck and Pfizer's post-2025 revenue protection strategies. (1) It correctly identifies Merck's U.S. market exclusivity loss for Januvia and Janumet in May 2026 and Janumet XR in July 2026, aligning with the ground truth. The IRA pricing timelines are slightly misstated: the ground truth specifies Januvia subject to government price-setting in 2026 and Janumet/Janumet XR in 2027, but the LLM specifies January 1, 2026 and January 1, 2027, which is overly precise and not confirmed in the original. While the years are correct, the exact start dates (Jan 1) are not present in the ground truth, introducing unwarranted specificity. (2) The LLM correctly contrasts Pfizer’s reliance on both patent and regulatory exclusivity, citing 5-year (chemical) and 12-year (biologic) periods, and notes long patent protection for Comirnaty and Paxlovid until 2041. However, this detail (2041) is not in the original answer and may reflect external knowledge; while plausible, it goes beyond the provided ground truth, which only states Pfizer uses regulatory exclusivity alongside patents without specifying drugs or dates. (3) The multi-hop reasoning is sound: the model synthesizes Merck’s dual challenge of patent expiration and IRA pricing with Pfizer’s structural advantages in exclusivity, correctly inferring divergent revenue protection strategies. (4) The semantic meaning is equivalent to the ground truth in intent and conclusion, though the LLM adds specificity (exact dates, drug names, extended patent terms) not present in the original. These additions do not contradict but slightly exceed the ground truth. Thus, the answer is highly accurate with minor over-precision and extraneous details, warranting a score of 8. Quantitative accuracy is high but not perfect due to the Jan 1 dates. Qualitative reasoning is strong. Contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 520,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the credit event risk associated with MS's investments in CLNs, which embed credit protection sold to issuers, compare to BAC's use of credit derivatives to mitigate commercial credit exposure, particularly in terms of how each firm manages counterparty risk through derivative instruments?",
      "original_answer": "Morgan Stanley (MS) invests in CLNs and CDOs, which are hybrid instruments containing embedded derivatives in which credit protection has been sold to the issuer of the note. If there is a credit event of a reference entity underlying the instrument, the principal balance of the note may not be repaid in full to the firm, indicating a direct exposure to counterparty risk. This contrasts with Bank of America (BAC), which actively purchases credit protection to cover both funded and unfunded portions of certain credit exposures as part of its commercial credit risk management strategy. BAC also uses credit derivatives to hedge risk, with changes in fair value recorded in other income. Both firms utilize credit derivatives, but MS assumes risk by investing in instruments where it has sold protection, while BAC mitigates risk by purchasing protection.",
      "llm_answer": "- Morgan Stanley’s CLN positions expose the firm to a **credit‑event loss** – the note’s principal may be partially or wholly unrecoverable if a reference entity defaults, because the credit protection is **sold to the issuer** ( MS 10‑K p. 112 ).  Morgan Stanley reins this counter‑party risk by posting collateral and by entering bilateral downgrade agreements that trigger additional collateral or termination payments if a counter‑party’s rating falls ( MS 10‑K p. 110 ).  \n\n- Bank of America, by contrast, uses credit‑derivative contracts (mainly CDS) to **buy protection on its commercial loan and unfunded‑commitment exposures** and sometimes sells protection to offset hedge costs ( BAC 10‑K p. 64‑65 ).  Counter‑party risk is managed through master‑netting arrangements, collateral requirements and ongoing monitoring of credit‑derivative limits, with the derivatives carried at fair value and changes recorded in other income.  \n\nThus, MS’s CLN risk is a direct loss‑given‑default exposure that is mitigated chiefly by collateral and downgrade‑trigger clauses, whereas BAC’s credit‑derivative strategy is a hedging program that limits commercial‑credit risk and controls counter‑party exposure through netting, collateral and fair‑value risk‑management frameworks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Morgan Stanley (MS) assumes credit event risk through its investments in CLNs where it has effectively sold credit protection, exposing it to potential principal loss upon a reference entity's credit event. It contrasts this with Bank of America (BAC), which primarily purchases credit protection via derivatives to hedge commercial credit exposures—this core distinction is accurately captured. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised; the LLM correctly references page numbers from the 10-Ks without introducing false data. (3) The multi-hop reasoning is sound: the model synthesizes information across two firms (MS and BAC), their use of credit derivatives (CLNs vs. CDS), and their opposing risk positions (selling vs. buying protection), then correctly extends to how each manages counterparty risk—MS via collateral and downgrade triggers, BAC via netting, collateral, and fair value accounting. The only minor shortcoming is that the original answer emphasizes BAC’s use of derivatives to cover both funded and unfunded exposures, which the LLM mentions but could have highlighted more clearly. However, it does state 'commercial loan and unfunded-commitment exposures,' which is semantically equivalent. (4) The LLM adds value by specifying mechanisms like 'bilateral downgrade agreements' and 'master-netting arrangements' not explicitly detailed in the original, demonstrating deeper contextual understanding without introducing inaccuracies. Wording differs but meaning is preserved. Thus, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning—justifying a 9/10 on correctness (deducting 1 point for slight under-emphasis on BAC’s funded/unfunded coverage scope).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 523,
        "total_tokens": 2094
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How does the indemnification structure established by 3M in connection with Solventum's spin-off compare to RTX's indemnification arrangements for its financial guarantees, particularly regarding the transfer of liability and the recognition of potential losses?",
      "original_answer": "3M transferred certain liabilities to Solventum as part of the spin-off, including those related to the Bair Hugger and Federal False Claims Act/Qui Tam Litigation, with Solventum assuming indemnification and defense obligations. 3M records liabilities for legal proceedings when probable and estimable, and discloses possible losses when not accrued. Similarly, RTX is subject to indemnification for certain liabilities under its financial guarantees, which could affect its financial exposure. Both companies recognize indemnification rights or obligations as part of their liability management, but 3M explicitly transferred liability to a spun-off entity, whereas RTX retains exposure subject to third-party indemnification terms. This distinction affects how each company accounts for contingent liabilities and insurance receivables under ASC 450 and ASC 610-30.",
      "llm_answer": "3M’s spin‑off agreement moves most of the post‑spin‑off risk to the new company: Solventum assumes the liabilities identified in the separation and distribution agreement and, for certain matters (e.g., the Bair Hugger and Federal False Claims Act actions), Solventum expressly **indemnifies and defends 3M**, leaving 3M with only the PFAS and other liabilities it elected to retain and with no accrued loss for the transferred obligations. By contrast, RTX keeps its financial‑guarantee obligations on its balance sheet; a portion of those guarantees is **subject to indemnification in RTX’s favor**, but the company still records a liability (the “maximum potential payment” and related carrying amount) and accrues for any probable loss, rather than transferring the underlying exposure to another entity. Thus, 3M’s structure shifts liability to the spin‑off and relies on Solventum’s indemnification, whereas RTX retains the liability and merely offsets it with indemnification rights while recognizing the potential loss in its own financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: 3M transferred liabilities (e.g., Bair Hugger, False Claims Act) to Solventum, which assumes indemnification and defense obligations, while 3M retains only specific liabilities like PFAS. RTX, in contrast, retains financial guarantee obligations on its balance sheet and accrues for probable losses despite having indemnification rights. The distinction between liability transfer (3M) versus retention with indemnification (RTX) is correctly articulated. (2) There are no numeric values in the question or answer requiring verification; thus, quantitative accuracy is not applicable in a traditional sense, but the absence of incorrect numbers supports a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (3M and RTX), two types of indemnification structures (spin-off vs. financial guarantees), and accounting implications (liability recognition under ASC 450/610-30). The reasoning correctly identifies that 3M does not accrue losses for transferred obligations because liability was shifted, whereas RTX does accrue due to retained exposure. (4) The only minor shortcoming is that the LLM does not explicitly name the accounting standards (ASC 450 and ASC 610-30) as in the original answer, which slightly reduces qualitative accuracy. However, the conceptual treatment of liability recognition and insurance receivables is implied through accurate description. Overall, the answer is semantically equivalent, contextually precise, and factually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 446,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the geographic revenue distribution of AMD in Taiwan compare to the potential supply chain risk NVIDIA faces through its foundry partners operating in the same region, given the geopolitical tensions mentioned in both companies' filings?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, highlighting the region's significance in its revenue distribution. Meanwhile, NVIDIA explicitly states that its foundry partners—critical to its chipset supply—are primarily located in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent NVIDIA from receiving chipset supply. This indicates that while Taiwan is a notable market for AMD's sales, it represents a core supply chain vulnerability for NVIDIA due to its dependency on foundry partners operating in the region.",
      "llm_answer": "AMD’s 2023 10‑K shows that sales to customers in Taiwan were $1.84 billion, roughly 8 percent of its total $22.68 billion net revenue (AMD 2023 Geographic Revenue table, p. 71). In NVIDIA’s 2023 10‑K the company warns that “geopolitical tensions, such as those involving Taiwan and China, … where we have suppliers, contract manufacturers and assembly partners” could materially disrupt its wafer‑and‑component supply chain (NVIDIA Risk Factors, p. 17). Thus, while AMD’s exposure to Taiwan is quantified at about 8 percent of revenue, NVIDIA’s exposure is expressed as a supply‑chain risk tied to its Taiwan‑based foundry partners, which could affect production even though a specific revenue share is not disclosed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: AMD's $1.84 billion in sales to Taiwan (equivalent to $1,841 million in the original answer) and the 8% of total revenue ($22.68 billion) are accurately reported. The formatting variation ($1.84 billion vs $1,841 million) is acceptable. (2) The LLM correctly identifies that NVIDIA does not disclose a specific revenue share tied to Taiwan but emphasizes supply chain risk through foundry partners in Taiwan, citing the correct risk factor language from its 10-K. (3) The multi-hop reasoning is sound: it contrasts AMD’s market exposure (revenue-side) with NVIDIA’s operational vulnerability (supply chain), synthesizing information from both companies’ filings. (4) The only minor shortcoming is that the LLM does not explicitly name TSMC or refer to 'chipset supply' as in the original, but it accurately captures the essence of foundry dependency and geopolitical risk. Overall, the answer is factually correct, well-contextualized, and directly responsive to the comparative question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 313,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does NEER's 15-year weighted average contract term for repowered wind facilities influence long-term revenue predictability, and how might this structural advantage compare to Southern Power's reliance on power sales agreements where specific contract terms are not disclosed?",
      "original_answer": "NEER benefits from a 15-year weighted average remaining contract term on its power sales agreements tied to repowered wind facilities, which enhances revenue predictability by locking in long-term pricing and output commitments. In contrast, Southern Power discloses its reliance on power sales agreements but does not specify contract durations, limiting visibility into its own revenue stability. This difference suggests NEER may have a more transparent and structured approach to securing long-term cash flows from renewable assets, which could influence investor confidence and financial planning strategies.",
      "llm_answer": "NEER’s portfolio is anchored by long‑term power‑sales contracts that, when the repowered wind assets are included, have a weighted‑average remaining term of roughly 15 years (NEE 10‑K p. 13). That multi‑decade lock‑in smooths earnings and gives the company a high degree of revenue predictability because a substantial share of its wind output is already priced into contracts for the next decade‑plus. By contrast, Southern Power’s results are driven by “power‑sales agreements” whose specific durations and pricing structures are not disclosed (Southern 10‑K p. 81‑82); without known contract lengths, its future cash flows are more exposed to market‑price swings and therefore less certain than NEER’s structurally protected wind revenue stream.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 15-year weighted average remaining contract term for NEER's repowered wind facilities is correctly cited, matching the original answer and referencing the correct source (NEE 10-K p.13). No calculations are required, but the characterization of 'multi-decade lock-in' is a reasonable interpretation of a 15-year average. (2) The contrast with Southern Power is accurate: the LLM correctly states that contract durations are not disclosed (Southern 10-K pp.81-82), which limits revenue certainty—this matches the original answer’s point about limited visibility. (3) Multi-hop reasoning is sound: the model synthesizes information from two different companies’ filings, compares their contract transparency, and draws a logical conclusion about revenue predictability and exposure to market swings. (4) The LLM slightly strengthens the conclusion by describing NEER’s revenue as 'structurally protected' and Southern Power’s as 'more exposed to market-price swings'—while this is a reasonable inference, the original answer is more cautious, focusing on transparency and investor confidence rather than direct financial risk. This minor interpretive leap prevents a perfect 10, but the core facts, entities, and logic are correct. Wording differs but semantic meaning is equivalent. All entities (NEER, Southern Power), metrics (contract term, revenue predictability), and sources are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 409,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does RTX's revenue recognition practices under FAR guidelines for U.S. government fixed-price contracts compare to Honeywell's exposure to contract termination risks under the same regulatory framework?",
      "original_answer": "RTX recognizes revenue in excess of billings under U.S. government fixed-price contracts due to performance-based or progress payments that typically cover only 80-90% of costs incurred, creating contract assets. These practices are governed by the FAR, which outlines allowable costs and payment structures. Honeywell, also subject to the FAR, faces unique risks such as the U.S. government's right to terminate contracts for convenience, which could impact its contract assets or liabilities similarly structured. Both companies are bound by the same FAR-regulated payment and cost frameworks, but Honeywell's risk profile includes potential contract termination that could disrupt revenue already recognized under FAR-compliant accounting practices.",
      "llm_answer": "RTX recognizes revenue on its U.S. government fixed‑price contracts under the FAR on a percentage‑of‑completion (over‑time) basis, so that billings often lag performance and the company records contract‑asset balances until the work is finished. In contrast, Honeywell’s 10‑K notes that its U.S. government contracts are subject to FAR‑governed termination‑for‑convenience rights, exposing the company to the risk that a contract – or a portion of it – could be ended and that it may have to absorb the associated revenue loss or make refunds. Thus, RTX’s FAR‑driven accounting creates contract‑asset timing differences, whereas Honeywell’s FAR exposure is primarily the risk of contract termination.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies RTX's revenue recognition practice under FAR for fixed-price contracts as being on a percentage-of-completion basis, leading to contract assets due to billings lagging performance—this aligns with the original answer's explanation of revenue in excess of billings due to partial cost recovery (80-90%) via progress payments. While the exact '80-90%' figure is omitted in the LLM answer, this is a minor detail and does not affect the overall correctness, as the concept of timing differences creating contract assets is preserved. (2) Quantitatively, there are no numerical inaccuracies; the absence of specific percentages does not constitute an error since the LLM does not make any incorrect claims about numbers. (3) The multi-hop reasoning is sound: the model correctly contrasts RTX’s accounting treatment (contract asset timing) with Honeywell’s termination-for-convenience risk under the same FAR framework, demonstrating proper synthesis across both companies’ disclosures. (4) Entity accuracy is perfect—RTX and Honeywell are correctly identified, and the FAR context is accurately applied to both. The LLM captures the key distinction: RTX faces timing differences in billing vs. revenue recognition, while Honeywell faces termination risk that could reverse recognized revenue. The answer is semantically equivalent to the ground truth, with slightly more concise phrasing. Only a 9 is given because the omission of the 80-90% payment coverage range—while not critical—adds contextual precision present in the original. Otherwise, reasoning, relevance, and factual accuracy are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 466,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the absence of voting rights associated with Alphabet's Class C Capital Stock compare to Comcast's relinquishment of voting rights in Hulu, particularly in terms of governance control and financial outcomes?",
      "original_answer": "Alphabet's Class C Capital Stock has no voting rights except as required by law, which allows the company to maintain control through higher-vote Class A and Class B shares while repurchasing non-voting shares to optimize capital structure. In 2024, Alphabet had $44.7 billion remaining available for Class A and Class C share repurchases. In contrast, Comcast relinquished substantially all voting rights in Hulu in 2019, giving Disney full operational control, and exercised a put option in 2023 to sell its interest for a minimum equity value of $9.2 billion. This resulted in a $8.6 billion payment from Disney (net of $557 million for prior capital calls) and a recorded investment value of $883 million as of December 31, 2024. Both companies strategically managed voting rights to influence governance and financial returns, albeit through different mechanisms and outcomes.",
      "llm_answer": "Alphabet’s non‑voting Class C capital stock gives its holders the same economic and dividend rights as the voting classes, but they have no say in corporate governance—the company’s control remains with the voting Class A and Class B shareholders (the founders) and the stock is simply repurchased like any other share【page_82】.  \n\nBy contrast, Comcast voluntarily gave up its board seats and “substantially all voting rights” in Hulu, ceding full operational control to Disney; the relinquishment generated a cash‑flow event—Disney paid Comcast an $8.6 billion minimum‑value settlement and a tax‑gain, while Comcast’s remaining equity‑method investment is now recorded at a value far below its fair value【page_85】.  \n\nThus, Alphabet’s non‑voting shares affect only voting power, leaving its financial position unchanged, whereas Comcast’s surrender of voting rights produced a concrete financial payout and a reduced accounting value for the underlying investment.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core distinction between Alphabet's structural use of non-voting shares and Comcast's strategic relinquishment of voting rights for financial gain. It accurately describes Alphabet’s Class C shares as having no voting rights but full economic rights, with control retained by Class A and B shareholders. It also correctly states that Comcast gave up substantially all voting rights in Hulu, leading to Disney gaining full operational control. (2) However, there are minor quantitative inaccuracies: the $8.6 billion payment from Disney is correctly cited, but the LLM omits that this was net of $557 million for prior capital calls and does not mention the $9.2 billion minimum equity value of the put option exercised in 2023. Additionally, the LLM fails to include Alphabet’s $44.7 billion remaining share repurchase authorization in 2024 and the $883 million recorded investment value for Comcast as of December 31, 2024—both key financial figures in the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes governance and financial implications across two different companies and events, correctly contrasting Alphabet’s capital structure strategy with Comcast’s divestiture-driven control surrender. It identifies the different outcomes—Alphabet maintains control without financial event, while Comcast receives payout and reduces investment value. (4) Despite missing specific numbers, the qualitative analysis and conceptual comparison are strong, and the answer remains highly relevant to the question. The omission of precise figures prevents a top score on quantitative accuracy, but reasoning and relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 465,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "Given LLY's ongoing challenges scaling production of incretin products while relying on third-party manufacturers, and TMO's $26.92 billion in remaining performance obligations—many tied to contract manufacturing over 3-5 year durations—how might shared vulnerabilities in quality assurance and supply chain execution affect both companies' ability to fulfill long-term commitments?",
      "original_answer": "LLY is experiencing intermittent supply delays for incretin products like Mounjaro and Zepbound, with tight supply expected to persist until additional manufacturing capacity becomes operational 'in the next several years.' These production constraints are tied to reliance on third-party manufacturers, which face quality assurance risks that could lead to regulatory actions, product recalls, or delays in approvals. Meanwhile, TMO has $26.92 billion in remaining performance obligations, with a significant portion linked to contract manufacturing agreements that typically span 3-5 years. If third-party manufacturers fail to maintain quality standards or encounter capacity limitations—as AMD also highlights in its 10-K—both companies could face fulfillment risks: LLY may struggle to meet patient demand amid supply volatility, while TMO could face delays or defaults on long-term manufacturing contracts, impacting revenue recognition and customer relationships.",
      "llm_answer": "Both Eli Lilly’s difficulty in scaling its incretin medicines—because it must depend on external manufacturers for capacity, yields and quality‑control—and Thermo Fisher’s $26.9 billion of performance‑obligation revenue that is largely tied to three‑to‑five‑year contract‑manufacturing arrangements share the same exposure: any lapse in a supplier’s ability to deliver product on time, at acceptable yields or to required quality standards can force allocation of limited supply, trigger penalties or lost sales, and erode customer relationships, jeopardizing each company’s ability to meet its long‑term contractual commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core multi-hop reasoning required. (1) Quantitatively, the $26.9 billion figure for TMO's performance obligations is correctly reported (ground truth: $26.92 billion; minor rounding to $26.9B is acceptable). No other numbers are misstated. (2) The answer correctly identifies both companies (LLY and TMO, referred to as Thermo Fisher), their respective challenges—LLY's reliance on third-party manufacturers for incretin drugs like Mounjaro/Zepbound and TMO's long-duration contract manufacturing obligations—and links them through shared supply chain and quality control risks. (3) The reasoning is sound: it synthesizes the vulnerability in third-party manufacturing (quality, yield, timing) and correctly infers downstream impacts—supply allocation, penalties, lost sales, damaged customer relationships—for both firms. It does not explicitly mention 'regulatory actions or recalls' or 'revenue recognition' as in the ground truth, which are minor omissions, but the essence of fulfillment risk to long-term commitments is clearly conveyed. (4) The term 'performance-obligation revenue' slightly conflates the concept of 'remaining performance obligations' (a backlog metric, not recognized revenue), but this is a nuanced accounting distinction and does not undermine the overall correctness. The answer is contextually spot-on, directly addressing how shared vulnerabilities affect both companies' ability to fulfill commitments. Minor deduction from 10 due to slight simplification of financial terminology and omission of regulatory risk specifics, but overall excellent alignment with ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 450,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What was the total cumulative impairment charge recognized by NextEra Energy Resources on its investment in XPLR as of December 31, 2024, and how does this compare to the carrying value of the investment before the 2024 impairment?",
      "original_answer": "As of December 31, 2024, NextEra Energy Resources had recognized a cumulative impairment charge of $2.0 billion on its investment in XPLR, combining the $1.2 billion impairment from September 30, 2023, and the $0.8 billion impairment from December 31, 2024. The carrying value of the investment before the 2024 impairment was approximately $2.6 billion, which was then written down to $1.8 billion after the 2024 impairment.",
      "llm_answer": "NextEra Energy Resources has recorded a **cumulative other‑than‑temporary impairment of roughly $2.0 billion** on its XPLR investment (the $1.2 billion impairment recognized in 2023 plus the $0.8 billion impairment recognized in 2024). Before the 2024 write‑down, the equity‑method investment was carried at **about $2.6 billion** on the balance sheet. Thus, the total impairments have reduced the carrying amount from $2.6 billion to an estimated fair value of about $1.8 billion.【page_92】【page_92】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts from the ground truth: the cumulative impairment charge of $2.0 billion, composed of a $1.2 billion impairment in 2023 and a $0.8 billion impairment in 2024. It accurately states the carrying value before the 2024 impairment was $2.6 billion and that the investment was written down to $1.8 billion after the 2024 impairment. (2) All numeric values match the ground truth exactly, and the sum ($1.2B + $0.8B = $2.0B) is correct. The before-and-after carrying values ($2.6B → $1.8B) are accurate and consistent with the $0.8B 2024 impairment. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two reporting periods (2023 and 2024) and two impairment events, correctly aggregating them into a cumulative charge and tracking the impact on carrying value. (4) The answer uses slightly different phrasing (e.g., 'other-than-temporary impairment', 'equity-method investment') but maintains full semantic equivalence with the original answer. All entities—NextEra Energy Resources, XPLR, correct years, and financial terms—are accurate. No omissions or errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 329,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does the adoption of ASU 2022-04 by GE impact its transparency around supplier finance obligations compared to MMM's disclosures under the same standard, particularly in terms of confirmed invoice balances and presentation in financial statements?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, which requires retrospective disclosures for supplier finance programs, with the annual roll-forward information applicable prospectively starting January 1, 2024. This means GE began disclosing key terms, balance sheet presentation, and confirmed amounts outstanding from its supplier finance programs in 2024. Similarly, MMM discloses that as of December 31, 2024 and 2023, its outstanding balances of confirmed invoices under supplier finance programs were approximately $0.3 billion each, and these amounts are included within accounts payable on MMM's consolidated balance sheet. Both companies now provide clearer visibility into their supplier finance obligations under the new standard, with MMM specifically quantifying its confirmed invoice balances and their classification in accounts payable, aligning with the enhanced disclosure requirements introduced by ASU 2022-04.",
      "llm_answer": "GE says it adopted ASU 2022‑04 on 1 Jan 2023 and that the change “did not have a material impact on the Company’s consolidated financial statements.” The filing only notes that the company evaluates supply‑chain finance programs and would re‑classify trade payables as borrowings if the nature of the payables changed, but it does not disclose a specific confirmed‑invoice balance or present a separate line‑item for the obligation.  \n\nIn contrast, 3M’s Note 16, prepared under the same ASU, quantifies the supplier‑finance program – reporting about $0.3 billion of confirmed‑invoice balances outstanding at year‑end 2024 (and the same amount in 2023) and stating that these amounts are included in accounts payable on the balance sheet. Thus MMM’s disclosure is far more granular, giving a concrete balance and explicitly showing where it appears in the financial statements, whereas GE’s disclosure is limited to a qualitative statement of adoption with no disclosed balance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: GE adopted ASU 2022-04 on January 1, 2023, with prospective roll-forward disclosures starting January 1, 2024. The LLM correctly notes that GE did not disclose a specific confirmed invoice balance or a separate line item, only a qualitative statement. For MMM, the LLM accurately reports the $0.3 billion outstanding confirmed invoice balances for both 2023 and 2024, and that these are included in accounts payable—matching the original answer. (2) Quantitative accuracy is perfect: the $0.3 billion figure is correctly cited for both years and companies, and dates (Jan 1, 2023 adoption; year-end 2023 and 2024) are consistent with the ground truth. (3) Multi-hop reasoning is sound: the LLM correctly compares GE’s lack of quantitative disclosure with MMM’s specific, granular reporting under the same standard, highlighting differences in transparency. (4) The only minor shortcoming is that the LLM does not explicitly mention that GE will begin providing retrospective disclosures in 2024 (as per the original answer), though it implies future disclosure by referencing the adoption timeline. This omission is minor given the focus on current transparency. Wording differs but semantic meaning and factual content are equivalent. The answer is fully relevant and directly addresses the comparative transparency question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 396,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does Altria's equity-method accounting for its Cronos investment expose it to financial risks tied to Cronos's compliance with FDA regulations, and how does this compare to Walmart's exposure through its pharmacy operations under the same regulatory framework?",
      "original_answer": "Altria's investment in Cronos is accounted for under the equity method, meaning its financial statements reflect Altria's share of Cronos's earnings or losses. Since Cronos operates in the cannabis-derived product space, it is subject to FDA regulations in the U.S., and any failure to comply could result in fines, penalties, or reputational harm, directly impacting Cronos's financial performance and, by extension, Altria's earnings. Walmart also faces exposure through its pharmacy operations, which must comply with FDA regulations governing the dispensing and sale of pharmaceuticals. Walmart notes that noncompliance could lead to significant sanctions and operational disruptions, mirroring the regulatory risk profile faced by Cronos. Both companies are thus financially exposed to the same regulatory framework, though through different business models and investment structures.",
      "llm_answer": "Altria records its 13 % stake in Cronos under the equity method, so the company’s reported earnings and the carrying value of the investment rise and fall with Cronos’s results.  Because Cronos’s U.S. cannabis business must obey FDA (and other federal) regulations, any FDA‑related enforcement action—such as civil or criminal penalties, loss of capital or reputational damage—could force Altria to record an impairment or reduce its share of Cronos’s earnings, directly hurting Altria’s net income and equity.  \n\nWalmart’s pharmacy business is not an equity‑method investment; it is a core operating segment that must comply with FDA, DEA and related pharmacy regulations.  Non‑compliance would expose Walmart to fines, license suspensions or litigation that would directly reduce pharmacy profitability, but the impact is confined to its own operations rather than flowing through an equity‑method accounting relationship.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Altria uses equity-method accounting for its investment in Cronos, which exposes it to Cronos's financial performance, including risks from FDA noncompliance. Walmart faces direct regulatory exposure through its pharmacy operations. The distinction between equity-method exposure (Altria) and operational exposure (Walmart) is correctly articulated. (2) Quantitatively, the 13% stake is factually accurate and consistent with public filings; no other numerical data (e.g., dollar amounts, dates) are present, and none are required. Format and precision are appropriate. (3) Multi-hop reasoning is sound: the model correctly synthesizes accounting treatment (equity method), regulatory framework (FDA), and cross-company comparison of risk transmission mechanisms. The only minor shortcoming is that the original answer emphasizes the similarity in regulatory risk profile despite different business models, while the LLM focuses more on differences. This slightly reduces qualitative completeness but does not introduce error. (4) The response is fully contextually relevant, directly addressing both companies, their respective regulatory exposures, and the financial accounting implications. Overall, the answer is factually excellent with only a slight nuance missing in comparing the similarity of risk profiles, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 402,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does LLY's reliance on Cardinal Health for U.S. distribution impact CVS's consolidated financial exposure to Red Oak Sourcing, given Cardinal's dual role in the joint venture?",
      "original_answer": "LLY depends on Cardinal Health for 15-20% of its U.S. revenue through distribution, which makes Cardinal a critical link in LLY's supply chain. Cardinal also co-owns Red Oak Sourcing with CVS, a generic pharmaceutical sourcing entity that CVS consolidates due to its primary beneficiary status. As part of the Red Oak arrangement, Cardinal makes quarterly payments to CVS (e.g., $183 million annually as of 2021), which reduce CVS's inventory costs. Therefore, any disruption in Cardinal's ability to distribute LLY products could affect Cardinal’s financial health, which in turn could impact its ability to meet its financial commitments to Red Oak—and consequently, CVS’s consolidated financial position.",
      "llm_answer": "Lilly’s 10‑K notes that about 15‑20 % of its U.S. drug sales are shipped through Cardinal Health, which also serves as Lilly’s co‑owner of the Red Oak generic‑sourcing joint venture (LLY and Cardinal each own 50 %).  Cardinal’s quarterly reimbursements to Lilly for Red Oak are described as “immaterial” to Lilly’s results (LLY 10‑K p. 138), and Lilly is the primary beneficiary that consolidates Red Oak.  Because CVS’s exposure to Red Oak is only indirect—through its reliance on Cardinal as a wholesale distributor—and the payments and liabilities associated with Red Oak are immaterial, CVS’s consolidated financial exposure to the venture is negligible.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains multiple critical factual and entity errors that severely undermine its correctness. (1) Entity Accuracy: The LLM incorrectly states that Lilly (LLY) co-owns Red Oak Sourcing with Cardinal Health and is the primary beneficiary that consolidates Red Oak. In reality, Red Oak Sourcing is a joint venture between Cardinal Health and CVS, not Lilly. Lilly has no ownership stake in Red Oak. This fundamental misidentification of entities invalidates the entire reasoning chain. (2) Quantitative Accuracy: While the 15–20% figure for LLY’s U.S. revenue distributed through Cardinal is correct, the claim that Cardinal makes 'immaterial' payments to Lilly is false—the ground truth states Cardinal makes $183 million annually in payments to CVS (not Lilly) as part of the Red Oak arrangement. The LLM fabricates a financial relationship between Cardinal and Lilly that does not exist. (3) Reasoning: The multi-hop logic fails because it is based on incorrect premises. The question asks how LLY’s reliance on Cardinal affects CVS’s exposure to Red Oak. The correct reasoning path is: LLY → depends on Cardinal for distribution → Cardinal is financially tied to Red Oak (with CVS) → Cardinal’s financial health affects Red Oak → impacts CVS. The LLM inverts this by inserting LLY as a party in Red Oak, which is false, and concludes CVS has negligible exposure, which contradicts the ground truth that CVS’s consolidation of Red Oak creates meaningful exposure. (4) Semantic Equivalence: The answer is not semantically equivalent—it conveys a completely different and incorrect financial structure. (5) Contextual Relevance: The answer addresses distribution reliance and financial exposure, so it is partially relevant, but the incorrect entities and relationships make it misleading. Overall, the answer fails on core facts, calculations, and logic, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 512,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Oracle's use of its $6.0 billion commercial paper program for short-term financing compare to Cisco's debt structure, particularly in light of Cisco's $13.5 billion senior fixed-rate note issuance and the pari passu ranking of those notes with commercial paper obligations?",
      "original_answer": "Oracle utilizes a $6.0 billion commercial paper program for short-term financing, with $401 million in outstanding notes as of May 31, 2024, which mature through August 2024. These notes are unsecured and issued under a private placement exemption. In contrast, Cisco issued $13.5 billion in senior fixed-rate notes in February 2024, which are redeemable at any time with a makewhole premium and are ranked at par with Cisco’s own commercial paper obligations. This indicates that while both companies use commercial paper as part of their short-term financing strategies, Cisco has a significantly larger long-term debt component through its senior notes, which are hedged via interest rate swaps to manage interest rate exposure.",
      "llm_answer": "Oracle’s $6 billion commercial‑paper program is a short‑term, unsecured financing tool that it uses only for general corporate purposes, with outstanding CP balances of about $0.4 billion (2024) and $0.6 billion (2023). Cisco, by contrast, maintains a much larger CP facility of up to $15 billion (about $10.9 billion outstanding) and in February 2024 issued $13.5 billion of senior fixed‑rate notes; those senior notes are expressly ranked pari‑passu with the commercial‑paper obligations, giving the notes the same seniority as Cisco’s CP debt. Thus Oracle relies on a modest CP program for short‑term needs, while Cisco couples a sizable CP program with senior notes that share equal seniority with its CP liabilities.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the core comparison between Oracle and Cisco's debt structures correctly: Oracle uses a $6.0 billion commercial paper (CP) program with minimal outstanding ($0.4 billion mentioned, close to ground truth $401 million), while Cisco issued $13.5 billion in senior fixed-rate notes ranked pari passu with its CP obligations. However, there are key quantitative inaccuracies: the LLM states Cisco has a 'much larger CP facility of up to $15 billion' and '$10.9 billion outstanding'—this is not supported by the ground truth, which does not specify the size of Cisco’s CP program or its outstanding balance beyond the $13.5B notes. This introduces a significant factual error. 2) Numbers: Oracle’s CP program size ($6B) and approximate outstanding ($0.4B) are accurate (matches $401M in ground truth). Cisco’s $13.5B senior note issuance in February 2024 is correct. But the $15B CP facility and $10.9B outstanding for Cisco are fabricated or misattributed—no such figures appear in the original answer. 3) Reasoning: The multi-hop synthesis is mostly sound—correctly identifying that both companies use CP, and that Cisco’s senior notes rank pari passu with CP, indicating equal seniority. It correctly contrasts Oracle’s reliance on modest CP with Cisco’s use of large-scale long-term debt. However, the erroneous claim about Cisco’s CP size undermines the quantitative comparison. 4) Despite the incorrect CP facility size and outstanding amount for Cisco, the qualitative insight about Cisco combining a large CP program with pari passu senior notes is directionally correct and relevant. The answer remains contextually appropriate and conveys the essential financial structure contrast, just with flawed specifics on Cisco’s CP. Hence, correctness is reduced due to unsupported numbers, but not severely because the core comparative insight holds.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 504,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Duke Energy's reliance on wind energy in its Commercial Renewables segment compare with Southern Company's strategic commitment to the Skookumchuck wind project, given the 136 MW nameplate capacity and 20-year PPA term associated with Skookumchuck?",
      "original_answer": "Duke Energy's Commercial Renewables segment relies on wind as one of several generation sources, alongside solar, fuel cells, and batteries, but does not disclose specific capacity figures for wind. In contrast, Southern Company's Skookumchuck wind project has a defined 136 MW nameplate capacity and is supported by a 20-year PPA, indicating a concrete long-term commitment to wind energy in a specific geographic location (Lewis and Thurston Counties, WA). While both companies are engaged in wind energy, Southern's detailed disclosure around capacity and contract duration provides clearer evidence of a targeted wind strategy compared to Duke's broader renewable portfolio approach.",
      "llm_answer": "Duke Energy’s Commercial Renewables segment draws on wind power as one component of a diversified portfolio that also includes solar, fuel‑cell and battery assets, but the filing does not single out a specific wind‑only project or long‑term contract. In contrast, Southern Company’s strategy highlights a concrete wind commitment – the 136 MW Skookumchuck facility, which is owned by Southern Power and secured by a 20‑year power‑purchase agreement. Thus, Duke’s wind exposure is part of a broader mix, whereas Southern’s is anchored in a defined 136‑MW, 20‑year wind project.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Duke Energy's Commercial Renewables segment includes wind as part of a diversified portfolio without disclosing specific wind capacity, while Southern Company's Skookumchuck project has a 136 MW nameplate capacity and a 20-year PPA. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect: the 136 MW and 20-year PPA duration are correctly reported with no calculation errors. (3) The multi-hop reasoning is sound—comparing Duke’s broad renewable strategy with Southern’s specific, contract-backed wind project demonstrates proper synthesis across entities and strategies. (4) The only minor limitation is that the LLM does not explicitly name the location (Lewis and Thurston Counties, WA) mentioned in the original answer, but this detail is contextual and not central to the core comparison. The LLM correctly identifies Southern Power as the owner, which adds precision beyond the original. Wording differs slightly but maintains semantic equivalence. Overall, the answer is factually complete, logically structured, and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 336,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does the capital buffer requirement structure under the Advanced Approach for MS compare with SCHW's requirements, given the role of the Countercyclical Capital Buffer which is currently set at zero by the Federal Reserve?",
      "original_answer": "Morgan Stanley's (MS) capital buffer requirement under the Advanced Approach includes a fixed 2.5% Capital Conservation Buffer, a G-SIB capital surcharge, and the Countercyclical Capital Buffer (CCyB), which is currently set at zero by the Federal Reserve. Schwab (SCHW) is also subject to the same CCyB, which was zero as of December 31, 2023, and must maintain a 2.5% Capital Conservation Buffer. Therefore, both firms have identical Capital Conservation Buffer percentages and are influenced by the same CCyB policy, though SCHW is not subject to the G-SIB surcharge that applies to systemically important institutions like MS.",
      "llm_answer": "Under the Advanced Approach, Morgan Stanley must hold a 2.5 % capital‑conservation buffer **plus** a 3.0 % G‑SIB surcharge – a total buffer of **5.5 %** (the counter‑cyclical buffer is 0 % because the Fed has set it at zero).  \nCharles Schwab’s requirements consist of a 2.5 % stress‑capital buffer and a 2.5 % capital‑conservation buffer – a total buffer of **5.0 %**, also with a 0 % counter‑cyclical buffer.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains partially correct information but introduces significant inaccuracies. It correctly states that Morgan Stanley (MS) must maintain a 2.5% Capital Conservation Buffer and is subject to a G-SIB surcharge, and that the Countercyclical Capital Buffer (CCyB) is 0%. However, it incorrectly specifies the G-SIB surcharge as 3.0%—the original answer does not provide a specific percentage for MS's G-SIB surcharge, only that it applies. This specific numerical claim is unsupported by the ground truth. Additionally, the LLM claims Schwab (SCHW) has a '2.5% stress-capital buffer' and a '2.5% capital-conservation buffer', totaling 5.0%. This is incorrect: the ground truth states SCHW must maintain only a 2.5% Capital Conservation Buffer and does not mention a stress-capital buffer. There is no indication in the original answer that Schwab has a dual buffer structure. 2) Quantitative inaccuracies include the fabricated 3.0% G-SIB surcharge for MS and the invented 2.5% stress-capital buffer for SCHW. While the total buffer calculations (5.5% for MS and 5.0% for SCHW) are mathematically consistent within the LLM’s own assumptions, those assumptions are factually incorrect. The ground truth confirms only the 2.5% Capital Conservation Buffer for both, with MS having additional unspecified G-SIB surcharge and CCyB at zero for both. 3) The multi-hop reasoning is partially sound in that the model recognizes both firms are subject to the same CCyB (0%) and have the 2.5% Capital Conservation Buffer. It also correctly identifies that MS, as a G-SIB, has an additional surcharge while SCHW does not. However, the introduction of a non-existent stress-capital buffer for SCHW and the specific 3.0% G-SIB value breaks the reasoning chain and reflects a failure to accurately synthesize the provided information. 4) The contextual relevance is high—the answer addresses the structure of capital buffers, compares MS and SCHW, and incorporates the CCyB policy. However, due to key factual and quantitative errors in buffer components and values, the correctness and qualitative accuracy scores are moderate. The answer conveys a misleading impression of the actual regulatory requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 588,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does Disney's use of discounted cash flow models for valuing Level 2 derivatives compare to Meta's application of the same models in assessing impairment losses on operating lease assets, given Disney's $383 million impairment charge in fiscal 2024?",
      "original_answer": "Disney utilizes internal discounted cash flow models with observable inputs like interest rates and foreign exchange rates to value its Level 2 derivatives, ensuring fair value estimates remain accurate and counterparty risk is mitigated. Meanwhile, Meta applies discounted cash flow models with Level 3 inputs—such as projected sublease income and downtime assumptions—to estimate the fair value of impaired operating lease assets, which led to a $383 million impairment charge in 2024. While both companies use discounted cash flow techniques, Disney applies them in a Level 2 fair value context for derivatives, whereas Meta uses them in a Level 3 context for non-recurring asset impairments.",
      "llm_answer": "Disney values its Level 2 derivatives with internal discounted‑cash‑flow models that rely on observable market inputs such as interest‑rate curves, yield curves and foreign‑exchange rates, and the credit‑risk impact is not material. Meta, by contrast, uses discounted‑cash‑flow (income‑approach) models with Level 3, unobservable market‑participant assumptions to estimate the fair value of operating‑lease right‑of‑use assets and leasehold improvements, which led to a $383 million impairment charge in fiscal 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $383 million impairment charge in fiscal 2024 is correctly attributed to Meta, matching the original answer. There are no calculation errors or incorrect figures. (2) Entity accuracy is strong: Disney and Meta are correctly identified, with proper linkage to Level 2 derivatives (Disney) and operating lease impairments (Meta). Fiscal year 2024 is correctly referenced. (3) The multi-hop reasoning is sound—LLM correctly contrasts Disney’s use of discounted cash flow (DCF) models with observable (Level 2) inputs for derivatives valuation versus Meta’s use of DCF with unobservable (Level 3) inputs for impairment of lease assets. The distinction between Level 2 and Level 3 inputs is accurately captured. (4) The only minor shortcoming is that the LLM does not explicitly state that Disney’s counterparty risk is mitigated (a small omission in qualitative detail), and it does not directly compare the two applications in a concluding sentence as the original answer does. However, the semantic meaning and technical accuracy are equivalent. Wording differences (e.g., 'income-approach' models, 'right-of-use assets') add precision without deviating from truth. All key components of the multi-hop comparison are present and correctly synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 373,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the 8.2% increase in Turkey's total tobacco market volume, partly offset by higher illicit trade prevalence, impact PM's market share dynamics, and how does this compare to MO's exposure to illicit trade risks in the broader context of their respective tobacco businesses?",
      "original_answer": "PM's shipments in Turkey increased to 55.7 billion units in 2021 from 47.5 billion in 2020, contributing to a rise in its market share from 41.3% to 44.8%. This growth was partly offset by a higher estimated prevalence of illicit trade in Turkey, which negatively impacts legitimate sales and tax revenues. Similarly, MO highlights that illicit trade in tobacco products, including counterfeit goods and untaxed sales, adversely affects its business by reducing lawful sales and potentially triggering regulatory actions. While PM directly benefits from increased volume in Turkey despite illicit trade, MO emphasizes the broader systemic risks illicit trade poses to the tobacco industry, including brand dilution and loss of tax revenues that could lead to stricter regulations.",
      "llm_answer": "In Turkey, the 8.2 % rise in total market volume – even though it was partly offset by a higher prevalence of illicit trade – still allowed Philip Morris International to grow its shipment volume in the country by 17.2 % and lift its Middle‑East & Africa regional market‑share by 1.1 percentage point to 23.1 % (see PM pages 56‑57). By contrast, Altria’s 2022 filing flags illicit‑trade activity as a broad, systemic risk that can erode sales, tax revenues and brand equity across its U.S. and international tobacco businesses, without a specific offsetting market‑share gain (MO pages 40‑44). Thus, PM turned Turkey’s market expansion – despite illicit‑trade pressure – into a share‑gain, whereas MO views illicit trade primarily as a downside exposure that could threaten its overall tobacco business.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While the 8.2% increase in Turkey's total tobacco market volume is mentioned in the question, it is not verified in the ground truth, and the LLM incorrectly attributes a 17.2% shipment growth to PM without grounding it in the provided data. The ground truth states PM's shipments increased from 47.5B to 55.7B units, which is a 17.26% increase—so this number is accidentally correct—but the LLM does not reference the correct absolute figures or Turkey-specific market share. Instead, it cites a 1.1 percentage point increase in PM's Middle-East & Africa regional market share to 23.1%, which is irrelevant to Turkey specifically and contradicts the ground truth that PM's *Turkey* market share rose from 41.3% to 44.8%. This misrepresents the geographic scope of the data. (2) The reference to MO’s 2022 filing (pages 40–44) discussing illicit trade as a systemic risk aligns qualitatively with the ground truth, though no specific numbers are provided, which is acceptable. However, the LLM fails to mention MO’s exposure in the context of specific markets or quantify any impact, missing an opportunity for direct comparison. (3) The multi-hop reasoning is partially sound—comparing PM’s ability to grow share despite illicit trade to MO’s more defensive stance on illicit trade risks—but it is undermined by incorrect data mapping (regional vs. country-level market share). The synthesis is conceptually valid but factually flawed. (4) The contextual relevance is high because the answer addresses both companies and the role of illicit trade in their business dynamics. However, due to major quantitative errors and misattribution of market share data, the correctness score is low. The qualitative accuracy is moderate because the reasoning framework is logical, but entity and metric accuracy are poor.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 509,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the redesign of the Medicare Part D program under the Inflation Reduction Act affect both CVS's financial exposure to Medicare Part D liabilities and AbbVie's pricing strategy for drugs like Imbruvica under Medicare Part D?",
      "original_answer": "The redesign of the Medicare Part D program under the Inflation Reduction Act shifts more claim liability to insurers like CVS, which could negatively impact their profitability due to increased financial risk and administrative complexity. At the same time, AbbVie is subject to government-set pricing for certain drugs, such as Imbruvica, starting in 2026, which will cap reimbursement rates at a statutory ceiling likely below current average prices, significantly affecting revenue projections. These changes create a dual pressure where CVS faces higher liability and AbbVie faces downward pricing pressure, both under the same regulatory framework.",
      "llm_answer": "The Inflation Reduction Act’s redesign of Medicare Part D moves a larger share of the drug‑claim risk from the federal government to the health‑plan side of the program – a shift that raises CVS’s potential liability for Part D claims and therefore increases its financial exposure to those obligations. At the same time, the same reform caps and sets prices for certain single‑source drugs in Part D; AbbVie’s Imbruvica was named one of the first ten products to be subject to a government‑set price beginning in 2026, forcing the company to price the drug at a statutory ceiling and accept lower reimbursements under the new Part D discount structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the Inflation Reduction Act shifts more financial risk to insurers like CVS, increasing their liability exposure; AbbVie's Imbruvica is subject to government-set pricing starting in 2026. (2) Quantitative elements—specifically the 2026 start date for price controls on Imbruvica—are correctly stated and match the original answer. No numerical calculations are required, but the temporal and structural details (e.g., 'beginning in 2026') are precise. (3) Multi-hop reasoning is sound: the answer correctly links policy changes to two distinct entities (CVS as insurer, AbbVie as drug manufacturer) and explains the divergent financial impacts—increased liability for CVS and reduced reimbursement due to price caps for AbbVie. (4) The response fully addresses both parts of the question, uses correct entity names (CVS, AbbVie, Imbruvica), and accurately describes the regulatory mechanism (government-set pricing, statutory ceiling, Part D redesign). Wording differs slightly but meaning is preserved with high fidelity. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 337,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Boeing's use of third-party aircraft value publications for valuing impaired customer financing assets compare to RTX's quarterly valuation methodology for private equity limited partnerships, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "Boeing derives the fair value of impaired customer financing assets, including operating lease equipment, by calculating a median collateral value from a consistent group of third-party aircraft value publications, which are based on market trades and other market factors. Management reviews these publications quarterly and may adjust values based on specific aircraft attributes. In contrast, RTX values private equity limited partnerships quarterly using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results or financial condition of the portfolio companies. Both approaches rely on unobservable inputs typical of Level 3 assets, but Boeing leans more on consistent third-party market data while RTX applies more forward-looking financial modeling.",
      "llm_answer": "Boeing values its impaired customer‑financing assets by taking a median collateral value from a set of third‑party aircraft‑value publications and then adjusting for aircraft condition; the publications are based on market‑trade knowledge but the adjustments are considered significant **unobservable (Level 3) inputs**. RTX, by contrast, values its private‑equity limited‑partnership interests each quarter with internal discounted‑cash‑flow, earnings‑multiple and market‑multiple models (or, alternatively, the fund’s reported NAV per unit as a practical expedient), which also depend on **significant unobservable inputs**. Thus both companies rely on Level 3‑type inputs, but Boeing leans on external aircraft‑valuation data, whereas RTX builds its own valuation models (or uses NAV) for the private‑equity holdings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Boeing uses a median from third-party aircraft value publications, adjusts for specific aircraft attributes (unobservable inputs), and reviews quarterly. RTX uses discounted cash flows, earnings multiples, and market multiples for private equity valuations, with reliance on unobservable inputs. Both are classified as Level 3 assets due to significant unobservable inputs. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in numbers or calculations. (3) The multi-hop reasoning is sound: the model correctly contrasts Boeing’s reliance on external market-based data with RTX’s internal modeling approach, capturing the key distinction in methodology despite both using Level 3 inputs. (4) Minor difference: the LLM mentions RTX may use NAV per unit as a practical expedient, which is not in the original answer—this is a plausible detail consistent with accounting standards but not confirmed in the ground truth. This addition does not detract from accuracy but slightly extends beyond the provided information. Overall, the answer is semantically equivalent, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 373,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does the voting power disparity between Class A and Class B common stock at META and GOOGL affect the concentration of corporate control, particularly given META's outstanding share structure and GOOGL's recent share repurchase activity?",
      "original_answer": "At META, Class A common stock has full voting rights while Class B common stock has no voting rights except in limited circumstances, which concentrates control among Class A shareholders. As of January 24, 2025, META had 2,189,898,148 shares of Class A common stock and 343,761,117 shares of Class B common stock outstanding, indicating a significant majority of voting power is held by Class A shareholders. In contrast, at GOOGL, Class B common stockholders have 10 votes per share compared to 1 vote per share for Class A, giving disproportionate voting control to Class B holders. GOOGL repurchased $62.0 billion of Class A and Class C shares in 2024, which could further consolidate voting power among remaining Class B shareholders by reducing the overall number of voting shares in circulation.",
      "llm_answer": "Meta’s charter gives each Class A share one vote and each Class B share ten votes.  At year‑end 2024 Meta had about 2.19 billion Class A shares and 0.34 billion Class B shares, so roughly 60 % of all voting power resides in the much smaller block of Class B stock, concentrating control in the handful of holders of that class.  Google’s structure is the same (Class A = 1 vote, Class B = 10 votes, Class C = no vote), and its recent buy‑backs of tens of millions of Class A shares and hundreds of millions of non‑voting Class C shares have shrunk the pool of voting‑eligible shares, thereby raising the percentage of total votes held by the remaining Class B holders and further concentrating corporate control.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) It incorrectly states that Meta's Class B shares have 10 votes and Class A have 1 vote, when in fact the opposite is true: Class A shares have full voting rights (1 vote per share) and Class B shares have no voting rights except in limited circumstances. This fundamental error reverses the entire voting structure and leads to a completely incorrect conclusion about control concentration. (2) The claim that '60% of all voting power resides in the much smaller block of Class B stock' is false under the correct structure; since Class B shares have no voting rights, 100% of voting power is held by Class A shareholders. (3) The share counts are approximately correct (2.19B vs 2.189B Class A; 0.34B vs 0.344B Class B), but the interpretation is wrong due to the inverted voting rights. (4) For GOOGL, the description of share classes is mostly correct (Class A = 1 vote, Class B = 10 votes, Class C = no vote), but the repurchase activity is inaccurately described: the ground truth states $62.0 billion in share repurchases in 2024, while the LLM vaguely refers to 'tens of millions of Class A shares and hundreds of millions of non-voting Class C shares' — this misrepresents the scale (tens of millions is far below the actual magnitude) and omits the dollar amount. (5) The reasoning about how buybacks concentrate voting power among Class B holders is conceptually sound and represents correct multi-hop logic, but it is based on incomplete and partially inaccurate data. (6) The answer incorrectly claims that Meta and Google have 'the same' structure, when in fact they are opposites in terms of voting control. Overall, while the answer attempts to address the question and shows some understanding of dual-class structures and repurchase effects, the core facts about voting rights at Meta are inverted, leading to a fundamentally incorrect analysis. This results in a low correctness score despite partial contextual relevance and reasonable qualitative logic where not based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 559,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does PEP's 19% convenient foods unit volume growth in APAC, including low-single-digit growth in Taiwan, compare with PG's market position across Greater China, where Taiwan is explicitly included in its regional structure?",
      "original_answer": "PEP reported 19% convenient foods unit volume growth in APAC in 2022, with Taiwan contributing low-single-digit growth as part of that performance. In contrast, PG holds a leadership or significant market share position in many of its product segments across Greater China, a region that explicitly includes Taiwan according to Apple's segment reporting. This suggests PG maintains a strong competitive presence in the broader regional market, while PEP's exposure in Taiwan appears more modest but still positive.",
      "llm_answer": "PepsiCo reported that its convenient‑foods business in the Asia‑Pacific region grew **19 % in unit volume in 2022**, with the increase “primarily reflecting … double‑digit growth in China (excluding the Be & Cheery acquisition) and Thailand” and “low‑single‑digit growth” in **Taiwan** (PEP 10‑K page 48).  \n\nProcter & Gamble, by contrast, does not give a growth percentage for that market but states that its **Greater China segment – defined to include mainland China, Hong Kong and Taiwan – is a focus market where the company “generally has the number‑one or number‑two market‑share position” in the categories it competes** (PG 10‑K page 40 and the market‑share discussion on page 19).  \n\nThus, while PepsiCo is highlighting a **strong 19 % volume expansion** in APAC (including modest growth in Taiwan), P&G emphasizes **its leading market‑share position** across the same broader region that explicitly incorporates Taiwan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and timeframes are correct: PEP's 19% convenient foods unit volume growth in APAC in 2022 and low-single-digit growth in Taiwan are accurately reported, with proper citation to PEP's 10-K. PG's market position in Greater China (including Taiwan) as number-one or number-two in key categories is correctly stated, consistent with the original answer’s claim of 'leadership or significant market share.' (2) The calculations and comparisons are sound—no numerical errors. (3) The multi-hop reasoning is strong: the model correctly synthesizes PEP's growth performance in APAC (with Taiwan as a sub-component) and contrasts it with PG's structural market position in Greater China, which explicitly includes Taiwan. (4) The only minor shortcoming is that the LLM does not explicitly state that PG's regional definition (Greater China) is confirmed via Apple’s segment reporting as in the original answer—this is a small omission in sourcing clarity, but the substance is correct. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 341,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How do the updated PCA Framework thresholds under Basel III affect capital requirements differently for banks like BAC and COF, particularly in terms of CET1 capital ratios and classification as well-capitalized institutions?",
      "original_answer": "Under Basel III, the PCA Framework thresholds were updated to require higher capital ratios for banks to be classified as well-capitalized. For COF, as a Category III institution, it must maintain a minimum CET1 capital ratio of 4.5%, Tier 1 capital ratio of 6.0%, and total capital ratio of 8.0%. However, to be considered well-capitalized under PCA, COF must meet higher thresholds: a CET1 capital ratio of 6.5% or more, Tier 1 capital ratio of 8% or more, and total risk-based capital ratio of 10% or more. Similarly, BAC is subject to these same PCA thresholds, with its CET1 capital regulatory minimum set at 4.5% under Basel III, but to be well-capitalized under PCA, it must maintain a CET1 ratio of 6.5% or more, reflecting the updated PCA requirements. This means both banks must hold significantly more capital to avoid PCA restrictions, impacting their capital planning and dividend capacity.",
      "llm_answer": "The new PCA framework raises the CET 1 “well‑capitalized” floor to **6.5 %** (plus the 2.5 % capital‑conservation buffer) for ordinary banks, while a U.S. G‑SIB must also add its G‑SIB surcharge. Bank of America, which is a G‑SIB, therefore has a regulatory CET 1 minimum of **9.5 %** (4.5 % base + 2.5 % surcharge + 2.5 % buffer) to be deemed well‑capitalized, whereas Capital One (a non‑G‑SIB) only needs **6.5 %** CET 1. Both institutions comfortably exceed those thresholds – BAC reported CET 1 ratios of **11.8 % (standardized) and 13.5 % (advanced)** versus the 9.5 % minimum, and COF reported a CET 1 ratio of **12.9 %** versus the 6.5 % minimum – but the required level for “well‑capitalized” status is materially higher for BAC because of the G‑SIB surcharge.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in quantitative details and misrepresents the regulatory framework, despite addressing the right topic and entities. (1) The original answer states that both BAC and COF must maintain a CET1 ratio of 6.5% or more to be classified as well-capitalized under PCA, with no mention of G-SIB surcharges being part of the PCA 'well-capitalized' threshold. However, the LLM incorrectly claims BAC needs a 9.5% CET1 ratio due to a G-SIB surcharge (4.5% base + 2.5% buffer + 2.5% surcharge), which conflates general capital requirements with PCA thresholds. The PCA framework itself does not include the G-SIB surcharge in its formal well-capitalized definitions; the 6.5% CET1 is the actual PCA threshold for all large banks, regardless of G-SIB status. (2) The LLM introduces the capital conservation buffer (2.5%) and G-SIB surcharge as components of the 'well-capitalized' classification under PCA, which is incorrect—these are regulatory minimums for capital adequacy, not PCA categorization. The PCA framework uses fixed thresholds (6.5% CET1) without adding buffers or surcharges. (3) While the reported CET1 ratios (BAC: 11.8%/13.5%, COF: 12.9%) may be factually accurate, they are not present in the ground truth and cannot be verified from the provided knowledge graph; their inclusion adds unsupported detail. (4) The core multi-hop reasoning—comparing how Basel III updated PCA thresholds for BAC and COF—is partially correct in noting that both must meet higher CET1 ratios (6.5%) to be well-capitalized, but the explanation is undermined by incorrect regulatory logic. (5) The answer is contextually relevant and identifies the correct institutions and metrics, but the synthesis is flawed due to regulatory misinterpretation. Thus, while some surface-level facts align (e.g., 6.5% CET1 for well-capitalized status), the reasoning and quantitative accuracy are significantly off.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 521,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How does the sensitivity of NFLX's content amortization to viewing pattern assumptions compare to T's sensitivity analyses around pension discount rates and goodwill impairment assumptions?",
      "original_answer": "NFLX's auditor performed sensitivity analyses on content amortization assumptions, particularly focusing on historical and forecasted viewing hour consumption, which directly affects the timing of content amortization recognition. T's auditor, on the other hand, conducted sensitivity analyses on two key areas: pension discount rates tied to corporate bond credit quality and timing of benefit payments, and goodwill impairment assumptions such as terminal growth rates, EBITDA margins, and weighted average cost of capital (WACC). While both companies undergo sensitivity testing, NFLX's focus is on consumption-based amortization estimates, whereas T's analyses center on long-term financial obligations and asset valuations.",
      "llm_answer": "Both companies’ auditors performed sensitivity‑analysis procedures, but they focus on different drivers. Netflix’s analysis tests how changes in the historical‑ and forecast‑based viewing‑pattern assumptions would alter the timing and amount of content amortization, whereas AT&T’s analysis evaluates how changes in the actuarial discount rates used for pension and post‑retirement obligations—and in the valuation inputs (terminal growth, EBITDA margins, WACC) used for goodwill‑impairment testing—would affect those measurements. Thus, Netflix’s sensitivity is confined to a single, consumption‑based estimate, while AT&T’s sensitivity spans multiple, highly judgmental assumptions affecting both pension liabilities and goodwill valuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: NFLX's sensitivity analysis focuses on viewing patterns affecting content amortization timing, while T's (AT&T's) analyses cover pension discount rates and goodwill impairment assumptions (terminal growth, EBITDA margins, WACC). The entities (Netflix, AT&T), financial concepts (content amortization, pension liabilities, goodwill impairment), and drivers are accurately identified. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not applicable in a strict sense—however, the absence of incorrect numbers supports a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies undergo auditor-led sensitivity analyses but on fundamentally different types of assumptions—consumption-based for NFLX vs. long-term financial and valuation assumptions for T. The comparison is logically structured and highlights the scope difference (single estimate vs. multiple judgmental inputs). (4) Minor deduction in qualitative accuracy due to slightly stronger characterization of NFLX's sensitivity as 'confined to a single' estimate—while broadly accurate, the original answer allows for multiple viewing-pattern assumptions rather than implying only one; this is a nuance, not an error. Overall, the answer is highly relevant, complete, and correctly contrasts the nature and scope of the sensitivities.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 416,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Adobe's localized field office presence in Taiwan compare to Apple's broader Greater China segment strategy, particularly given Apple's $74.2 billion in net sales attributed to that region which includes Taiwan?",
      "original_answer": "Adobe maintains a localized field office in Taiwan as part of its global operations, allowing it to directly engage with customers in that market. Apple, on the other hand, reports its financial performance for the broader Greater China segment, which includes Taiwan along with mainland China and Hong Kong, and generated $74.2 billion in net sales in 2022. While Adobe's approach focuses on direct local engagement through physical offices, Apple manages the region as a consolidated market with a unified strategy, reflecting its larger scale and different operational model.",
      "llm_answer": "Adobe’s 2022 filing shows that Taiwan is served by a single, dedicated local field office — one of many country‑specific offices listed for its sales and support network. In contrast, Apple does not single out Taiwan; it groups Taiwan together with mainland China and Hong Kong in its “Greater China” segment, a regional market that generated about $74.2 billion in net sales in 2022. Thus, Adobe’s presence in Taiwan is a narrow, country‑level footprint, whereas Apple’s approach treats Taiwan as part of a much larger, high‑revenue Greater China strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Adobe has a localized field office in Taiwan, while Apple includes Taiwan in its Greater China segment, which reported $74.2 billion in net sales in 2022 — this figure and year match the original answer exactly. Number format ($74.2 billion) is consistent and accurate. (2) The answer addresses all parts of the question: it compares Adobe’s localized presence to Apple’s broader regional strategy, notes the inclusion of Taiwan in Apple’s segment, and references the correct financial figure. (3) Entities are correctly identified: Adobe, Apple, Taiwan, Greater China (including mainland China and Hong Kong), and the 2022 fiscal year are all accurately named. (4) The reasoning is sound — the LLM correctly synthesizes information across two companies’ operational models, drawing a valid contrast between country-level engagement (Adobe) and consolidated regional reporting (Apple). The only minor shortcoming is that the LLM slightly reframes Adobe’s presence as a 'narrow, country-level footprint' — while semantically reasonable, this characterization is not explicitly in the original and could imply a value judgment about scale. However, this does not detract from factual correctness. Overall, the answer is factually complete, quantitatively precise, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 386,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Lockheed Martin's exposure to LIBOR-based financing instruments compare to 3M's preparedness for reference rate reform, given the provisions of ASU 2020-04 that both companies reference in their filings?",
      "original_answer": "Lockheed Martin (LMT) has credit facilities and derivative instruments referencing LIBOR-based rates and has adhered to the ISDA 2020 IBOR Fallbacks Protocol, expecting minimal financial impact from the transition to alternative rates by December 31, 2022. 3M (MMM) also reviewed its relevant arrangements and concluded that ASU 2020-04 would not have a material impact on its financial statements, indicating a similar low expectation of disruption. Both companies rely on ASU 2020-04 to ease the accounting burden of transitioning from LIBOR to alternative rates like SOFR, showing parallel preparedness despite differing financial structures.",
      "llm_answer": "Lockheed Martin notes that its credit facility and a portion of its derivative portfolio still reference LIBOR, but the facility contains fallback language that will switch to an alternative rate and the company has adopted the ISDA 2020 IBOR‑Fallback Protocol; consequently it expects only a limited impact from the transition. 3M, by contrast, has already evaluated all of its contracts under ASU 2020‑04, incorporated the required expedients and fallback provisions, and concluded that the reform will not have a material effect on its results, indicating a more fully‑prepared stance.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its representation of both Lockheed Martin's and 3M's exposure to LIBOR and their preparedness for reference rate reform, with correct references to ASU 2020-04, ISDA 2020 IBOR Fallbacks Protocol, fallback provisions, and expected minimal financial impact. All entities (Lockheed Martin, 3M, ASU 2020-04, ISDA protocol), financial instruments (credit facilities, derivatives), and outcomes (limited or immaterial impact) are correctly identified and contextually accurate. There are no numeric values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not compromised. The reasoning is sound and reflects multi-hop synthesis across both companies’ disclosures. However, the LLM slightly overstates the contrast by suggesting 3M has a 'more fully-prepared stance,' which is not supported in the ground truth—both companies are portrayed as having similarly low expected disruption and relying on ASU 2020-04 for accounting relief. The original answer emphasizes parallel preparedness despite differing structures, whereas the LLM implies a hierarchy of readiness. This subtle but important distinction reduces qualitative accuracy slightly. Overall, the answer is highly relevant, factually correct, and well-reasoned, warranting a high correctness score with minor deduction for interpretive overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 383,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What is the voting power distribution between Class A and Class B common stock at CMCSA, and how does the structure of Class B common stock's 15 votes per share impact overall shareholder control?",
      "original_answer": "At CMCSA, holders of Class A common stock have 66⅔% of the combined voting power, while the Class B common stock, which has 15 votes per share, represents 33⅓% of the combined voting power. This structure gives disproportionate voting control to the holder(s) of Class B common stock, despite their minority ownership on a share count basis.",
      "llm_answer": "Comcast’s capital structure gives each Class A share one vote, while each Class B share carries 15 votes.  As a result, holders of Class A stock collectively control roughly 66 ⅔ % of the total voting power, and the single holder of all Class B shares (Mr. Brian L. Roberts) controls the remaining 33 ⅓ % despite owning a tiny fraction of the equity.  The 15‑vote‑per‑share design therefore concentrates a substantial one‑third of voting authority in the hands of the Class B owner, giving him significant influence over corporate decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: 66⅔% and 33⅓% voting power distribution is accurately reported, and the 15 votes per share for Class B is correctly stated. These match the original answer exactly. (2) The answer correctly identifies that Class A has one vote per share and Class B has 15 votes per share, which is consistent with the knowledge graph. The calculation implied by the voting structure (i.e., disproportionate control despite minority share ownership) is sound. (3) The qualitative addition about Mr. Brian L. Roberts being the sole holder of Class B shares is not in the original answer but is factually correct and adds useful context without distorting the truth. This reflects strong multi-hop reasoning, connecting ownership structure to control implications. (4) The answer fully addresses both parts of the question: the voting power distribution and the impact of the 15-vote structure on shareholder control. The only reason for not scoring a 10 is that the original answer does not explicitly name Mr. Roberts, so while accurate, this detail slightly exceeds the provided ground truth without being incorrect. Overall, the response is semantically equivalent, contextually relevant, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 365,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How do the different uses of sensitivity analyses by CMCSA and NFLX reflect their distinct financial risk exposures, particularly given that both are audited by the same firm?",
      "original_answer": "CMCSA uses sensitivity analyses to assess its exposure to interest rate risk, which is critical given its reliance on derivative instruments like interest rate swaps that decreased consolidated interest expense by $56 million in 2023. In contrast, NFLX applies sensitivity analyses in the context of content amortization, a judgment-heavy process where changes in estimated viewing patterns can significantly affect the timing of amortization expenses. Both companies rely on the same auditor, who has served NFLX since 2012 and also reviews CMCSA’s market risk disclosures, suggesting a consistent audit approach despite the differing applications and financial impacts of sensitivity analyses at each firm.",
      "llm_answer": "Comcast (CMCSA) applies sensitivity‑analysis in its market‑risk monitoring to test how changes in interest‑rate assumptions would affect the fair value of its fixed‑rate debt and interest‑rate swaps, because the company’s biggest exposure is to movements in borrowing costs (see the “interest‑rate risk management” discussion on page 60). Netflix (NFLX), by contrast, runs sensitivity‑analyses on the assumptions used to estimate future viewing hours that drive the amortization of its film‑ and TV‑content library, reflecting a risk that actual consumption will differ from forecasts (see the audit description of content‑amortization testing on page 40). Although both firms are audited by the same accounting firm, the analyses focus on different underlying risks—interest‑rate market risk for Comcast versus content‑valuation and revenue‑forecast risk for Netflix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies CMCSA's use of sensitivity analysis for interest rate risk related to debt and swaps, and NFLX's use for content amortization driven by viewing pattern assumptions. The key financial risks—interest rate exposure for CMCSA and content valuation uncertainty for NFLX—are accurately contrasted. (2) There are no numeric values in the LLM answer, but the ground truth includes a $56 million reduction in interest expense due to swaps in 2023. This specific figure is missing in the LLM response, which prevents a perfect score despite the otherwise correct qualitative description. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies use sensitivity analyses but for different risk types, and acknowledges the same auditor is involved, aligning with the ground truth. (4) The answer is contextually excellent—focused, relevant, and directly responsive to the question about differing risk exposures and audit consistency. The only minor omission is the lack of the $56 million quantitative impact from CMCSA’s derivative usage, which slightly reduces completeness. However, the absence of this number does not undermine the overall correctness of the conceptual comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 368,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How does the expiration timeline of Enbrel's key U.S. formulation patent in 2037 impact Pfizer's competitive positioning compared to AbbVie's regulatory exclusivity strategy for its biologics?",
      "original_answer": "Pfizer's Enbrel, marketed outside the U.S. and Canada, benefits from a U.S. formulation patent that expires in 2037, offering extended protection for its composition and preparation methods. This long runway could help Pfizer maintain market presence for Enbrel in key international markets by deterring biosimilar competition. In contrast, AbbVie relies on a broader regulatory exclusivity strategy, including 12-year exclusivity for biologics under the BPCIA and potential pediatric exclusivity extensions, which may allow it to manage competitive threats through both patent and regulatory mechanisms. While Pfizer’s formulation patent provides a specific technical barrier, AbbVie’s layered approach combines patent protection with statutory exclusivity to maximize market control post-approval.",
      "llm_answer": "Pfizer’s flagship TNF‑blocker Enbrel is protected in the United States by a formulation patent that does not expire until October 19 2037 (see Pfizer 10‑K, Patents table)【page_11】. By contrast, AbbVie’s biologics rely primarily on the 12‑year regulatory exclusivity granted under the Biologics Price Competition and Innovation Act (with possible pediatric or orphan extensions), which typically ends far sooner than a 2037 patent horizon【page_9】. Consequently, Pfizer can expect a substantially longer period of market protection for Enbrel than AbbVie can secure for its biologics through regulatory exclusivity alone, giving Pfizer a stronger competitive foothold in that therapeutic space.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the key date of October 19, 2037, for Enbrel's U.S. formulation patent expiration is correct and matches the ground truth's reference to 2037. The mention of the 12-year regulatory exclusivity under the BPCIA is also accurate. (2) The LLM correctly identifies Pfizer and AbbVie as the relevant companies and accurately characterizes their respective intellectual property and regulatory strategies—Pfizer relying on a long-term formulation patent and AbbVie on regulatory exclusivity with possible extensions. (3) The reasoning is sound: the comparison between a 2037 patent expiry and the typically shorter duration of BPCIA exclusivity (12 years from approval, often ending before 2037) supports the conclusion that Pfizer has a longer protection horizon. The LLM synthesizes this multi-hop information correctly across patent and regulatory frameworks. (4) The only minor shortcoming is that the LLM omits the nuance that AbbVie also uses patent thickets and other patent-based protections in practice, not just regulatory exclusivity—though the original answer acknowledges AbbVie combines both, the LLM focuses more narrowly on regulatory exclusivity. However, this does not make the answer factually incorrect, as it still correctly contrasts Pfizer’s specific long-term patent with AbbVie’s reliance on statutory exclusivity. Wording differences are semantically equivalent and acceptable. Overall, the answer is factually strong, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 429,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How would a potential shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge proposal impact JPMorgan Chase's capital requirements under a resolution scenario where the Parent Company enters bankruptcy, given the loss-absorbing structure of its eligible long-term debt?",
      "original_answer": "The proposed shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge under the Federal Reserve's proposal would likely allow for more granular calibration of capital requirements for systemically important institutions like JPMorgan Chase. For JPM, this could mean a more tailored capital burden, which would interact with its 'single point of entry' resolution strategy where losses would first be imposed on equity holders and then on unsecured creditors, including holders of eligible long-term debt. If this surcharge adjustment is adopted, JPM may experience either a marginal increase or decrease in required capital depending on its G-SIB score, which would influence how much loss-absorbing capacity it must maintain under its current regulatory framework.",
      "llm_answer": "A move from 0.5‑percentage‑point to 0.1‑percentage‑point increments in the Method 2 G‑SIB surcharge would lower the G‑SIB surcharge component of JPMorgan Chase’s risk‑based capital requirement, thereby reducing the total amount of regulatory capital (including TLAC‑eligible long‑term debt) that the firm must hold. In a “single‑point‑of‑entry” resolution in which the Parent Company files for Chapter 11, the loss‑absorbing hierarchy – equity first, then unsecured creditors that include the eligible long‑term debt – would remain the same, but the reduced surcharge would mean a smaller tranche of eligible LTD would be needed to satisfy the TLAC requirement.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual inaccuracy in its core claim: it asserts that shifting from 0.5- to 0.1-percentage-point increments in the G-SIB surcharge would definitively *lower* JPMorgan Chase's capital requirements. This is incorrect according to the ground truth, which states that the impact could be either a marginal *increase* or *decrease* depending on JPMorgan's G-SIB score under the revised calibration. The shift to finer increments enables more granular, tailored capital requirements but does not inherently reduce them. This misrepresents the policy's effect and reflects flawed reasoning. Quantitatively, no specific numbers are misstated (e.g., 0.5 to 0.1 basis point shift is correctly noted), so numerical accuracy is acceptable. The explanation of the 'single point of entry' resolution and loss-absorbing hierarchy (equity first, then unsecured creditors including eligible long-term debt) is accurate and contextually relevant. However, the conclusion that a reduced surcharge would require a smaller tranche of eligible long-term debt presumes a decrease in TLAC requirements, which is not necessarily true—the TLAC requirement depends on the final assigned surcharge, not the increment size. Thus, while the structural understanding of resolution and capital hierarchy is sound, the multi-hop synthesis between regulatory increment changes and firm-level capital outcomes is flawed. The answer is relevant and addresses the right concepts but reaches an unsupported and potentially incorrect conclusion, warranting a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 432,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does LMT's use of a discounted cash flow approach in valuing Level 3 fixed income investments compare to HON's application of the same method in testing goodwill and indefinite-lived intangible assets, particularly in terms of the sensitivity to projected cash flows and discount rates?",
      "original_answer": "LMT applies the discounted cash flow approach to certain Level 3 fixed income investments, relying on projected annuity payments and a discount rate applied to those payments. This valuation method is used when observable market inputs are unavailable, and it introduces sensitivity to changes in these projected cash flows and discount assumptions. Similarly, HON utilizes a discounted cash flow approach for testing goodwill and indefinite-lived intangible assets, incorporating strategic and annual operating plans adjusted for terminal value assumptions. HON also performs sensitivity analyses on key estimates, including expected growth rates, sales volumes, and discount rates, to assess the impact of changes in assumptions. Both companies depend on forward-looking financial projections and discounting techniques, making their valuations highly sensitive to shifts in economic conditions and internal performance expectations.",
      "llm_answer": "Lockheed Martin (LMT) values its Level 3 fixed‑income holdings with a discounted‑cash‑flow model in which the key drivers are the projected annuity‑type cash‑flows and the discount rate applied to those payments; the fair‑value of those assets therefore moves directly with any change in those cash‑flow projections or in the discount‑rate assumption. Honeywell (HON) uses a discounted‑cash‑flow approach for goodwill and indefinite‑life intangibles, but its model incorporates a broader set of forecasts—industry and business growth rates, sales volumes, prices, costs and terminal‑value assumptions—and the company explicitly runs sensitivity analyses on those inputs, making its valuation similarly responsive to cash‑flow and discount‑rate changes but with a wider range of assumptions that are tested for material impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: LMT uses a discounted cash flow (DCF) approach for Level 3 fixed income investments based on projected annuity payments and discount rates, and HON applies DCF to goodwill and indefinite-lived intangibles using forward-looking financial projections and terminal value assumptions. The sensitivity to cash flows and discount rates is correctly highlighted for both companies. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LMT and HON), two asset types (Level 3 fixed income vs. goodwill/intangibles), and compares their use of DCF with attention to sensitivity and assumptions. The LLM adds slight elaboration (e.g., 'prices, costs') not explicitly in the original, but these are reasonable inferences consistent with 'strategic and annual operating plans' and do not introduce inaccuracies. (4) The answer is fully contextually relevant, directly addressing the comparison in methodology and sensitivity. The only minor shortcoming is that the original mentions HON performs sensitivity analyses on 'expected growth rates, sales volumes, and discount rates'—the LLM captures this well but slightly overgeneralizes by listing 'industry and business growth rates, sales volumes, prices, costs'—a bit more expansive than the source, but still within acceptable semantic equivalence. Thus, correctness is 9 (not 10) due to slight over-specification of HON's inputs, though not factually incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 470,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does AT&T's use of discount rates tied to corporate bond credit quality in pension obligations compare to Netflix's reliance on forecasted viewing patterns in content amortization, given both are subject to auditor evaluation of significant assumptions?",
      "original_answer": "AT&T's pension obligations are sensitive to discount rates derived from corporate bonds' credit quality, which directly affects the measurement of $67,854 million in goodwill and postretirement liabilities. Netflix, on the other hand, relies on forecasted viewing patterns to amortize content assets, a process that is similarly judgmental and subject to auditor scrutiny. Both companies' financial statements depend heavily on significant assumptions—discount rates for AT&T and viewing forecasts for Netflix—that are evaluated by auditors using sensitivity analyses and comparisons to historical data. This highlights a parallel in how both firms manage subjectivity in long-term financial reporting, despite differing industries and asset types.",
      "llm_answer": "AT&T measures its pension and post‑retirement obligations with discount rates that are built from a yield curve of high‑quality corporate bonds, so the auditor must evaluate the credit quality of those bonds and how their cash‑flow timing matches expected benefit payments. Netflix, by contrast, amortizes its content on the basis of historical and forecasted viewing‑hour patterns, and the auditor tests the reasonableness of those viewing forecasts, the underlying data and the related controls. Both companies therefore rely on significant, judgment‑heavy assumptions that are subject to detailed auditor scrutiny, but AT&T’s assumptions are rooted in market‑based bond yields while Netflix’s are rooted in projected consumer‑usage behavior.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor omissions affecting completeness. (1) Quantitative Accuracy: There are no numeric values in the LLM answer that contradict the ground truth; the ground truth mentions $67,854 million in goodwill and postretirement liabilities, but the LLM answer does not include this figure. However, since the LLM response does not make any numerical claims, its lack of the number does not make it factually incorrect—just less specific. Thus, no penalty is warranted for quantitative inaccuracy. (2) Completeness: The LLM addresses both companies, their respective significant assumptions (discount rates for AT&T, viewing forecasts for Netflix), and the role of auditors in evaluating these assumptions. It correctly identifies the nature of the assumptions and the basis for auditor scrutiny. The only missing element is the specific dollar amount ($67,854 million) tied to AT&T’s liabilities, which was present in the original answer and adds concrete context. This omission prevents a perfect score but does not undermine the correctness. (3) Entity Accuracy: Both companies are correctly identified, and the financial concepts—pension obligations, discount rates, content amortization, auditor evaluation—are accurately applied. (4) Reasoning: The multi-hop reasoning is sound. The LLM correctly synthesizes that while the industries and asset types differ, both companies rely on judgment-heavy assumptions subject to auditor evaluation, drawing a valid parallel. It distinguishes the market-based nature of AT&T’s assumptions versus Netflix’s behavior-based forecasts, adding analytical depth. (5) Semantic Equivalence: The meaning and intent of the original answer are preserved. The LLM captures the essence of auditor scrutiny, sensitivity of assumptions, and comparative insight across firms. Wording differs but meaning aligns. Contextual relevance is excellent—the response directly addresses the comparison asked in the question. Overall, this is a strong, factually correct answer with high qualitative and contextual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 571,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the adoption timeline of ASU No. 2023-07 differ between MO and PM, and what specific changes did each company implement in their segment reporting as a result?",
      "original_answer": "MO adopted ASU No. 2023-07 in 2024 and began including expanded footnote disclosures in Note 17, with interim disclosure requirements set to appear in Q1 2025. PM adopted the ASU retrospectively for the year ended December 31, 2024, and updated its segment reporting by incorporating the former Swedish Match segment into its four existing geographical segments starting in January 2024.",
      "llm_answer": "- **Adoption timing** – Altria (MO) adopted ASU 2023‑07 for its 2024 fiscal year and, because the ASU also adds interim‑reporting requirements, it said it will begin providing the new interim segment disclosures in the first quarter of 2025. Philip Morris International (PM) also adopted the ASU for the year ended December 31 2024, but its filing does not note any later interim‑reporting rollout; the change is applied only to the 2024 annual statements.  \n\n- **Segment‑reporting changes** – Altria’s adoption resulted in “expanded footnote disclosures” of incremental segment information (added in Note 17) and the promise of interim segment data beginning Q1 2025. PM’s adoption was accompanied by a restructuring of its segment layout: in January 2024 it eliminated the stand‑alone Swedish Match segment and folded those results into its four existing geographic segments, restating prior‑year amounts to conform with the new structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MO adopted ASU 2023-07 in 2024 with interim disclosures starting Q1 2025; PM adopted it for the year ended December 31, 2024, applying it retrospectively. The segment reporting changes are accurately described—MO added expanded footnote disclosures in Note 17, while PM integrated the Swedish Match segment into its four geographic segments starting January 2024 and restated prior periods. (2) Quantitative accuracy is perfect: all dates (2024 adoption, Q1 2025 interim start, January 2024 restructuring) match the original answer. No numerical calculations were required, but temporal references are precise and consistent. (3) Multi-hop reasoning is sound—information is correctly synthesized across two companies (MO and PM), their respective adoption timelines, and the operational impact on segment reporting. The LLM correctly distinguishes between MO’s incremental disclosure approach and PM’s structural segment reorganization. (4) The only minor shortcoming is that the LLM does not explicitly state that PM adopted the standard 'retrospectively,' though it implies this by mentioning restated prior-year amounts. This nuance is present in the original answer and slightly strengthens the qualitative precision, but the LLM’s description of restatement conveys equivalent meaning. Wording differs but semantic equivalence is maintained. Overall, the response is factually complete, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 421,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the inclusion of Pomalyst in the Inflation Reduction Act's (IRA) drug price negotiation program impact BMY's revenue outlook compared to PFE's exposure under the same IRA provisions, given both companies' reliance on Medicare Part D sales and regulatory exclusivity timelines?",
      "original_answer": "BMY faces potential revenue erosion for Pomalyst starting in 2027 due to its selection by HHS for government-set pricing under the IRA, which could accelerate prior to the expiry of its intellectual property protections. Similarly, PFE anticipates a net unfavorable revenue impact of approximately $1 billion in 2025 due to IRA-driven Medicare Part D redesign changes and faces additional IRA pricing pressures on products like Ibrance and Xtandi, which were selected for price negotiation effective 2027. Both companies are exposed to the IRA’s long-term financial implications, but BMY’s risk is specifically tied to Pomalyst’s regulatory exclusivity and market dynamics, while PFE’s exposure spans a broader portfolio affected by Part D redesign and inflation rebates.",
      "llm_answer": "Bristol‑Myers Squibb says that Pomalyst was the first of its portfolio to be named by HHS for IRA‑mandated price negotiation (the “negotiation” program will begin in 2027) and that the drug is already expected to see generic erosion outside the United U.S. in 2025 (see BMY 10‑K p. 43‑44).  Because Pomalyst’s market‑exclusivity date is not listed (‑‑ in the exclusivity table on p. 9) and its Medicare Part D sales are a material revenue source, the company now expects a material downward pressure on its 2025‑2026 revenue outlook.  \n\nPfizer’s filing notes that its exposure to the same IRA provisions is limited to a smaller set of drugs that will be subject to negotiation later and that most of its high‑revenue products retain longer regulatory exclusivity periods; consequently, the expected revenue impact from the IRA price‑negotiation program is modest relative to BMY’s, which faces an immediate hit from Pomalyst’s inclusion.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several inaccuracies and omissions that significantly affect correctness. (1) Quantitative inaccuracy: The LLM claims BMY expects 'material downward pressure on its 2025–2026 revenue outlook' due to IRA negotiation starting in 2027, but the original answer states the impact begins in 2027, not 2025–2026. This misaligns the timeline and implies an earlier financial hit not supported by the ground truth. Additionally, the LLM omits PFE’s specific $1 billion net unfavorable revenue impact in 2025 from the IRA-driven Part D redesign, a key quantitative fact. (2) Completeness: The LLM fails to mention PFE’s exposure to IRA pricing pressures on Ibrance and Xtandi, both selected for negotiation in 2027, which is a core part of the comparison. It also omits that PFE’s exposure spans a broader portfolio affected by inflation rebates and Part D redesign, reducing completeness. (3) Entity accuracy: While BMY and PFE are correctly identified, the LLM incorrectly implies Pomalyst’s revenue pressure begins in 2025–2026 due to IRA negotiation, when in fact the negotiation starts in 2027. The mention of generic erosion outside the U.S. in 2025 is not in the original answer and introduces unverified information. (4) Reasoning: The multi-hop synthesis is partially sound—comparing BMY’s Pomalyst-specific risk to PFE’s broader but less immediate exposure—but the flawed timeline and missing PFE drug details weaken the logic. (5) Semantic equivalence: The overall direction of impact (greater near-term risk for BMY, broader but smaller impact for PFE) is somewhat aligned, but missing key facts and incorrect timing reduce fidelity. The LLM overemphasizes BMY’s 2025–2026 impact and underrepresents PFE’s quantified and multi-drug exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 477,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does the exposure of MDLZ's Argentine operations, which contributed $401 million in 2021 net revenues, compare to KO's reliance on Arca Continental in Argentina, given that Arca Continental is one of KO's top bottlers and operates in northern Argentina?",
      "original_answer": "MDLZ's Argentine operations contributed $401 million in net revenues in 2021 and were subject to significant currency risk due to Argentina's highly inflationary status, resulting in a $13 million remeasurement loss in that year. Meanwhile, KO relies on Arca Continental, one of its top five bottlers, which operates in northern Argentina and contributes to KO's global unit case volume. Arca Continental is a key distribution partner in the region, and KO's bottler agreements require Arca to source concentrates exclusively from KO, making KO's exposure in Argentina indirect but strategically significant through this contractual relationship.",
      "llm_answer": "Mondelēz’s Argentine business generated $401 million of net revenue in 2021 – about 1.4 % of the company’s total net revenues.  By contrast, Coca‑Cola does not report a specific revenue amount for Argentina; its exposure comes through Arca Continental, one of Coca‑Cola’s five largest independent bottlers, which “has bottling and distribution operations … in northern Argentina.”  Thus, Mondelēz’s Argentine exposure is quantified at a modest 1.4 % of sales, whereas Coca‑Cola’s Argentine exposure is indirect and limited to the portion of the market served by a top bottler in the country’s northern region, with no disclosed revenue share.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies MDLZ's $401 million net revenue from Argentina in 2021, matching the ground truth. It adds a calculated percentage (1.4%) of total MDLZ revenue, which is not in the original answer but is a reasonable inference and does not contradict any facts. The characterization of Arca Continental as one of KO’s top five bottlers and its operations in northern Argentina is accurate. However, the LLM omits the $13 million remeasurement loss due to currency risk in Argentina, a key financial impact mentioned in the ground truth, which slightly reduces completeness. 2) All numeric values are correct: $401 million is accurately cited, and the 1.4% revenue contribution is a plausible approximation (based on MDLZ’s ~$29 billion total revenue in 2021). No calculation errors. 3) The multi-hop reasoning is sound: the model correctly contrasts MDLZ’s direct exposure (own operations) with KO’s indirect exposure (via bottler relationship), synthesizing information across two companies and business models. It correctly identifies Arca Continental’s role and geographic scope. 4) The answer is semantically aligned with the ground truth, though less detailed on KO’s contractual relationship (e.g., exclusive sourcing of concentrates), which is part of the strategic significance. The omission of the remeasurement loss and contractual details prevents a top score, but core facts and comparisons are accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 399,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does BMY's engagement with the FDA's Fast Track Designation process inform the strategic value of LLY's acquisition of Prevail's PR006 gene therapy, given PR006's regulatory status and the CVR payment timeline tied to its approval?",
      "original_answer": "BMY's engagement with the FDA's Fast Track Designation process highlights the importance of expedited regulatory pathways in accelerating drug approvals and improving patient access to critical therapies. LLY acquired Prevail in 2021, including PR006, which was granted Fast Track Designation by the FDA for treating frontotemporal dementia with GRN mutations. The acquisition included a CVR entitling Prevail shareholders to up to an additional $4.00 per share (approximately $160 million total) upon the first regulatory approval of a Prevail product in specified countries by December 31, 2024. Given the Fast Track status of PR006, the likelihood of expedited approval may directly influence the timing and value of the CVR payout, thereby enhancing the strategic value of the acquisition if PR006 achieves regulatory approval within the stipulated timeline.",
      "llm_answer": "Bristol‑Myers’ 10‑K notes that the company relies on FDA tools such as Fast‑Track designation to shorten development timelines and bring products to market more quickly (see LLY page 18). Eli Lilly’s acquisition of Prevail therefore targets a gene‑therapy asset—PR006—that already carries Fast‑Track status, meaning the therapy is positioned for an accelerated regulatory path. The contingent‑value right (CVR) tied to the first approval of PR006 (or any Prevail product) must be earned by 31 Dec 2024, with its value eroding thereafter, so the deal’s upside is directly linked to achieving that fast‑track approval within the CVR window, mirroring the strategic value BMY places on fast‑track pathways.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information in the ground truth with strong multi-hop reasoning. (1) All key facts are correct: PR006 has Fast Track Designation, the CVR deadline is December 31, 2024, and the potential payout is up to $4.00 per share (~$160M total). The LLM correctly identifies that Fast Track status accelerates development and impacts the CVR timeline. (2) Quantitative accuracy is perfect: dates (Dec 31, 2024), dollar amounts ($4.00 per share, implied $160M), and the regulatory pathway are all consistent with the ground truth, even if the total $160M is not explicitly stated in the LLM answer—it can be reasonably inferred from context. (3) Reasoning is sound: the model correctly links BMY’s use of Fast Track (from 10-K) to LLY’s strategic rationale in acquiring a Fast Track asset (PR006), and ties this to the time-sensitive CVR. The only minor gap is that the LLM does not explicitly name frontotemporal dementia with GRN mutations as the indication, which slightly reduces completeness. (4) The answer is contextually excellent—directly addresses how Fast Track informs strategic value via regulatory acceleration and CVR timing. Wording differs but meaning is semantically equivalent. Minor deduction in qualitative accuracy for missing the specific disease indication, but otherwise excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 373,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does V's increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024 compare with MA's Class B-to-A conversion mechanism, especially considering MA's disclosure that only 7 shares of Class B common stock were outstanding in 2024, to assess the differing dynamics of shareholder structure evolution in both companies?",
      "original_answer": "V reported an increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024, indicating an expansion in its Class A shareholder base. Meanwhile, MA disclosed that only 7 shares of Class B common stock were outstanding in 2024, showing minimal remaining shares eligible for conversion into Class A. This contrast highlights different dynamics in shareholder structure evolution: V is seeing organic growth or issuance in its Class A shares, while MA's structure is shaped by its conversion rules, which require Class B holders (typically principal or affiliate customers) to convert and then divest Class A shares, limiting long-term Class B retention.",
      "llm_answer": "V’s balance sheet shows that the number of Class A common‑stock shares rose from **1,594 shares in 2023 to 1,733 shares in 2024** – an increase of **139 shares (about 8.7 %)** (see V 10‑K, page 58).  \n\nMastercard, by contrast, does not add new Class A shares through a public issuance; its only source of change is the **one‑for‑one conversion of its tiny Class B pool**.  The 2024 filing notes that **only 7 Class B shares were outstanding** (page 92) and that conversions are limited to those shares, with the converted A shares required to be sold or transferred (page 92‑93).  Consequently, Mastercard’s shareholder structure is essentially static, with any A‑share increase coming from a negligible conversion of a handful of B shares, whereas V’s A‑share count grew materially through its own issuance/repurchase activity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: V's Class A shares increased from 1,594 to 1,733 (a difference of 139 shares), and MA had 7 Class B shares outstanding in 2024. The calculated increase of 8.7% is accurate (139 / 1,594 ≈ 0.087). (2) The LLM correctly identifies the mechanisms: V’s growth stems from issuance activity, while MA’s Class A share changes are limited to one-for-one conversions from a minimal pool of Class B shares, which must then be divested. (3) Multi-hop reasoning is sound—comparing V’s organic Class A expansion with MA’s structurally constrained conversion process demonstrates synthesis across both companies’ filings. (4) The only minor shortcoming is that the LLM does not explicitly mention that MA’s conversion rules are tied to principal or affiliate customers, a nuance present in the original answer. However, the core dynamics—conversion requirement and divestment—are correctly captured. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent, directly addressing the comparative shareholder structure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 332,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How might Saudi Arabia's data localization requirements, which Adobe identifies as a risk to its international operations, affect NVIDIA's ability to deploy its H100 and L40S chips in the country under U.S. export control regulations?",
      "original_answer": "Saudi Arabia's implementation of data localization requirements mandates that data be stored and processed within the country, which Adobe notes could adversely impact its international business operations. NVIDIA, which relies on Saudi Arabia as a market for its high-performance chips like the H100 and L40S, faces U.S. export licensing restrictions on these products to Saudi Arabia under updated Country Group D4 rules. Since these chips require U.S. government approval for export and NVIDIA has not received such licenses for restricted products, the combination of Saudi regulatory requirements and U.S. export controls could significantly limit NVIDIA's ability to serve Saudi customers with these advanced AI chips, potentially reducing its market access and revenue opportunities in the region.",
      "llm_answer": "Adobe warns that Saudi Arabia’s data‑localisation rules – which require personal data to be stored and processed inside the kingdom – add a new layer of regulatory scrutiny for any foreign‑origin technology that handles that data. NVIDIA’s 10‑K notes that its H100 and L40S GPUs are classified as “Country Group D5” products (which include Saudi Arabia) and therefore need a U.S. export licence; the licence process is already described as lengthy and may impose onerous conditions. If Saudi data‑localisation requirements are applied, they could make obtaining or complying with the export licence even more difficult, potentially preventing or delaying the deployment of H100 and L40S chips in Saudi Arabia.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies the key issue: Saudi Arabia's data localization requirements combined with U.S. export controls restrict NVIDIA's ability to deploy H100 and L40S chips. It correctly references NVIDIA’s 10-K and the need for U.S. export licenses due to Country Group classification. However, it contains a critical error in specifying 'Country Group D5' instead of 'D4' as stated in the ground truth. While D5 is a real designation, the correct group for Saudi Arabia under the relevant export rules (as per the knowledge graph) is D4, which directly impacts the accuracy of the entity and regulatory reasoning. This misclassification undermines the precision of the multi-hop synthesis between U.S. export policy and market access. There are no numerical values to evaluate, so quantitative accuracy is scored as 10 by default. The reasoning is otherwise sound and contextually relevant, correctly linking data localization with export licensing challenges, but the incorrect Country Group reduces qualitative accuracy. The answer captures the essence and risk correctly, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 330,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How do FedEx's and GE's disclosures regarding the discontinuation of LIBOR reflect differing applications of the accounting relief provided by ASU 2020-04, as extended by ASU 2022-06?",
      "original_answer": "FedEx notes that there has been 'no material effect' from reference rate reform on its financial condition as of May 31, 2024, but continues to monitor contracts for potential application of ASU 2022-06, which extended the optional expedients in ASU 2020-04 through December 31, 2024. In contrast, GE explicitly states that the overall impact of LIBOR reform under ASU 2020-04 on its financial statements is 'immaterial.' This suggests that while both companies applied the same accounting framework (ASU 2020-04, extended by ASU 2022-06), FedEx maintained a more cautious stance with ongoing monitoring, whereas GE concluded the transition had no significant financial impact.",
      "llm_answer": "FedEx’s filing notes that, because of ASU 2020‑04 and its 2022‑06 extension, it can use the optional expedients for contracts that referenced LIBOR, but it has seen **no material effect to date** and is simply continuing to monitor its agreements through the 2024 sunset date. GE’s filing, by contrast, states that it **evaluated the impact of the LIBOR‑cessation under ASU 2020‑04** (without specifically citing the 2022‑06 deferral) and concluded that the effect on its financial statements is **immaterial**. Thus, FedEx emphasizes the availability of relief and ongoing monitoring, while GE reports having applied the relief and already determined the impact to be immaterial.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: FedEx reports 'no material effect' as of May 31, 2024, and continues monitoring contracts under ASU 2020-04 and ASU 2022-06, which extends relief through December 31, 2024. GE states the impact under ASU 2020-04 is 'immaterial.' The LLM correctly captures these key disclosures. (2) Quantitative accuracy is perfect: dates (2020-04, 2022-06, 2024 sunset), and the absence of material financial impact are all correctly stated. Format variations (e.g., '2024 sunset date') are semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly synthesizes disclosures from two companies, compares their application of the same accounting standards, and infers differing approaches—FedEx's ongoing monitoring vs. GE's concluded assessment. The only minor shortcoming is that the LLM does not explicitly note that GE did not reference ASU 2022-06, which slightly weakens the contrast in how each company engaged with the extension. However, this omission does not distort the overall conclusion. (4) The answer is contextually relevant, directly addressing the differing applications of accounting relief in response to LIBOR discontinuation. Wording differs slightly but preserves semantic equivalence. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 402,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How might geopolitical tensions involving Taiwan impact both Apple's and NVIDIA's supply chain operations, considering their reliance on manufacturing locations and foundry partners in the region?",
      "original_answer": "Apple's business is significantly impacted by geopolitical tensions involving Taiwan, as it relies heavily on outsourcing partners located in Taiwan for manufacturing critical components. A significant or prolonged conflict involving Taiwan could severely limit Apple's ability to manufacture and deliver products, creating delays and inefficiencies in its supply chain. Similarly, NVIDIA depends on foundry partners in Taiwan for chipset supply, and any disruption due to geopolitical tensions could severely limit or prevent NVIDIA from receiving this supply, which would have a material adverse impact on its business. Both companies face heightened risks due to their reliance on operations in a region with ongoing geopolitical instability.",
      "llm_answer": "Both companies flag Taiwan as a critical node in their supply chains. Apple notes that “substantially all of the Company’s manufacturing is performed … in Taiwan” and that political or military conflict there could “significantly disrupt… suppliers, contract manufacturers, logistics providers” and force costly redesigns or sourcing changes【page_9】. NVIDIA similarly warns that “geopolitical tensions… involving Taiwan and China… where we have suppliers, contract manufacturers, and assembly partners… could have a material adverse impact” and that its “dependency on foundries… located in Taiwan” makes wafer supply, capacity and pricing vulnerable to any disruption【page_17】【page_18】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies both Apple and NVIDIA as being heavily reliant on Taiwan for manufacturing and foundry operations, respectively. The key risks from geopolitical tensions—supply chain disruptions, material adverse impacts, and vulnerabilities in wafer supply—are all accurately conveyed. (2) There are no numeric values, dates, or financial figures in either the question or answers, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers supports a perfect score. (3) The multi-hop reasoning is sound: the model synthesizes information across both companies, correctly linking Apple’s reliance on Taiwanese manufacturing partners and NVIDIA’s dependency on TSMC-like foundries in Taiwan. It appropriately cites page references (e.g., page_9, page_17, page_18), suggesting accurate grounding. (4) The wording differs slightly from the original answer but maintains semantic equivalence—e.g., 'material adverse impact' is directly quoted from NVIDIA’s disclosures, and Apple’s exposure is accurately summarized. One minor point preventing a perfect 10 is that the LLM slightly overstates Apple’s case by saying 'substantially all of the Company’s manufacturing is performed … in Taiwan,' when in reality Apple’s final assembly occurs mostly in China, though key components and suppliers are indeed based in Taiwan. This nuance is missing, but the overall risk assessment remains valid. Thus, the answer is factually strong, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 432,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What percentage of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition is specifically tied to VMware Cloud Foundation, and how does this compare to Oracle's net value of developed technology as a percentage of its total intangible assets?",
      "original_answer": "Of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition, a 'significant portion' is tied to VMware Cloud Foundation (VCF), though the exact percentage is not disclosed. Oracle's net value of developed technology was $1,276 million as of May 31, 2024, which represents approximately 18.4% of Oracle's total intangible assets of $6,890 million. While Broadcom emphasizes that a significant portion of its developed technology relates to VCF, Oracle's developed technology is a much smaller share of its overall intangible asset base, indicating differing strategic valuations of technology assets post-acquisition.",
      "llm_answer": "Broadcom’s filing tells us that the **$24,156 million** of “developed‑technology” intangible assets acquired in the VMware merger “includes a significant portion related to VMware Cloud Foundation,” but it does **not break out a dollar amount or a percentage** for the VCF‑related portion – the company only says the VCF share is “significant.”\n\nOracle’s 2023 filing does give a dollar amount for its own “developed‑technology” intangible assets and for total intangible assets, allowing a percentage to be calculated. The filing shows that Oracle’s net “developed‑technology” intangible assets equal **$ X million**, while its total intangible assets equal **$ Y million**, so the developed‑technology component represents **(X ÷ Y) × 100 ≈ Z %** of Oracle’s total intangible assets. (The exact X, Y and Z figures are disclosed in Oracle’s 10‑K but are not provided in the excerpts you shared.)",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that Broadcom does not disclose the exact percentage or dollar amount of its $24,156 million developed technology intangible asset tied to VMware Cloud Foundation (VCF), only stating it is a 'significant portion,' which aligns with the ground truth. However, the LLM fails to provide actual numbers for Oracle's developed technology or total intangible assets, instead using placeholders (X, Y, Z), despite these values being available in the ground truth: Oracle's developed technology was $1,276 million and total intangibles were $6,890 million, resulting in ~18.4%. The model acknowledges that Oracle's percentage can be calculated but does not perform the calculation or cite the correct figures, which undermines quantitative accuracy. While the reasoning structure is sound—recognizing that Broadcom lacks a disclosed breakdown while Oracle allows for a calculation—the failure to retrieve and compute the actual Oracle percentage represents a significant omission in multi-hop synthesis. The answer is contextually relevant and correctly frames the comparison, but the lack of concrete numbers and calculation prevents it from being factually complete. Thus, the correctness score is reduced to 4 due to major gaps in quantitative delivery despite correct qualitative framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 366,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the relative stockholder ownership structure at GOOGL, particularly in terms of non-affiliate market value and class-based control mechanisms?",
      "original_answer": "At CMCSA, holders of Class B common stock, of which there are only 3 record holders, maintain 33⅓% of the combined voting power of the company’s common stock, with each share carrying 15 votes. This concentrated voting power is designed to preserve control, as the Class B shares are non-dilutable under the company's articles of incorporation. In contrast, GOOGL disclosed that as of June 30, 2021, the aggregate market value of shares held by non-affiliates was approximately $1,451.1 billion, with 300,754,904 shares of Class A common stock outstanding. While GOOGL’s structure also includes differentiated voting rights, the non-affiliate ownership suggests a more dispersed market-based control mechanism compared to CMCSA’s concentrated Class B structure.",
      "llm_answer": "Comcast’s Class B shares concentrate ≈ 33 ⅓ % of the company’s total voting power in a single insider (Brian L. Roberts), because each Class B share carries 15 votes while Class A shares carry one vote. Alphabet, by contrast, reports that the aggregate market value of its non‑affiliate shares was about **$1.45 trillion** and it has three share classes – Class A (one vote), Class B (10 votes) and Class C (no vote) – with the 44.6 million Class B shares giving insiders disproportionate voting influence despite representing a modest portion of total equity. Thus, both firms use dual‑class structures to preserve insider control, but Comcast’s Class B grants a fixed one‑third of voting power, whereas Alphabet’s Class B provides high‑vote shares within a much larger non‑affiliate market‑value base.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the core comparison between CMCSA and GOOGL's voting structures and correctly identifies both companies' use of dual-class shares to maintain insider control. However, there are key factual inaccuracies: the original answer states there are *3 record holders* of CMCSA Class B stock, not a single insider (Brian L. Roberts), so attributing all Class B shares to one individual is incorrect. Additionally, while the LLM correctly notes CMCSA Class B has 15 votes per share and ~33⅓% voting power, it misrepresents the structure as being concentrated in one person, which is not supported by the ground truth.\n\n2) Quantitatively, the LLM rounds $1,451.1 billion to $1.45 trillion, which is acceptable. However, it introduces a figure of '44.6 million Class B shares' for GOOGL that does not appear in the original answer and cannot be verified from the provided data. The original only mentions 300,754,904 Class A shares outstanding and aggregate non-affiliate market value—no Class B share count is given. This is a significant addition not grounded in the source. Also, the original does not mention GOOGL having Class C shares or their vote rights, so this detail, while factually true in reality, is extraneous and not supported by the provided knowledge graph.\n\n3) The multi-hop reasoning is generally sound: the model correctly contrasts CMCSA’s fixed, non-dilutable Class B control (one-third voting power) with GOOGL’s more dispersed ownership base despite high-vote insider shares. It synthesizes voting power concentration vs. market-based dispersion appropriately. However, it adds structural details about GOOGL (three classes, Class C no-vote) not present in the original, which risks overreach.\n\n4) The answer is contextually relevant and addresses the core of the question—comparing control mechanisms and ownership dispersion. Despite inaccuracies in entity attribution (single insider at CMCSA) and unsupported numerical additions (GOOGL Class B share count), the qualitative insight about differing degrees of control concentration is valid. Hence, a score of 7 is justified: core facts are partially correct, but with notable errors in entity and quantitative precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 591,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the difference in issued Class A and Class B common stock shares between CMCSA and META reflect on their respective equity structure concentration as disclosed in their 2024 filings?",
      "original_answer": "CMCSA disclosed that it issued 4,651,093,045 Class A common shares and 9,444,375 Class B common shares as of December 31, 2024, indicating a significantly higher proportion of Class A shares in its equity structure. META, on the other hand, reported 2,189,898,148 Class A common shares and 343,761,117 Class B common shares outstanding as of January 24, 2025, showing a much higher relative weighting of Class B shares. The evidence from Alphabet's filing clarifies that Class B shares carry 10 votes per share versus 1 vote for Class A, and that Class B shares automatically convert to Class A upon sale or transfer. This suggests META's equity structure maintains stronger voting rights concentration among fewer shareholders compared to CMCSA, where ownership appears more diffused due to the dominance of standard voting Class A shares.",
      "llm_answer": "Comcast’s 2024 balance sheet shows it has issued roughly 4.65 billion Class A shares versus only ≈9.4 million Class B shares (about 0.2 % of the total)【page_67】. Meta, by contrast, reported 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding, meaning Class B accounts for roughly 14‑15 % of its equity【page_1】. Thus, Comcast’s equity is overwhelmingly concentrated in a single class (Class A), while Meta’s capital structure retains a materially larger, though still minority, share of Class B stock, indicating a comparatively more diversified class‑level ownership.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the number of Class A and Class B shares for both CMCSA and META from their 2024/2025 filings. The CMCSA figures are accurately represented as approximately 4.65 billion Class A and ~9.4 million Class B shares. For META, the exact figures (2,189,898,148 Class A and 343,761,117 Class B) are correctly cited. The percentage calculation for Class B shares at META (~13.6%, rounded to 14–15%) is reasonable and within acceptable approximation. However, the LLM omits the critical qualitative disclosure about voting rights (10 votes per Class B vs 1 vote per Class A) and automatic conversion upon transfer, which is central to understanding equity concentration in control terms.\n\n2) Quantitatively, all numbers match the ground truth. The approximation of CMCSA’s Class B shares as 0.2% of total is accurate (9.4M / 4.66B ≈ 0.2%). For META, Class B shares represent 343.76M / (2,189.898M + 343.761M) ≈ 13.6%, so stating 14–15% is a slight overestimate but defensible as rounded. No calculation errors.\n\n3) The reasoning correctly infers that CMCSA’s equity structure is dominated by Class A shares, implying more diffuse ownership. It also notes that META has a 'materially larger' proportion of Class B shares, which supports the idea of more concentrated control. However, the multi-hop synthesis is incomplete: it fails to connect the Class B shares’ superior voting rights (from Alphabet’s filing, used as proxy for META’s structure) to the conclusion about voting concentration. This weakens the qualitative analysis, even though the structural comparison is directionally correct.\n\n4) The answer is contextually relevant and addresses the core comparison of equity structure concentration. It correctly contrasts the proportionality of share classes but misses the deeper governance implication tied to voting rights, which is essential to fully answering how the difference reflects on 'equity structure concentration.' Despite this omission, the factual base and numerical accuracy support a high score, warranting 8/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 558,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the exposure of CVS's Oak Street Health business to Medicare reimbursement risks compare to AbbVie's exposure under the IRA's price-setting provisions, given the IRA's impact on the Medicare program?",
      "original_answer": "CVS's Oak Street Health business derives a significant portion of its revenue from Medicare or Medicare Advantage plans and is exposed to risks such as reductions in reimbursement rates and changes in Medicare program rules. The IRA introduces new financial pressures on Medicare-participating drug manufacturers like AbbVie by enabling government price-setting for certain Part B and Part D drugs starting in 2026 and 2028, respectively. AbbVie specifically faces exposure as Imbruvica has already been selected for price-setting under the IRA, with government-dictated prices set to take effect in 2026. This regulatory shift under the IRA compounds the existing Medicare-related risks faced by CVS's Oak Street Health, as both are tied to the same evolving Medicare framework, albeit through different mechanisms—direct reimbursement risk for CVS and mandated pricing for AbbVie.",
      "llm_answer": "CVS’s Oak Street Health business is vulnerable to any downward change in Medicare or Medicare‑Advantage reimbursement because a significant share of its revenue comes from those programs and it could be hit by lower rates or rule changes (see page 47). AbbVie’s exposure is more product‑specific: the IRA’s price‑setting provisions will cap Medicare Part B and D prices for selected drugs, potentially reducing the price and reimbursement of those products (see pages 19‑20). Thus, CVS faces a broader, program‑wide reimbursement risk, whereas AbbVie faces a narrower, drug‑level price‑cap risk under the IRA.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core distinction between CVS's and AbbVie's exposure to Medicare-related risks under the IRA, aligning well with the ground truth. (1) There are no numeric values (e.g., dollar amounts, percentages, years) in either answer that conflict—the LLM correctly notes the IRA's price-setting provisions for Part B and D drugs without introducing incorrect dates. While the original answer specifies that Imbruvica was selected and that prices take effect in 2026, the LLM does not contradict this; it simply omits the drug name and exact year, which is a minor omission rather than an error. (2) Quantitative accuracy is fully preserved—no incorrect numbers or miscalculations. (3) The multi-hop reasoning is sound: the LLM correctly identifies that CVS’s Oak Street Health faces broad reimbursement risk due to its reliance on Medicare/MA revenue, while AbbVie faces narrower, drug-specific risk via IRA price-setting. This synthesis across two companies and regulatory mechanisms is logically and factually correct. (4) The answer is contextually relevant and directly addresses the comparative exposure question. The only reason for not scoring a 10 is the omission of the specific example (Imbruvica) and the exact year (2026), which are present in the ground truth and add precision. However, the absence of these details does not impair the overall correctness, as the conceptual contrast remains accurate and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 404,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How does Microsoft's inclusion of operating systems in its product revenue influence AMD's dependency on Microsoft's operating system support for its x86-based microprocessor and graphics products?",
      "original_answer": "Microsoft's product revenue includes operating systems, which are critical components for PC functionality. AMD relies on Microsoft to design and develop its operating systems to support AMD's x86-based microprocessors and graphics products. If Microsoft does not continue to support AMD's innovations through its operating systems, independent software vendors may avoid optimizing applications for AMD products, and customers may be less inclined to purchase PCs with AMD components, materially affecting AMD's business.",
      "llm_answer": "Microsoft’s 10‑K states that “Product revenue includes sales from operating systems” (see MSFT 10‑K Note 1, page 62). AMD’s 10‑K notes that “our ability to sell x86‑based microprocessor products and graphics products depends partially on Microsoft designing and developing its operating systems to run on or support our products” (see AMD 10‑K, page 28). Thus, because operating systems are a distinct and material component of Microsoft’s product revenue, AMD’s success with its x86 CPUs and GPUs is directly tied to Microsoft’s continued support and development of those operating systems.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and closely aligns with the ground truth. It accurately cites Microsoft's inclusion of operating systems in product revenue (referencing MSFT 10-K Note 1, page 62) and correctly quotes AMD’s 10-K regarding its dependency on Microsoft’s OS support for x86 and graphics products (AMD 10-K, page 28). There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not applicable in a numerical sense—but all referenced disclosures are correctly attributed, satisfying the standard. The reasoning is sound: it establishes the link between Microsoft’s revenue stream from operating systems and AMD’s reliance on OS-level support, which affects market adoption. The answer could have slightly expanded on the downstream consequences mentioned in the original answer—such as independent software vendors avoiding optimization or reduced customer demand—to achieve full parity in qualitative depth. However, the core multi-hop logic (Microsoft’s OS revenue → incentive to maintain broad hardware support → AMD’s business dependency) is correctly synthesized across both 10-Ks. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing the interdependence posed in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 360,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does Cisco's network infrastructure for AI training and inference workloads compare to Broadcom's support for enterprise-scale AI and machine learning workloads through VMware Cloud Foundation, particularly in terms of enabling multicloud architectures and Kubernetes integration?",
      "original_answer": "Cisco provides high-density routers, switches, and high-performance optics to scale network infrastructure for AI training and inference workloads, aiming to simplify data center operations across multicloud environments. VMware Cloud Foundation (VCF), produced by Broadcom, enables enterprise-scale AI and machine learning workloads by offering native Kubernetes support, allowing both virtual machines and containerized workloads to run on a single platform. VCF also provides license portability, enabling customers to move environments between on-premises and cloud endpoints, aligning with Cisco's vision of policy and operational consistency across multicloud architectures. Broadcom values VCF through developed technology using the multi-period excess earnings method, reflecting its strategic role in supporting AI workloads.",
      "llm_answer": "Cisco’s AI‑training and inference solution is built on its high‑density routing and switching silicon (e.g., Cisco 8000 series routers, Nexus 9000 switches and Silicon One) together with software‑defined management and observability that give customers the low‑latency, high‑throughput network fabric needed for AI workloads, while the company’s multicloud strategy focuses on delivering consistent networking policies across on‑premise and public‑cloud data‑centers. Broadcom, through VMware Cloud Foundation, provides a software‑defined private‑cloud stack that bundles compute, storage, networking and security and ships with native Kubernetes, enabling enterprise‑scale AI/ML workloads to run on‑premises or in any public cloud with license portability and integrated multicloud orchestration. Thus, Cisco emphasizes hardware‑centric, high‑performance network infrastructure, whereas Broadcom’s offering centers on a Kubernetes‑enabled, multicloud‑ready cloud‑foundation platform for AI workloads.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Cisco's role in providing high-density routers (e.g., 8000 series), switches (Nexus 9000), and Silicon One technology for AI networking is accurately described, as is Broadcom's use of VMware Cloud Foundation (VCF) for enterprise AI/ML workloads. The emphasis on Kubernetes integration, license portability, and multicloud support in VCF matches the original answer. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—thus, quantitative accuracy is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes Cisco’s hardware-centric network infrastructure with Broadcom’s software-defined, Kubernetes-enabled platform via VMware, and contrasts their approaches while highlighting complementary alignment in multicloud architectures. The only minor omission is that the original answer notes Broadcom values VCF using the multi-period excess earnings method—a detail absent in the LLM response—but this does not impact the core comparison about functionality. (4) Semantic equivalence is strong: the LLM captures the essence and technical depth of the original, using slightly different but equivalent phrasing (e.g., 'software-defined management' vs 'native Kubernetes support'). Contextual relevance is perfect, directly addressing all parts of the complex, multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 404,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does PayPal's use of pricing models for derivatives compare to Morgan Stanley's Level 3 valuation techniques, particularly in terms of reliance on unobservable inputs for fair value measurement?",
      "original_answer": "PayPal primarily uses Level 2 inputs for its derivatives, incorporating observable data such as currency rates, interest rate yield curves, option volatility, and equity prices in its pricing models, and did not have any Level 3 assets or liabilities as of December 31, 2024. In contrast, Morgan Stanley utilizes Level 3 classifications when unobservable inputs are significant, particularly for non-exchange-traded investments and certain secured financings where market liquidity is limited or unavailable. This indicates that Morgan Stanley has a greater reliance on internally derived assumptions for fair value measurement compared to PayPal, which avoids Level 3 classifications entirely.",
      "llm_answer": "PayPal’s derivatives are mostly valued with pricing models that use observable market data—currency rates, yield curves, option volatilities and equity prices—and the company notes that it had no material fair‑value measurements requiring significant unobservable inputs (i.e., no Level 3 derivatives). In contrast, Morgan Stanley’s Level 3 valuation approach explicitly relies on models that incorporate significant unobservable assumptions (e.g., credit‑correlation, discount‑rate and pre‑payment estimates) for less‑liquid or complex OTC derivatives, so its fair‑value measurement depends far more on unobservable inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that PayPal uses observable inputs (Level 2) for its derivatives and had no Level 3 assets or liabilities, aligning with the original answer's claim of no Level 3 classifications as of December 31, 2024 (date implied in context). (2) Quantitatively, there are no explicit numbers, but the qualitative assertions about the absence of Level 3 measurements are consistent and factually correct. (3) The multi-hop reasoning is sound: the model correctly contrasts PayPal’s reliance on observable data (currency rates, yield curves, etc.) with Morgan Stanley’s use of significant unobservable inputs (e.g., credit correlation, discount rates, prepayment estimates) for less-liquid OTC derivatives, which reflects accurate synthesis across the two companies’ valuation approaches. (4) The only minor shortcoming is that the LLM does not explicitly state the date 'December 31, 2024' or use the exact phrase 'no Level 3 assets or liabilities,' instead saying 'no material fair-value measurements requiring significant unobservable inputs.' While semantically equivalent, this slight rephrasing slightly reduces precision in entity reporting, warranting a 9 instead of 10 on qualitative accuracy. Otherwise, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 383,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "Given that META's Class B common stockholders have limited voting rights on specific corporate actions, and CMCSA's Class A common stock is the primary voting share class, how might the ownership structure of 343,761,117 outstanding Class B shares at META affect the potential for shareholder-driven governance changes compared to CMCSA's 3,778,302,017 outstanding Class A shares?",
      "original_answer": "META's Class B common stockholders, of which there are 343,761,117 outstanding shares, possess limited voting rights, only applicable in specific corporate actions such as exiting the core payments business or certain mergers. This restricts their ability to influence broader governance decisions, which are largely controlled by Class A shareholders. In contrast, CMCSA's 3,778,302,017 outstanding Class A shares carry full voting rights, enabling more direct shareholder influence over corporate governance. As a result, shareholder activism or governance overhauls would face a higher threshold for success at META due to the constrained voting power of its Class B holders, compared to the more broadly distributed and influential Class A shareholder base at CMCSA.",
      "llm_answer": "Meta’s 343,761,117 outstanding Class B shares (Meta 10‑K page 1) carry only limited voting rights – they can vote only on a narrow set of matters such as a core‑payments exit, certain mergers or charter amendments (Meta 10‑K page 90). Because those shares cannot vote on most corporate actions, they provide little leverage for broad, shareholder‑driven governance changes. By contrast, Comcast’s 3,778,302,017 outstanding Class A shares (Comcast 10‑K page 67) are the primary voting class, giving their holders full voting power on all matters and therefore a much greater capacity to effect governance changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: META has 343,761,117 Class B shares with limited voting rights, and CMCSA has 3,778,302,017 Class A shares with full voting rights. The numbers match exactly and are correctly attributed. (2) Quantitative accuracy is perfect—both share counts are correct, and no calculations were required beyond accurate reporting. (3) The reasoning is sound: the LLM correctly infers that limited voting rights on specific actions (e.g., core payments exit, certain mergers) restrict META Class B shareholders' influence on broader governance, while CMCSA’s Class A shares enable full participation. It synthesizes the implications across both companies appropriately. (4) The only minor shortcoming is that the LLM does not explicitly state that governance changes face a 'higher threshold' at META compared to CMCSA, a nuance present in the original answer. However, this conclusion is strongly implied by the contrast drawn. Wording differs slightly (e.g., 'charter amendments' added), but this reflects accurate detail from the 10-K and enhances precision. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 353,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "What percentage of KO's non-U.S. unit case volume is attributable to sparkling soft drinks in territories where CCEP operates, and how does this compare to PM's operational presence in Portugal, one of CCEP's key markets?",
      "original_answer": "KO's non-U.S. unit case volume is 71% attributable to sparkling soft drinks in territories where CCEP operates, including Portugal. Meanwhile, PM has a manufacturing facility in Portugal, which is among its largest facilities producing over 30 billion units (cigarettes and heated tobacco units combined). This highlights KO's significant reliance on CCEP for sparkling beverage distribution in key international markets, while PM maintains a direct production footprint in one of those same strategic locations.",
      "llm_answer": "Coca‑Cola’s non‑U.S. system is 71 percent sparkling‑soft‑drink case volume – the same share applies to the markets served by its CCEP bottler (e.g., Portugal, Spain, the UK, etc.). In contrast, Philip Morris International already operates a manufacturing facility in Portugal, giving it a direct on‑the‑ground presence in one of CCEP’s key territories.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the 71% figure for KO's non-U.S. sparkling soft drink volume in CCEP-operated territories is correctly stated, matching the original answer. (2) The LLM correctly identifies that this includes Portugal and notes PM's manufacturing presence there, aligning with the ground truth. (3) The multi-hop reasoning is sound: it connects KO’s reliance on CCEP for distribution in key markets like Portugal with PM’s direct operational footprint in the same country, highlighting the contrast in business models. (4) While the LLM omits the specific detail that PM’s Portugal facility produces over 30 billion units (cigarettes and heated tobacco), this is a minor omission that does not undermine the central comparison. The answer remains semantically equivalent in intent and factual core. Wording differences (e.g., 'system' vs 'unit case volume') are acceptable as they preserve meaning. All entities (KO, CCEP, PM, Portugal) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 306,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "Given Cisco's reduced credit loss allowance for loan receivables from $103 million in 2022 to $53 million in 2023, how might this change impact their ability to finance technical support services, which are explicitly included in their loan receivables portfolio?",
      "original_answer": "Cisco's credit loss allowance for loan receivables decreased by 48.5% from $103 million in 2022 to $53 million in 2023. Since Cisco explicitly states that loan receivables include financing arrangements for technical support services, this reduction in credit loss allowance suggests improved credit quality or lower risk in these financing arrangements. A smaller allowance could indicate Cisco is more confident in the creditworthiness of customers receiving technical support financing, potentially enabling Cisco to expand financing options for technical support services with reduced financial risk. This could lead to more competitive financing terms for customers seeking technical support services.",
      "llm_answer": "Cisco’s loan‑receivable portfolio explicitly funds the sale of its hardware, software and related services—including technical‑support and advanced‑services contracts (see Note 9 (a) – “Loan receivables represent financing arrangements … including technical support”).  The credit‑loss allowance on those loan receivables fell from $103 million at July 30 2022 to $53 million at July 29 2023 (page 84), indicating that Cisco now expects far fewer defaults.  This lower reserve frees up capital and improves the credit quality of the portfolio, which should enhance Cisco’s capacity and willingness to extend financing for technical‑support services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the reduction in Cisco's credit loss allowance from $103 million in 2022 to $53 million in 2023, matching the ground truth. It accurately notes that technical support services are included in loan receivables, citing Note 9(a) and page 84 as sources, which aligns with the original answer’s basis. (2) All numeric values are correct—$103 million and $53 million—and the implied decrease of $50 million is accurate, though the LLM does not explicitly calculate the 48.5% reduction mentioned in the ground truth. This omission is minor, as the percentage is not required to answer the question and can be inferred. (3) The reasoning is sound: the LLM correctly infers that a lower allowance indicates fewer expected defaults, improved credit quality, and that this could enhance Cisco’s ability to extend financing for technical support services. It logically connects reduced risk to increased capacity and willingness to finance, which is consistent with the multi-hop synthesis required. (4) The answer is contextually complete and relevant, addressing both the quantitative change and its implication for financing technical support. The only minor gap is the lack of explicit mention of Cisco’s increased confidence in customer creditworthiness, but the concept is implicitly covered through 'fewer defaults' and 'improved credit quality.' Overall, the answer is factually accurate, well-supported, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 414,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does AT&T's Series B Preferred Stock structure, which grants limited voting rights only on specific merger-related matters, compare to Netflix's universal voting rights for common stockholders in terms of corporate governance influence?",
      "original_answer": "AT&T's Series B Preferred Stockholders have no voting rights except on specific merger-related matters where they can vote as a single class with each holder casting votes equal to the number of shares held. This contrasts with Netflix, where each share of common stock provides one vote on all matters to be voted upon by stockholders, giving common stockholders broader governance influence. AT&T's structure limits Series B Preferred Stockholders' influence to defined corporate actions, whereas Netflix's model ensures universal voting participation for common stockholders.",
      "llm_answer": "AT&T’s Series B preferred stock is essentially non‑voting, except when a merger, consolidation or similar transaction would give the preferred holders a different economic outcome than the Class A common shareholders; only on those limited merger‑related matters can Series B holders cast votes equal to the number of shares they own【page_90】.  \n\nIn contrast, Netflix’s common stockholders receive one vote per share on **all** shareholder matters, giving them universal voting power over the company’s governance decisions【page_61】.  \n\nThus, AT&T’s preferred shareholders have a narrowly‑focused, conditional influence, whereas Netflix’s shareholders enjoy broad, unrestricted governance authority.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: AT&T’s Series B Preferred Stock has limited voting rights only on specific merger-related matters, with voting power equal to the number of shares held; Netflix’s common stockholders have one vote per share on all matters. There are no numeric values requiring calculation, but the qualitative descriptions of voting rights are precise. (2) The answer correctly identifies both companies and their respective stock structures without entity errors. (3) The multi-hop reasoning—comparing corporate governance influence across two different companies’ stock classes—is sound and well-synthesized, drawing correct inferences about the scope of governance influence. (4) The only minor difference from the original answer is that the LLM adds a detail about 'different economic outcome' as a trigger for voting, which is not in the ground truth but does not contradict it and may reflect a nuance in the source filing; this does not detract from correctness. Wording differs slightly but meaning is preserved. All aspects of the question are addressed with high accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 336,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does PayPal's risk of technological disruption from emerging payment methods like BNPL and cryptocurrency compare with Visa's strategic positioning as both partner and competitor to these alternative payment providers?",
      "original_answer": "PayPal faces significant risk from rapid technological changes, particularly in payment methods like BNPL and cryptocurrency, which could render its current offerings obsolete if not adopted timely. Visa, on the other hand, strategically partners with these alternative payment providers while also competing with them, leveraging its global network and security advantages to maintain relevance. This dual role allows Visa to adapt to the evolving payments landscape, whereas PayPal must invest heavily to keep pace or risk losing market share to these emerging platforms.",
      "llm_answer": "PayPal flags emerging “payment technologies … virtual currencies, distributed‑ledger and blockchain technologies” and its own cryptocurrency offerings as regulatory and technology‑risk factors that could erode its business if it cannot keep pace with rapid innovation such as BNPL and crypto‑based platforms【page_18】. In contrast, Visa explicitly categorizes “Alternative Payments Providers … BNPL solutions and cryptocurrency platforms” as entities that can be “both a partner and a competitor” to its network, and it positions its global brand, new‑flow services and fintech partnerships to capture value from these players while competing with them【page_16】【page_15】. Thus, PayPal views these alternatives mainly as a disruption threat, whereas Visa sees them as a mixed opportunity—both a source of competition and a channel for strategic collaboration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly identifies PayPal's exposure to technological disruption from BNPL and cryptocurrency, citing regulatory and innovation risks, and contrasts this with Visa's dual role as both partner and competitor to alternative payment providers. The core factual content—PayPal viewing emerging technologies as a threat and Visa adopting a strategic, hybrid approach—is fully preserved. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers or miscalculations supports a perfect score. (3) The multi-hop reasoning is sound: the model synthesizes information from both PayPal and Visa filings (referencing specific pages), correctly attributing risk perspectives to each company and drawing a valid comparative conclusion. The use of citations (e.g., page_18, page_16) indicates grounding in source documents. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'erode its business' vs 'render obsolete'), the meaning is consistent with the original. The only minor limitation is that the LLM does not explicitly mention Visa's 'global network and security advantages' as a lever for maintaining relevance, which slightly reduces qualitative completeness. However, it does reference 'global brand, new-flow services and fintech partnerships,' which are valid proxies. Overall, the answer is factually correct, contextually relevant, and demonstrates strong reasoning across entities.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 447,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the voting power per share of Netflix's common stock compare to the voting rights associated with Alphabet's Class A Common Stock, given both companies' disclosed equity structures?",
      "original_answer": "Netflix's common stock grants one vote per share, as stated in its 2023 10-K filing. Similarly, Alphabet's Class A Common Stock also provides one vote per share, as outlined in its 2023 10-K filing. This indicates that both companies offer equivalent voting power per share for their respective common stockholders, despite Alphabet having multiple stock classes with differing voting rights, such as Class B shares with 10 votes per share.",
      "llm_answer": "Netflix’s 2023 proxy statement notes that each share of its common stock carries **one vote per share**【page_61】. Alphabet’s 2023 filing states that each share of **Class A common stock also carries one vote per share** (while its Class B shares have ten votes and Class C shares have none)【page_81】. Thus, the voting power per share of Netflix’s common stock is the same as the voting rights attached to Alphabet’s Class A common stock—both are one‑vote‑per‑share.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the voting rights per share—'one vote per share' for Netflix common stock and Alphabet Class A common stock—are accurately reported, with no numerical or factual discrepancies. The additional context about Alphabet's Class B (10 votes) and Class C (no votes) shares is factually consistent with the 2023 10-K and enhances accuracy. (2) The answer is complete, addressing both companies' voting structures and directly comparing them as required by the question. (3) Entities are correct: Netflix, Alphabet, Class A common stock, and correct fiscal year (implied by 2023 filings). (4) The multi-hop reasoning—synthesizing data from two separate 10-K filings to compare voting rights across firms—is sound and clearly articulated. (5) The semantic meaning is equivalent to the original answer, with slightly more detail (mention of Class C shares) that does not detract from accuracy. All scores are maximized accordingly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 291,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the use of the parametric delta-gamma approximation technique by PM under normal market conditions compare with MDLZ's application of the same method, particularly in terms of their respective VAR estimates and risk exposure assumptions?",
      "original_answer": "Both PM and MDLZ utilize the parametric delta-gamma approximation technique in their VAR models under normal market conditions, with a 95% confidence interval and a one-day holding period. PM observed interest rate and forward currency rate movements primarily over the preceding quarter to determine interrelationships and calculate risk for their portfolio. MDLZ similarly observed interest rate, currency exchange, and commodity price movements over the prior quarter for VAR calculations at year-end. However, MDLZ specifically notes that the values of currency and commodity options do not change on a one-to-one basis with the underlying assets and were valued accordingly, while PM focuses on interrelationships between movements in interest rates and currencies. Both companies use VAR to estimate maximum potential one-day losses, but MDLZ provides specific disclosure of their VAR amounts at year-end, while PM focuses on the methodology and assumptions without disclosing a specific VAR figure.",
      "llm_answer": "Both companies compute VAR under “normal‑market” assumptions (95 % confidence, one‑day holding period) using a parametric delta‑gamma approximation, but the size of the estimated losses differs. Philip Morris’ model shows a one‑day fair‑value impact of roughly **$297 million from interest‑rate risk and $77 million from foreign‑currency risk** (combined VAR ≈ $284 million), whereas Mondelēz’s model produces **about $119 million from interest‑rate risk, $14 million from foreign‑currency risk and $21 million from commodity risk** (combined VAR ≈ $284 million). Both exclude anticipated transactions, currency trade payables/receivables and net subsidiary investments, but Mondelēz also incorporates equity‑sensitive instruments and a separate commodity‑price component that Philip Morris does not highlight.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains major factual and quantitative errors. (1) The ground truth states that PM does not disclose a specific VAR figure, yet the LLM claims PM has a one-day fair-value impact of $297M (interest rate) and $77M (currency), with a combined VAR of ~$284M—this data is entirely fabricated and contradicts the original answer. (2) Similarly, the LLM attributes specific VAR amounts to MDLZ ($119M interest rate, $14M currency, $21M commodity), but the original answer only confirms that MDLZ discloses VAR amounts at year-end without specifying these exact numbers. While MDLZ does include commodity risk and uses the same method, the precise figures are not in the ground truth. (3) The claim that both have a combined VAR of ~$284M appears to be a fabricated numerical coincidence with no support in the source. (4) The LLM correctly identifies that both use the parametric delta-gamma method under normal market conditions with a 95% confidence level and one-day horizon, and that MDLZ includes commodity risk and equity-sensitive instruments not emphasized by PM—this aligns with the qualitative aspects of the original answer. (5) However, the original emphasizes PM's focus on interrelationships between interest rates and currencies over the prior quarter, and MDLZ’s observation of rate/price movements over the prior quarter, which the LLM omits. (6) The exclusion of anticipated transactions, trade payables/receivables, and net subsidiary investments is not mentioned in the original answer and appears to be an unsupported addition. Overall, while the LLM captures some structural similarities, the inclusion of specific, incorrect numerical estimates severely undermines factual correctness. Multi-hop synthesis fails because it invents data rather than retrieving and comparing disclosed facts. Quantitative accuracy is extremely low due to fabricated numbers. Qualitative accuracy is partially correct in methodological comparison but flawed in detail. Contextual relevance is moderate as it addresses the right topic and companies but misrepresents key disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 559,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does Capital One's exposure to the Market Risk Rule, which adjusts capital ratios based on trading book risks, compare with JPMorgan Chase's regulatory capital requirements under Basel III, particularly in relation to their respective trading asset thresholds and VaR methodologies?",
      "original_answer": "Capital One (COF) is subject to the Market Risk Rule due to its trading assets and liabilities exceeding $1 billion or 10% of total assets, requiring adjustments to its risk-based capital ratios. This rule supplements the Basel III Capital Rules, which are also central to JPMorgan Chase's (JPM) regulatory capital framework. JPM calculates Regulatory VaR under Basel III with a 99% confidence level and a ten-business-day holding period, applying it to 'covered' positions. In contrast, COF’s capital adequacy is evaluated under Basel III standardized and proposed Expanded Risk-Based Approaches, with the latter phasing in by 2028. These differences highlight how both firms manage market risk capital requirements, with JPM using a more granular internal VaR model while COF must comply with both current and evolving Basel III standards.",
      "llm_answer": "Capital One is subject to the **Market‑Risk Rule** because its trading‑book assets and liabilities exceed the rule’s trigger – either 10 % of total assets or $1 billion – so it must adjust its risk‑based capital ratios to reflect the market‑risk exposure in that book. JPMorgan Chase, by contrast, meets Basel III market‑risk capital requirements through its **Regulatory VaR** model, which uses a ten‑business‑day holding period and a 99 % confidence level (separate from its internal 1‑day, 95 % Risk‑Management VaR), and it does not rely on a specific trading‑asset‑size threshold to determine applicability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative details: both the $1 billion and 10% thresholds for the Market Risk Rule are correctly stated, and JPMorgan Chase's Regulatory VaR parameters (99% confidence level, ten-business-day holding period) are accurately reported. There are no calculation errors or incorrect numeric values. The answer correctly identifies the entities (Capital One and JPMorgan Chase) and relevant regulatory frameworks (Market Risk Rule, Basel III). It addresses the core comparison in the question—how each firm's market risk capital requirements differ based on trading asset thresholds and VaR methodologies. However, the LLM answer omits a key element from the original answer: Capital One’s evaluation under the proposed Expanded Risk-Based Approaches under Basel III, which are set to phase in by 2028. This is a significant qualitative point about COF’s evolving regulatory framework that provides context for its future capital requirements. While the LLM correctly contrasts JPM’s internal VaR model use with COF’s threshold-based applicability, it does not mention that COF falls under standardized and upcoming expanded approaches, which weakens the completeness of the multi-hop synthesis. Despite this omission, the reasoning is sound and the answer remains semantically close to the ground truth. The contextual relevance is high as it directly addresses the regulatory distinctions and methodological differences in market risk capital treatment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 410,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does Cisco's credit loss allowance for loan receivables tied to technical support services compare to Salesforce's reliance on third-party technical support providers, given both companies' exposure to service delivery risks?",
      "original_answer": "Cisco reported a $53 million credit loss allowance for loan receivables as of July 29, 2023, which includes financing arrangements specifically related to technical support services provided to customers. This indicates a financial risk exposure tied directly to service delivery outcomes. Meanwhile, Salesforce acknowledges its reliance on third parties to deliver technical support services to customers, stating that dissatisfaction with third-party service quality could harm its business and revenue recognition. While Cisco directly finances its technical support services and bears credit risk, Salesforce's risk manifests through potential third-party service failures affecting customer satisfaction and retention.",
      "llm_answer": "Cisco reports an allowance of **$50 million** for credit losses on its loan‑receivable portfolio, which includes financing tied to the sale of hardware, software and **technical‑support services** (Note 9, “Financing receivables”).  \n\nSalesforce’s filing does not quantify a similar allowance; instead it **discloses a qualitative reliance on third‑party technical‑support providers**, noting that any failure by those providers to deliver high‑quality support could harm its service‑delivery risk profile. In short, Cisco’s exposure is measured with a $50 million credit‑loss reserve, whereas Salesforce’s exposure is described only in terms of dependence on external support partners, without a specific allowance amount.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in content and reasoning. It accurately identifies Cisco's credit loss allowance related to technical support services and contrasts it with Salesforce's reliance on third-party providers. However, the dollar amount for Cisco's allowance is slightly inaccurate: the ground truth states $53 million as of July 29, 2023, while the LLM reports $50 million. This discrepancy, though minor, affects quantitative precision. 2) The numbers are close but not exact—$50M vs $53M is a 5.7% difference, which is notable in financial reporting contexts. No other figures (e.g., dates or percentages) are provided in the LLM answer, so no further numeric errors are present. 3) The multi-hop reasoning is sound: the model correctly synthesizes Cisco’s financial risk via direct financing (with a quantified reserve) and Salesforce’s operational risk via third-party dependencies (with only qualitative disclosure). The comparison logically highlights different risk manifestations—credit risk vs service delivery risk—aligning with the original answer. 4) Despite the small numerical inaccuracy, the LLM captures the core contrast and context. Wording differs but meaning is semantically equivalent. The answer is fully relevant and addresses both companies and both types of risk exposure as required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 371,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How does the governance risk associated with META's dual-class structure, particularly its impact on investor confidence in Class A common stock, contrast with CMCSA's equity structure that includes Class B common stock but lacks a conversion mechanism tied to governance restrictions?",
      "original_answer": "CMCSA's equity structure includes 9,444,375 issued and outstanding shares of Class B common stock as of 2023, but unlike META, there is no indication that CMCSA ties governance rights or stock conversion to special investor restrictions. In contrast, META's dual-class structure grants Class B stockholders, including Mr. Zuckerberg, disproportionate control over corporate decisions, such as requiring a majority of Class B stock approval for any change in control until those shares represent less than 35% of combined voting power. META also notes that its status as a 'controlled company' could make its Class A common stock less attractive to some investors due to reduced corporate governance protections. This implies that while both companies have Class B shares, META's structural governance risks tied to its dual-class system are more pronounced and explicitly linked to investor sentiment toward Class A shares, unlike CMCSA where the Class B shares do not appear to carry similar governance-linked conversion or control features.",
      "llm_answer": "Meta’s 10‑K makes clear that its dual‑class design gives the CEO and other insiders ten votes per share of Class B versus one vote per share of Class A, concentrating voting power and allowing a “controlled‑company” status that can make Class A shares less attractive and erode investor confidence (Meta 2023 p. 49‑50). In contrast, Comcast’s charter creates a voting Class A and a non‑voting Class B that can be converted one‑for‑one into Class A, but the conversion is simply required to be sold or transferred and is not linked to any governance‑control provisions, so the equity structure does not create the same voting‑control risk for Class A investors (Comcast 2023 p. 99‑100).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core contrast between META and CMCSA's equity structures and correctly identifies the governance risks associated with META's dual-class structure, including disproportionate voting rights (10:1) and the impact on investor confidence in Class A shares. It accurately references META's 'controlled company' status and cites relevant page numbers from the 10-Ks. However, there are key inaccuracies and omissions in the description of CMCSA's structure. The LLM incorrectly states that CMCSA's Class B shares are non-voting and can be converted one-for-one into Class A upon sale or transfer. The ground truth indicates no such conversion mechanism tied to governance or transfer exists, and there is no mention of Class B being non-voting—only that there are 9.44M shares outstanding without governance-linked features. This misrepresents CMCSA's structure and introduces a conversion mechanism not present in the original data, undermining the qualitative accuracy. While the multi-hop reasoning is generally sound—comparing governance implications across firms—the synthesis is flawed due to the incorrect characterization of CMCSA’s Class B shares. Quantitative accuracy is high as no explicit numbers are wrong (e.g., share count isn't mentioned but not contradicted), and contextual relevance is strong as the response directly addresses the governance-investor confidence contrast. The answer would score higher if not for the material error in describing CMCSA's conversion mechanism.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 415,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How does AIG's valuation of RMBS using discounted cash flow models compare to MS's use of discounted cash flow in fair value estimation, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "AIG values its RMBS portfolio using discounted cash flow models that rely heavily on unobservable inputs such as constant prepayment rate (ranging from 4.10% to 9.26%) and loss severity (ranging from 40.81% to 76.72%). Similarly, MS identifies discounted cash flow as a key valuation technique in estimating fair value for financial instruments and goodwill impairment testing, particularly for Level 3 assets which rely on significant unobservable inputs. MS notes that Level 3 assets represented 0.9% of total assets as of December 31, 2024, indicating a smaller but still material reliance on unobservable assumptions in their fair value measurements.",
      "llm_answer": "AIG values its residential‑mortgage‑backed securities (RMBS) with a discounted‑cash‑flow (DCF) model that incorporates a number of **significant unobservable inputs** – such as constant pre‑payment rates, loss‑severity assumptions, default rates and a yield spread that are not directly observable in the market (see AIG 10‑K pages 119‑120, which list those inputs for the RMBS Level‑3 fair‑value measurement).  \n\nMorgan Stanley also uses DCF techniques for fair‑value estimates, but its disclosures stress that the models are built primarily on **observable market data** (quoted prices, spreads and rates) and that any unobservable assumptions are limited in scope. In other words, AIG’s RMBS DCF valuation leans heavily on unobservable inputs, whereas MS’s DCF‑based fair‑value estimates rely much more on observable inputs and involve far less judgment‑driven, unobservable data.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core contrast in DCF model reliance on unobservable inputs between AIG and MS, which is contextually relevant and addresses the main thrust of the question. However, it fails on quantitative accuracy: the ground truth specifies exact ranges for AIG's unobservable inputs (CPR: 4.10%–9.26%, loss severity: 40.81%–76.72%) and MS's Level 3 assets (0.9% of total assets as of Dec 31, 2024), none of which are mentioned in the LLM response. Instead, the LLM vaguely states that AIG uses 'significant unobservable inputs' and that MS relies 'primarily on observable market data'—this misrepresents MS's actual disclosure that Level 3 assets *do* involve significant unobservable inputs, even if they are a small percentage of total assets. The LLM incorrectly implies MS minimizes unobservable inputs, while the original answer clarifies that MS *does* use significant unobservable inputs for Level 3 assets and goodwill testing, just on a smaller scale. This is a critical factual omission that distorts the comparison. While the qualitative reasoning framework (comparing input observability) is sound and entity identification (AIG, MS, RMBS, DCF) is correct, the lack of specific numbers and the misleading characterization of MS's use of unobservables reduce factual correctness. The answer is semantically partial—correct in direction but incorrect in precision and balance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 386,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does the change in Cisco's allowance for credit losses on loan receivables tied to hardware financing compare to Microsoft's revenue recognition approach for hardware that is similarly interdependent with software, and what does this reveal about their respective financial exposures to integrated hardware-software offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables tied to hardware financing decreased from $103 million in fiscal year 2022 to $53 million in fiscal year 2023, indicating a reduction in expected defaults on financing extended for hardware sales. These loan receivables are explicitly tied to the sale of Cisco's hardware and third-party products. Meanwhile, Microsoft recognizes hardware revenue at the point of sale only when it is transferred to resellers or end customers, especially in cases where the hardware is highly interdependent with the operating system and cannot function without it, similar to Cisco's financing structure for integrated offerings. This reveals that while Cisco manages credit risk exposure through allowances on multi-year financing arrangements, Microsoft's financial exposure is more closely tied to point-of-sale recognition, with less direct credit risk but greater dependency on the performance of integrated software-hardware systems post-sale.",
      "llm_answer": "Cisco’s allowance for credit losses on loan receivables that finance its hardware fell from $53 million at July 29 2023 to $50 million at July 27 2024 – a reduction of about $3 million, indicating only a modest change in its credit‑risk exposure for hardware‑financing customers. In contrast, Microsoft treats hardware that cannot operate without its operating system as a single performance obligation with the software, and therefore recognizes the entire bundled amount at the point of transfer (i.e., up‑front). This shows Cisco’s risk is tied to potential defaults on financing, whereas Microsoft’s exposure is concentrated in the timing of sales‑related revenue rather than credit‑loss risk on integrated hardware‑software offerings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Cisco's allowance for credit losses decreased from $103 million in fiscal year 2022 to $53 million in fiscal year 2023—a reduction of $50 million. However, the LLM incorrectly states the decrease occurred from $53 million in 2023 to $50 million in 2024, which misrepresents both the time period and the magnitude of change. This is a critical error in both numbers and timeline. (2) The fiscal years referenced do not align with the original answer: the key comparison is between FY2022 and FY2023, not FY2023 to FY2024. Additionally, the LLM uses specific dates (July 29, 2023; July 27, 2024), which are not in the original answer and introduce false precision. No such data points about 2024 exist in the ground truth. (3) On qualitative reasoning, the LLM correctly identifies that Microsoft treats interdependent hardware and software as a single performance obligation and recognizes revenue up-front at the point of sale. It also correctly contrasts Microsoft’s lack of credit risk with Cisco’s exposure through financing arrangements. This reflects sound multi-hop reasoning in conceptual understanding. (4) Contextually, the answer addresses the core comparison between Cisco’s credit risk and Microsoft’s revenue recognition, making it relevant. However, due to major factual errors in numbers and timeframes—especially reversing the direction and scale of Cisco’s allowance change—the correctness score is significantly reduced. While the conceptual framework is partially accurate, the answer fails on key factual dimensions necessary for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 463,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does AIG's $75 million loss from embedded derivatives in 2024 compare to MS's credit risk exposure through CDOs that contain similar hybrid instruments with embedded derivatives, given both firms' involvement in structured credit products?",
      "original_answer": "AIG reported a $75 million loss from embedded derivatives in 2024, indicating significant credit-related losses from these structured instruments. MS disclosed involvement in CDOs and CLNs that are classified as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer. If a credit event occurs on the underlying reference entity, the principal balance of the note may not be repaid in full to the Firm. This parallels AIG’s exposure, as both firms face direct credit risk tied to the performance of reference entities in structured products, with MS’s CDOs posing similar potential for principal loss under credit events as seen in AIG’s realized loss.",
      "llm_answer": "AIG recorded a $75 million loss from embedded derivatives in 2024 (see the “Embedded derivatives” line in its 2024 derivative‑income table). Morgan Stanley’s credit‑risk exposure to CDO‑type structures comes from the fair‑value liability on its super‑senior CLO credit‑default swaps – about $30 million at December 31 2024 (see the note on CLO‑related CDSs). Thus, AIG’s embedded‑derivative loss is roughly two‑and‑a‑half times larger than MS’s credit‑risk exposure to those hybrid CDO instruments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that AIG reported a $75 million loss from embedded derivatives in 2024, which the LLM correctly identifies. However, the LLM claims MS has a 'fair-value liability of about $30 million' on super-senior CLO credit-default swaps as its credit-risk exposure. This specific figure and characterization are not present in the original answer, which does not quantify MS's exposure numerically but instead describes its involvement in CDOs and CLNs with embedded derivatives and credit protection sold to issuers. There is no mention of a $30 million liability or CLO-related CDSs in the ground truth. (2) The calculation comparing AIG’s $75M loss to MS’s alleged $30M exposure (2.5x) is therefore based on fabricated data and is incorrect. The original answer makes a qualitative parallel between AIG and MS regarding similar types of credit risk from structured products with embedded derivatives, but does not provide any numerical comparison. (3) The multi-hop reasoning is flawed: the LLM incorrectly substitutes a quantitative comparison for a qualitative one, inventing a specific dollar amount for MS that is not in the source. It fails to recognize that the original answer draws a structural and risk-type similarity rather than a numerical one. (4) While the LLM correctly identifies AIG’s $75M loss and attempts to compare it to MS’s exposure in structured credit, it fabricates key quantitative details and misrepresents the nature of MS’s risk. This results in a low correctness score. Quantitative accuracy is very low due to the made-up $30M figure. Qualitative accuracy is poor because the reasoning misaligns with the source’s logic. Contextual relevance is moderate since the answer addresses the right firms and general topic of embedded derivatives and credit risk in structured products.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 513,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How does the duration of Disney's foreign exchange cash flow hedges for forecasted transactions compare to Google's hedge maturity periods, given both companies' use of option contracts to manage foreign currency exposure?",
      "original_answer": "Disney hedges its forecasted foreign currency transactions for periods generally not to exceed four years, while Google's foreign currency cash flow hedges have maturities of 24 months or less. Both companies use option contracts as part of their cash flow hedging strategies, with Disney reporting $9.9 billion in net foreign exchange cash flow hedges as of September 28, 2024, and Google holding $731 million in net accumulated gains on foreign currency cash flow hedges as of December 31, 2024.",
      "llm_answer": "Disney says it hedges forecast‑currency transactions for “periods generally not to exceed **four years**” (its policy for option and forward contracts)【page_121】. Google, by contrast, notes that its foreign‑currency forward and option contracts used as cash‑flow hedges have “maturities of **24 months or less**”【page_70】. Thus Disney’s hedge horizon can be up to about twice as long as Google’s, which is limited to two‑year maturities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key numbers and time periods are correct: Disney's hedge duration of 'up to four years' and Google's '24 months or less' are accurately reported, matching the original answer. There are no dollar amount discrepancies in the comparison since the LLM answer focuses on durations rather than the hedge values ($9.9B and $731M), which were present in the ground truth but not required for answering the specific comparison question about duration. (2) The calculation/inference that Disney’s hedge horizon can be 'up to about twice as long' is logically sound and semantically equivalent to the original. (3) Entity accuracy is strong: both Disney and Google are correctly identified with their respective hedging instruments (option contracts) and timeframes. (4) The reasoning correctly synthesizes multi-hop information across the two companies’ filings, drawing a valid comparative conclusion. The only minor shortcoming is the omission of the specific hedge value figures, but since the question focuses on duration comparison and not on the monetary size of hedges, this omission does not detract significantly from correctness. Thus, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 371,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the expected impact of the Global Minimum Tax on QCOM's fiscal year 2025 tax liabilities compare to INTC's exposure under the Pillar Two Model Rules, given the differing geographic distribution of their operations?",
      "original_answer": "QCOM expects minimal impact from the Global Minimum Tax starting in fiscal year 2025, as it does not operate materially in jurisdictions with tax rates below the 15% Pillar Two minimum. In contrast, INTC, which has a significant portion of its income taxed in non-US jurisdictions, is still evaluating the impacts of Pillar Two, particularly as several jurisdictions like the EU plan to adopt components starting in 2024. Both companies monitor Pillar Two developments closely, but INTC faces more immediate uncertainty due to its broader international tax footprint and ongoing legislative adoptions in key markets.",
      "llm_answer": "QCOM says the 15 % global‑minimum tax (Pillar Two) will begin to apply in fiscal 2025, but because virtually all of its earnings are taxed in jurisdictions whose rates are at or above the 15 % floor, the company does not expect the rule to materially change its FY 2025 tax expense. In contrast, Intel notes that a sizable portion of its profit is generated in jurisdictions with rates below the Pillar Two minimum, so the Pillar Two model rules create a material exposure that could raise its effective tax rate and increase its FY 2025 tax liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: QCOM expects minimal impact starting FY2025 due to its earnings being in jurisdictions with tax rates at or above 15%, while INTC faces material exposure because a significant portion of its profits are in lower-rate jurisdictions. (2) Quantitative accuracy is perfect: the 15% Pillar Two threshold and FY2025 applicability are correctly stated; no numerical errors. (3) Multi-hop reasoning is sound—correctly contrasts QCOM’s limited exposure with INTC’s broader risk based on geographic distribution of income and tax rates. (4) Minor deduction in qualitative accuracy because the LLM omits that INTC is still evaluating the impacts and that jurisdictions like the EU are adopting rules starting in 2024, which adds context to the uncertainty. However, the essence of the comparison—QCOM’s low exposure vs. INTC’s material risk—is preserved. Wording differs but semantic meaning aligns closely. Contextual relevance is full, directly addressing the comparative impact of Pillar Two on both firms’ FY2025 tax liabilities.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 323,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the difference in voting power ratios between Alphabet's Class B to Class A conversion structure and Comcast's non-dilutable Class B voting rights affect the degree of founder control in corporate governance decisions?",
      "original_answer": "Alphabet maintains a 10:1 voting power ratio between Class B and Class A shares, with Class B shares converting automatically to Class A upon sale or transfer, which allows for dynamic founder control that can diminish with share transfers. In contrast, Comcast's Class B shares hold 33⅓% of voting power that is non-dilutable and convertible share-for-share into Class A, preserving a fixed level of control for Class B holders regardless of share issuance. This means Alphabet's structure allows for more fluid founder influence depending on shareholding behavior, while Comcast's design guarantees a minimum level of voting control that cannot be diluted, offering stronger long-term governance insulation for its Class B shareholders.",
      "llm_answer": "Alphabet’s dual‑class structure gives its Class B shares ten votes each (vs. one vote for Class A) and lets the holders convert those shares share‑for‑share into Class A stock, which reduces the voting power of the converted shares (see Alphabet Note 13, p. 81‑83). Comcast’s Class B shares carry fifteen votes each and the 33 ⅓ % of total voting power attached to them is expressly non‑dilutable, so the voting weight of the founders cannot be eroded by new issuances (see Comcast Note 12, p. 91). Because Alphabet’s Class B votes are a higher‑ratio (10‑to‑1) but can be converted and thus potentially diluted, the founders retain a more entrenched majority control, whereas Comcast’s founders are limited to a fixed, minority‑block of voting power (15‑to‑1 but capped at 33 ⅓ %) that still dominates decisions but cannot expand to a full majority.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right question and attempting multi-hop reasoning. (1) Quantitative inaccuracy: The LLM incorrectly states that Comcast's Class B shares have 'fifteen votes each'—the ground truth does not specify a per-share vote count but instead emphasizes that Class B holds a non-dilutable 33⅓% of total voting power. There is no evidence in the original answer that Comcast uses a 15:1 voting ratio; this number is fabricated or misattributed. (2) Mischaracterization of control dynamics: The LLM claims Alphabet’s structure allows 'a more entrenched majority control' due to the 10:1 ratio, but this contradicts the original answer, which explains that Alphabet’s control is *fluid* and diminishes upon transfer, whereas Comcast’s is *fixed and non-dilutable*. The LLM incorrectly frames Alphabet’s structure as more protective of founder control, when in fact Comcast’s design offers stronger long-term insulation. (3) Incorrect synthesis: The original answer highlights that Comcast’s 33⅓% is a floor that cannot be diluted, while Alphabet’s control depends on continued holding—this key distinction is reversed in the LLM answer. (4) The mention of 'Alphabet Note 13' and 'Comcast Note 12' adds apparent credibility but is not verifiable from the provided ground truth and may be hallucinated. (5) Contextual relevance is high—the response directly addresses the comparative governance impact and attempts to contrast the two structures. However, due to critical errors in numbers and reasoning about control implications, the overall correctness is only partial. Minor wording differences are acceptable, but the reversal of the core conclusion (which company has stronger founder insulation) is a major error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 490,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the indemnification agreement between PM USA and PMI affect Altria's (MO) financial exposure to tobacco-related litigation liabilities compared to PM's retained obligations through RBH deconsolidation?",
      "original_answer": "Under the Distribution Agreement, PMI indemnifies Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured by PM USA, while PM USA indemnifies PMI for liabilities related to its own manufactured products, excluding those made for PMI. Altria has not recorded a liability for this indemnification as its fair value is considered insignificant. Meanwhile, PM retains obligations tied to the deconsolidation of RBH, which involved reclassifications from accumulated other comprehensive losses. This structure limits Altria's direct financial exposure to PMI-related litigation, while PM faces ongoing impacts from RBH-related reclassifications.",
      "llm_answer": "The distribution‑indemnification agreement makes PMI responsible for any tobacco‑product claims that arise from cigarettes it manufactures (or that PM USA contract‑manufactures for PMI), and PM USA in turn indemnifies PMI for claims based on products it makes on its own.  Because the fair‑value of that indemnity is deemed immaterial, Altria records no liability for those claims (page 108).  By contrast, PMI’s liability for the Canadian “RBH” judgments was not transferred; PMI booked a $194 million pre‑tax charge for RBH’s share of the damages and remains on the hook for any further exposure while the RBH entity is de‑consolidated and the litigation stays in place (pages 113‑114).  Thus Altria’s exposure is essentially eliminated by the indemnity, whereas PMI retains the substantive litigation risk associated with RBH.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The $194 million pre-tax charge for RBH is not mentioned in the original answer and is factually incorrect in context—RBH deconsolidation involved reclassifications from accumulated other comprehensive losses, not a specific charge booked by PMI. The original answer does not state that PMI remains on the hook for RBH litigation; rather, it notes PM retains obligations tied to RBH deconsolidation, which is a different financial impact. (2) The LLM incorrectly attributes ongoing litigation risk to PMI for RBH, while the original answer states that Altria's exposure is limited due to indemnification, and PM (not PMI) faces impacts from RBH-related reclassifications—this confuses PM USA/PMI roles and misassigns liability. (3) The multi-hop reasoning is flawed: the LLM conflates PMI’s indemnification responsibilities with RBH litigation, which are separate issues. The original answer makes no mention of RBH judgments being retained by PMI or any dollar amount related to RBH. (4) While the first part about indemnification structure is semantically close to the original, the second part introduces unsupported details (e.g., $194M charge, pages 113–114) not present in the ground truth, suggesting hallucination. (5) Contextual relevance is high because the answer attempts the right framework—comparing indemnification effects on financial exposure—but fails in execution due to incorrect entity mapping and invented quantitative data. Thus, despite correct general structure, the answer is substantially factually wrong on key points.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 445,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the decline in Cisco's allowance for credit losses on loan receivables from $103 million in 2022 to $53 million in 2023 impact the financing of technical support services, and how does this compare to Adobe's approach in funding its technical support offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables decreased significantly from $103 million in 2022 to $53 million in 2023, indicating a reduced financial risk in their financing arrangements tied to hardware, software, and services—including technical support. This decline may suggest either improved credit quality of borrowers or a strategic reduction in financing extended for such services. Cisco offers financing, including loans and leases, for the sale of its products and services, which explicitly include technical support and advanced services. In contrast, Adobe funds its technical support through subscription entitlements and annual fee-based maintenance programs, providing customers with technical support, product help, and upgrades over 1- to 3-year terms. Unlike Cisco, Adobe does not rely on loan receivables but integrates support funding directly into its subscription and maintenance models.",
      "llm_answer": "Cisco’s loan‑receivable allowance fell from $103 million in 2022 to $53 million in 2023, reflecting a lower expected loss on the financing it provides for hardware, software and the associated technical‑support and advanced‑services contracts (see Note 9, page 82‑84). The smaller reserve frees up capital and signals that Cisco can continue to fund its technical‑support services through these financing arrangements with less credit‑risk drag. By contrast, Adobe does not rely on loan‑receivable financing; its technical‑support is funded directly from subscription entitlements and annual maintenance‑fee programs embedded in its SaaS and perpetual‑license models (see Technical Support section, pages 16‑17).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the decline in Cisco's allowance for credit losses from $103 million in 2022 to $53 million in 2023 is accurately reported, with no calculation errors. (2) The answer correctly identifies that Cisco provides financing for technical support services through loan receivables and that the reduced allowance reflects lower expected credit losses, which in turn reduces risk and frees up capital—this reasoning is sound and consistent with the original answer. (3) The comparison to Adobe is accurate: Adobe funds technical support via subscription entitlements and annual maintenance fees, not through loan receivables, and this is correctly contrasted with Cisco’s model. (4) Minor deduction in qualitative accuracy due to slightly less explicit detail on the duration (1- to 3-year terms) of Adobe’s programs, though the core mechanism is correctly described. The LLM cites document sections (e.g., Note 9, pages 82–84; Technical Support section, pages 16–17), which adds credibility and context, even if not required. Overall, the answer is factually correct, well-reasoned, and fully relevant to the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 346,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the involvement of Citibank, N.A. as administrative agent in Caterpillar's 2022 5-Year Credit Facility compare with its role in Boeing's similarly named 2019 Five-Year Credit Agreement, particularly in terms of the amendment timelines and the syndication structure?",
      "original_answer": "Citibank, N.A. served as the administrative agent in both Caterpillar's 2022 5-Year Credit Facility and Boeing's 2019 Five-Year Credit Agreement. In Caterpillar's case, Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, indicating a modification within one year of the original agreement. For Boeing, Amendment No. 1 to its Five-Year Credit Agreement occurred on August 25, 2022, nearly three years after the initial agreement on October 30, 2019. Additionally, Boeing's syndication structure included JPMorgan Chase Bank, N.A. as syndication agent and joint lead arranger alongside Citibank, N.A., while Caterpillar's syndication involved Citibank, N.A. and MUFG Bank, Ltd. in agent roles without a comparable dual lead arranger structure.",
      "llm_answer": "Both companies name Citibank, N.A. as the administrative agent of the five‑year facility, but the surrounding structures differ. In Boeing’s original 2019 Five‑Year Credit Agreement Citibank is paired with JPMorgan Chase, which acts as the syndication agent and, together with Citibank, serves as joint lead arranger and book‑manager; the agreement was later amended (Amendment No. 1) on August 25, 2022. In Caterpillar’s 2022 five‑year credit facility Citibank is listed only as the administrative agent, with no separate syndication agent or joint‑lead‑arranger role disclosed, and the filing does not reference any amendment to that facility.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of key facts and dates but contains a significant omission regarding Caterpillar's amendment timeline, which undermines completeness and multi-hop synthesis. Quantitatively, the dates for Boeing’s Amendment No. 1 (August 25, 2022) and the roles of Citibank and JPMorgan Chase are accurate. The description of Boeing’s syndication structure — with Citibank and JPMorgan as joint lead arrangers and JPMorgan as syndication agent — matches the ground truth. For Caterpillar, the LLM correctly identifies Citibank as administrative agent and notes the absence of a dual lead arranger structure, correctly contrasting it with Boeing. However, the LLM incorrectly states that 'the filing does not reference any amendment' to Caterpillar’s facility, while the ground truth confirms Amendment No. 1 was dated August 31, 2023. This is a critical factual omission that affects the comparison of amendment timelines — Caterpillar amended within one year, Boeing after nearly three years — which was a central part of the question. The reasoning is otherwise sound and the answer is contextually relevant, with appropriate comparison structure and correct entity identification. The missing Caterpillar amendment detail reduces completeness and weakens the multi-hop analysis, justifying a 7 on correctness and qualitative accuracy despite strong performance on other dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 388,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's and Qualcomm's supply chain reliability, given their shared dependency on foundry partners in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt both NVIDIA's and Qualcomm's supply chains, as both companies rely heavily on foundry partners located in Taiwan for critical semiconductor manufacturing. NVIDIA has explicitly stated that challenges in estimating demand could be exacerbated by geopolitical tensions involving Taiwan and China, which are significant to their revenue and supply continuity. Similarly, Qualcomm depends on consistent chipset supply from foundry partners in Taiwan, and a conflict could severely limit or prevent them from receiving these components, directly impacting their ability to manufacture and deliver products. Both companies face the risk of supply constraints, production delays, and potential revenue loss due to the geographic concentration of their manufacturing dependencies in a geopolitically sensitive region.",
      "llm_answer": "Both companies warn that a prolonged China‑Taiwan conflict would jeopardize the “consistent and reliable” chip supply they obtain from foundries concentrated in Taiwan. Qualcomm states that such a conflict could “severely limit or prevent us from receiving chipset supply from Taiwan,” while NVIDIA notes that “geopolitical tensions … involving Taiwan and China … could have a material adverse impact” on its ability to secure wafers and components from its Taiwanese foundry partners. In either case, the disruption would likely cause supply shortages, production delays and higher costs, undermining each firm’s supply‑chain reliability and earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual information is correct: both NVIDIA and Qualcomm are correctly identified as relying on Taiwanese foundries, and the direct quotes or paraphrased risk disclosures are consistent with the original answer. The consequences—supply shortages, production delays, higher costs, and impacts on earnings—are all valid and supported. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a traditional sense, but the absence of incorrect numbers earns full marks. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies depend on the same geographic region for manufacturing and that geopolitical conflict would disrupt both, despite their different business models. The use of direct phrasing like 'severely limit or prevent' (Qualcomm) and 'material adverse impact' (NVIDIA) reflects accurate representation of risk language from filings. (4) The only reason for not scoring a 10 in qualitative accuracy is minor: the LLM slightly condenses the original answer’s emphasis on 'geographic concentration of manufacturing dependencies' as a systemic risk, though the implication is still present. Otherwise, the answer is contextually precise, fully relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 387,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Boeing's indemnification risk exposure from U.S. government contracts compare with 3M's indemnification liabilities transferred to Solventum following the spin-off, particularly in relation to their respective legal proceedings and liability assumptions?",
      "original_answer": "Boeing discloses indemnification risks tied to U.S. government contracts where pension cost allocations under CAS may affect contract profitability. Meanwhile, 3M transferred indemnification obligations related to historical legal proceedings—such as the Bair Hugger and Federal False Claims Act litigation—to Solventum as part of the April 1, 2024 spin-off. Both companies face potential liabilities from legal proceedings, but Boeing's exposure is tied to contract cost allocations and uninsurable risks from defense and aerospace products, whereas 3M's transferred liabilities are now the responsibility of Solventum, which must indemnify and defend claims previously held by 3M.",
      "llm_answer": "Boeing’s 10‑K notes that a portion of its exposure on U.S. government contracts is mitigated by possible government indemnification, but the company cautions that its insurance may be insufficient and that many of the related product‑liability risks (e.g., SAFETY‑Act‑covered weapons and aerospace systems) remain on its books and could generate material costs if a claim materializes. In contrast, 3M’s filing explains that, as part of the April 1 2024 spin‑off, Solventum assumed a range of indemnification and defense obligations—including the Bair Hugger and Federal False‑Claims Act matters and PFAS‑related liabilities—so that those potential losses are now the responsibility of Solventum rather than 3M. Thus, Boeing retains its indemnification risk while 3M has transferred its indemnification liabilities to the newly independent entity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Boeing retains indemnification risk related to U.S. government contracts, particularly due to uninsurable product-liability risks in defense and aerospace (e.g., SAFETY-Act-covered systems), and acknowledges insurance may be insufficient. 3M transferred indemnification obligations—including Bair Hugger, False Claims Act, and PFAS-related liabilities—to Solventum in the April 1, 2024 spin-off. (2) Quantitative accuracy is perfect: the date 'April 1, 2024' is correctly cited, and no numerical errors are present. Format variations (e.g., 'April 1 2024' vs 'April 1, 2024') are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly contrasts Boeing’s retained risk with 3M’s transferred liabilities, synthesizing information across two companies and events (contract risk vs. spin-off liability transfer). (4) The only minor shortcoming is that the LLM mentions 'PFAS-related liabilities' as part of the transferred obligations, which, while likely accurate, is not explicitly mentioned in the original answer. However, this does not contradict the ground truth and is contextually plausible given 3M’s known litigation history. Overall, the answer captures the core contrast accurately and provides relevant context, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 389,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does the voting power structure of CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance risks associated with META's Class A common stock, particularly in light of META's controlled company status and dual-class structure?",
      "original_answer": "CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power, with each share carrying 15 votes. This concentrated voting power allows the holder significant influence over corporate decisions. Similarly, META's governance structure gives its Class B common stockholders, including Mark Zuckerberg, outsized voting control, with the dual-class structure requiring a majority of Class B votes for any change in control until they fall below 35% of voting power. This setup increases governance risks for Class A shareholders, as it limits their influence and could deter investors, mirroring the concerns raised in META's 10-K about its 'controlled company' status making Class A shares less attractive.",
      "llm_answer": "CMCSA’s capital structure gives the sole holder of its Class B shares – Brian L. Roberts – 15 votes per share, which translates into roughly one‑third of the company’s total voting power despite representing only a single share class (see CMCSA 10‑K p. 33). That concentration of control creates a governance model in which a single shareholder can dominate board elections and corporate decisions, a dynamic that is mirrored at META, where the founder’s Class B stock (10 votes per share) makes the firm a “controlled company” and limits the ability of Class A shareholders to influence matters, heightens anti‑takeover protections, and reduces independent oversight (META 10‑K pp. 49‑50). Thus, the same voting‑power concentration that gives Roberts decisive control at CMCSA underscores the governance risk for META’s Class A investors, who face similarly limited influence over a company whose voting power is tightly held by its founder.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies that CMCSA's Class B stock, owned entirely by Brian L. Roberts, carries 15 votes per share and constitutes roughly one-third (33⅓%) of total voting power, which matches the original answer. It also accurately describes META's dual-class structure, noting 10 votes per Class B share (though the original does not specify the vote ratio, this is a known fact and consistent with public filings). (2) Quantitatively, all figures are correct: 15 votes per CMCSA Class B share and the one-third voting power are accurate. The LLM approximates 'roughly one-third' instead of the exact '33⅓%', which is acceptable for semantic equivalence. META’s Class B control threshold (below 35% of voting power) is implied through context, though not explicitly stated—this is a minor omission. (3) The multi-hop reasoning is sound: the model correctly draws a parallel between the concentrated voting power in CMCSA and the governance risks in META due to founder control, linking both to reduced influence for Class A shareholders and anti-takeover effects. It references the appropriate risk factors from both 10-Ks (CMCSA p.33, META pp.49–50), demonstrating proper synthesis. (4) The answer is contextually relevant, directly addressing how CMCSA's structure informs the understanding of governance risks in META’s controlled company status. The only reason for not scoring a 10 is the slight imprecision in not explicitly stating the 35% threshold for META’s control mechanism, though the concept is conveyed. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 462,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Coca-Cola's reliance on Arca Continental for beverage distribution in northern Argentina intersect with Procter & Gamble's foreign exchange risk exposure in the same country?",
      "original_answer": "Coca-Cola relies on Arca Continental for beverage distribution in northern Argentina, which accounts for a portion of its 17% worldwide unit case volume through bottling partners. Arca Continental's operations in northern Argentina expose Coca-Cola indirectly to macroeconomic risks in the country. Meanwhile, Procter & Gamble directly cites Argentina as one of the countries with significant exchange rate fluctuations that have historically impacted its financials, noting foreign exchange volatility in Argentina has significantly affected its net sales, costs, and earnings. This creates a shared exposure point where both companies face risks tied to Argentina’s economic environment, with Coca-Cola exposed through its supply chain dependency and P&G through direct market operations.",
      "llm_answer": "Coca‑Cola’s beverage system in Argentina is largely run through its bottling partner Arca Continental, which “has bottling and distribution operations in … northern Argentina” (KO 10‑K p. 7). Procter & Gamble notes that “a number of foreign currencies have weakened … including Argentina” and that these fluctuations create both translation and transaction foreign‑exchange exposure that can depress its sales, costs and earnings (PG 10‑K p. 23). Thus, the same Argentine market that Coca‑Cola depends on Arca Continental to reach consumers is also a source of currency‑risk for P&G, linking the two companies’ performance in northern Argentina to the volatility of the Argentine peso.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Coca-Cola's reliance on Arca Continental for distribution in northern Argentina and cites the correct source (KO 10-K p.7), and accurately references Procter & Gamble’s foreign exchange risk disclosure related to Argentina (PG 10-K p.23). (2) There are no numeric values in the original or LLM answer that conflict—both avoid specific percentages or financial figures beyond what’s in the filings, so quantitative accuracy is preserved. (3) The multi-hop reasoning is sound: it connects Coca-Cola’s indirect exposure via its bottling partner to P&G’s direct FX risk in the same country, correctly synthesizing cross-company, cross-filing insights. The only minor shortcoming is that the LLM answer does not explicitly mention Coca-Cola’s 17% global unit case volume through bottlers (a detail in the ground truth), which adds contextual depth about scale. However, this omission does not undermine the core correctness. (4) The answer is contextually relevant, directly addressing how both firms are exposed to Argentina’s economic volatility—one through supply chain dependency, the other through currency risk—tying them together via the Argentine peso’s impact. Wording differs slightly but meaning is semantically equivalent. Thus, high scores across all dimensions with a 9/10 on correctness due to the minor completeness gap.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 394,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might the expiration of Alimta's patent protection impact Eli Lilly's oncology revenue stream compared to Amgen's exposure to patent-related risks for its biologics, given the differing regulatory frameworks governing small molecule drugs and biologics?",
      "original_answer": "The expiration of Alimta's patent protection is expected to result in a rapid and severe decline in Eli Lilly's revenue from the product due to the entry of generic competitors in the U.S. and other jurisdictions. This is typical for small molecule drugs like Alimta, where loss of exclusivity often leads to immediate and significant revenue erosion. In contrast, Amgen, which relies heavily on patent protection for its biologics, faces a different regulatory landscape where biosimilars may not enter the market as quickly due to manufacturing complexities and regulatory uncertainties, such as the FDA's stance on 'umbrella exclusivity'. However, Amgen still faces increasing biosimilar competition in the U.S., Europe, and elsewhere, which has had and could increasingly have a material adverse effect on its product sales. Thus, while both companies are exposed to patent-related risks, the speed and severity of revenue impact differ due to the nature of their product portfolios and the regulatory frameworks governing them.",
      "llm_answer": "The 10‑K notes that Alimta is a small‑molecule chemotherapy and that “the entry of generic competition for Alimta … will cause a rapid and severe decline in revenue for the product and have a material adverse effect on our consolidated results of operations” (LLY p. 25).  By contrast, Amgen’s biologics are protected by the BPCIA’s 12‑year data‑exclusivity and by additional manufacturing and regulatory hurdles, so loss of patent protection “may or may not result in the near‑term entry of competitor versions (i.e., biosimilars)” and any revenue impact is generally slower and more uncertain, although the company warns that legislative or FDA changes could shorten that exclusivity (AMGN p. 44‑46).  Thus, Lilly’s oncology sales are likely to fall sharply once Alimta’s patents expire, whereas Amgen’s biologic portfolio faces a more gradual, contingent exposure to biosimilar competition because of the different regulatory frameworks governing small‑molecule drugs and biologics.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies the rapid and severe revenue decline for Eli Lilly's Alimta due to generic competition upon patent expiration, citing the appropriate risk from the 10-K (LLY p.25), and contrasts this with Amgen’s more gradual and uncertain exposure due to biosimilar hurdles, referencing the BPCIA’s 12-year data exclusivity and regulatory complexities (AMGN pp.44–46). (2) There are no numerical values requiring calculation (e.g., dates like '12-year exclusivity' are correctly stated), and all financial impact descriptions ('material adverse effect', 'near-term entry') are consistent with the source. (3) The multi-hop reasoning is sound: it synthesizes information across two companies (Eli Lilly and Amgen), two drug types (small molecule vs. biologic), and two regulatory frameworks (generic approval under Hatch-Waxman vs. biosimilar pathway under BPCIA), correctly drawing the comparative conclusion about the speed and severity of revenue impact. (4) The answer fully addresses all parts of the question: impact on Lilly’s oncology revenue, Amgen’s patent-related risks, and the role of differing regulatory frameworks. Wording differs slightly but meaning is preserved with high precision. All scores are 10 due to full factual correctness, proper sourcing, and logical coherence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 387,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the impact of the OECD's Pillar Two Model Rules on Intel's non-US tax benefits compare to Microsoft's exposure under the global minimum tax, given the differences in their international tax strategies?",
      "original_answer": "Intel's tax benefits have increased due to a higher proportion of income taxed in non-US jurisdictions, and the company is actively evaluating the impact of Pillar Two Model Rules, which may begin in 2024 in several jurisdictions where Intel operates. In contrast, Microsoft acknowledges the global minimum tax as part of its broader regulatory exposure but does not expect a material increase in tax costs due to limited operations in jurisdictions below the 15% minimum rate. This suggests that while both companies are subject to Pillar Two, their exposure differs based on geographic tax strategy and operational footprint.",
      "llm_answer": "Intel says that because it does not have material operations in jurisdictions whose statutory rates are below the 15 % Pillar‑Two floor, the new OECD Model Rules are **not expected to materially increase its global tax cost** and therefore will have only a limited effect on the non‑U.S. tax benefits it currently enjoys【page_44】.  \n\nMicrosoft, by contrast, relies on a much larger portfolio of foreign earnings and profit‑allocation practices that have produced a low effective tax rate; consequently the same 15 % global minimum tax is likely to **raise Microsoft’s overall tax expense more materially** than it will for Intel, even though the filing does not quantify the impact. This difference reflects the companies’ divergent international tax strategies.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in its characterization of Intel's exposure. The original answer states that Intel's tax benefits have *increased* due to a higher proportion of income in non-US jurisdictions and that it is *actively evaluating* the impact of Pillar Two, with potential implementation starting in 2024. In contrast, the LLM claims Intel 'does not have material operations' in jurisdictions below 15% and therefore the rules are 'not expected to materially increase its global tax cost'—this contradicts the original, which does not make such a definitive assertion about materiality or operational footprint. For Microsoft, the original answer states it does *not expect a material increase* in tax costs due to limited operations in low-rate jurisdictions, while the LLM claims the opposite—that the minimum tax will 'raise Microsoft’s overall tax expense more materially' than Intel’s. This reverses the actual comparative exposure. (2) Quantitatively, the 15% Pillar Two rate is correctly cited, and no incorrect calculations are made since no numerical computations are performed. However, the directional impact on tax costs is misassigned, undermining quantitative accuracy. (3) The multi-hop reasoning is structurally sound—comparing two companies’ Pillar Two exposure based on international tax strategies—but the factual basis for the comparison is inverted. The LLM incorrectly attributes lower exposure to Microsoft when the original assigns it to Intel, failing to correctly synthesize the comparative impact. (4) Contextual relevance is high because the answer addresses the right question, cites appropriate concepts (Pillar Two, effective tax rates, geographic footprint), and attempts a direct comparison. However, due to the reversal in exposure assessment, the core factual correctness is severely compromised, warranting a low correctness score despite good structure and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 528,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does KO's 2024 transfer of $523 million in surplus international pension assets to general assets affect its exposure to limited partnerships compared to PEP's continued use of limited partnerships in its pension investment strategy?",
      "original_answer": "KO's transfer of $523 million in surplus international pension assets to general assets in 2024 reduced its exposure to limited partnerships, as these assets were previously part of its pension plan investments, which include vehicles like limited partnerships (as seen in NEE's pension strategy). Meanwhile, PEP continues to maintain exposure to limited partnerships through its pension investments, as explicitly stated in its 2024 10-K, where it holds investments in limited partnerships and private credit funds valued based on net asset value. This indicates a strategic divergence: KO reduced its pension-linked alternative investments, while PEP maintains them as part of its diversified pension fund strategy.",
      "llm_answer": "KO’s 2024 move of $523 million of surplus international pension assets out of the pension trusts and into the company’s general‑asset pool trims the amount of assets that remain in the pension plan – including the limited‑partnership and private‑credit funds that are held in the plan’s “real‑estate commingled” vehicles. In contrast, PepsiCo (PEP) continues to allocate pension‑plan assets to limited‑partnership structures, so its exposure to those partnerships remains unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the $523 million transfer by KO in 2024 is accurately stated, and the direction of the effect (reducing pension assets) is correct. (2) The answer correctly identifies that KO's transfer reduces the assets within the pension plan, which includes limited partnerships held in 'real-estate commingled' vehicles—this aligns with the ground truth's implication that such alternative investments were part of the pension structure and are now diminished due to the asset transfer. (3) The comparison to PEP is sound: PEP continues to allocate to limited partnerships, maintaining exposure, as confirmed in its 2024 10-K. The LLM correctly captures this strategic contrast. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly mention 'private credit funds valued at net asset value' or directly cite PEP’s 10-K language as in the original, slightly reducing completeness in contextual detail. However, the core reasoning and multi-hop synthesis—linking KO’s asset transfer to reduced LP exposure and contrasting it with PEP’s ongoing use of LPs—are logically and factually sound. Wording differs but semantic meaning is equivalent. No calculation errors. Full contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 368,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 relate to the role of patent rights in determining market exclusivity periods, especially when considering LLY's reliance on 12-year U.S. biologic data protection to safeguard revenue post-patent expiration?",
      "original_answer": "The $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 was partly due to factors like lower asset impairment charges and higher net gains on equity securities. However, PFE acknowledges that patent expirations could materially affect revenues, as patent rights are a key determinant of market exclusivity in the pharmaceutical industry. According to evidence, market exclusivity for pharmaceuticals is largely determined by patent rights and regulatory data protection. In the U.S., biologics benefit from a 12-year data protection period under the BPCIA, which LLY explicitly references as a critical mechanism to retain market exclusivity and protect revenues even after compound patents expire. This implies that while PFE's short-term financial performance saw a significant boost, the long-term sustainability of such gains for patented products will depend on both patent strength and complementary regulatory exclusivity mechanisms like those LLY relies on for its biologics.",
      "llm_answer": "Pfizer’s income from continuing operations rose by $17.3 billion in 2021 versus 2020 — a jump the company attributes mainly to higher revenues (plus net‑periodic‑benefit credits, lower impairments and equity gains)【page_36】.  That revenue growth is underpinned by the market‑exclusivity that patents provide; as Pfizer notes, “patents are a key determinant of market exclusivity for most branded pharmaceuticals” and protect the company’s products from generic competition while the patents and any regulatory data‑exclusivity are in force【page_7】.  Eli Lilly’s strategy mirrors this reliance on exclusivity: it counts on the 12‑year U.S. biologic data‑protection period granted under the BPCIA to keep biosimilar competitors out and preserve revenue after its compound patents expire【page_9】.  In both cases, the ability to maintain exclusivity through patent rights (or statutory data protection) directly fuels the sizable earnings gains reported.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $17.3 billion increase in PFE's income from continuing operations in 2021 vs. 2020, matching the ground truth exactly. It accurately attributes the increase to factors including lower impairments and equity gains, consistent with the original answer. The reference to higher revenues and net-periodic-benefit credits aligns with the broader context of PFE's financial performance. (2) All numeric values are correct: the $17.3 billion figure is accurately reported, and no calculations are required beyond that. There are no discrepancies in dollar amounts, years (2020–2021), or the 12-year U.S. biologic data protection period under BPCIA. (3) The multi-hop reasoning is sound: the LLM connects PFE’s financial performance to the role of patent rights in market exclusivity, then cross-references LLY’s reliance on statutory data protection post-patent expiration. It correctly synthesizes information across PFE and LLY, recognizing that both companies depend on intellectual property and regulatory exclusivity to protect revenue, even if the mechanisms differ slightly (patents vs. data protection). The logic that exclusivity enables earnings gains is consistent with the ground truth. (4) The only minor shortcoming is that the LLM slightly overemphasizes revenue growth as the primary driver of the income increase, while the original answer highlights non-operational factors like lower asset impairment charges and gains on equity securities more prominently. However, the LLM does mention these, so the omission is not material. Overall, the answer is factually accurate, contextually appropriate, and demonstrates strong qualitative reasoning with full quantitative correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 473,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How does the revenue-sharing arrangement between ESPN and Hulu, as reflected in Disney's 2024 financials, relate to the $8.6 billion payment Comcast received in late 2023 following the partial exit of its Hulu stake?",
      "original_answer": "Disney's ESPN receives fees from Hulu for the right to air its networks, as noted in the elimination section of Disney's 2024 financials. This relationship is central to Hulu's content costs and revenue model. In late 2023, Comcast exercised a put option, requiring Disney to buy its 33% stake in Hulu for $8.6 billion, which included a $9.2 billion minimum equity value less $557 million for prior capital calls. This payment reflects the financial value derived from Comcast’s stake in Hulu, which is partially driven by revenue streams like those from ESPN content licensing fees. Thus, the revenue-sharing mechanism between ESPN and Hulu underpins part of the valuation that led to the $8.6 billion payment to Comcast.",
      "llm_answer": "Disney’s 2024 filing notes that “fees paid by Hulu to ESPN and the Entertainment linear‑networks business for the right to air their networks on Hulu Live” are recorded as inter‑segment revenue and then eliminated in the consolidated results 【page_38】. When Comcast exercised its put right in November 2023, Disney paid it $8.6 billion to buy out Comcast’s roughly 33 % stake in Hulu 【page_85】, meaning Disney now captures 100 % of the Hulu‑related cash flows—including the ESPN‑Hulu carriage fees that were previously shared with Comcast as a minority owner.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Disney paid Comcast $8.6 billion in November 2023 for its ~33% stake in Hulu, as confirmed in the filing (page 85), and Hulu pays ESPN for the right to carry its networks, with those fees recorded as inter-segment revenue and eliminated upon consolidation (page 38). These numbers—$8.6 billion, 33%, November 2023—are all factually correct and match the ground truth. (2) Quantitative accuracy is perfect: no calculations are required beyond correctly citing the $8.6 billion payment and the 33% stake, both of which are accurate. The LLM correctly notes that the payment followed Comcast’s exercise of a put option, though it doesn’t mention the $9.2 billion minimum equity value or the $557 million adjustment, which are minor omissions. (3) The multi-hop reasoning is sound: the LLM correctly links ESPN’s revenue-sharing with Hulu to the broader financial structure of Hulu, and explains that Disney now captures 100% of Hulu’s cash flows, including those ESPN-related fees, post-buyout. This captures the core economic relationship implied in the original answer. (4) The only minor gap is that the LLM does not explicitly state that the ESPN-Hulu revenue stream contributed to the valuation that justified the $8.6 billion payment—this causal link is present in the ground truth but only implied in the LLM answer. However, the semantic meaning is sufficiently close, and the omission does not undermine the overall correctness. Contextual relevance is excellent, directly addressing both parts of the multi-hop question using precise filing references.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 453,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How do KO's and MDLZ's respective uses of financial assumptions differ in terms of the instruments they apply them to and the time periods over which the associated costs are recognized?",
      "original_answer": "KO uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, which are expensed on a straight-line basis over a typical four-year vesting period. This approach incorporates weighted-average assumptions such as volatility and expected term. In contrast, MDLZ applies weighted-average assumptions to determine net periodic postretirement healthcare costs, which are measured annually and reflect actuarial estimates for long-term obligations. The key differences are that KO applies these assumptions to equity-based compensation instruments with a fixed four-year expense recognition period, while MDLZ applies them to postretirement benefit liabilities that are recalculated annually based on updated actuarial estimates.",
      "llm_answer": "- **The Coca‑Cola Company (KO)** uses financial assumptions for two different instruments: (1) a weighted‑average discount rate and health‑care cost‑trend rates to measure service‑ and interest‑costs of its post‑retirement health‑care plans, with those costs recorded in the period they accrue; and (2) Black‑Scholes inputs (risk‑free rate, expected life, volatility, dividend yield) for employee stock‑option awards, with the option expense amortized over the typical four‑year vesting period.  \n\n- **Mondelez International (MDLZ)** applies weighted‑average discount rates (and an expected return on plan assets) to its U.S. and non‑U.S. pension plans, and uses Black‑Scholes assumptions (risk‑free rate, expected life, volatility, dividend yield) for its stock‑option and other equity‑based awards, but the un‑amortized compensation expense from those awards is expected to be recognized over a much shorter weighted‑average period of about 1.7 years, while pension costs are reflected in the periods of service and interest on the plan obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the general structure of the question. (1) The Original Answer states that KO uses the Black-Scholes-Merton model solely for stock option awards, with expenses recognized over a four-year vesting period, while MDLZ applies weighted-average assumptions to postretirement healthcare costs. However, the LLM incorrectly assigns postretirement healthcare cost assumptions to KO and pension assumptions to MDLZ—this reverses the core distinction. The ground truth specifies that MDLZ applies assumptions to postretirement healthcare costs, not KO. (2) Quantitatively, the LLM introduces a '1.7-year' weighted-average recognition period for MDLZ equity awards, which is not mentioned in the original answer and contradicts the focus on four-year vesting for KO. The original makes no comparison of vesting periods between the two firms, so this addition is unsupported. (3) The multi-hop reasoning is flawed: the key differentiator in the ground truth is the *type of instrument* (equity compensation vs. postretirement benefits) and the *recalculation frequency* (fixed vesting vs. annual actuarial updates), but the LLM conflates pension and postretirement healthcare plans and misattributes them. (4) While the mention of Black-Scholes for stock options at KO aligns with the truth, and both companies do use such models for equity awards, the LLM incorrectly implies MDLZ uses Black-Scholes for pension plans, which is not accurate—pensions rely on actuarial assumptions, not option-pricing models. Overall, the answer misrepresents the central contrast and introduces unsupported details, warranting a low correctness score despite some accurate elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 476,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How might the expiration timeline of specific patent protections for Enbrel impact Pfizer's international revenue from the drug, given AbbVie's broader strategy around patent term restoration and regulatory exclusivity?",
      "original_answer": "The expiration timeline for Enbrel's U.S. patents begins in 2028 (fusion protein composition) and extends to 2037 for formulation methods, which could delay biosimilar competition internationally. However, AbbVie's strategy of seeking patent term restoration and leveraging regulatory exclusivity under the Hatch-Waxman Act—where patent extensions can add up to five years—may further extend protection in key markets. Pfizer, which markets Enbrel outside the U.S. and Canada, could see prolonged exclusivity in certain regions, potentially extending beyond 2028, thereby preserving revenue streams if biosimilar challenges are delayed or unsuccessful.",
      "llm_answer": "Pfizer’s Enbrel patents in the United States run until November 2028 (fusion‑protein patent), April 2029 (DNA‑encoding‑fusion‑protein patent) and October 2037 (formulation patent) (see Pfizer 10‑K, Patents table).  Because Pfizer’s International Commercial Division markets Enbrel outside the U.S., those U.S. expiry dates set a baseline for when generic or biosimilar competition could appear abroad, and any later‑expiring foreign patents would extend that horizon even further.  AbbVie’s 10‑K notes that it routinely pursues patent‑term restoration and regulatory exclusivities (e.g., up to five‑year extensions under Hatch‑Waxman) to lengthen protection beyond the original filing date, so similar extensions for Enbrel could keep the drug under Pfizer’s exclusive control internationally well past the listed dates, cushioning international revenue from erosion by competitors.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the LLM provides more granular expiration dates (November 2028, April 2029, October 2037) than the original answer, which only states '2028' and '2037'. These specific dates are plausible and consistent with the general timeline in the ground truth; minor discrepancies in month-level precision do not constitute factual errors, especially since the core years (2028 and 2037) match. The mention of Hatch-Waxman allowing up to five years of extension is correct and matches the original. (2) The answer correctly identifies that Pfizer markets Enbrel internationally (outside the U.S. and Canada), and that U.S. patent expirations set a baseline for international biosimilar entry—this reflects accurate entity and role mapping. (3) The reasoning is sound: it synthesizes information across Pfizer’s and AbbVie’s strategies—Pfizer’s patent portfolio and AbbVie’s use of patent term restoration—even though Pfizer markets the drug internationally. The logic that U.S. expirations influence global competition timelines, and that further foreign protections or extensions could delay erosion, is a correct multi-hop inference. (4) The only minor shortcoming is that the original answer emphasizes AbbVie’s broader strategy more directly, while the LLM attributes some strategy to Pfizer (e.g., 'later-expiring foreign patents'), though this is not incorrect—both companies may hold relevant IP. Overall, the answer is factually correct, contextually complete, and semantically equivalent to the ground truth with slightly more detail. Hence, a score of 9 is appropriate—excellent but not perfect due to slight ambiguity in attributing patent strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 472,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How does MET's stress testing approach, which factors in early policyholder withdrawal scenarios, influence its reliance on global funding sources like commercial paper compared to COF's liquidity framework that emphasizes diversified funding sources and liquidity reserves?",
      "original_answer": "MET's stress testing includes scenarios of early policyholder withdrawal, which directly impacts its reliance on global funding sources like commercial paper to meet liquidity needs under stress conditions. MET adjusts asset mix and maturities based on rolling 12-month forecasts and relies on alternatives such as commercial paper and credit facilities when anticipated liquidity is exceeded. Similarly, COF's Liquidity Framework emphasizes diversified funding sources and maintains a liquidity reserve of cash, high-quality unencumbered securities, and committed credit lines to withstand systemic and idiosyncratic liquidity events. Both companies use stress testing to inform their funding strategies, but MET's exposure to policyholder behavior introduces a unique risk factor that directly affects its funding source selection, aligning with AIG's defined liquidity stress scenarios that impact funding sources.",
      "llm_answer": "MetLife’s liquidity plan is built around cash‑flow and stress testing that explicitly models “early contract‑holder and policy‑holder withdrawal” scenarios. When those tests show a shortfall, MetLife’s contingency options include tapping “global funding sources including commercial paper and various credit and committed facilities,” indicating a material reliance on external market funding to bridge any withdrawal‑driven gap. In contrast, Capital One’s Liquidity Framework is centered on a “Liquidity Adequacy Framework” that uses internal and regulatory stress tests to confirm that a “sizable liquidity reserve comprised of cash, high‑quality unencumbered securities and committed collateralized credit lines” and a “stable and diversified funding sources” are available, thereby limiting dependence on any single source such as commercial paper.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: MET's stress testing includes early policyholder withdrawal scenarios, which leads to reliance on global funding sources like commercial paper and credit facilities when liquidity shortfalls occur. COF (Capital One) emphasizes diversified funding and maintains a liquidity reserve of cash, high-quality unencumbered securities, and committed credit lines. These points are all present and correctly represented. (2) There are no numeric values in the question or answers requiring verification; thus, quantitative accuracy is 10 as no numbers were misstated. (3) The multi-hop reasoning is sound: the model correctly contrasts MET’s policyholder-driven liquidity risk with COF’s reserve-based, diversified funding strategy, and links each firm’s stress testing approach to its funding reliance. The only minor gap is that the LLM answer does not explicitly mention AIG’s defined liquidity stress scenarios, which the original answer references as a comparative benchmark. However, this is a supplementary detail and not central to the core comparison. (4) The wording differs (e.g., 'contract-holder' in addition to 'policy-holder', 'sizable liquidity reserve' vs 'liquidity reserve'), but semantic equivalence is maintained. The LLM uses 'Capital One' instead of 'COF'—acceptable as COF is the ticker. Overall, the response is contextually relevant, factually correct, and synthesizes across entities appropriately, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 438,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the adoption of ASU 2022-04 impact the comparability of supplier finance obligation disclosures between CAT and GE, particularly regarding the roll-forward requirements that GE began applying in 2024?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, and began applying the annual roll-forward disclosure requirement prospectively starting January 1, 2024 (GE_10k_2024.pdf:page_47). This aligns with CL's explanation that ASU 2022-04 mandates disclosures including key terms, balance sheet presentation, and a roll-forward of confirmed obligations (CL_10k_2024.pdf:page_57). CAT, in its 2024 10-K (CAT_10k_2024.pdf:page_111), provides a roll-forward of its supplier finance obligations, showing $830 million outstanding at year-end 2024. The adoption of ASU 2022-04 enhances comparability between CAT and GE by standardizing how supplier finance obligations are disclosed, particularly with the new roll-forward requirement that GE implemented in 2024.",
      "llm_answer": "Both companies now have to disclose the amount of supplier‑finance obligations and a roll‑forward of those balances under ASU 2022‑04. GE adopted the standard on a retrospective basis but, as the standard requires, it only began presenting the annual roll‑forward prospectively in the 2024 filing (see GE 10‑K p. 47‑48). Caterpillar, by contrast, had been applying the roll‑forward already in its 2023 and 2024 disclosures (see CAT 10‑K p. 111‑112), so GE’s earlier‑year supplier‑finance data lack the roll‑forward detail that CAT provides, limiting direct comparability of the two companies’ supplier‑finance obligation disclosures for periods prior to 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but introduces a significant factual inaccuracy regarding Caterpillar's (CAT) adoption timeline. The ground truth states that CAT provided the roll-forward in its 2024 10-K, showing $830 million outstanding at year-end 2024, but does not indicate that CAT applied the roll-forward in 2023. The LLM incorrectly claims CAT had been applying the roll-forward in both 2023 and 2024 disclosures, which is not supported by the original answer or cited document (CAT_10k_2024.pdf:page_111). This misrepresents the comparability timeline and undermines the reasoning. (2) Quantitatively, no specific dollar amounts are misstated in the LLM answer—though it omits the $830 million figure mentioned in the ground truth, which reduces completeness. Dates are mostly accurate: GE beginning roll-forward in 2024 is correct, and adoption in 2023 is implied correctly. However, the claim about CAT’s earlier application lacks support. (3) The multi-hop reasoning is partially sound—LLM correctly infers that prospective application of roll-forwards affects comparability and links ASU 2022-04 to disclosure requirements. However, it draws an incorrect conclusion about CAT’s earlier compliance, leading to flawed synthesis. The original answer emphasizes enhanced comparability due to alignment under ASU 2022-04, while the LLM suggests reduced comparability due to CAT’s earlier adoption—contradicting the ground truth. (4) Contextual relevance is high as the response addresses supplier finance disclosures, roll-forwards, and comparability. Qualitative accuracy is reduced due to incorrect entity-year attribution. Quantitative accuracy is strong because no wrong numbers are introduced, though key ones are omitted. Correctness score is 6 due to partial factual correctness with a major error in cross-company comparison logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 508,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the valuation methodology for MDLZ's Level 1 financial assets, which include exchange-traded commodity futures, differ from PEP's treatment of exchange-traded commodity futures, particularly in terms of fair value determination and daily settlement practices?",
      "original_answer": "MDLZ determines the fair value of its Level 1 financial assets, including exchange-traded commodity futures, based on quoted market prices on commodity exchanges. In contrast, PEP notes that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in their fair value hierarchy tables. While MDLZ relies directly on observable exchange prices for valuation, PEP's daily cash settlement approach for these instruments results in their exclusion from balance sheet reporting, highlighting distinct operational and accounting treatments despite both companies engaging with the same class of financial instruments.",
      "llm_answer": "Mondelez International classifies exchange‑traded commodity futures as **Level 1** financial assets – they are measured at fair value using the quoted prices on the commodity exchanges (the fair‑value hierarchy’s most observable inputs). PepsiCo, on the other hand, treats exchange‑traded commodity futures as **cash‑settled each day**; because the contracts are settled daily, the gains and losses are recognized through that daily cash‑settlement flow and the contracts are not carried on the balance‑sheet fair‑value tables.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that MDLZ classifies exchange-traded commodity futures as Level 1 assets valued using quoted prices on commodity exchanges, which aligns with the original answer's description of fair value determination based on observable market prices. (2) It accurately contrasts this with PEP's treatment: the contracts are cash-settled daily, leading to exclusion from fair value hierarchy tables, as gains/losses are settled in cash daily and not carried on the balance sheet. (3) The multi-hop reasoning is sound—synthesizing information across two companies' accounting treatments for the same type of financial instrument—and correctly highlights the distinction in reporting despite similar underlying instruments. (4) There are no numerical inaccuracies (no specific numbers involved beyond classification levels, which are correctly cited as Level 1), and all entities (MDLZ, PEP, exchange-traded commodity futures, Level 1, daily cash settlement) are accurately referenced. Wording differs slightly but conveys identical meaning. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 333,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How does the voting rights structure between Class A and Class B common stock at CMCSA compare with META's dual-class share structure?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders collectively hold 33 1/3%, with each share of Class B having 15 votes. In contrast, META also maintains a dual-class share structure, with Class B common stock possessing superior voting rights, although the exact vote ratio per share is not disclosed in the evidence. META had 343,761,117 shares of Class B common stock outstanding as of January 24, 2025.",
      "llm_answer": "Comcast’s capital structure consists of two classes of common stock. Class A shares carry one vote each and together account for roughly 66 percent of the company’s voting power, while each Class B share carries 15 votes and represents about 33 percent of the total voting power (non‑dilutable and held by Brian Roberts)【page_31】.  \n\nMeta also uses a dual‑class system – it has both Class A and Class B common stock (2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding)【page_1】 – but the excerpt does not specify the exact vote‑per‑share allocation. In practice Meta’s Class B shares carry a higher voting weight than Class A, giving its founder‑leadership greater control, similar to Comcast’s “super‑voting” Class B shares, though the specific vote multiplier (e.g., 10‑to‑1) is not disclosed in the pages provided.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key aspects. (1) Quantitative accuracy: All numbers are correct — CMCSA's Class A has ~66% voting power, Class B has ~33% with 15 votes per share; META has 343,761,117 Class B shares outstanding as of January 24, 2025 (implied by context), and 2.19 billion Class A shares aligns with typical disclosures. The 15 votes per Class B share at CMCSA is correctly stated. (2) Completeness: The answer addresses both companies' dual-class structures, voting power distribution, and notes the lack of specific vote ratio for META — all required elements. (3) Entity accuracy: CMCSA and META are correctly identified; share classes and outstanding figures match the ground truth. (4) Reasoning: The multi-hop comparison is sound — correctly contrasts CMCSA’s explicit 15:1 voting ratio with META’s undisclosed but superior voting rights for Class B, highlighting structural similarity (founder control via super-voting shares). (5) Semantic equivalence: Minor phrasing differences (e.g., 'roughly 66 percent' vs '66 2/3%') are acceptable; 'non-dilutable and held by Brian Roberts' adds context not in the original but is factually consistent. The only minor shortcoming is that the original specifies META's Class B voting superiority without disclosing the ratio, which the LLM correctly conveys, but could have more explicitly mirrored the 'combined voting power' phrasing. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 414,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How do AIG's and MetLife's exposures to CLOs differ in terms of their credit loss evaluation methodologies and unrealized loss recognition, given that both hold these instruments within structured products portfolios?",
      "original_answer": "AIG evaluates credit losses on CLOs by estimating future cash flows based on delinquency rates, default expectations, loss severity timing, and structural features like credit enhancement, with unrealized losses split between credit-related impairments and non-credit fair value changes recorded in OCI. MetLife, while also holding CLOs as part of structured products within AFS fixed maturity securities, limits its involvement to passive investment in trusts without substantial equity and does not appear to disclose the same level of detailed cash flow modeling for credit loss evaluation, instead focusing on maximum exposure to loss being limited to carrying amounts. AIG explicitly accounts for credit impairments under CECL with reversibility features, whereas MetLife emphasizes its passive investor status and lack of active management involvement in CLO structures.",
      "llm_answer": "- **AIG:**  CLOs are part of its “structured products” within Fixed‑Maturity Securities AFS.  Credit loss is measured under the CECL approach – management estimates the recoverable cash‑flows of each security (delinquency rates, expected defaults, loss‑severity, pre‑payment speeds and structural credit‑enhancement features) and records an allowance for the difference between amortised cost and that recoverable value.  When a credit‑related decline occurs the allowance is increased and the security is written down to fair value; any unrealised appreciation or depreciation that is not credit‑related (including the residual unrealised component on CLOs) is reported in OCI, not in earnings.\n\n- **MetLife:**  CLOs are also held in its Fixed‑Maturity Securities AFS, but credit‑loss allowances are reflected directly in the earnings line.  Changes to the allowance for credit losses on these securities are included in “Net realized gains (losses)” and the unrealised gain or loss on the fair‑value change of the CLOs is recognised in net investment income (i.e., in earnings).  Thus MetLife records both the allowance adjustment and the unrealised loss on CLOs in earnings, whereas AIG records the unrealised component in OCI.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its description of accounting treatments and correctly identifies that both AIG and MetLife hold CLOs within AFS fixed maturity securities. It accurately notes AIG's use of CECL, cash flow estimation inputs (delinquency rates, defaults, loss severity, structural features), and the split between credit-related impairments (in earnings) and non-credit fair value changes (in OCI). However, the LLM misrepresents MetLife’s methodology. The original answer states that MetLife does not disclose detailed cash flow modeling and emphasizes its passive investor status with maximum exposure limited to carrying amounts—there is no indication that MetLife records allowance changes in earnings or recognizes unrealized fair value changes in net investment income. In fact, for AFS securities, unrealized gains/losses (non-credit) are typically recorded in OCI, not earnings. The LLM incorrectly asserts that MetLife records both credit loss adjustments and unrealized losses in earnings, which contradicts standard AFS accounting and the ground truth. This is a significant qualitative error in reasoning and synthesis. While the quantitative aspects (no actual numbers involved) are accurate by default, the model fails to correctly interpret MetLife’s disclosure stance and misattributes accounting treatments that are not supported by the original answer. The contextual relevance is high as it addresses the comparison of methodologies and unrealized loss recognition, but the incorrect characterization of MetLife’s approach undermines the correctness. Semantic equivalence is partially achieved for AIG but not for MetLife.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 452,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does the Inflation Reduction Act's redesign of Medicare Part D affect CVS's ability to forecast medical cost trends and BMY's rebate accruals for the same program?",
      "original_answer": "The Inflation Reduction Act (IRA) redesigns Medicare Part D by reducing federal reinsurance in the catastrophic phase and shifting more costs to manufacturers like BMY starting in 2025, which increases their rebate obligations. This directly impacts BMY’s gross-to-net U.S. rebate accruals for Medicare Part D, as they must account for these new liabilities in their financial reporting. For CVS, the IRA’s changes to Medicare Part D contribute to the uncertainty in forecasting health care and benefit costs, especially as new cost-sharing obligations for manufacturers may alter utilization patterns and overall program dynamics. These shifts make it more challenging for CVS to predict medical cost trends and manage profitability in their Medicare-insured products.",
      "llm_answer": "The Inflation Reduction Act’s redesign of Medicare Part D pushes a larger share of drug‑cost growth onto manufacturers and plans (through out‑of‑pocket caps, reduced catastrophic re‑insurance and inflation‑penalty rebates). For CVS, that redesign adds a new source of volatility to health‑care utilization and price trends, making its forecasts of medical‑cost trends less certain and harder to price into fixed‑premium products. For Bristol‑Myers Squibb, the same changes create additional and more uncertain Medicare Part D rebate obligations, so its GTN U.S. rebate accruals must incorporate new assumptions about inflation penalties and manufacturer‑paid discounts, increasing the complexity and judgment required in those accruals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the key provisions of the Inflation Reduction Act (IRA) affecting Medicare Part D: increased manufacturer cost-sharing, reduced federal reinsurance in the catastrophic phase, and inflation-based penalties. These changes are set to take effect in 2025, though the LLM does not explicitly mention the year—this is a minor omission but not a factual error, as the focus is on the mechanism rather than timing. (2) There are no specific numbers (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all references to financial impacts are qualitative and consistent. (3) The multi-hop reasoning is sound: the LLM correctly links IRA changes to increased rebate obligations for BMY (Bristol-Myers Squibb), noting the impact on gross-to-net (GTN) U.S. rebate accruals, and separately connects the same policy changes to greater forecasting uncertainty for CVS due to altered utilization and pricing dynamics. (4) The LLM uses slightly different phrasing (e.g., 'inflation-penalty rebates', 'manufacturer-paid discounts') but these are semantically equivalent to the original's 'increased rebate obligations' and 'new liabilities'. The only minor gap is that the original emphasizes the shift of costs specifically to manufacturers starting in 2025, which the LLM omits mentioning explicitly—hence a 9 instead of 10 on qualitative accuracy. Overall, the answer is contextually precise, factually correct, and synthesizes across entities (CVS and BMY) appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 442,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does JPMorgan Chase's exposure to Stress Capital Buffer requirements influence its capital distribution constraints compared to Charles Schwab's obligations under the Capital Conservation Buffer, given the composition of their respective regulatory buffer requirements?",
      "original_answer": "JPMorgan Chase is subject to a Stress Capital Buffer (SCB) as part of its regulatory capital requirements, which could increase based on stress loss estimates from the Federal Reserve’s Comprehensive Capital Analysis and Review. This buffer, along with the GSIB surcharge and countercyclical buffer (CCyB), contributes to JPMorgan’s total capital buffer requirement. On the other hand, Charles Schwab’s banking subsidiary, Charles Schwab Bank (CSB), is required to maintain a Capital Conservation Buffer (CCB) of 2.5%, which imposes restrictions on capital distributions if not met. According to regulatory definitions, the CCB is a fixed component of capital buffer requirements, whereas JPMorgan’s SCB is dynamic and tied to stress testing outcomes. Therefore, JPMorgan faces a more variable and forward-looking capital constraint tied to macroeconomic stress scenarios, while Schwab faces a static buffer requirement that acts as a floor to avoid distribution limitations.",
      "llm_answer": "JPMorgan Chase must hold a **Stress‑Capital Buffer (SCB)** in addition to a GSIB surcharge (≈3 %) and any counter‑cyclical buffer, so the total buffer it must keep above the regulatory minima is roughly **8 %‑plus** of CET1.  If the SCB falls below its target, the firm is barred from paying dividends, repurchasing stock or granting discretionary bonuses until the buffer is restored, making its distribution limits much tighter.  \n\nCharles Schwab’s banking subsidiaries are only required to maintain a **Capital‑Conservation Buffer (CCB)** of **2.5 %** (with a separate 2.5 % stress buffer on its holding‑company bank), so the distribution constraints kick in only when that modest 2.5 % buffer is breached, resulting in a less restrictive capital‑distribution regime than JPMorgan’s larger, multi‑component buffer.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core distinction between JPMorgan Chase's dynamic Stress Capital Buffer (SCB) and Charles Schwab's static Capital Conservation Buffer (CCB), correctly identifying that JPMorgan faces tighter, multi-component capital constraints tied to stress testing, while Schwab’s requirements are less restrictive. However, there are key quantitative inaccuracies: the LLM states JPMorgan’s total buffer is '8%+ of CET1' and implies a GSIB surcharge of ≈3%, but the ground truth does not specify exact percentages or a total buffer size, nor does it confirm the 3% GSIB figure—this is an unsupported addition. Additionally, the claim that Schwab has a 'separate 2.5% stress buffer on its holding-company bank' is not present in the original answer and appears incorrect or unsubstantiated; the ground truth only mentions a 2.5% CCB for Charles Schwab Bank. The reasoning is otherwise sound: it correctly links SCB to stress testing outcomes and distribution restrictions, and contrasts the dynamic vs. static nature of the buffers. The answer is contextually relevant and synthesizes the regulatory implications well, but the added numerical specifics reduce quantitative accuracy. Semantic equivalence is mostly preserved, but the extra details introduce factual overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 358,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do General Dynamics and Raytheon Technologies differ in their financial exposure to state and local income taxes on U.S. government contracts regulated by the FAR, especially considering GD's exclusion of these taxes from its tax provision and RTX's FAR-governed cost allowability and pricing mechanisms?",
      "original_answer": "General Dynamics excludes state and local income taxes allocable to U.S. government contracts from its tax provision, instead recognizing them in operating costs and expenses. This treatment is governed by the Federal Acquisition Regulation (FAR), which dictates how costs are allocated and allowed on government contracts. Raytheon Technologies, also subject to the FAR, structures its pricing under these contracts based on allowable costs, including mechanisms like performance-based payments and progress payments that influence revenue recognition patterns. The difference in financial exposure stems from GD directly expensing these taxes while RTX incorporates them into broader cost considerations under FAR-regulated pricing frameworks.",
      "llm_answer": "- **General Dynamics (GD):** GD’s tax footnote states that state‑ and local‑income taxes that are allocable to U.S. government contracts are **included in operating costs and expenses** and therefore **are not part of the company’s income‑tax provision** (i.e., they are absorbed as ordinary operating expense). 【page_66】\n\n- **Raytheon Technologies (RTX):** RTX notes that state‑income‑tax payments tied to its RIS and RMD segments are **generally recoverable through FAR‑governed pricing**; the taxes are **allocated to the contracts and recorded as SG&A when paid (or otherwise reimbursed by the government)**, so the exposure is largely offset by contract reimbursements. 【page_78】【page_79】\n\nThus, GD bears state and local tax costs directly in its operating results, whereas RTX can recover those taxes under FAR‑allowable cost and pricing mechanisms, limiting its net exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that General Dynamics excludes state and local income taxes allocable to U.S. government contracts from its income tax provision and instead includes them in operating costs and expenses, which matches the original answer. Raytheon Technologies' treatment is also accurately described: such taxes are generally recoverable through FAR-governed pricing mechanisms and are recorded as SG&A when paid, with reimbursement offsetting exposure. (2) There are no numeric values in the question or answers that require calculation or verification—both responses are qualitative and consistent in that regard. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about two different companies’ tax treatments under the FAR, compares their financial exposure, and draws a valid contrast—GD bears the cost directly, while RTX recovers it via allowable cost mechanisms. (4) The only minor shortcoming is that the LLM answer does not explicitly mention RTX’s use of performance-based or progress payments (part of the broader FAR pricing framework noted in the original), which slightly reduces completeness in describing RTX’s mechanism. However, the core distinction in financial exposure is correctly captured. Wording differs but semantic meaning is equivalent. Thus, high scores across all dimensions with a 9 on correctness due to slight omission in contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 410,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the voting power distribution in META's dual-class structure, including the dividend initiation on Class B shares, compare with GOOGL's structure where Class B shares automatically convert to Class A upon transfer?",
      "original_answer": "META’s Class B common stock is entitled to a non-dilutable 33 1/3% aggregate voting power, with each share receiving 15 votes, and it now receives the same $0.50 per share quarterly dividend as Class A stock following META’s initiation of dividends in 2024. Class B shares can convert share-for-share into Class A common stock, subject to restrictions. In contrast, GOOGL’s Class B shares are entitled to 10 votes per share and automatically convert to Class A shares upon sale or transfer, ensuring a more fluid transition between voting tiers. Both companies maintain dual-class systems to preserve founder control, but the structural mechanics and dividend treatment differ significantly.",
      "llm_answer": "Meta Platforms’ dual‑class structure gives each Class B share ten votes versus one vote for a Class A share, and the company’s 2024 dividend of $0.50 per share is payable to holders of **both** classes (so Class B shareholders receive the same cash dividend as Class A shareholders). Alphabet’s (Google’s) structure is the same on paper – Class B shares carry ten votes and Class A shares one vote – but every Class B share must be **converted share‑for‑share into Class A** when it is sold or otherwise transferred, so the extra voting power stays only with insiders and does not travel with the shares; the filing does not mention any dividend on Class B shares.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it states that Meta's Class B shares have 'ten votes' per share, but the ground truth specifies 15 votes per Class B share. This is a significant quantitative error. Second, while it correctly notes the $0.50 quarterly dividend initiated in 2024 and that both classes receive it, it omits the critical detail that Meta’s Class B shares hold a non-dilutable 33 1/3% aggregate voting power, which is a key structural feature. The LLM also incorrectly implies that GOOGL’s Class B shares carry ten votes 'on paper' and are otherwise identical except for transfer conversion, but fails to clarify that GOOGL’s Class B shares do not exist publicly — they are held only by insiders and automatically convert upon transfer, which limits their circulation. (2) The dividend amount ($0.50 per share) and year (2024) are correct, but the vote count for Meta (10 vs actual 15) is wrong. GOOGL’s 10 votes per Class B share is accurate. (3) The reasoning correctly identifies the core purpose of dual-class structures (founder control) and contrasts the transfer-triggered conversion in GOOGL versus Meta’s voluntary conversion, showing sound multi-hop synthesis. However, missing Meta’s 33 1/3% non-dilutable voting power weakens the comparison. (4) The answer is contextually relevant and well-structured, but the vote count error and omission of Meta’s guaranteed voting bloc reduce factual correctness. Hence, correctness score is 6 due to partial accuracy with significant factual gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 427,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the use of a 95% confidence interval in the VaR model under normal market conditions impact the one-day loss estimation methodology for both Philip Morris's derivative instruments and Mondelez's currency and commodity exposures, given their shared reliance on the parametric delta-gamma approximation technique?",
      "original_answer": "Both Philip Morris (PM) and Mondelez (MDLZ) rely on the parametric delta-gamma approximation technique within their Value at Risk (VaR) models, which operate under the assumption of normal market conditions and a 95% confidence interval. This methodology estimates the potential one-day loss by observing interest rate and currency movements—PM excludes anticipated transactions and hedges in its calculation, while MDLZ includes currency and commodity instruments, explicitly noting the non-linear response of options in the computation. The shared modeling assumption limits both firms' risk assessments to typical market behavior, potentially underestimating losses during periods of market stress.",
      "llm_answer": "Both companies model VaR assuming “normal market conditions” with a **one‑day holding period and a 95 % confidence interval**. The 95 % confidence level means the VaR figure represents the loss that would be exceeded only 5 % of the time; it is derived by applying a **parametric delta‑gamma approximation** to the observed return distribution of the underlying rates, currencies or commodities. Consequently, PMI’s VaR estimates the potential one‑day loss in the fair value of its interest‑rate‑ and foreign‑currency‑sensitive derivatives, while Mondelez’s VaR uses the same confidence‑interval‑driven, delta‑gamma‑based methodology to estimate the one‑day loss in pre‑tax earnings (and fair‑value impact) from its currency and commodity exposures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key elements are correct: the 95% confidence interval, one-day holding period, and use of the parametric delta-gamma approximation are accurately stated for both Philip Morris (PMI) and Mondelez (MDLZ). These match the original answer’s description of VaR methodology under normal market conditions. (2) The LLM correctly identifies that PMI estimates one-day loss in fair value of interest-rate and foreign-currency derivatives, while Mondelez assesses impact on pre-tax earnings and fair value from currency and commodity exposures—this reflects the correct scope of each firm’s application. (3) The reasoning is sound: it acknowledges the shared modeling framework and its limitations in capturing extreme events, though it does not explicitly mention PM’s exclusion of anticipated transactions and hedges or MDLZ’s treatment of non-linear option responses, which are present in the original answer. These omissions are minor in impact but prevent a perfect score. (4) Despite these nuances, the LLM captures the core multi-hop synthesis—linking the 95% VaR, delta-gamma method, normal market assumptions, and firm-specific applications—demonstrating strong qualitative accuracy and full contextual relevance. Minor lack of detail on hedging exclusions and non-linearity keeps qualitative accuracy at 9 rather than 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 391,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do the embedded derivatives within CDOs referenced by Morgan Stanley compare in risk exposure to Bank of America's structured liabilities that also contain embedded derivatives, particularly in the context of credit events impacting their market-making activities?",
      "original_answer": "Morgan Stanley's involvement with CDOs includes hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer of the note, exposing the firm to risk in the event of a credit event on the reference entity, which could result in the principal balance of the note not being repaid in full. Similarly, Bank of America's structured liabilities also contain embedded derivatives that are part of their market-making activities, and these derivatives are typically offset by gains or losses on hedging instruments. Both firms face credit risk tied to these derivatives, though the specific impact on Morgan Stanley is tied to the performance of the CDOs' underlying reference entities, while Bank of America's exposure is more broadly tied to the performance of their structured liabilities and the effectiveness of their hedging strategies.",
      "llm_answer": "Morgan Stanley’s CDO holdings contain embedded credit‑linked derivatives – the firm sells credit protection to the CDO issuer, so a credit event on any reference entity can reduce or eliminate the principal repayment of the note (see MS page 109). Bank of America’s “structured liabilities” also embed derivatives, but they are carried at fair value and the gains or losses on those derivatives are used to offset the earnings impact of its market‑making activities (see BAC pages 162‑164). Thus, Morgan Stanley’s exposure is a direct credit‑loss risk to the principal of the CDO, whereas Bank of America’s exposure is primarily earnings‑volatility risk from fair‑value changes in the embedded derivatives that hedge its market‑making positions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Morgan Stanley's CDOs involve selling credit protection, exposing the firm to credit events that could impair principal repayment (as noted in MS page 109, consistent with the knowledge graph). Bank of America's structured liabilities contain embedded derivatives tied to market-making, with gains/losses offsetting earnings impact (supported by BAC pages 162–164). (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in numbers or calculations. (3) The multi-hop reasoning is sound: the model correctly synthesizes risk characteristics across two firms, instruments (CDOs vs. structured liabilities), and risk types (credit loss vs. earnings volatility), drawing a valid comparative conclusion. (4) The only minor gap is that the LLM slightly reframes Bank of America’s hedging as primarily managing 'earnings-volatility risk' rather than explicitly stating the broader credit risk tied to structured liabilities and hedge effectiveness as in the original. However, this is a nuance in emphasis, not a factual error. The core insight—that Morgan Stanley faces direct credit risk while BofA faces offset, fair-value-driven earnings impact—is semantically equivalent and well-supported. Contextual relevance is perfect: the response directly addresses the comparative risk exposure in the context of credit events and market-making.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 421,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does the global minimum tax under the OECD's Pillar Two model rules impact Salesforce's effective tax rate compared to Microsoft's projected tax liability, given the uncertainty around implementation timelines and jurisdictional adoption?",
      "original_answer": "Salesforce notes that global tax developments, including the OECD's Pillar Two model rules introducing a 15% global minimum tax, may have a material impact on its business, cash flows, or financial results. Microsoft, which currently operates with an effective tax rate of 19% (down to 18% in fiscal 2024), expects Pillar Two to apply to its operations starting in fiscal 2025 but does not currently estimate a material impact to its consolidated financial statements. However, uncertainty remains as to the final Pillar Two model rules and their adoption across jurisdictions, which could affect both companies differently depending on their global footprint and tax planning strategies.",
      "llm_answer": "Salesforce notes that the OECD‑Pillar Two global minimum‑tax rules are a “global tax development” that could affect its effective tax rate, but because the rules are still being rolled out and many jurisdictions have not yet adopted them, the company cannot quantify the impact and says the effect “may not be fully reflected” in its results (CRM 10‑K p. 29). In contrast, Microsoft states that the Pillar Two rules will begin to apply to its worldwide operations in fiscal 2025, but it does not expect a material increase to its tax expense; its effective tax rate is already low (about 18 % for FY 2024 and 19 % for FY 2023) and its projected tax liability remains essentially unchanged (MSFT 10‑K p. 47).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: Microsoft's effective tax rate of 19% for FY2023 and ~18% for FY2024 matches the original answer, and the fiscal 2025 start date for Pillar Two application is correctly cited. Salesforce's inability to quantify the impact due to ongoing implementation is accurately represented. (2) The LLM correctly cites specific 10-K page references (p.29 for CRM, p.47 for MSFT), indicating precise sourcing, though these were not part of the ground truth but do not detract from accuracy. (3) Multi-hop reasoning is sound: the model correctly contrasts Salesforce’s cautious, uncertain stance with Microsoft’s more definitive view that Pillar Two will apply in fiscal 2025 without material impact, despite both companies facing the same regulatory framework. (4) The answer captures the core uncertainty around jurisdictional adoption and differential impacts based on global footprint, as required by the question. The only minor shortcoming is a slight omission of the explicit mention that Microsoft 'does not currently estimate a material impact to its consolidated financial statements'—though this is implied by 'does not expect a material increase to its tax expense.' Wording differs slightly but meaning is preserved. Overall, the answer is factually correct, well-synthesized, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 394,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does Boeing's Five-Year Credit Agreement, which involves JPMorgan Chase Bank, N.A. as syndication agent, compare with Honeywell's credit agreement with JPMorgan Chase Bank, N.A. in terms of syndication structure and key banking partners?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, includes JPMorgan Chase Bank, N.A. as syndication agent alongside Citibank, N.A. as administrative agent, with both also serving as joint lead arrangers and joint book managers. Honeywell's Amended and Restated Five-Year Credit Agreement, dated March 20, 2023, also features JPMorgan Chase Bank, N.A., along with Wells Fargo Bank, National Association, as syndication agents, with Bank of America, N.A. serving as administrative and swing line agent. Both agreements involve JPMorgan Chase Bank, N.A. in a syndication role, but differ in the lead arranger structure and partner institutions involved.",
      "llm_answer": "Boeing’s five‑year credit facilities name JPMorgan Chase Bank, N.A. as the sole syndication agent, while Citibank, N.A. serves as the administrative agent and, together with JPMorgan, acts as joint lead arranger and joint book‑manager. Honeywell’s comparable credit agreements name JPMorgan Chase Bank, N.A. **and** Wells Fargo Bank, N.A. as co‑syndication agents, with Bank of America, N.A. acting as the administrative (and swing‑line) agent and no joint‑lead‑arranger role for JPMorgan. Thus Boeing relies on a single syndication partner and Citibank as co‑lead, whereas Honeywell uses a dual‑syndication structure with JPMorgan and Wells Fargo and a different administrative bank.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All entities are correctly identified: Boeing's agreement correctly names JPMorgan Chase Bank, N.A. as syndication agent, Citibank, N.A. as administrative agent, and both as joint lead arrangers and joint book managers. Honeywell's agreement correctly identifies JPMorgan Chase Bank, N.A. and Wells Fargo Bank, N.A. as co-syndication agents, and Bank of America, N.A. as administrative and swing line agent. (2) Quantitative accuracy is perfect: while no numeric values (e.g., dollar amounts or dates) are explicitly mentioned in the LLM answer, the absence does not detract from correctness because the question focused on syndication structure and key partners, not financial amounts or exact dates. The omission of the October 30, 2019, and March 20, 2023, dates from the original answer is minor and does not affect the structural comparison. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two different credit agreements, identifying the role of JPMorgan in both, and contrasting the syndication structures (sole vs. co-syndication agents) and differing lead arranger and administrative agent roles. (4) The only minor inaccuracy is the claim that JPMorgan does not serve as a joint lead arranger in Honeywell’s agreement — the original answer does not specify this, so the LLM may be overreaching slightly by asserting its absence. However, since the original does not confirm JPMorgan’s role as joint lead arranger for Honeywell, the LLM’s omission is not definitively incorrect, just potentially overinterpreted. Overall, the answer is semantically equivalent, contextually relevant, and factually sound, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 502,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How does the absence of the Countercyclical Capital Buffer requirement impact the total capital buffer requirements for both Bank of America and Morgan Stanley under the Advanced Approaches framework, given their respective G-SIB surcharges of 2.5% and inclusion of the 2.5% Capital Conservation Buffer?",
      "original_answer": "For Bank of America, the absence of the Countercyclical Capital Buffer (CCyB) means its total Common Equity Tier 1 (CET1) capital buffer requirement under the Advanced Approaches framework is the sum of its G-SIB surcharge of 2.5% and the 2.5% Capital Conservation Buffer, totaling 5.0%. Similarly, Morgan Stanley’s CET1 capital buffer requirement under the same framework is also the sum of its G-SIB surcharge (which is not quantified in the provided data but assumed to be included), the 2.5% Capital Conservation Buffer, and the zero CCyB. Therefore, the absence of CCyB directly reduces the total CET1 buffer requirement for both banks by the amount the CCyB would have otherwise contributed.",
      "llm_answer": "Because the Counter‑cyclical Capital Buffer (CCyB) is set at 0 % for both firms, the only components that remain in the Advanced‑Approaches buffer are the Capital Conservation Buffer (CCB) of 2.5 % and each firm’s G‑SIB surcharge.  \n\n* **Bank of America** – its Advanced‑Approaches regulatory minimum adds a 2.5 % CCB plus a 2.5 % G‑SIB surcharge (the CCyB is zero), so the total required buffer is **5.0 %** of risk‑weighted assets【page 146】.  \n\n* **Morgan Stanley** – the Advanced‑Approaches buffer consists of the 2.5 % CCB; the firm does not carry an additional G‑SIB surcharge in the disclosed table, and the CCyB is also zero, giving a total required buffer of **2.5 %** of risk‑weighted assets【page 134】.  \n\nThus, the lack of a CCyB simply leaves each institution with the sum of its CCB and any G‑SIB surcharge, resulting in a 5.0 % buffer for Bank of America and a 2.5 % buffer for Morgan Stanley.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error regarding Morgan Stanley's G-SIB surcharge. The ground truth states that Morgan Stanley has a G-SIB surcharge of 2.5%, the same as Bank of America, but the LLM incorrectly claims that 'the firm does not carry an additional G-SIB surcharge in the disclosed table,' leading to a calculated total buffer of 2.5% instead of the correct 5.0%. This is a major quantitative and qualitative error. While the explanation of the CCyB being zero is correct and the calculation logic (CCB + G-SIB surcharge) is sound, the incorrect assumption about Morgan Stanley’s G-SIB surcharge undermines the multi-hop synthesis required. The LLM also cites specific pages (146, 134), which may reflect document references, but the data interpretation for Morgan Stanley is inconsistent with the ground truth. The absence of CCyB is correctly understood to reduce total buffer requirements, but the final totals are only correct for Bank of America (5.0%). For Morgan Stanley, the answer should also be 5.0% (2.5% CCB + 2.5% G-SIB), not 2.5%. Thus, despite correct reasoning structure and partial numerical accuracy, the answer fails on key factual synthesis, especially in cross-entity comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 341,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What was NVIDIA's effective tax rate in fiscal year 2022, and how does it compare to Apple's operating income margin in the Greater China region during the same period?",
      "original_answer": "NVIDIA's effective tax rate in fiscal year 2022 was 1.9%, significantly lower than the U.S. federal statutory rate of 21%, due in part to income earned in jurisdictions like Hong Kong that have lower tax rates. Meanwhile, Apple reported $31,153 million in operating income from $74,200 million in net sales in the Greater China region during fiscal year 2022, resulting in an operating income margin of approximately 42%. These metrics reflect different financial impacts from operating in the region, with NVIDIA benefiting from lower tax rates and Apple demonstrating strong profitability from its sales in the same market.",
      "llm_answer": "- NVIDIA’s fiscal‑year 2022 effective tax rate was **1.9%**【page_52】.  \n- Apple’s Greater China segment generated **$31,153 million of operating income on $74,200 million of net sales**, giving an operating‑income margin of roughly **42%** (31,153 ÷ 74,200)【page_52】.  \n\nThus, Apple’s Greater China operating‑income margin was dramatically higher—about 20 times—than NVIDIA’s overall effective tax rate.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: NVIDIA's effective tax rate is correctly stated as 1.9%, and Apple's Greater China operating income ($31,153 million) and net sales ($74,200 million) are exact. The calculated operating income margin of approximately 42% (31,153 ÷ 74,200 ≈ 0.4199) is correct. (2) The answer is complete, addressing both parts of the multi-part question: NVIDIA's tax rate and Apple's operating margin in Greater China for fiscal year 2022. (3) Entity accuracy is perfect—correct companies (NVIDIA, Apple), correct metrics (effective tax rate, operating income margin), and correct geographic and fiscal period (Greater China, fiscal year 2022). (4) The reasoning is sound and includes a valid multi-hop comparison: the LLM correctly synthesizes data from two different companies and metrics, and logically compares the 1.9% tax rate to the 42% margin, noting the dramatic difference (approximately 20 times higher). The semantic meaning fully aligns with the original answer, even if slightly more concise. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 328,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How do BA's and UPS's uses of pricing models for valuing Level 2 assets differ based on the observable inputs they emphasize in their 2024 filings?",
      "original_answer": "BA values its fixed income investments categorized as Level 2 using pricing models that incorporate inputs such as benchmark yields, swap curves, and inter-dealer broker rates. These models are primarily income-based and rely on structured cash flow analysis and rating agency data. In contrast, UPS applies pricing models to value its Level 2 derivatives—mainly over-the-counter instruments—using market observable inputs like yield curves, foreign currency exchange rates, and investment forward prices. While both companies rely on observable market data for Level 2 classifications, BA emphasizes credit and yield-related inputs for fixed income instruments, whereas UPS focuses on currency and interest rate dynamics for its derivative positions.",
      "llm_answer": "Both companies classify their derivative‑related Level 2 assets on the basis of pricing models that use observable market data, but the inputs they highlight differ. Boeing’s 2024 filing notes that its Level 2 valuations rely on benchmark yields, swap‑curve rates, cash‑flow analyses, rating‑agency spreads and broker‑quoted data (e.g., reported trades and base spreads). United Parcel Service, by contrast, says its Level 2 models are driven mainly by market‑observable yield curves, foreign‑currency exchange rates and investment forward prices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All entities are correct: Boeing (BA) and United Parcel Service (UPS) are accurately identified, and the context of their 2024 filings is properly referenced. (2) The observable inputs emphasized by each company are correctly reported: BA's use of benchmark yields, swap curves, broker-quoted data, rating-agency spreads, and cash-flow analyses aligns with the ground truth's description of income-based models with credit and yield-related inputs. UPS’s reliance on yield curves, foreign currency exchange rates, and investment forward prices matches the original answer’s emphasis on currency and interest rate dynamics for derivatives. (3) The multi-hop reasoning is sound—comparing two companies’ use of pricing models across Level 2 assets—and the synthesis correctly highlights differences in input focus despite both using observable market data. (4) Minor deduction in qualitative accuracy due to slightly less explicit framing of the asset types (e.g., not clearly stating BA focuses on fixed income while UPS focuses on OTC derivatives), though this is implied through context. No numerical data errors; all information is non-quantitative and factually consistent. Semantic equivalence is strong, and the response is fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 375,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How does the voting power disparity between Class A and Class B common stock at GOOGL compare to the uniform voting rights structure at NFLX, particularly in light of GOOGL's $62.2 billion share repurchase program in 2023?",
      "original_answer": "GOOGL's Class A common stockholders have 1 vote per share, while Class B common stockholders have 10 votes per share, creating a significant disparity in voting power. This contrasts sharply with NFLX, where each share of common stock carries exactly one vote, ensuring equal voting rights across all shareholders. Additionally, GOOGL's 2023 share repurchase program, which retired $62.2 billion worth of shares, primarily targeted Class A and Class C shares, potentially influencing the overall voting balance by reducing the number of shares that convert from Class B to Class A upon transfer, thereby preserving the voting control of existing Class B holders.",
      "llm_answer": "Alphabet (GOOGL) issues two voting‑weighted common‑stock classes: each Class A share gets one vote, while each Class B share gets ten votes — a ten‑fold voting‑power gap 【page_81】. In 2023 Alphabet repurchased $62.2 billion of its Class A and Class C shares, underscoring the concentration of economic ownership in the lower‑voting Class A stock 【page_81】.  \n\nNetflix, by contrast, has only a single class of common stock, with each share entitled to one vote, so all shareholders vote on an equal‑per‑share basis 【NFLX 10‑K pages 59‑63】.  \n\nThus, GOOGL’s capital structure creates a pronounced voting‑power disparity (10 votes vs 1 vote per share), whereas NFLX’s uniform one‑share‑one‑vote structure provides no such disparity, even as Alphabet undertook a massive $62.2 billion share‑repurchase program in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GOOGL's Class A has 1 vote/share, Class B has 10 votes/share; NFLX has uniform 1 vote/share; and GOOGL's 2023 share repurchase was $62.2 billion. These numbers match the original answer exactly, with acceptable formatting (e.g., $62.2 billion). (2) The answer addresses all parts of the multi-hop question: voting structure comparison between GOOGL and NFLX, and the impact of the $62.2B repurchase. (3) Entity accuracy is strong: correct tickers (GOOGL, NFLX), correct share classes, correct year (2023). (4) Reasoning is sound: correctly identifies the 10:1 voting disparity and contrasts it with NFLX’s one-share-one-vote model. It also notes that repurchases targeted Class A and C shares, which is factually correct and relevant. However, the LLM slightly underdevelops the *impact* of the repurchase: while it mentions repurchasing lower-voting shares underscores ownership concentration, it does not fully explain how retiring Class A shares (which are non-convertible and dilution-absorbing) helps preserve Class B's relative voting control by reducing potential future dilution or conversion dynamics. The original answer notes this more precisely: repurchases reduce shares that could affect the balance when Class B shares are transferred (and downgraded to Class A). This nuance is missing, but the core logic is intact. Thus, the answer is factually excellent but loses one point for minor incompleteness in multi-hop synthesis regarding the repurchase's structural effect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 434,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does ACN's classification of U.S. government debt securities as Level 2 assets affect comparability with AVGO's investment disclosures, given that such securities are typically categorized as Level 1 based on active market pricing?",
      "original_answer": "ACN classified its U.S. government debt securities as Level 2 assets totaling $9,765 million, which contrasts with AVGO's disclosures where Level 1 securities are described as being valued based on quoted prices in active markets. This is notable because the UPS evidence indicates that U.S. government debt securities are generally categorized as Level 1 due to quoted prices in active markets. AVGO’s disclosures explicitly differentiate Level 1 and Level 2 securities based on valuation methodology, suggesting that ACN’s choice to classify these assets as Level 2 could reduce transparency and comparability in investment valuation practices between the two firms.",
      "llm_answer": "Accenture (ACN) places its U.S. government‑debt securities in the Level 2 tier of the fair‑value hierarchy, meaning they are valued using observable inputs other than quoted market prices (e.g., yield curves and broker quotes). Broadcom (AVGO) reports the same securities as Level 1 assets, which are measured directly from active‑market quoted prices. Because of this difference, the two companies present the same class of investment with different levels of valuation certainty, making a side‑by‑side comparison of their investment disclosures less straightforward and potentially overstating the liquidity of AVGO’s holdings relative to Accenture’s.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies the key difference between ACN and AVGO in classifying U.S. government debt securities as Level 2 vs. Level 1, respectively. It accurately reflects that Level 1 assets are based on quoted prices in active markets, while Level 2 uses other observable inputs, which aligns with the ground truth. There are no numeric inaccuracies—the $9,765 million figure from the original answer is not mentioned in the LLM response, which is a minor omission affecting completeness but not overall correctness. The reasoning is sound: it correctly infers that differing classification affects comparability and transparency, particularly around valuation certainty and perceived liquidity. The multi-hop synthesis across ACN and AVGO is logically valid, and the entities (Accenture/ACN, Broadcom/AVGO) and financial concepts (Level 1 vs. Level 2 hierarchy) are correctly identified. The answer could have strengthened its argument by referencing the UPS evidence (as in the original) about typical Level 1 classification of U.S. government securities, which would improve qualitative depth. However, the absence of this reference does not invalidate the conclusion. Wording differs but semantic meaning is equivalent on key points. Thus, the answer is highly accurate and relevant, meriting a high score with a slight deduction for missing the specific dollar amount and contextual benchmark from UPS.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 403,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does Colgate-Palmolive's adoption timeline for ASU 2022-04, which mandates detailed disclosures on supplier finance obligations, compare to Target's implementation of similar disclosures, particularly regarding the confirmed amount outstanding at year-end?",
      "original_answer": "Colgate-Palmolive adopted ASU 2022-04 beginning January 1, 2023, with the roll-forward information disclosure effective January 1, 2024. Target discloses its confirmed obligations outstanding under supplier finance programs within Accounts Payable on its Consolidated Statements of Financial Position, with early payment options available to vendors up to 120 days from the invoice date. While Colgate-Palmolive references Note 15 for program details, Target explicitly outlines the structure of its arrangements and vendor discretion in electing early payments, though exact confirmed amounts are not quantified in the provided excerpt.",
      "llm_answer": "- **Colgate‑Palmolive** – The company began applying ASU 2022‑04 on **January 1 2023** (the roll‑forward schedule was added on January 1 2024). Its Note 15 shows **$3.4 billion** of vendor obligations eligible for early payment confirmed outstanding at the end of the fiscal year (February 3 2024).  \n\n- **Target** – Target also adopted the supplier‑finance disclosure requirements of ASU 2022‑04 **effective January 1 2023**. In its 2024 Form 10‑K the company reports **approximately $2.2 billion** of confirmed supplier‑finance obligations outstanding at year‑end (January 31 2024).  \n\nThus, while both companies adopted the ASU at the same time (the start of 2023), Colgate‑Palmolive’s disclosed confirmed obligations are roughly $1.2 billion higher than Target’s at the respective year‑ends.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Colgate-Palmolive adopted ASU 2022-04 on January 1, 2023, with roll-forward disclosures effective January 1, 2024 — this part is correctly reported. However, the LLM claims that Colgate-Palmolive’s Note 15 shows $3.4 billion of confirmed obligations outstanding, and that Target reports approximately $2.2 billion — both figures are fabricated and not present in the original answer. The ground truth explicitly states that 'exact confirmed amounts are not quantified in the provided excerpt' for Target, and while Colgate-Palmolive references Note 15, no dollar amount is given in the original. Thus, the LLM invents precise numbers unsupported by the source. (2) The calculation comparing $3.4B vs $2.2B, concluding a $1.2B difference, is based on false data and therefore invalid. Dates of adoption (January 1, 2023) are correctly attributed to both companies, but fiscal year-ends (February 3, 2024 for Colgate; January 31, 2024 for Target) are added details not in the original and not verifiable from the ground truth. (3) The multi-hop reasoning is partially sound in structure — the model attempts to compare adoption timelines and disclosure content — but fails in execution because it hallucinates critical financial data. It incorrectly implies that both companies disclosed quantified confirmed amounts, which contradicts the original answer’s emphasis that such amounts are not explicitly provided. (4) The contextual relevance is fair because the response addresses the adoption timeline and attempts a comparison of disclosures, aligning with the question’s intent. However, the high scores are penalized severely due to fabrication of numbers, leading to a low correctness score despite correct qualitative elements like adoption date and note reference.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 506,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does BlackRock's exposure to operational risks through third-party technology partners like Microsoft compare to Mastercard's approach in managing similar reputational risks stemming from their own operational resilience strategies?",
      "original_answer": "BlackRock discloses that its reliance on key technology partners like Microsoft for hosting Aladdin on Azure introduces operational and execution risks, including infrastructure reliability, software security, and regulatory oversight, which could lead to reputational harm or legal liability if not managed properly. Operational risk is explicitly defined in the COF evidence as having the potential to result in reputational impact due to internal process failures, system issues, or external events. Mastercard identifies 'Reputational Impact' as a named risk factor in its 10-K and structures its risk management framework around it, listing 'Operational Resilience' as a core component of its reputational risk mitigation strategy. This suggests that while both firms recognize the reputational consequences of operational failures, BlackRock's risk is heightened by its dependency on external cloud providers, whereas Mastercard integrates operational resilience directly into its brand protection framework.",
      "llm_answer": "BlackRock flags its reliance on Microsoft Azure for the Aladdin platform as a specific operational‑risk source – a cloud‑service outage or a security breach at the third‑party provider could trigger execution failures, regulatory scrutiny and reputational harm (see BlackRock 10‑K p. 28). Mastercard, by contrast, manages comparable reputational exposure through an enterprise‑wide operational‑resilience framework that is built into its governance, risk‑management and privacy‑security policies (see Mastercard 10‑K pp. 23‑27), rather than depending on a single external technology partner.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BlackRock's reliance on Microsoft Azure for Aladdin is accurately cited as a source of operational risk, with potential consequences including execution failures, regulatory scrutiny, and reputational harm. Mastercard's integration of operational resilience into its broader risk governance framework is correctly described. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the absence of any incorrect numbers or miscalculations supports a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (BlackRock and Mastercard), identifies their differing approaches to operational and reputational risk, and contrasts third-party dependency (BlackRock) with internal resilience strategies (Mastercard). The only minor shortcoming is that the LLM does not explicitly name 'Reputational Impact' as a formally listed risk factor in Mastercard’s 10-K, which is included in the ground truth and adds a small nuance to the qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the comparison asked in the question with precise, document-supported reasoning. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the original answer, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 439,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How significant was Cardinal Health as a customer for BMY in 2021, and what role does Cardinal play in CVS's generic pharmaceutical sourcing strategy through Red Oak Sourcing, LLC?",
      "original_answer": "Cardinal Health represented 20% of BMY's revenue in 2021, making it a significant customer relationship. CVS partners with Cardinal through Red Oak Sourcing, LLC, where both companies hold 50% ownership and jointly negotiate generic pharmaceutical supply contracts. This strategic arrangement enables CVS and Cardinal to leverage combined sourcing capabilities, though it does not involve inventory ownership by Red Oak. The shared sourcing venture highlights Cardinal's dual role as both a key BMY customer and a strategic partner in CVS's supply chain infrastructure.",
      "llm_answer": "Cardinal Health was a major BMS customer in 2021 – the wholesaler accounted for about 20 % of Bristol‑Myers Squibb’s global gross product‑sales revenue that year, making it the third‑largest pharmaceutical distributor for the company. At CVS, Cardinal is a 50 % owner of Red Oak Sourcing, LLC; together they contribute sourcing and supply‑chain expertise and use Red Oak to negotiate and procure generic‑drug contracts on behalf of both CVS and Cardinal.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, the 20% revenue figure for Cardinal Health's share of BMY's (Bristol-Myers Squibb's) 2021 revenue is correct, satisfying the first part of the question. The percentage is accurately reported with acceptable formatting (20% vs. 'about 20%'). (2) The entity names are correct: Cardinal Health, Bristol-Myers Squibb (referred to as BMS, a common abbreviation; minor deviation from BMY in the question, but semantically equivalent), CVS, and Red Oak Sourcing, LLC. The 50% ownership in Red Oak is correctly stated. (3) The reasoning and synthesis across entities are sound: the dual role of Cardinal as both a major customer of BMS and a strategic partner with CVS via Red Oak is clearly communicated. The function of Red Oak—negotiating generic drug contracts without owning inventory—is partially mentioned (negotiation and procurement are noted, but the lack of inventory ownership is omitted). This is a minor omission that does not undermine the core accuracy. (4) Contextual relevance is strong: both sub-questions are addressed with appropriate detail. The only slight shortfall is the omission of Red Oak not owning inventory, a detail present in the original answer that adds nuance to the sourcing model. However, this does not affect the overall correctness. Wording differences (e.g., 'procure' vs. 'jointly negotiate') are semantically equivalent. The reference to Cardinal as the 'third-largest pharmaceutical distributor' is additional context not in the ground truth but not factually incorrect. Final scores reflect high accuracy with a minor deduction in qualitative accuracy for the omitted operational detail about inventory.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 475,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How does the voting power of Class B common stockholders at META compare to that of NFLX common stockholders, given that META Class B shares are restricted to specific voting scenarios and each share carries a multiplier based on the conversion rate?",
      "original_answer": "META's Class B common stockholders have restricted voting rights, only applicable in specific scenarios such as exiting the core payments business, a merger, or certain amendments to the certificate of incorporation. In these cases, each Class B share's voting power is multiplied by the applicable conversion rate in effect on the record date. In contrast, NFLX common stockholders receive one vote per share on all matters requiring stockholder approval. This means that while META Class B shareholders have conditional voting rights with variable influence based on the conversion rate, NFLX shareholders have consistent, unconditional voting power proportional to their shareholding.",
      "llm_answer": "Meta Platforms’ Class B common‑stock holders do **not** vote on ordinary matters; they can vote only on a few defined actions (e.g., a core‑payments exit, a merger, or certain charter amendments). When they do vote, each Class B share is counted as a multiple of votes equal to the current conversion rate that would turn the share into Class A stock (so a single share can carry many votes).  \n\nNetflix, by contrast, has a single class of common stock that carries **one vote per share** on all shareholder matters.  \n\nThus, Meta’s Class B holders have restricted voting rights but, when exercised, their votes are multiplied by the conversion rate, whereas Netflix shareholders have unrestricted, straight‑one‑vote‑per‑share voting power.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that Meta's Class B shareholders have restricted voting rights, applicable only in specific scenarios such as a core payments exit, merger, or charter amendments—matching the original answer. It accurately describes that each Class B share's voting power is multiplied by the conversion rate during those events. For NFLX, it correctly notes the single class of common stock with one vote per share on all matters. (2) There are no numerical values requiring calculation (e.g., conversion rate multipliers are not quantified in either answer), so quantitative accuracy is preserved as no incorrect numbers are introduced. (3) The multi-hop reasoning—comparing voting structures across two companies (META and NFLX) with different share classes and voting rules—is sound and well-synthesized. The model correctly contrasts conditional, multiplied voting power (META Class B) with unconditional, per-share voting (NFLX). (4) All entities (Meta Platforms, Netflix, Class B common stock, conversion rate) are accurately identified and contextualized. The answer fully addresses the comparative aspect of the question and maintains high contextual relevance. Minor wording differences (e.g., 'core-payments exit' vs 'exiting the core payments business') do not affect meaning. No omissions or inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 392,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How does the automatic conversion of Class B shares upon transfer at GOOGL contrast with META's structural protections that require Class B approval for change-of-control transactions, and what role does Mastercard's mandatory post-conversion Class A stock transfer mechanism play in evaluating dual-class governance frameworks?",
      "original_answer": "META requires that any change-of-control transaction must be approved by a majority of its outstanding Class B common stock voting as a separate class until those shares represent less than 35% of combined voting power. In contrast, GOOGL's Class B shares automatically convert to Class A shares upon sale or transfer, effectively limiting concentrated voting control over time. Mastercard's framework mandates that converted Class B shares become Class A shares that must be sold or transferred, creating a structural mechanism that prevents long-term retention of higher-vote shares. This contrast reveals different approaches to dual-class governance: META entrenches control through voting rights preservation, while GOOGL and Mastercard implement mechanisms that eventually dilute concentrated voting power through mandatory conversion and divestiture.",
      "llm_answer": "Alphabet’s charter says that every Class B share automatically converts to a voting‑one‑share Class A share when the holder sells or otherwise transfers the stock, instantly stripping the holder of the ten‑vote super‑voting rights. By contrast, Meta’s charter preserves those super‑voting rights until a change‑of‑control transaction is proposed, at which point a separate majority of Class B votes must approve the deal, keeping the voting control in the hands of the founders and other Class B owners. Mastercard adds another layer of governance scrutiny: its certificate of incorporation requires that any Class B holder who converts to Class A must subsequently sell or otherwise transfer the newly‑issued Class A shares, a mandatory post‑conversion divestiture that analysts use to gauge how effectively a dual‑class system limits the accumulation of voting power.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) All key facts are correct: GOOGL's Class B shares automatically convert to Class A upon transfer, stripping super-voting rights; META requires separate Class B approval for change-of-control transactions, preserving founder control; Mastercard mandates post-conversion sale or transfer of Class A shares after Class B conversion. (2) There are no numeric values (percentages, dollar amounts, dates) in either answer, so quantitative accuracy is unaffected and remains perfect. (3) The multi-hop reasoning is sound: the LLM correctly contrasts GOOGL’s automatic conversion upon transfer with META’s voting protection mechanism and integrates Mastercard’s mandatory divestiture rule as a governance feature that limits long-term voting power accumulation. The only minor shortcoming is that the LLM does not explicitly mention the 35% voting power threshold for META’s Class B protections (a detail in the ground truth), nor does it directly state that GOOGL and Mastercard both dilute concentrated voting over time—though this is implied. (4) Despite these small omissions, the LLM captures the essential contrast in dual-class governance philosophies and maintains semantic equivalence. The answer is fully relevant, well-structured, and synthesizes across all three companies appropriately. Hence, correctness is docked slightly to 9 for near-perfect but not fully complete coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 416,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MRK's pediatric market exclusivity opportunities compare with AMGN's regulatory exclusivity risks given recent changes to data protection periods for biologics?",
      "original_answer": "MRK benefits from six-month pediatric market exclusivity extensions that can apply to products like its high-risk adult COVID-19 treatment, potentially extending protection beyond patent expiration. In contrast, AMGN faces regulatory exclusivity risks as the FDA considers changes to biologic data exclusivity, including whether umbrella exclusivity applies, which could reduce the effective protection period for products like EPOGEN. These differences reflect MRK's proactive IP strategy versus AMGN's exposure to policy shifts in biologic exclusivity frameworks.",
      "llm_answer": "Merck’s filings note that, under the U.S. FDAMA pediatric‑exclusivity provision and comparable EU rules, it can earn an additional six months of market exclusivity for any product that completes FDA‑requested pediatric studies (page 16). In contrast, Amgen warns that recent regulatory shifts—such as the removal of a mandatory 10‑year data‑exclusivity requirement for biologics under the US‑Mexico‑Canada Agreement and the FDA’s uncertainty about “umbrella” exclusivity for biologic reference products—could shorten the 12‑year biologic data‑protection period and expose its biologics to biosimilar competition earlier (page 46). Thus, Merck enjoys a modest, predictable pediatric‑exclusivity boost, while Amgen faces heightened risk of losing regulatory exclusivity for its biologics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and time periods are correct: the six-month pediatric exclusivity for Merck (MRK) and the 12-year biologic data protection period (with risks from policy changes) for Amgen (AMGN) are accurately reported. The mention of the USMCA impact and FDA uncertainty around 'umbrella exclusivity' is factually consistent. (2) The answer is complete, addressing both MRK's opportunity and AMGN's risk, fulfilling the comparative, multi-hop nature of the question. (3) Entities are correctly identified: MRK and AMGN, pediatric exclusivity, biologics, EPOGEN (implied via context of AMGN’s biologics), and relevant regulatory frameworks (FDAMA, USMCA, FDA rules). (4) Reasoning is sound: it contrasts MRK’s predictable, proactive IP strategy (via pediatric studies) with AMGN’s exposure to regulatory uncertainty, mirroring the original answer’s logic. The only minor gap is that the LLM answer does not explicitly name EPOGEN as the example biologic at risk, though it refers generally to 'its biologics,' which is contextually sufficient. Wording differs but semantic meaning and factual content are equivalent. No calculation errors. High contextual relevance throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 354,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MA's and V's dual-class stock structures differ in terms of voting power distribution and control concentration mechanisms, particularly regarding the balance between Class A and Class B shares?",
      "original_answer": "MA's dual-class structure grants Class B common stock 15 votes per share, with all outstanding shares held by Mr. Brian L. Roberts, representing 33⅓% of the combined voting power, while Class A common stockholders collectively hold 66⅔% of the voting power. In contrast, V's structure ties Class B common stock transferability and convertibility to the resolution of U.S. covered litigation, with conversion rates for Class B shares into Class A shares subject to adjustments based on follow-on offerings or litigation outcomes. Additionally, V's Class C common stock has no transfer restrictions, and its exchange program allows for partial release of restrictions on Class B shares, further differentiating its control mechanisms from MA's more static voting power allocation.",
      "llm_answer": "Mastercard’s capital structure consists of publicly‑traded Class A common stock that carries one vote per share and a non‑public Class B common stock that carries a superior voting multiplier (10 votes per share) and is owned almost entirely by the company’s founders, giving them majority voting control despite holding a small percentage of the equity 【page 1】.  \n\nVisa, by contrast, has three classes: Class A common stock with one vote per share, Class B common stock with fifteen votes per share that together represent roughly one‑third of the total voting power and are held almost exclusively by Brian L. Roberts, and non‑voting Class C common stock; the B and C shares can vote only on limited matters and their voting weight is tied to the applicable conversion rate, while the B shares remain non‑convertible and transfer‑restricted until certain litigation‑related events are resolved 【page 90】【page 89】.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. It incorrectly attributes the 15-vote Class B shares to Visa (V), when in fact the ground truth states that MA (Mastercard) has Class B shares with 15 votes per share held by Brian L. Roberts. The LLM reverses the companies: it assigns 10 votes per share to Mastercard (MA), but the ground truth specifies 15 votes per share for MA, not 10. Additionally, the LLM claims Visa has Class B shares with 15 votes per share, which contradicts the ground truth—Visa’s structure does not specify a fixed 15-vote advantage; instead, its Class B voting power is tied to conversion rates affected by litigation and follow-on offerings. The LLM also incorrectly states that Visa has non-voting Class C stock, while the ground truth clarifies that Class C has no transfer restrictions (not that it is non-voting), and can vote on certain matters. (2) Quantitative inaccuracies include the vote multiplier for MA (10 vs. correct 15), misattribution of voting percentages (e.g., 'roughly one-third' for Visa’s Class B when it's actually MA’s Class B that holds 33⅓%), and omission of the exact 66⅔% voting power held by MA’s Class A. (3) The multi-hop reasoning is partially sound in recognizing that both companies have dual/triple-class structures with differential voting rights and control mechanisms, but the synthesis is flawed due to misattribution of key facts across companies. The LLM fails to capture Visa’s litigation-linked convertibility and adjustment mechanisms, instead oversimplifying them as transfer restrictions. (4) Contextual relevance is high because the response addresses voting power distribution and control concentration as asked, and attempts to compare both firms’ structures. However, due to significant factual and quantitative errors in entity attribution and numbers, the correctness and qualitative accuracy scores are moderate. Minor formatting variations in numbers are acceptable, but incorrect assignment of vote counts and companies undermines reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 551,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does RTX's financial exposure to FAR-regulated U.S. government fixed-price contracts compare to LMT's risk profile under similar contracts, particularly in terms of revenue recognized in excess of billings and potential liabilities from government audits?",
      "original_answer": "RTX reports that under U.S. government fixed-price contracts, they typically receive performance-based or progress payments, which often result in revenue recognized in excess of billings, presented as Contract assets on their Consolidated Balance Sheet. This indicates a financial exposure tied to delayed cash receipt despite early revenue recognition. The FAR regulates these payment structures and cost-allowability, directly shaping RTX's financial reporting and risk. Similarly, LMT, which is also heavily dependent on U.S. government contracts, faces potential liabilities from government audits and investigations, including the risk of debarment or suspension from future contracts, which could have a material adverse effect given their 'dependence on contracts with the U.S. Government.' While RTX's exposure is primarily balance sheet-related (e.g., contract assets), LMT's risk is more compliance and enforcement-oriented, with potential financial penalties or operational restrictions stemming from FAR-regulated audits. Both companies are therefore financially and operationally impacted by the FAR’s regulatory framework, but through different risk mechanisms.",
      "llm_answer": "RTX explicitly states that its U.S.‑government fixed‑price contracts – which are governed by the Federal Acquisition Regulation (FAR) – “generally result in revenue recognized in excess of billings which we present as **Contract assets** on the Consolidated Balance Sheet.” Because those contracts are FAR‑regulated, any post‑award audit that disallows costs could force RTX to reverse that excess revenue and create a liability.  \n\nBy contrast, Lockheed Martin’s 2022 filing does not quantify contract‑asset balances for FAR‑regulated fixed‑price work, nor does it call out a material exposure to audit‑related adjustments. Thus, RTX’s exposure to revenue‑ahead‑of‑billings and the attendant audit‑risk is disclosed and appears materially larger than the risk profile that Lockheed Martin reports for comparable government contracts.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of RTX's financial exposure, correctly citing that FAR-regulated fixed-price contracts lead to revenue recognized in excess of billings, reported as Contract assets, and that audit risk could result in revenue reversal. This aligns with the ground truth. The statement about LMT is partially correct but incomplete: while it's true that LMT's 2022 filing may not quantify contract assets or highlight audit adjustments as a material risk, the ground truth emphasizes that LMT faces significant compliance risks—including debarment and material adverse effects—from government audits due to its heavy reliance on U.S. government contracts. The LLM downplays LMT's risk profile by interpreting lack of disclosure as lower risk, whereas the original answer stresses that LMT’s risk is compliance- and enforcement-driven rather than balance-sheet-driven. This mischaracterization affects the comparative analysis, making RTX’s risk appear disproportionately higher without acknowledging that LMT’s risks are different in nature, not necessarily smaller in magnitude. There are no numerical inaccuracies (quantitative accuracy is perfect), and the context is highly relevant. However, the qualitative reasoning is weakened by incomplete synthesis of LMT's risk exposure, leading to a less nuanced comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 376,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the specific voting rights tied to each share class?",
      "original_answer": "At META, Class B common stockholders hold 33 1/3% of the combined voting power, with each Class B share carrying 15 votes, while Class A shares (publicly traded) hold the remaining 66 2/3% of voting power. In contrast, at GOOGL, Class B shares carry 10 votes per share and Class A shares carry 1 vote per share, though the equity note does not specify the exact percentage split between the two classes. This indicates that both companies use dual-class structures to concentrate voting control, but META's structure gives significantly more per-share voting power to Class B shares compared to GOOGL.",
      "llm_answer": "Both companies use a dual‑class structure in which the “B” shares carry ten votes per share while the “A” shares carry one vote per share. Meta’s capital consists only of Class A and Class B stock, so the relatively few Class B shares held by insiders give them a disproportionate share of the total voting power. Alphabet (Google) also has Class A (1 vote) and Class B (10 votes) shares, but in addition it issues a non‑voting Class C series, meaning that voting power is concentrated in the Class B shares while the large pool of Class C shares carries no voting rights. In short, Meta’s voting power is split between two classes (1‑vote vs 10‑vote), whereas Google’s voting power is split among three classes (1‑vote, 10‑vote, and 0‑vote).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding META's voting structure. According to the ground truth, META's Class B shares have 15 votes per share, not 10 as stated in the LLM answer. Additionally, the ground truth specifies that Class B holds exactly 33 1/3% of voting power and Class A holds 66 2/3%, but the LLM fails to mention these precise percentages. For GOOGL, the LLM correctly states that Class B shares have 10 votes and Class A have 1 vote, but incorrectly implies that GOOGL uses a three-class voting structure due to Class C shares, which is misleading—while Class C shares exist and are non-voting, the question is about voting power distribution between Class A and B, which the LLM misrepresents by shifting focus to Class C. (2) Quantitative accuracy is low: the 15 votes per share for META Class B is a critical data point that was incorrectly reported as 10, and the exact 33 1/3% and 66 2/3% splits were omitted. These are key numerical facts required by the question. (3) The reasoning is partially sound in recognizing dual-class structures and control concentration, but fails in accurate multi-hop comparison—instead of contrasting META’s 15:1 vs GOOGL’s 10:1 voting ratios and the actual distribution of power, it incorrectly equates both at 10:1 and introduces Class C as a structural differentiator that isn't directly relevant to the A/B comparison asked. (4) Contextual relevance is high because the answer addresses the dual-class structures and attempts a comparative analysis, but correctness and quantitative accuracy are severely impacted by key factual errors in vote ratios and missing percentage distributions, warranting a moderate score of 4/10 overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 475,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "Given BMY's reliance on regulatory data protection for key products like Opdivo, how does the expiration of such protections create a precedent for increased Paragraph IV ANDA challenges that could directly impact JNJ's litigation exposure for drugs like Stelara facing similar patent cliffs in the coming years?",
      "original_answer": "BMY's 2022 10-K highlights that when market exclusivity expires, there are often 'substantial and rapid declines' in sales of the original product, and that ANDAs with Paragraph IV certifications are frequently filed after four years of a five-year regulatory data protection period. AbbVie's filing demonstrates how such Paragraph IV challenges directly lead to increased patent litigation exposure, with companies filing Abbreviated New Drug Applications seeking to market generic forms of branded drugs before patent expiration. JNJ's 2022 10-K specifically cites patent litigation as a material risk, noting the company faces litigation related to its major products and that adverse judgments could significantly impact financial performance. Stelara, which generated over $8 billion in 2022, is a prime target for such challenges once exclusivity periods lapse, mirroring the pathway seen in BMY's and AbbVie's experiences.",
      "llm_answer": "When a product’s regulatory data‑protection period ends, the FDA is no longer barred from using the innovator’s safety‑and‑efficacy data, so generic makers can file a Paragraph IV aNDA as soon as the four‑year “four‑year rule” is satisfied (see the discussion of Paragraph IV certifications and five‑year data protection in the BMY filing). Because Opdivo’s data‑protection will eventually expire, BMY expects a surge of Paragraph IV filings and related patent suits, establishing a clear precedent that once data exclusivity lapses, competitors will move quickly to challenge patents. Johnson & Johnson faces the same dynamic with Stelara—its upcoming patent cliffs and any remaining data‑protection will likely trigger a wave of Paragraph IV ANDA challenges, exposing JNJ to comparable litigation risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: it correctly identifies the 4-year rule for Paragraph IV ANDA filings following a 5-year regulatory data protection period, referencing BMY's experience with Opdivo. It accurately describes the mechanism by which expiration of data exclusivity leads to increased Paragraph IV challenges and subsequent patent litigation. The connection to JNJ and Stelara is logically drawn, mirroring the precedent set by BMY and AbbVie. (2) Quantitative accuracy is strong: while no specific dollar figures or years (e.g., Stelara’s $8B in 2022) are mentioned in the LLM answer, it does not misstate any numbers and correctly references the structural timeline (four-year rule, five-year exclusivity), which matches the original. The omission of the $8 billion figure and explicit mention of JNJ’s 2022 10-K citation is a minor gap but does not detract from core correctness. (3) Multi-hop reasoning is sound: the model synthesizes the regulatory framework from BMY’s context, applies it to generic entry patterns, and correctly extends the logic to JNJ’s exposure with Stelara. It captures the cause-effect chain: data protection expiry → Paragraph IV filings → patent litigation → financial risk. (4) Semantic equivalence is high—though the LLM does not name AbbVie explicitly, it refers to the same dynamic, and the core message about precedent and litigation risk is preserved. The answer is fully contextually relevant, directly addressing how BMY’s situation informs JNJ’s future risk. One point deducted from qualitative accuracy for not citing the material risk disclosure in JNJ’s 10-K or the magnitude of Stelara’s sales, which are key supports in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 479,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does the structure of META's dual-class stock system, which requires Class B approval for change-of-control transactions until their voting power drops below 35%, compare with GOOGL's dual-class voting framework where Class B shares carry 10 votes each but automatically convert to Class A upon transfer?",
      "original_answer": "META's dual-class structure requires a separate Class B majority vote for any change-of-control transaction until Class B shares fall below 35% of total voting power, providing concentrated control to its primary stockholder. In contrast, GOOGL allows Class B shares to carry 10 votes each but mandates automatic conversion to Class A voting rights upon sale or transfer, limiting long-term entrenchment while still preserving enhanced voting power during ownership retention. Both structures concentrate control, but META's framework offers more enduring governance insulation due to its non-automatic nature and threshold-based trigger.",
      "llm_answer": "Meta’s charter ties change‑of‑control protection to its Class B stock: any transaction that would shift control must be approved by a majority of the outstanding Class B votes ‑ which together hold at least 35 % of the company’s total voting power ‑ until the Class B shares fall below that 35 % threshold (at which point other amendment rules apply)【page_50】.  \n\nGoogle’s (Alphabet’s) dual‑class scheme also gives each Class B share ten votes, but those shares are convertible at the holder’s option and automatically convert to one‑vote Class A shares whenever they are sold or transferred, so voting power erodes as the shares change hands rather than being tied to a fixed control‑approval threshold【page_81】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: META's Class B approval requirement for change-of-control transactions until voting power drops below 35% is accurately described, as is GOOGL's 10-vote Class B shares that automatically convert to 1-vote Class A shares upon transfer. (2) Quantitative elements—specifically the 35% threshold and 10 votes per Class B share—are correctly reported with no calculation errors. (3) Multi-hop reasoning is sound: the model correctly synthesizes differences in governance durability (non-automatic vs. automatic conversion) and control mechanisms across both companies. (4) The answer fully addresses the comparative aspect of the question, clearly contrasting META’s threshold-based, enduring control structure with GOOGL’s transfer-triggered dilution of voting power. Wording differs slightly but meaning is preserved, and citations to page numbers suggest grounding in source material. No factual, numerical, or logical errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 299,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "UPS chose not to apply the practical expedients under ASU 2020-04 for its transition to SOFR in 2023 - how does this approach contrast with how MMM likely managed its hedging relationships affected by reference rate reform, given the optional relief available through December 31, 2024?",
      "original_answer": "UPS explicitly stated it did not elect to apply the practical expedients provided under ASU 2020-04 when transitioning its affected debt instruments to SOFR in 2023. In contrast, MMM's detailed disclosures of hedging relationships suggest it may have utilized the optional relief under the same standard, particularly since ASU 2022-06 extended the sunset date to December 31, 2024, allowing companies to apply the expedients to contracts modified through that date. MMM's reporting includes extensive hedging activity data, such as $152 million reclassified from accumulated other comprehensive income into income in 2023 for foreign currency contracts, which implies active management of hedging relationships—potentially benefiting from the optional relief provided by ASU 2020-04 as extended.",
      "llm_answer": "UPS elected to transition its LIBOR‑linked debt to SOFR on a straight‑forward basis and **did not use any of the practical‑expedient provisions in ASU 2020‑04**, meaning it applied the full GAAP transition requirements in 2023. In contrast, 3M’s filing notes that the ASU 2020‑04 (as amended through 2022‑06) **offers optional relief for contracts and hedging relationships through December 31 2024**, and 3M’s discussion of its derivative and hedge accounting indicates it relied on those expedients to manage the reference‑rate reform impact, thereby taking a more permissive, relief‑driven approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that UPS did not apply the practical expedients under ASU 2020-04 during its 2023 SOFR transition, which matches the original answer. It also correctly contrasts this with 3M (MMM), noting that 3M likely used the optional relief under ASU 2020-04 as extended by ASU 2022-06 through December 31, 2024. (2) There are no numeric values in the LLM answer that conflict with the ground truth; while the original answer mentions $152 million reclassified from AOCI, the LLM answer does not include this figure. However, its absence does not detract from correctness because the LLM still supports the inference of active hedging management through qualitative reasoning. The omission is minor and does not affect the core factual claim. (3) The multi-hop reasoning is sound: the model correctly links ASU 2020-04, its extension via ASU 2022-06, the sunset date of December 31, 2024, and infers likely different corporate behaviors (UPS non-use vs. MMM likely use) based on disclosure patterns. (4) Semantic equivalence is maintained—'did not use any of the practical-expedient provisions' matches 'did not elect to apply the practical expedients'; 'relied on those expedients to manage the reference-rate reform impact' aligns with 'may have utilized the optional relief'. The only minor shortcoming is the lack of specific quantitative support (the $152M) from MMM’s disclosures, which would have strengthened the argument, but the qualitative inference remains valid. Hence, a score of 9 is appropriate—excellent accuracy with a slight deduction for incomplete use of available quantitative evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 459,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does the daily cash-settlement of exchange-traded commodity futures impact MDLZ's valuation methodology for Level 1 financial assets, given PEP's similar exposure to these instruments?",
      "original_answer": "MDLZ values its Level 1 financial assets, which include exchange-traded commodity futures, based on quoted market prices from commodity exchanges. These instruments are marked-to-market daily, as noted in PEP's disclosure that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the balance sheet table as of year-end. This daily cash-settlement mechanism directly supports MDLZ's use of quoted market prices for fair value measurement, as both companies are exposed to the same class of instruments that are subject to daily valuation adjustments through cash settlement.",
      "llm_answer": "Mondelez classifies exchange‑traded commodity futures as Level 1 financial assets because their fair value can be taken directly from quoted exchange prices; however, because these contracts are cash‑settled each day, the positions are settled out of cash and therefore do not appear on the balance sheet at period‑end (they are excluded from the fair‑value tables). PepsiCo’s commodity‑price risk program also uses exchange‑traded futures that are cash‑settled, and it marks them to market each reporting period, recognizing the resulting gains or losses in earnings—so the valuation approach (quoted‑price Level 1 measurement) and the effect of daily settlement are essentially the same for both companies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: MDLZ classifies exchange-traded commodity futures as Level 1 assets due to observable quoted prices, and daily cash settlement results in these positions not appearing on the balance sheet at period-end. The reference to PEP’s similar use of exchange-traded futures that are marked-to-market and cash-settled daily is consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly links MDLZ’s valuation methodology to the nature of exchange-traded futures, infers the balance sheet exclusion due to daily cash settlement (a point explicitly stated in PEP’s disclosures), and draws a valid parallel between MDLZ and PEP’s treatment of similar instruments. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'settled out of cash' vs 'not included in the balance sheet table'), the meaning is preserved. One minor point preventing a perfect 10 is that the LLM does not explicitly state that the daily cash settlement 'directly supports' the use of quoted prices for fair value measurement—a causal link emphasized in the original—but this is implied in the explanation. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 410,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare to GOOGL's approach, given that GOOGL also maintains a multi-tier voting rights system with Class B common stock?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while the Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power, with each Class B share carrying 15 votes. In contrast, GOOGL's Class B common stockholders have 10 votes per share, while Class A common stockholders have 1 vote per share, and Class C capital stock has no voting rights. This indicates that CMCSA concentrates more voting power in Class B shares relative to GOOGL, where Class B shares have a lower per-share vote weight but still serve to maintain control for certain key stakeholders.",
      "llm_answer": "Comcast’s capital structure gives the publicly‑traded Class A shares about two‑thirds (≈66 %) of the total voting power, while the single holder of Class B shares – each carrying 15 votes – controls the remaining one‑third (≈33 %) of the votes. Alphabet (Google) uses a similar dual‑class system, but its Class B shares carry ten votes each and concentrate voting control with insiders, whereas Class A shares have one vote and Class C shares have none, resulting in a majority of voting power residing with the Class B holders. Thus, Comcast’s voting split is roughly 2‑to‑1 in favor of Class A, whereas Google’s split heavily favors the high‑vote Class B stock.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a critical error in the comparative analysis that affects the overall reasoning. (1) Quantitatively, the numbers are largely accurate: CMCSA's Class A has ~66% and Class B ~33% voting power, with Class B shares carrying 15 votes per share — all correct. GOOGL’s Class B has 10 votes per share, Class A has 1 vote, and Class C has none — also correct. (2) However, the LLM incorrectly states that in Google’s structure, 'a majority of voting power resides with the Class B holders' — this is unsupported by the original answer and not necessarily true; while Class B shares have superior voting rights, the original answer does not confirm they hold a majority of total voting power, only that they concentrate control. This is a significant qualitative inaccuracy. (3) The reasoning flaw occurs in the conclusion: the LLM claims 'Comcast’s voting split is roughly 2-to-1 in favor of Class A', which matches the 66% vs 33% split, but then says 'Google’s split heavily favors the high-vote Class B stock' — implying a different power distribution than what is described. The original answer emphasizes that CMCSA concentrates *more* voting power per share in Class B (15 votes) than GOOGL (10 votes), but the LLM reverses the implication by suggesting GOOGL's structure more strongly favors Class B in overall control, which is not supported. (4) Despite this, the answer correctly identifies ownership concentration (Brian L. Roberts for CMCSA), per-share vote weights, and stock classes, and addresses both companies’ structures as required. Wording is flexible but mostly semantically aligned, except for the misleading comparative conclusion. Hence, correctness is reduced to 7 due to flawed synthesis and inference, though core facts are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 484,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does BAC's market-making gains related to embedded derivatives compare to MS's involvement in CLNs structured as hybrid instruments with embedded derivatives, given the shared exposure to credit event risks in structured notes?",
      "original_answer": "BAC reports that its net gains (losses) in market-making activities relate to embedded derivatives in structured liabilities and are typically offset by gains (losses) on derivatives and securities used to hedge these liabilities. MS, on the other hand, structures CLNs as hybrid instruments containing embedded derivatives, where the Firm sells credit protection and faces risk of principal loss upon a credit event in the reference entity. Both firms demonstrate exposure to credit-linked derivatives, but BAC actively hedges these exposures while MS retains risk through structured note design.",
      "llm_answer": "**Bank of America (BAC)** – In the “Gains (Losses) Related to Assets and Liabilities Accounted for Under the Fair‑Value Option” table, the line that captures market‑making and similar activities (which are driven by the embedded derivatives in its structured liabilities) shows a **net gain of $4.2 billion for 2024** (and $4.8 billion for 2023).\n\n**Morgan Stanley (MS)** – The 10‑K describes the firm’s participation in credit‑linked notes (CLNs) as a hybrid instrument that contains embedded derivatives and therefore carries exposure to a credit‑event loss on the reference asset.  Rather than reporting a gain, the filing quantifies the related credit‑protection exposure as a **fair‑value liability of about $4.3 billion (total credit protection sold) and net derivative liabilities with credit‑risk contingencies of $22.4 billion**.\n\n**Comparison** – BAC actually records a positive $4.2 bn of market‑making gains that arise from those embedded derivatives, whereas MS’s CLN activity is presented as a credit‑risk exposure that could generate losses, reflected by a $4.3 bn liability (and a much larger $22 bn of credit‑risk‑related derivative liabilities). Both businesses are linked to the same type of credit‑event risk in structured notes, but BAC’s result is a sizable gain, while MS’s result is a disclosed potential loss exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. The original answer (ground truth) does not provide specific dollar amounts such as BAC's '$4.2 billion market-making gains in 2024' or MS's '$4.3 billion liability' or '$22.4 billion net derivative liabilities'—these figures are fabricated or misattributed, with no support in the provided ground truth. The ground truth emphasizes qualitative distinctions: BAC hedges its embedded derivative exposures in structured liabilities, leading to offsetting gains/losses, while MS structures CLNs as hybrid instruments where it sells credit protection and retains principal risk upon credit events. The LLM correctly identifies the conceptual contrast—BAC recording gains from market-making activities involving embedded derivatives vs. MS facing potential losses from credit-event risk in CLNs—and notes both firms' exposure to credit-linked derivatives. This demonstrates sound multi-hop reasoning and entity accuracy (BAC vs. MS, embedded derivatives, CLNs, credit event risk). However, the inclusion of precise but unsupported financial figures severely compromises factual accuracy. While the directionality of the comparison (gains vs. risk exposure) aligns semantically with the ground truth, the answer introduces false precision through invented numbers. The contextual relevance is high, as the response directly addresses the comparative structure of the question and synthesizes across both firms’ risk profiles. Thus, the correctness score is reduced due to major quantitative errors, despite strong qualitative reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 445,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does the implementation of the OECD's Pillar Two Model Rules, which Salesforce (CRM) identifies as a global tax development, potentially affect Intel's (INTC) effective tax rate given Intel's exposure to non-US jurisdictions and ongoing evaluation of Pillar Two impacts?",
      "original_answer": "Salesforce (CRM) identifies the OECD's Pillar Two Model Rules, which introduce a global minimum tax of 15%, as a material global tax development that could impact multinational businesses. Intel (INTC), which reports that a higher proportion of its income is taxed in non-US jurisdictions, is actively evaluating the impact of Pillar Two, particularly as several non-US jurisdictions, including EU Member States, have enacted or plan to enact legislation aligning with the rules starting in 2024. Since Intel's effective tax rate has been influenced by its geographic income distribution and non-US tax regimes, the implementation of Pillar Two could constrain its ability to benefit from lower tax jurisdictions, thereby increasing its effective tax rate or reducing future tax benefits.",
      "llm_answer": "Intel notes that many non‑U.S. jurisdictions are beginning to adopt the OECD Pillar Two rules, which impose a 15 % global minimum tax. Because a larger share of Intel’s earnings is now taxed outside the United States, the company is “continuing to evaluate the impacts of enacted legislation and pending legislation to enact Pillar Two Model Rules in the non‑U.S. tax jurisdictions we operate in” (Intel 2023 10‑K, p. 44). If those rules are applied, they could lift the tax rate on income earned in low‑tax jurisdictions and therefore push Intel’s effective tax rate higher, although Intel currently expects the effect to be limited given its modest exposure to jurisdictions with rates below the 15 % floor.【page_44】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the 15% global minimum tax under OECD Pillar Two is accurately stated, and the reference to Intel's 2023 10-K, page 44, supports the claim. The characterization of Intel's higher share of non-U.S. earnings and ongoing evaluation of Pillar Two impacts is factually consistent. (2) The answer correctly notes that Pillar Two could increase Intel’s effective tax rate by limiting benefits from low-tax jurisdictions, which matches the original answer’s logic. The only minor deviation is the addition of the claim that Intel 'currently expects the effect to be limited given its modest exposure to jurisdictions with rates below the 15% floor'—this nuance is not present in the original answer and, while plausible, is not confirmed by the provided ground truth. (3) Multi-hop reasoning is sound: the model correctly links Salesforce identifying Pillar Two as a material tax development (context from CRM) to Intel’s exposure and evaluation (from INTC filings), synthesizing cross-company, cross-jurisdictional implications. (4) The answer is contextually relevant, directly addressing how Pillar Two could affect Intel’s effective tax rate given its non-U.S. income exposure. The slight overreach in asserting Intel’s expectation of limited impact prevents a perfect 10, but overall accuracy and reasoning are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 395,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does RTX's revenue recognition timing under FAR-regulated U.S. government fixed-price contracts compare to BA's exposure to termination risk in their U.S. government contracts, and what implications does this have for cash flow predictability?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to retained customer payments until contract completion, typically receiving performance-based payments (PBPs) or progress payments covering 80-90% of costs incurred. This creates contract assets on their balance sheet. In contrast, BA faces risks of contract termination at the convenience of the U.S. government, which could limit payments to work completed and allowable termination costs, or even result in liability for re-procurement costs if terminated for default. The FAR regulations that govern both companies' U.S. government contracts allow for interim payments but expose contractors to different financial risks—RTX to cash flow timing mismatches, and BA to potential revenue reversals or liabilities—making BA's cash flow more unpredictable despite similar regulatory frameworks.",
      "llm_answer": "Raytheon (RTX) records most of its defense work – which is subject to FAR‑regulated fixed‑price contracts – on a percentage‑of‑completion basis, so revenue is recognized as costs are incurred even though the government often retains a portion of the price until the contract is finished. This creates contract‑asset balances (revenue > billings) and means cash receipts can lag the recognized revenue, making cash‑flow timing less predictable. Boeing, by contrast, is exposed to the government’s right to terminate contracts for convenience or default; while it is usually paid for work already performed, a termination can abruptly stop future cash inflows, adding a separate source of cash‑flow uncertainty.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core financial distinctions between RTX and BA regarding revenue recognition and termination risk under FAR-regulated contracts. (1) It correctly identifies that RTX recognizes revenue on a percentage-of-completion basis, leading to revenue exceeding billings and creating contract assets—this aligns with the ground truth about retained payments and interim billing coverage (implied 80-90% via PBPs/progress payments). While the exact percentage range (80-90%) is omitted, the qualitative effect—cash lagging revenue—is accurately described. (2) No specific numbers (dates, dollar amounts) are present in either answer, so quantitative accuracy is fully preserved. (3) The reasoning correctly synthesizes multi-hop concepts: RTX’s accounting policy leads to timing mismatches in cash flow, while BA’s exposure to termination (for convenience or default) introduces uncertainty in future cash inflows. The implication for cash flow predictability—less predictable for both, but due to different mechanisms—is logically sound and consistent with the original answer. (4) The only minor omission is that the original answer specifies BA could face liabilities for re-procurement costs if terminated for default, which adds severity beyond just lost future revenue; this nuance is missing in the LLM response. However, mentioning termination for default does imply higher risk. Overall, the LLM captures the essential contrast and implications with high fidelity, warranting a 9/10 on correctness and qualitative accuracy. Contextual relevance is perfect—directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 448,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the $119 million in floating rate notes with put provisions due in 2025 disclosed by MMM compare to GE's $315 million investment in fixed and floating rate notes containing similar 2025 put options, considering both companies' exposure to near-term debt obligations?",
      "original_answer": "MMM discloses $119 million in floating rate notes with put provisions due in 2025, which are classified as current portion of long-term debt. GE holds $315 million in fixed and floating rate notes that also contain put options exercisable in 2025, despite contractual maturities occurring after 2025. Both companies are exposed to near-term liquidity risks tied to these put options, though GE’s exposure is more than 2.5 times larger than MMM’s. This indicates a significant potential cash outflow in 2025 for both companies depending on whether the put options are exercised.",
      "llm_answer": "MMM’s 2024 10‑K shows that the only debt that must be repaid in 2025 because of a put provision is $119 million of floating‑rate notes classified as the current portion of long‑term debt【page_69】. GE’s 2024 filing discloses that $315 million of its fixed‑ and floating‑rate notes carry 2025 put options, although the notes themselves do not mature until later dates【page_55】. Thus, GE’s potential 2025 cash‑out from the puts is roughly three times the amount that MMM actually has to refinance in 2025, giving GE a larger near‑term exposure, but the GE notes would only be called if holders exercise the puts, whereas MMM’s $119 million is already due.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: MMM's $119 million floating rate notes with 2025 put provisions classified as current portion of long-term debt, and GE's $315 million in fixed and floating rate notes with 2025 put options despite later contractual maturities. All dollar amounts ($119M, $315M), years (2025), and financial classifications are accurate and match the ground truth. (2) Quantitative accuracy is perfect: numbers are correct, and the comparison stating GE’s exposure is 'roughly three times' MMM’s is reasonable (315/119 ≈ 2.65), which rounds to 'roughly three times' in qualitative terms—this is acceptable semantic variation. The ground truth says 'more than 2.5 times,' so the LLM's approximation is within acceptable bounds. (3) Multi-hop reasoning is sound: the model correctly synthesizes data from both MMM and GE filings, compares their near-term liquidity risks due to put options, and distinguishes between contractual maturity and put option exercise. It adds a nuanced point not in the original answer—that MMM’s amount is already classified as due, while GE’s depends on holder exercise—which is a correct and insightful addition supported by the disclosures. (4) The only reason for not scoring a 10 is minor: the ground truth emphasizes that both companies face 'significant potential cash outflow' depending on exercise, while the LLM slightly overemphasizes certainty by saying MMM 'must be repaid'—though classified as current, repayment could still involve refinancing; however, this is a subtle distinction and not factually incorrect. Overall, the answer is factually accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 460,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the valuation methodology for exchange-traded commodity futures used by PEP compare to MDLZ's treatment of Level 1 financial assets, given both companies' reliance on daily market pricing for fair value determination?",
      "original_answer": "PEP excludes exchange-traded commodity futures from its fair value table because they are cash-settled daily, while MDLZ explicitly includes exchange-traded commodity futures as Level 1 financial assets, valued based on quoted market prices on commodity exchanges. Both companies rely on daily market pricing for fair value determination, but PEP focuses on the daily cash settlement mechanism as the reason for exclusion, whereas MDLZ emphasizes quoted market prices as the basis for Level 1 classification.",
      "llm_answer": "PepsiCo notes that its exchange‑traded commodity futures are cash‑settled each day, so their fair value is measured directly from the daily settlement price and they are excluded from the summary tables of fair‑value hierarchy items. Mondelez classifies the same type of instruments as Level 1 financial assets, valuing them at fair value using the quoted market prices on the commodity exchanges. Thus, both companies rely on the same daily market pricing to determine fair value, but PepsiCo simply omits those futures from its disclosed hierarchy tables, whereas Mondelez reports them explicitly as Level 1 assets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that PEP excludes exchange-traded commodity futures from its fair value hierarchy tables due to daily cash settlement, while MDLZ includes them as Level 1 assets based on quoted market prices—this matches the original answer exactly in substance. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct representation of non-numeric financial concepts, which is accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (PEP and MDLZ), their respective valuation methodologies, and the conceptual distinction in reporting despite shared reliance on daily market pricing. (4) The answer addresses all parts of the question: both companies’ use of daily market pricing, the difference in treatment (exclusion vs. inclusion in fair value hierarchy), and the rationale (cash settlement vs. quoted prices). Wording differs slightly but meaning is preserved. All entities (PEP, MDLZ, Level 1, exchange-traded commodity futures) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 343,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does Apple's revenue from the Greater China region, which includes Taiwan, compare to Intel's revenue specifically from Taiwan operations in 2022?",
      "original_answer": "Apple generated $74,200 million in net sales from the Greater China region in 2022, which includes Taiwan among other markets. In contrast, Intel reported $13,461 million in net revenue specifically from Taiwan operations during the same period. This indicates that Apple's revenue exposure through the Greater China segment, which encompasses Taiwan, is significantly higher than Intel's direct revenue from Taiwan.",
      "llm_answer": "Apple’s 2022 Greater‑China segment (which includes Taiwan) generated **about $74.2 billion** in net sales【page_52】.  \nIntel’s most recent disclosed revenue for its Taiwan operations was **$13.5 billion** (the 2021 figure shown in the 2022 Form 10‑K)【page_87】.  \n\nThus, Apple’s Greater‑China revenue is roughly **5‑½ times larger** than Intel’s revenue from Taiwan.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Apple's 2022 Greater China revenue as $74.2 billion (equivalent to $74,200 million in the ground truth), and Intel's Taiwan revenue as $13.5 billion, which is a rounded version of the ground truth $13,461 million. The use of 'about' and rounding to one decimal place is acceptable and common in financial reporting. (2) The calculation comparing Apple's revenue to Intel's (74.2 / 13.5 ≈ 5.5) is accurate, supporting the '5-½ times larger' claim. However, the LLM notes that Intel's figure is from 2021, citing the 2022 Form 10-K, which introduces a minor inaccuracy — the question specifically asks for 2022 data. While companies sometimes report regional revenues with delays, the ground truth states Intel's 2022 Taiwan revenue as $13,461 million, so the LLM should have used that. This is a small but notable deviation in temporal accuracy. (3) The multi-hop reasoning is sound: the model correctly distinguishes Apple's broader regional segment (Greater China including Taiwan) from Intel's country-specific revenue and synthesizes the comparison appropriately. (4) The answer is contextually complete and relevant, clearly addressing the comparative scope of revenue exposure. The only deduction is for the slight misrepresentation of Intel's data as 2021 instead of 2022, despite the ground truth providing 2022 figures, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 393,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the combined net property, plant, and equipment investment in the Americas by MMM compare to GD's revenue contribution from South America over the same geographic footprint, given that the Americas segment includes South America as part of its geographic definition?",
      "original_answer": "MMM reported $5,864 million in net property, plant, and equipment for the Americas in 2021, which includes South America. GD, in the same year, generated $234 million in revenue specifically from South America. This indicates that while GD's revenue from South America is relatively small, MMM has a significantly larger asset base tied to the broader Americas region, which encompasses South America.",
      "llm_answer": "3M’s 2021 net property‑plant‑and‑equipment (PP&E) for its Americas segment was reported at **$106 million** (the net PP&E figure shown in the 3M note on property, plant and equipment).  General Dynamics earned **$234 million** of revenue from South America in 2021 (the “South America” line in its geographic‑revenue table).  Thus, 3M’s combined PP&E investment in the Americas is **well below** General Dynamics’ South‑America revenue contribution.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in key numeric values. It reports 3M's net PP&E for the Americas as $106 million, whereas the ground truth from the knowledge graph states $5,864 million—a significant discrepancy. The revenue figure for General Dynamics ($234 million from South America) is correct and matches the original answer. (2) The calculation or comparison between the two figures is therefore flawed: the LLM concludes that 3M’s PP&E is 'well below' GD’s South America revenue, when in fact, $5,864 million (MMM) is vastly larger than $234 million (GD). This reverses the correct interpretation. (3) The multi-hop reasoning is partially sound in structure—comparing asset investment in a region to revenue from a subregion—but fails due to incorrect data retrieval for MMM. The model identifies the correct companies (MMM and GD), metric types (PP&E and revenue), geography (Americas including South America), and year (2021), showing some understanding of the required synthesis. (4) Despite correct identification of GD's revenue and the right year and concept, the severe inaccuracy in MMM’s PP&E value undermines the entire conclusion. The contextual relevance is moderate because the framework of the response aligns with the question, but factual correctness is critically compromised. Hence, low scores on correctness and quantitative accuracy; slightly higher on qualitative and contextual due to structural alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 404,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the use of sensitivity analyses by NFLX's auditor in evaluating content amortization assumptions compare to CMCSA's application of sensitivity analyses in managing interest rate risk exposure?",
      "original_answer": "NFLX's auditor performed sensitivity analyses to evaluate how changes in assumptions about viewing patterns could affect content amortization timing, which directly impacts financial reporting accuracy. In contrast, CMCSA uses sensitivity analyses as part of its interest rate risk management strategy to assess the potential impact of interest rate fluctuations on its debt portfolio, with derivative instruments reducing interest expense by $56 million in 2023. While both companies apply sensitivity analyses, NFLX uses it for accounting policy judgment, whereas CMCSA applies it for financial risk management.",
      "llm_answer": "Netflix’s auditor applied sensitivity analyses to the content‑amortization model, testing how alternative viewing‑hour assumptions would change the amount of amortization recorded. Comcast, by contrast, uses sensitivity analyses as a market‑risk tool to gauge how shifts in interest rates would affect the fair value and expense of its fixed‑ and variable‑rate debt and related interest‑rate‑swap derivatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core distinction between NFLX and CMCSA's use of sensitivity analyses. (1) It correctly identifies that NFLX's auditor used sensitivity analyses on content amortization assumptions related to viewing hours, and that CMCSA used sensitivity analyses to assess interest rate risk on debt and derivatives—matching the ground truth in substance. (2) There are no numeric inaccuracies; the LLM does not include the $56 million figure from CMCSA's derivative impact in 2023, which is present in the original answer. This is the only omission, but it does not distort the overall meaning or correctness of the comparison. (3) The multi-hop reasoning is sound: the model correctly synthesizes that NFLX applies sensitivity analysis in an accounting/auditing context (amortization policy), while CMCSA uses it for financial risk management (interest rate exposure), which is the key conceptual contrast. (4) The answer is contextually precise and directly responsive. The missing $56M detail slightly reduces completeness but does not affect the qualitative or quantitative core of the comparison. Hence, a score of 9 is warranted—excellent accuracy with a minor omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 339,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does PEP's use of exchange-traded commodity futures to manage risk compare with COST's disclosure regarding the absence of Level 1 financial liabilities, given that both companies report under the same fair value hierarchy framework?",
      "original_answer": "PEP actively uses exchange-traded commodity futures, which are cash-settled daily and excluded from the balance sheet as of December 25, 2021, to manage market risk, particularly in relation to deferred compensation liabilities. These instruments fall under Level 1 of the fair value hierarchy, which includes instruments valued using quoted market prices. In contrast, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different risk management approach with no direct use of such derivatives. This contrast highlights differing strategies in managing financial risk exposure under the same fair value reporting framework.",
      "llm_answer": "PepsiCo notes that it manages commodity‑price risk with exchange‑traded commodity futures, which are cash‑settled daily and therefore are not listed in its Level 1 fair‑value table but are used as active hedges (see PEP 10‑K p. 107). Costco, by contrast, explicitly states that it held no Level 1 (or Level 3) financial assets or liabilities measured at fair value on a recurring basis, indicating it does not rely on exchange‑traded instruments for risk management (see COST 10‑K p. 51). Thus, while both companies report under the same fair‑value hierarchy, PepsiCo employs Level 1 commodity futures as a risk‑management tool, whereas Costco reports the absence of any Level 1 financial liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All entities are correct: PEP and COST are accurately identified, with proper reference to their use (or non-use) of Level 1 financial instruments and exchange-traded commodity futures. The fair value hierarchy framework is correctly referenced. (2) Quantitative accuracy is strong: while no specific dollar amounts or percentages are cited, the key dates (December 25, 2021 for PEP and August 28, 2022 for COST in the original) are not mentioned in the LLM answer, which is a minor omission. However, the absence of these dates does not impair the factual correctness, as the focus is on the structural comparison of risk management approaches. (3) Multi-hop reasoning is sound: the model correctly synthesizes that both companies report under the same fair value hierarchy, yet differ in practice—PEP uses Level 1 instruments (exchange-traded commodity futures) for hedging, even if not always listed in the Level 1 table due to daily cash settlement, while COST reports no Level 1 or Level 3 financial assets/liabilities, implying no use of such derivatives. The LLM correctly infers differing risk management strategies. (4) Semantic equivalence is maintained: the LLM slightly rephrases the exclusion of PEP's futures from the balance sheet as 'not listed in its Level 1 fair-value table,' which is consistent with the original's 'excluded from the balance sheet.' This is a reasonable interpretation given daily cash settlement. The only minor shortcoming is the lack of explicit mention of deferred compensation liabilities as the risk being hedged by PEP, which is present in the original and adds context. Overall, the answer is factually correct, well-reasoned, and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 488,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the expiration timeline of U.S. patent protections for Enbrel, as detailed in Amgen's 2024 10-K, impact Merck's competitive positioning and Pfizer's international production strategy for the drug, especially considering Merck's stated exposure to biosimilar competition and pricing pressures?",
      "original_answer": "The U.S. patent protections for Enbrel expire in three key phases: fusion protein composition in November 2028, DNA encoding in April 2029, and formulations in October 2037. This staggered expiration timeline creates a gradual risk of biosimilar entry in the U.S., which could indirectly affect global pricing dynamics. Merck, which depends heavily on patent protection to maintain sales and profitability, faces intensified risk of generic competition following these expirations, compounding existing pricing pressures from government programs like the 340B Drug Discount Program. Meanwhile, Pfizer produces Enbrel outside the U.S. and Canada, meaning it will likely face competitive pressure from biosimilars in those international markets sooner than in the U.S., aligning with its broader specialty care portfolio strategy. Thus, the expiration of Enbrel’s U.S. patents affects Merck’s competitive positioning by increasing biosimilar risk and influences Pfizer’s international production strategy by accelerating exposure to generic competition outside the U.S.",
      "llm_answer": "Amgen’s 2024 10‑K shows that the key U.S. patents covering Enbrel (etanercept) do not expire until 11 Nov 2028, 24 Apr 2029 and, for the formulation patent, 19 Oct 2037 【page_11】. Because those patents keep Enbrel off the U.S. biosimilar market for another decade, Merck – which in its 2024 10‑K flags “exposure to biosimilar competition and pricing pressure” as a risk 【page_33】【page_35】 – is insulated from direct U.S. competition but remains vulnerable to biosimilar entry and price erosion in markets where Amgen’s protection is weaker. Consequently, Pfizer’s commercial structure lists Enbrel only “outside the U.S. and Canada” 【page_10】, indicating that its international production and sales strategy is deliberately focused on non‑U.S. territories where the Amgen patents do not block the drug, allowing Pfizer to capture revenue while Merck leans on its U.S.‑only advantage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key dates for U.S. patent expirations are correct: November 11, 2028 (fusion protein composition), April 24, 2029 (DNA encoding), and October 19, 2037 (formulation), matching the ground truth’s timeline with precise dates. These are minor formatting differences (e.g., '11 Nov 2028' vs 'November 2028') but semantically equivalent. (2) The answer correctly identifies Merck’s exposure to biosimilar competition and pricing pressures as stated in its 10-K, and accurately notes that Pfizer produces Enbrel outside the U.S. and Canada. (3) The multi-hop reasoning is sound: it connects Amgen’s U.S. patent protection timeline to Merck’s competitive positioning (insulated in U.S., vulnerable internationally) and links Pfizer’s international production strategy to the absence of U.S. patent barriers abroad. (4) The only minor shortcoming is that the LLM does not explicitly mention the 340B Drug Discount Program or the broader 'specialty care portfolio strategy' context for Pfizer, which slightly reduces completeness in qualitative synthesis. However, the core logic and all factual claims remain correct. Thus, the answer earns a 9/10 for correctness—excellent but not fully exhaustive in contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 360,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How does the $90 of unfunded commitments in private equity funds disclosed by EMR compare to the $2.7 billion of unfunded commitments to private equity and other limited partnerships reported by UPS, given both companies measure these investments at NAV?",
      "original_answer": "EMR reports $90 of unfunded commitments in private equity funds as of September 30, 2024, while UPS reports a significantly larger amount of $2.7 billion in unfunded commitments to private equity, private debt, and real estate limited partnerships as of December 31, 2024. Both companies disclose these commitments in the context of investments measured at NAV, indicating similar accounting treatment for these alternative assets despite the large difference in scale.",
      "llm_answer": "EMR reports that its private‑equity funds have roughly **$90 of unfunded commitments** (measured at NAV) as of September 30, 2024. In contrast, UPS reports **about $2.7 billion of unfunded commitments** to private‑equity and other limited‑partnership funds (also measured at NAV) as of December 31, 2024. Thus, UPS’s unfunded commitment is orders of magnitude larger—roughly 30,000 times the amount disclosed by EMR.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: EMR reports $90 of unfunded commitments in private equity funds as of September 30, 2024, and UPS reports $2.7 billion in unfunded commitments to private equity and other limited partnerships as of December 31, 2024. Both are measured at NAV, which is correctly noted. (2) Quantitative accuracy is excellent: the dollar amounts and dates match exactly, and the comparison—while phrased dramatically as '30,000 times'—is mathematically sound ($2.7 billion / $90 = 30,000,000 / 1,000 = 30,000). This is a valid calculation, though potentially misleading without context, but not factually incorrect. (3) Multi-hop reasoning is solid: the model correctly synthesizes data from two different companies, time periods, and disclosure contexts, and draws a valid comparative conclusion. (4) The only minor shortcoming is that the original answer notes UPS includes commitments to private debt and real estate LPs, not just private equity, while the LLM answer generalizes to 'other limited-partnership funds'—slightly less precise but still semantically acceptable. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 353,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "What percentage of PepsiCo's APAC segment revenue in 2024 came from beverages, and how does this compare to Mondelēz's total beverage revenue in 2024?",
      "original_answer": "In 2024, 23% of PepsiCo's APAC segment revenue came from beverages. Given that PepsiCo's APAC revenue was $10 million in 2024, this translates to $2.3 million from beverages. In comparison, Mondelēz reported total beverage revenue of $1,096 million in 2024, which is significantly higher than PepsiCo's beverage revenue in the APAC region.",
      "llm_answer": "PepsiCo’s APAC division generated **$4.845 billion** of net revenue in 2024, of which **23 %** (about **$1.1 billion**) came from beverages【page 72】【page 73】.  \n\nMondelēz International reported **total beverage revenue of roughly $5 billion for 2024**【MDLZ 10‑K pages 119‑123】—a larger absolute amount than PepsiCo’s APAC beverage sales, even though it represents a smaller proportion of Mondelēz’s overall revenue.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in key numbers. While it correctly states that 23% of PepsiCo's APAC segment revenue came from beverages, it reports PepsiCo's APAC revenue as $4.845 billion, which is vastly different from the ground truth value of $10 million. This leads to an incorrect beverage revenue calculation of $1.1 billion instead of $2.3 million. Similarly, Mondelēz's total beverage revenue is reported as $5 billion, whereas the ground truth is $1,096 million (~$1.1 billion), overestimating by more than 4x. (2) Quantitative accuracy is very low: the APAC revenue figure is off by orders of magnitude, and the derived beverage revenue ($1.1B vs $2.3M) is incorrect by a factor of nearly 500. Mondelēz's beverage revenue is also significantly overstated. (3) The qualitative reasoning is partially sound—multi-hop synthesis is attempted (comparing PepsiCo's regional beverage share to Mondelēz's total beverage revenue), and the direction of comparison (Mondelēz higher) is correct. However, the reasoning is based on fabricated or incorrect data. (4) Contextual relevance is moderate because the answer addresses the right companies, metric (beverage revenue), and year, and attempts the correct comparison. However, due to severe numerical inaccuracies, the overall correctness is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 373,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How does the volume of Capital One's (COF) delinquent loans as of December 31, 2023, influence the availability of reperforming loans that MetLife (MET) can purchase for its residential mortgage loan portfolio?",
      "original_answer": "Capital One reported total delinquent loans of $623 million as of December 31, 2023, which contributes to the pool of potentially reperforming loans. MetLife purchases reperforming loans that have returned to performing status after being delinquent for at least 12 months. The availability of such loans is directly influenced by the volume and characteristics of initial delinquencies, like those disclosed by Capital One, as these form the source pool for future reperforming loan opportunities.",
      "llm_answer": "Capital One reported $623 million of loans that were delinquent (30 days‑plus) as of December 31 2023 (Table 3.8, COF 10‑K). Those delinquent balances represent the pool from which “reperforming” loans can be created after borrowers are modified and return to current status, and MetLife’s residential‑mortgage portfolio relies on such re‑performing assets – it held about $2.6 billion of reperforming RMBS at year‑end 2023 (Table 98, MET 10‑K). Thus, the size of Capital One’s delinquent loan book directly limits the supply of re‑performing loans MetLife can acquire; a larger delinquent balance would expand MetLife’s potential source of re‑performing loans, while the $623 million figure indicates the current upstream availability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Capital One's delinquent loans as $623 million as of December 31, 2023, matching the ground truth. It accurately states that MetLife holds reperforming loans (citing $2.6 billion in reperforming RMBS), which aligns with the concept that MetLife purchases such loans for its residential mortgage portfolio. All numeric values are correct and properly attributed to the respective companies and filings. (2) Quantitative accuracy is perfect: $623 million in delinquent loans from COF and $2.6 billion in reperforming RMBS from MET are factually consistent with the knowledge graph. No calculations are required, but the causal link between delinquency volume and future reperforming supply is correctly framed. (3) The multi-hop reasoning is sound—connecting COF’s delinquent loans to the upstream pool for reperforming loans that MET can purchase. The explanation of how delinquencies evolve into reperforming status after modification is logically consistent with industry practice and the ground truth. The only minor gap is that the original answer emphasizes the 12-month delinquency threshold for reperforming status, which the LLM mentions implicitly ('return to current status') but not explicitly. This does not invalidate the reasoning but slightly reduces completeness in qualitative terms. (4) Contextual relevance is excellent—the answer directly addresses how COF's delinquency volume influences MET's loan acquisition opportunities, with proper synthesis across both companies’ 10-K disclosures. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only a minor omission in specificity regarding the 12-month criterion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 474,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How does the exposure of UNP's pension plan to limited partnerships investing in real estate compare with UPS's unfunded commitments to similar structures, given both companies' reliance on NAV-based valuations for these illiquid assets?",
      "original_answer": "UNP's pension plan holds interests in limited partnerships that primarily invest in privately-held companies and reports these using NAV-based valuations, while UPS has unfunded commitments totaling approximately $3.3 billion to limited partnerships focused on private equity, private debt, and real estate funds. Both companies rely on NAV as a practical expedient for valuing these illiquid investments, with UPS specifically noting the limited redemption provisions until the end of the partnership terms, typically 10 to 15 years from inception. This indicates that both firms face similar challenges in liquidity and valuation transparency for these alternative investments.",
      "llm_answer": "Union Pacific’s pension‑plan assets are valued at NAV, but the master trust’s only “future‑contribution” exposure to private‑equity and real‑estate limited partnerships is modest – about $80 million for private‑equity partnerships and $5 million for real‑estate partnerships (≈ $85 million total) 【page_58】.  United Parcel Service also values its limited‑partnership interests at NAV, yet it reports unfunded commitments of roughly $3.3 billion to those same types of private‑equity and real‑estate structures 【page_89】.  Consequently, UPS’s unfunded NAV‑based exposure is orders of magnitude larger than the relatively small commitment exposure in Union Pacific’s pension plan.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims about UNP's exposure. The original answer (ground truth) states that UNP's pension plan holds interests in limited partnerships using NAV-based valuations but does not specify any dollar amount for unfunded commitments. In contrast, the LLM claims UNP has $80 million for private equity and $5 million for real estate in 'future-contribution' exposure, totaling $85 million — figures not present in the ground truth and potentially misattributed or hallucinated. This severely undermines quantitative accuracy. While the LLM correctly reports UPS's $3.3 billion in unfunded commitments and both companies' use of NAV as a practical expedient for illiquid assets, it incorrectly frames UNP’s exposure as quantified future commitments when the ground truth only describes holdings, not commitments. The reasoning is partially sound in comparing NAV reliance and illiquidity, but fails on the core multi-hop synthesis: the ground truth does not support a direct numerical comparison because it does not provide UNP's unfunded commitment data. The LLM invents specific figures unsupported by the source, breaking factual integrity. Contextually, the response is relevant and addresses valuation methods and liquidity challenges, but the erroneous attribution of $85 million in commitments to UNP distorts the comparison. Semantic equivalence fails on key financial data. Thus, while some elements (UPS number, NAV usage) are correct, the central comparative claim is based on fabricated data, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 441,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does AMD's reliance on third-party manufacturers for 7 nm and smaller node production impact its exposure to quality control risks compared to Cisco's approach of maintaining quality control through automated testing and ISO 9001-certified processes?",
      "original_answer": "AMD's reliance on third-party manufacturers like TSMC for 7 nm and smaller node production exposes it to risks related to manufacturing yields, delivery schedules, and quality assurance, as these manufacturers are responsible for implementing leading-edge process technologies and maintaining acceptable yields. In contrast, Cisco maintains quality control internally through automated testing equipment, burn-in procedures, and ISO 9001-certified manufacturing processes, which are designed to ensure product reliability and reduce variability. This difference suggests that AMD has less direct control over quality assurance in its supply chain compared to Cisco, which integrates quality control directly into its manufacturing procedures.",
      "llm_answer": "AMD’s most advanced products (7 nm and smaller) are fabricated by external foundries such as TSMC, UMC and GlobalFoundries, and the filing notes that this dependence gives AMD “limited control over … yield, … quality‑assurance” and that any manufacturing inefficiencies or low yields could delay shipments or raise costs (see AMD pages 23‑25). Cisco, by contrast, builds its hardware through contract manufacturers that follow “automated testing equipment and burn‑in procedures, … comprehensive inspection, testing, and statistical process controls” and are “generally certified to ISO 9001 standards” (see Cisco page 9), giving it direct oversight of quality and reducing exposure to the kind of quality‑control risks that AMD faces.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies AMD's reliance on third-party foundries (TSMC, UMC, GlobalFoundries) for 7 nm and smaller nodes and accurately cites the associated risks—limited control over yield and quality assurance—with direct reference to AMD’s filing (pages 23–25). It also correctly characterizes Cisco’s quality control approach using automated testing, burn-in procedures, inspection, and ISO 9001 certification, citing Cisco’s page 9. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable in a traditional sense, but all referenced details (page numbers, standards) are correct and consistent with the source material. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two different companies’ filings to contrast their supply chain and quality control strategies. The conclusion that AMD has less direct control compared to Cisco is logically supported. (4) The only minor shortcoming is that the LLM slightly overstates AMD’s use of multiple foundries—while UMC and GlobalFoundries are mentioned in AMD’s filings, TSMC is the primary manufacturer for 7 nm and below; however, this does not materially distort the core risk assessment. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 408,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's structure of Class C Capital Stock, which also carries no voting rights, particularly in terms of how each company manages governance influence versus financial exposure?",
      "original_answer": "Comcast does not have voting rights or the power to direct the activities of Atairos, which is classified as a VIE, and therefore does not consolidate it, limiting its governance influence while still being exposed to financial risk up to its investment balance and remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet issues Class C Capital Stock, which carries no voting rights except as required by law, but the company actively manages these shares through large-scale repurchases—$62.0 billion in 2024—allowing it to maintain governance control through Class A and B shares while offering different voting structures to investors. Both entities separate voting rights from certain stakeholders, but Alphabet retains control through its dual-class share structure, whereas Comcast has no such governance influence over Atairos despite significant financial exposure.",
      "llm_answer": "Comcast’s stake in Atairos gives it **no voting power or ability to direct the VIE’s operations** – it is treated as an equity‑method investment and its maximum loss is limited to the $5.1 billion carrying amount plus the $1.4 billion of unfunded capital commitments (its economic exposure is therefore capped). Alphabet’s Class C capital stock also carries **no voting rights**, but Class C shareholders retain the full economic rights of ordinary equity – they share in all earnings, dividends and price appreciation and therefore bear the company’s entire market‑risk exposure. In short, both entities lack governance influence, but Comcast’s financial exposure is limited to a fixed investment amount, whereas Alphabet’s Class C holders face unrestricted financial exposure tied to the company’s overall performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core contrast in governance and financial exposure between Comcast's relationship with Atairos and Alphabet's Class C stock structure, making it contextually relevant and conceptually sound in framing the comparison. However, there are significant factual inaccuracies affecting correctness. First, the LLM states Comcast's carrying amount in Atairos is $5.1 billion, but the ground truth does not specify this number—only the $1.4 billion unfunded commitment as of December 31, 2024, is confirmed. This $5.1 billion figure is unsupported and likely incorrect, undermining quantitative accuracy. Second, while the ground truth emphasizes that Alphabet actively manages governance via repurchases ($62.0 billion in 2024) to maintain control through Class A/B shares, the LLM omits this key strategic mechanism entirely, instead focusing on the economic exposure of Class C shareholders without addressing Alphabet’s active capital management. This weakens the qualitative accuracy, as it misses a critical multi-hop insight: Alphabet uses repurchases to preserve founder control, whereas Comcast has no such influence over Atairos. The LLM correctly notes both lack voting rights and contrasts limited financial exposure (Comcast) vs. full market risk (Alphabet), which supports partial credit. Entity accuracy (Comcast, Atairos, Alphabet, Class C stock, VIE, equity method) and general reasoning are sound, and the answer addresses the governance vs. financial exposure framework. However, due to the unsupported $5.1 billion figure and omission of Alphabet’s $62.0 billion repurchase activity and dual-class control strategy, the answer is only partially correct despite strong structural reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 468,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does Coca-Cola HBC's distribution footprint in Austria compare with Philip Morris's market presence in the same country, based on their respective operational disclosures?",
      "original_answer": "Coca-Cola HBC, as a key bottler for The Coca-Cola Company, operates in Austria and contributes to 41% of Coca-Cola’s total worldwide unit case volume through its five largest bottlers. Meanwhile, Philip Morris reports a market share of at least 15% in Austria, as part of its presence across approximately 100 markets globally. Both companies maintain a direct or dedicated distribution presence in Austria, with Coca-Cola HBC managing bottling and distribution of beverages, and Philip Morris leveraging its exclusive zonified and direct distribution strategies to maintain its competitive market position.",
      "llm_answer": "Coca‑Cola HBC AG includes Austria in the list of countries where it operates bottling and distribution facilities, confirming a direct operational footprint in that market. Philip Morris International states that Austria is one of the roughly 100 markets in which it holds a market share of at least 15%, indicating a significant but comparatively modest presence in the country’s tobacco market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitative accuracy: The key numbers—Austria being one of ~100 markets for Philip Morris and its market share of at least 15%—are correctly reported. While the ground truth mentions Coca-Cola HBC’s contribution to 41% of Coca-Cola’s global unit case volume via its top five bottlers, this specific figure is not attributed solely to Austria in the original, so its omission in the LLM answer does not constitute an error. The LLM correctly avoids misattributing that 41% to Austria specifically. (2) Completeness: The LLM confirms both companies' presence in Austria—Coca-Cola HBC via operational bottling and distribution, Philip Morris via market share and geographic reach. It captures the core comparison requested: operational footprint vs. market presence. The only minor omission is not explicitly stating that both have a 'direct' distribution model, though 'direct operational footprint' for Coca-Cola HBC and 'exclusive zonified and direct distribution' are implied in context. (3) Entity accuracy: Both companies are correctly identified, and the metrics (market share, number of markets) are properly assigned. (4) Reasoning: The multi-hop synthesis—linking Coca-Cola HBC’s operations in Austria to its role as a bottler and Philip Morris’s market share to its broader global footprint—is sound and logically presented. (5) Semantic equivalence: The LLM conveys the same essential information as the original answer, with slightly more concise wording but no loss of factual integrity. The answer is contextually relevant and directly addresses the comparative scope of distribution and market presence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 460,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does the deterioration in BAC's commercial real estate credit quality, particularly in office properties, influence MET's use of the Bornhuetter-Ferguson Method and its annual updates to unpaid claims assumptions for Protection Life and Health products?",
      "original_answer": "BAC experienced a deterioration in commercial credit quality during 2023, especially in the commercial real estate office property type, due to stagnant office space demand and evolving employment models (BAC chunk). MET updates its unpaid claims assumptions annually to reflect emerging trends in claim experience, including macroeconomic conditions (MET chunk). MET uses the Bornhuetter-Ferguson Method to estimate unpaid claims for Protection Life and Health products, relying on historical claims data and expected loss ratios, which are sensitive to economic shifts (Hop2 chunk). Therefore, a worsening macroeconomic environment—such as declining commercial real estate values and increased defaults in office properties—could affect MET’s claims estimation by altering expected loss ratios, particularly for long-duration Protection Health claims or experience-rated contracts where adverse claim experience is passed to sponsors (MET chunk). This creates a multi-hop chain where BAC's credit quality trends serve as an early indicator of macroeconomic deterioration that MET must incorporate into its actuarial models.",
      "llm_answer": "Bank of America’s 2023 commercial‑real‑estate slide – driven mainly by higher non‑performing office loans – is a credit‑risk issue that is confined to its banking portfolio. MetLife’s IBNR calculations for its Protection Life and Protection Health lines are based on the Bornhuetter‑Ferguson method, using factors derived from MetLife’s own historical claim experience and are refreshed each year to reflect emerging claim‑development trends. Therefore, the deterioration in BAC’s office‑property credit quality does not directly alter MetLife’s methodology or its annual assumption updates; MetLife’s assumptions are driven by its own claim data, not by external bank credit‑quality developments.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core conclusion. While it correctly identifies that MetLife (MET) uses the Bornhuetter-Ferguson method for estimating unpaid claims (IBNR) for Protection Life and Health products and updates assumptions annually, it incorrectly asserts that BAC's commercial real estate credit deterioration has no influence on MET’s actuarial assumptions. The ground truth establishes a multi-hop causal chain: BAC’s credit quality deterioration in office properties during 2023 reflects broader macroeconomic stress (e.g., declining demand for office space, shifting work models), which serves as an early indicator of economic trends that MET must incorporate into its actuarial models. MET explicitly considers macroeconomic conditions when updating expected loss ratios, which are inputs to the Bornhuetter-Ferguson method. Thus, while MET does rely on its own historical data, those assumptions are not isolated from external economic indicators like commercial real estate performance. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is flawed: the LLM fails to connect BAC’s credit trends → macroeconomic deterioration → impact on MET’s expected loss ratios → effect on Bornhuetter-Ferguson estimates. Instead, it breaks the chain prematurely by claiming no connection exists, contradicting the documented sensitivity of MET’s models to macro trends. (4) Correctness is low (3/10) because the central claim is wrong; qualitative accuracy is also low due to faulty reasoning; contextual relevance is moderate because the answer discusses the right companies and methods but draws an incorrect inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 484,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the voting rights structure of Netflix's common stock compare to Meta's, considering the influence of Class A Common Stock in both companies' governance frameworks?",
      "original_answer": "Netflix's common stockholders are entitled to one vote per share, creating a uniform voting rights structure. In contrast, Meta's Class A Common Stock also provides one vote per share, but Meta has a multi-tiered stock structure that includes Class B Common Stock with 10 votes per share, giving certain shareholders disproportionate voting power. This difference means that while both companies grant one vote per share for Class A Common Stock, Meta's governance framework allows for greater concentration of control through its Class B shares.",
      "llm_answer": "Netflix’s capital structure is single‑class – every share of its common stock carries **one vote per share** (see Netflix 10‑K, “Voting Rights” page 60). By contrast, Meta operates a dual‑class system: the filing lists both **Class A and Class B common stock** (Meta 10‑K, page 1), and the company’s charter gives **Class A shares one vote each while Class B shares carry ten votes per share**, concentrating control in the holders of Class B stock. Thus, Netflix’s shareholders all have equal voting power, whereas Meta’s Class A shareholders have relatively limited influence compared with the higher‑voting Class B holders.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) It correctly states that Netflix has a single class of common stock with one vote per share, while Meta has a dual-class structure where Class A shares have one vote and Class B shares have ten votes per share—this matches the original answer exactly in substance. (2) All quantitative elements are correct: 'one vote per share' for Netflix and Meta's Class A, 'ten votes per share' for Meta's Class B—no calculations are required, but the comparison of voting power is accurately presented. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance structures across two different companies (Netflix and Meta), identifies the structural implications of their stock classes, and draws the valid conclusion that Meta’s framework concentrates control, unlike Netflix’s uniform voting system. (4) The answer is semantically equivalent to the original, with slightly more detailed phrasing (e.g., mentioning 'concentrating control') that enhances clarity without introducing error. All entities (Netflix, Meta, Class A and Class B common stock) are correctly identified, and the response directly addresses the comparative aspect of the question regarding voting rights and governance influence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 361,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the fair value treatment of exchange-traded commodity futures under Level 1 financial liabilities differ between PEP and MDLZ, given that both companies cash-settle these instruments and include them in their respective liability portfolios?",
      "original_answer": "PEP explicitly states that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the fair value hierarchy table as of December 25, 2021. In contrast, MDLZ includes exchange-traded commodity futures in its Level 1 financial liabilities, with fair value determined based on quoted market prices on commodity exchanges. Both companies treat these futures as part of their Level 1 liabilities, but PEP excludes them from reported tables due to daily cash settlement, whereas MDLZ continues to report them based on market pricing as of the balance sheet date.",
      "llm_answer": "PepsiCo says that its exchange‑traded commodity futures are cash‑settled each day, so the resulting liability never exists on the balance sheet at period‑end and the contracts are omitted from the fair‑value hierarchy table (they are not reported as a Level 1 liability). Mondelez, by contrast, classifies exchange‑traded commodity futures as Level 1 financial liabilities, measuring them at quoted market prices on the commodity exchanges and reporting their fair value in the Level 1 column of its derivative‑fair‑value tables.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the key distinction between PEP and MDLZ in their treatment of exchange-traded commodity futures within the fair value hierarchy. (1) There are no numeric values (e.g., dollar amounts, percentages, dates) in the original or LLM answer beyond the reference to December 25, 2021, in the ground truth, which the LLM omits. However, this date is contextually relevant but not central to the conceptual comparison, and its absence does not impair factual correctness—thus, quantitative accuracy remains high. (2) The LLM correctly identifies both companies (PEP and MDLZ), the financial instrument (exchange-traded commodity futures), the valuation level (Level 1), and the impact of daily cash settlement on balance sheet recognition. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies use Level 1 pricing (quoted market prices), but differ in reporting due to PEP's exclusion from fair value tables owing to daily cash settlement, while MDLZ includes them. (4) The semantic meaning fully aligns with the ground truth—PEP excludes from Level 1 tables due to settlement mechanics, while MDLZ reports them in Level 1 based on market prices. The only minor shortcoming is the omission of the specific date (December 25, 2021), which slightly reduces qualitative completeness but does not affect the correctness of the conceptual explanation. Hence, a score of 9 is warranted for both correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 429,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How do the cost-sharing arrangements between Merck and Gilead for the development of HIV treatments combining islatravir and lenacapavir compare to Pfizer's cost-reduction initiatives, and what implications might this have on each company's financial exposure in long-acting HIV therapies?",
      "original_answer": "Merck and Gilead share global development and commercialization costs for HIV treatments combining islatravir and lenacapavir at a 60/40 split (Gilead/Merck), with equal revenue sharing until certain thresholds are met ($2.0 billion for oral and $3.5 billion for injectable combinations), after which Gilead's revenue share increases. In contrast, Pfizer's 2024 filing highlights enterprise-wide cost realignment and manufacturing optimization programs aimed at reducing costs and improving productivity. These initiatives carry risks such as potential disruption of ongoing business, including impacts on the delivery of their pipeline, which could include HIV-related R&D. While Merck and Gilead are jointly investing in a high-potential, long-acting HIV therapy with shared financial exposure, Pfizer is focusing on internal cost controls that may affect its ability to invest in or compete with such collaborative models. This contrast suggests differing strategic approaches to managing financial exposure in the evolving HIV treatment landscape.",
      "llm_answer": "Gilead’s agreement with Merck splits the development‑and‑commercialization bill for the long‑acting islatravir/lenacapavir combo 60 % to Gilead and 40 % to Merck, with each company also sharing product‑revenue (initially 50‑50, rising to 65 % for the higher‑selling partner once sales cross set thresholds) 【page_74】. In contrast, Pfizer’s 2024 filing describes only internal cost‑reduction programmes—an enterprise‑wide cost‑realignment and manufacturing‑optimization effort—that lower its own expense base rather than sharing costs with a partner 【page_30】. Thus, Gilead and Merck retain proportional financial exposure to the HIV programme (and upside from revenue splits), whereas Pfizer seeks to shrink overall cost exposure across its business, limiting the amount of capital it must commit to any single long‑acting HIV project.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, it correctly states the 60/40 cost split (Gilead/Merck) and the 50-50 initial revenue sharing, with a note that the higher-selling partner's share increases after thresholds—this matches the ground truth, though it omits the specific thresholds of $2.0 billion (oral) and $3.5 billion (injectable). This omission is minor given the focus on financial exposure and strategic comparison. (2) The characterization of Pfizer’s initiatives as internal cost-reduction and manufacturing optimization programs from its 2024 filing is accurate and contextually appropriate. (3) The multi-hop reasoning is sound: the model correctly contrasts a collaborative, shared-exposure model (Merck/Gilead) with a unilateral cost-control strategy (Pfizer), drawing a logical implication about differing financial exposure in long-acting HIV therapies. (4) Entity accuracy is strong—correct companies, correct drug names (islatravir/lenacapavir), and correct framing of revenue and cost structures. The only minor shortcoming is the lack of explicit dollar thresholds for revenue-sharing changes, which slightly reduces quantitative completeness but does not undermine the overall correctness. Wording differences (e.g., 'higher-selling partner' vs. specifying Gilead’s increased share) are semantically acceptable. The answer is contextually excellent, directly addressing the comparison and its financial implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 410,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does FDX's exposure to LIBOR-related hedging adjustments under ASU 2022-06 compare to UPS's use of hedging relationships, particularly in light of ASU 2022-06's extended sunset date through 2024?",
      "original_answer": "FDX has stated that reference rate reform, including ASU 2022-06, has had no material effect on its financial condition or results of operations as of May 31, 2024, though it continues to monitor contracts for potential application of the standard. ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform—including LIBOR transitions—to December 31, 2024. UPS, which designates derivative instruments in hedging relationships, including cash flow and fair value hedges, may benefit from the extended relief under ASU 2022-06 to manage LIBOR-related contracts through 2024 without significant accounting disruptions. Therefore, while FDX has not seen material impacts, UPS could be actively leveraging the extended ASU 2022-06 provisions in its hedging strategies.",
      "llm_answer": "FedEx notes that, although it has applied the optional expedients of ASU 2022‑06 to contracts and hedges that reference LIBOR, the change “has had no material effect on our financial condition, results of operations or cash flows” as of the May 31 2024 reporting date (FedEx 10‑K p. 93). UPS, by contrast, describes a broader set of designated derivative instruments that it classifies as cash‑flow, fair‑value or net‑investment hedges (UPS 10‑K p. 73), but it does not disclose any specific LIBOR‑related adjustment; the extended sunset provision of ASU 2022‑06 (effective through Dec 31 2024 per UPS 10‑K p. 74) simply allows UPS to continue applying the same optional relief on any such hedges through 2024. Thus, FedEx’s exposure is essentially immaterial, whereas UPS maintains active hedging relationships that could benefit from the extended sunset date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: FDX (FedEx) reports no material effect from ASU 2022-06 as of May 31, 2024, and continues to monitor its contracts; the sunset date for ASU 2022-06 is correctly stated as December 31, 2024. UPS’s use of cash flow, fair value, and net investment hedges is accurately described, and it does not disclose specific LIBOR-related adjustments. (2) Quantitative accuracy is perfect: dates (May 31, 2024; December 31, 2024) match the original answer and are cited correctly from the 10-Ks. No numerical calculations are required, but the temporal and regulatory details are precise. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (FDX and UPS), applies the context of ASU 2022-06, and contrasts FDX’s immaterial exposure with UPS’s potential benefit from extended relief due to its active hedging relationships. (4) The only minor shortcoming is a slight omission in not explicitly stating that UPS 'may benefit' from the extended relief—the LLM says the extension 'allows UPS to continue applying the same optional relief,' which is factually correct but slightly less forward-looking than the original’s 'could be actively leveraging.' However, this does not distort the meaning. Wording differences are acceptable under semantic equivalence. Overall, the answer is factually robust, well-sourced, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 406,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the dual-class stock structure's impact on investor protections at META compare to the voting power differential in GOOGL's Class B common stock, especially given that Class B shares automatically convert to Class A upon sale or transfer?",
      "original_answer": "META's dual-class structure allows its controlling stockholder to maintain decision-making power even if they own significantly less than a majority of shares, which could make Class A common stock less attractive to investors due to reduced governance protections. In contrast, GOOGL's Class B common stock provides 10 votes per share compared to 1 vote per share for Class A, but these Class B shares automatically convert to Class A upon sale or transfer, potentially limiting long-term control by insiders. This conversion mechanism in GOOGL may offer more eventual governance balance compared to META's structure, where Class B shares can maintain control for extended periods unless their voting power drops below 35% of the combined voting power.",
      "llm_answer": "Meta’s dual‑class system gives the founder and a small group of insiders ten votes per Class B share while ordinary shareholders have only one vote per Class A share, and the company’s charter and Delaware anti‑takeover provisions let the Class B holders retain decisive control even when they own a relatively small percentage of the total equity (Meta 10‑K p. 49‑50). In contrast, Alphabet’s Class B shares also carry ten votes per share, but the charter requires that any Class B share automatically convert to a one‑vote Class A share when it is sold or transferred, which gradually erodes the voting‑power concentration and provides a modest safeguard for other investors (Alphabet 10‑K p. 81). Thus, Meta’s structure markedly limits investor influence, whereas Alphabet’s automatic‑conversion feature tempers the voting‑power differential and offers comparatively stronger protections for non‑controlling shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: both Meta and Alphabet (GOOGL) have Class B shares with 10 votes per share versus 1 vote for Class A, and the automatic conversion of GOOGL's Class B shares upon sale or transfer is correctly stated. These details match the original answer and are consistent with the cited 10-K references (Meta p.49-50, Alphabet p.81). (2) The answer is complete, addressing both the structural differences in voting rights and the implications for investor protections. It correctly contrasts Meta’s enduring control mechanism with Alphabet’s erosion of control via conversion, which addresses the core of the multi-hop comparison. (3) The reasoning is sound: it logically infers that Meta’s structure limits investor influence more severely than Alphabet’s, due to the lack of mandatory conversion, which is consistent with the ground truth’s conclusion about long-term control and governance balance. (4) The only minor shortcoming is that the LLM does not explicitly mention Meta’s 35% combined voting power threshold, beyond which Class B shares might lose super-voting status—a detail present in the original answer. However, this omission does not undermine the overall correctness, as the central contrast (enduring vs. eroding control) is accurately conveyed. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 427,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does KO's use of option contracts to hedge forecasted transactions compare to MDLZ's disclosure of gains and losses on forecasted transactions in terms of financial impact and hedging strategy?",
      "original_answer": "KO utilizes option contracts as part of its broader hedging strategy to mitigate foreign currency exchange rate risk, commodity price risk, and interest rate risk, with the goal of reducing earnings volatility from market fluctuations. These contracts are designated as cash flow hedges, and the unrealized gains or losses are deferred in AOCI until the forecasted transactions occur. In contrast, MDLZ disclosed that in 2024, it recognized $106 million in gains on forecasted transactions through cost of sales, and $17 million through interest and other expense, net, indicating the financial impact of these hedging activities on specific income statement line items. While KO emphasizes a structured hedging approach with clear accounting treatment for deferred gains/losses, MDLZ provides more granular disclosure on the realized financial outcomes of its hedging activities on forecasted transactions.",
      "llm_answer": "The Coca‑Cola Company hedges its forecast‑transaction exposure with foreign‑currency forward contracts, options and collars that are formally designated as cash‑flow hedges; the fair‑value changes are first recorded in other‑comprehensive income and later re‑classified into earnings, and the program covered roughly $9.2 billion of notional exposure at year‑end 2024. In contrast, Mondelēz International treats its “economic hedges” on forecasted transactions as ordinary earnings items – the 2024 pre‑tax results show gains of $106 million (cost of sales), $17 million (interest) and a $8 million loss (SG&A) that are recognized directly in the income statement rather than being deferred in AOCI. Thus KO’s strategy postpones the financial impact via AOCI, whereas MDLZ’s approach reflects the hedge gains and losses immediately in earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the LLM correctly states MDLZ's 2024 gains of $106 million in cost of sales and $17 million in interest and other expense, matching the original answer. However, it introduces an additional $8 million loss in SG&A not present in the original answer, which may be an extraneous detail or misattribution. The $9.2 billion notional exposure for KO is not mentioned in the original answer, so its accuracy cannot be verified from the provided ground truth, but it does not contradict it. (2) The core financial figures from the original answer (MDLZ’s $106M and $17M) are correctly reported. (3) Qualitatively, the LLM accurately contrasts KO’s use of cash flow hedges with deferral in AOCI versus MDLZ’s immediate recognition in earnings, capturing the key difference in hedging strategy and financial impact. It correctly identifies KO’s use of options (and other instruments) and MDLZ’s economic hedges treated in earnings. (4) The reasoning is sound, synthesizing multi-hop information across both companies’ hedging disclosures and accounting treatments. The only minor issues are the unverified $9.2B notional amount and the extra $8M loss, which slightly affect quantitative accuracy but do not undermine the overall correctness. The answer is fully contextually relevant, directly addressing the comparison of financial impact and hedging strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 398,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the valuation approach for TMO's fixed income funds, which are reported as 'not subject to leveling', contrast with BMY's classification of fixed income funds under Level 2 in the fair value hierarchy, and what does this indicate about their respective reliance on observable market data for pension asset valuation?",
      "original_answer": "TMO reports its fixed income funds as 'not subject to leveling,' indicating that these assets are valued outside the standard fair value hierarchy and likely measured using methods other than quoted market prices or observable inputs. In contrast, BMY classifies its fixed income funds under Level 2, which means their valuation relies on observable market data, such as quoted prices for similar instruments or in nonactive markets. This contrast suggests that BMY's pension assets have a more structured and market-based valuation methodology for fixed income funds, while TMO's approach implies less direct reliance on standardized market inputs for these assets.",
      "llm_answer": "Thermo Fisher (TMO) reports its fixed‑income funds in the “not subject to leveling” column, meaning the funds are valued using a practical‑expedient NAV rather than being placed in the fair‑value hierarchy.  By contrast, Bristol‑Myers Squibb (BMY) classifies its fixed‑income funds as Level 2 assets, valuing them at the funds’ NAV but using observable market inputs (prices of similar securities, quoted yields, etc.).  Thus TMO’s pension‑asset valuation relies less on observable market data, whereas BMY’s valuation depends more heavily on such observable inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: TMO's fixed income funds are reported as 'not subject to leveling,' meaning they use the practical expedient of NAV (Net Asset Value) under ASC 820, which places them outside the fair value hierarchy. BMY classifies its fixed income funds as Level 2, indicating use of observable market inputs such as quoted prices for similar assets, yields, and other market-based data. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the absence of any incorrect numbers or misstatements earns a perfect score by default. (3) The multi-hop reasoning is sound: the model correctly contrasts two companies' pension asset valuation methodologies, links 'not subject to leveling' to exclusion from the fair value hierarchy, and connects Level 2 classification to reliance on observable inputs. (4) The only minor shortcoming is that the LLM slightly simplifies the implication by stating BMY values assets 'at the funds’ NAV' using observable inputs—while NAV may be used, Level 2 classification specifically means the NAV is derived from observable market data, which is implied but could be more precisely articulated. Still, this does not distort the meaning. Overall, the answer is semantically equivalent, contextually relevant, and factually correct with only negligible room for refinement.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 417,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How does the application of the Federal Acquisition Regulation (FAR) in cost-plus-fixed-fee contracts impact revenue recognition timing differences between LMT and BA for their respective U.S. Government contracts?",
      "original_answer": "LMT applies FAR to its U.S. Government contracts, which results in standalone selling prices being equal to the stated contract price, and revenue being recognized over time as control of work in process transfers continuously to the customer due to clauses allowing unilateral termination and payment for costs incurred plus profit. Similarly, BA notes that U.S. Government contracts can be terminated for convenience, entitling them to payment for completed work and allowable termination costs. This creates a comparable revenue recognition pattern for both companies under FAR-regulated cost-plus-fixed-fee contracts, where revenue is recognized progressively rather than at a point in time, but differences may arise based on contract-specific termination clauses and profit margin negotiations.",
      "llm_answer": "Lockheed Martin explains that its U.S.‑government cost‑plus‑fixed‑fee (CPFF) contracts are governed by the Federal Acquisition Regulation (FAR).  Because the FAR requires the price to be “estimated or actual costs plus a reasonable profit margin,” Lockheed Martin measures progress with a cost‑to‑cost percentage‑of‑completion method and recognizes revenue **as work is performed** (i.e., before the customer’s billings are received) and records any excess billings as a contract liability 【page_77】.  This creates a timing gap between when costs are incurred (and revenue is booked) and when cash is collected.\n\nBoeing’s 2022 filing merely notes that its U.S.‑government contracts can be terminated for convenience and that it would be paid for work performed, but it does **not** describe a FAR‑driven cost‑to‑completion or CPFF revenue‑recognition approach.  Consequently, Boeing’s revenue on government contracts is presented as being recognized when control passes or milestones are met, without the explicit early‑recognition timing effect that Lockheed Martin attributes to the FAR‑mandated CPFF accounting. 【page_7】",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. Contextual relevance is high because the response addresses the core topic of revenue recognition under FAR for CPFF contracts at LMT and BA. However, the qualitative accuracy is low due to significant factual and reasoning errors in synthesizing the ground truth. The original answer states that both LMT and BA have comparable revenue recognition patterns due to FAR's termination for convenience clauses, which allow payment for costs incurred plus profit, enabling progressive revenue recognition. The LLM incorrectly asserts that Boeing does not apply a FAR-driven cost-to-completion method and implies a different revenue recognition pattern, contradicting the ground truth that BA also recognizes revenue progressively under similar contractual terms. While LMT's use of cost-to-cost percentage-of-completion is correctly described, the contrast with Boeing is factually inaccurate—the original answer emphasizes similarity, not difference, in recognition patterns due to shared FAR provisions. The LLM fails in multi-hop reasoning by not recognizing that termination for convenience with payment for costs plus profit inherently supports over-time revenue recognition under ASC 606, even if not explicitly labeled as cost-to-cost. This leads to an incorrect conclusion about timing differences, when the ground truth indicates only minor variations due to contract-specific clauses, not a fundamental methodological divergence. Thus, despite correct terminology and citation, the core comparative analysis is flawed, warranting a mid-range correctness score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 465,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How does the structure of AbbVie's debt agreements with U.S. Bank National Association compare to Abbott Laboratories' use of Abbott Ireland Financing DAC as an issuer, particularly in terms of trustee roles and note issuance timelines?",
      "original_answer": "AbbVie has multiple Supplemental Indentures with U.S. Bank National Association serving as trustee, transfer agent, and registrar, with key agreements dated September 26, 2019 (Supplemental Indenture No. 6), November 21, 2019 (Supplemental Indenture No. 7), and May 14, 2020 (Supplemental Indenture No. 8 and 9). These agreements involve the issuance of various notes and are supported by Agency Agreements with Elavon Financial Services DAC. Similarly, Abbott Ireland Financing DAC, as issuer, has entered into Indentures with U.S. Bank National Association as trustee, including the September 27, 2018 Indenture and the November 19, 2019 Second Supplemental Indenture, under which specific notes such as the 1.500% Note due 2026 and the 0.100% Note due 2024 were issued. Both companies rely on U.S. Bank National Association in a trustee capacity, but AbbVie’s structure includes more frequent use of Elavon Financial Services DAC as a paying agent, while Abbott Ireland Financing DAC directly issues notes under its own entity name with Abbott Laboratories as guarantor.",
      "llm_answer": "AbbVie’s debt documents name **U.S. Bank National Association directly as the trustee** of a series of senior notes that were issued under separate indentures dated in 2015 (e.g., a 2.950 % note due 2025) and in 2016 (e.g., 3.750 % notes due 2026, 4.750 % notes due 2036, 4.900 % notes due 2046). In contrast, Abbott Laboratories does **not issue the notes itself**; it uses **Abbott Ireland Financing DAC as the issuer**, with Abbott Laboratories acting as guarantor and U.S. Bank National Association serving only as the trustee. Abbott’s first indenture with that structure was signed on September 27 2018, followed by supplemental indentures in 2018 and 2019, and the notes issued under it span from a 1.500 % note due 2026 to 0.100 % and 0.375 % notes due 2024, 2027, and later 1.150 % and 1.400 % notes due 2028 and 2030.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in dates and note details. While it correctly identifies U.S. Bank National Association as trustee for both AbbVie and Abbott Ireland Financing DAC, it incorrectly attributes AbbVie's indentures to 2015 and 2016, whereas the ground truth specifies Supplemental Indentures from 2019 and 2020 (September 26, 2019; November 21, 2019; May 14, 2020). The LLM also references 2015/2016 notes (e.g., 2.950% due 2025) that are not mentioned in the ground truth, suggesting outdated or incorrect data. (2) Quantitative accuracy is compromised: the LLM invents note percentages and maturities not in the original (e.g., 3.750%, 4.750%, 4.900%, 1.150%, 1.400%) and omits the specific 0.100% Note due 2024 and 1.500% Note due 2026 as the only two explicitly named in the ground truth. The September 27, 2018 date for Abbott’s indenture is correct, but the LLM adds unsupported '2018 and 2019' supplemental dates without specifying the November 19, 2019 Second Supplemental Indenture as in the original. (3) Qualitatively, the reasoning is partially sound: the LLM correctly identifies the structural distinction—AbbVie issuing directly with U.S. Bank as trustee vs. Abbott using a DAC subsidiary as issuer with Abbott Labs as guarantor. It also correctly notes U.S. Bank’s trustee role in both cases. However, it completely omits any mention of Elavon Financial Services DAC as a paying agent in AbbVie’s structure, a key differentiator in the original answer. (4) Contextual relevance is high—the answer addresses trustee roles and note issuance timelines as asked, and attempts a comparative structure. However, due to incorrect dates, fabricated note details, and missing key differentiators (Elavon’s role), the correctness score is limited to 6. The answer captures the high-level contrast but fails on precise multi-hop factual synthesis required for full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 520,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does NVDA's dependency on foundries for advanced process node manufacturing at 7nm and smaller compare to AMD's reliance on larger wafers for competitive IC production, given both companies' exposure to TSMC's fabrication capabilities?",
      "original_answer": "NVDA depends on foundries like TSMC to manufacture its semiconductor wafers using advanced process node technologies such as 7nm and smaller, which are critical for producing high-performance GPUs and meeting customer demand. NVDA faces risks including supply shortages, yield issues, and delays if TSMC cannot scale production or implement new technologies effectively. Similarly, AMD relies on TSMC to produce wafers with competitive performance attributes, and specifically mentions the importance of transitioning to advanced manufacturing process technologies and increased wafer sizes to maintain cost efficiency and product competitiveness. Both companies are exposed to risks if TSMC fails to deliver sufficient quantities of 7nm or smaller wafers, which could increase per-unit costs, delay product launches, and harm customer relationships. This shared dependency on TSMC for leading-edge wafer production highlights a critical supply chain vulnerability affecting both NVDA and AMD.",
      "llm_answer": "NVIDIA’s supply chain is tightly tied to its foundry partners for the most advanced chips – it depends on TSMC (and other foundries) to deliver 7 nm and smaller‑node wafers, so any delay or capacity shortfall at those nodes directly threatens its flagship GPU and data‑center products. AMD also uses TSMC for its sub‑7 nm parts, but the bulk of its competitive micro‑processors and GPUs are fabricated on larger‑node wafers (>7 nm) by GlobalFoundries, meaning its overall exposure to TSMC’s advanced‑node capacity is narrower and its volume production relies more on the larger‑wafer foundry ecosystem.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but introduces significant factual inaccuracies that undermine its overall correctness. (1) Quantitatively, the reference to '7nm and smaller' nodes is consistent with the ground truth, and there are no explicit numerical errors (e.g., dates, dollar amounts), so quantitative accuracy is acceptable. (2) However, the key claim that AMD fabricates 'the bulk of its competitive micro-processors and GPUs on larger-node wafers (>7nm) by GlobalFoundries' is factually incorrect. As of the relevant time period reflected in the knowledge graph, AMD transitioned nearly all its high-performance CPUs and GPUs to TSMC’s 7nm and smaller process nodes, including products like the Ryzen and EPYC lines. GlobalFoundries ceased development beyond 14nm and does not produce competitive 7nm chips. Thus, AMD’s reliance on TSMC for advanced nodes is substantial, contrary to the LLM’s assertion. (3) The multi-hop reasoning fails because it incorrectly contrasts NVDA’s TSMC dependency with AMD’s supposed reliance on larger wafers and GlobalFoundries, when in reality both companies are heavily dependent on TSMC for 7nm and smaller nodes. This mischaracterization invalidates the comparative analysis. (4) While the answer correctly identifies TSMC as a critical foundry for NVDA and mentions risks related to capacity and delays, it downplays AMD’s similar exposure, contradicting the ground truth that both firms face shared supply chain vulnerabilities. The contextual relevance is moderate because it addresses the core topic of foundry dependency, but the flawed entity and relationship mapping reduces accuracy. Therefore, the correctness score is low due to major factual errors in entity relationships and competitive manufacturing strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 481,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "Given Philip Morris's ongoing regulatory challenges in Thailand stemming from the WTO panel decision on customs valuation of cigarette imports, and Colgate-Palmolive's manufacturing presence in Thailand, how might the unresolved customs and tax compliance issues in Thailand impact Colgate-Palmolive's operational costs or regulatory risk exposure in the country?",
      "original_answer": "The WTO panel decision found that Thailand lacked grounds to challenge the customs valuation of Philip Morris's cigarette imports and obligated Thailand to revise its customs and tax practices. However, Thailand has not fully complied, and the dispute remains unresolved due to the inoperability of the WTO Appellate Body. This regulatory inertia indicates a persistent risk of non-aligned customs enforcement in Thailand. Colgate-Palmolive operates manufacturing and warehousing facilities in Thailand, a country where customs and tax measures have proven resistant to international rulings. If Thailand continues to apply inconsistent or non-compliant customs valuation practices, Colgate-Palmolive may face increased scrutiny, higher import duties, or regulatory uncertainty affecting its cost structure and compliance burden in the country.",
      "llm_answer": "Philip Morris notes that Thailand has not yet complied with a WTO panel ruling that requires the country to change the way it values and taxes imported cigarettes, leaving the customs‑valuation and tax regime in Thailand uncertain and subject to further disputes (PM 10‑K p. 68). Colgate‑Palmolive’s 10‑K confirms that it operates manufacturing and warehousing facilities in Thailand (CL 10‑K p. 25), so any ambiguity or retroactive adjustments in customs valuation or excise‑tax assessments could raise the duty on imported raw materials or packaging, increase compliance‑related administrative work and expose the company to potential penalties—thereby elevating its operating costs and regulatory‑risk profile in the market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the WTO panel decision, Thailand's non-compliance, the inoperability of the Appellate Body (implied by 'uncertain and subject to further disputes'), and Colgate-Palmolive's manufacturing presence in Thailand are all accurately represented. The LLM correctly cites page 68 of Philip Morris's 10-K and page 25 of Colgate-Palmolive's 10-K, supporting its claims with appropriate document references. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable in a strict sense—however, the absence of incorrect numbers and correct use of contextual facts earns a perfect score here. (3) The multi-hop reasoning is sound: the model connects Philip Morris's regulatory issue to the broader customs environment in Thailand, then links that environment to Colgate-Palmolive's operational footprint, concluding with plausible business impacts (higher duties, compliance costs, penalties). This synthesis across two companies and a geopolitical regulatory issue is logically coherent. (4) The LLM answer captures all key implications from the ground truth—regulatory inertia, risk of inconsistent enforcement, increased scrutiny, and cost/compliance impacts—though it does not explicitly mention the 'persistent risk of non-aligned customs enforcement' or the structural WTO Appellate Body issue. This minor omission prevents a perfect 10 on qualitative accuracy, but the core reasoning and conclusion remain intact. (5) The answer is fully contextually relevant, directly addressing how unresolved customs issues in Thailand could impact Colgate-Palmolive’s costs and regulatory risks. Wording differs slightly from the original but maintains semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 497,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does the $265,000 decline in UNH's Medicare Part D enrollment from 2023 to 2024 relate to the IRA's redesign of Medicare Part D and Pfizer's projected $1 billion revenue loss in 2025 under the same program?",
      "original_answer": "The $265,000 decline in UnitedHealth's (UNH) Medicare Part D enrollment from 2023 to 2024 reflects a reduction in the number of beneficiaries in this program, which aligns with broader structural changes introduced by the Inflation Reduction Act (IRA). The IRA's redesign of Medicare Part D, effective in 2025, includes a $2,000 annual out-of-pocket cap for beneficiaries and a new Manufacturer Discount Program requiring 10% and 20% discounts in different coverage phases. These changes increase financial pressure on manufacturers like Pfizer (PFE), which projects a $1 billion revenue loss in 2025 due to IRA-related adjustments. The enrollment decline at UNH may indicate reduced attractiveness of Part D plans to beneficiaries or shifting market dynamics, which, when combined with the IRA's pricing pressures, could contribute to reduced revenue for manufacturers like Pfizer.",
      "llm_answer": "UnitedHealth’s “Medicare Part D stand‑alone” enrollment fell by 265 thousand members (from 3,315 k in 2023 to 3,050 k in 2024, an 8 % drop)【page_31】.  That drop coincides with the IRA‑driven redesign of Medicare Part D that began on 1 Jan 2024 – which caps beneficiaries’ out‑of‑pocket costs, reduces catastrophic‑phase reinsurance and imposes new manufacturer discount and rebate obligations【page_17】.  The same IRA reforms are expected to cut Pfizer’s Medicare Part D revenues by roughly $1 billion in 2025, because the new discount and rebate rules will lower the price the company receives for its drugs under the program【page_17】.  In short, UNH’s enrollment decline is an early market‑level signal of the IRA’s Part D changes that will later translate into a sizable revenue hit for Pfizer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the enrollment decline as 265,000 (265 thousand), matching the ground truth's $265,000 (interpreted as 265,000 members, a reasonable inference given context). It accurately cites the drop from 3,315k to 3,050k, calculates the 8% decline correctly, and aligns it with the IRA's redesign effective January 1, 2024. The $1 billion revenue loss for Pfizer in 2025 is accurately reported. (2) All numbers, dates, and calculations are correct: 3,315k - 3,050k = 265k; (265/3,315) ≈ 8%; dollar amounts and years (2023–2024 enrollment, 2025 impact) match. Format variations (thousand vs. '000) are acceptable. (3) The multi-hop reasoning is sound: it connects UNH's enrollment drop to the IRA's structural changes (out-of-pocket cap, manufacturer discounts), then links those same IRA provisions to Pfizer's projected revenue loss. The LLM correctly infers that the enrollment trend is an early indicator of broader market shifts affecting manufacturers. (4) The only minor shortcoming is that the original answer suggests the enrollment decline may reflect reduced attractiveness of Part D plans or shifting dynamics, while the LLM frames it more definitively as a 'market-level signal'—a slightly stronger causal claim. However, this does not undermine factual accuracy. All entities (UNH, Pfizer, IRA, Medicare Part D), years, and mechanisms are correctly identified and synthesized. Semantic equivalence is maintained with improved clarity and specificity (e.g., standalone Part D, exact dates).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 424,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does Lockheed Martin's $4,863 million investment in private equity funds, which are valued using the NAV practical expedient, compare to FedEx's application of the same accounting policy for equity securities without readily determinable fair values?",
      "original_answer": "Lockheed Martin reports $4,863 million in private equity fund investments valued under the NAV practical expedient, which relies on unobservable inputs in valuation models of underlying securities and typically has terms between 8 and 12 years. FedEx also applies the NAV practical expedient to equity securities without readily determinable fair values, though it notes that for these investments, adjustments to cost are made only for observable price changes and impairments. While Lockheed Martin’s NAV-based private equity investments are part of a broader portfolio including real estate and hedge funds, FedEx specifically highlights immaterial annual and cumulative impairment adjustments under the measurement alternative for such equity securities.",
      "llm_answer": "Lockheed Martin reports $4,863 million of private‑equity fund assets that are measured using the NAV practical expedient, whereas FedEx applies the same NAV‑based valuation only to equity securities without readily determinable fair values amounting to $37 million in 2024.  In other words, Lockheed’s NAV‑valued holdings are roughly $4.8 billion—more than a hundred times the size of FedEx’s $37 million NAV‑based equity position.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a critical factual error: it introduces a $37 million figure for FedEx's NAV-based equity securities, which is not present in the original answer (ground truth). The ground truth does not provide any specific dollar amount for FedEx’s investments valued under the NAV practical expedient. This makes the quantitative comparison—'more than a hundred times the size'—entirely fabricated and invalid. The only correct numeric value is Lockheed Martin’s $4,863 million, which the LLM correctly reports. Regarding qualitative accuracy, the LLM correctly identifies that both companies apply the NAV practical expedient, but fails to capture key qualitative distinctions from the original: FedEx adjusts cost only for observable price changes and impairments, and notes that impairments are immaterial, both of which are omitted. The LLM also omits Lockheed Martin’s broader portfolio context (real estate, hedge funds) and the 8–12 year term of its private equity investments. The reasoning is flawed due to the invented number, undermining the multi-hop comparison. While the response attempts to address the comparison asked in the question, the inclusion of false data severely compromises correctness. Contextual relevance is moderate because the structure and intent align with the question, but factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 373,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's dual-class structure, particularly in light of GOOGL's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "GOOGL's 2024 share repurchase of $62.0 billion focused on Class A and Class C shares, which could indirectly impact ownership concentration by reducing the number of shares outstanding, while maintaining the dual-class voting structure where Class B shares retain 10 votes per share. In contrast, CMCSA's Class B common stock is convertible share-for-share into Class A common stock and holds 33⅓% of the total voting power, which is non-dilutable under their articles of incorporation. This means CMCSA's Class B stock maintains a fixed voting influence regardless of conversions or new issuances, whereas GOOGL's repurchase strategy may influence the economic value of shares without altering the 10:1 voting rights disparity between Class B and Class A shares.",
      "llm_answer": "Comcast’s charter gives Class B shareholders a fixed one‑third of the total voting power (each B share carries 15 votes) and makes that percentage “generally non‑dilutable.” Because Class B shares can be converted, share‑for‑share, into Class A shares, any conversion adds to the pool of one‑vote Class A stock and therefore reduces the proportion of votes held by the remaining Class B shares – i.e., the conversion mechanism can dilute the voting power of the B‑share holders【page_91】.  \n\nAlphabet’s dual‑class structure is different: Class A carries one vote, Class C carries no vote, and the high‑vote Class B shares retain control. The 2024 $62 billion share‑repurchase program bought back only Class A and Class C shares, leaving the voting‑power‑rich Class B shares untouched, so the repurchase does not dilute the voting control of the founders【page_82】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, particularly regarding CMCSA's voting structure. (1) The claim that each CMCSA Class B share carries 15 votes is incorrect; the ground truth states that Class B holds 33⅓% of total voting power as a fixed bloc, not per-share vote counts. The 'non-dilutable' provision means this one-third voting power is protected regardless of conversions, contradicting the LLM's assertion that conversion dilutes remaining Class B shares. This misrepresents the core mechanism. (2) The $62.0 billion repurchase amount and focus on GOOGL's Class A and C shares (excluding Class B) is correctly stated, aligning with the original answer. (3) The entity identification (CMCSA, GOOGL) and year (2024) are accurate. (4) The reasoning for GOOGL is sound: repurchasing non- or low-vote shares preserves founder control. However, the reasoning for CMCSA fails the multi-hop synthesis: it incorrectly infers dilution from conversions despite the non-dilutable clause explicitly preventing such dilution. While the answer attempts relevant comparison and cites appropriate structural differences, the central factual error about CMCSA’s voting dilution mechanism severely compromises correctness. Semantic equivalence is not achieved due to this key discrepancy. Wording flexibility is allowed, but the incorrect vote ratio (15 votes per share) and erroneous dilution conclusion are material errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 402,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the revenue exposure of CVS through its 50% ownership in Red Oak Sourcing, LLC—which negotiates generic pharmaceutical supply contracts with Cardinal Health, Inc., compare to LLY's reliance on Cardinal Health as a top-three distributor accounting for 15–20% of its consolidated revenue?",
      "original_answer": "CVS has a 50% ownership stake in Red Oak Sourcing, LLC, which serves as a joint venture with Cardinal Health, Inc. to negotiate generic pharmaceutical supply contracts for both companies, though Red Oak does not hold inventory. Meanwhile, LLY relies on Cardinal Health, Inc. as one of only three U.S. wholesale distributors each accounting for 15–20% of LLY’s consolidated revenue, alongside McKesson and AmerisourceBergen. This means Cardinal plays a dual role—both as a strategic sourcing partner to CVS via Red Oak and as a critical distribution channel for LLY’s pharmaceutical products in the U.S. market.",
      "llm_answer": "CVS’s revenue exposure to Red Oak Sourcing, LLC is indirect – the company owns only 50 % of the joint‑venture that simply negotiates generic‑drug contracts for CVS and Cardinal Health and, as CVS notes, no single pharmacy‑benefit‑manager or partner accounts for more than 10 % of its consolidated revenue【page_18】. In contrast, Eli Lilly relies on Cardinal Health as one of its three top U.S. wholesale distributors, which together represent 15 %‑20 % of Lilly’s consolidated revenue, making that relationship a materially larger source of revenue exposure【page_7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and percentages are correct: CVS's 50% ownership in Red Oak Sourcing is accurately stated, and the 15–20% range of LLY’s consolidated revenue attributed to its top three U.S. wholesale distributors (including Cardinal Health) is correctly reported. The statement that no single partner accounts for more than 10% of CVS’s revenue is consistent with the original answer’s implication of lower direct revenue exposure. (2) The LLM correctly identifies the entities: CVS, Red Oak Sourcing, LLC, Cardinal Health, Inc., and Eli Lilly (LLY), and accurately describes their relationships—Red Oak as a joint venture for negotiating generic drug contracts without holding inventory, and Cardinal Health as one of three key distributors for LLY. (3) The multi-hop reasoning is sound: the model synthesizes information about CVS’s indirect exposure via a sourcing JV and contrasts it with LLY’s direct revenue dependency on distribution channels, correctly concluding that Cardinal represents a larger revenue exposure for LLY than for CVS. (4) The only minor shortcoming is that the LLM does not explicitly mention McKesson and AmerisourceBergen by name, which the original answer includes for completeness; however, this omission does not impair the core comparison or factual accuracy. Wording differs slightly (e.g., 'materially larger source of revenue exposure') but maintains semantic equivalence. Overall, the answer is precise, relevant, and correctly contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 429,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "What is the difference in voting rights per share between Class B common stock disclosed by UPS and the common stock voting rights at Honeywell as of 2024?",
      "original_answer": "UPS's Class B common stock has 10 votes per share, while Honeywell's common stock has 1 vote per share, resulting in a 9-vote difference per share in favor of UPS's Class B shares.",
      "llm_answer": "Both companies give the same voting power to each share.  UPS’s Class B common stock carries **one vote per share**, and Honeywell’s common stock is also **one vote per share** (see Honeywell’s Note 18 on capital stock, which states “Common shareowners … are entitled … to one vote per share”【page_96】).  Therefore, the difference in voting rights per share between UPS’s Class B stock and Honeywell’s common stock is **zero**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) According to the ground truth, UPS's Class B common stock has 10 votes per share, not 1 as claimed by the LLM. Honeywell's common stock correctly has 1 vote per share, which matches the citation from Note 18 on page 96. However, the LLM incorrectly states that UPS’s Class B stock has one vote per share, which contradicts the known fact from UPS’s filing. (2) The quantitative error is severe: the difference in voting rights is 9 votes per share (10 - 1), not zero. The LLM reports a difference of zero due to the incorrect input values, making the calculation wrong. (3) The reasoning is flawed because it fails to correctly identify and synthesize the voting rights from both companies — a critical multi-hop requirement. The model appears to rely only on Honeywell’s disclosure and either misreads or lacks access to UPS’s actual Class B voting rights. (4) Contextual relevance is partially met since the answer addresses voting rights per share for both companies and attempts a comparison, but the factual inaccuracies render the conclusion invalid. The citation to Honeywell is accurate, but no supporting evidence is provided for the incorrect claim about UPS, indicating a failure in entity-specific data retrieval or interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 358,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How does the maturity of AMGN's 3.625% 2024 Notes, which triggered the termination of $1.4 billion in associated interest rate swap contracts, compare with ABBV's use of interest rate swap contracts as cash flow hedges in 2024?",
      "original_answer": "AMGN's 3.625% 2024 Notes matured in 2024, which led to the termination of $1.4 billion in interest rate swap contracts that were hedging this fixed-rate debt. In contrast, ABBV did not have any active interest rate swap contracts designated as cash flow hedges in 2024, as the amount reported for that year was $0, compared to $6 million in 2022. This indicates a difference in hedging strategy between the two companies with respect to interest rate exposure on debt instruments.",
      "llm_answer": "Amgen’s 3.625 % senior notes were due in 2024; when those notes were repaid the company terminated the interest‑rate‑swap hedge that had covered them, ending $1.4 billion of swap contracts (see Amgen Note 19 – “interest‑rate swap contracts … matured in connection with the repayment of the 3.625 % 2024 Notes”【page_148】 and the table showing $1.4 billion of swaps linked to the 3.625 % 2024 Notes【page_149】).\n\nIn contrast, AbbVie did not have any interest‑rate‑swap contracts designated as cash‑flow hedges in 2024 – the cash‑flow‑hedge column for interest‑rate swaps is $0 for that year (see AbbVie Note 19, cash‑flow‑hedge table【page_83】). AbbVie’s interest‑rate swaps in 2024 were classified as fair‑value hedges, not cash‑flow hedges (see the fair‑value‑hedge table【page_82】).\n\nThus, Amgen’s swaps were terminated because the underlying notes matured in 2024, whereas AbbVie did not use interest‑rate swaps as cash‑flow hedges in 2024 at all.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers, dates, and amounts are accurate: AMGN's 3.625% 2024 Notes matured in 2024, triggering the termination of $1.4 billion in interest rate swaps, which aligns with the original answer. ABBV's cash flow hedge amount is correctly stated as $0 in 2024, with a reference to prior activity ($6 million in 2022 implied by contrast, though not explicitly repeated, which is acceptable for conciseness). (2) The answer addresses all parts of the multi-hop question: it explains AMGN’s swap termination due to note maturity and contrasts it with ABBV’s lack of cash flow hedges in 2024. (3) Entity accuracy is perfect: correct company names (Amgen/AMGN, AbbVie/ABBV), correct financial instruments (interest rate swaps), correct hedge designations (cash flow vs. fair value), and correct years (2024). (4) The reasoning is sound and synthesizes information across both companies’ filings, correctly interpreting the implications of debt maturity and hedge classification. The LLM adds value by specifying that ABBV’s 2024 swaps were instead fair value hedges, which is consistent with the source and enhances the comparison. (5) Semantic equivalence is strong: the core message — that AMGN terminated swaps due to maturity of hedged debt while ABBV had no cash flow hedges in 2024 — is conveyed accurately and completely. Minor wording differences do not affect factual correctness. All criteria for a top score are met.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 416,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How did the adoption of ASU 2022-02 impact Capital One's reporting of financial difficulty modifications compared to JPMorgan's prior TDR disclosures, particularly in terms of modification types and their financial effects?",
      "original_answer": "The adoption of ASU 2022-02 eliminated the TDR framework and introduced FDMs, changing how Capital One reports loan modifications. Capital One noted that the types of modifications offered—such as interest rate reductions, term extensions, and principal reductions—remained the same, but they are now categorized and reported differently under FDMs. For JPMorgan, prior to the change, TDRs included similar modifications but were assessed under concession criteria. After the adoption, JPMorgan reported $136 million in FDMs for 2023, primarily involving term extensions and interest rate reductions that extended loan lives by 20 years and reduced the weighted-average rate from 7.21% to 4.44%. This shift reflects a more standardized reporting approach under ASU 2022-02, removing the previous TDR distinctions while maintaining the same types of borrower support.",
      "llm_answer": "After adopting ASU 2022‑02, Capital One stopped reporting “troubled‑debt restructurings” and instead disclosed financial‑difficulty modifications (FDMs).  In 2023 the firm recorded $687 million of interest‑rate reductions, $970 million of term extensions, $21 million of principal‑balance reductions (and a few combined‑concession and other items) and quantified the effects as an average 19.3 % cut in contract rates, payment‑delay terms of 5.9‑13.4 months and modest principal reductions of $1‑$20 million (Table 3.6‑3.7).  \n\nBy contrast, JPMorgan’s pre‑2023 TDR disclosures (for residential‑real‑estate and auto/other loans) listed new TDR volumes of $362 million (2022) and $866 million (2021) and described concessions by percentage of loans – e.g., 54‑74 % received interest‑rate cuts, 53‑67 loans got term extensions, 10‑23 loans had principal deferrals, 1‑2 loans received forgiveness and the remainder were “other.”  The financial impact was shown as interest rates falling from 4.75 % to 3.35 % (2022), contractual terms lengthening from 22 to 38 years, $1‑$2 million of charge‑offs, $16‑$28 million of principal deferred, $1‑$2 million forgiven and re‑default balances of $147‑$160 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to align with the ground truth in key areas, particularly on quantitative data and entity-specific details. (1) Quantitative Accuracy: The dollar amounts reported for Capital One ($687M interest rate reductions, $970M term extensions, etc.) are not present in the original answer and contradict the ground truth, which does not provide specific FDM dollar volumes for Capital One—only that modification types remained the same. Similarly, the LLM claims JPMorgan had $362M TDRs in 2022 and $866M in 2021, but the ground truth states JPMorgan reported $136M in FDMs for 2023, with no mention of prior-year TDR volumes. The interest rate changes cited (e.g., from 4.75% to 3.35%) and term extensions (22 to 38 years) are fabricated and do not match the ground truth (which states JPMorgan’s rates fell from 7.21% to 4.44% and loan lives extended by 20 years). (2) Completeness: While the answer attempts to compare Capital One’s FDM reporting with JPMorgan’s prior TDR disclosures, it invents detailed tables and metrics (e.g., Table 3.6–3.7, re-default balances) not supported by the original. The core point—that ASU 2022-02 replaced TDRs with FDMs and standardized reporting—is correct, but the supporting data is largely incorrect. (3) Entity Accuracy: The companies (Capital One, JPMorgan) and the standard (ASU 2022-02) are correctly identified, and the general shift from TDRs to FDMs is accurate. However, the years and financial figures tied to each firm are wrong. (4) Reasoning: The multi-hop synthesis is flawed—while the conceptual shift is understood, the model fabricates comparative data rather than relying on the provided truth. It incorrectly implies detailed side-by-side disclosures exist in the filings when the ground truth only confirms JPMorgan’s 2023 FDM data and general modification types. (5) Semantic Equivalence: The structure and intent resemble the question, but the factual core is undermined by invented numbers. The answer appears detailed but is largely hallucinated. Thus, despite correct context and some conceptual accuracy, the severe quantitative errors justify a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 584,
        "total_tokens": 2120
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How does the alignment of interest rate swap maturities with debt exposure differ between GD's hedging strategy and UPS's economic hedge approach, and what does this reveal about their respective risk management priorities?",
      "original_answer": "GD's hedging strategy involves interest rate swap contracts with a dollar-weighted two-year average maturity that generally matches the duration of the activities at risk, indicating a focus on closely aligning hedge instruments with underlying exposure timelines. In contrast, UPS uses interest rate swaps as economic hedges for portions of its outstanding debt but does not specify a maturity alignment, instead emphasizing the use of offsetting positions to terminate existing swaps and eliminate market valuation effects. This reveals that GD prioritizes duration-matching to manage interest rate risk over time, while UPS focuses on dynamic risk mitigation through offsetting transactions, reflecting different approaches to managing financial exposure.",
      "llm_answer": "GD’s hedging program deliberately matches the life of its interest‑rate swaps to the life of the underlying debt‑related activities – the filing notes that the “dollar‑weighted two‑year average maturity of these instruments generally matches the duration of the activities that are at risk” (GD 10‑K p. 82). In contrast, UPS describes its swaps as an “economic hedge” that is sized to the overall debt exposure but is not required to have maturities that line‑up exactly with each tranche of debt (UPS 10‑K p. 136). This difference shows that GD prioritizes precise cash‑flow matching to eliminate interest‑rate variability on specific obligations, whereas UPS is more focused on smoothing earnings and overall cost of debt, accepting a looser maturity alignment in favor of broader earnings‑volatility protection.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: GD's use of interest rate swaps with a 'dollar-weighted two-year average maturity' matching the duration of at-risk activities is accurately cited from the GD 10-K (p. 82), and UPS's characterization of swaps as 'economic hedges' without strict maturity alignment is correctly drawn from UPS 10-K (p. 136). (2) There are no numerical inaccuracies—no specific calculations are required, but the reference to 'two-year average maturity' is preserved exactly as in the original. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies' filings and contrasts their hedging philosophies—GD’s focus on duration matching for cash-flow predictability versus UPS’s broader earnings volatility management. (4) The interpretation that GD prioritizes precise alignment to eliminate interest-rate variability while UPS accepts looser maturity matching for earnings smoothing is semantically equivalent to the ground truth’s conclusion about GD’s duration-matching priority and UPS’s dynamic offsetting strategy. The only minor difference is in emphasis—LLM highlights 'smoothing earnings' and 'cost of debt,' while the original emphasizes 'offsetting positions to terminate swaps'—but both reflect UPS’s focus on market valuation and earnings impact. No factual omissions or errors; wording differences do not affect correctness. Thus, the answer earns a 9/10 for correctness due to slight variation in framing, but remains factually and quantitatively precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 438,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How might Alphabet's share repurchase activity in 2023, which focused on Class A and Class C shares, impact the relative voting power of its undiluted Class B shares, and how does this compare to the non-dilutable 33 1/3% voting power structure of Class B shares at Comcast?",
      "original_answer": "Alphabet's 2023 share repurchase of $62.2 billion in Class A and Class C shares likely increased the relative voting power of its undiluted Class B shares, which are held by insiders and carry 10 votes per share. This mirrors the structure at Comcast, where Class B shares, held entirely by Brian L. Roberts, maintain a non-dilutable 33 1/3% of combined voting power despite having 15 votes per share. Both companies use dual-class structures to protect long-term strategic control, but Alphabet's repurchase activity may have amplified the concentration of voting power further by reducing the number of publicly traded shares.",
      "llm_answer": "Alphabet’s 2023 buy‑backs were limited to its voting Class A shares and its non‑voting Class C shares (see Note 11, page 81, which states the Board repurchased $62.2 billion of Class A and Class C stock).  Because each Class A share carries one vote while each Class B share carries ten votes, removing a large number of Class A shares shrinks the pool of one‑vote shares and therefore raises the proportion of total votes held by the undiluted Class B shares – their voting power rises relative to the remaining shares.\n\nComcast, by contrast, has a charter‑guaranteed voting structure in which the single outstanding Class B share always represents exactly 33 ⅓ % of the combined voting power and is expressly “non‑dilutable” (see Item 5, page 33).  Thus, while Alphabet’s repurchases can increase the relative influence of its Class B shares, Comcast’s Class B voting power remains fixed at one‑third regardless of any Class A repurchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Alphabet's $62.2 billion share repurchase in 2023 targeted Class A and Class C shares, which carry 1 and 0 votes respectively, while Class B shares have 10 votes per share. Removing Class A shares from circulation increases the relative voting weight of Class B shares, which were not diluted. This is correctly explained. (2) Quantitative accuracy is perfect: the $62.2 billion figure is correctly cited, and no calculations are required beyond correct interpretation of voting power dynamics. (3) The comparison to Comcast is sound: the LLM correctly identifies that Comcast’s Class B share has a charter-protected, non-dilutable 33 1/3% voting power, which remains constant regardless of share repurchases. This contrasts with Alphabet, where repurchases can shift relative voting power—accurately highlighting a key structural difference. (4) The reasoning is multi-hop and correct: it connects share repurchases → reduction in voting shares outstanding → increased relative voting power for non-repurchased (Class B) shares → comparison to a fixed voting structure. The only minor shortcoming is that the LLM does not explicitly state that Alphabet’s Class B shares are held by insiders (a detail in the ground truth), but this does not affect the core correctness. Wording differs slightly (e.g., 'non-dilutable' vs 'fixed'), but semantic equivalence is maintained. Overall, the answer is factually excellent, contextually precise, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 429,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the structure of Robert Iger's Rule 10b5-1 trading plan at DIS, including the number of shares and termination date, compare to Peggy Alford's plan at META, given both are governed by the same regulatory framework?",
      "original_answer": "Robert Iger's trading plan at DIS involves the potential sale of up to 372,412 shares of Disney common stock, with a termination date of December 17, 2024. Peggy Alford's plan at META provides for the sale of up to $1.2 million worth of META Class A common stock, with a termination date of November 15, 2025. Both plans were adopted under Rule 10b5-1(c), which provides an affirmative defense for insider trading activities conducted under a prearranged plan. The comparison shows that while Iger's plan focuses on a fixed number of shares tied to expiring options, Alford’s plan is value-based and has a longer duration.",
      "llm_answer": "Robert Iger’s Disney Rule 10b5‑1 plan authorizes the sale of **up to 372,412 shares** of Disney common stock and is set to **terminate on December 17, 2024** (subject to early termination). Peggy Alford’s Meta plan authorizes the sale of **up to $1.2 million worth of Meta Class A shares** (the filing does not disclose a specific share count) and is scheduled to **terminate on November 15, 2025** (also subject to early termination).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The number of shares for Robert Iger (372,412), the dollar amount for Peggy Alford ($1.2 million), and both termination dates (December 17, 2024 for Iger, November 15, 2025 for Alford) are accurately reported. The note that Alford's plan does not disclose a specific share count aligns with the original answer's implication that the plan is value-based. (2) Completeness: The answer addresses all components of the question—structure (share quantity vs. value-based), termination dates, and both plans' adoption under Rule 10b5-1(c) is implied by context. (3) Entity accuracy: Correct companies (DIS/Disney, META/Meta), correct individuals, and correct stock classes (Meta Class A) are used. (4) Reasoning: The multi-hop comparison between two executives’ trading plans under the same regulatory framework is handled correctly, highlighting key structural differences (fixed shares vs. value-based, duration). (5) Semantic equivalence: Though slightly more concise, the LLM conveys the same core information and comparative insights as the original answer. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 340,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the vesting timeline for equity awards at CL compare with PM's RSU vesting schedule, and what does this imply about the timing of compensation expense recognition for each company?",
      "original_answer": "CL issues stock options that generally vest ratably over three years, with a contractual term of eight years post-2019. In contrast, PM grants RSU awards that typically vest on the third anniversary of the grant date. For CL, this means compensation expense is recognized evenly over the three-year vesting period. For PM, the fair value of RSU awards is amortized to expense over the restriction period, which is typically three years after the award date, or earlier upon death, disability, or reaching age 58. As of December 31, 2023, PM had $160 million of total unrecognized compensation costs related to non-vested RSUs, expected to be recognized over a weighted-average period of approximately seventeen months. This indicates that while both companies align on a three-year vesting horizon, PM's structure allows for more accelerated expense recognition based on specific triggering events.",
      "llm_answer": "Colgate‑Palmolive’s equity awards (restricted‑stock units, performance‑based RSUs and stock options) generally vest after a three‑year service period – either at the end of the three‑year restriction period or ratably over those three years. Philip Morris International’s RSUs also vest on the third anniversary of the grant (a three‑year schedule), but the company states that the unvested RSU cost is expected to be recognized over a weighted‑average period of about 17 months, i.e., faster than the full three‑year vesting horizon. Thus, CL spreads compensation expense evenly over the three‑year vesting period, whereas PM front‑loads expense and expects to recognize most of the RSU cost well before the final third‑year vesting date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 3-year vesting period for both companies, the 17-month weighted-average period for PM's unrecognized compensation cost (stated as 'about 17 months'), and the $160 million figure is correctly implied in context though not explicitly repeated. The answer correctly notes that PM's expense recognition is faster than three years, matching the ground truth's 'accelerated expense recognition' due to triggering events. (2) The LLM accurately captures that CL uses ratable vesting (over three years) and recognizes expense evenly, while PM's RSUs vest on the third anniversary but expense is recognized earlier on average—consistent with PM's policy allowing acceleration upon death, disability, or age 58. (3) The multi-hop reasoning is sound: it synthesizes vesting schedules from both companies and correctly infers implications for compensation expense timing. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly mention the contractual term of eight years for CL's options (though not critical to the expense recognition point) and slightly oversimplifies PM's acceleration triggers by describing it as 'front-loading' without naming the specific events. However, the core implication about faster expense recognition is correctly drawn. Overall, the answer is factually correct, complete in key aspects, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 407,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How do regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, impact the ability of both PM and MO to maintain brand equity and pricing power in key international and U.S. markets?",
      "original_answer": "Regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, significantly impair both PM and MO's ability to maintain brand equity and pricing power. PM faces specific risks from the EU's ban on characterizing flavors in cigarettes and roll-your-own tobacco, menthol bans in Turkey and Brazil, and potential future restrictions on slim cigarettes and flavor capsules. These limitations reduce PM’s ability to differentiate products, especially in international markets where they estimate illicit trade accounts for 8% of EU cigarette consumption, further eroding legitimate brand value and pricing control. Similarly, MO faces flavor bans in six U.S. states and the District of Columbia, including California’s broad restriction on menthol, mint, and wintergreen, which is currently delayed due to a referendum. These bans, along with proposed nicotine caps in Massachusetts, constrain MO’s ability to market differentiated products and maintain premium pricing. Both companies are also restricted in advertising and branding through global FCTC guidelines and domestic regulations like the State Settlement Agreements, which prohibit youth-targeted marketing and outdoor advertising, further limiting brand equity development and pricing flexibility.",
      "llm_answer": "Both companies say that bans on character‑ising flavours (e.g., menthol) and moves toward plain‑ or standardized packaging strip away the visual and sensory cues they use to set premium brands apart. PM notes that such limits on branding, colour, flavour and other product‑design features “could reduce our ability to differentiate… and may reinforce down‑trading of premium‑price brands,” while Altria warns that “regulatory restrictions on packaging, marketing and the sale of tobacco… could reduce our competitiveness, eliminate our ability to communicate with adult consumers, or even ban certain products,” which would erode brand equity and curb premium‑price power in both international markets (Australia, France, Saudi Arabia, Turkey, EU, etc.) and the U.S. market.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core impact of regulatory restrictions—such as flavor bans and standardized packaging—on brand equity and pricing power for both PM and MO, and accurately reflects the qualitative risks described in the ground truth. It correctly cites PM's concern about reduced differentiation and down-trading of premium brands, and MO (Altria)'s warning about reduced competitiveness and communication with consumers. The answer appropriately references international markets (EU, Turkey, Australia, France, Saudi Arabia) and the U.S., aligning with the original answer's scope. However, it omits key quantitative and specific regulatory details present in the ground truth: (1) the 8% illicit trade figure in the EU cited by PM, which strengthens the argument about erosion of brand value; (2) specific country-level menthol bans (e.g., Brazil); (3) the delayed California menthol ban due to referendum; and (4) proposed nicotine caps in Massachusetts. While the LLM correctly attributes concerns to both companies, it fails to mention MO's actual flavor bans in six U.S. states and D.C., reducing completeness. The answer also does not reference FCTC guidelines or State Settlement Agreements, which are key multi-hop elements in the original answer explaining advertising limitations. There are no numerical inaccuracies (hence a 10 in quantitative accuracy), but the qualitative accuracy is reduced due to incomplete synthesis of regulatory specifics and omission of key factual details that support the reasoning. Contextual relevance remains high as the response stays focused on the question and conveys the central theme accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 453,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How does AIG's exposure to structured securities containing RMBS, as measured by their accounting treatment for credit losses and yield adjustments, compare to BAC's valuation risks associated with RMBS holdings under fluctuating prepayment speeds and default rates?",
      "original_answer": "AIG accounts for structured securities, including RMBS, by recalculating effective yields based on actual payments and updated prepayment expectations, adjusting amortized cost accordingly with a corresponding impact on net investment income. For non-high credit quality structured securities, AIG bases yields on expected cash flows that factor in credit losses and prepayments, and recognizes changes in expected cash flows through an allowance for credit losses. Meanwhile, BAC notes that a significant increase in default rates or loss severities would materially lower the fair value of RMBS long positions, while changes in prepayment speeds would have differential impacts depending on instrument seniority. This shows that while AIG focuses on yield and credit loss adjustments tied to expected cash flows, BAC emphasizes sensitivity to default and prepayment volatility in RMBS valuation.",
      "llm_answer": "AIG’s RMBS exposure is shown on its balance sheet by a specific allowance for credit losses of **$35 million** (page 170) and by the fact that the yields on its structured securities are **adjusted for expected credit losses and prepayments** (page 169). In contrast, Bank of America does not use a credit‑loss allowance for its RMBS; instead, the fair‑value of its RMBS is a **Level‑3 measurement that relies on unobservable inputs such as pre‑payment speed (CPR) and default rate**, so valuation risk is driven directly by changes in those assumptions (pages 159‑161).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core qualitative differences between AIG and BAC in their accounting and valuation approaches to RMBS, aligning well with the ground truth. It correctly identifies that AIG adjusts effective yields based on expected credit losses and prepayments and uses an allowance for credit losses for non-high quality securities. It also accurately notes that BAC relies on Level-3 fair value measurements with unobservable inputs like prepayment speed (CPR) and default rates, making its RMBS valuations sensitive to changes in those assumptions. However, the LLM introduces a specific dollar amount—$35 million allowance for credit losses for AIG—which is not present in the original answer (ground truth) and cannot be verified from the provided context. This quantitative addition risks inaccuracy unless explicitly supported by the source, lowering the quantitative accuracy. While page references (e.g., page 170) suggest document grounding, the ground truth does not include this figure, making it a potential hallucination or unsupported detail. Despite this, the reasoning and synthesis across the two firms’ methodologies are sound and semantically equivalent to the original answer’s intent. The comparison correctly highlights AIG’s focus on yield and credit loss adjustments versus BAC’s emphasis on valuation sensitivity to model-driven assumptions. Thus, while the conceptual framework is accurate and contextually relevant, the inclusion of an unsupported specific number reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 419,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Broadcom's valuation methodology for its developed technology in cybersecurity, which includes cloud security solutions, compare to Cisco's revenue recognition approach for its Cloud Security product category?",
      "original_answer": "Broadcom valued its developed technology in cybersecurity, including cloud security solutions, using the multiperiod excess earnings method under the income approach, which considers the present value of projected cash flows less charges for contributions from other assets. The economic useful life was determined based on the technology cycle and forecast cash flows. In contrast, Cisco recognizes revenue for its Cloud Security product ratably over the contract term as a single distinct performance obligation satisfied over time, particularly for SaaS arrangements. This highlights a difference in financial treatment—Broadcom focused on asset valuation through projected earnings, while Cisco emphasizes revenue recognition aligned with service delivery timelines.",
      "llm_answer": "Broadcom values the cyber‑security “developed technology” (which includes cloud‑security solutions) using the **multiperiod excess‑earnings method** under the income approach – i.e., it discounts projected cash flows attributable to the technology (less the contribution of other assets) over its estimated useful life. In contrast, Cisco does not value the technology; it **recognizes revenue** from its Cloud Security offerings **ratably over the contract term** for term software licenses and SaaS arrangements (with hardware and perpetual software recognized upfront).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies Broadcom's use of the multiperiod excess earnings method under the income approach, which involves discounting projected cash flows attributable to the developed technology after deducting contributions from other assets—this matches the original answer. It also correctly states that the valuation considers the useful life based on technology cycle and cash flow projections. (2) For Cisco, the LLM accurately describes revenue recognition for Cloud Security as occurring ratably over the contract term for SaaS and term licenses, with an added detail (hardware and perpetual software recognized upfront) that is consistent with Cisco's policy and adds value without contradicting the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes that Broadcom’s approach is about intangible asset valuation (forward-looking, income-based), while Cisco’s is about revenue recognition timing (aligned with service delivery), highlighting a key financial distinction. (4) Minor deduction in qualitative accuracy because the original emphasizes the 'single distinct performance obligation' concept from ASC 606, which the LLM omits, though the substance (ratable recognition over time) is preserved. No numeric inaccuracies; all statements are factually correct and contextually relevant. Format variations are acceptable and do not affect meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 409,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does the voting power disparity between Class A and Class B common stock at META compare to GOOGL's dual-class structure, particularly in relation to the number of shares outstanding and the potential influence of high-vote shares on corporate governance decisions?",
      "original_answer": "At META, Class A common stock has 2,189,898,148 shares outstanding with one vote per share, while Class B common stock has 343,761,117 shares outstanding, each with voting rights only in specified circumstances and tied to the conversion rate. This creates a concentrated voting structure where Class B shares can exert significant influence during specific corporate events. Similarly, GOOGL's Class B common stock has 10 votes per share, giving disproportionate voting power to holders of this class, although the rights of Class A and Class B are otherwise identical. Both companies use dual-class structures to maintain control with certain stakeholders, but META's Class B shares only gain enhanced voting rights under defined conditions, whereas GOOGL's Class B shares have consistently higher voting power. This difference affects how corporate governance decisions are influenced at each company.",
      "llm_answer": "Meta’s capital structure gives each Class A share one vote and each Class B share ten votes.  As of the most recent filing Meta had 2.19 billion Class A shares and 0.34 billion Class B shares, which translates to roughly 2.19 billion votes from Class A and 3.44 billion votes from Class B – the high‑vote shares alone command more than 60 % of the total voting power despite representing only about 13 % of the outstanding shares.\n\nAlphabet’s (GOOGL) dual‑class system is similar in that each Class B share carries ten votes while Class A shares carry one vote and Class C shares carry none.  However, Alphabet’s Class B pool is much smaller relative to its total share base (hundreds of millions of Class B versus several billions of Class A and Class C shares).  Consequently, the ten‑vote shares give founders and insiders disproportionate influence, but the voting power is less concentrated than Meta’s, where the ten‑vote shares already outweigh the one‑vote shares in total votes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual errors, particularly regarding META's voting structure. According to the ground truth, META's Class B shares do *not* have ten votes per share under normal circumstances; instead, they have voting rights only in specified circumstances and are tied to conversion conditions. The LLM incorrectly states that Class B shares have ten votes, which fundamentally misrepresents the structure. This error invalidates all subsequent calculations and comparisons. (2) The share counts are approximately correct (2.19B and 0.34B vs. 2,189,898,148 and 343,761,117), but the derived voting power calculation (3.44B votes for Class B) is based on a false premise. The claim that Class B holds over 60% of voting power is unsupported by the ground truth, which does not confirm any ongoing ten-vote structure at META. (3) For GOOGL, the LLM correctly identifies that Class B shares have ten votes and Class A have one, but the comparison is flawed because it assumes META has the same ten-vote structure, which it does not. The reasoning fails the multi-hop synthesis: it should contrast META’s conditional voting rights with GOOGL’s consistent high-vote rights, but instead treats both as structurally similar. (4) While the answer is relevant and attempts a comparative analysis, the core factual inaccuracy about voting rights severely undermines correctness. The contextual framing and structure are sound, hence moderate scores in qualitative and relevance categories, but quantitative accuracy is low due to incorrect numbers and invalid calculations based on wrong assumptions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 440,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Coca-Cola FEMSA's bottling operations in Argentina impact both KO's net sales to equity method investees and CL's organic sales growth in Latin America, considering KO's contractual pricing model with its bottlers?",
      "original_answer": "Coca-Cola FEMSA's operations in Argentina contribute to KO's $14,471 million in net sales to equity method investees in 2021 through the incidence-based concentrate pricing model, where bottler pricing and package mix directly affect the concentrate prices charged by KO. As Coca-Cola FEMSA bottles in Argentina (federal capital of Buenos Aires and surrounding areas), this relationship supports KO's financial dependency on equity method investees. Meanwhile, CL reported a 7.0% net sales increase in Latin America in 2021, with Argentina being one of the key growth drivers. Specifically, CL's Oral Care, Personal Care, and Home Care segments in Argentina benefited from favorable market conditions that also likely supported Coca-Cola FEMSA's operations, creating parallel growth effects across both companies' financial performance in the region.",
      "llm_answer": "Coca‑Cola FEMSA’s Argentine bottling business is part of the equity‑method investments that The Coca‑Cola Company reports. The Company recorded $14.5 billion of net sales to equity‑method investees in 2021 (page 89), and those sales include the concentrates and syrups sold to FEMSA’s Argentine operations (page 7). Because KO’s bottler contracts use an incidence‑based concentrate‑pricing model – the price it charges each bottler is tied to the bottler’s own pricing, channel mix and packaging (page 8) – the volume and pricing of the Argentine bottler flow directly into KO’s net sales to equity‑method investees.\n\nFor Colgate‑Palmolive, the same Argentine market was highlighted as a key contributor to the 8 % organic‑sales increase in its Latin America segment in 2021 (page 40). Thus, FEMSA’s Argentine bottling activity boosts KO’s reported sales to equity‑method investees and simultaneously underpins CL’s organic‑sales growth in Latin America.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Coca-Cola FEMSA's operations in Argentina contribute to KO's net sales to equity method investees and that KO uses an incidence-based pricing model, which ties concentrate pricing to bottler performance. It also correctly links Argentina as a growth driver for CL's Latin America segment. However, there is a key quantitative inaccuracy: the LLM states CL had an '8% organic-sales increase' in Latin America in 2021, while the ground truth specifies a 7.0% net sales increase. This discrepancy affects the correctness of the financial data. Additionally, the LLM refers to 'organic-sales increase' while the original answer cites 'net sales increase'—though related, these are not always equivalent (organic adjusts for currency/divestitures), introducing a slight metric mismatch. (2) The $14.5 billion figure for KO’s net sales to equity-method investees is a rounded version of the exact $14,471 million in the original, which is acceptable (format variation). However, the CL growth rate is off by 1 percentage point and mischaracterized as 'organic' without confirmation from the original answer, which reports 'net sales.' (3) The multi-hop reasoning is sound: the model correctly connects KO’s contractual pricing model to its sales via FEMSA in Argentina, and separately links Argentina’s market performance to CL’s regional growth. It synthesizes across KO and CL appropriately, though it assumes parallel support without explicit evidence of shared drivers beyond geography. (4) The contextual relevance is high—answer addresses both KO and CL impacts and explains the pricing mechanism. Qualitative accuracy is strong in reasoning and entity identification (KO, CL, FEMSA, Argentina, equity method, incidence-based pricing). The primary deduction is for the incorrect CL growth figure and slight metric imprecision, lowering quantitative accuracy and overall correctness to a 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 525,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Abbott's investment in private equity funds, which are valued using NAV as a practical expedient, compare to Merck's use of NAV for measuring similar alternative investments, considering the typical redemption restrictions associated with these fund types?",
      "original_answer": "Abbott holds investments in private equity funds valued at NAV, with $555 million in unfunded commitments as of December 31, 2023, and these funds cannot be redeemed but will make distributions through liquidation over periods ranging from 2024 to 2033. These private equity funds are subject to NAV valuation practices consistent with those described in UPS's 10-K, where private equity funds typically have redemption restrictions until the end of the partnership term (10–15 years) and are valued at NAV adjusted for known cash flows. Merck similarly discloses NAV-based valuations for alternative investments, reporting $382 million in NAV-based assets in 2023, including private real estate and equity funds. Both companies rely on NAV as a practical expedient for illiquid alternative investments, but Abbott faces longer liquidation timelines and greater unfunded commitments compared to Merck's disclosed NAV-based portfolio.",
      "llm_answer": "Abbott reports that its private‑equity, private‑credit, private‑real‑estate and private‑energy fund holdings are valued at the funds’ net‑asset value (NAV) on a one‑quarter lag and that, for most of these funds, investors can only redeem on a monthly or quarterly basis after a 45‑ to 90‑day notice period; a subset of the funds cannot be redeemed at all and will only return capital through liquidation over a 2024‑2033 horizon【page_71】.  \n\nMerck’s 10‑K likewise states that its alternative‑investment positions (e.g., private‑equity‑type funds) are measured at NAV, which likewise reflects the industry‑standard redemption limits—typically no‑redemption rights until the partnership term ends (often 10‑15 years) or only limited periodic redemption windows.  \n\nThus, both companies use NAV as a practical expedient to value private‑equity‑style investments, and in each case the valuations are subject to the same typical redemption restrictions that limit liquidity until scheduled redemption windows or final liquidation.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies that both Abbott and Merck use NAV as a practical expedient to value private equity and similar alternative investments, and both face typical redemption restrictions such as limited or no redemption rights until the end of partnership terms. It accurately notes Abbott's liquidation horizon (2024–2033) and references redemption mechanics like notice periods and quarterly lags. However, it omits key quantitative details from the ground truth: Abbott’s $555 million in unfunded commitments and Merck’s $382 million in NAV-based assets as of 2023. These figures are central to the comparison and were not included, significantly reducing quantitative accuracy.\n\n2) Quantitative accuracy is compromised because the LLM fails to report the specific dollar amounts for unfunded commitments (Abbott) and NAV-based assets (Merck), which are critical for comparing the scale of investments. While the timeframes (2024–2033) are correct, the absence of financial magnitudes means the comparison lacks depth and precision required by the original answer.\n\n3) Qualitatively, the reasoning is sound: the model correctly synthesizes information across Abbott and Merck, recognizes the use of NAV as a practical expedient, and links it to industry-standard redemption restrictions. It also references appropriate fund types and valuation lags. However, it incorrectly implies that most of Abbott’s funds allow monthly or quarterly redemptions with notice, which contradicts the ground truth stating that the funds 'cannot be redeemed but will make distributions through liquidation.' This misrepresents the liquidity profile and introduces a factual error.\n\n4) Contextual relevance is high—the response directly addresses the question about NAV usage and redemption restrictions, and draws a valid high-level comparison. Despite missing numbers and a partial mischaracterization of redemption terms, the overall structure and intent align well with the query. The synthesis across companies and fund types is appropriate, though not fully accurate in detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 559,
        "total_tokens": 2078
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does BlackRock's management of Separate Account Assets, which are legally segregated and not subject to general creditor claims, impact AIG's reporting of equal and offsetting Separate Account Liabilities tied directly to contract holder account balances?",
      "original_answer": "BlackRock discloses that its Separate Account Assets, which include equity securities, debt securities, money market funds, and derivatives, are legally segregated and not subject to general claims of creditors. These assets are held to fund individual and group pension contracts and are offset by equal and offsetting liabilities on BlackRock’s consolidated statements of financial condition. AIG reports Separate Account Liabilities that directly reflect the contract holder's account balance in these assets, and they are required to be equal and offsetting to the total Separate Account Assets. Therefore, any changes in the valuation or composition of BlackRock's Separate Account Assets would directly influence AIG’s liability reporting, as AIG must mirror these asset values in its liabilities to reflect the contract holders' beneficial interest.",
      "llm_answer": "BlackRock holds the separate‑account assets in a wholly‑owned UK life‑insurance subsidiary that is **legally segregated** from BlackRock’s other businesses and therefore **cannot be reached by BlackRock’s general creditors**.  Because those assets back the contract‑holder balances, AIG records a matching **Separate‑Account Liability** that is “equal and offsetting” to the assets, reflecting the amount owed to the contract holders regardless of BlackRock’s creditor claims.  The segregation thus lets AIG present a liability that mirrors the protected assets, keeping the two sides of the balance sheet in lock‑step.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core relationship between BlackRock's legally segregated Separate Account Assets and AIG's reporting of equal and offsetting liabilities. It correctly identifies that these assets are protected from BlackRock’s general creditors and that AIG records a matching liability reflecting contract holder balances. The answer conveys the essential mechanism—AIG must mirror the asset values in its liabilities—ensuring balance sheet symmetry. However, it adds a specific detail not present in the original answer or ground truth: that the assets are held in a 'wholly-owned UK life-insurance subsidiary.' This introduces an entity and jurisdictional claim (UK subsidiary) that is not supported by the provided ground truth and may be factually inaccurate or at least unverifiable from the given context. This over-specificity slightly undermines the qualitative accuracy. There are no numerical values in the question or answer, so quantitative accuracy is scored as 10 by default. The reasoning is logically sound and multi-hop synthesis (linking BlackRock's asset treatment to AIG's liability reporting) is correctly executed. The answer remains highly relevant and semantically aligned with the original, despite the extraneous detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 357,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How does AbbVie's revenue recognition for Imbruvica sales in the U.S. reflect its cost-sharing arrangement with Janssen Biotech, and how does this compare to Johnson & Johnson's global commercialization strategy for the same drug?",
      "original_answer": "AbbVie recognizes 100% of Imbruvica sales in the U.S. as net revenue, while Janssen's share of profits is deducted as part of cost of products sold, indicating a co-exclusive commercialization model where AbbVie acts as the principal. Both companies share pre-tax profits and losses equally, with Janssen covering approximately 60% of development costs and AbbVie 40%. Meanwhile, Johnson & Johnson, through its subsidiary Janssen, holds exclusive rights to commercialize Imbruvica outside the U.S. and also shares pre-tax profits equally with AbbVie. This global division of commercial rights and cost-sharing creates a dual-market strategy where Janssen leverages its international infrastructure to drive global expansion of Imbruvica, while AbbVie leads in the domestic market.",
      "llm_answer": "AbbVie records all U.S. Imbruvica sales as its own net revenue, but then deducts Janssen Biotech’s share of the co‑exclusive profit (the “Janssen share of profits” – $1.2 billion in 2023) as a cost of products sold, reflecting the 60 %/40 % development‑cost split and the 50/50 pre‑tax profit‑sharing arrangement in the U.S. collaboration【page_68】.  \n\nIn contrast, Johnson & Johnson commercializes Imbruvica worldwide through its Janssen subsidiary, which holds the exclusive license outside the United States and a co‑exclusive right in the U.S.; J&J’s earnings from the drug are therefore recognized as its proportional share of the joint‑venture profit rather than the full sales amount, consistent with the same equal‑profit‑sharing model that AbbVie describes for the partnership【page_8】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that AbbVie recognizes 100% of U.S. Imbruvica sales as net revenue and deducts Janssen's profit share as cost of products sold, reflecting the co-exclusive model. It accurately describes the 50/50 pre-tax profit sharing and notes the 60%/40% development cost split (Janssen 60%, AbbVie 40%), which matches the original answer. (2) The mention of '$1.2 billion in 2023' as Janssen’s share of profits is a specific quantitative addition not present in the ground truth; however, since this figure is plausible and consistent with public disclosures (and not contradicted by the ground truth), it does not count as an error but rather as added detail. No calculation errors are present. (3) The reasoning across entities—AbbVie, Janssen, Johnson & Johnson—is sound: it correctly identifies Janssen as a subsidiary of J&J and explains the division of commercial rights (co-exclusive in U.S., exclusive outside U.S. for Janssen). It also correctly notes that J&J reports its share of profits rather than full sales, consistent with the joint profit-sharing model. (4) The answer fully addresses both parts of the multi-hop question: revenue recognition under the cost-sharing arrangement and the comparison to J&J’s global strategy. The only minor shortcoming is that it could more explicitly state that Janssen leverages international infrastructure for global expansion, a point emphasized in the original answer. However, the core facts, synthesis, and logic are correct. Wording differs but semantic equivalence is maintained. All entities, financial terms, and relationships are accurately represented.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 461,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's supply chain execution and Apple's manufacturing operations, considering NVIDIA's dependency on foundry partners in Taiwan and Apple's reliance on manufacturing in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt NVIDIA's supply chain execution due to its dependency on foundry partners in the region, particularly for advanced GPU manufacturing. This could lead to production delays, inventory shortages, and an inability to meet customer demand, which NVIDIA has previously warned could damage customer relationships and reduce revenue. Similarly, Apple relies heavily on manufacturing operations in Taiwan, as part of its broader supply chain concentrated in the region. A disruption in Taiwan would likely delay product manufacturing and delivery, increase costs, and potentially force Apple to restructure its supply chain, which it has noted could be expensive and time-consuming. Both companies would face significant operational and financial risks due to their shared exposure to Taiwan's geopolitical stability.",
      "llm_answer": "A prolonged Taiwan‑China conflict would threaten NVIDIA’s ability to obtain wafers because the company “depends on foundries … in Taiwan” and its supply chain is “geographically concentrated” (NVDA 10‑K pp. 18‑19).  If those foundries were forced to shut down or divert capacity, NVIDIA could face “lack of guaranteed supply of wafer…higher wafer prices, longer lead‑times and production delays,” which would hurt its supply‑chain execution and margins.  \n\nApple’s manufacturing is similarly exposed: the 10‑K notes that “substantially all of the Company’s manufacturing … is performed … in Taiwan” and that “a significant portion of our key suppliers and their manufacturing foundries … are primarily located in Taiwan and Korea” (AAPL 10‑K pp. 9, 11, 35).  A sustained geopolitical clash would therefore risk “delaying or preventing our suppliers … from providing us with critical components” and could halt assembly of iPhones, iPads and other products, leading to inventory shortages, higher costs and lost sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer in both factual content and reasoning. (1) All key points are correctly addressed: NVIDIA’s dependency on Taiwanese foundries for wafer supply and the risks of production delays, higher costs, and supply shortages are accurately described, with direct citations from the NVDA 10-K (pp. 18–19). Similarly, Apple’s reliance on manufacturing and suppliers in Taiwan is correctly noted with references to AAPL 10-K (pp. 9, 11, 35), including the risk of component shortages and assembly halts. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable in a traditional sense—however, the absence of incorrect numbers and the correct use of qualitative financial and operational risks earns a perfect score here. (3) The multi-hop reasoning—linking geopolitical risk to supply chain exposure for both companies based on their SEC disclosures—is sound and well-synthesized across both 10-Ks. The LLM correctly infers operational and financial consequences (e.g., lost sales, higher costs, margin pressure) consistent with the original answer. (4) The only minor shortcoming is that the LLM does not explicitly mention the shared exposure of both companies to Taiwan’s geopolitical stability as a unifying theme, nor does it reference Apple’s potential need to restructure its supply chain at high cost, which is noted in the ground truth. This slight omission in synthesis prevents a perfect 10 on qualitative accuracy. Otherwise, the answer is contextually complete, precise, and directly responsive to the multi-part, multi-entity nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 463,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How does the use of pricing models for Level 2 fixed income investments by LMT compare to HON's use of pricing models for corporate bonds and government securities in terms of observable market data inputs and risk adjustments?",
      "original_answer": "LMT values its Level 2 fixed income investments using pricing models that rely on verifiable observable market data such as interest rates, yield curves, and credit spreads, or through bids from brokers and quoted prices of similar securities. In contrast, HON uses pricing models for corporate bonds, mortgage/asset-backed securities, and government securities that also incorporate observable inputs but may include unobservable adjustments for risks like credit and liquidity. This indicates that while both companies use pricing models involving market data, HON's valuations may involve more subjective risk-based adjustments not always present in LMT's Level 2 valuations.",
      "llm_answer": "Lockheed Martin’s Level 2 fixed‑income assets are valued with pricing models that rely on **verifiable observable market inputs** – such as current interest‑rate and yield‑curve levels and quoted credit spreads – and the fair value is derived directly from those market quotes (Lockheed Martin 10‑K p. 88).  \n\nHoneywell’s corporate bonds and government securities are also priced using models that draw on observable market data, but the company **adds explicit adjustments for non‑observable risks** (e.g., credit‑ and liquidity‑risk premiums) when the model is applied (Honeywell 10‑K p. 111).  \n\nThus, while both firms use market‑based pricing models, LMT’s approach is limited to observable inputs, whereas HON’s approach incorporates additional risk adjustments beyond the observable data.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that LMT uses pricing models for Level 2 fixed income investments based solely on verifiable observable market data such as interest rates, yield curves, and credit spreads, consistent with the original answer. It also accurately states that HON uses observable market data for corporate bonds and government securities but adds unobservable risk adjustments for credit and liquidity risks. (2) There are no numerical values (e.g., dollar amounts, percentages, dates) in the question or answers, so quantitative accuracy is not applicable in that sense, but all referenced inputs and risk factors are correctly stated—no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LMT and HON), compares their use of pricing models, and draws a valid contrast regarding the inclusion of unobservable risk adjustments in HON’s approach but not in LMT’s. The citation of specific 10-K pages (p. 88 and p. 111) adds precision, though not required, and does not detract from accuracy. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'mortgage/asset-backed securities' as part of HON’s portfolio, which the original answer includes. While not central to the core comparison about inputs and risk adjustments, this omission slightly reduces completeness. Otherwise, the semantic meaning, factual content, and reasoning are equivalent to the ground truth. Hence, a score of 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 457,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the unfavorable foreign currency exchange rate impact from a stronger U.S. dollar affect Coca-Cola's (KO) Europe, Middle East and Africa segment in 2024, and how does this compare to the exposure risk described by Mondelez (MDLZ) under similar macroeconomic conditions?",
      "original_answer": "Coca-Cola (KO) reported that fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 11% in 2024, with a stronger U.S. dollar affecting several segments including Europe, Middle East and Africa. While the euro and British pound provided some offsetting benefit, the segment was still significantly affected by the stronger dollar. Mondelez (MDLZ) similarly noted that a stronger U.S. dollar relative to other functional currencies adversely affects its consolidated earnings and net assets, as the company translates non-U.S. dollar financials into U.S. dollars for reporting. Although KO quantified the impact (11% unfavorable), MDLZ emphasized the inherent unpredictability and volatility introduced by such currency movements, despite active hedging strategies.",
      "llm_answer": "Coca‑Cola reported that the stronger U.S. dollar produced an **unfavourable foreign‑currency impact of about 15 % on the Europe, Middle East & Africa segment’s operating income in 2024** (see KO ‑ page 52). Mondelez, by contrast, only describes the same macro‑economic pressure qualitatively – it says a stronger dollar “adversely affects our consolidated earnings and net assets” and that it relies on derivative hedges but cannot fully eliminate the currency‑exchange risk (see MDLZ ‑ page 65). Thus, Coca‑Cola quantifies a sizable 15 % hit to the EMEA segment, whereas Mondelez merely flags the exposure as a general earnings‑and‑asset risk that it seeks to mitigate with hedging.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the quantitative claim — it states that the unfavorable foreign currency impact on Coca-Cola's Europe, Middle East and Africa (EMEA) segment was 'about 15%' in 2024, while the ground truth specifies an 11% unfavorable impact on *consolidated operating income*, not specifically the EMEA segment. The original answer does not isolate the EMEA segment’s exact percentage impact, so asserting a 15% hit to EMEA alone is unsupported and incorrect. This major numerical inaccuracy undermines the core of the response. (2) The date (2024) and company tickers (KO, MDLZ) are correct, and the qualitative description of Mondelez’s exposure aligns with the ground truth — MDLZ does describe the adverse effect of a stronger dollar on earnings and net assets and references hedging limitations. However, the LLM incorrectly implies that MDLZ provides no quantitative data at all, while the ground truth does not rule out qualitative-only reporting — but also doesn’t confirm it. (3) The multi-hop reasoning is partially sound: the model correctly identifies that KO faced currency headwinds and that MDLZ faces similar macro risks, and it draws a valid contrast in disclosure style (quantitative vs. qualitative). However, the synthesis fails because it fabricates a segment-specific figure not present in the ground truth, breaking the chain of accurate inference. (4) Contextual relevance is high — the answer addresses both parts of the question and uses appropriate financial terminology. Due to the critical numerical error, the correctness and quantitative accuracy scores are low, but qualitative reasoning and relevance are reasonably maintained.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 467,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How does the $365 million in long-lived assets that AVGO reported in Taiwan for fiscal 2024 compare to the risk QCOM highlighted regarding its reliance on foundry partners in Taiwan for chipset supply, particularly in the context of geopolitical tensions involving China and Taiwan?",
      "original_answer": "AVGO reported $365 million in long-lived assets in Taiwan for fiscal 2024, indicating a significant operational presence in the region. Meanwhile, QCOM explicitly stated that its business depends on receiving consistent and reliable chipset supply from foundry partners in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent this supply, materially impacting QCOM’s business. This highlights that both companies have substantial exposure to Taiwan, but while AVGO’s exposure is reflected in its asset base, QCOM’s risk is operational and supply chain-dependent, making them vulnerable to the same regional geopolitical tensions in different ways.",
      "llm_answer": "Broadcom reported $365 million of long‑lived assets (property, plant and equipment) located in Taiwan for fiscal 2024【page_91】. Qualcomm, by contrast, does not quantify a monetary exposure but warns that its business “depends on our ability to receive consistent and reliable chipset supply from our foundry partners, particularly in Taiwan,” and that a “significant or prolonged military or other geopolitical conflict involving China and Taiwan could severely limit or prevent us from receiving chipset supply from Taiwan, which would have a material adverse impact on our business”【page_35】. Thus, Broadcom’s $365 million reflects a concrete asset stake in Taiwan, whereas Qualcomm’s risk is an operational supply‑chain vulnerability that could disrupt its chipset production if Taiwan‑China tensions escalated.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $365 million in long-lived assets for AVGO (Broadcom) in Taiwan for fiscal 2024 is accurately reported, with correct formatting and context. (2) The answer correctly identifies that QCOM (Qualcomm) does not report a monetary value for its Taiwan exposure but highlights operational risk related to foundry partners in Taiwan, accurately quoting the nature and impact of geopolitical tensions. (3) Multi-hop reasoning is sound: it synthesizes AVGO’s asset-based exposure with QCOM’s supply chain risk, correctly contrasting the two types of exposure (asset vs. operational) while linking both to the same geopolitical concern. (4) Entities (AVGO/Broadcom, QCOM/Qualcomm), fiscal year (2024), and financial metric (long-lived assets) are all correctly identified. (5) The answer is semantically equivalent to the original, with slightly enhanced clarity through the use of quotes and page references. All scoring categories warrant perfect marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 298,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How does Apple's reliance on manufacturing operations in Taiwan for a majority of its product assembly impact its exposure to regional geopolitical risks compared to Microsoft's business operations in Greater China through its regional center in Singapore?",
      "original_answer": "Apple's reliance on manufacturing in Taiwan for a significant portion of its product assembly increases its exposure to regional geopolitical risks, particularly given that Taiwan is included in Apple's Greater China segment, which is subject to trade policies and disputes that could result in tariffs, sanctions, and other business restrictions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports logistics and vendor management across the region. However, unlike Apple, Microsoft's operations are not heavily dependent on localized manufacturing, reducing its exposure to supply chain disruptions tied to geopolitical tensions. Apple's outsourced manufacturing in Asia, including Taiwan, makes it more vulnerable to interruptions from tariffs, export controls, and public health crises, while Microsoft's regional center in Singapore primarily supports administrative and logistics functions, which can be more easily adapted or relocated if necessary.",
      "llm_answer": "Apple’s 10‑K notes that “substantially all of the Company’s manufacturing is performed … in Asia, including … Taiwan” and that a “significant concentration of this manufacturing is currently performed by a small number of outsourcing partners, often in single locations” (Apple 10‑K p. 9).  Because most iPhone, iPad and Mac assembly is done in Taiwan, Apple is directly exposed to any cross‑strait political tension, trade restrictions or natural‑disaster events that affect that island, and a disruption there could quickly impair product supply and margins.  \n\nMicrosoft, by contrast, runs its Greater‑China operations from a regional services center in Singapore (Microsoft 10‑K p. 16) and its devices are built by “third‑party contract manufacturers” located throughout Asia, with the ability to shift to other vendors if a single site becomes unavailable (Microsoft 10‑K p. 16).  Thus Microsoft’s exposure to Taiwan‑specific geopolitical risk is lower; its risk is broader‑based to the whole Asia‑Pacific region and to the functioning of its Singapore hub rather than to a single manufacturing locale.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Apple's heavy reliance on manufacturing in Taiwan through outsourced partners, citing its 10-K to support the claim, and accurately contrasts this with Microsoft's regional operations center in Singapore. The key factual elements—Apple’s concentration of assembly in Asia/Taiwan and Microsoft’s decentralized manufacturing and administrative hub in Singapore—are all correct. (2) There are no numeric values, dates, or financial figures in either the question or answers, so quantitative accuracy is not applicable in a traditional sense; however, the absence of incorrect numbers and proper referencing of qualitative disclosures (e.g., 'substantially all' manufacturing in Asia) maintains full fidelity, warranting a 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Apple’s and Microsoft’s 10-Ks to compare their differing exposure to geopolitical risk based on operational structure. It captures the core distinction—Apple’s vulnerability due to concentrated manufacturing vs. Microsoft’s flexibility via distributed contract manufacturing and a non-manufacturing regional hub. The only minor shortcoming is a slight underemphasis on the 'Greater China segment' classification of Taiwan in Apple’s reporting, which is mentioned in the original answer and adds regulatory context. However, the geopolitical risk from cross-strait tensions is adequately covered. (4) The answer is fully contextually relevant, directly addressing the comparative exposure to regional geopolitical risks as structured in the question. Overall, the response is factually correct, well-supported, and logically structured—just shy of perfect due to the slight omission of Apple’s segment reporting nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 495,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did Nebraska's 2023 corporate tax rate reduction impact Union Pacific's deferred tax expense in relation to Boeing's exposure to federal appropriations delays as disclosed in their respective 10-K filings?",
      "original_answer": "Nebraska's 2023 corporate tax rate reduction contributed to a $114 million reduction in Union Pacific's deferred tax expense, as disclosed in their 2024 10-K filing. In contrast, Boeing highlighted in its 2024 10-K that delays in U.S. government appropriations, such as continuing resolutions or government shutdowns, could disrupt operations, delay new programs, and negatively impact revenue. While Union Pacific benefited from state-level tax legislation, Boeing faces regulatory and funding risks tied to federal legislation, which could impair its ability to execute contracts or deliver commercial airplanes.",
      "llm_answer": "Union Pacific disclosed that the 2023 corporate‑income‑tax‑rate reductions enacted by Nebraska (along with Iowa, Kansas and Arkansas) cut its deferred‑tax expense by **$114 million** for the year. In contrast, Boeing’s 10‑K only flags the risk that **delays in federal appropriations could disrupt cash‑flows, delay program execution and affect earnings**, but it does not quantify a dollar‑amount impact. Thus, Union Pacific’s tax‑rate change produced a measurable $‑114 million reduction, whereas Boeing’s exposure to appropriations delays remains a qualitative risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $114 million reduction in Union Pacific's deferred tax expense is correctly reported, matching the original answer. The absence of a quantified impact for Boeing is also accurately reflected—Boeing’s 10-K discloses only qualitative risks related to federal appropriations delays. (2) The LLM correctly identifies the relevant entities: Union Pacific and Boeing, and the correct time frame (implied 2023 tax changes affecting 2024 10-K disclosures). It also correctly references Nebraska’s tax rate reduction, though it adds Iowa, Kansas, and Arkansas—information not in the ground truth. This addition, while potentially true, slightly overreaches the scope of the question, which focuses only on Nebraska. (3) The multi-hop reasoning is sound: the model contrasts a measurable financial benefit (Union Pacific’s tax savings) with a non-quantified operational risk (Boeing’s appropriations exposure), which is the core of the comparative analysis requested. (4) The answer is contextually relevant and synthesizes information across both companies’ filings appropriately. The only minor deviation is the inclusion of other states’ tax changes, which, while not incorrect, introduces extraneous detail not in the original answer. This does not undermine correctness but slightly affects qualitative precision. Hence, a score of 9/10 on correctness and qualitative accuracy is warranted, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 424,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How might the expiration timelines of specific Enbrel-related patents in the U.S. influence MRK's strategic focus on maintaining patent protection for its own products, given the competitive dynamics in the biopharmaceutical industry?",
      "original_answer": "The expiration timelines for Enbrel-related patents in the U.S.—including the Fusion protein and pharmaceutical compositions patent expiring on 11/22/2028, the DNA encoding fusion protein and methods of making fusion protein patent on 4/24/2029, and the formulations and methods of preparing formulations patent on 10/19/2037—suggest a phased decline in AMGN's exclusivity for this product. This gradual patent erosion likely reinforces MRK's emphasis on actively protecting its own patents, as outlined in its 2024 10-K, where it states that loss of patent protection typically leads to generic substitutes and reduced sales. MRK acknowledges that political and regulatory pressures to encourage early approval of generics could further exacerbate this risk, making robust patent defense a strategic imperative to maintain market position and profitability in the face of increasing biosimilar competition.",
      "llm_answer": "Amgen’s filing shows that its core Enbrel patents in the United States run until 11 Nov 2028 (fusion‑protein composition), 24 Apr 2029 (DNA‑encoding fusion protein) and even 19 Oct 2037 for the formulation (Amgen 10‑K, p. 11). Because the biopharma market is “intensely competitive” and loss of patent protection “is followed promptly by generic or biosimilar substitutes” that can erode sales (Merck 10‑K, p. 33), the long‑run Enbrel protection highlights the risk of a product’s revenue falling once exclusivity ends. Consequently, Merck is likely to double‑down on extending and defending patents for its own blockbuster assets (e.g., Keytruda, Gardasil, Lynparza) and on building a pipeline of next‑generation therapies to avoid a similar post‑expiry sales decline.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All dates are correct: 11/22/2028 (listed as Nov 11, 2028 — minor formatting difference, acceptable), 4/24/2029 (Apr 24, 2029), and 10/19/2037 (Oct 19, 2037). These match the original answer exactly in substance. (2) The answer correctly cites Amgen’s 10-K and Merck’s 2024 10-K (implied by reference to p.33, consistent with MRK’s disclosures), confirming entity and source accuracy. (3) The reasoning is sound: it connects Enbrel’s phased patent expirations to the broader competitive biopharma landscape, infers strategic implications for Merck, and references Merck’s own stated risk regarding generic/biosimilar substitution post-patent expiry. (4) The LLM adds contextual value by naming Merck’s key products (Keytruda, Gardasil, Lynparza), which are not in the original answer but are factually relevant and support the logical extension of the argument. This demonstrates strong multi-hop synthesis across Amgen’s patent data and Merck’s strategic disclosures. The only minor shortcoming is that the original answer explicitly mentions political and regulatory pressures encouraging generics, a nuance slightly underemphasized in the LLM version, though the core strategic imperative is still conveyed. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 380,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has AMD's revenue from operations in Taiwan compared to Apple's revenue contribution from Taiwan (as part of Greater China) in 2022, and what does this suggest about their relative market presence in the region?",
      "original_answer": "In 2022, AMD reported $2,091 million in revenue from operations in Taiwan. Apple, on the other hand, reported $74,200 million in net sales from the Greater China region, which includes Taiwan, China mainland, and Hong Kong. Since Taiwan is only a subset of Apple's Greater China segment, and no specific breakdown is provided for Taiwan's contribution within that region, we cannot directly compare the absolute revenue from Taiwan between the two companies. However, AMD's $2,091 million in Taiwan revenue represents a significant portion of its regional operations, whereas Apple's revenue in the broader Greater China region dwarfs AMD's exposure. This suggests that while Taiwan is a meaningful market for AMD, Apple's market presence and revenue scale in the broader Greater China region, including Taiwan, is substantially larger.",
      "llm_answer": "AMD generated roughly **$2.1 billion** in sales to customers in Taiwan (its “sales to external customers” table shows Taiwan at $2,091 million)【page_78】.  \n\nApple’s “Greater China” segment – which includes mainland China, Hong Kong and Taiwan – recorded **$74.2 billion** of net sales in 2022【page_52】.  \n\nThus, Apple’s revenue tied to the Taiwan‑inclusive Greater China region is an order of magnitude larger than AMD’s Taiwan‑only revenue, indicating that Apple has a far stronger market presence in that part of Asia.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports AMD's 2022 revenue from Taiwan as $2,091 million (rounded to $2.1 billion), matching the ground truth. Apple's Greater China net sales are accurately cited as $74.2 billion, consistent with the original answer. All numeric values are correct and properly attributed to the respective companies and regions. (2) Quantitative accuracy is perfect: $2,091 million = $2.1 billion and $74,200 million = $74.2 billion; both figures match the ground truth, and the order-of-magnitude comparison is valid. (3) The reasoning is sound: the LLM correctly identifies that Apple’s revenue includes Taiwan as part of a broader region (Greater China), while AMD’s figure is specific to Taiwan. It avoids claiming a direct comparison of Taiwan-only revenues, which aligns with the original answer’s caution. However, it slightly underplays the uncertainty in comparing the two due to Apple’s lack of Taiwan-specific breakdown—this nuance is present in the ground truth but not explicitly stated in the LLM answer. Still, the conclusion about Apple’s stronger regional presence is logically supported. (4) The answer is contextually relevant, directly addressing both parts of the question: the revenue comparison and the implication for market presence. The only minor gap is the absence of explicit mention that Taiwan is a subset within Apple’s reporting segment, which slightly reduces qualitative accuracy, but the implication is still correctly drawn.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 409,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does Alphabet's repurchase of Class C shares, which carry no voting rights, enable different capital allocation flexibility compared to Netflix's share repurchase strategy under its uniform voting rights structure?",
      "original_answer": "Alphabet's repurchase of Class C shares, which carry no voting rights, allows the company to return capital to shareholders while preserving insider control through the retention of higher-vote Class A and B shares. In 2023, Alphabet repurchased $62.2 billion of Class A and Class C shares, with an additional $36.3 billion remaining available under the repurchase authorization. In contrast, Netflix's capital stock carries uniform voting rights — one vote per share — meaning any significant share repurchase could potentially dilute voting control among existing shareholders. This structural difference implies that Netflix may need to be more cautious in its repurchase activity to avoid unintended shifts in governance, unlike Alphabet which can execute larger buybacks without affecting its core governance structure.",
      "llm_answer": "Alphabet can retire its non‑voting Class C shares – which “has no voting rights, except as required by applicable law” (page 81) – without altering the balance of voting power among shareholders, so the company can return cash or adjust its capital structure while preserving control. Netflix, by contrast, has a single‑class common stock in which “the holders of each share of common stock shall be entitled to one vote per share” (page 61), so any buy‑back reduces both equity and voting power, limiting the firm’s ability to separate capital‑return decisions from control considerations. Thus Alphabet’s Class C repurchases give it greater flexibility to allocate capital independently of voting influence, whereas Netflix’s uniform‑voting structure ties its repurchase activity directly to its voting base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that Alphabet's Class C shares carry no voting rights and that repurchasing them allows capital return without affecting voting control, while Netflix's uniform voting structure (one vote per share) means buybacks reduce voting power proportionally. This captures the key contrast in capital allocation flexibility due to governance structure. (2) The LLM answer does not include the specific dollar figures from the original answer ($62.2 billion repurchased, $36.3 billion remaining), which are quantitative omissions. However, the question does not explicitly ask for these numbers, so their absence does not undermine the conceptual explanation. All other factual claims (e.g., share classes, voting rights, implications for control) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about corporate share structures (from implied 10-K references) and infers the strategic implications for share repurchases and governance. It logically connects Alphabet’s dual-class structure to greater capital allocation flexibility, contrasting it with Netflix’s single-class constraints. (4) The answer is contextually relevant and directly addresses the comparative aspect of the question. The only reason for not scoring a 10 is the omission of the specific financial figures present in the original, which, while not critical to the main argument, add completeness. Wording differences are acceptable and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 434,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does MET's exposure to non-agency pass-through mortgage-backed securities with $1,699 million in NQM and Alt-A loans compare to AIG's liquidity risk from mortgage assets, particularly in light of MET's $1,294 million in unrealized losses on pass-through securities versus AIG's concerns about valuing illiquid mortgage-related investments?",
      "original_answer": "MET holds $12,567 million in pass-through mortgage-backed securities, including $1,699 million in NQM and Alt-A loans categorized under non-agency RMBS, with $1,294 million in unrealized losses in 2024. These pass-through securities are directly secured by pools of mortgage loans, including lower-quality segments like NQM and Alt-A that carry elevated credit risk. AIG, meanwhile, faces liquidity risk from its mortgage and loan portfolio, particularly due to its holdings of less liquid assets like private equity, hedge funds, mortgage loans, and real estate. AIG explicitly warns that adverse market conditions or valuation volatility in these assets could lead to material losses if sold in stressed environments. Thus, while MET's exposure is more specifically defined and marked-to-market with known unrealized losses, AIG's risk lies in the uncertain valuation and potential illiquidity of its broader mortgage-linked investments, which could realize even greater losses under unfavorable market conditions.",
      "llm_answer": "MET’s RMBS portfolio includes $1.7 billion of non‑agency securities that are classified as non‑qualified (NQM) and Alt‑A loans, and the pass‑through mortgage‑backed securities segment carries a $1.3 billion unrealized loss at year‑end 2024 (see MET 10‑K p. 88). In contrast, AIG does not quantify a specific dollar amount but warns that a sizable portion of its investment portfolio consists of illiquid mortgage‑related assets (including residential RMBS) whose valuation is difficult and that, if market conditions worsen, could limit AIG’s ability to generate cash and create a material liquidity risk (see AIG 10‑K p. 20‑21).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all numbers are correct: $1.7 billion (rounded from $1,699 million) for non-agency NQM and Alt-A loans, and $1.3 billion (rounded from $1,294 million) in unrealized losses are properly reported for MET in 2024. The LLM correctly notes that AIG does not provide a specific dollar amount, which aligns with the original answer. (2) The formatting variations ($1.7 billion vs $1,699 million) are acceptable and do not affect accuracy. (3) The qualitative reasoning is sound: the LLM correctly identifies that MET’s exposure is specifically quantified and marked-to-market, while AIG’s risk stems from valuation uncertainty and illiquidity in mortgage-related assets, including RMBS. It accurately cites AIG’s liquidity risk due to difficult valuation and potential cash generation issues under stress. (4) The multi-hop synthesis across MET and AIG is appropriate—comparing MET’s concrete, measured unrealized losses to AIG’s qualitative, forward-looking liquidity concerns. The only minor shortcoming is that the LLM omits MET’s total pass-through MBS portfolio size ($12,567 million), which provides context for the $1,699 million NQM/Alt-A segment. While not critical to the core comparison, this detail would have improved completeness. Otherwise, the answer is factually correct, well-reasoned, and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 393,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the revenue contribution from beverage operations in the Asia Pacific region compare between Coca-Cola (KO) and PepsiCo (PEP) in 2021, based on their regional and product segment reporting?",
      "original_answer": "In 2021, Coca-Cola (KO) generated $4,682 million in third-party beverage revenue from its Asia Pacific (APAC) operations. PepsiCo (PEP) reported that 20% of its total revenue in the APAC region came from beverage operations, though the exact dollar amount is not disclosed. This indicates that while KO's APAC beverage revenue is directly quantifiable for 2021, PEP's APAC beverage revenue would require further calculation based on total regional revenue to determine the precise figure.",
      "llm_answer": "In 2021 Coca‑Cola’s Asia‑Pacific operating segment generated **about $5.3 billion** in net operating revenues, which for Coca‑Cola is essentially all beverage revenue. PepsiCo’s Asia‑Pacific division reported **$4.6 billion** of total net revenue, of which **≈20 %** is from beverages, equating to roughly **$0.9 billion**. Thus, Coca‑Cola’s beverage revenue in the region was roughly **five‑to‑six times larger** than PepsiCo’s.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Coca-Cola's 2021 third-party beverage revenue in APAC was $4,682 million ($4.682 billion), but the LLM states 'about $5.3 billion', which is incorrect. For PepsiCo, the ground truth confirms that 20% of APAC revenue came from beverages but explicitly states the dollar amount is not disclosed. However, the LLM incorrectly calculates PepsiCo's APAC beverage revenue as $0.9 billion (20% of $4.6 billion), which is unsupported because the $4.6 billion total APAC revenue figure is not in the original answer and cannot be verified from the provided truth. (2) The calculation of $4.6 billion × 20% = $0.9 billion is mathematically correct, but it is based on fabricated input data. The comparison that Coca-Cola’s revenue was 'five-to-six times larger' is therefore also invalid, as it relies on incorrect underlying figures. (3) The multi-hop reasoning fails because the model invents PepsiCo’s total APAC revenue rather than acknowledging it is not disclosed, as required by the ground truth. It incorrectly synthesizes non-existent data to produce a precise comparison that cannot be made from the available information. (4) While the answer addresses the question's structure and attempts a comparison (hence moderate contextual relevance), the core quantitative claims are false, and the reasoning is flawed, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 401,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does Gilead's revenue-sharing structure with Merck for long-acting HIV products compare to Merck's royalty obligations to BMS and Ono for Keytruda sales, and what implications does this have for Merck's profitability from both partnerships?",
      "original_answer": "Gilead and Merck share global product revenues equally for long-acting HIV products until $2.0 billion (oral) or $3.5 billion (injectable) in net sales are surpassed, after which Gilead's share increases to 65%. Meanwhile, Merck pays BMS and Ono royalties of 6.5% through 2023 and 2.5% from 2024–2026 on global Keytruda sales, with BMS receiving 75% of those payments. In 2023, Merck recorded $212 million in alliance revenue from its collaboration with BMS on Reblozyl, which includes a 20–24% sales royalty. These structures indicate that Merck both shares in revenue from joint development (with Gilead) and pays significant royalties (to BMS and Ono), which directly affects its net profitability from these partnerships depending on the scale of product sales.",
      "llm_answer": "Gilead’s agreement with Merck gives each company an equal (50 %) split of global product revenue from the long‑acting oral and injectable HIV combos until the products exceed set thresholds ($2 billion for oral, $3.5 billion for injectable); beyond those levels Gilead’s share rises to 65 % and Merck’s falls to 35 % (no revenue has been recognized yet)【page_76】. By contrast, Merck must pay ongoing royalties on every dollar of Keytruda sales – 6.5 % of net sales through 2023 (dropping to 2.5 % thereafter) – with the royalty bill split 75 % to BMS and 25 % to Ono, amounting to roughly $1.2 billion in 2023 alone【page_90】. Consequently, the HIV partnership offers Merck a potential upside that is contingent on future product success but limits its share of revenue, whereas the Keytruda royalty obligation is an immediate, sizable cost that directly reduces Merck’s profitability on that blockbuster drug.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures all key quantitative elements from the ground truth: the 50% revenue split between Gilead and Merck up to $2B (oral) and $3.5B (injectable) thresholds, Gilead's increased 65% share beyond those thresholds, the 6.5% royalty rate through 2023 and 2.5% from 2024–2026 on Keytruda sales, and the 75%/25% split of royalty payments between BMS and Ono. The mention of ~$1.2B in royalty payments in 2023 is consistent with known Keytruda sales (approx $24B in 2023; 6.5% of that is ~$1.56B, but split 75% to BMS implies ~$1.17B to BMS and ~$0.39B to Ono, totaling ~$1.56B in total royalties — the $1.2B figure may reflect a partial or adjusted amount, possibly net or pre-tax, but is in the plausible range and does not constitute a factual error given contextual interpretation). (2) The LLM adds contextual detail not in the original — that no revenue has been recognized yet from the Gilead-Merck HIV collaboration — which is plausible and consistent with development-stage products, and cites page numbers (76, 90), suggesting proper grounding. (3) The multi-hop reasoning is sound: it contrasts Merck’s revenue-sharing (upside potential with capped share) in HIV with its royalty outflows (immediate cost) for Keytruda, correctly inferring the divergent impact on profitability. (4) The only minor omission is the mention of Merck’s $212M alliance revenue from BMS on Reblozyl (including 20–24% royalty), which is part of the original answer but not included in the LLM response. However, this is a secondary detail and does not undermine the core comparison between the two partnership structures. Overall, the LLM answer is factually accurate, well-reasoned, and contextually appropriate, with only slight incompleteness on a peripheral point.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 487,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does BAC's investment in CDOs, which contain embedded credit default swaps that transfer risk through tranche structures, compare to AIG's $75 million loss from embedded derivatives in 2024, considering the role of credit events in triggering losses for both institutions?",
      "original_answer": "BAC invests in CDOs, which are hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer. These structures pass credit event losses from junior tranches to more senior ones, exposing investors like BAC to cascading risk. AIG, in turn, reported a $75 million loss from embedded derivatives in 2024, which includes similar instruments like credit default swaps tied to reference entities. A credit event in the underlying reference entity would directly impact both BAC’s CDO value and AIG’s derivative exposure, linking their financial risks through the same type of structured credit mechanism.",
      "llm_answer": "Bank of America’s CDO investments are held through VIEs that embed credit‑default‑swap protection and allocate that protection across senior‑ and junior‑tranches; the company reports a **maximum loss exposure of roughly $7 billion** for those VIE positions (e.g., $7,353 million for the residential‑mortgage VIEs)【page_130】.  By contrast, AIG recorded an **actual $75 million loss** in 2024 from embedded derivatives that were triggered when a credit event occurred on the underlying reference obligations【page_144】.  In both cases a credit event – a default or restructuring of the reference entity – is the loss‑trigger, but BAC’s exposure is a far larger, off‑balance‑sheet potential loss, whereas AIG’s loss was a realized, relatively modest amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: BAC's maximum loss exposure of $7.353 billion (rounded to $7 billion) for residential-mortgage VIEs and AIG's $75 million actual loss in 2024 match the source data. The years, amounts, and formatting (e.g., $75 million vs $75M) are consistent and acceptable. (2) The answer addresses all parts of the multi-hop question: it explains BAC’s CDO structure with embedded credit default swaps and tranche-based risk allocation, AIG’s $75M loss from embedded derivatives in 2024, and the role of credit events as a common trigger. (3) Entity accuracy is strong: BAC and AIG are correctly identified, as are the financial instruments (CDOs, credit default swaps, VIEs), and the year 2024 is correctly attributed to AIG’s loss. (4) Reasoning is sound: the LLM correctly contrasts BAC’s potential off-balance-sheet exposure with AIG’s realized loss, highlighting the shared risk mechanism via credit events. The only minor shortcoming is that the original answer emphasizes the 'cascading risk' through tranches and the 'hybrid instrument' nature of CDOs more explicitly, which the LLM touches on but could have elaborated slightly. However, the core multi-hop synthesis—linking BAC’s structural exposure and AIG’s realized loss through credit event triggers—is accurately conveyed. Thus, the answer is factually complete and semantically equivalent to the ground truth, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 412,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "What specific roles does Citibank, N.A. hold in both 3M's May 2023 Five-Year Credit Agreement and Caterpillar's September 2022 credit facilities, and how do these roles differ in terms of administrative responsibilities across the two agreements?",
      "original_answer": "In 3M’s May 2023 Five-Year Credit Agreement, Citibank, N.A. serves as an administrative agent and joint lead arranger alongside JPMorgan Chase Bank, N.A., with responsibilities including coordination of the lending group and oversight of borrowing procedures. In Caterpillar’s September 2022 credit facilities, Citibank, N.A. acts as the Agent for both the 3-Year and 5-Year Facilities, and also as the Local Currency Agent through Citibank Europe plc, UK Branch, and Japan Local Currency Agent in coordination with MUFG Bank, Ltd. These roles differ in that Citibank holds multiple layered responsibilities in Caterpillar’s structure, including cross-border coordination, while at 3M it shares leadership with another bank without such international scope.",
      "llm_answer": "- In 3M’s May 2023 Five‑Year Credit Agreement, Citibank, N.A. is named **the administrative agent** for the revolving credit facility.  \n\n- In Caterpillar’s September 2022 credit facilities, Citibank, N.A. is also listed as **the agent** for the facility, but the agreement designates it **both as the administrative agent and as the local‑currency agent for the U.S. dollar portion of the facility** (with separate agents for other currencies).  \n\nThus, while Citibank’s role in both deals is to act as the primary administrator of the loan, the Caterpillar facility expands that responsibility to include local‑currency administration, whereas the 3M agreement limits Citibank’s duties to a single U.S.‑dollar administrative‑agent function.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in entity roles and responsibilities, particularly regarding the structure and scope of Citibank's roles in the two credit agreements. (1) On quantitative accuracy: All dates (May 2023, September 2022) and entity names (Citibank, N.A., 3M, Caterpillar) are correct, and there are no numerical errors—thus scoring 10. (2) However, the qualitative accuracy is low because the LLM misrepresents key aspects of Citibank’s roles. In the 3M agreement, Citibank is not 'the' administrative agent alone—it is a *joint* administrative agent and joint lead arranger alongside JPMorgan Chase Bank, N.A., a critical detail omitted in the LLM answer. This shared leadership role is a key differentiator. In Caterpillar’s facilities, the LLM incorrectly simplifies the structure: Citibank, N.A. acts as Agent for both 3-Year and 5-Year Facilities, but the local currency agent roles are more complex—Citibank Europe plc, UK Branch serves as Local Currency Agent, and MUFG Bank, Ltd. is involved as Japan Local Currency Agent. The LLM incorrectly states that Citibank, N.A. serves as both administrative and local-currency agent for the U.S. dollar portion, which mischaracterizes the agreement. (3) The multi-hop reasoning is flawed: while the model attempts to compare roles across agreements, it fails to accurately synthesize the layered, cross-border responsibilities in Caterpillar’s case versus the shared, domestic-focused role in 3M’s. (4) Contextual relevance is high because the answer addresses the core question about roles and differences in administrative responsibilities, but due to factual inaccuracies in the nature and structure of those roles, the overall correctness score is reduced to 6—partially correct but with significant omissions and misrepresentations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 496,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How does the use of option contracts by KO to hedge foreign currency exposure compare with PEP's foreign exchange risk management strategy, given the impact of these instruments on their respective foreign currency liabilities?",
      "original_answer": "KO uses option contracts as part of its derivative strategy to hedge foreign currency exchange rate risk, aiming to mitigate the impact of currency fluctuations on its financial performance. These contracts are designated as cash flow hedges and affect KO's foreign currency liabilities by deferring gains and losses in AOCI until the hedged transactions occur. Similarly, PEP actively manages foreign exchange risk through derivatives, including option and forward contracts, which are also used to hedge forecasted transactions and firm commitments. PEP reported that foreign exchange movements unfavorably impacted net revenue by 1.5 percentage points in 2024, highlighting the importance of these hedges. Both companies rely on option contracts to manage foreign currency liabilities, but KO specifically emphasizes the deferral of mark-to-market impacts in AOCI, while PEP focuses on offsetting exposure from its significant international operations (44% of revenue).",
      "llm_answer": "Coca‑Cola’s foreign‑currency program relies chiefly on **designated cash‑flow hedges** – forward contracts, purchased options and collars that are recorded at fair value in AOCI and only re‑classified into earnings when the underlying cash‑flow occurs. The fair‑value of the foreign‑currency contracts that sit on the liability side of the balance sheet (e.g., $14 million on accounts payable and $39 million on other non‑current liabilities) therefore affect earnings indirectly, through the AOCI re‑classification mechanism.  \n\nPepsiCo also uses options and forwards, but it combines **designated cash‑flow hedges** (net notional $9.9 billion) with a sizable pool of **non‑designated foreign‑exchange contracts** whose gains and losses are recognized immediately in earnings (e.g., a $63 million loss on foreign‑currency‑denominated assets and a $6 million loss on interest expense). Thus, PepsiCo’s strategy produces a more direct impact on the income statement of its foreign‑currency liabilities, whereas Coca‑Cola’s option‑based hedges keep most of the effect in AOCI until the hedged transaction is settled.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all key aspects of the question with strong multi-hop reasoning. It correctly identifies that both KO and PEP use option contracts as part of their foreign exchange risk management, with KO emphasizing cash flow hedges recorded in AOCI, while PEP uses both designated and non-designated derivatives. The qualitative distinction between KO's deferral of mark-to-market impacts via AOCI and PEP's more direct income statement impact due to non-designated contracts is well articulated and aligns with the ground truth. However, the ground truth mentions PEP's 1.5 percentage point unfavorable impact on net revenue in 2024 and that 44% of its revenue comes from international operations—specific contextual details not included in the LLM response, slightly reducing completeness. Quantitatively, the LLM introduces specific figures not in the original answer: $14M in accounts payable, $39M in other non-current liabilities, $9.9B net notional for PEP’s designated hedges, and $63M/$6M losses. While plausible, these numbers are not present in the ground truth and cannot be verified against it, lowering quantitative accuracy slightly. Still, the use of such figures supports the reasoning and does not contradict known facts. The entities (KO, PEP), financial instruments (options, forwards), and accounting treatments (AOCI, cash flow hedges) are correctly identified. The comparison of strategies—KO’s more deferred, conservative approach vs. PEP’s mixed model with immediate earnings impact—is logically sound and semantically equivalent to the original. Thus, the answer is factually strong, contextually relevant, and well-reasoned, meriting a high correctness score despite minor omissions and unverified numerical additions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 481,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "How does the use of discounted cash flow models by GE in assessing goodwill impairment risk compare with LMT's application of DCF in valuing Level 3 fixed income investments, particularly in terms of sensitivity to discount rate assumptions and projected cash flow estimates?",
      "original_answer": "GE uses a discounted cash flow (DCF) approach as part of its annual goodwill impairment testing, relying on cash flow forecasts, terminal value assumptions, and discount rates to estimate fair value. The company performs sensitivity analyses due to the material impact that changes in these assumptions could have on impairment determinations. Similarly, LMT applies DCF models to value certain Level 3 fixed income investments when observable market data is unavailable, using projected annuity payments and discount rates as key inputs. Both companies depend on forward-looking cash flow projections and discount rate assumptions, making their valuations sensitive to shifts in economic conditions or interest rate environments. However, GE’s DCF use is tied to internal strategic and operational planning, while LMT’s is externally focused on asset valuation within its pension fund investments.",
      "llm_answer": "GE says that its goodwill‑impairment test uses a discounted‑cash‑flow model built on internal cash‑flow forecasts and a terminal‑value assumption, and it explicitly runs sensitivity analyses because a change in the discount rate or the projected cash‑flow estimates can materially alter the fair‑value result. Lockheed Martin also values its Level 3 fixed‑income holdings with a discounted‑cash‑flow approach that relies on projected annuity payments and the discount rate applied to them, but the filing does not describe formal sensitivity testing, implying the valuation is likewise rate‑ and cash‑flow‑dependent but without the same stated emphasis on quantifying that sensitivity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. It correctly identifies that GE uses DCF models for goodwill impairment testing, relying on internal cash flow forecasts, terminal value, and discount rates, and explicitly conducts sensitivity analyses due to the material impact of assumption changes. It also accurately states that LMT applies DCF to value Level 3 fixed income investments using projected annuity payments and discount rates, particularly when market data is lacking. The answer correctly contrasts GE’s internal strategic use of DCF with LMT’s external asset valuation purpose, noting the absence of explicit sensitivity testing disclosures in LMT’s filings. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (GE, LMT, goodwill impairment, Level 3 fixed income, DCF components) are correctly identified. The reasoning is sound and synthesizes multi-hop information across both companies’ practices. The only minor shortcoming is a slightly less explicit articulation of the shared sensitivity to economic and interest rate shifts compared to the original answer, but this is implied in the discussion of rate and cash flow dependence. Thus, the answer is semantically equivalent with high completeness and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 362,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the voting power distribution in CMCSA's Class A and Class B common stock compare to GOOGL's structure, given the repurchase activity and voting rights differences?",
      "original_answer": "In CMCSA, holders of Class A common stock collectively hold 66 2/3% of the combined voting power, while Class B common stock (held entirely by Brian L. Roberts) holds 33 1/3%, with each Class B share carrying 15 votes. In contrast, GOOGL's Class A shares carry 1 vote each, while Class B shares have 10 votes per share, giving disproportionate voting power to Class B holders in both companies. Additionally, GOOGL repurchased $62.2 billion of Class A and Class C shares in 2023, which could affect ownership concentration and voting dynamics, though CMCSA does not disclose such repurchase volumes for Class A shares directly.",
      "llm_answer": "CMCSA’s capital structure gives its publicly‑traded Class A shares one vote each and its single Class B share 15 votes; the record‑holder data show that Class A shareholders control about 66 % of the total voting power while the lone Class B holder (Brian L. Roberts) retains roughly 33 % (page 33). Alphabet (GOOGL) also has a dual‑class system, but its Class A shares carry one vote, its non‑public Class B shares carry ten votes, and its Class C shares have no voting rights; the company’s repurchase program targets only Class A and Class C shares, leaving the insider‑held Class B stock with a dominant voting bloc (page 81). Thus, CMCSA’s voting power is split two‑thirds public/one‑third insider, whereas Alphabet’s voting power remains heavily concentrated with insiders because the high‑vote Class B shares are untouched by repurchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures all key factual elements from the ground truth. It accurately states that CMCSA's Class A shareholders hold approximately 66% (matching the exact 66 2/3%) of voting power with one vote per share, while Brian L. Roberts, as the sole holder of Class B shares, holds about 33% (matching 33 1/3%) with each Class B share carrying 15 votes. For GOOGL, it correctly identifies that Class A shares have 1 vote, Class B shares (insider-held) have 10 votes, and Class C shares have no voting rights. The $62.2 billion repurchase figure is not explicitly repeated in the LLM answer, but it correctly notes that GOOGL repurchased Class A and C shares in 2023 (implied by context), which aligns with the original answer’s point about repurchases affecting ownership concentration. (2) All numeric values—percentages, vote weights, and structural details—are factually correct. The rounding of 66 2/3% to 'about 66%' and 33 1/3% to 'roughly 33%' is acceptable and semantically equivalent. The absence of the exact dollar amount ($62.2 billion) is a minor omission but does not undermine the correctness of the repurchase activity description, as the focus is on the impact on voting dynamics rather than the precise figure. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across CMCSA and GOOGL, comparing their dual-class structures, voting rights, and the effect of share repurchases on voting power concentration. It correctly infers that since GOOGL repurchases only low/no-vote shares, insider control via Class B is preserved and even strengthened, which is a valid qualitative conclusion. (4) The answer is highly relevant, directly addressing the comparison of voting power distribution and the impact of repurchase activity. The only reason for not scoring a perfect 10 is the omission of the specific $62.2 billion repurchase amount, which was present in the ground truth and adds precision, though it does not alter the core reasoning. Overall, the answer is factually accurate, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 564,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the 8.2% increase in Turkey's total cigarette market, driven by increased in-bound tourism, impact PM's business performance in comparison to CL's operational footprint in the same country?",
      "original_answer": "The 8.2% growth in Turkey's total cigarette market, attributed to the easing of pandemic-related measures and increased in-bound tourism (particularly by Turkish expatriates), positively contributed to PM's net revenues and shipment volumes in the region. PM reported favorable volume/mix and pricing variances in Turkey, which were key contributors to its Middle East & Africa regional performance. Meanwhile, CL operates manufacturing and warehousing facilities in Turkey as part of its global Oral, Personal and Home Care product segment, indicating a significant operational presence in the country. Therefore, while PM benefits from increased consumer activity linked to tourism, CL maintains a physical and ongoing business infrastructure in Turkey, suggesting differing but regionally aligned exposure to the country's economic dynamics.",
      "llm_answer": "The 10‑K shows that the 8.2 % rise in Turkey’s total cigarette market – driven by a rebound in inbound tourism – translated into a 17.2 % jump in PMI’s shipment volume in Turkey and a higher market‑share for Marlboro and Parliament, contributing to revenue growth in the Middle‑East & Africa region. In contrast, the Philip Morris International filing only notes that the company has manufacturing/warehousing facilities in Turkey (as part of its global property portfolio) and does not report any comparable sales‑volume or market‑share uplift, indicating that its impact in the country is limited to an operational footprint rather than the market‑driven performance gains seen by PM.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly attributes a 17.2% jump in shipment volume to PMI based on the 8.2% market growth, which is not supported by the original answer or ground truth. The original answer mentions PM benefited from volume/mix and pricing variances but does not specify a 17.2% increase in shipment volume. Additionally, the LLM falsely claims that CL (which is actually Colgate-Palmolive) has manufacturing/warehousing in Turkey per its filing, but misattributes this to Philip Morris International (PMI), stating PMI has such facilities—this is incorrect. The original answer clearly states that CL (Colgate-Palmolive) operates these facilities, not PM or PMI. (2) Quantitative accuracy is poor: the 17.2% figure is fabricated and not present in the ground truth. The 8.2% market growth is correct, but no secondary percentages are provided in the original, so the LLM’s addition of specific performance metrics is unsupported. (3) Multi-hop reasoning fails: the model confuses CL with PMI, incorrectly assigning CL’s operational footprint to PMI. It also creates a false contrast by suggesting PMI had market-driven gains while CL did not, when in fact the original answer contrasts PM (Philip Morris) with CL (Colgate-Palmolive), not PMI with itself. The synthesis between market growth, PM’s performance, and CL’s operations is therefore fundamentally flawed. (4) Contextual relevance is moderate—the answer addresses Turkey’s cigarette market growth and attempts to compare PM and CL’s presence, but due to entity confusion and invented data, the core comparison is invalid. The structure follows the question’s intent but collapses under factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 470,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How might geopolitical tensions involving Taiwan impact both NVIDIA's ability to secure timely supply from its foundry partners and Qualcomm's operations in the region, given their shared dependency on Taiwanese manufacturing infrastructure?",
      "original_answer": "NVIDIA faces risks related to its dependency on foundry partners, particularly in Taiwan, where it relies on timely production capacity to meet customer demand. If geopolitical tensions involving Taiwan disrupt operations, NVIDIA may not be able to secure sufficient supply to fulfill orders on time, which could damage customer relationships and lead to revenue loss. Similarly, Qualcomm explicitly states that its business depends on receiving consistent chipset supply from foundry partners in Taiwan, and a significant or prolonged conflict involving Taiwan could severely limit or prevent this supply, materially impacting its business. Both companies are exposed to the same regional risk due to their reliance on Taiwanese manufacturing infrastructure, amplifying the cross-company impact of geopolitical instability in the region.",
      "llm_answer": "Both companies note that a flare‑up over Taiwan would threaten the wafer‑fabrication capacity they rely on. NVIDIA says its business “depends on our ability to receive consistent and reliable chipset supply from our foundry partners, particularly in Taiwan,” and a prolonged China‑Taiwan conflict could “severely limit or prevent us from receiving chipset supply from Taiwan” (NVDA 10‑K p. 35). Qualcomm likewise points out that its primary foundry suppliers – TSMC, GlobalFoundries, Samsung and SMIC – are “located in Taiwan and Korea,” and that “acts of war… could… prevent us from receiving chipset supply from Taiwan,” which would disrupt its Snapdragon and RF‑product manufacturing and testing operations in the region (QCOM 10‑K p. 11 & 35).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the original (ground truth) answer. (1) All key factual elements are correct: both NVIDIA and Qualcomm depend on Taiwanese foundry partners for chipset supply, and geopolitical tensions involving Taiwan could disrupt this supply, impacting their operations and revenue. The LLM correctly identifies the core risk—disruption to wafer-fabrication capacity in Taiwan—and links it to both companies’ reliance on foundries. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not applicable; however, the LLM accurately cites page numbers from the 10-K filings (p. 35 for NVDA, pp. 11 and 35 for QCOM), which supports verifiability and adds precision. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (NVIDIA and Qualcomm), connects their shared dependency on Taiwanese manufacturing (especially TSMC, though not explicitly named for NVIDIA), and correctly infers the operational and supply chain risks from geopolitical instability. The only minor shortcoming is that the LLM slightly misattributes Qualcomm’s foundry list—while TSMC (Taiwan) and Samsung (Korea) are correct, GlobalFoundries is primarily U.S.-based and SMIC is China-based; thus, the claim that all are 'located in Taiwan and Korea' is imprecise. This does not undermine the core argument but introduces a small factual inaccuracy in entity mapping. (4) The answer is contextually excellent—directly addresses the question, uses appropriate citations, and maintains semantic equivalence with the original answer, even enhancing it with specific 10-K references. The conclusion about disrupted Snapdragon and RF-product operations is a reasonable inference. Overall, the answer is factually strong, well-reasoned, and highly relevant, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 518,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How has the application of ASU 2020-04 impacted FDX's exposure to LIBOR-related contract modifications, and how does this compare to MMM's financial treatment of hedging relationships affected by reference rate reform?",
      "original_answer": "FDX has not experienced any material effect from reference rate reform, including ASU 2020-04, as of May 31, 2024, although it continues to monitor contracts that may be affected by LIBOR discontinuation. In contrast, MMM actively manages its hedging relationships, including those affected by reference rate changes, and reported $9 million in losses related to interest rate contracts in 2023, indicating active financial impact and accounting treatment under the ASU 2020-04 framework. This suggests that while FDX has not yet seen significant financial effects, MMM has recognized tangible impacts in its hedging activities tied to reference rate reform.",
      "llm_answer": "FedEx says that, after applying ASU 2020‑04, the optional expedients for reference‑rate reform “have had no material effect to our financial condition, results of operations or cash flows” and the company’s exposure to LIBOR‑related contract modifications remains immaterial (FedEx 10‑K p. 93). 3M likewise notes that the same guidance “has reduced the operational and financial impacts of contract modifications … and the adoption of the guidance did not have a material impact on the Company’s consolidated financial statements” (3M 10‑K p. 167), but because several LIBOR‑based cash‑flow hedges were de‑designated, the resulting gains and losses are now recorded directly in earnings rather than in other‑comprehensive income (3M 10‑K p. 76‑78).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that FDX has not experienced a material effect from ASU 2020-04 and that its exposure to LIBOR-related contract modifications remains immaterial, aligning with the ground truth. It also accurately notes that 3M applied the same guidance and did not see a material impact on financial statements, which matches the original answer’s context. However, the LLM fails to include the key quantitative detail from the ground truth—MMM (3M) reported $9 million in losses related to interest rate contracts in 2023. This omission significantly weakens the comparison, as the ground truth uses this figure to demonstrate tangible financial impact at MMM, while FDX has no such impact. (2) Quantitatively, the LLM answer does not present any incorrect numbers, but it omits the $9 million loss—a critical data point in the ground truth. All other non-numeric assertions are consistent with the source documents. (3) The multi-hop reasoning is partially sound: the model correctly contrasts FDX’s and MMM’s application of ASU 2020-04 and references hedging de-designation at 3M. However, without the $9 million loss figure, the synthesis lacks the financial magnitude needed to fully support the comparison. The mention of de-designation and reclassification to earnings is accurate and adds depth, but it doesn’t substitute for the missing quantitative impact. (4) The answer is contextually relevant and well-sourced with correct page references, showing strong document grounding. Due to the omission of a key financial figure essential to the comparative analysis, the correctness score is reduced to 7, as the core contrast in financial impact is underdeveloped despite accurate qualitative framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 474,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have differential voting rights?",
      "original_answer": "CMCSA's Class B common stock, entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power with each share carrying 15 votes, creating a non-dilutable control mechanism. This contrasts with GOOGL's structure, where Class A shares (1 vote per share) and Class B shares (10 votes per share) allow insiders to maintain control while enabling broader public ownership. Both systems use dual-class structures to preserve founder/leadership control, but differ in the vote ratios and ownership concentration, with CMCSA's setup being more concentrated and structurally rigid due to the non-dilutable nature of Class B shares.",
      "llm_answer": "Comcast’s governance is shaped by a single‑shareholder “super‑voting” class.  All of the company’s 9.44 million Class B shares are owned by Brian L. Roberts; each Class B share carries **15 votes** and together they account for **about one‑third (33 %) of the total voting power** of Comcast’s common stock, giving Roberts decisive influence over director elections and other shareholder votes despite holding a very small economic stake【page_31】.  \n\nAlphabet (Google) uses a dual‑class structure in which the publicly traded Class A shares have **one vote per share**, the non‑public Class B shares have **ten votes per share**, and the non‑voting Class C shares carry no voting rights.  This arrangement concentrates control in the hands of founders and senior executives who own the high‑voting Class B stock, while public investors holding only Class A (or Class C) shares have proportionally less influence【page_82】.  \n\nThus, both companies give insiders outsized voting power, but Comcast concentrates that power in a single shareholder’s 33 % voting block, whereas Google’s control is spread among a small group of insiders who hold the ten‑vote Class B shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: CMCSA's Class B shares carry 15 votes per share and represent 33⅓% (rounded to 33% in the answer) of total voting power, entirely owned by Brian L. Roberts. GOOGL's Class A shares have 1 vote, Class B have 10 votes, and Class C have none—correctly described. (2) Quantitative accuracy is excellent: '33%' is an acceptable rounding of '33⅓%', and the 15:1 vs 10:1 vote ratios are precisely stated. No calculation errors. (3) Multi-hop reasoning is sound: the model correctly synthesizes governance implications across two companies, contrasting concentrated single-shareholder control (CMCSA) vs. insider group control (GOOGL). (4) The only minor omission is the explicit mention of CMCSA's Class B shares being 'non-dilutable', a structural rigidity highlighted in the original answer. While implied by 'decisive influence', it is not directly stated. Otherwise, the answer is complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 301,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does Amgen's remaining repatriation tax payment schedule under the 2017 Tax Act compare with Eli Lilly's cash payment obligations for the same tax provision as of December 31, 2023?",
      "original_answer": "Amgen has remaining scheduled repatriation tax payments under the 2017 Tax Act, which it is paying over an eight-year period beginning in 2018. Similarly, Eli Lilly made the election to pay the Toll Tax over the same eight-year period, with its future cash payments extending through 2025. Both companies are managing their obligations under the same regulatory framework introduced by the 2017 Tax Act, though the specific amounts differ based on their foreign earnings and individual tax calculations.",
      "llm_answer": "Amgen’s 2017 Tax Act “Toll‑Tax” election leaves it with two scheduled cash payments after 31 Dec 2023 – $634.2 million in 2024 and $792.8 million in 2025 (total $1.427 billion)【page_92】. Eli Lilly’s 2023 filing does not disclose any remaining cash‑payment obligation for the same 2017 repatriation‑tax provision, indicating that it has no such liability outstanding as of 31 Dec 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) Quantitatively, the LLM claims Amgen has two remaining payments totaling $1.427 billion in 2024 and 2025, but the ground truth does not specify exact dollar amounts—only the payment schedule. More critically, the LLM states Eli Lilly has *no remaining obligation* as of December 31, 2023, which directly contradicts the original answer stating Eli Lilly's payments extend *through 2025*, implying ongoing obligations. This is a major factual error. (2) The ground truth confirms both companies are paying over an eight-year period beginning in 2018 (thus ending in 2025), so Eli Lilly must still have payments due after 2023. The LLM’s claim that Eli Lilly has no disclosure and thus no liability is unsupported inference and incorrect. (3) The reasoning fails on multi-hop synthesis: while both companies are under the same eight-year framework, the LLM incorrectly infers full payment completion for Eli Lilly based on lack of disclosure, which is not logically or factually justified. (4) Contextual relevance is moderate because the answer addresses the right topic and timeframe, but the core comparison is flawed. The answer incorrectly frames Amgen as having specific remaining payments while portraying Eli Lilly as debt-free on this item, which misrepresents the equivalence in payment schedules emphasized in the ground truth. Thus, despite some structural relevance, the factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 412,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "How does the risk of biosimilar competition following loss of exclusivity for Amgen's biologics compare to Bristol Myers Squibb's exposure, given the differing regulatory pathways and product portfolios in the U.S. and EU?",
      "original_answer": "Amgen's reliance on biologics such as 'Erbitux, Cyramza, Trulicity, Taltz, and Emgality' is at risk due to the potential entry of biosimilars, which could occur after 12 years of regulatory data protection in the U.S. However, litigation and expedited review processes like IPR could weaken patent protection and accelerate biosimilar entry. Similarly, Bristol Myers Squibb faces biosimilar threats to its biologics including 'Opdivo, Yervoy, Orencia, Reblozyl, and Empliciti,' with regulatory data protection lasting 12 years in the U.S., but also faces earlier generic competition in the EU under the '8+2+1' regime, where biosimilars can enter after 8 years of data exclusivity. Both companies are exposed to rapid revenue declines upon loss of exclusivity, but the timing and competitive intensity differ based on regional regulatory frameworks and the complexity of biosimilar development.",
      "llm_answer": "Amgen warns that once the statutory and regulatory exclusivity periods on its biologics end, “loss of exclusivity may or may not result in the near‑term entry of competitor versions (i.e., biosimilars) due to many factors, including development timelines, manufacturing challenges, and uncertainties regarding the regulatory pathways for approval of the competitor versions”【page_25】.  In the United States a biosimilar can be filed after four years but cannot be approved until 12 years after the reference product’s first approval, and the same product may face earlier generic‑type competition in the EU where patents are not listed with regulators and a generic can be authorized after the 8‑year data‑protection window (or 10‑11 years with a supplemental indication)【page_9】.  \n\nBristol‑Myers Squibb’s 10‑K notes that its portfolio is weighted toward small‑molecule drugs and only a limited number of biologics, so its overall exposure to biosimilar competition is materially lower than Amgen’s.  Because fewer of its key products rely on the biosimilar pathway, the impact of loss of exclusivity in the U.S. and EU is expected to be less severe【page_8】.  \n\nThus, Amgen faces a higher biosimilar‑competition risk after exclusivity loss—especially given the 12‑year U.S. data‑protection period and the EU’s earlier generic‑entry rules—whereas Bristol‑Myers Squibb’s more modest biologic slate and greater reliance on small‑molecule products limit its comparable exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies key regulatory timelines in the U.S. (12-year data protection for biologics, with biosimilar approval possible after 12 years) and the EU (8-year data exclusivity, with earlier biosimilar entry), which aligns with the ground truth. It accurately notes that Amgen faces higher biosimilar risk due to its biologic-heavy portfolio and outlines relevant regulatory differences between the U.S. and EU. However, there are significant factual inaccuracies in the entity identification: the LLM attributes 'Erbitux, Cyramza, Trulicity, Taltz, and Emgality' to Amgen in the ground truth, but these are not Amgen products (e.g., Erbitux is Eli Lilly/ImClone, Cyramza is Lilly, Trulicity is Lilly, Taltz and Emgality are Lilly). Amgen’s key biologics include products like Enbrel, Neulasta, and Repatha—none of which are mentioned. Similarly, the LLM incorrectly claims that Bristol Myers Squibb (BMS) has a portfolio 'weighted toward small-molecule drugs' and 'only a limited number of biologics,' which contradicts the ground truth that BMS has major biologics like Opdivo, Yervoy, Orencia, Reblozyl, and Empliciti—indicating significant biologic exposure. This undermines the core comparison: the LLM concludes BMS has materially lower exposure, while the ground truth states both companies face substantial biosimilar threats, differing mainly in timing and regional regulatory impact, not overall exposure level. The reasoning is partially sound in discussing regulatory pathways, but the flawed entity attribution and incorrect comparative risk assessment (downplaying BMS’s biologic exposure) lead to an inaccurate synthesis. Quantitatively, the 12-year U.S. and 8-year EU timelines are correct, and the explanation of the '8+2+1' regime is reasonably reflected, earning a 7 for quantitative accuracy. Contextual relevance is high as the answer addresses regulatory pathways, regional differences, and company-specific risks. However, due to major errors in product portfolio attribution and the resulting flawed comparative risk conclusion, the overall correctness score is 6—partially correct but with significant factual deficiencies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1611,
        "completion_tokens": 578,
        "total_tokens": 2189
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How does Medtronic's exposure to Medicaid reimbursement policies compare to AbbVie's pricing pressures under the IRA, particularly in relation to their respective product portfolios and revenue risks?",
      "original_answer": "Medtronic faces increased price sensitivity from Medicaid reimbursement limitations, which affects hospitals' purchasing behavior and creates a need for competitively priced medical devices. AbbVie, on the other hand, is directly impacted by the Inflation Reduction Act (IRA), which allows the U.S. Department of Health and Human Services to set government prices for certain drugs like Imbruvica (selected in 2023 for pricing starting in 2026) and Vraylar and Linzess (selected in 2025 for pricing starting in 2027), potentially accelerating revenue erosion before patent expiration. While both companies face healthcare cost-containment pressures, Medtronic’s Medicaid exposure affects device pricing strategies, whereas AbbVie must navigate IRA-driven government pricing that could apply to more high-revenue products in the future.",
      "llm_answer": "Medtronic’s revenue is vulnerable to Medicaid‑related reimbursement reforms because many of its devices are paid for through Medicare and Medicaid, but the risk is diffused across a broad, diversified portfolio of medical‑device and therapy products. By contrast, AbbVie’s exposure to the Inflation Reduction Act is concentrated on a few blockbuster drugs—Humira, Skyrizi and Rinvoq—which together account for roughly 47 % of its 2024 net revenue, so government‑set price caps and higher Medicaid rebates could erode a much larger share of its earnings. Thus, Medtronic faces a more modest, portfolio‑wide reimbursement risk, while AbbVie confronts a sharper, product‑specific pricing pressure that threatens a substantial portion of its revenue.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding AbbVie's products affected by the IRA. The ground truth specifies that Imbruvica, Vraylar, and Linzess are the drugs selected under the IRA—not Humira, Skyrizi, or Rinvoq, which the LLM incorrectly identifies as being subject to government pricing. This is a major error in entity accuracy. Additionally, the claim that these three drugs account for roughly 47% of AbbVie’s 2024 net revenue is unsupported by the original answer and not verifiable from the provided context, making the quantitative assertion suspect. (2) There are no correct numbers in the LLM answer that align with the ground truth: the 47% figure is unverified, and no such percentage was mentioned in the original. The original answer focused on future pricing impacts starting in 2026 and 2027, but the LLM references 2024 revenue without justification. (3) The reasoning partially captures the contrast between Medtronic’s broad reimbursement risk and AbbVie’s concentrated pricing pressure, which shows some valid multi-hop synthesis. However, because it misidentifies the key drugs and regulatory timeline (IRA selections in 2023 and 2025 for implementation in 2026 and 2027), the logical foundation is flawed. (4) Contextual relevance is strong—the answer addresses Medicaid vs. IRA pressures, compares portfolio diversification, and discusses revenue risks. But due to critical errors in entities and unsupported quantitative claims, the correctness score is limited to 5—partially correct but with significant factual deficiencies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 440,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does the $2.7 billion in unfunded commitments to private equity funds held by UPS compare to General Dynamics' use of NAV for valuing its Level 1 plan assets, given both companies rely on NAV as a practical expedient for alternative investments?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private equity and similar funds as of December 31, 2024, with contributions expected over 3 to 6 years. These investments are valued using NAV as a practical expedient due to the lack of readily determinable fair value. Similarly, General Dynamics (GD) uses NAV for its Level 1 plan assets, which include commingled equity and fixed-income funds valued using a unit price or NAV. Both companies rely on NAV for valuation, but UPS's private equity commitments carry longer redemption restrictions (10–15 year terms), whereas GD's NAV-based assets are generally redeemable monthly or quarterly. This suggests UPS has a less liquid exposure to NAV-based investments compared to GD.",
      "llm_answer": "UPS reports that its pension and post‑retirement plans include roughly **$2.7 billion of unfunded commitments to private‑equity, private‑debt and real‑estate limited‑partnership interests** (see UPS 10‑K, p. 93). By contrast, General Dynamics does not disclose a comparable dollar amount of unfunded commitments; instead, it states that it **values certain Level 1 plan assets using net‑asset‑value (NAV) as a practical expedient for alternative‑investment holdings** (see General Dynamics 10‑K, p. 93). Thus, UPS’s exposure is quantified at $2.7 billion, whereas General Dynamics’ reliance on NAV is a valuation approach without a disclosed commitment figure.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the $2.7 billion in unfunded commitments for UPS and accurately notes that General Dynamics uses NAV as a practical expedient for valuing certain Level 1 plan assets. The quantitative accuracy is high—$2.7 billion is correct, and the reference to NAV usage by both companies aligns with the ground truth. However, the LLM fails to fully address the comparative aspect of the question, particularly regarding liquidity differences and redemption terms. The ground truth highlights that UPS’s private equity commitments have 10–15 year terms with contributions over 3–6 years, implying low liquidity, whereas GD’s NAV-based assets are redeemable monthly or quarterly, indicating higher liquidity. This key qualitative distinction is missing in the LLM response. Instead, the LLM incorrectly frames the difference as being about disclosure of dollar amounts, stating GD does not disclose a comparable commitment figure—this misrepresents the comparison. The question asks how the $2.7B in commitments compares in context of both companies using NAV, expecting a synthesis of valuation approach and liquidity implications. The LLM only partially performs this multi-hop reasoning, correctly identifying inputs but failing to draw the correct comparative conclusion. Thus, while factually accurate on individual points, it lacks completeness and correct qualitative synthesis, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 395,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does CMCSA's issuance of Class B Common Stock in 2024 influence its shareholder voting rights structure, and how does this compare to META's dual-class framework as disclosed in their respective filings?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B Common Stock in 2024, which, as per the governance structure outlined in V_10k_2024.pdf, carries no voting rights except in limited circumstances such as exiting the core payments business or specific merger scenarios. This creates a tiered voting rights system where Class A shareholders maintain full voting control. Similarly, META's filing reveals a dual-class structure with Class A and Class B common stock, where Class A stockholders have full voting rights while Class B stockholders generally do not, except in defined events like a merger. Both companies thus concentrate voting power among a subset of shareholders, reinforcing control while allowing for differentiated capital structures.",
      "llm_answer": "- Comcast (CMCSA) added a new series of Class B common shares in 2024 (‑ 499 million B‑1, 123 million B‑2, 61 million B‑3, 31 million B‑4, 15 million B‑5 and 1.1 billion C shares authorized 【page 88】).  The company’s charter makes the holders of Class B and Class C common stock **non‑voting** on most matters; they can vote only on a few defined issues (e.g., a merger that would give them different rights, an exit of the core payments business, or certain charter amendments), and even then their votes are weighted by the applicable conversion rate 【page 90】.  Thus, the 2024 issuance expands the pool of economically‑interested shareholders but does **not** dilute the voting power of Class A shareholders, whose votes remain the sole determinant for ordinary corporate decisions.\n\n- Meta Platforms (META) operates a **dual‑class** system in which the publicly‑traded Class A shares carry one vote per share, while a separate Class B series (held mainly by founders and insiders) carries ten votes per share, concentrating control with the Class B holders.  Consequently, unlike Comcast’s non‑voting Class B shares, Meta’s dual‑class structure deliberately gives a distinct class of shareholders **greater voting power** than their economic ownership would suggest.  \n\n**Comparison:** Comcast’s new Class B shares add economic participation but keep voting rights essentially with Class A holders, whereas Meta’s dual‑class framework assigns amplified voting rights to a separate class, concentrating control in the hands of insiders.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that CMCSA issued 9,444,375 shares of Class B Common Stock in 2024, but the LLM claims Comcast authorized hundreds of millions across multiple subclasses (B-1 to B-5) and 1.1 billion C shares, which is not supported by the original answer and contradicts the known facts. These numbers are entirely fabricated or misread from a source not reflected in the ground truth. (2) There is no mention in the original answer of subclasses (B-1, B-2, etc.) or Class C shares, nor are there any figures close to 499 million or 1.1 billion. The LLM’s numbers fail verification and severely undermine quantitative accuracy. (3) Qualitatively, the reasoning about voting rights is partially sound: the LLM correctly identifies that CMCSA’s Class B shares carry limited voting rights and do not dilute Class A control, and it accurately contrasts this with META’s dual-class structure where Class B has superior voting power. The comparison correctly highlights that CMCSA’s structure preserves voting power with Class A while adding economic participants, whereas META amplifies insider control via high-vote shares. (4) Contextually, the response is well-structured and directly addresses both parts of the multi-hop question—CMCSA’s 2024 issuance impact and comparison with META. However, the severe numerical errors, especially the invention of share classes and massive discrepancies in share counts, result in a low correctness score despite reasonable qualitative logic. The core conclusion about voting concentration is directionally correct but built on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1585,
        "completion_tokens": 459,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How might the IRA's Medicare price-setting provisions impact revenue erosion timelines for Amgen's products that rely on federal reimbursement, especially in light of AbbVie's experience with Imbruvica and Vraylar being selected for government pricing starting in 2026 and 2027?",
      "original_answer": "The IRA's Medicare price-setting provisions could accelerate revenue erosion for Amgen's products that depend on federal reimbursement by imposing government-determined prices as early as nine or thirteen years post-FDA approval, depending on whether the product is a small molecule or biologic. This mirrors AbbVie's experience where Imbruvica was selected for price setting in 2026 and Vraylar and Linzess in 2027, leading to potential revenue declines before patent expiration. Amgen, which also relies heavily on Medicare reimbursement, faces similar risk as these policies reduce pricing flexibility and increase downward pressure on profitability.",
      "llm_answer": "The IRA allows HHS to set a ceiling price for single‑source drugs paid under Medicare Part B or D as early as nine years after FDA approval, and Amgen already expects its own products—such as ENBREL—to be subject to a government‑set price beginning 1 Jan 2026 and Otezla in 2027. That mandatory pricing will compress margins and can trigger revenue erosion well before a product’s patent expires, just as AbbVie warns that the selection of Imbruvica (2026) and Vraylar (2027) for price‑setting is likely to accelerate the loss of revenue for those drugs. Thus, Amgen’s federally reimbursed medicines could see an earlier‑than‑expected decline in sales‑derived earnings, mirroring AbbVie’s experience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates (2026 and 2027) and timeframes (nine years post-approval) are correct. The mention of ENBREL and Otezla facing government-set prices starting Jan 1, 2026 and 2027 respectively is consistent with known Amgen product timelines under the IRA. The reference to AbbVie’s Imbruvica (2026) and Vraylar (2027) matches the original answer. (2) The explanation of the IRA allowing HHS to set prices as early as nine years after FDA approval is accurate for small molecules; while the original answer notes biologics face a 13-year timeline, this detail is omitted in the LLM response but does not materially misrepresent Amgen’s exposure since ENBREL and Otezla are subject to earlier pricing. (3) The multi-hop reasoning is sound: it correctly links the IRA’s pricing mechanism to AbbVie’s experience and applies it to Amgen’s situation, showing how revenue erosion can occur pre-patent expiry due to mandatory pricing. (4) Semantically, the LLM conveys the same core message: IRA-driven price setting accelerates revenue decline for Medicare-reliant drugs, as seen with AbbVie and now impacting Amgen. The only minor gap is the lack of explicit distinction between small molecule (9 years) and biologic (13 years) timelines, which slightly reduces completeness but doesn’t undermine the overall correctness. Hence, high scores across all dimensions with a 9 on correctness due to this partial omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 411,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive compare to the total remaining available securities disclosed by Procter & Gamble, based on their respective disclosures?",
      "original_answer": "Colgate-Palmolive reported 37,028,000 securities remaining available under equity compensation plans approved by security holders, while Procter & Gamble disclosed a total of 133,185,995 remaining available securities across both Stock Options/SARs and RSUs/PSUs under the same category of approved plans. This indicates PG has a significantly larger pool of available securities for future issuance compared to CL.",
      "llm_answer": "Colgate‑Palmolive reports that equity‑compensation plans approved by security holders have **37,028 thousand shares** (≈ 37 million) still available for future issuance (Item 12, Table on page 61).  \n\nProcter & Gamble discloses that the only plan that can issue new shares – the 2019 Stock and Incentive Compensation Plan – has **about 119 million shares** remaining available for future issuance (Item 12, Table on page 69 and footnote).  \n\nThus, Colgate‑Palmolive’s pool of issuable shares is roughly one‑third the size of Procter & Gamble’s disclosed pool.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies Colgate-Palmolive's available securities as 37,028,000 (reported as 37,028 thousand), which matches the ground truth. However, it reports Procter & Gamble's remaining available securities as 'about 119 million', whereas the ground truth is 133,185,995. This is a significant numerical discrepancy—approximately 14 million fewer shares—likely due to the LLM referencing only one plan or misinterpreting the disclosure. The ground truth explicitly states that P&G's total includes both Stock Options/SARs and RSUs/PSUs under approved plans, summing to 133.2 million. The LLM may have omitted one component or used outdated/incorrect data.\n\n2) Quantitative accuracy is compromised due to the incorrect P&G figure. While Colgate's number is accurate (37,028 thousand = 37,028,000), P&G's should be ~133.2 million, not ~119 million. This affects the comparison: the LLM concludes Colgate’s pool is 'roughly one-third' of P&G’s, but with correct numbers, 37M is actually about 27.8% of 133.2M—still roughly one-third, so the qualitative comparison is directionally correct.\n\n3) The reasoning is logically sound and addresses the comparative nature of the question. The LLM correctly identifies the relevant equity compensation plans approved by security holders for both companies and attempts to synthesize across filings. It cites correct document locations (Item 12, page numbers), showing proper multi-hop sourcing. However, the failure to capture the full scope of P&G’s available securities indicates incomplete synthesis.\n\n4) Contextual relevance is excellent—the response directly answers the comparative question, uses appropriate terminology, and provides source references. Despite the numerical error, the structure and intent align perfectly with the query. The conclusion is semantically close but based on inaccurate input for P&G.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 505,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the joint commercialization of BMY's biologics in Taiwan compare with MRK's strategic spin-off of its biosimilars business, given Taiwan's regulatory requirement for local clinical trial data for biologics registration?",
      "original_answer": "BMY jointly commercializes biologics like Opdivo and Yervoy in Taiwan with Ono, where BMS handles supply and both parties share development costs and profits. This suggests a collaborative, market-access-focused strategy in Taiwan, which requires local clinical trial data for biologics registration. In contrast, MRK spun off its biosimilars business into Organon, signaling a strategic retreat from the biosimilars segment, which faces increasing global competition and regulatory complexity, including in markets like Taiwan that require additional local data for registration. Thus, while BMY maintains a direct and collaborative presence in Taiwan's biologics market, MRK has opted to divest its biosimilars portfolio, potentially avoiding the added burden of meeting such regulatory requirements in markets requiring local trials.",
      "llm_answer": "BMS’s biologics (e.g., Opdivo and Yervoy) are brought to Taiwan through a co‑development and co‑commercialization alliance with Ono, which shares development‑costs, supplies the product and splits profits while BMS retains the right to supply the drugs in Taiwan 【page 86】. In contrast, Merck removed its biosimilars portfolio from the core company by spinning it off into the independent public company Organon, thereby separating those products from Merck’s main operations and leaving any Taiwan‑specific registration (which would require local clinical‑trial data) to the new entity 【page 1】. Thus, BMS relies on a partnership that can generate the required local data and market the biologics in Taiwan, whereas Merck’s strategy is to divest the biosimilars business entirely, outsourcing any Taiwan‑specific regulatory work to the spun‑off Organon.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: BMS (BMY) collaborates with Ono on Opdivo and Yervoy in Taiwan, sharing development costs, supply, and profits; Merck spun off its biosimilars business into Organon. The regulatory context—Taiwan requiring local clinical trial data for biologics registration—is correctly acknowledged. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not applicable but no errors exist. (3) Multi-hop reasoning is sound: the model correctly contrasts BMS’s collaborative market-access strategy in Taiwan with Merck’s strategic divestiture, linking both to the regulatory burden of local clinical data. The only minor inaccuracy is the statement that 'BMS retains the right to supply the drugs in Taiwan'—the original answer states BMS handles supply, but the LLM slightly misattributes this as a retained right, which is less precise. Also, the LLM says Ono 'supplies the product', while the original states BMS handles supply—this is a small contradiction. (4) Despite this minor confusion in supply responsibility, the overall reasoning and strategic comparison remain valid and insightful. The answer is contextually excellent, directly addressing the comparison between BMY’s joint commercialization and MRK’s spin-off in light of Taiwan’s regulatory requirements. Thus, the correctness score is 9 due to a minor factual discrepancy in supply roles, but all other dimensions are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 430,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How does AAPL's 2022 revenue contribution from Taiwan, as part of its Greater China segment, compare to ADBE's operational presence in the same region?",
      "original_answer": "AAPL reported $74,200 million in net sales for its Greater China segment in 2022, which includes Taiwan among other regions. ADBE maintains a local field office in Taiwan as part of its global operations, indicating a direct market presence. While AAPL's exposure to Taiwan is embedded within its broader Greater China revenue, ADBE's operational footprint in Taiwan suggests a more targeted geographic strategy in the region.",
      "llm_answer": "Apple’s 2022 Form 10‑K shows that the Greater China segment – which “includes Hong Kong and Taiwan” – generated **$74.2 billion** in net sales for the year【page_52】. Adobe’s 2022 filing only notes that it maintains a **local field office in Taiwan** as part of its worldwide sales network, without providing any Taiwan‑specific revenue figure【page_15】. Thus, Apple’s Taiwan contribution is embedded in a multi‑billion‑dollar Greater China revenue stream, whereas Adobe’s presence in Taiwan is limited to a sales office with no disclosed revenue amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AAPL's 2022 Greater China net sales as $74.2 billion (equivalent to $74,200 million in the ground truth), accurately reflecting the quantitative contribution that includes Taiwan. It also correctly states that ADBE has a local field office in Taiwan with no disclosed revenue, aligning with the original answer’s claim of ADBE’s operational presence. (2) Numeric values are accurate and properly converted between formats ($74.2 billion = $74,200 million); no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes AAPL’s revenue data (from 10-K) and ADBE’s operational footprint (from its filing), comparing revenue exposure versus operational presence. It appropriately notes that AAPL’s Taiwan contribution is embedded in a broader regional figure, while ADBE lacks revenue disclosure but has a physical presence. (4) The only minor shortcoming is that the LLM answer does not explicitly use the term 'Greater China segment' when discussing AAPL’s revenue embedding Taiwan, though it quotes the segment definition directly. This does not detract from factual accuracy but slightly reduces qualitative precision. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 359,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do CMCSA and META differ in terms of the voting control concentration between Class A and Class B common stockholders, and what implications does this have for shareholder influence in corporate governance decisions?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while Class B stockholders (led by Brian L. Roberts) hold 33 1/3%, with each Class B share carrying 15 votes. In contrast, META's Class B common stock, though not publicly traded, holds significant voting rights, but the specific voting power percentage is not disclosed. However, META's Class A shares are publicly traded under the ticker META, and as of December 31, 2023, there were only 23 stockholders of record for Class B shares, indicating concentrated control. This means CMCSA maintains a structured balance of voting power, while META's control is more opaque and concentrated among fewer Class B holders.",
      "llm_answer": "- **Comcast (CMCSA)** – The company’s dual‑class structure gives each Class B share 15 votes versus one vote for a Class A share.  The single holder of all Class B shares (Brian L. Roberts) therefore controls about **33 % of the total voting power**, while the roughly 320 000 record holders of Class A shares own the remaining **≈66 %** (CMCSA 10‑K, p. 33).  Because a third of the votes are concentrated in one person, that holder can block actions that require a super‑majority, but ordinary director elections and most decisions are still driven by the much larger Class A shareholder base.\n\n- **Meta Platforms (META)** – Meta’s Class B shares are not listed on any exchange and are held by a small group of insiders; each Class B share carries **ten votes per share**, while Class A shares have one vote each (Meta 10‑K, p. 57).  This gives the insiders a **majority of the voting power** despite the far larger number of public Class A shareholders.  Consequently, the founders and insiders can control board elections and major corporate‑governance decisions, limiting the influence of ordinary public shareholders.\n\n**Implication:** Comcast’s voting power is split between a dispersed Class A base and a single Class B holder, allowing public shareholders to have a meaningful say in most matters but giving the Class B holder a veto on high‑threshold votes.  Meta’s structure concentrates voting control almost entirely with the insider‑owned Class B shares, so public Class A shareholders have minimal ability to affect governance outcomes.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the dual-class structures of both CMCSA and META and explains the differing voting rights per share class. However, there are key quantitative inaccuracies: for CMCSA, the LLM states that Class A holds approximately 66% and Class B (Brian L. Roberts) holds about 33%, but the ground truth specifies that Class A holds 66 2/3% and Class B holds 33 1/3%—a precise split that the LLM approximates as '≈66%' and 'about 33%', which is close but not fully accurate. More critically, the LLM incorrectly states that the Class B holder controls 33% of voting power, when in fact the structure (with 15 votes per Class B share) is designed to give that class exactly 33 1/3%, and the answer downplays the structural intent. For META, the LLM correctly notes that Class B shares carry 10 votes each (per Meta 10-K), but the ground truth does not disclose the exact voting power percentage—yet the LLM asserts that insiders have a 'majority of the voting power', which, while likely true, is not explicitly confirmed in the ground truth and thus introduces an unverified claim.\n\n2) Number verification: CMCSA’s 66 2/3% and 33 1/3% split is misrepresented as approximate values. The LLM’s use of '≈66%' and 'about 33%' loses precision. META’s 10 votes per Class B share is correct per the 10-K, but the inference of 'majority voting power' goes beyond the disclosed data in the ground truth, which only notes 23 stockholders of record and concentrated control without quantifying the majority.\n\n3) Multi-hop reasoning is generally sound: the LLM synthesizes information about voting rights, share classes, and governance implications across two companies. It correctly contrasts CMCSA’s more balanced (though still skewed) structure with META’s insider-dominated control. The implications for shareholder influence are logically derived and align with the question.\n\n4) The answer is contextually excellent—directly addressing the comparison of voting control and governance implications. The qualitative reasoning about veto power and influence on board elections is strong. However, the correctness score is reduced due to the imprecise percentages for CMCSA and the unsupported assertion about META’s majority control, which affect factual reliability. A score of 7 reflects mostly correct facts with notable quantitative shortcomings.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 629,
        "total_tokens": 2208
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do LLY and MRK benefit differently from pediatric exclusivity provisions in the U.S. and EU regulatory frameworks?",
      "original_answer": "LLY benefits from pediatric exclusivity in the U.S. by receiving an additional six months of exclusivity added to data protection, orphan drug exclusivity, or non-expired patents. MRK, on the other hand, benefits in the U.S. through an additional six months of market exclusivity added to Orange Book-listed patents and regulatory data exclusivity, and in the EU through an additional six months added to the Supplementary Protection Certificate (SPC) term. This difference in application highlights how the U.S. framework ties pediatric exclusivity to both patents and data protection, while the EU framework applies it only to the SPC term.",
      "llm_answer": "- **Eli Lilly (LLY)** – Under the U.S. Pediatric Exclusivity Provision, Lilly can obtain an extra six‑month period that is **tacked onto the FDA’s data‑protection term (and, for non‑biologic drugs, onto any still‑in‑force patent)**. The LLY filing does not describe a comparable EU‑specific mechanism; its discussion of pediatric exclusivity is limited to the U.S. data‑protection extension.  \n\n- **Merck (MRK)** – Merck’s filing notes that the same U.S. provision adds six months **to the patent term for all Orange‑Book‑listed patents (and to the data‑exclusivity term for both small‑molecule and biologic products)**, and that **the EU grants a six‑month pediatric extension that is attached to the product’s Supplementary Protection Certificate (SPC)**.  \n\nThus, Lilly’s benefit is framed as a U.S. data‑protection/patent extension, whereas Merck’s benefit is described as both a U.S. patent‑term extension and an EU SPC‑based extension.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: both LLY and MRK receive six-month extensions in the U.S., and MRK additionally benefits from a six-month extension to the SPC in the EU. The answer correctly identifies that U.S. pediatric exclusivity applies to data protection and patents (including Orange Book-listed patents), while in the EU it applies only to the SPC term. (2) Quantitative accuracy is perfect: the six-month duration is consistently and correctly stated across both jurisdictions and companies. No calculations are required, but the temporal extensions are accurately reported. (3) Multi-hop reasoning is sound: the model correctly synthesizes differences between LLY and MRK by referencing their respective regulatory frameworks (U.S. vs. EU) and the specific mechanisms (data protection, patents, SPC). The only minor shortcoming is that the LLM implies LLY has no EU pediatric exclusivity mechanism, while the ground truth does not explicitly state this absence—though it only describes MRK’s EU benefit. This is a subtle distinction and does not constitute a factual error, but slightly limits completeness. (4) The answer is contextually precise, directly addressing how each company benefits differently under U.S. and EU frameworks. Wording differs from the original but preserves semantic equivalence. Overall, this is a strong, factually correct response with only negligible room for improvement.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 408,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the change in EMR's foreign currency liabilities from 2023 to 2024 compare with the scale of LMT's foreign currency hedge exposure, and what might this indicate about their respective foreign exchange risk management strategies?",
      "original_answer": "EMR's foreign currency liabilities decreased from $22 billion in 2023 to $20 billion in 2024, a $2 billion reduction, while LMT maintained $7.5 billion in outstanding foreign currency hedges at the end of 2024. This indicates that LMT is proactively hedging a significant portion of its foreign exchange exposure, whereas EMR appears to be reducing its overall foreign currency liability position rather than necessarily increasing hedging activity. The use of option contracts by LMT suggests a strategy focused on offsetting earnings volatility from exchange rate fluctuations, while EMR's declining liabilities may reflect either reduced international operations or a shift in risk management approach.",
      "llm_answer": "Emerson (EMR) saw its foreign‑currency‑denominated liabilities fall only modestly – from about $22 million in 2023 to roughly $20 million in 2024, a decrease of roughly $2 million.  By contrast, Lockheed Martin (LMT) reports foreign‑currency hedge contracts with a notional amount of roughly $7.5 billion (and cash‑flow‑hedge notional of about $9.9 billion) at the end of 2024.  The tiny change in EMR’s liabilities suggests a relatively limited foreign‑exchange exposure and a low‑scale hedging program, whereas LMT’s multi‑billion‑dollar hedge portfolio indicates a much larger exposure that the company actively manages through extensive derivative hedges.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in scale: it reports EMR's foreign currency liabilities as $22 million and $20 million in 2023 and 2024 respectively, whereas the ground truth states $22 billion and $20 billion — a 1,000-fold difference. This error invalidates the quantitative comparison with LMT's $7.5 billion hedge exposure. The $2 million decrease cited is also wrong; the actual reduction is $2 billion. While LMT's $7.5 billion hedge notional is correctly reported, the LLM adds an unsupported figure of $9.9 billion in cash-flow-hedge notional not present in the original answer, introducing extraneous and unverified data. (2) Calculations are conceptually correct (e.g., difference of $2 million is consistent with the erroneous inputs), but the inputs themselves are catastrophically inaccurate. The scale of the error undermines all financial reasoning. (3) The multi-hop reasoning is partially sound in structure — comparing liability changes to hedge positions to infer risk management strategies — but the flawed data leads to incorrect conclusions. The LLM incorrectly infers that EMR has 'limited foreign-exchange exposure' due to the 'tiny change' in liabilities, when in fact EMR has a $20–22 billion exposure, comparable in scale to LMT’s hedges. The original answer’s insight — that EMR may be reducing liabilities rather than hedging, while LMT actively hedges — is missed due to misinterpretation of the data. (4) Contextual relevance is moderate: the answer addresses the right companies, time frame, and general topic of FX risk management. However, due to the magnitude of the numerical errors and resulting flawed interpretation, the qualitative and correctness scores are low. Semantic equivalence fails on core facts despite similar structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 489,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the $3.6 billion in dividends paid by AENB to AXP in 2023 relate to the leverage ratio requirements that both AENB and WFC are subject to under federal banking regulations?",
      "original_answer": "The $3.6 billion in dividends paid by AENB to AXP in 2023 is directly tied to AENB's compliance with leverage ratio requirements, as AENB must consider the impact of such distributions on its regulatory capital ratios. AENB, as a subsidiary bank of AXP, is subject to federal banking regulations that restrict dividend payments if they would cause the bank to fall short of required leverage ratios. Similarly, WFC, as a large bank holding company, is also subject to leverage and supplementary leverage ratio requirements under Basel III and FRB rules, which constrain its ability to make capital distributions like dividends. Therefore, both AENB and WFC must ensure that any dividend payments comply with these leverage constraints, making the $3.6 billion distribution by AENB a function of its ability to maintain required capital levels under the same type of regulatory framework that governs WFC.",
      "llm_answer": "The $3.6 billion dividend that AENB paid to its parent, American Express, directly reduces the bank’s Tier 1 capital, and because AENB – like all U.S. depository institutions – must keep its Tier 1 leverage ratio (Tier 1 capital ÷ average total assets) above the regulator‑set minimum, the payout can be made only to the extent that the bank’s leverage‑ratio buffer remains satisfied【page_67】.  The same leverage‑ratio constraint applies to Wells Fargo, which is also required to maintain a minimum Tier 1 (and supplementary) leverage ratio and therefore must limit dividend distributions so that they do not cause the bank to fall below those regulatory thresholds【page_4】.  In both cases, the $3.6 billion dividend is subject to, and must be calibrated against, the leverage‑ratio requirements imposed by federal banking regulators.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $3.6 billion dividend amount and the year 2023 are correctly referenced (implied in context), and no calculations are required beyond correct interpretation of regulatory constraints. (2) The answer correctly identifies AENB (American Express National Bank) and WFC (Wells Fargo) as subject to leverage ratio requirements, and accurately describes how dividend payments affect Tier 1 capital and the Tier 1 leverage ratio. It correctly references federal banking regulations and the need to maintain minimum ratios post-distribution. (3) The multi-hop reasoning is sound: it connects AENB’s dividend to its regulatory capital constraints and draws a valid parallel to WFC’s similar obligations under the same regulatory framework (Basel III and FRB rules, though not explicitly named here, are implied via 'regulator-set minimum'). The mention of 'Tier 1 leverage ratio' and 'supplementary leverage ratio' for WFC matches the original answer’s scope. (4) Minor deduction in qualitative accuracy because the LLM answer focuses more narrowly on Tier 1 capital and does not explicitly mention that AENB is a subsidiary of AXP (American Express) or that these rules stem from broader capital distribution restrictions—context present in the original. However, the core regulatory logic and comparative structure between AENB and WFC are preserved. Semantic equivalence is strong, and all key facts are correct. Contextual relevance is perfect—the response directly addresses the relationship between the dividend and leverage requirements for both institutions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 450,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does the geographic distribution of Microsoft's pre-tax income ($62.9B U.S. and $44.9B foreign in fiscal 2024) influence its exposure to the OECD's Pillar Two Model Rules, and how does this compare to Qualcomm's expected impact under the same Global Minimum Tax framework given their similar fiscal year 2025 implementation timeline?",
      "original_answer": "Microsoft's geographic distribution of pre-tax income shows significantly higher earnings in the U.S. ($62.9B) compared to foreign jurisdictions ($44.9B), which may reduce its exposure to the Pillar Two Model Rules since these rules target multinational enterprises with operations in low-tax jurisdictions. Microsoft notes it does not expect a material impact from Pillar Two. Similarly, Qualcomm acknowledges the global minimum tax framework will apply to them starting in fiscal 2025 and also states they do not expect a material impact on their financial statements, suggesting both companies anticipate minimal disruption from the same regulatory framework.",
      "llm_answer": "Microsoft’s 2024 pre‑tax income was split ≈ $62.9 billion from U.S. operations and ≈ $44.9 billion from foreign subsidiaries (Item 7, page 47). Because the bulk of its earnings are taxed in the United States and the foreign earnings are already subject to rates that are at or above the 15 % OECD Pillar‑Two floor, Microsoft says the new global‑minimum‑tax rules that begin to apply to it in fiscal 2025 are not expected to have a material impact on its consolidated tax expense.  \n\nQualcomm’s 10‑K also notes that the OECD Pillar‑Two model rules will become effective for it in fiscal 2025, and it expects the Global Minimum Tax to raise its effective tax rate to some extent because a larger share of its profit is generated in jurisdictions with statutory rates below the 15 % floor. Thus, while Microsoft’s exposure is limited by its predominantly U.S.‑taxed income, Qualcomm anticipates a modest but measurable increase in tax cost under the same framework.   (Microsoft citation: page 47; Qualcomm citation: 10‑K discussion of Pillar Two, fiscal 2025 implementation).",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer correctly reports Microsoft's pre-tax income figures ($62.9B U.S., $44.9B foreign) and fiscal 2025 implementation timeline for Pillar Two, which matches the ground truth. It also correctly identifies that Microsoft does not expect a material impact, aligning with the original answer. However, it incorrectly states that Qualcomm expects a 'measurable increase' in tax cost and that a 'larger share of its profit is generated in jurisdictions below the 15% floor.' This contradicts the ground truth, which states Qualcomm, like Microsoft, 'does not expect a material impact.' The LLM introduces a false distinction between the two companies' expected impacts. 2) Quantitative accuracy is high: all dollar amounts, percentages (15%), and fiscal years (2024, 2025) are correctly reported or reasonably approximated. No calculation errors. 3) The multi-hop reasoning fails in the comparison step. While the model correctly synthesizes Microsoft's income distribution and its low exposure, it incorrectly infers that Qualcomm will face a higher impact due to profit distribution—information not supported by the ground truth. The original answer emphasizes that both companies anticipate minimal disruption, but the LLM creates a divergence not present in the source data. 4) Contextual relevance is strong—the answer addresses geographic income distribution, Pillar Two exposure, and cross-company comparison. However, the qualitative inaccuracy in representing Qualcomm’s position significantly undermines the correctness, warranting a low overall score despite accurate numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 434,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does WMT's $37.2 billion in unrecorded purchase obligations expose the company to financial risks that aren't captured by the VAR models used by peers like MDLZ?",
      "original_answer": "WMT has $37.2 billion in unrecorded purchase obligations as of January 31, 2025, which includes firm commitments for inventory, utility purchases, and capital expenditures. These obligations are legally binding but are not reflected on the balance sheet. However, according to DIS's 10-K filing, VAR models — like the one used by MDLZ — exclude forecasted transactions and firm commitments when estimating financial risk exposure. MDLZ's VAR model specifically uses a parametric delta-gamma approximation technique based on interest rate, currency, and commodity price movements to estimate potential one-day losses, but does not include firm commitments in its calculations. This means that while WMT has significant off-balance sheet obligations, companies using VAR models like MDLZ do not incorporate these types of commitments into their risk assessments, leaving WMT potentially more exposed to market volatility that isn't captured through standard VAR modeling practices.",
      "llm_answer": "Walmart discloses that it has $37.2 billion of “unrecorded purchase obligations” – legally binding contracts for inventory, capital‑expenditure, software licences and services that are not reflected on the balance sheet and whose timing and amount can change (page 45).  Mondelēz’s VAR model, by contrast, only measures one‑day market‑price risk on existing interest‑rate, currency and commodity derivatives and expressly excludes anticipated transactions, firm commitments and net foreign‑subsidiary exposures (pages 65‑66).  Consequently, Walmart’s large, off‑balance‑sheet purchase commitments create liquidity and covenant‑risk that can material‑ly affect cash flow but are invisible to the VAR‑type market‑risk metrics that peers such as Mondelēz rely on.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $37.2 billion figure for WMT's unrecorded purchase obligations is correct, and no other numerical values (e.g., dates, percentages) are misstated. The amount, entity (WMT), and nature of the obligations are all factually sound. (2) The answer correctly identifies that MDLZ uses a VAR model that excludes firm commitments, anticipated transactions, and subsidiary exposures, which matches the ground truth referencing DIS's 10-K and MDLZ's specific modeling approach. While the LLM does not explicitly name DIS as the source of the VAR model description, it correctly attributes the model behavior to MDLZ, which is the focus of the comparison. (3) The multi-hop reasoning is solid: it connects WMT’s off-balance-sheet obligations to the limitations of VAR models used by peers like MDLZ, concluding that such risks are not captured—this is logically and factually consistent with the original answer. (4) Minor deduction in qualitative accuracy due to the omission of the DIS 10-K as the source of the VAR model description, though the substance about MDLZ’s model is correct. The LLM also adds detail (e.g., software licenses, services, covenant risk) not in the original but plausibly consistent with the context. Overall, the answer is semantically equivalent, contextually precise, and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 388,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does UNH's use of interest rate swaps to manage exposure to floating-rate liabilities compare with AMGN's use of similar instruments in relation to their respective $1.4 billion repayments of the 3.625% 2024 Notes?",
      "original_answer": "UNH uses interest rate swaps as part of its broader strategy to manage exposure to market interest rate fluctuations on both assets and liabilities, including $27 billion of floating-rate financial liabilities as of December 31, 2024. AMGN, on the other hand, specifically entered into interest rate swap contracts to convert fixed-rate coupons to floating-rate SOFR-based coupons, with $1.4 billion of such swaps maturing in 2024 in connection with the repayment of the 3.625% 2024 Notes. While both companies use interest rate swaps, UNH's application is broader in scope across its balance sheet, whereas AMGN's use is directly tied to specific debt instruments like the 3.625% 2024 Notes that were fully repaid in 2024.",
      "llm_answer": "UnitedHealth Group (UNH) entered into a portfolio of interest‑rate‑swap contracts that were designated as fair‑value hedges and that “effectively convert fixed‑rate coupons to floating‑rate SOFR‑based coupons.”  In 2024 the portion of that portfolio equal to about **$1.4 billion of notional** matured at the same time UNH repaid its 3.625 % 2024 notes, so the swaps were unwound as the notes were retired, eliminating the floating‑rate exposure on those notes.\n\nAmgen (AMGN) also uses interest‑rate‑swap contracts as fair‑value hedges to turn fixed‑rate debt into floating‑rate exposure.  For the 3.625 % 2024 notes AMGN has an **ongoing swap with $1.4 billion of notional** that references SOFR + 3.4 %, meaning the company continues to hedge the cash‑flow risk of those notes rather than terminating the hedge at repayment.  \n\nThus, UNH’s swaps were purpose‑built to mature and be terminated when the $1.4 billion of notes were repaid, while AMGN’s swaps remain in place, converting the same $1.4 billion of fixed‑rate notes to floating‑rate exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) It incorrectly states that UNH used interest rate swaps to convert fixed-rate coupons to floating-rate SOFR-based coupons on its $1.4 billion 3.625% 2024 Notes, implying the swaps were terminated upon repayment. However, the ground truth states that UNH’s use of interest rate swaps is part of a broader strategy covering $27 billion of floating-rate liabilities and does not specify that the swaps were tied to or terminated with the 3.625% 2024 Notes. In fact, UNH’s swaps are not described as being directly linked to that specific debt issuance. (2) The LLM incorrectly claims AMGN has an 'ongoing swap' with $1.4 billion notional that continues after 2024, whereas the ground truth explicitly states that AMGN entered into swaps maturing in 2024 in connection with the repayment of the 3.625% 2024 Notes—meaning the swaps ended with the repayment. Thus, the core comparison is inverted: the LLM portrays UNH as terminating swaps and AMGN as continuing them, while the truth is that both companies used swaps in relation to the 2024 maturities, but AMGN’s use was specifically tied to the notes being repaid, whereas UNH’s use is broader and not specifically linked to those notes. (3) The multi-hop reasoning fails because the LLM misattributes the purpose and timing of the swaps for both companies. (4) While the $1.4 billion notional amount and the 3.625% 2024 Notes are correctly referenced, the interpretation of their relationship to the swaps is factually wrong. The contextual relevance is moderate because the answer addresses the right companies and instruments, but the substantive conclusion is incorrect. Quantitative accuracy is low due to misapplication of correct numbers in wrong contexts. Qualitative accuracy suffers from flawed entity-instrument linkage and incorrect inference about hedging strategy timelines.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 517,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 194,
      "question": "How does the potential acceleration of AMD's 3.924% Senior Notes Due 2032 in the event of an 'Event of Default' compare with Oracle's exposure to similar default-triggered obligations under their Revolving Credit Agreement, particularly in terms of debt repayment structure and maturity conditions?",
      "original_answer": "AMD's 3.924% Senior Notes Due 2032 could be accelerated upon an Event of Default, which would require AMD to repay $1.0 billion in aggregate principal issued in 2022, plus accrued interest. Oracle, under its Revolving Credit Agreement, also faces potential acceleration if an Event of Default occurs, with the full $6.0 billion facility becoming due unless terminated earlier. Unlike AMD's notes, which are unsecured senior obligations, Oracle's Revolving Facility allows borrowing, prepayment, and reborrowing until March 8, 2027, with interest rates tied to credit ratings. Both companies face significant financial obligations upon default, but Oracle's structure allows more flexibility in managing short-term liquidity.",
      "llm_answer": "AMD’s 3.924 % senior notes are a fixed‑rate, unsecured obligation that matures on March 1 2032, but the indenture provides that an “event of default” would accelerate the notes, making the entire principal and accrued interest immediately payable (the notes can also be redeemed early at a make‑whole price). Oracle’s unsecured $6 billion revolving credit facility has no scheduled principal amortization; all amounts borrowed are contractually due on March 8 2027, and the agreement states that, if an event of default occurs, the lenders may accelerate the facility so that the outstanding balance becomes immediately due (or earlier if the facility is terminated). Thus, AMD’s default‑triggered acceleration converts a single‑maturity bond into an immediate lump‑sum payment, whereas Oracle’s default‑triggered acceleration converts a revolving line of credit with flexible borrowing into an immediate payoff of the entire outstanding balance, both shifting the original maturity dates to the date of default.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD's 3.924% Senior Notes Due 2032 can be accelerated upon an Event of Default, requiring immediate repayment of the $1.0 billion principal (issued in 2022) plus accrued interest; Oracle's $6.0 billion Revolving Credit Agreement can also be accelerated upon default, making the outstanding balance immediately due, with a final maturity of March 8, 2027. These numbers, dates, and dollar amounts match the original answer exactly, with acceptable formatting (e.g., $6 billion = $6.0 billion). (2) Quantitative accuracy is perfect: all figures (3.924%, 2032, $1.0B, $6.0B, March 8, 2027) are correct and properly attributed. (3) The multi-hop reasoning is sound: the model correctly compares two different debt instruments across companies (AMD bonds vs Oracle credit facility), synthesizing terms around acceleration, maturity, and repayment structure. It accurately contrasts a fixed-term bond with a revolving facility, highlighting differences in flexibility, prepayment, and reborrowing. (4) The only minor omission is that the original answer notes Oracle's interest rates are tied to credit ratings, which the LLM answer does not mention—this is a small qualitative gap but does not undermine the core comparison. Otherwise, the reasoning and semantic content are equivalent to the ground truth. The response is fully relevant and directly addresses the comparison in debt repayment structure and maturity conditions under default scenarios.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 425,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How does the $31.0 billion of trust assets under reinsurance agreements at GE, which are subject to strict investment guidelines, compare to General Dynamics' $191 million in marketable securities held in trust as of December 31, 2021, in terms of investment policy and risk exposure?",
      "original_answer": "GE holds $31.0 billion in trust assets associated with reinsurance contracts and is subject to strict investment guidelines that include limitations on asset class concentration, issuer exposure, and duration variances, with a focus on diversification and credit quality while considering risk-based capital requirements. These trust assets are managed to support insurance liabilities and are reviewed periodically for asset allocation changes, including the potential inclusion of non-traditional asset classes. In contrast, General Dynamics held $191 million in marketable securities in trust as of December 31, 2021, governed by an investment policy that restricts purchases to investment-grade fixed-income securities with a maximum maturity of five years, indicating a more conservative and short-duration approach. This highlights a significant difference in scale and investment strategy between the two companies' trust asset management, with GE facing broader credit, interest rate, and reinvestment risks due to the larger and more diverse asset base.",
      "llm_answer": "GE’s run‑off trusts hold about $31 billion of assets that are managed under “strict investment guidelines” that limit concentration, single‑issuer exposure, duration mismatches and require credit‑quality, yield, liquidity and diversification standards; the portfolio is being shifted toward higher‑yielding private‑equity, equity‑like and high‑yield credit strategies, exposing it to credit, interest‑rate and equity‑price risk. In contrast, General Dynamics’ $191 million of marketable securities held in trust are limited to investment‑grade fixed‑income securities with maturities of five years or less, giving the GD trust a much narrower, lower‑risk investment policy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $31.0 billion for GE and $191 million for General Dynamics as of December 31, 2021, are accurately reported (format variations like $31 billion vs $31.0 billion are acceptable). (2) The entities—GE and General Dynamics—are correctly identified, and the time reference (implied as of December 31, 2021, based on context) is consistent with the original answer. (3) The reasoning correctly synthesizes multi-hop information: it contrasts GE’s broader, more complex investment policy involving diversification, credit quality, and a shift toward higher-risk strategies (private equity, high-yield credit) with General Dynamics’ narrow, conservative policy limited to short-duration, investment-grade fixed income. This captures the core difference in risk exposure and investment policy. (4) The LLM omits minor contextual details present in the original—such as GE’s alignment with risk-based capital requirements, periodic portfolio reviews, and explicit mention of reinvestment risk—but these omissions do not undermine the central factual or comparative accuracy. The answer correctly identifies the key risks (credit, interest rate, equity-price risk) for GE and implies lower risk for GD due to policy constraints. Overall, the semantic meaning and analytical comparison are equivalent to the ground truth, warranting a high correctness score with only a slight deduction for minor completeness gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 417,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How do the observable market data inputs used in Lockheed Martin's fixed income pricing models compare to the inputs used in PayPal's derivative valuations, given both institutions rely on Level 2 pricing methodologies?",
      "original_answer": "Lockheed Martin's fixed income investments categorized as Level 2 are valued using pricing models that incorporate verifiable observable market data such as interest rates, yield curves at commonly quoted intervals, and credit spreads. Similarly, PayPal values a majority of its derivative instruments using pricing models that consider observable inputs like currency rates, interest rate yield curves, option volatility, and equity prices. Both institutions rely on Level 2 methodologies, indicating a shared dependence on observable market factors to determine fair value, although applied to different asset classes—fixed income for Lockheed Martin and derivatives for PayPal.",
      "llm_answer": "Lockheed Martin’s fixed‑income pricing models (Level 2) are built on verifiable market data such as current interest‑rate levels, yield‑curve points, credit‑spread levels and broker‑provided bids or comparable‑security quotes. PayPal’s derivative valuations (also Level 2) use observable inputs that include currency exchange rates, interest‑rate yield curves, option‑price volatility and equity market prices. Thus, both rely on observable market data, but Lockheed’s models are centered on fixed‑income benchmarks, whereas PayPal’s models draw on a broader set of market inputs that also cover FX, equity and volatility data.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Lockheed Martin uses observable inputs like interest rates, yield curves, and credit spreads for its Level 2 fixed income pricing, and PayPal uses currency rates, yield curves, volatility, and equity prices for its Level 2 derivative valuations. The LLM correctly identifies both firms' use of Level 2 methodologies and appropriately distinguishes the asset classes (fixed income vs. derivatives). (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no calculations were needed, and all referenced inputs are consistent with the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different companies and asset classes, comparing their use of Level 2 inputs while highlighting differences in scope (fixed income benchmarks vs. broader FX, equity, and volatility data). The slight difference in wording—mentioning 'broker-provided bids or comparable-security quotes' and 'option-price volatility'—adds minor detail not in the original but does not contradict it and reflects plausible enhancements from actual disclosures. (4) The answer is contextually relevant, fully addressing the comparison requested. The only reason for not scoring a 10 is that the original emphasizes the 'shared dependence on observable market factors' more explicitly, while the LLM focuses slightly more on differences; however, the core synthesis remains intact. Overall, this is a semantically equivalent, well-reasoned response with full factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 459,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to the impact of CSCO's interest rate swap on their fixed-rate debt, given both companies' exposure to market interest rate fluctuations?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes as of November 3, 2024, would see a $1.7 billion change in fair value with a 50 basis point interest rate shift, while CSCO has an interest rate swap with a notional amount of $0.5 billion that converts a portion of its fixed-rate debt to floating, offsetting changes in fair value due to interest rate movements. CSCO’s swap specifically hedges a senior note due in fiscal 2025, whereas AVGO uses treasury rate lock contracts to hedge anticipated future debt issuances, indicating differing hedging strategies despite both managing interest rate risk on fixed-rate debt.",
      "llm_answer": "AVGO’s fixed‑rate senior notes are directly exposed to market‑rate movements – a 50‑basis‑point rise or fall would shift the fair value of the notes by roughly **$1.7 billion** (about $1.4 billion at the prior year level), even though the interest expense itself does not change.  \n\nCisco, by contrast, has entered into an **interest‑rate swap** that converts the fixed‑rate portion of about **$0.5 billion** of senior notes to a floating rate; the swap’s gain or loss “substantially offsets” the change in fair value of those notes, so the market‑rate fluctuation has little or no net effect on the hedged debt’s fair‑value exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) All key numbers are correct: AVGO's $1.7 billion fair value change with a 50 basis point rate shift and CSCO's $0.5 billion notional swap are accurately reported. The mention of $1.4 billion as the prior year amount is not in the ground truth but does not contradict it and may reflect actual filing data; it is not penalized as it's plausible and labeled appropriately. (2) Quantitative accuracy is perfect: dollar amounts, basis points, and financial impacts match the original answer. (3) The reasoning correctly contrasts AVGO’s direct exposure to interest rate changes (with no offsetting hedge for existing debt) versus CSCO’s use of an interest rate swap that offsets fair value changes, demonstrating sound multi-hop synthesis across both companies’ hedging strategies. (4) The only minor omission is that the original specifies CSCO’s swap hedges a senior note due in fiscal 2025 and that AVGO uses treasury rate locks for *future* debt issuances—this contextual detail about the *timing and purpose* of hedges is missing in the LLM answer, slightly reducing qualitative completeness. However, the core comparison of exposure and hedging impact is correctly conveyed. (5) The answer is fully relevant, directly addressing the comparative sensitivity of AVGO’s fixed-rate debt to CSCO’s hedged position. Overall, the LLM captures the essential financial and strategic contrast with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 411,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does BMY's joint research and commercialization obligations with Pfizer under the Eliquis alliance compare to Pfizer's financial commitments in its collaboration with Beam for in vivo base editing programs, particularly in terms of upfront payments and potential milestone obligations?",
      "original_answer": "BMY and Pfizer share joint research and commercialization responsibilities under the Eliquis alliance, with Pfizer receiving co-exclusive license rights in exchange for an upfront payment and potential milestone payments, which are being amortized over BMY’s co-promotion obligation period. Separately, Pfizer paid Beam $300 million upfront upon entering their collaboration for in vivo base editing programs and may pay up to an additional $1.05 billion in development, regulatory, and commercial milestone payments across three targets, for a total potential deal value of $1.35 billion. This shows that Pfizer’s financial commitment to Beam could significantly exceed its initial payments under the Eliquis alliance, depending on development progress and milestone achievements.",
      "llm_answer": "The Eliquis alliance obligates Bristol Myers and Pfizer to jointly fund research, development, distribution, sales and marketing, with Pfizer covering roughly 50‑60 % of development costs and the two companies sharing profits equally; the agreement includes an upfront payment (recorded as deferred income) and unspecified milestone payments, but the amount is not disclosed in the excerpts. By contrast, Pfizer’s collaboration with Beam required a $300 million upfront payment and provides Beam with the right to earn up to $1.05 billion in development, regulatory and commercial milestones (for a total possible consideration of $1.35 billion).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: the $300 million upfront payment and up to $1.05 billion in milestones (total $1.35 billion) for the Beam collaboration are accurately reported. The LLM correctly notes that the Eliquis upfront and milestones are not disclosed in the excerpts, which aligns with the ground truth's implication that specific amounts are not detailed. (2) The LLM adds useful context not in the original answer—specifically, that Pfizer covers 50–60% of development costs and that profits are shared equally—which is consistent with known Eliquis alliance terms and enhances completeness without contradicting the ground truth. (3) The multi-hop reasoning is sound: the model correctly distinguishes between the two collaborations (BMY-Pfizer for Eliquis vs. Pfizer-Beam for base editing), identifies the nature of obligations (joint funding vs. upfront + milestones), and contrasts financial commitments. (4) The only minor gap is that the LLM does not explicitly mention the amortization of Eliquis payments over the co-promotion period, a detail present in the original answer. However, this does not undermine the overall correctness. The comparison of financial scale—highlighting that Pfizer’s potential $1.35B commitment to Beam could exceed its Eliquis payments—is logically supported and contextually appropriate. Wording differs but semantic meaning is equivalent or enhanced. No factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 417,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How do Texas Instruments' accounting practices for lease extension and termination options compare with Cisco's treatment of similar provisions in their customer financing arrangements, particularly regarding the impact on long-term liabilities and revenue recognition?",
      "original_answer": "Texas Instruments accounts for lease extension and termination options by recognizing lease assets and liabilities based on the present value of lease payments when it is reasonably certain they will be exercised, using their incremental borrowing rate. This affects long-term liabilities on their balance sheet. Cisco, on the other hand, includes similar extension and termination provisions in its customer financing arrangements, which are primarily collateralized and affect the timing of revenue recognition. Cisco also defers revenue on arrangements involving guarantees until the risk is removed. Both companies incorporate these options into their financial reporting, but with different implications: TXN affects liability valuation, while CSCO affects revenue timing and credit exposure.",
      "llm_answer": "Texas Instruments includes any lease‑extension or lease‑termination options in the lease liability (and the corresponding right‑of‑use asset) when it is “reasonably certain” the options will be exercised, so the present‑value of those optional periods is added to its long‑term lease obligations and the expense is spread straight‑line over the extended term. Cisco, by contrast, records its customer‑financing leases at the minimum lease payments and recognizes the associated profit as unearned income that is amortized over the lease term; optional extension or termination periods are not automatically added to the financing receivable or liability unless they are actually exercised, and revenue from the lease is recognized as lease income (or as the deferred revenue is released) rather than through a larger long‑term liability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of both factual content and reasoning. (1) It accurately describes Texas Instruments' accounting practice: including lease extension/termination options in lease liabilities and right-of-use assets when it is 'reasonably certain' they will be exercised, using present value, which impacts long-term liabilities. This matches the original answer's emphasis on TXN affecting liability valuation. (2) For Cisco, the LLM correctly notes that customer financing arrangements involve minimum lease payments, with profit recorded as unearned income amortized over time, and that optional periods are not included unless exercised—this contrasts with TXN and correctly highlights that Cisco does not automatically incorporate such options into financing receivables or liabilities. The point about revenue being recognized as lease income or through deferred revenue release aligns with the original answer’s note on revenue timing. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in how two companies treat similar contractual provisions in different contexts—leases (TXN) vs. customer financing (CSCO)—and links them to different financial statement impacts (liabilities vs. revenue recognition). (4) Minor omission: the original answer mentions Cisco defers revenue on arrangements involving guarantees until risk is removed, and that these financing arrangements are collateralized—details not included in the LLM response. While not critical, this contextual nuance about credit exposure and guarantees is part of the full comparison. However, the core financial reporting implications are correctly captured. No numeric inaccuracies; all statements are qualitative and consistent with the source. Thus, high scores across the board with a slight deduction in qualitative accuracy for partial completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 516,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does Disney's 73% stake in National Geographic influence the content differentiation strategy on Disney+, and what implications does this have for subscriber acquisition costs relative to YouTube's content licensing model?",
      "original_answer": "Disney's 73% stake in National Geographic allows it to integrate National Geographic-branded programming directly into Disney+ as a top-level tile within the interface, providing exclusive access to content that is not subject to third-party licensing fees (chunk 1 and chunk 2). This vertical integration reduces dependency on external content providers and lowers long-term content acquisition costs. In contrast, YouTube, as a digital video service competitor, relies more heavily on licensed and third-party content, which may involve ongoing licensing expenditures (chunk 3). This structural advantage could give Disney+ a cost edge in subscriber acquisition by leveraging proprietary content like National Geographic to attract and retain users at a lower marginal cost than YouTube.",
      "llm_answer": "Disney’s 73 % ownership of National Geographic (see the Domestic Channels list that includes “National Geographic (73 % interest)” 【page_78】) gives Disney direct control over the channel’s documentary and science‑focused library, which it places as a top‑level tile on Disney+ (“Disney+ is a subscription‑based DTC service with Disney, Pixar, Marvel, Star Wars and National Geographic branded programming” 【page_13】). Because the content is largely owned rather than licensed from third parties, Disney can staff it on Disney+ at the cost of internal amortization rather than paying external licensing fees, thereby lowering the cost of acquiring subscribers compared with YouTube’s model that relies on costly third‑party content licensing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 73% stake in National Geographic is correctly stated and matches the original answer. No other numerical values (e.g., costs, subscriber numbers) are present in either answer, so no calculations are required. (2) The LLM correctly identifies the key entities: Disney, National Geographic, Disney+, YouTube, and their respective content models. It accurately references the integration of National Geographic as a top-level tile on Disney+, supported by the citation from page 13, and ownership via the 73% interest (page 78). (3) The reasoning is sound: the LLM correctly infers that owning National Geographic content reduces reliance on third-party licensing, lowers content distribution costs (attributing it to internal amortization), and provides a cost advantage in subscriber acquisition compared to YouTube’s licensing model. This mirrors the multi-hop logic in the ground truth—ownership → exclusive content → reduced licensing costs → lower subscriber acquisition costs. (4) The only minor shortcoming is that the LLM does not explicitly mention YouTube’s model involving 'ongoing' or 'recurring' licensing expenditures, which slightly weakens the contrast. However, the implication of 'costly third-party content licensing' captures the essence. Wording differs but semantic equivalence is strong. All parts of the question are addressed: content differentiation strategy (via exclusive branded tile) and implications for subscriber acquisition costs (lower marginal cost via ownership). Thus, the answer is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 455,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does the impact of regulatory exclusivity expiration timelines on BMY's biologic products compare to MRK's experience with Januvia family market exclusivity delays, considering the role of regulatory exclusivity in extending market protection beyond patent terms?",
      "original_answer": "BMY's biologic products, such as Opdivo and Yervoy, benefit from 12 years of regulatory exclusivity in the U.S., which prevents the FDA from approving biosimilars until 12 years after initial approval. This regulatory exclusivity can extend beyond patent terms and provide additional market protection. In contrast, MRK's Januvia family of products saw their key U.S. patent expire in January 2023, but due to favorable court rulings and settlement agreements on a later-expiring salt-form patent, MRK expects to maintain market exclusivity until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This shows that while BMY relies on the standard 12-year biologic exclusivity framework, MRK was able to extend market exclusivity for its chemical products through litigation and secondary patents, highlighting different strategies and outcomes tied to regulatory exclusivity mechanisms.",
      "llm_answer": "BMY’s biologics are protected by a statutory 12‑year FDA biosimilar exclusivity that pushes their estimated minimum U.S. market‑exclusivity dates out to 2025‑2036 (e.g., Opdivo 2028, Yervoy 2025, Reblozyl 2031), extending protection well beyond the life of any underlying patents. In contrast, Merck’s Januvia/Janumet patents expired in 2023, but court settlements and other regulatory actions delayed loss of U.S. market exclusivity only until May 2026 (Januvia/Janumet) and July 2026 (Janumet XR), a much shorter, case‑specific extension rather than a built‑in regulatory exclusivity period. Thus, BMY’s biologics benefit from a predefined 12‑year exclusivity that systematically extends market protection, whereas Merck’s experience reflects a limited, litigation‑driven delay of a few years.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in presentation. (1) Quantitatively, the key dates and exclusivity periods are correct: BMY's 12-year biologic exclusivity is accurately described, and the May 2026 and July 2026 exclusivity end dates for MRK's Januvia family products match the original answer. The LLM correctly notes that MRK's extension stems from litigation and settlements, not statutory exclusivity. (2) The LLM adds specific product expiration years (e.g., Opdivo 2028, Yervoy 2025, Reblozyl 2031), which are not in the ground truth but are plausible and do not contradict it; however, since these specific dates are not verifiable from the original answer, they introduce slight overprecision, slightly reducing quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly contrasts BMY’s reliance on statutory biologic exclusivity with MRK’s use of secondary patents and litigation to delay generic entry, highlighting different regulatory and legal strategies. (4) The answer is contextually excellent, directly addressing the comparison of regulatory exclusivity mechanisms and their impact on market protection beyond patents. The semantic meaning fully aligns with the original, with only minor elaboration on product timelines. Thus, the answer earns a 9 for correctness due to high factual accuracy and strong reasoning, with a small deduction for unverified specific product exclusivity dates.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 415,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does MetLife's issuance of 40,000 shares of Series F preferred stock, with redemption terms tied to a 'rating agency event,' intersect with AIG's exposure to financial risks from potential rating downgrades, particularly given AIG's acknowledgment that a downgrade could limit its ability to write new business and impair customer retention?",
      "original_answer": "MetLife has issued 40,000 shares of Series F preferred stock, which includes a redemption clause triggered by a 'rating agency event'—defined as a change in rating criteria that lowers equity credit assigned to such securities. This creates a financial contingency for MetLife should credit agencies revise their treatment of these instruments. Similarly, AIG acknowledges in its 10-K that a downgrade in its Insurer Financial Strength ratings could materially impair its ability to write new business and retain customers. Therefore, both companies face strategic and operational risks tied to rating agency actions, with MetLife facing potential redemption obligations and AIG facing direct business constraints due to a potential loss of creditworthiness.",
      "llm_answer": "MetLife’s 2024 filing shows that it issued 40,000 shares of Series F non‑cumulative preferred stock and that, under the redemption provisions, the company may be required to redeem the shares at $25.50 per share (plus any accrued dividends) within 90 days of a “rating‑agency event” – i.e., any change by a nationally recognized rating agency that lowers the equity credit assigned to the security (MetLife 10‑K p. 264).  \n\nAIG’s 2024 filing explicitly warns that a downgrade by a rating agency could restrict its ability to write new insurance business and erode customer retention (AIG 10‑K p. 85). Because both firms’ capital structures are directly tied to rating‑agency actions, a downgrade that triggers MetLife’s redemption obligation would also be the same event that AIG flags as a material business‑risk, linking the two companies’ financial exposures to the same rating‑agency outcome.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and terms are correct: MetLife issued 40,000 shares of Series F preferred stock, with a redemption price of $25.50 per share plus accrued dividends upon a 'rating-agency event'—this matches the filing details. The reference to MetLife’s 10-K page 264 and AIG’s 10-K page 85 adds precision. (2) The answer correctly identifies the definition of a 'rating-agency event' as a change that lowers equity credit, which is consistent with the original answer. (3) The multi-hop reasoning is sound: it connects MetLife’s contingent redemption obligation to AIG’s business risk from rating downgrades, noting that both are exposed to the same triggering event—a rating agency action—though with different consequences (redemption vs. business constraints). (4) The only minor shortcoming is that the LLM slightly overemphasizes the idea that the *same* downgrade event would affect both companies, which is plausible but not explicitly supported by the ground truth; the original answer draws a parallel in risk type, not necessarily a shared event. This nuance prevents a perfect 10 on qualitative accuracy. Otherwise, the answer is complete, factually correct, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 359,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does the use of matrix pricing for U.S. Government Securities differ between LMT's portfolio as of December 31, 2021, and UPS's valuation methodology for similar assets, based on their respective Level 2 classifications?",
      "original_answer": "LMT reported $121 million in U.S. Government Securities as of December 31, 2021, which were classified under Level 2 inputs, indicating they were valued using matrix pricing or similar methods when broker quotes were unavailable. UPS also utilized matrix pricing for Level 2 marketable securities, including U.S. government debt, though the specific amount was not disclosed. Both companies rely on matrix pricing as a fallback when direct market data is not available, aligning with the broader accounting policy described by MO, which lists matrix pricing as a standard valuation technique for government securities when broker quotes are absent.",
      "llm_answer": "LMT’s December 31 2021 portfolio places its U.S. Treasury and agency securities in the Level 2 fair‑value hierarchy and values them with “matrix pricing” (i.e., pricing models that rely on observable yield‑curve and broker‑quote data when a direct quoted price is not available).  \n\nUPS, by contrast, reports its U.S. government and agency debt securities entirely at Level 1 (quoted market prices); the company’s valuation policy notes that matrix pricing is used only when broker quotes are unavailable, but none of its U.S. government holdings required that approach.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding UPS's classification of U.S. government securities. The ground truth states that UPS used matrix pricing for Level 2 marketable securities, including U.S. government debt, implying some holdings were classified as Level 2. However, the LLM claims UPS reports all U.S. government and agency debt entirely at Level 1 and that none required matrix pricing, which directly contradicts the original answer. This is a major error in entity and methodology accuracy. (2) Quantitatively, the LMT figure of $121 million in U.S. Government Securities as of December 31, 2021, is missing from the LLM response, which fails to mention any dollar amount—this omission reduces quantitative completeness despite no incorrect numbers being stated. (3) The multi-hop reasoning is flawed: the question asks for a comparison between LMT and UPS regarding use of matrix pricing for Level 2 U.S. Government Securities. The LLM incorrectly asserts that UPS does not use matrix pricing for these assets, failing to correctly synthesize the information that both companies use matrix pricing as a fallback when broker quotes are unavailable. The reference to MO’s policy in the ground truth further supports this shared approach, but the LLM does not reflect this alignment. (4) Contextual relevance is moderate—the response addresses valuation methodologies and hierarchy levels, so it stays on topic, but the incorrect conclusion about UPS undermines the core comparison. While the description of matrix pricing itself is accurate, the key comparative insight is wrong, warranting a low correctness and qualitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 464,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does PM's use of market inputs for derivative valuations compare to MDLZ's approach for its real estate fund investments, given the differing levels of observability in their respective valuation models?",
      "original_answer": "PM values its derivative contracts using standard valuation models based on readily observable market inputs such as foreign exchange spot rates, interest rate differentials, and maturity dates. In contrast, MDLZ values its real estate fund investments using the present value of future cash flows, relying on unobservable inputs like projected operating performance and local market conditions. While PM's approach falls under Level 1 or 2 fair value measurements due to the use of observable data, MDLZ's real estate fund valuations are categorized as Level 3 due to the reliance on unobservable inputs that cannot be corroborated by market data.",
      "llm_answer": "PMI values its derivatives with standard models that are driven almost entirely by observable market data—spot FX rates, interest‑rate differentials, volatilities and futures prices—and classifies the contracts as Level 2 fair‑value measurements. By contrast, Mondelez’s real‑estate fund assets are valued using net‑asset‑value calculations, appraisals and discounted‑cash‑flow projections that depend on market‑based inputs **and** significant unobservable assumptions, placing many of those investments in the Level 3 portion of the fair‑value hierarchy. Thus PMI’s valuations rely on highly observable inputs, whereas MDLZ’s real‑estate valuations incorporate more judgment‑heavy, less‑observable inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that PM (PMI) uses observable market inputs (FX spot rates, interest rate differentials, volatilities, futures prices) in standard models for derivative valuations, classifying them as Level 2—consistent with the ground truth stating Level 1 or 2, with emphasis on observable data. (2) For MDLZ, the LLM correctly states that real estate fund investments are valued using discounted cash flows, appraisals, and net asset value calculations involving both market-based and unobservable inputs, leading to Level 3 classification—this aligns with the ground truth’s emphasis on unobservable inputs like projected performance and local market conditions placing valuations in Level 3. (3) The multi-hop reasoning is sound: the model correctly contrasts PM’s observable, market-driven approach with MDLZ’s judgment-heavy, less observable methodology, directly addressing the question about differing levels of observability. (4) Minor difference: the ground truth does not mention 'volatilities' or 'futures prices' for PM, and the LLM adds these—while plausible, they are not in the original, but do not contradict it. Also, the LLM mentions 'net-asset-value' and 'appraisals' for MDLZ, which are not in the ground truth; however, these are reasonable valuation techniques for real estate funds and do not conflict with the stated use of discounted cash flows and unobservable inputs. Overall, all entities (PM, MDLZ, Level 2 vs Level 3) and financial concepts are correct. Wording differs slightly but maintains semantic equivalence. No numerical inaccuracies—no specific numbers involved, but classification levels and input types are correctly represented.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 480,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does MetLife's repayment strategy for its junior subordinated debentures compare to AIG's obligations under the AIGLH-issued junior subordinated debentures, particularly in terms of liquidity constraints and deferral provisions?",
      "original_answer": "MetLife has provisions allowing it to defer interest payments on its junior subordinated debentures under certain conditions, which in turn triggers dividend stopper provisions. Additionally, MetLife is subject to replacement capital covenants that require it to raise specified replacement securities before repaying, redeeming, or purchasing the debentures. In contrast, AIG's obligations under the AIGLH-issued junior subordinated debentures include specific maturities such as $54 million of 8.5% debentures due in 2030, $142 million of 8.125% debentures due in 2046, and $31 million of 7.57% debentures due in 2045, all of which are guaranteed by AIG Parent. However, AIG does not guarantee any of the borrowings of AIGLH post-distribution of debentures, indicating a different liquidity risk profile compared to MetLife's structured repayment and deferral constraints.",
      "llm_answer": "MetLife’s junior‑subordinated debentures are structured so that the company may **electively defer interest payments** (subject to “dividend‑stopper” and trigger‑event tests) and, because of its replacement‑capital covenants, can only redeem or repurchase the securities after it has generated cash proceeds from the sale of replacement securities – a framework that ties repayment directly to MetLife’s available liquidity and capital ratios【page_130】.  \n\nIn contrast, the AIGLH junior‑subordinated debentures held by AIG are **plain‑vanilla guaranteed obligations** with fixed maturities (2030‑2046) and no elective deferral feature; AIG meets those obligations using its broader credit facilities and cash resources rather than any built‑in repayment deferral mechanism【page_289】【page_290】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: MetLife's ability to defer interest payments subject to dividend-stopper provisions and replacement capital covenants is accurately described. The AIGLH-issued debentures' maturities and guaranteed status by AIG Parent are correctly represented in substance, though the LLM does not list the exact dollar amounts ($54M, $142M, $31M) or interest rates (8.5%, 8.125%, 7.57%)—this is a minor omission but does not distort the overall comparison. (2) Quantitative accuracy is strong: while specific figures are omitted, no incorrect numbers are presented, and the maturities (2030–2046) are correctly cited. The absence of deferral features in AIGLH debentures is correctly noted. (3) Multi-hop reasoning is sound: the model synthesizes differences in repayment strategy, liquidity constraints, and deferral provisions between MetLife and AIGLH, correctly contrasting structural flexibility (MetLife) vs. fixed obligations (AIG). (4) Semantic equivalence is maintained: the LLM captures the core distinction—MetLife’s repayment is constrained by capital-raising requirements and deferral mechanisms, while AIG’s obligations are fixed and guaranteed without elective deferral. The lack of explicit mention of post-distribution non-guarantee of AIGLH borrowings is a slight gap but does not undermine the central comparison. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 413,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does NVIDIA's competitive positioning against Samsung in the SoC and GPU markets influence Intel's strategic challenges in scaling its IFS Foundry Services, particularly given Intel's historical manufacturing delays and competitive pressures?",
      "original_answer": "NVIDIA competes with Samsung in the SoC and GPU markets, which are critical to automotive, gaming, and accelerated computing applications. Samsung is also a key competitor to Intel's IFS Foundry Services, which Intel established as part of its IDM 2.0 strategy to become a major foundry provider. Intel highlights that IFS must compete with established players like Samsung on multiple fronts including time-to-market, process performance, and ecosystem support. However, Intel's history of manufacturing delays, such as the setbacks with its 10nm and Intel 4 (formerly 7nm) process technologies, creates a disadvantage compared to Samsung's mature foundry capabilities. These delays have already impacted Intel's product competitiveness and gross margins, and could hinder IFS's ability to attract customers in a market where timely access to advanced processes is critical. Therefore, NVIDIA's competitive pressure on Samsung indirectly affects Intel's ability to scale IFS, as Samsung remains a dual threat both in end-product markets and in the underlying manufacturing ecosystem.",
      "llm_answer": "NVIDIA lists Samsung as a direct rival in the system‑on‑chip (SoC) space (NVDA 10‑K p. 15) and competes with Samsung‑designed GPUs, showing that Samsung is a strong, vertically‑integrated player in the same product categories Intel hopes to serve through its new Intel Foundry Services (IFS). Intel’s 10‑K (p. 54‑56) warns that IFS must win business against “well‑established competitors such as TSMC and Samsung” and that Intel’s own history of delayed node introductions (10 nm, Intel 4) has already let rivals gain performance‑per‑watt and density leads, making it harder for Intel to scale IFS capacity, meet customer design windows, and compete with Samsung‑backed SoC/GPU offerings. Thus, NVIDIA’s positioning against Samsung highlights the intensity of the Samsung threat, while Intel’s past manufacturing delays and the need to catch up on advanced‑process leadership compound the strategic challenge of growing a competitive IFS business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: NVIDIA competes with Samsung in SoC and GPU markets (correctly citing NVDA 10-K p.15), Samsung is a competitor to Intel's IFS (citing Intel 10-K pp.54–56), and Intel’s manufacturing delays (10nm, Intel 4) have created competitive disadvantages. These delays are correctly tied to impacts on time-to-market, process leadership, and IFS’s ability to scale. (2) There are no numeric values (e.g., dates, dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that Samsung is both a product competitor (via NVIDIA’s rivalry) and a foundry competitor to Intel, creating a dual threat. It logically connects Intel’s past delays to weakened competitiveness in scaling IFS, and correctly infers that NVIDIA’s pressure on Samsung underscores the intensity of the competitive environment. (4) The only minor shortcoming is that the LLM does not explicitly mention TSMC as a broader competitive context (though Samsung is the focus of the question), and slightly less emphasis is placed on the 'ecosystem support' aspect mentioned in the original. However, the core logic, entities, and strategic implications are accurately conveyed with strong citation support. Wording differs but semantic meaning is equivalent. Thus, the answer is excellent with only negligible omissions, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 432,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "Given that Alphabet repurchased $62.0 billion in Class A and Class C shares in 2024, how does the difference in voting rights between Class A and Class B shares at both Alphabet and Comcast impact their respective share repurchase strategies, particularly in light of Comcast's concentrated ownership of Class B shares by a single individual?",
      "original_answer": "Alphabet's share repurchase strategy in 2024 focused on Class A and Class C shares, with $62.0 billion repurchased, while maintaining the balance between voting classes since Class B shares automatically convert to Class A upon sale. This preserves the concentrated voting power of Class B holders. Similarly, Comcast's Class B shares, which carry 15 votes per share and represent 33⅓% of the combined voting power, are entirely owned by Brian L. Roberts. This concentrated ownership influences Comcast's repurchase strategy, as repurchases of Class A shares increase the relative voting power of the Class B shares. Both companies manage their share structures to maintain governance control while returning capital to shareholders.",
      "llm_answer": "Alphabet’s 2024 buy‑back of $62 billion was limited to its Class A (one‑vote) and Class C (no‑vote) shares — the company does not repurchase its high‑voting Class B stock, which carries ten votes per share (see GOOGL Note 11, p. 82).  By buying only the lower‑voting shares, Alphabet can return cash to investors while preserving the voting power of the founders and insiders that sit in the Class B pool.\n\nComcast’s share‑repurchase program likewise targets only its publicly‑traded Class A stock; its single‑holder Class B stock (15 votes per share) is untouched (see CMCSA Item 5, p. 31 and Note 11, p. 82).  Because all of the voting‑rich Class B shares are owned by Brian L. Roberts, the buy‑back of Class A shares does not dilute his control, allowing the company to use repurchases for capital return without affecting the concentrated voting structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Alphabet repurchased $62.0 billion in Class A and Class C shares in 2024 (correct dollar amount and year), and did not repurchase Class B shares, which carry higher voting rights (10 votes per share). The answer correctly notes that Class B shares are not repurchased, preserving founder control. For Comcast, it accurately states that Class B shares carry 15 votes per share and are entirely owned by Brian L. Roberts, and that repurchases are limited to Class A shares. (2) Quantitative accuracy is perfect: $62 billion is correctly cited, and voting rights (10 votes for Alphabet Class B, 15 for Comcast Class B) match the ground truth. (3) Multi-hop reasoning is sound: the LLM correctly infers that by repurchasing only low/no-vote shares, both companies return capital without diluting control of high-vote shareholders. It synthesizes governance impact across both firms. (4) Minor deduction in qualitative accuracy: the ground truth mentions that Alphabet’s Class B shares convert to Class A upon sale, which the LLM omits; this is a small but relevant structural detail. Otherwise, reasoning and completeness are excellent. Wording differs but meaning is semantically equivalent. Contextual relevance is full—directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 381,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does Amgen's focus on NSCLC therapies compare with Bristol Myers Squibb's recent FDA approval of Opdivo Qvantig in terms of administration method and potential market expansion for adult solid tumor indications?",
      "original_answer": "Amgen's 2024 disclosures highlight its strategic focus on NSCLC therapies, indicating a strong commitment to oncology innovation. Meanwhile, Bristol Myers Squibb's FDA approval in December 2024 for Opdivo Qvantig enables subcutaneous administration for most previously approved adult solid tumor indications of Opdivo, either as monotherapy, maintenance therapy, or in combination with chemotherapy or cabozantinib. This administration route offers a more convenient alternative to traditional intravenous delivery, potentially expanding market access and improving patient adherence. The combination of Amgen’s ongoing NSCLC development and BMS’s subcutaneous innovation in Opdivo Qvantig reflects divergent strategies in addressing the same therapeutic area, with BMS leveraging delivery mechanism improvements to enhance market positioning in solid tumor oncology.",
      "llm_answer": "Amgen’s 2024 filing shows that its NSCLC strategy is built around oral, small‑molecule agents (e.g., KRAS‑G12C inhibitors) that are taken as tablets and target genetically‑defined subsets of lung‑cancer patients. In contrast, Bristol‑Myers Squibb’s newly approved Opdivo Qvantig is a sub‑cutaneous formulation of nivolumab‑hyaluronidase that delivers the same PD‑1 blockade by injection, enabling the drug to be used across most of Opdivo’s existing adult solid‑tumor indications and thereby expanding its market reach through a more convenient administration route.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Amgen's focus on NSCLC through oral small-molecule agents (e.g., KRAS-G12C inhibitors), which matches Amgen’s 2024 strategic emphasis on targeted oncology therapies. It also accurately describes Bristol Myers Squibb’s Opdivo Qvantig as a subcutaneous formulation (nivolumab-hyaluronidase) approved for most adult solid tumor indications of Opdivo, reflecting the correct administration method and market expansion potential. (2) There are no numeric values, dates, or financial figures in the LLM answer that contradict the ground truth; while the original answer specifies the December 2024 FDA approval, the LLM omits the exact date but refers to it as 'newly approved,' which is contextually acceptable and does not impair factual accuracy. (3) The multi-hop reasoning is sound: the model correctly contrasts Amgen’s strategy (targeted oral therapies for NSCLC) with BMS’s delivery innovation (subcutaneous administration broadening use across solid tumors), capturing the divergent strategic approaches in the same therapeutic space. (4) The LLM conveys semantic equivalence to the original answer, even enhancing it with specific mechanistic detail (e.g., 'nivolumab-hyaluronidase', 'PD-1 blockade'), though it does not explicitly mention combination regimens (with chemotherapy or cabozantinib) or maintenance therapy, which are minor omissions. These do not undermine the core correctness. Overall, the response is factually robust, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 439,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "Given CMCSA's non-dilutable 33 1/3% voting power protection for Class B shares and the conversion mechanism to Class A shares, how does this structure limit GOOGL's influence despite its stake in Class A common stock?",
      "original_answer": "CMCSA's capital structure protects 33 1/3% of the voting power through Class B shares, which cannot be diluted by additional issuances of common stock. Each Class B share converts on a 1:1 basis into Class A shares, but this conversion is subject to restrictions. Meanwhile, GOOGL holds a stake in Class A common stock, which carries voting rights that could otherwise influence corporate decisions. However, due to CMCSA's structural protections, even if all Class B shares were converted to Class A, the non-dilutable voting safeguard would still preserve the 33 1/3% voting control, limiting GOOGL’s ability to shift governance outcomes through its Class A stake alone.",
      "llm_answer": "Comcast’s charter gives the nine million Class B shares a fixed aggregate voting power of **33 ⅓ %** of all votes, and that percentage is “generally non‑dilutable” (see CMCSA 10‑K p. 91). Each Class B share can be converted, at the holder’s option, into one Class A share (which carries only one vote) on a share‑for‑share basis (CMCSA 10‑K p. 81). Because the Class B voting block cannot be reduced by issuing or converting additional Class A shares, the most voting power any holder of Class A stock—such as Google’s stake in Alphabet’s Class A shares—can ever command is the remaining **66 ⅔ %**, preventing Google from attaining a controlling or blocking position despite its ownership of Class A common stock.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: CMCSA's Class B shares have a non-dilutable 33 1/3% voting power, each Class B share converts 1:1 to Class A, and this structure limits GOOGL's influence. The percentages (33 1/3% and 66 2/3%) are correctly stated. (2) Quantitative accuracy is perfect: the 33 1/3% and 66 2/3% figures match the original, and no calculations are required beyond these fixed proportions, which are correctly interpreted. (3) The multi-hop reasoning is sound: the model correctly synthesizes how the non-dilutable voting block in Class B shares constrains the maximum voting power available to any Class A holder (including GOOGL), even post-conversion. (4) The answer is contextually precise, directly addressing how CMCSA’s capital structure limits GOOGL’s governance influence despite its Class A stake. Minor wording differences (e.g., 'preventing Google from attaining a controlling or blocking position' vs. 'limiting GOOGL’s ability to shift governance outcomes') do not affect factual equivalence. All entities (CMCSA, GOOGL, Class A/B shares) are correctly identified and logically connected.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 336,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "How does the 13.2% increase in South Africa's total tobacco market volume, partly offset by higher illicit trade prevalence, affect both PEP's merger-related socioeconomic obligations and MO's illicit trade risk exposure in their respective international operations?",
      "original_answer": "The 13.2% increase in South Africa's total tobacco market volume, which was partly offset by higher illicit trade prevalence, directly impacts both companies through different mechanisms. For PEP, this market dynamic influences the scope and cost of their socioeconomic program obligations in South Africa, which are explicitly included in their merger and integration charges. For MO, the increased prevalence of illicit trade associated with this market growth contributes to the illicit trade risks outlined in their filings, which they state can lead to lost sales, brand dilution, and potential legal or regulatory actions against their distribution channels.",
      "llm_answer": "The 13.2 % rise in South Africa’s total tobacco market (PM 10‑K 2022 p. 56) shows a larger pool of legal sales, but the commentary also notes that the gain is “partly offset by a higher estimated prevalence of illicit trade.” For PepsiCo, the larger market reinforces the importance of the socioeconomic commitments it made when it acquired Pioneer Foods – a fixed‑amount pledge of roughly 8.8 billion rand (≈ $0.5 bn) for employee ownership, agricultural, education and capital‑expenditure programmes that will be funded over the next five years (PEP 10‑K 2022 pp. 113‑115). The market expansion can help generate the cash needed to satisfy those obligations, even as illicit‑trade leakage may modestly curb the volume upside. Conversely, for Altria (MO), the same rise in illicit‑trade prevalence raises its illicit‑trade risk exposure in international markets, increasing the likelihood of lost sales, tax‑revenue losses and potential regulatory or litigation actions (MO 10‑K 2022 pp. 40‑42).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly identifies PepsiCo (PEP) as the company with merger-related socioeconomic obligations in South Africa, when the ground truth refers to Philip Morris International (PM), not PepsiCo. This is a critical entity error. The $0.5 billion (8.8 billion rand) socioeconomic pledge is attributed to PEP in the LLM answer, but in reality, this commitment is associated with British American Tobacco (BAT) or PMI in South Africa, not PepsiCo. PepsiCo is a food and beverage company with no tobacco operations. Similarly, the LLM incorrectly refers to Altria (MO) having illicit trade risk exposure in international operations, but Altria’s operations are primarily domestic (U.S.), and it does not have significant international tobacco operations; the illicit trade risk in international markets applies more directly to PMI or BAT, not MO. (2) Quantitative accuracy is partially correct: the 13.2% market increase and reference to higher illicit trade prevalence are accurate and correctly cited from PM’s 10-K 2022, p. 56. However, the $0.5 billion figure and 8.8 billion rand are misattributed to PEP, which is factually wrong. There is no evidence in standard filings that PEP made such a pledge related to tobacco in South Africa. (3) Multi-hop reasoning is flawed due to incorrect entity mapping. The model fails to correctly link the socioeconomic obligations to the right company (should be PM or BAT, not PEP) and misattributes international illicit trade risk to MO, which lacks international operations. The reasoning chain breaks at the entity level, undermining the synthesis. (4) Contextual relevance is moderate—the answer addresses market growth and illicit trade and attempts to link them to corporate obligations and risks, which aligns with the question’s intent. However, due to the fundamental misidentification of companies and misattribution of financial commitments, the correctness score is low. While the structure and intent are sound, the factual foundation is incorrect, leading to a score of 4 for correctness, 3 for quantitative accuracy (due to misattributed numbers), 5 for qualitative accuracy (partial reasoning but wrong entities), and 7 for contextual relevance (on-topic but misdirected).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 614,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How do the legal risks associated with securities litigation in Slack's IPO compare to Meta's exposure from its privacy-related lawsuits, particularly in terms of procedural outcomes and potential financial liabilities?",
      "original_answer": "Slack faced securities litigation related to its IPO, where a motion to dismiss was partially granted and partially denied in 2020, followed by a Ninth Circuit reversal in 2025 that led to the dismissal of the complaint with prejudice, significantly reducing its legal exposure. In contrast, Meta faced a $725 million settlement in a consumer privacy class action, which was approved in 2023, and continues to face ongoing litigation and regulatory scrutiny, including a $5.0 billion FTC penalty paid in 2020 and pending appeals in several state attorney general cases. Unlike Slack's litigation, which was ultimately dismissed, Meta's legal challenges have resulted in substantial financial liabilities and ongoing regulatory constraints.",
      "llm_answer": "Slack’s securities‑litigation surrounding its IPO has been largely resolved procedurally: after a series of motions to dismiss, a Supreme Court‑directed remand and a Ninth Circuit opinion in February 2025, the district court was ordered to dismiss the complaint with prejudice, and the remaining state‑court action is stayed pending the outcome of the federal appeal.  By contrast, Meta’s privacy‑related suits remain active – a 2022 settlement required a $725 million payment, a 2020 FTC consent order imposed a $5 billion penalty, and several other class actions and regulator investigations are still in discovery or appeal, leaving the company exposed to additional, as‑yet‑unquantified liabilities.  Thus, Slack’s litigation has been largely terminated with no disclosed financial exposure, whereas Meta continues to face ongoing privacy claims that have already produced multi‑hundred‑million‑dollar payouts and could generate further sizable liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Correctly identifies that Slack's IPO-related securities litigation was dismissed with prejudice following a Ninth Circuit decision in 2025, which matches the original answer's key procedural outcome. The mention of a Supreme Court-directed remand is an additional detail not in the ground truth but does not contradict it and may reflect accurate procedural nuance. (2) Financial figures for Meta are correct: $725 million settlement (approved in 2023, though LLM says 2022 — minor date discrepancy), $5.0 billion FTC penalty in 2020. The $725M settlement date is off by one year, which slightly affects quantitative accuracy. (3) The multi-hop reasoning is sound: correctly contrasts Slack’s resolved litigation with no financial liability against Meta’s substantial, ongoing liabilities and regulatory exposure. (4) The LLM captures the core comparison: Slack’s case dismissed with prejudice (final outcome), while Meta faces active litigation, prior large payouts, and future risk. Only minor issues: the $725M settlement date should be 2023, not 2022, and the Supreme Court remand detail, while plausible, isn't in the ground truth and slightly over-specifies. Overall, the answer is factually correct in substance, with high completeness, proper entity identification, and strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 380,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How does the difference in vesting timelines for RSU awards between PM and WMT affect the recognition period of compensation costs, given PM's $160 million in unrecognized RSU costs and WMT's shift from 25% annual vesting to 8% quarterly vesting?",
      "original_answer": "PM has $160 million in unrecognized compensation costs from non-vested RSU awards, which are expected to be recognized over a weighted-average period of seventeen months, typically over three years or upon specific events like death, disability, or reaching age 58. This vesting schedule aligns with PM's policy where RSU awards generally vest on the third anniversary of the grant date. In contrast, WMT shifted its vesting schedule for RSU awards in fiscal 2023 to an 8% quarterly vesting rate over three years, down from a previous 25% annual vesting rate over four years. This change in WMT's vesting schedule accelerates the recognition of compensation costs earlier in the vesting period compared to PM’s structure. As a result, WMT’s updated vesting approach leads to a more evenly distributed cost recognition over the three-year period, whereas PM's cost recognition is more back-loaded due to its cliff-vesting structure tied to specific events or the three-year anniversary.",
      "llm_answer": "- Philip Morris International (PM) ‑ RSU awards vest on the third anniversary of grant.  The company reported $160 million of un‑recognized RSU compensation that it expects to expense over a weighted‑average period of **about 17 months** (≈1.4 years) 【page_110】.  \n\n- Walmart (WMT) ‑ Until fiscal 2022 its RSUs vested **25 % per year over four years** (a four‑year expense period).  Beginning fiscal 2023 the company changed the schedule to **≈8 % each quarter over three years**, so the amortisation window is now roughly **three years** instead of four 【page_66】.  \n\n**Effect:** PM’s RSU costs are being recognized much faster – in roughly a year and a half – because the awards are already near their three‑year vesting date, whereas Walmart’s change shortens the recognition horizon from a four‑year to a three‑year period, accelerating expense recognition but still over a longer span than PM’s current 17‑month average.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies key facts: PM has $160 million in unrecognized RSU costs to be recognized over a weighted-average period of 17 months, and WMT changed its vesting from 25% annually over four years to approximately 8% quarterly over three years. These numbers are quantitatively accurate and match the ground truth. The mention of 'about 17 months' and '≈8%' is acceptable as minor rounding. 2) Quantitatively, all figures are correct: $160M, 17 months, 25% annual over four years (pre-2023), and 8% quarterly over three years (from fiscal 2023). The calculation of a three-year amortization period for WMT is accurate. However, the LLM incorrectly implies that PM’s 17-month recognition period is due to awards being 'near their three-year vesting date,' which is not stated in the original answer. The original explains that vesting occurs on the third anniversary or upon specific events (e.g., age 58, death), and the 17-month period is a weighted average — not necessarily because awards are close to vesting. This misrepresents the reason for the short recognition period. 3) The multi-hop reasoning is partially flawed. While the LLM correctly compares the duration of cost recognition, it mischaracterizes PM’s vesting structure as currently expensing costs faster than WMT. In reality, PM uses cliff vesting (back-loaded), while WMT’s new 8% quarterly schedule leads to more even and earlier cost recognition. Thus, WMT’s approach accelerates expense recognition relative to its prior model and spreads it more evenly, whereas PM’s is back-loaded. The LLM incorrectly concludes PM is recognizing costs 'much faster' than WMT, when structurally, WMT’s new model leads to earlier recognition of a larger portion of costs. 4) Despite this key reasoning error, the answer includes all relevant entities (PM, WMT), correct fiscal years, and correct metrics. The contextual relevance is high as it directly addresses the question’s focus on recognition periods. However, the qualitative inaccuracy in reasoning and the incorrect comparative conclusion reduce the overall correctness. Hence, a score of 7 is justified: core data is correct, but the synthesis and conclusion contain significant flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 592,
        "total_tokens": 2094
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the $620 million unrecognized tax benefit risk at Boeing compare to Lockheed Martin's assessment of Pillar 2's impact, given the OECD's global minimum tax framework and differing implementation timelines across jurisdictions?",
      "original_answer": "Boeing identifies a $620 million risk in unrecognized tax benefits related to federal tax matters under audit, with Pillar 2's global minimum tax of 15% potentially applying to its worldwide operations, though it expects minimal impact due to lack of material operations in low-tax jurisdictions. Meanwhile, Lockheed Martin also anticipates no material impact from Pillar 2 on its effective tax rate or consolidated results, despite the framework's phased implementation starting in 2024 and 2025. This assessment is complicated by the OECD's Pillar 2 model rules, which, while providing a framework, allow for varied national adoption timelines and potential modifications to domestic tax incentives, as noted by General Electric's evidence.",
      "llm_answer": "Boeing says that, because of ongoing audits, the amount of unrecognized tax benefits could fall by as much as $620 million in the next 12 months, even as it notes that the OECD‑mandated Pillar 2 global minimum tax (effective 1 Jan 2024, with some jurisdictions applying it on 1 Jan 2025) is not expected to materially raise its overall tax cost. Lockheed Martin, by contrast, gives only a qualitative assessment – it acknowledges the Pillar 2 framework but says the rules are unlikely to have a material impact on its effective tax rate or consolidated results, without quantifying a dollar amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: Boeing's $620 million risk in unrecognized tax benefits is accurately reported, and the Pillar 2 implementation timeline (effective January 1, 2024, with some jurisdictions in 2025) matches the context. No incorrect figures or miscalculations are present. (2) The answer correctly identifies both companies—Boeing and Lockheed Martin—and their respective assessments of Pillar 2’s impact, satisfying entity accuracy. (3) Reasoning is sound: the LLM correctly synthesizes that Boeing quantifies its tax risk while expecting minimal Pillar 2 impact due to lack of operations in low-tax jurisdictions (implied by 'not expected to materially raise its overall tax cost'), and Lockheed provides only a qualitative 'no material impact' assessment. While the LLM does not explicitly mention Boeing’s rationale (lack of material operations in low-tax jurisdictions), it captures the outcome accurately. (4) The reference to General Electric in the original answer adds contextual nuance about implementation variability, but since the question focuses on Boeing and Lockheed Martin, the LLM’s omission of GE does not undermine the core comparison. The answer is semantically equivalent, uses flexible but accurate phrasing, and fully addresses the multi-hop comparison between Boeing’s quantified risk and Lockheed’s qualitative assessment under Pillar 2. One point deducted from qualitative accuracy for slight underdevelopment of Boeing’s reasoning, but overall correctness remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 438,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How will the implementation of ASU No. 2023-07 impact the way PepsiCo reports its newly reorganized segments starting in Q1 2025, and how does this align with Altria's adoption timeline and disclosure requirements under the same standard?",
      "original_answer": "PepsiCo will recast its historical segment reporting beginning in Q1 2025 to reflect its new organizational structure, which includes combining FLNA and QFNA into PepsiCo Foods North America and reorganizing international food businesses into Latin America Foods, EMEA, and Other International Foods. This aligns with ASU No. 2023-07, which requires incremental disclosures of disaggregated expense information by reportable segment. Altria adopted the standard in 2024 and included expanded disclosures in Note 17, with interim requirements to be implemented starting Q1 2025. Thus, both companies are aligning with the new standard's timeline for retrospective application and enhanced reporting beginning in 2025.",
      "llm_answer": "- **PepsiCo:** Because of the re‑organization of its North‑American and international food and beverage businesses, PepsiCo will restate its segment results to the new “PepsiCo Foods North America,” “Latin America Foods,” “EMEA,” “Other International Foods,” “International Beverages Franchise,” and “EMEA Bottling” segments. Under ASU 2023‑07 it must provide incremental, disaggregated expense information for each reportable segment, and it will begin publishing those expanded foot‑note disclosures in its interim condensed consolidated financial statements starting in the **first quarter of 2025** (the quarter in which the new segment structure is first reflected). (See PepsiCo Note 17 and the segment‑re‑organization description – pages 63 and 7.)\n\n- **Altria:** Altria already adopted ASU 2023‑07 in preparing its 2024 annual filing and therefore will be required to furnish the same incremental segment‑level expense disclosures for its reportable segments in its 2024 Form 10‑K and in all subsequent quarterly reports. (Adoption noted in Altria Note 1 – page 62.)\n\n**Alignment:** Both companies are subject to the same new disclosure mandate; Altria’s adoption was effective for its FY 2024 filing, while PepsiCo’s first‑quarter‑2025 interim statements will be the initial period in which the ASU‑required segment detail is presented for its newly reorganized segments. This timing ensures that, once PepsiCo’s new segment structure is in place, its reporting will be consistent with the disclosure framework Altria is already using.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PepsiCo will restate segment results starting Q1 2025 due to its reorganization and must provide disaggregated expense disclosures under ASU 2023-07; Altria adopted the standard in 2024 with expanded disclosures in its annual filing. The dates (Q1 2025 for PepsiCo, 2024 for Altria) and reporting timelines are accurate. (2) Quantitative accuracy is perfect: no numerical errors, and the timing (first quarter of 2025) matches the ground truth’s reference to Q1 2025. Format and references to Note 17 (PepsiCo) and Note 1 (Altria) are consistent with disclosure expectations. (3) Multi-hop reasoning is sound: the model correctly synthesizes PepsiCo’s structural changes with the ASU’s disclosure requirements and contrasts PepsiCo’s upcoming adoption with Altria’s earlier adoption, noting both will comply by Q1 2025 interim reporting. The only minor deviation is that the LLM lists more segments than the ground truth (e.g., 'International Beverages Franchise' and 'EMEA Bottling' are not mentioned in the original), which may reflect over-detailing but does not contradict the core reorganization. (4) The answer is contextually excellent—directly addresses both companies, the standard’s impact, and alignment in timeline. The conclusion about alignment in disclosure framework is logically sound and semantically equivalent to the original. Thus, the answer earns a 9 for correctness due to slight over-specification of segments, but remains factually and structurally accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1588,
        "completion_tokens": 434,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the expiration timeline of Merck's MK-7962 (sotatercept) patent protection in the U.S. compare to Pfizer's broader patent strategy for biologics, especially considering potential extensions in both portfolios?",
      "original_answer": "Merck's MK-7962 (sotatercept) has a base U.S. patent expiration of 2027, with potential additional protection extending to 2037 if patent term extensions (PTEs) are granted. This reflects a strategy of relying on both initial and extended patent coverage for biologics. Pfizer also leverages PTEs and supplementary protection certificates (SPCs), particularly in Europe, to extend exclusivity beyond basic patent expirations. Both companies utilize regulatory exclusivity and patent filings to maximize product lifecycle management, though Pfizer explicitly notes variability in extension outcomes due to external factors.",
      "llm_answer": "Merck’s sotatercept (MK‑7962) is covered by a U.S. compound patent that runs out in 2027, but because it is a biologic it will also receive 12 years of data‑exclusivity on approval and it holds method‑of‑use patents that would not expire until 2037 if no patent‑term extension (PTE) is granted【page_16†L1-L5】【page_16†L6-L9】.  \n\nPfizer’s biologics strategy, by contrast, leans on filing PTEs and other extensions to push key patent expirations farther out – for example, interim extensions have already moved a patent’s expiry from Dec 2023 to Dec 2024 and the company has pending PTE applications that could extend protection to 2028【page_15†L31-L34】 – while also relying on regulatory exclusivity and biosimilar barriers.  \n\nThus, Merck’s core sotatercept patent expires earlier (2027, with possible method‑use protection to 2037), whereas Pfizer is actively seeking extensions that would keep its biologic patents in force at least until the late‑2020s.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct information but introduces inaccuracies in the expiration timeline for Merck's sotatercept. The original answer states that the base U.S. patent expires in 2027 with potential extension to 2037 *if* patent term extensions (PTEs) are granted. However, the LLM incorrectly implies that method-of-use patents would expire in 2037 *without* PTEs, which contradicts the ground truth—2037 is the potential date *with* PTEs, not without. This misrepresents the role of PTEs and creates a factual error in the conditional logic of patent extension. (2) For Pfizer, the LLM cites a specific example of a patent extended from Dec 2023 to Dec 2024 and pending applications extending to 2028. While this reflects Pfizer’s strategy of pursuing extensions, the original answer does not include these specific dates or examples, making them potentially unsupported or over-specific. These numbers cannot be verified against the ground truth and may reflect hallucination or overinterpretation of source material. (3) The multi-hop reasoning is generally sound—comparing Merck’s and Pfizer’s biologic patent strategies involving PTEs, regulatory exclusivity, and lifecycle management. The synthesis across companies and strategies is appropriate and captures the core intent of the question. (4) Despite the misstatement about when the 2037 expiration applies and the unverified specifics on Pfizer’s extensions, the overall strategic comparison is valid and contextually relevant. The answer correctly identifies both companies’ use of PTEs and exclusivity mechanisms. However, due to the significant quantitative error regarding the 2037 date and unsupported specifics on Pfizer, the correctness score is reduced to 7, with lower quantitative accuracy (6), while qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 502,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How do cost overruns under fixed-price contracts impact both Lockheed Martin's financial performance and GE's operational execution, given the sensitivity of these contracts to inflationary pressures and project complexity?",
      "original_answer": "Lockheed Martin reported cumulative reach-forward losses of $270 million and $280 million on two fixed-price contracts as of December 31, 2023, with potential for additional losses if cost overruns continue. These contracts are especially vulnerable to inflation, as noted in RTX's 10-K, which stated that rising material and labor costs can lead to losses on fixed-price contracts when overruns occur. Similarly, GE's operational execution is negatively impacted by cost overruns, particularly in large-scale projects such as those in its Power and Renewable Energy segments, where delays or technical issues can lead to contractual penalties and joint liability in consortiums. This highlights how both companies face significant financial and operational risks stemming from fixed-price contract structures under current economic and project execution conditions.",
      "llm_answer": "Lockheed Martin says that when the actual cost of a fixed‑price or fixed‑price‑incentive contract exceeds the contract’s estimated total cost, it must record a “reach‑forward” loss at the contract level, which lowers the profit‑booking rate and directly reduces segment operating profit and net earnings (the company reported cumulative reach‑forward losses of roughly $270 million‑$280 million in 2023). GE warns that the same sensitivity to inflation‑driven material, labor and component price spikes – combined with the technical complexity of many of its fixed‑price projects – can produce cost overruns that delay schedules, trigger penalties or liquidated‑damage claims, and erode operating margins and cash‑flow, thereby impairing its overall operational execution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the $270 million to $280 million cumulative reach-forward losses for Lockheed Martin in 2023 are correctly reported, matching the original answer's figures and time frame. The format variation (range vs. two separate values) is acceptable and semantically equivalent. (2) The explanation of reach-forward losses—how they reduce profit-booking rates, segment operating profit, and net earnings—is factually correct and aligns with standard accounting practices for fixed-price contracts. (3) For GE, the LLM correctly identifies that inflation-driven cost increases in materials, labor, and components, combined with technical complexity, lead to cost overruns that result in schedule delays, penalties, and margin erosion. While the original answer specifies Power and Renewable Energy segments and mentions consortium liability, the LLM captures the essential operational and financial consequences (penalties, margin pressure, cash flow impact) without misrepresenting any facts. (4) The multi-hop reasoning is sound: it synthesizes Lockheed Martin’s financial reporting with broader industry risks noted in RTX’s 10-K (inflation sensitivity) and applies similar logic to GE’s operational execution. The only minor omission is the lack of explicit mention of GE’s segment-level exposure or joint liability in consortiums, which slightly reduces completeness but does not undermine the overall correctness. (5) Contextual relevance is excellent—the response directly addresses both companies, the impact of cost overruns under fixed-price contracts, and the role of inflation and complexity. Wording differs but meaning is preserved. No factual errors or calculation issues.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 483,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 207,
      "question": "How does MDLZ's use of commodity futures for raw material price risk compare with COST's disclosure of Level 1 financial liabilities in terms of fair value measurement and derivative instrument exposure?",
      "original_answer": "MDLZ actively uses commodity futures to hedge against price risk for raw materials like cocoa, sugar, and wheat, with these instruments classified as Level 1 financial liabilities measured at fair value based on quoted market prices. In contrast, COST disclosed that it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis as of August 28, 2022, indicating no direct exposure to exchange-traded commodity futures like those used by MDLZ. This highlights a strategic difference in derivative usage and fair value exposure between the two companies.",
      "llm_answer": "Mondelez International explicitly uses exchange‑traded commodity futures and listed options to hedge the price of raw‑material inputs (cocoa, sugar, wheat, oils, etc.). These contracts are classified as Level 1 financial instruments and are measured at fair value using the quoted market prices on the commodity exchanges. Costco’s filing, however, states that it held no Level 1 financial assets or liabilities measured at fair value on a recurring basis, indicating that it does not have comparable commodity‑futures exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: MDLZ uses commodity futures (cocoa, sugar, wheat, oils) and classifies them as Level 1 financial instruments measured at fair value using quoted market prices. COST discloses no Level 1 financial assets or liabilities measured at fair value on a recurring basis, implying no exposure to exchange-traded commodity futures. (2) There are no numeric values, dates, or calculations in the question or answer that require verification—both mention the absence of Level 1 liabilities for COST and the presence for MDLZ, which aligns with the original. The only minor omission is the specific fiscal date (August 28, 2022) from the original answer, which slightly reduces completeness but does not affect the overall correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (MDLZ and COST), compares their derivative instruments, and links fair value hierarchy levels (Level 1) to the use of exchange-traded futures. (4) Semantic equivalence is strong—wording differs slightly (e.g., 'listed options' and 'oils' added by LLM), but these are reasonable inferences or elaborations consistent with typical hedging practices and do not introduce inaccuracies. The conclusion about differing derivative exposure strategies is logically supported. Thus, the answer is excellent, meriting a 9/10 for correctness due to the missing date detail, but full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 432,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 208,
      "question": "What is the total number of UPS Class A shares that are convertible into Class B shares, and how does this compare to the assets held in Lockheed Martin's nonqualified pension trust as of December 31, 2024?",
      "original_answer": "As of December 31, 2024, there were 4.6 billion UPS Class A shares that are fully convertible into Class B shares. Lockheed Martin reported $658 million in assets held in a separate trust for its nonqualified defined benefit pension plans as of the same date.",
      "llm_answer": "UPS’s Class A shares are all convertible into Class B shares; the company had **about 121 million Class A shares outstanding** at December 31 2024. Lockheed Martin’s non‑qualified pension trust held **approximately $658 million of assets** as of the same date. Thus, UPS’s convertible share count (121 million shares) is a share‑quantity measure, while Lockheed’s figure is a dollar‑value of roughly $658 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in the number of UPS Class A shares. The ground truth states 4.6 billion shares, but the LLM reports 'about 121 million,' which is off by more than an order of magnitude. This is a critical quantitative error. However, the Lockheed Martin nonqualified pension trust asset value of $658 million is correctly reported. (2) Number verification: UPS Class A shares — incorrect (121M vs 4,600M); Lockheed Martin pension assets — correct ($658M). The comparison between share count and dollar value is noted but does not compensate for the incorrect share figure. (3) Multi-hop reasoning: The model identifies both entities and the relevant metrics (convertible shares and pension trust assets), showing awareness of the required synthesis. However, due to the incorrect UPS share number, the comparison is fundamentally flawed. The reasoning structure is sound but built on incorrect data. (4) The contextual relevance is high because the answer addresses both parts of the question and attempts a meaningful contrast between share quantity and asset value. However, the severe inaccuracy in the UPS share count drastically reduces correctness and quantitative accuracy. The qualitative accuracy is partially preserved due to correct entity and metric identification, but reasoning based on wrong data limits its validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 383,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to CSCO's use of interest rate swaps in managing similar debt exposure, given the specific fair value impacts and hedging strategies outlined?",
      "original_answer": "AVGO's fixed rate senior notes are highly sensitive to interest rate changes, with a 50 basis point increase in rates causing a $1.7 billion decline in fair value as of November 3, 2024. In contrast, CSCO actively manages this risk using an interest rate swap with a $0.5 billion notional amount, which converts fixed interest payments on a portion of its senior notes to floating rates based on SOFR, thereby offsetting changes in the fair value of the hedged debt. This indicates that while AVGO faces significant exposure due to the size of its unhedged fixed-rate debt ($56.3 billion), CSCO employs targeted hedging strategies to mitigate similar risks on its smaller fixed-rate debt base.",
      "llm_answer": "Broadcom’s (AVGO) fixed‑rate senior notes are highly sensitive to rate moves – a 50‑basis‑point shift in market rates would alter the fair‑value of the $56.3 billion of notes outstanding by about $1.7 billion (about $1.4 billion in the prior year). Cisco (CSCO), by contrast, has entered into a $0.5 billion interest‑rate swap that is accounted for as a fair‑value hedge; the swap’s gain or loss is recorded in interest expense and is designed to “substantially offset” the change in the fair value of the hedged portion of its fixed‑rate senior notes. Thus, while AVGO’s notes experience a material fair‑value swing with interest‑rate changes, CSCO’s swap hedge neutralizes that exposure for the portion of debt it covers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: AVGO's $56.3 billion in fixed-rate notes, $1.7 billion fair value impact from a 50 bps rate change (with a correct prior-year reference of $1.4 billion, which is not in the ground truth but does not contradict it), and CSCO's $0.5 billion notional interest rate swap hedging fixed-to-floating rate debt based on SOFR (implied in 'floating rates' in LLM answer). (2) Quantitative accuracy is perfect: all dollar amounts, percentages, and financial impacts match or are consistent with the original. The mention of a prior-year value ($1.4B) is additional context not in the ground truth but is not incorrect. (3) Multi-hop reasoning is sound: the model correctly contrasts AVGO's unhedged exposure with CSCO's active hedging via swaps, synthesizing across two companies and financial instruments. (4) The only minor gap is that the LLM does not explicitly name SOFR as the floating rate benchmark (though 'floating rates' is semantically acceptable), and slightly less detail on the hedging mechanism (e.g., 'based on SOFR') compared to the original. However, the core comparison of risk exposure and mitigation strategy is fully preserved. Wording differs but meaning is equivalent. No factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 367,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How do PM and MDLZ differ in their application of the parametric delta-gamma approximation technique within their VAR models to estimate one-day loss under normal market conditions?",
      "original_answer": "PM applies the parametric delta-gamma approximation technique by observing interest rate and forward currency rate movements primarily over the preceding quarter for determining VAR at year-end, and over each of the four preceding quarters for average, high, and low VAR amounts during the year. MDLZ also uses the parametric delta-gamma method but extends its parameter estimation to include commodity price movements, in addition to interest rates and currencies. Furthermore, MDLZ observes movements over the prior quarter for year-end VAR calculations and across each of the four prior quarters for average VAR amounts, similar to PM, but explicitly accounts for the non-linear behavior of currency and commodity options in its computation.",
      "llm_answer": "Both companies state that their VAR models are built on a **95 % confidence, one‑day holding‑period and assume normal market conditions**, and that the **expected‑return distribution is generated with a parametric delta‑gamma approximation**.  \n\n- **Philip Morris International (PM)** applies the delta‑gamma technique only to its **interest‑rate‑sensitive debt and foreign‑currency forwards, swaps and options** (the VAR computation covers interest‑rate and foreign‑currency risk).  \n\n- **Mondelēz International (MDLZ)** uses the same delta‑gamma approach but extends it to **interest‑rate, currency and commodity instruments** (and separately reports VAR for each of those risk categories).  \n\nThus, while the mathematical technique is identical, PM’s VAR is limited to interest‑rate and FX exposures, whereas MDLZ’s VAR incorporates an additional commodity (and equity) component.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has a minor omission in the qualitative details of how MDLZ handles non-linear behavior in options. (1) Quantitatively, all stated facts are accurate: both companies use a 95% confidence level, one-day holding period, and parametric delta-gamma approximation—these are correctly reported. The risk categories (interest rates, FX, commodities) are correctly attributed to each company. (2) The LLM correctly identifies that PM applies the technique only to interest-rate and foreign-currency instruments, while MDLZ extends it to include commodities (and mentions equity, which is not contradicted by the ground truth). (3) However, the ground truth specifies that MDLZ 'explicitly accounts for the non-linear behavior of currency and commodity options,' a key methodological nuance that the LLM omits. This is a meaningful detail in the context of delta-gamma approximation (which is designed to capture non-linearity), so its absence reduces completeness. (4) The LLM also states MDLZ includes an 'equity' component, which is not mentioned in the original answer—this is a minor overextension, though not clearly incorrect. Overall, the reasoning is sound and the comparison is logically structured, with strong contextual relevance. The answer captures the core differences but misses a subtle but important aspect of MDLZ's methodology.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 390,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does Medtronic's emphasis on increasing global patient access to its therapies compare with Amgen's challenges in maintaining patient affordability under pressure from payers like Express Scripts, particularly in light of Express Scripts' role in negotiating deeper discounts that limit access to Amgen's products such as Repatha?",
      "original_answer": "Medtronic aims to expand global patient access to its therapies by leveraging its product pipeline and local presence, as stated in its 2024 10-K. In contrast, Amgen faces significant challenges in ensuring patient affordability for products like Repatha due to increasing payer pressure, particularly from large PBMs such as Express Scripts. Express Scripts, as part of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, utilizes Rebate Management Organizations to negotiate deeper discounts, which in turn leads to formulary restrictions and higher out-of-pocket costs for patients. This dynamic negatively affects Amgen's product sales and patient access, especially for Medicare patients who abandon prescriptions due to high co-pays, despite Amgen's efforts to lower the list price of Repatha. Therefore, while Medtronic's strategy positively impacts patient access, Amgen's ability to maintain access is constrained by the market power of entities like Express Scripts.",
      "llm_answer": "Medtronic’s 2024 filing stresses that “patients around the world deserve access to our life‑saving products” and that the company will use its local presence and scale to increase adoption of its therapies in markets worldwide【page_6】. In contrast, Amgen’s filing notes that dominant PBMs such as Express Scripts, through rebate‑management organizations, are demanding ever‑deeper discounts that have already forced price cuts on Repatha yet still limit patient affordability and access, creating a continual challenge for the company【page_37】. Thus, while Medtronic is actively expanding global access, Amgen is contending with payer‑driven discount pressures that can restrict access to its products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between Medtronic's proactive strategy to expand global patient access and Amgen's challenges with payer-driven discount pressures limiting access, particularly for Repatha. All entities (Medtronic, Amgen, Express Scripts, PBMs, Repatha) and the relevant year (implied 2024 via Medtronic's filing) are correctly identified. There are no numeric values in the original or LLM answer requiring verification, so quantitative accuracy is 10. The qualitative reasoning is sound: the LLM correctly synthesizes information across the two companies and highlights the multi-hop dynamic—Express Scripts, as a major PBM, uses rebate management to negotiate deep discounts that lead to formulary restrictions and high out-of-pocket costs, undermining patient access despite price reductions. The only minor shortcoming is that the LLM omits specific contextual details present in the ground truth, such as the 'top six PBMs controlling 94% of U.S. pharmacy prescriptions' and the explicit mention of Medicare patients abandoning prescriptions due to high co-pays. While these details enrich the explanation, their absence does not undermine the central factual accuracy or reasoning. The answer remains semantically equivalent in conveying the key contrast and causal mechanisms. Thus, correctness is 9 (not 10) due to slight incompleteness in contextual depth, but all critical facts and logic are preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 402,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How does Alphabet's share repurchase strategy prioritize certain stock classes relative to their conversion rights, and what might this imply about potential voting control considerations given that Class A shares are also publicly traded by another major corporation?",
      "original_answer": "Alphabet repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining available under the repurchase authorization as of December 31, 2023. Notably, Class B common stock—which carries 10 votes per share—can be converted to Class A shares at the stockholder's option or automatically upon sale or transfer. The company has focused repurchases on Class A and Class C shares rather than Class B, preserving the weighted voting power associated with Class B shares. Meanwhile, Class A common stock is also publicly traded by Comcast Corporation (CMCSA), suggesting Class A shares may represent a broader market standard for voting equity that could be strategically maintained for governance purposes.",
      "llm_answer": "Alphabet’s buy‑back program is directed only at its Class A (one‑vote) and Class C (non‑voting) shares, while it does not repurchase Class B shares that carry ten votes each. Class B stock can be converted at any time into Class A shares (and automatically converts on a sale or transfer) 【page_81†L1-L4】, so by targeting the lower‑voted classes the company preserves the voting power held in the convertible, high‑vote Class B pool. Because Class A shares are also publicly traded by other large firms (e.g., Comcast’s publicly listed Class A common stock) 【page_1†L1-L4】, the strategy reflects a focus on reducing the number of market‑traded voting shares while maintaining founder‑controlled voting control.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core reasoning and facts from the ground truth. (1) It correctly identifies that Alphabet repurchases Class A and Class C shares but not Class B, preserving the high-voting Class B shares, and explains the conversion mechanism accurately. It also correctly notes that Class A shares are publicly traded by another major corporation (Comcast), supporting the governance implication. (2) However, the LLM omits the specific dollar figures from the original answer: $62.2 billion repurchased in 2023 and $36.3 billion remaining authorization as of December 31, 2023. While the absence of these numbers does not invalidate the reasoning, it reduces quantitative completeness. The LLM does not make any calculation errors—it simply avoids the numbers altogether—hence a score of 8 on quantitative accuracy. (3) The multi-hop reasoning is sound: it connects Alphabet’s repurchase strategy, the conversion rights of Class B shares, the preservation of voting control, and the broader market context of Class A shares being used by other firms like Comcast. The logic that repurchasing non- or low-voting shares maintains founder control is correctly inferred. (4) The answer is contextually relevant and semantically equivalent in meaning, even though it uses slightly different phrasing (e.g., 'founder-controlled voting control' vs 'preserves weighted voting power'). Minor omission of exact figures prevents a perfect 10 on correctness, but the qualitative and contextual accuracy is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 421,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How might UnitedHealth Group's formulary restrictions on high-cost biologics, as demonstrated by Repatha's access challenges, impact Eli Lilly's ability to maintain revenue growth for its biologic therapies given their dependence on patient access?",
      "original_answer": "UnitedHealth Group, as one of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, has significant leverage to impose formulary restrictions and require prior authorization for high-cost biologics. This is exemplified by the access limitations placed on Repatha, which resulted in reduced patient affordability and use despite price reductions. Eli Lilly acknowledges that its revenue prospects for biologics are directly affected by patient access issues, including payer restrictions such as prior authorization and formulary exclusions. Given the concentration of payer power and the precedent set by Repatha’s access challenges, Eli Lilly’s ability to maintain revenue growth for its biologic therapies may be significantly constrained if similar restrictions are applied to its products.",
      "llm_answer": "UnitedHealth Group’s use of step‑therapy, prior‑authorization and aggressive rebate demands to keep the high‑cost PCSK9 inhibitor Repatha off its formulary shows how a few large PBMs can sharply limit patient access to expensive biologics (Amgen 10‑K p. 37). Eli Lilly’s biologic portfolio is similarly dependent on payer coverage and unrestricted patient use—its 10‑K notes that “payers are increasingly focused on costs…lower reimbursement rates…or narrower patient populations for which payers will reimburse” (Lilly 10‑K p. 24‑27). If UnitedHealth or other dominant payers impose comparable formulary restrictions on Lilly’s biologics, utilization could fall and the company’s ability to sustain revenue growth for those therapies would be materially weakened.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UnitedHealth Group's formulary restrictions on high-cost biologics like Repatha are accurately described, including the use of prior authorization and step-therapy, which are supported by the Amgen 10-K reference. Eli Lilly’s dependence on patient access and payer coverage is correctly cited from its 10-K (pp. 24–27), with accurate emphasis on payer cost focus, lower reimbursement, and narrower eligible populations. (2) There are no numeric values, dates, or percentages in either answer, so quantitative accuracy is not compromised—format and content are consistent. (3) The multi-hop reasoning is sound: the model correctly links UnitedHealth’s restrictive practices (via the Repatha example) to broader payer power dynamics and applies this precedent to Eli Lilly’s biologic revenue risks. The synthesis across Amgen and Lilly 10-Ks is appropriate and logically structured. (4) The LLM slightly enhances the original answer by specifying 'step-therapy' and 'aggressive rebate demands,' which are plausible and contextually consistent, though not explicitly mentioned in the ground truth. However, these additions do not contradict but rather enrich the explanation without introducing inaccuracies. The core conclusion—that formulary restrictions could materially weaken Lilly’s revenue growth—is semantically equivalent and well-supported. Minor deduction in qualitative accuracy only because the original answer emphasizes the concentration of six PBMs controlling 94% of prescriptions, a key contextual data point that the LLM omits, slightly reducing completeness on systemic payer power. Otherwise, the response is factually correct, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 483,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does Oracle's use of its $3.0 billion commercial paper program compare with Cisco's treatment of its $9.0 billion in senior fixed-rate notes, particularly in light of their shared exposure to short-term debt financing mechanisms?",
      "original_answer": "Oracle maintains a $3.0 billion commercial paper program, which allows it to issue unsecured short-term promissory notes under a private placement exemption. As of May 31, 2022, Oracle had no outstanding commercial paper notes. Cisco, on the other hand, had $9.0 billion in principal amount of senior fixed-rate notes outstanding as of July 30, 2022, which rank at par with any commercial paper notes it may issue in the future under its short-term debt financing program. Cisco also uses interest rate swaps to convert fixed interest rates on $1.5 billion of these notes to floating rates based on LIBOR. This indicates that while Oracle actively manages short-term liquidity through a flexible commercial paper facility, Cisco has a larger, more structured long-term debt profile with embedded risk management through interest rate hedging.",
      "llm_answer": "Oracle treats its $3 billion commercial‑paper program as a short‑term, on‑demand source of unsecured promissory notes that it can draw on for general corporate purposes; the program is expressly linked to its senior‑note capital structure, with the senior notes ranking pari‑passu with any commercial‑paper notes that may be issued (ORCL 10‑K, Note 12‑a). Cisco, on the other hand, carries $9 billion of senior fixed‑rate notes that are recorded as long‑term borrowings, are unsecured, and may be redeemed early only with a make‑whole premium (CSCO 10‑K, Note 12‑b). Thus, while both companies are exposed to market‑rate and covenant risks inherent in unsecured senior debt, Oracle’s exposure is through a revolving short‑term commercial‑paper facility, whereas Cisco’s exposure is tied to a fixed‑rate, long‑term note issuance.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies Oracle's $3.0 billion commercial paper program and Cisco's $9.0 billion senior fixed-rate notes, matching the dollar amounts in the ground truth (quantitative accuracy is high). However, it introduces a significant factual error by claiming Oracle's commercial paper program is 'expressly linked to its senior-note capital structure' and that 'senior notes rank pari-passu' with commercial paper—this detail is not present in the original answer or supported by the ground truth, which states Oracle had no outstanding commercial paper as of May 31, 2022. The LLM also incorrectly implies a structural linkage between Oracle’s senior notes and commercial paper, which misrepresents Oracle’s actual use of the program as a flexible, on-demand liquidity tool with zero outstanding balance. For Cisco, the LLM correctly notes the $9.0 billion in long-term unsecured notes and early redemption with a make-whole premium, but omits the critical detail from the ground truth that Cisco uses interest rate swaps to convert $1.5 billion of fixed-rate debt to floating rates based on LIBOR—a key element of Cisco’s risk management strategy and a core part of the comparison. This omission weakens the qualitative accuracy and multi-hop synthesis, as the contrast in risk management approaches (Oracle’s flexible short-term access vs. Cisco’s structured long-term debt with hedging) is only partially captured. While the LLM recognizes the difference between short-term and long-term instruments, it fails to fully convey the strategic and operational distinctions highlighted in the original answer. Contextual relevance is strong, as the response stays focused on the comparison of debt financing mechanisms. Overall, the answer is partially correct with accurate numbers but flawed in key qualitative details and missing a major component of Cisco’s treatment of its debt.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 511,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does the extension of ASU 2022-06's optional hedging relief until 2024 impact FedEx's and Caterpillar's management of LIBOR-related interest rate risk in their respective derivative instruments?",
      "original_answer": "ASU 2022-06 extends the optional expedients and exceptions for accounting related to reference rate reform, including LIBOR, until December 31, 2024. FedEx, which references this ASU, continues to monitor its contracts and hedging relationships affected by LIBOR, though it has not yet experienced a material impact. Caterpillar, which actively uses interest rate contracts as part of its risk management strategy, benefits from the extended relief by maintaining flexibility in accounting for LIBOR-based hedging relationships without disruption. The extension allows both companies to continue transitioning away from LIBOR without immediate accounting complications, supporting consistent treatment of derivative instruments tied to legacy rates.",
      "llm_answer": "The FASB’s ASU 2022‑06, which postpones the “sun‑set” of the optional hedging expedients for contracts that reference LIBOR until 31 December 2024, lets both companies keep their existing LIBOR‑linked swaps in hedge‑accounting treatment for another two years. FedEx notes that, although it has been monitoring the reform, the relief has so far had no material effect on its financial results and it can continue to use the LIBOR‑based interest‑rate contracts that are designated as fair‑value or cash‑flow hedges (FedEx 10‑K Note 3, p. 93). Caterpillar likewise relies on interest‑rate swaps to match‑fund its debt and receivables (Caterpillar 10‑K Note 4, p. 75‑76); the extension of ASU 2022‑06 permits those swaps to remain designated hedges through 2024, avoiding forced derecognition or re‑measurement and thereby limiting earnings‑volatility as it transitions away from LIBOR.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ASU 2022-06 extends optional hedging relief until December 31, 2024, which both FedEx and Caterpillar use to manage LIBOR-related derivative instruments. The date (December 31, 2024) is correctly stated, and there are no numerical inaccuracies. (2) Quantitative accuracy is perfect: the extension date is correct, and no erroneous calculations are present. Format variations (e.g., '31 December 2024' vs 'December 31, 2024') are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the answer correctly synthesizes information across both companies, referencing their respective hedging practices and the impact of the ASU extension. It accurately notes FedEx's monitoring stance and lack of material impact (citing Note 3, p. 93), and Caterpillar’s use of swaps for match-funding (citing Note 4, pp. 75–76), showing proper cross-document synthesis. (4) The answer conveys the same core meaning as the original: both companies benefit from delayed accounting disruption, maintain hedge accounting, and avoid earnings volatility during LIBOR transition. The only minor shortcoming is slightly less emphasis on the 'transition away from LIBOR' as an ongoing process, but this is implied. Wording differences are acceptable under semantic equivalence. No factual errors or omissions affect the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 396,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's engagement of Citibank in its multi-facility credit agreements in terms of syndication structure and amendment activity in 2022 and 2023?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, involved Citibank, N.A. as administrative agent alongside JPMorgan Chase Bank, N.A. as syndication agent, with both also serving as joint lead arrangers and joint book managers. Caterpillar, on the other hand, had Citibank, N.A. acting as agent in both its 3-Year and 5-Year Facilities dated September 1, 2022, with additional roles for Citibank Europe plc and MUFG Bank, Ltd. in local currency management. Both companies saw Citibank play a central role in structuring and managing credit facilities, but Caterpillar’s agreements included more complex international components, while Boeing’s amendment in 2022 was a singular update to its existing agreement.",
      "llm_answer": "Boeing’s five‑year credit facilities name **Citibank, N.A. as the administrative agent** and **JPMorgan Chase Bank, N.A. as the syndication agent**, with both banks acting as joint lead arrangers and book‑managers (see BA 10‑K p.126).  The agreement was amended once in 2022 (Amendment No. 1 dated August 25 2022) and a new five‑year facility was issued in 2023 that kept the same agent‑syndication structure (see BA 10‑K p.125‑126).\n\nCaterpillar’s multi‑facility 364‑day credit program lists **Citibank, N.A. as the sole agent** (with Citibank Europe and MUFG as local‑currency agents) and does not identify a separate syndication agent (see CAT 10‑K p.128).  The 2022 364‑day facility was subsequently amended in 2023 through a Local‑Currency Addendum and a Japan Local‑Currency Addendum, indicating amendment activity in 2023 but no distinct syndication‑agent role (see CAT 10‑K p.128).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy regarding Boeing's 2023 facility. The original answer states that Boeing's Five-Year Credit Agreement was amended on August 25, 2022, with no mention of a new facility issued in 2023. However, the LLM claims a 'new five-year facility was issued in 2023,' which is not supported by the ground truth and represents a factual overstatement—this affects quantitative and qualitative accuracy. All other dates (August 25, 2022 amendment), roles (Citibank as administrative agent, JPMorgan as syndication agent), and structural details for Boeing are accurate. For Caterpillar, the LLM correctly identifies Citibank, N.A. as agent, the involvement of Citibank Europe and MUFG Bank, Ltd. in local currency roles, absence of a syndication agent, and amendment activity in 2023 via addenda. The comparison effectively highlights Caterpillar’s more complex international structure versus Boeing’s simpler, agent-led syndication. The reasoning is sound and multi-hop synthesis across both companies and years is appropriate. Wording differs but semantic meaning is equivalent on most points. The contextual relevance is excellent, directly addressing syndication structure and amendment activity as required. The minor error in implying a new Boeing facility in 2023 prevents a top score, but core facts and entities are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 392,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the dual-class stock structure at META, which gives Class B shareholders disproportionate voting control, compare to CMCSA's dual-class framework in terms of potential impact on investor confidence, especially given CMCSA's Class B to Class A conversion mechanism?",
      "original_answer": "META's dual-class stock structure gives Class B shareholders, such as Mark Zuckerberg, disproportionate voting control, which could make its Class A common stock less attractive to some investors. This is due to reduced corporate governance protections and potential conflicts of interest. Similarly, CMCSA has a dual-class framework where Class B common stockholders hold 33⅓% of the voting power, and each share of Class B stock is convertible, share for share, into Class A stock. The conversion mechanism in CMCSA could allow for shifts in voting control, much like META's structure, though CMCSA's Class B shares currently represent a much smaller total quantity (9,444,375 issued and outstanding). This structural similarity may affect investor confidence in both companies, especially if control remains concentrated in a minority of shareholders.",
      "llm_answer": "Meta’s charter creates a classic “founder‑controlled” dual‑class system: each Class B share carries ten votes and, because the nine‑plus percent of Class B shares held by Mark Zuckerberg and other insiders represent a majority of the total voting power, ordinary Class A shareholders have little ability to influence corporate decisions, a feature that analysts often cite as a drag on investor confidence. Comcast also uses a dual‑class structure, but its Class B shares own only about one‑third of the total voting power (each Class B share gets 15 votes) and are convertible share‑for‑share into Class A stock, a mechanism that can gradually dilute the concentrated voting block and therefore is viewed as less restrictive and less likely to erode confidence than Meta’s entrenched arrangement.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and addresses the core comparison between META and CMCSA's dual-class structures in terms of investor confidence. It correctly identifies that META's Class B shares (held by Zuckerberg and insiders) carry disproportionate voting power (10 votes per share), which reduces influence for Class A shareholders and may harm investor confidence—a key point in the ground truth. It also correctly notes CMCSA’s dual-class framework, the 33⅓% voting power held by Class B shares, and the share-for-share convertibility into Class A stock, which aligns with the ground truth. However, there is a quantitative inaccuracy: the LLM states that each CMCSA Class B share gets 15 votes, but this detail is not present in the original answer or commonly reported in public filings; the ground truth only specifies the 33⅓% aggregate voting power and conversion mechanism, not per-share vote count. This introduces a potentially misleading detail not supported by the source. Additionally, while the LLM captures the broader implication about investor confidence and structural similarity, it omits the specific figure of 9,444,375 Class B shares outstanding for CMCSA, a minor but relevant completeness gap. The reasoning is sound and synthesizes multi-hop elements (structure, control, conversion, confidence impact) across both firms. Wording differs but meaning is semantically equivalent on most points. The answer is highly relevant and well-framed, earning high marks on qualitative and contextual dimensions despite the numerical overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 427,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "What was The Coca-Cola Company's net sales to equity method investees in 2021, and which regions does Coca-Cola FEMSA specifically cover in its bottling and distribution operations?",
      "original_answer": "The Coca-Cola Company's net sales to equity method investees in 2021 were $14,471 million. Coca-Cola FEMSA operates in several countries including Mexico (central, southeast, and northeast), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (parts of São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina, parts of Rio Grande do Sul, Goiás, and Rio de Janeiro), Argentina (Buenos Aires and surrounding areas), and Uruguay.",
      "llm_answer": "The Coca‑Cola Company reported net sales to its equity‑method investees of **$14.471 billion in 2021**【page_89】.  \n\nCoca‑Cola FEMSA’s bottling and distribution footprint includes **Mexico (central, southeast and northeast regions), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (key states such as São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina, parts of Rio Grande do Sul, Goiás and Rio de Janeiro), Argentina (the Buenos Aires federal capital and surrounding area), and Uruguay**【page_7】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the net sales amount of $14,471 million in 2021 is accurately reported as $14.471 billion, which is a valid format conversion (1 billion = 1,000 million). (2) The regions covered by Coca-Cola FEMSA are listed with complete accuracy, including all specified regions in Mexico, Central and South American countries, and the detailed Brazilian states and Argentine areas. Minor wording differences (e.g., 'key states such as' or 'federal capital and surrounding area') do not alter the factual meaning and are semantically equivalent. (3) The multi-hop reasoning is sound—correctly identifying both a financial figure from The Coca-Cola Company's 2021 filing and synthesizing geographic operational data about Coca-Cola FEMSA. (4) All entities (The Coca-Cola Company, equity-method investees, Coca-Cola FEMSA) and the year 2021 are correctly identified. The answer is contextually precise, directly addressing both sub-questions with no irrelevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 300,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the decline in Remicade sales due to biosimilar competition impact Merck's overall immunology segment revenue, and how does this compare to AbbVie's exposure to biosimilar pressures on biologics like Humira?",
      "original_answer": "Merck's Remicade sales declined by 9% in 2021 and 20% in 2020 due to biosimilar competition in Europe, where it lost market exclusivity in 2015. This decline directly affected its immunology segment, which includes Remicade and Simponi, both impacted by biosimilar pressures. In 2021, Remicade generated $299 million in international sales, contributing to the overall decline in the segment. AbbVie, on the other hand, faces similar biosimilar threats, particularly with Humira, which is now facing direct biosimilar competition in Europe and other countries. Unlike Merck, AbbVie continues to invest heavily in biologics infrastructure and emphasizes patent protection and regulatory exclusivity to delay biosimilar entry, particularly in the U.S. market.",
      "llm_answer": "Merck’s immunology sales fell from $1,168 million in 2020 (Simponi $838 m + Remicade $330 m) to $1,124 million in 2021, a drop of roughly 4 percent; the 9 percent decline in Remicade (to $299 m) was the primary driver of that segment‑wide contraction. AbbVie likewise notes that its flagship anti‑TNF biologic Humira is now facing direct biosimilar competition in Europe and elsewhere, creating a material exposure to biosimilar‑driven pricing and volume pressure that is comparable to Merck’s Remicade situation but on a larger scale because Humira represents a far bigger share of AbbVie’s overall revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Remicade declined 9% in 2021 to $299 million (matches ground truth), and the 2020 figure is correctly implied as $330 million (299 / 0.91 ≈ 330), consistent with a 9% drop. The immunology segment total of $1,168 million in 2020 (Simponi $838M + Remicade $330M) and $1,124M in 2021 are accurate and correctly imply a ~4% decline. These figures are not in the original answer but are consistent with the data provided and represent valid inference. (2) The LLM correctly identifies that Remicade’s decline is due to biosimilar competition in Europe, matching the ground truth’s timeline (lost exclusivity in 2015, declines in 2020 and 2021). (3) The comparison to AbbVie is qualitatively sound: both companies face biosimilar pressure on anti-TNF biologics (Remicade and Humira), and the LLM correctly notes Humira’s exposure in Europe and elsewhere. It appropriately contextualizes that Humira’s impact is larger due to its greater revenue contribution, which is implied in the ground truth. (4) Minor omission: the original answer mentions Merck’s 20% decline in Remicade in 2020, which the LLM does not include, but the focus is on 2021, so this is not critical. Also, AbbVie’s strategy around patent protection and U.S. exclusivity is omitted, slightly reducing completeness. However, the core multi-hop reasoning—linking biosimilar impact on Remicade to Merck’s immunology revenue and comparing it to AbbVie’s Humira exposure—is logically sound and factually correct. Wording differs but semantic meaning is equivalent. No calculation errors. Format variations are acceptable.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 460,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How did Honeywell's investment in Garrett's Series B Preferred Stock, originally tied to indemnification agreements, impact its long-term receivables after the partial redemptions in late 2021, and what was the remaining present value of the unredeemed shares as of December 31, 2021?",
      "original_answer": "Honeywell received $375 million and 834.8 million shares of Garrett's Series B Preferred Stock as part of the resolution of indemnification and tax matters agreements following Garrett's emergence from bankruptcy. The Series B Preferred Stock was subject to mandatory redemptions, with the First Partial Redemption of $211 million completed on December 28, 2021, and a planned Second Partial Redemption of $200 million in early 2022. As of December 31, 2021, the present value of the remaining mandatory redemptions of the Series B Preferred Stock was $423 million, which was included in Honeywell’s long-term receivables and investments.",
      "llm_answer": "Honeywell’s settlement of the Garrett indemnity and tax‑matters agreements left the company with an investment in Garrett that is now shown on the balance sheet as a **long‑term receivable of about $423 million** (the amount recorded for its Series B Preferred Stock, Series A Preferred Stock and common‑stock holdings after the December 2021 redemptions)【page_103】.  \n\nBecause the second amendment to the Series B Preferred Stock required a second partial redemption that would leave the **present value of the remaining un‑redeemed shares at roughly $207 million**, that was the fair‑value amount reported for the outstanding shares as of December 31, 2021【page_102】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in key quantitative figures. According to the ground truth, the present value of the remaining mandatory redemptions of Garrett's Series B Preferred Stock as of December 31, 2021, was $423 million, which was included in Honeywell’s long-term receivables. However, the LLM incorrectly states that the fair value of the outstanding shares was $207 million, which contradicts the ground truth. Additionally, the LLM mentions a 'second amendment' requiring a second partial redemption that would leave the present value at $207 million, which is not supported by the original answer. The original answer states that after the $211 million First Partial Redemption in December 2021, the remaining present value was $423 million, with a planned $200 million Second Partial Redemption in early 2022 — not that the remaining value was $207 million. (2) The LLM also incorrectly combines the value of Series B Preferred Stock with Series A Preferred Stock and common stock in stating the $423 million long-term receivable, while the ground truth attributes the $423 million solely to the remaining present value of the Series B Preferred Stock redemptions. There is no mention of Series A or common stock in the original answer. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the sequence of redemptions and their impact on receivables. It misrepresents the timing and valuation logic, suggesting a post-redemption fair value of $207 million when the ground truth clearly states $423 million remains after the first redemption. (4) Despite these serious errors, the answer is contextually relevant — it addresses Honeywell’s investment, the redemption events, and the accounting treatment in long-term receivables — hence a moderate contextual relevance score. However, the quantitative inaccuracy is severe, warranting a low correctness score of 3.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 521,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the voting power distribution in CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, relate to the repurchase activity and voting structure of GOOGL's Class A and Class B common stock, given the interplay between their respective share classes and repurchase programs?",
      "original_answer": "In CMCSA, Class B common stock has 15 votes per share and represents 33 1/3% of the combined voting power, which is entirely owned by Brian L. Roberts. This structure ensures concentrated voting control despite broader share repurchases of Class A stock. Similarly, GOOGL’s Class A shares carry one vote each, while Class B shares have 10 votes per share, and the company repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining under the repurchase authorization. These repurchases primarily affect the float of lower-vote shares, preserving the relative control of insiders who hold Class B stock. Thus, both companies maintain dual-class structures that insulate control while using share repurchases to manage capital allocation.",
      "llm_answer": "Comcast’s proxy‑statement shows that the single Class B share owned by Brian L. Roberts carries 15 votes per share and accounts for roughly 33 percent of the company’s total voting power, while the much larger pool of Class A shares (which are the only shares the company repurchases) represent the remaining 66 percent of voting power 【page_33】. Alphabet’s capital structure is analogous: each Class B share carries 10 votes and is held almost entirely by insiders, whereas the open‑market repurchase program authorized in 2023 targets only Class A and non‑voting Class C shares, leaving the high‑vote Class B stock untouched and preserving insider control 【page_81】. Thus, in both firms the repurchase activity is confined to the low‑vote, publicly‑traded shares, while the high‑vote Class B stock—Roberts’ 33 % stake at Comcast and Alphabet’s insider‑held Class B—continues to dominate voting power.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Brian L. Roberts owns the sole Class B share in CMCSA with 15 votes per share, representing approximately 33 1/3% of voting power (rounded to 33% is acceptable). For GOOGL, the 10 votes per Class B share and the targeting of Class A and Class C shares in repurchases are correctly stated. The $62.2 billion repurchase and $36.3 billion remaining authorization from the original answer are not mentioned, but the LLM correctly identifies that repurchases target low-vote shares and preserve insider control—this omission is minor given the focus on structural interplay rather than specific dollar figures. (2) No calculation errors; all percentages and voting rights are accurately represented. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across CMCSA and GOOGL, identifying the parallel dual-class structures and how repurchase programs selectively affect lower-vote shares to maintain insider control. (4) Semantic equivalence is strong—while the LLM does not cite exact repurchase amounts, it captures the core dynamic: repurchases are confined to low-vote shares, preserving high-vote Class B dominance in both firms. The answer is contextually excellent, directly addressing the interplay between voting structure and repurchase activity. One point deducted from correctness and qualitative accuracy for the omission of specific repurchase figures, which were present in the ground truth and part of the multi-hop detail, though the conceptual synthesis remains robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 440,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the Value-at-Risk (VAR) calculation methodology under normal market conditions used by MDLZ compare to PM's approach, particularly in terms of the time horizon for observing interest rate and currency movements and the confidence interval applied?",
      "original_answer": "Both MDLZ and PM use a VAR model that assumes normal market conditions and applies a 95% confidence interval with a one-day holding period. However, MDLZ observes interest rate, currency exchange, and commodity price movements over the prior quarter for point-in-time VAR calculations and over each of the four prior quarters for average VAR amounts. Similarly, PM observes interest rate and forward currency rate movements primarily over the preceding quarter for point-in-time VAR and over each of the four preceding quarters for average, high, and low VAR amounts. This indicates a largely consistent methodology between the two companies, with both relying on quarterly historical data for risk estimation under normal market conditions.",
      "llm_answer": "Both companies compute VAR assuming normal‑market conditions with a one‑day holding period and a **95 % confidence interval**.  Mondelēz (MDLZ) bases the parameters on **interest‑rate, currency‑exchange and commodity‑price movements observed over the prior quarter** (and uses the four most recent quarters for its “average” VAR).  Philip Morris (PM) does the same – it derives the inter‑relationships from **interest‑rate and forward‑currency movements primarily over the preceding quarter** (and similarly uses the four preceding quarters for its average/high/low VAR).  Thus, the time‑horizon and confidence level are essentially identical for the two firms.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: both MDLZ and PM use a 95% confidence interval and a one-day holding period under normal market conditions. (2) The time horizons for data observation are correctly reported: MDLZ uses the prior quarter for point-in-time VAR and the four prior quarters for average VAR; PM uses the preceding quarter for point-in-time and the four preceding quarters for average, high, and low VAR amounts. (3) The multi-hop reasoning—comparing two companies' VAR methodologies across time horizon, confidence level, and data observation periods—is sound and complete. (4) Minor wording differences (e.g., 'forward-currency movements' vs 'forward currency rate movements') do not affect factual accuracy. All entities (MDLZ, PM, VAR components) are correctly identified. No calculation errors or omissions. The answer fully addresses the comparative aspect of the question with precise, factually aligned details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 292,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Apple's reliance on China Mainland for manufacturing, as a component of its Greater China segment, compare with Microsoft's operational footprint in Greater China, particularly in terms of regional support infrastructure and localized product offerings?",
      "original_answer": "Apple relies heavily on China Mainland for manufacturing, which is a key part of its Greater China segment that also includes Hong Kong and Taiwan. This reliance exposes Apple to risks such as trade tensions, tariffs, and supply chain disruptions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports Japan, India, Greater China, and Asia-Pacific. Microsoft also localizes many of its products to reflect local languages and conventions, modifying user interfaces and translating text to better serve the region. Both companies are significantly engaged in Greater China, but Apple's exposure is more supply-chain intensive while Microsoft's is more focused on localized customer engagement and regional support infrastructure.",
      "llm_answer": "Apple’s Greater China segment is tightly linked to China‑mainland manufacturing – “substantially all of the Company’s manufacturing is performed … by outsourcing partners located primarily in Asia, including China mainland” (Apple 10‑K p. 9) and the segment itself is defined as “China mainland, Hong Kong and Taiwan” (Apple 10‑K p. 40).  \n\nMicrosoft’s Greater China footprint, by contrast, is not based on Chinese production; it is supported by a regional operations center in Singapore that handles order processing, vendor management and logistics for Greater China (Microsoft 10‑K p. 16) and the company “localizes many of our products to reflect local languages and conventions” (Microsoft 10‑K p. 16).  \n\nThus Apple relies on China‑mainland factories for its hardware supply chain, whereas Microsoft relies on a Singapore‑based support hub and localized software offerings to serve the Greater China market.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Apple's reliance on China Mainland for manufacturing as part of its Greater China segment (including Hong Kong and Taiwan) is accurately cited with direct references to the 10-K, and Microsoft's regional operations center in Singapore supporting Greater China is correctly described. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Apple’s and Microsoft’s 10-K filings to contrast Apple’s supply-chain-intensive exposure with Microsoft’s customer-engagement and infrastructure-focused presence. (4) The LLM includes specific citations (page numbers and quotes) from the 10-Ks, enhancing credibility and precision. It captures the core distinction in operational models—Apple’s manufacturing dependency vs. Microsoft’s localized software and regional support infrastructure—exactly as in the original answer. Wording differs slightly but meaning is preserved with high fidelity. All aspects of the question are addressed: manufacturing reliance, regional support infrastructure, and localized product offerings.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 366,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does UPS's use of pricing models for foreign currency derivatives (classified as Level 2) contrast with GE's use of Level 3 valuation techniques in its insurance and pension liabilities, particularly regarding the role of unobservable inputs?",
      "original_answer": "UPS primarily uses pricing models with observable inputs like yield curves and exchange rates for its foreign currency derivatives, which are classified as Level 2 due to reliance on market-observable data. In contrast, GE employs Level 3 valuation techniques—such as discounted cash flow (DCF) methodologies—for certain insurance and pension liabilities, where significant unobservable assumptions are required. This distinction highlights that while UPS’s derivatives are grounded in active market data, GE’s long-duration insurance contracts and postretirement benefit obligations require internal modeling with assumptions not corroborated by market data, resulting in a higher degree of estimation uncertainty.",
      "llm_answer": "UPS values its foreign‑currency forward, swap and option contracts with pricing models that depend almost entirely on market‑observable inputs such as yield curves, spot and forward FX rates, so the derivatives are placed in Level 2 of the fair‑value hierarchy. By contrast, GE measures the fair value of its run‑off insurance liabilities and its pension‑plan obligations using models that incorporate significant unobservable assumptions (e.g., mortality, longevity, future benefit‑cash‑flow and discount‑rate estimates), which pushes those liabilities into Level 3. Thus, unobservable inputs play only a peripheral role for UPS’s hedges, but they are a core component of GE’s insurance and pension‑liability valuations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies that UPS uses market-observable inputs (yield curves, spot/forward FX rates) for foreign currency derivatives, justifying their Level 2 classification, while GE uses significant unobservable inputs (mortality, longevity, benefit cash flows, discount rates) for insurance and pension liabilities, placing them in Level 3. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly contrasts two companies (UPS and GE), two financial instruments (derivatives vs. insurance/pension liabilities), and two levels of the fair value hierarchy (Level 2 vs. Level 3), synthesizing the role of observable vs. unobservable inputs. (4) The answer matches the original in both technical precision and conceptual emphasis, highlighting that unobservable inputs are peripheral for UPS but central for GE, thus capturing the core of the question. All entities (UPS, GE, foreign currency derivatives, insurance liabilities, pension obligations, Level 2, Level 3) are correctly identified and contextualized. No factual, conceptual, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 365,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Coca-Cola's reliance on Swire Beverages for distribution in Hong Kong compare to Colgate-Palmolive's operational performance in the same market, given both companies' reported activities in the region?",
      "original_answer": "Coca-Cola relies on Swire Beverages for distribution in Hong Kong, where Swire is one of Coca-Cola's top bottling partners, contributing to a significant portion of Coca-Cola’s non-U.S. unit case volume, which totaled 83% of worldwide volume in 2021. In the same region, Colgate-Palmolive reported $2,867 million in Asia Pacific net sales in 2021, with growth led by the Greater China region, particularly in Oral Care categories such as toothpaste and manual toothbrushes. While Coca-Cola’s distribution strategy in Hong Kong is managed through its bottler partner, Colgate-Palmolive directly manages its operations and achieved 3.0% organic sales growth in Asia Pacific, driven by volume increases and cost savings. This comparison highlights differing market strategies—Coca-Cola through a key bottling partner versus Colgate-Palmolive through direct brand growth—within the same geographic region.",
      "llm_answer": "Coca‑Cola’s presence in Hong Kong is provided through Swire Beverages, one of its five largest independent bottling partners that “has bottling and distribution operations … in Hong Kong” (KO 10‑K, p. 7). By contrast, Colgate‑Palmolive reports its own performance for the Asia‑Pacific segment—which includes Hong Kong—showing net sales of $2.9 billion (up 6 %) and operating profit of $844 million (up 9 %) with a 29.4 % margin in 2021 (CL 10‑K, p. 42). Thus, Coca‑Cola relies on an external bottler to reach Hong Kong, while Colgate‑Palmolive records strong, internally‑generated sales and profit growth in the region that covers Hong Kong.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Coca-Cola's reliance on Swire Beverages in Hong Kong and Colgate-Palmolive's direct operations in the Asia-Pacific region, which includes Hong Kong. However, there are key quantitative inaccuracies. The LLM states Colgate-Palmolive's Asia-Pacific net sales as $2.9 billion, while the ground truth reports $2,867 million (i.e., $2.867 billion), which is close but rounded imprecisely. More critically, the LLM introduces an operating profit of $844 million and a 29.4% margin—details not present in the original answer and not supported by the provided ground truth. These figures may be accurate in Colgate’s 10-K, but they go beyond the scope of the original answer and introduce unverified data, reducing quantitative accuracy. (2) The original answer emphasizes Colgate’s 3.0% organic sales growth driven by volume and cost savings in Greater China, particularly in Oral Care; this nuance is missing in the LLM response, which instead cites 6% sales growth and 9% profit growth—again, potentially true but not aligned with the ground truth. (3) The multi-hop reasoning is sound in structure: the model correctly contrasts Coca-Cola’s indirect distribution model via Swire with Colgate-Palmolive’s direct regional performance. It synthesizes information across two companies and correctly attributes operational models. However, it fails to fully align with the specific metrics emphasized in the ground truth (organic growth, unit volume contribution, and regional focus on Greater China). (4) Despite the introduction of extraneous financial figures, the LLM answer remains contextually relevant and captures the core strategic contrast. The qualitative reasoning is strong, and the entity identification (Coca-Cola, Swire, Colgate-Palmolive, Hong Kong, 2021) is accurate. The main deduction is for quantitative fidelity and completeness relative to the original answer’s specific data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 525,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does BAC's investment in CDOs, which contain embedded derivatives, compare to JPM's valuation methodology for similar structured notes with embedded derivatives, particularly in terms of risk exposure and modeling techniques?",
      "original_answer": "BAC invests in CDOs that are part of its broader involvement with VIEs, and while the Corporation does not consolidate these vehicles, it recognizes maximum loss exposure tied to the value of its investment balances. These CDOs are linked to embedded derivatives, as noted in the context of hybrid instruments where credit protection has been sold to the issuer, exposing the investor to credit events. JPM, on the other hand, explicitly discloses that structured notes with embedded derivatives are valued using discounted cash flow analyses and models such as Black-Scholes or simulation models, depending on the derivative features. JPM also adjusts valuations for its own credit risk (DVA), indicating a more detailed and model-driven approach to managing the risk of these instruments. This comparison highlights differing approaches to both risk exposure and valuation transparency in handling similar financial products.",
      "llm_answer": "Bank of America treats its CDO‑type holdings (ABS, CLOs and other VIE‑issued structured assets) as off‑balance‑sheet investments whose risk is measured by the “maximum loss exposure” – essentially the amount it would lose if every asset in the VIE were worthless – and they are reported at fair value (generally Level 2/3) with credit‑loss allowances based on macro‑economic scenarios. JPMorgan, on the other hand, values comparable structured notes with embedded derivatives by running discounted‑cash‑flow models that explicitly price the derivative component (using Black‑Scholes, simulation or other option‑pricing techniques) and then adjusts the result for its own credit risk (DVA), also classifying them in Level 2 or Level 3. Thus, BAC’s approach emphasizes a bounded loss‑exposure view, while JPM’s methodology relies on detailed option‑type modeling and credit‑risk adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All factual elements are correct: BAC's treatment of CDOs and similar structured investments as off-balance-sheet VIEs with maximum loss exposure, fair value measurement (Level 2/3), and credit-loss allowances based on macroeconomic scenarios are consistent with the source. JPM's use of discounted cash flow models, Black-Scholes or simulation techniques for valuing structured notes with embedded derivatives, and DVA adjustments are accurately represented. (2) There are no numeric values in the question or answer that require verification—both responses are qualitative and conceptual, and all financial modeling terms (e.g., Level 2/3, DVA, Black-Scholes) are used correctly. (3) The multi-hop reasoning is sound: the model correctly synthesizes BAC’s risk exposure framework with JPM’s valuation methodology across different structured products (CDOs vs. structured notes) and highlights the contrast in approach—bounded loss exposure vs. detailed derivative modeling. (4) The LLM adds slight elaboration (e.g., mentioning ABS/CLOs, macroeconomic scenarios for allowances) not in the original but consistent with plausible extensions of the truth, without introducing inaccuracies. The only minor gap is that the original emphasizes BAC’s exposure via credit protection sold (hybrid instruments), which the LLM omits, slightly weakening the completeness of the risk exposure mechanism. However, the core comparison on modeling and risk transparency remains intact. Hence, a score of 9 is justified—excellent accuracy with a small omission in explanatory depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 450,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the voting structure of CMCSA's Class B Common Stock compare to NFLX's common stock voting rights, given the specific limitations outlined in CMCSA's disclosure?",
      "original_answer": "CMCSA's Class B Common Stock has limited voting rights, only allowing votes on specific matters such as exiting the core payments business, certain consolidation or merger transactions, or amendments to the certificate of incorporation, and votes are calculated by multiplying shares held by the applicable conversion rate. In contrast, NFLX grants one vote per share on all matters to be voted upon by stockholders, providing more generalized voting power. CMCSA's disclosure also indicates that Class B Common Stock was issued and outstanding as of 2023, reinforcing the structured governance framework in place.",
      "llm_answer": "Comcast’s Class B common stock is essentially non‑voting – the holders “have no right to vote on any matters, except for certain defined matters… (i) a decision to exit the core‑payments business, (ii) a merger or similar transaction, and (iii) specific amendments to the certificate of incorporation” – and even in those cases their votes are counted only as a single class and are weighted by the conversion rate (CMCSA 10‑K, p. 90).  \n\nNetflix’s common stock, by contrast, carries the ordinary right of one vote per share on all shareholder matters, without the class‑specific restrictions that apply to Comcast’s Class B shares.  \n\nThus, Comcast’s Class B shares have very limited, conditional voting power, whereas Netflix’s shares provide full, unrestricted voting rights.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that CMCSA's Class B Common Stock has limited voting rights, only on specific matters: exiting the core payments business, merger/consolidation transactions, and amendments to the certificate of incorporation. It accurately notes that votes are weighted by the conversion rate, consistent with the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages, or share counts), so quantitative accuracy is not compromised—no numbers are misstated. (3) The multi-hop reasoning is sound: the model correctly contrasts CMCSA’s restricted voting structure with NFLX’s one-vote-per-share standard, demonstrating proper synthesis across two companies’ governance frameworks. (4) The only minor omission is that the LLM does not explicitly mention that CMCSA’s Class B shares were 'issued and outstanding as of 2023,' which appears in the ground truth and reinforces the current applicability of the structure. However, this does not affect the core comparison on voting rights. Wording differs slightly (e.g., 'essentially non-voting' vs 'limited voting rights'), but the semantic meaning is equivalent. Overall, the answer is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 371,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the treatment of embedded derivatives within CDOs by Morgan Stanley compare to JPMorgan Chase's valuation methodology for similar instruments, given their respective involvement in structured note products?",
      "original_answer": "Morgan Stanley treats CDOs as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer of the note, and if there is a credit event of a reference entity, the principal balance of the note may not be repaid in full. JPMorgan Chase, on the other hand, values structured notes using discounted cash flow analyses that consider the embedded derivative features through models like Black-Scholes or simulation models, with adjustments for the Firm's own credit risk (DVA). Both firms recognize the complexity and risk associated with these instruments, but differ in how they disclose and value the embedded derivatives within their portfolios.",
      "llm_answer": "Morgan Stanley records its CDO and CLO interests as trading assets measured at fair value and treats the embedded derivatives as part of the hybrid instrument, valuing them with model‑based (Level 2/3) fair‑value techniques similar to its other derivative holdings. JPMorgan Chase, by contrast, values structured‑note products that contain embedded derivatives with a discounted‑cash‑flow analysis that incorporates option‑pricing or simulation models and then adjusts the result for the firm’s own credit risk (DVA), also placing the fair value in Level 2 or 3. Thus, while both firms use Level 2/3 model valuations, JPMorgan explicitly adds a credit‑risk adjustment to the embedded‑derivative valuation, whereas Morgan Stanley’s discussion does not reference such an adjustment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Morgan Stanley treats CDOs as hybrid instruments with embedded derivatives, valued using model-based Level 2/3 fair value techniques, consistent with the original answer's description of Morgan Stanley's approach. JPMorgan Chase's use of discounted cash flow analysis incorporating option-pricing (e.g., Black-Scholes) or simulation models is accurately described, as is the inclusion of DVA (debt valuation adjustment) for its own credit risk—this is a key differentiator highlighted in both answers. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised; all financial concepts are correctly referenced. (3) The multi-hop reasoning is sound: the model synthesizes information across two firms, their respective valuation methodologies for structured notes and CDOs, and draws a valid comparison regarding the treatment of embedded derivatives and credit risk adjustments. The only minor shortcoming is that the LLM answer emphasizes the Level 2/3 classification more than the original, which is contextually relevant but not explicitly in the ground truth—this does not reduce accuracy. (4) The LLM correctly notes that Morgan Stanley’s disclosure does not reference a DVA-like adjustment, which is a valid inference from the original answer implying differing disclosure and valuation practices. Overall, the answer is semantically equivalent, factually correct, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy due to slight emphasis on fair value hierarchy not present in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 471,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Abbott's exposure to intellectual property risks, particularly regarding patent enforcement, intersect with AbbVie's legal actions through its subsidiary Forest Laboratories Holdings Limited to protect the exclusivity of Vraylar, and what implications does this have for both companies' pharmaceutical revenue streams?",
      "original_answer": "Abbott faces significant risks related to the expiration or loss of intellectual property protection, which could reduce future revenues and operating income. In parallel, AbbVie's subsidiary Forest Laboratories Holdings Limited is actively involved in patent enforcement litigation concerning Vraylar (cariprazine), seeking to prevent generic competition from companies like Sun Pharmaceutical and Aurobindo Pharma. This litigation, initiated in the U.S. District Court for the District of Delaware in December 2019, aims to preserve market exclusivity for Vraylar, a key pharmaceutical product. If successful, the enforcement of these patents would protect AbbVie’s revenue from Vraylar. However, if generic versions are allowed to enter the market, both companies could face competitive pressure—Abbott due to its reliance on strong IP protections and AbbVie through reduced exclusivity for Vraylar—highlighting the interplay between IP enforcement and pharmaceutical revenue sustainability.",
      "llm_answer": "Abbott warns that “competitors’ intellectual property may prevent Abbott from selling its products… a successful claim of patent … could subject Abbott to … an injunction preventing the manufacture, sale or use of affected Abbott products” and that “the expiration or loss of intellectual‑property protection … could affect Abbott’s future revenues and operating income”【page_14】.  By contrast, AbbVie notes that its subsidiary Forest Laboratories Holdings Limited is pursuing litigation to protect the exclusivity of Vraylar, a strategy intended to keep generic competition at bay and preserve Vraylar’s contribution to AbbVie’s pharmaceutical sales.  Consequently, Abbott’s exposure to IP‑related litigation creates a downside risk to its drug revenues, while AbbVie’s aggressive enforcement through Forest Laboratories is aimed at safeguarding and sustaining the revenue stream from Vraylar.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. (1) All factual elements are correct: Abbott's exposure to IP risks, including patent litigation and expiration affecting revenues, is accurately cited with relevant context from its disclosures. AbbVie’s subsidiary Forest Laboratories Holdings Limited is correctly identified as pursuing litigation to protect Vraylar’s exclusivity. (2) There are no numeric values, dates, or calculations in the LLM answer that conflict with the ground truth; while the original answer mentions the December 2019 filing in the U.S. District Court for the District of Delaware, the LLM omits this specific date and court detail. This is a minor omission but does not affect the overall correctness, as the focus is on the strategic enforcement action rather than procedural details. (3) The multi-hop reasoning is sound: the model correctly distinguishes Abbott’s defensive IP risks from AbbVie’s offensive patent enforcement, and links both to implications for pharmaceutical revenue streams. It synthesizes information across two related but distinct corporate entities (Abbott and AbbVie) and their respective IP strategies. (4) The answer is contextually precise, directly addressing the intersection of IP risks and litigation impact on revenue. The only reason for not scoring a 10 is the omission of the specific litigation date and counterparties (Sun Pharmaceutical, Aurobindo Pharma), which are part of the full factual picture but not central to the main inference about revenue implications. Overall, the response is factually correct, well-reasoned, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 459,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Citigroup's use of foreign currency forwards and cross-currency swaps in its net investment hedging strategy compare to Morgan Stanley's reliance on VaR models for managing market risk exposure in trading portfolios?",
      "original_answer": "Citigroup utilizes foreign currency forwards, cross-currency swaps, and options to hedge foreign exchange risk on equity investments in non-U.S.-dollar subsidiaries, recording changes in fair value in CTA within AOCI under ASC 815. In contrast, Morgan Stanley employs Value-at-Risk (VaR) models as a key risk management tool to estimate aggregate market risk exposure across trading portfolios, incorporating diversification and hedging effects, while acknowledging VaR's limitations in capturing extreme market events or liquidity constraints. Southern Company Gas, which connects the two entities, also uses weather derivative instruments and other risk management tools to mitigate weather-related revenue volatility in its gas marketing services segment, demonstrating a broader industry application of risk management frameworks.",
      "llm_answer": "Citigroup’s net‑investment hedge program actively uses foreign‑currency forwards, cross‑currency swaps (along with options and foreign‑currency‑denominated debt) to offset the FX risk of its equity stakes in non‑U.S. subsidiaries, with the fair‑value changes of those derivatives recorded in the foreign‑currency translation adjustment (CTA) component of AOCI. In contrast, Morgan Stanley does not rely on specific FX‑hedge contracts for its trading book; it manages market‑risk exposure primarily through a Value‑at‑Risk (VaR) framework that quantifies the aggregate risk of its portfolios (using historical‑simulation and Monte‑Carlo models at a 95 % one‑day confidence level) and is supplemented by stress‑testing and scenario analysis.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies Citigroup's use of foreign currency forwards, cross-currency swaps, and options (adding foreign-currency-denominated debt, which is consistent with hedging strategies under ASC 815 though not in the original answer) to hedge FX risk on equity investments in non-USD subsidiaries, with fair value changes recorded in CTA within AOCI—this matches the original answer's accounting treatment. (2) It accurately contrasts Morgan Stanley’s reliance on VaR models for managing market risk in trading portfolios, specifying the use of historical-simulation and Monte Carlo methods at a 95% one-day confidence level, which adds granularity not in the original but does not contradict it—VaR's role in capturing aggregate risk, diversification, and hedging effects is correctly conveyed. (3) The LLM omits the mention of Southern Company Gas and its use of weather derivatives, which was part of the original answer’s broader illustration of risk management frameworks. However, this detail serves as contextual extension rather than core to the Citigroup–Morgan Stanley comparison. Since the question focuses on comparing Citigroup and Morgan Stanley, the omission does not undermine the primary multi-hop reasoning. (4) The LLM enhances the original by specifying VaR methodology (95%, one-day, model types), which is plausible and consistent with industry practice, though not in the ground truth—this is acceptable under semantic equivalence. No numerical inaccuracies exist; all entities, financial instruments, and accounting treatments are correct. The reasoning is sound, synthesizing distinct risk management approaches across firms. Thus, the answer earns a 9 for correctness due to slight over-elaboration on Morgan Stanley’s VaR model and omission of the Southern Company Gas example, but remains factually and conceptually aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 521,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does Colgate-Palmolive's use of option contracts to hedge foreign exchange risk compare to Walmart's exposure through firm commitments, given the impact of these financial instruments on their respective cash flow stability?",
      "original_answer": "Colgate-Palmolive utilizes option contracts as part of its foreign exchange risk management strategy, hedging portions of its foreign currency purchases and firm commitments with contracts valued using observable market rates, aiming to minimize earnings volatility from currency fluctuations. These contracts, with a typical duration of no more than 12 months, are aligned with the company's policy of matching derivative terms to underlying exposures. In contrast, Walmart reports $37.2 billion in unrecorded purchase obligations as of January 31, 2025, including $15.9 billion due within one year, which includes firm commitments for inventory, utilities, and capital expenditures. These obligations are legally binding and expose Walmart to cash flow risks if market conditions change. The impact of Colgate's use of option contracts is to stabilize the U.S. dollar equivalent value of foreign currency transactions, while Walmart lacks such financial instrument protections on its firm commitments, leaving it more exposed to market volatility affecting its cash flow stability.",
      "llm_answer": "Colgate‑Palmolive actively hedges its foreign‑exchange exposure by entering into forward and **option** contracts (as well as swaps) on both its existing foreign‑currency assets and liabilities and on its firm‑commitment and forecasted transactions.  The notional amount of these cash‑flow hedges was about **$9.9 billion** at the end of 2024, and gains or losses on the contracts are recorded in AOCI and then re‑classified to earnings when the underlying transactions occur, which smooths the impact of currency moves on cash flow.\n\nWalmart, by contrast, does not use such derivative hedges for its foreign‑exchange risk; its cash‑flow exposure comes mainly from **firm‑commitment purchase obligations** (e.g., inventory contracts) that are simply recorded as liabilities.  Because these commitments are not offset with option or forward contracts, any adverse currency movement flows directly through earnings and operating cash flow, making Walmart’s cash‑flow profile more vulnerable to exchange‑rate swings than Colgate‑Palmolive’s hedged position.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Colgate-Palmolive uses option contracts (and other derivatives) to hedge foreign exchange risk on firm commitments and forecasted transactions, and that Walmart relies on firm commitments without using derivative hedges, exposing it to currency volatility. This core comparison on cash flow stability is accurate and well-reasoned. (2) However, there is a significant quantitative inaccuracy: the LLM states Colgate’s notional amount of cash-flow hedges was '$9.9 billion at the end of 2024', which is not present in the ground truth. The original answer does not provide any notional value for Colgate’s derivatives. This figure is likely fabricated or misattributed, which undermines quantitative accuracy. Additionally, the ground truth specifies Walmart’s unrecorded purchase obligations as $37.2 billion as of January 31, 2025, with $15.9 billion due within one year—details omitted in the LLM answer. While the absence of hedging at Walmart is correctly noted, the lack of these specific figures reduces completeness and precision. (3) The multi-hop reasoning is sound: the model correctly infers that using option contracts stabilizes cash flows (via AOCI and reclassification), whereas unhedged firm commitments expose Walmart directly to FX risk. The logic connecting derivative use to earnings and cash flow smoothing is valid and synthesizes the implications across both companies. (4) Despite missing specific numbers and introducing an unsupported figure, the qualitative assessment and contextual relevance are strong. The answer addresses the comparative impact on cash flow stability, which is the central question. The correctness score is 7 due to accurate reasoning and entity identification but docked for unsupported quantification and omission of key data from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 502,
        "total_tokens": 2057
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does the adoption timeline of ASU No. 2023-07 for segment reporting differ between TMO and CVS, and what specific disclosures were required by each company as a result of this new standard?",
      "original_answer": "TMO adopted ASU No. 2023-07 for its 2024 annual report and applied it retrospectively, resulting in increased disclosures in Note 11. CVS adopted the standard on January 1, 2024, for fiscal year reporting and is required to provide additional disclosures related to its reportable segments, including the CODM's title, how the CODM uses segment operating results, and alignment of interim reporting with annual requirements, as detailed in Note 19. Both companies applied the standard retrospectively to prior periods, but TMO implemented it specifically for the 2024 annual report while CVS also aligned it with interim reporting requirements starting after December 15, 2024.",
      "llm_answer": "- **Adoption timing**  \n  * **Thermo Fisher Scientific (TMO)** – Adopted ASU 2023‑07 in its 2024 annual filing and will apply it to all interim reports thereafter (retrospective to prior periods).  \n  * **CVS Health (CVS)** – Adopted the update on January 1 2024 for its FY 2024 results; the rule becomes effective for interim periods of fiscal years that begin after December 15 2024 (also applied retrospectively).\n\n- **Disclosures required**  \n  * **Thermo Fisher** – Added Note 11 showing, for each reportable segment, the significant expenses that the CODM regularly receives, the total of any other items included in segment operating results and a qualitative description of those items, and disclosed the CODM’s title, position and how the CODM uses the segment‑operating‑result measure to evaluate performance and allocate resources.  \n  * **CVS Health** – In its new segment‑reporting note the company disclosed the same set of information: significant segment expenses provided to the CODM, the aggregate amount and composition of other items in segment operating results, the CODM’s title and role, and a description of how the CODM uses the reported segment‑operating‑result metric for performance assessment and resource allocation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: TMO adopted ASU 2023-07 for its 2024 annual report with retrospective application, and CVS adopted it on January 1, 2024, also applying it retrospectively. The LLM correctly notes that the standard affects interim reporting for periods beginning after December 15, 2024, aligning with the ground truth. (2) Quantitative accuracy is perfect: dates (January 1, 2024; December 15, 2024), fiscal years (2024), and note numbers (Note 11 for TMO, Note 19 for CVS) are correct. The LLM correctly identifies that both companies applied the standard retrospectively. (3) The multi-hop reasoning is sound—comparing adoption timelines and required disclosures across two companies and synthesizing segment reporting changes. The only minor omission is that the LLM does not explicitly mention that CVS’s interim reporting alignment starts *after* December 15, 2024, though it correctly states the effective date. Also, while the LLM accurately describes the disclosures, it refers to 'Note 19' for CVS in the ground truth but does not explicitly name the note in its response, though it implies the existence of a new segment-reporting note. (4) The answer is contextually excellent, directly addressing both parts of the question—adoption timeline and required disclosures—with precise, relevant details. Wording differs slightly but meaning is semantically equivalent. No factual errors; only very minor completeness gap regarding explicit mention of interim alignment timing. Hence, a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 442,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "What was the impact of the Philippines' corporate income tax rate reduction on ACN's 2021 effective tax rate, and how does this compare to AMD's disclosure of tax reform effects in the same period?",
      "original_answer": "ACN benefited from the Philippines' corporate income tax rate reduction enacted in Q1 2021, which favorably impacted its 2021 effective tax rate of 21.8%, partially offsetting other unfavorable tax factors like GILTI-related foreign tax credit limitations. In contrast, AMD reported no impact from the Tax Reform Act in 2021, as shown by the $0 value in their tax provision table for that line item, indicating different exposure or geographic applicability of the reform.",
      "llm_answer": "Accenture’s 2021 Form 10‑K does not quantify any effect of the Philippines’ corporate‑income‑tax reduction on its 2021 effective tax rate – the filing simply notes the change but gives no percentage‑point impact. In contrast, AMD’s 2021 filing explicitly states that the tax‑reform measures enacted during the year had no material effect on its effective tax rate.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a significant factual inaccuracy: it claims that Accenture's 10-K 'does not quantify' the impact of the Philippines' tax rate reduction, which contradicts the ground truth stating that the reduction 'favorably impacted' ACN's 2021 effective tax rate of 21.8%. While the exact percentage-point impact may not be disclosed, the ground truth confirms a qualitative and directional impact was present and acknowledged in context. The LLM incorrectly implies no measurable impact was reported. (2) Quantitatively, the LLM omits the key figure of ACN's 2021 effective tax rate (21.8%) and fails to reference any favorable impact, despite this being explicitly stated in the ground truth. It correctly notes AMD's $0 impact from tax reform, aligning with the 'no material effect' disclosure. (3) The multi-hop reasoning is partially sound—comparing ACN’s and AMD’s responses to tax reforms—but fails in synthesizing the correct direction of impact for ACN. The model should have recognized that mentioning the tax rate reduction in the context of the effective tax rate implies an acknowledged effect, even if not numerically broken out. (4) Scores reflect major loss in correctness and quantitative accuracy due to omission of the favorable impact and the effective tax rate figure, though the answer remains contextually relevant and correctly interprets AMD's disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 396,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Honeywell's use of pricing models for valuing fixed income investments in its pension plans compare to 3M's valuation methodology, particularly in terms of reliance on observable versus unobservable inputs?",
      "original_answer": "Honeywell values its fixed income investments using pricing models, broker bids, or discounted cash flows, incorporating adjustments for credit and liquidity risks when necessary. 3M similarly uses pricing models that rely on observable inputs like interest rates and yield curves for Level 2 fixed income investments, while Level 3 investments depend on unobservable inputs such as projected annuity payments and discount rates. Both companies apply discounted cash flow techniques in certain cases and disclose the use of NAV practical expedients for certain fund types, though 3M explicitly categorizes its fixed income investments by valuation hierarchy levels, whereas Honeywell focuses on the nature of the valuation adjustments made.",
      "llm_answer": "Honeywell values corporate bonds, mortgage‑ and asset‑backed securities “by using pricing models, bids from brokers or dealers, quoted prices of similar securities, or discounted cash‑flows,” and explicitly notes that these models “include adjustments for certain risks that may not be observable such as credit and liquidity risks.” In contrast, 3M’s fixed‑income valuations are based on “pricing models that use verifiable observable market data (interest‑rate and yield‑curve levels, credit spreads) … or quoted prices of similar securities,” and it only turns to unobservable inputs for Level 3 assets when observable inputs are unavailable. Thus Honeywell relies more heavily on unobservable inputs in its pricing models, whereas 3M relies primarily on observable market data and uses unobservable inputs only for Level 3 valuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Honeywell uses pricing models, broker bids, and discounted cash flows, and explicitly notes adjustments for unobservable risks like credit and liquidity—this matches the original answer. It also accurately describes 3M's use of observable inputs (interest rates, yield curves, credit spreads) for Level 2 investments and reliance on unobservable inputs only for Level 3, which is consistent with the ground truth. (2) There are no numerical values to verify, so quantitative accuracy is not applicable in a traditional sense, but all descriptive financial terms (Level 2, Level 3, credit spreads, etc.) are used correctly. (3) The multi-hop reasoning is sound: the model correctly synthesizes and contrasts the two companies' methodologies, noting that Honeywell incorporates unobservable adjustments more directly in its models, while 3M reserves unobservable inputs for Level 3—this is a valid inference supported by the original answer. (4) The only minor shortcoming is that the LLM omits the point about both companies using NAV practical expedients for certain funds, which is present in the original answer and adds a layer of comparability. However, this does not undermine the core comparison on observable vs. unobservable inputs. The answer remains semantically equivalent in focus and conclusion, with excellent contextual relevance and precise qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 407,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does the voting power distribution tied to Class B common stock conversion mechanisms at CMCSA compare with the share repurchase strategy for Class A and Class C shares at GOOGL, given the differing impacts on equity structure and shareholder control?",
      "original_answer": "At CMCSA, Class B common stockholders control 33 1/3% of the voting power, which is non-dilutable and convertible share-for-share into Class A common stock, while the voting power of Class A shares depends on the total number of Class A and Class B shares outstanding. This structure ensures continued influence by Class B holders. In contrast, GOOGL has repurchased $62.2 billion of Class A and Class C shares in 2023, with an additional $36.3 billion remaining under the repurchase authorization. These repurchases reduce the number of outstanding shares, increasing the proportional ownership of remaining shareholders, including those holding Class B shares, which carry 10 votes per share. Since Class B shares automatically convert to Class A upon sale or transfer, these repurchases indirectly influence the balance of voting control by reducing the total pool of shares subject to Class A voting calculations. Thus, while CMCSA’s structure protects Class B voting power through fixed percentages and conversion rules, GOOGL’s equity control dynamics are shaped by aggressive repurchases that affect the relative ownership and voting influence of remaining shareholders.",
      "llm_answer": "Comcast’s equity structure gives the 9 million Class B shares – each carrying 15 votes – a fixed 33 ⅓ % of the total voting power, and those shares can be converted share‑for‑share into Class A stock (which carries one vote per share) but the aggregate voting power of Class B is protected from dilution (page 91). Alphabet’s policy, by contrast, is to retire large amounts of its voting Class A shares and its non‑voting Class C shares (about 78 M Class A and 450 M Class C shares in 2023, with $36.3 B of repurchase authority still available; page 81), which shrinks the overall equity base and modestly concentrates voting power among the remaining Class A shares while leaving the high‑vote Class B shares untouched. Thus, Comcast’s conversion mechanism can shift control between high‑vote and low‑vote shares, whereas Alphabet’s repurchase program mainly reduces outstanding equity without altering the relative voting dominance of its Class B stock.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general contrast between CMCSA's voting structure and GOOGL's repurchase strategy but contains significant quantitative inaccuracies that undermine factual correctness. (1) On quantitative accuracy: The claim that CMCSA Class B shares carry '15 votes' is incorrect — the ground truth does not specify vote count per share, only that Class B holds a fixed 33 1/3% of voting power, which is the key mechanism. The LLM invents a specific vote ratio (15:1) not present in the original. Additionally, the LLM cites '78M Class A and 450M Class C shares' repurchased by GOOGL in 2023, but the ground truth states the repurchase amount as $62.2 billion in dollar terms, not share counts — these figures cannot be verified without price data and appear fabricated. While the $36.3 billion remaining authorization is correctly reported, the use of unsupported share numbers reduces quantitative accuracy. (2) Completeness: The answer addresses both companies and the core mechanisms — conversion at CMCSA and repurchases at GOOGL — and explains their differing impacts on control, satisfying the multi-part comparison. (3) Entity accuracy is correct: CMCSA and GOOGL are properly identified, as are share classes and relevant years (2023). (4) Reasoning is generally sound: The LLM correctly notes that GOOGL’s repurchases shrink the equity base and concentrate voting power, and that Class B shares convert to Class A upon transfer. It also correctly contrasts CMCSA’s fixed voting power protection with GOOGL’s dynamic through repurchases. However, it mischaracterizes the CMCSA mechanism by focusing on per-share votes rather than the structural 33 1/3% cap, weakening the qualitative accuracy. (5) Despite wording differences, the semantic intent aligns with the original in discussing control preservation vs. ownership concentration. However, the inclusion of fabricated vote multiples and share counts leads to a moderate correctness score due to factual overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1560,
        "completion_tokens": 533,
        "total_tokens": 2093
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Altria's exposure to FCTC-driven advertising restrictions, as outlined in its 2022 10-K, compare to Philip Morris International's experience with implemented advertising bans in markets like Australia and Russia, and what implications does this have for their respective international marketing strategies?",
      "original_answer": "Altria acknowledges in its 2022 10-K that while the U.S. is a signatory to the FCTC, it is not a party to the agreement, and therefore FCTC-driven advertising restrictions have limited direct regulatory impact in the U.S. However, the document notes that the FCTC has called for and influenced advertising bans globally. In contrast, Philip Morris International (PMI) reports that in markets like Australia and Russia, governments have already banned the display of tobacco products at the point of sale, which severely restricts visibility and marketing potential. These bans align with FCTC guidelines recommending the prohibition of all forms of communication with adult smokers. Given that Altria's primary market remains the U.S., where such bans are not yet widespread, its international marketing strategy is less constrained compared to PMI, which operates more heavily in FCTC-compliant markets where advertising and product visibility restrictions are already enforced. This divergence suggests that PMI must adapt more aggressively to restrictive advertising environments, while Altria faces more potential future risk if the U.S. adopts similar FCTC-aligned policies.",
      "llm_answer": "Al tria notes that most of the regulation shaping its business “is driven by the Framework Convention on Tobacco Control (the FCTC)” and that the treaty’s recommendations can lead to “restrictions on the packaging, marketing, and sale of tobacco…that could reduce our competitiveness or even ban certain of our products” (Altria 2022 10‑K, p. 40‑41). In contrast, Philip Morris International already faces concrete advertising‑related bans – for example, governments in Australia and Russia have prohibited the point‑of‑sale display of its products and imposed broader advertising, marketing and sponsorship restrictions (PMI 2022 10‑K, p. 42). Consequently, Al tria’s strategy must anticipate and prepare for future FCTC‑driven limits by diversifying toward reduced‑risk products and alternative communication channels, whereas PMI’s international marketing is already being reshaped to operate without traditional retail advertising in those markets, focusing on product innovation and adult‑only messaging to comply with existing bans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Altria, while not bound by the FCTC, acknowledges its influence on global tobacco regulation, citing its 2022 10-K. It accurately contrasts this with Philip Morris International (PMI), which faces implemented advertising and point-of-sale display bans in countries like Australia and Russia, as reported in PMI’s 2022 10-K. These entity and document references are correct. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—score is 10. (3) The reasoning is sound: the LLM correctly synthesizes information across two companies and their respective regulatory environments, drawing a logical comparison between Altria’s anticipatory strategy and PMI’s adaptive response to existing restrictions. The conclusion about differing marketing strategies—Altria preparing for future FCTC-driven limits vs. PMI already operating under them—is consistent with the original answer. One minor omission: the original answer notes that the U.S. is a signatory but not a party to the FCTC, a nuance not included in the LLM response, slightly weakening the completeness of the legal distinction. However, the core factual and strategic implications are preserved. (4) The answer is fully contextually relevant, directly addressing the comparative exposure to FCTC-driven restrictions and strategic implications for international marketing. Overall, the LLM demonstrates strong multi-hop reasoning and semantic equivalence with the ground truth, warranting a correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1596,
        "completion_tokens": 451,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Goldman Sachs' competitive disadvantage to JPMorgan in cryptocurrency offerings, influenced by Dodd-Frank compliance burdens, compare with Morgan Stanley's exposure to regulatory risks in emerging markets that could impact its cross-border cryptocurrency-related financial activities?",
      "original_answer": "Goldman Sachs faces a competitive disadvantage compared to JPMorgan due to Dodd-Frank compliance burdens that restrict its ability to offer cryptocurrencies and digital assets, as stated in its 2024 10-K filing. JPMorgan, as a competitor, offers these products, giving it a strategic edge in evolving financial markets. Meanwhile, Morgan Stanley's 2024 10-K highlights exposure to regulatory risks in emerging markets, where uncertain and rapidly changing laws could hinder its ability to structure and enforce cryptocurrency-related transactions across borders. Both firms face regulatory constraints, but Goldman Sachs' limitations are self-imposed due to U.S. regulatory frameworks, while Morgan Stanley's risks stem from external geopolitical and legal environments in foreign jurisdictions.",
      "llm_answer": "Goldman Sachs says that the Dodd‑Frank Act and related capital‑ and trading‑restriction rules increase its compliance costs and limit its ability to offer cryptocurrency products, putting it at a competitive disadvantage to rivals such as JPMorgan that are not subject to the same constraints【page_13】. Morgan Stanley, by contrast, highlights that its cross‑border cryptocurrency‑related activities are exposed to broader regulatory risks in emerging markets—including sanctions, AML/anti‑corruption rules and political‑economic instability—that could disrupt transactions or damage its reputation【page_24】. Thus, Goldman’s disadvantage is a U.S.‑centric regulatory cost burden, whereas Morgan Stanley’s risk stems from uncertain and volatile foreign regulatory environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Goldman Sachs faces competitive disadvantages due to Dodd-Frank compliance burdens (self-imposed U.S. regulatory constraints), while JPMorgan can offer cryptocurrency products. Morgan Stanley’s exposure is tied to external regulatory risks in emerging markets affecting cross-border crypto activities. These points are correctly attributed to the 2024 10-K filings (implied by context), and the core contrast between internal U.S. regulatory burden vs. external geopolitical risk is preserved. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two firms (Goldman Sachs and Morgan Stanley), compares their distinct regulatory challenges, and contrasts the nature of those constraints (domestic compliance vs. foreign regulatory uncertainty). The mention of specific risks like sanctions, AML/anti-corruption rules, and political-economic instability adds detail consistent with emerging market regulatory risk. (4) The only minor shortcoming is that the LLM does not explicitly state that JPMorgan’s ability to offer crypto products gives it a 'strategic edge'—a nuance present in the original—but this does not detract significantly from the overall correctness. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect as all parts of the complex, multi-firm, multi-regulatory question are addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 445,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure requirements for supplier finance obligations at both 3M and GE, particularly in terms of the roll-forward information introduced in 2024?",
      "original_answer": "The adoption of ASU 2022-04 requires companies like 3M and GE to disclose key terms, balance sheet presentation, and the confirmed amount outstanding under supplier finance programs. For 3M, this includes a $0.3 billion balance in confirmed invoices as of December 31, 2024, with $1.5 billion of invoices confirmed and paid during the year. GE adopted the standard on January 1, 2023, and in line with the ASU's phased requirements, began providing the annual roll-forward information in 2024. This roll-forward requirement, applicable prospectively from January 1, 2024, aligns both companies' disclosures to include changes in confirmed invoice balances over the reporting period, enhancing transparency in their accounts payable disclosures.",
      "llm_answer": "Both companies now must disclose, each year, the key terms of their supplier‑finance programs, the amount of confirmed invoices that remain on the balance sheet and a “roll‑forward” showing the invoices confirmed, paid and any adjustments during the period. 3M’s Note 16 already presents the 2024 roll‑forward (≈ $0.3 billion outstanding at year‑end, with about $1.5 billion of invoices confirmed and $1.5 billion paid in 2024), satisfying the new ASU 2022‑04 requirement. GE states that it adopted ASU 2022‑04 on 1 Jan 2023 and began providing the required roll‑forward information as of 1 Jan 2024, so its 2024 filing now includes the same type of activity‑by‑activity reconciliation for its supply‑chain finance obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: 3M's $0.3 billion year-end balance and $1.5 billion confirmed and paid during 2024 match the original answer. GE's adoption date of January 1, 2023, and the start of roll-forward disclosures in 2024 are accurately reported. The LLM correctly notes that the roll-forward requirement began prospectively in 2024. (2) The answer correctly identifies both companies (3M and GE), the relevant accounting standard (ASU 2022-04), and the nature of the new disclosure requirements—key terms, balance sheet presentation, and roll-forward of confirmed invoices. (3) The multi-hop reasoning is sound: the model synthesizes adoption timing (GE in 2023) with phased implementation of roll-forwards (starting in 2024), and applies this consistently to both firms. It correctly infers that 3M’s 2024 disclosures satisfy the new requirement and that GE began reporting the roll-forward in its 2024 filing. (4) The only minor shortcoming is that the LLM implies $1.5 billion confirmed and $1.5 billion paid are separate line items without clarifying that the paid amount includes those confirmed and settled, which the original answer handles more precisely by stating 'confirmed and paid during the year' as a single flow. However, this does not constitute a factual error, just a slight lack of nuance. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 411,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does MDT's geographic revenue concentration in 'Other Countries' expose it to similar regulatory and reimbursement challenges as those impacting AMGN's drug pricing strategies in international markets?",
      "original_answer": "MDT reports $32.251 billion in net sales from 'Total other countries, excluding Ireland' in fiscal 2024, which represents the majority of its revenue outside the U.S. This significant international exposure subjects MDT to regulatory environments where governments increasingly control healthcare costs through reimbursement and coverage limitations. As outlined in the DHR filing, these limitations include direct price controls, reference pricing, and mandatory licensing, which tie reimbursement to outcomes and constrain revenue potential. Similarly, AMGN notes that many countries outside the U.S. apply price controls, therapeutic-reference pricing, and volume caps, which limit both pricing and market access for its biologics. Both companies face parallel pressures from global payers seeking cost predictability and imposing narrower coverage criteria, despite operating in different healthcare sectors.",
      "llm_answer": "Medtronic’s 2024 10‑K shows that virtually all of its net‑sales come from “other countries” outside the United States (≈ $32.3 billion, or ≈ 99 % of total net‑sales)【page_105】.  Amgen’s filing notes that in most non‑U.S. markets governments are the primary payers and are increasingly using mandatory price controls, price‑referencing, health‑technology‑assessment‑based pricing and other reimbursement limits that pressure drug prices and sales【page_18】.  Because Medtronic’s revenue is so heavily concentrated abroad, it is exposed to the same regulatory and reimbursement constraints that curb Amgen’s international drug‑pricing strategies.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the core issue: MDT's heavy international revenue concentration exposes it to regulatory and reimbursement challenges similar to those faced by AMGN in non-U.S. markets. The comparison between MDT and AMGN is logically sound and addresses the multi-hop nature of the question by linking geographic revenue exposure to shared international pricing pressures.\n\n2) Quantitative accuracy has a minor issue: The LLM states that $32.3 billion represents '≈ 99% of total net sales' for MDT, which is not supported by the ground truth. The original answer specifies $32.251 billion from 'Total other countries, excluding Ireland' but does not state this as 99% of total revenue or imply near-total dependence on non-U.S. sales. This overstatement introduces a factual inaccuracy in magnitude interpretation, even though the $32.251B figure is approximately correct (rounded to $32.3B). No calculation errors beyond this inference.\n\n3) The reasoning is strong: The LLM correctly synthesizes information from both MDT and AMGN filings, identifying that both face government-imposed price controls, reference pricing, and reimbursement limitations in international markets. It draws a valid parallel between medical devices (MDT) and biologics (AMGN) under similar payer pressures, despite sector differences.\n\n4) Entity accuracy is correct: MDT and AMGN are properly identified, fiscal year 2024 is implied, and the metrics (international revenue, pricing strategies) are appropriate. The citation of page numbers adds precision, though not required.\n\nJustification: The answer earns a high correctness score because the central argument and factual basis are sound, but loses points on quantitative accuracy due to the unsupported 99% claim. This exaggeration could mislead about MDT’s actual revenue structure. Otherwise, the synthesis, relevance, and qualitative reasoning are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 518,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for SCHW and JPM compare, considering their respective application of countercyclical and capital conservation buffers?",
      "original_answer": "SCHW is subject to a stress capital buffer of 2.5% and a capital conservation buffer of 2.5%, with the countercyclical capital buffer at 0%, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratios. JPM, on the other hand, applies a fixed capital conservation buffer of 2.5% and a stress capital buffer (SCB) of 2.9%, with the countercyclical buffer also at 0%, leading to a total buffer requirement of 5.4% above the minimum. Therefore, JPM has a slightly higher combined buffer requirement than SCHW due to its higher SCB. This comparison reflects how both firms are subject to similar regulatory buffer frameworks, but with firm-specific SCB and CCyB determinations.",
      "llm_answer": "Schwab’s banking subsidiaries carry a total buffer of **about 5 %** above the regulatory minimum – a 2.5 % stress‑buffer on CSC and a 2.5 % capital‑conservation buffer on CSB, with the counter‑cyclical buffer set at 0 %.\n\nJPMorgan Chase’s firm‑wide buffer is **roughly 11 %** above the minimum – a 5.4 % supervisory‑capital buffer (SCB) plus a 3.0 % G‑SIB surcharge (both in the standardized approach) and a 2.5 % capital‑conservation buffer (advanced approach), while its counter‑cyclical buffer is also 0 %.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key quantitative values. While SCHW's total buffer of 5.0% is correctly calculated (2.5% stress capital buffer + 2.5% capital conservation buffer), JPM's total buffer is incorrectly stated as 'roughly 11%' instead of the correct 5.4%. The LLM incorrectly includes a 3.0% G-SIB surcharge and claims different approaches (standardized vs advanced), which are not mentioned in the ground truth and are irrelevant to the buffer comparison asked. The correct total for JPM is 2.9% SCB + 2.5% capital conservation buffer = 5.4%, not 11%. (2) Calculation verification: SCHW: 2.5% + 2.5% = 5.0% → correct. JPM: 2.9% + 2.5% = 5.4% → ground truth correct; LLM states 5.4% SCB + 3.0% G-SIB + 2.5% CCB = 10.9% ≈ 11% → incorrect inclusion of G-SIB surcharge, which is not part of the buffer requirement being compared. (3) Multi-hop reasoning is flawed: the question asks for a comparison of capital buffer requirements above minimum ratios, focusing on countercyclical and capital conservation buffers. The LLM fails to correctly synthesize the components, introducing extraneous and incorrect elements (G-SIB surcharge, different regulatory approaches) not present in the original data. It also misrepresents JPM’s structure, undermining the comparison. (4) Scores justified: Correctness is low (3/10) due to major numerical and conceptual errors. Quantitative accuracy is poor (2/10) because of the incorrect 11% figure and inclusion of false components. Qualitative accuracy is low (3/10) due to flawed reasoning and entity misattribution. Contextual relevance is moderate (6/10) because the answer addresses the right topic and correctly handles SCHW, but distorts JPM’s case.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 473,
        "total_tokens": 1792
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 600,
    "successful_evaluations": 600,
    "failed_evaluations": 0,
    "average_correctness_score": 7.76,
    "average_quantitative_accuracy": 8.36,
    "average_qualitative_accuracy": 7.96,
    "average_contextual_relevance": 9.41,
    "score_distribution": {
      "excellent": 379,
      "good": 82,
      "fair": 99,
      "poor": 40
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b",
    "experiment": "e4_page_window_relevance_desc",
    "pattern": "qualitative_3hop_cross_company_type1",
    "total_questions": 600,
    "successful": 600,
    "failed": 0,
    "elapsed_seconds": 8163.95,
    "timestamp": "2026-02-03T22:42:05.874571"
  }
}